{"natural killer cells activates endothelial cells": 0.03434, "il-6-induced cells resemble plasma cells": 0.03356, "human myeloid cell nuclear differentiation antigen gene promoter": 0.03011, "lipopolysaccharide-induced transcription factor regulating tumor necrosis factor alpha gene expression": 0.02998, "-responsive cells blocked il-1-induced gene transcription": 0.02877, "cell receptor positive cells": 0.02866, "multipotent eml cells harbor substantial nuclear hormone receptor coactivator activity": 0.02858, "human gm-csf receptor alpha promoter directs reporter gene activity": 0.02839, "cells contained nuclear stat protein": 0.02837, "human t-cell leukemia line jurkat cells": 0.02813, "peroxisome proliferator-activated receptor activators target human endothelial cells": 0.02798, "thp-1 cells c-jun mrna expression increased": 0.02796, "protein kinase c-depleted endothelial cells": 0.02775, "human t-cell leukemia virus type 1-transformed mt-2 cells": 0.02737, "cells protein kinase": 0.02723, "human t-cell leukemia virus type i-infected cells": 0.0272, "class ii transactivator-independent endothelial cell mhc class ii gene activation induced": 0.02719, "jurkat-t cells induced dramatic cell aggregation": 0.02715, "cells induces nuclear expression": 0.02682, "human monocytic m-csf receptor promoter directs reporter gene activity": 0.0267, "human myeloid leukemia cells induced": 0.02646, "pu.1 promoter directs cell type-specific reporter gene expression": 0.02642, "cells inhibits human immunodeficiency virus replication": 0.02614, "human myeloid-selective ccaat/enhancer binding protein gene": 0.02607, "human il-2 activated nk cells": 0.02604, "cells expressing macrophage cell surface ags": 0.02602, "normal human peripheral blood mononuclear cells": 0.026, "cell precursor acute lymphoblastic leukemia cells": 0.026, "endothelial cells increased expression": 0.026, "cell leukemia jurkat cells": 0.02592, "cells expressing cell surface glycophorin": 0.02582, "human immunodeficiency virus type 1-infected cells": 0.02578, "cell prolymphocytic leukemia cells mediated": 0.02578, "cells demonstrate accelerated cell cycle progression": 0.02573, "il-1 activated human umbilical vein endothelial cells": 0.02556, "normal bone marrow cells documents expression": 0.02542, "cells enhances transcription factor": 0.02541, "mature cells underwent premature cell death": 0.02531, "primary human peripheral blood mononuclear cells": 0.02514, "cells transcription factor": 0.02509, "mature normal human myeloid cells": 0.02509, "activated human nk cells": 0.02504, "human histiocytic u937 cells mrna": 0.02497, "normal immature human myeloid cells": 0.02495, "cell transcription factor gata-3 stimulates hiv-1 expression": 0.02494, "cell lineage cells arrested": 0.02486, "cells expressing high v-abl kinase activity": 0.02483, "cells selectively enhances il-4 expression relative": 0.02481, "transcription factor nf-kappa b. endothelial cell activation": 0.0248, "normal human hematopoietic cells": 0.0248, "duffy gene promoter abolishes erythroid gene expression": 0.02471, "cell hybridoma hs-72 cells": 0.02465, "transcription factor ccaat enhancer binding protein alpha": 0.02463, "human peripheral blood nk cells": 0.02461, "primary human blood mononuclear cells": 0.02458, "cell surface protein expression": 0.02448, "human peripheral blood mononuclear cells": 0.02448, "normal human cells": 0.02442, "human hl-60 myeloid leukemia cells differentiate": 0.02442, "human endothelial cells demonstrated": 0.02441, "stimulated human endothelial cells": 0.02433, "human thp-1 monocytic leukemia cells cultured": 0.02429, "transcription factor nf-kappab regulates inducible oct-2 gene expression": 0.02427, "human peripheral blood cells": 0.02426, "human nk cells activate porcine ec": 0.02419, "primary human erythroid cells": 0.02417, "chinese hamster ovary cells expressing human recombinant alphaiibbeta3": 0.02417, "cultured human blood mononuclear cells": 0.02416, "human blood mononuclear cells cultured": 0.02416, "cells decreased pkr expression": 0.02411, "activate human umbilical vein endothelial cells": 0.02411, "human cd34+ hematopoietic progenitor cells isolated": 0.02402, "human kg-1 myeloid leukemia cells": 0.02401, "human u-937 leukemia cells differentiate": 0.02399, "human monocytic cells results": 0.02399, "human myeloid leukemia cells": 0.02398, "irf family transcription factor gene expression": 0.02396, "treated cytokine-stimulated human saphenous vein endothelial cells": 0.02396, "human promyelocytic leukemia hl-60 cells": 0.02395, "human cd3-cd16+ natural killer cells express": 0.02395, "human monoblastic leukemia u937 cells": 0.02394, "cells activates expression": 0.02393, "human blood mononuclear cells": 0.02392, "human leukemia u937 cells": 0.02392, "activate human natural killer cells": 0.02391, "purified human hematopoietic cells": 0.02388, "human myeloblastic leukemia hl-60 cells": 0.02387, "human leukemia hl60 cells respond": 0.02386, "u-937 human promonocytic leukemia cells": 0.02383, "human monocytic cells express interleukin-1beta": 0.02382, "human nk cells provide": 0.02381, "human u-937 leukemia cells": 0.0238, "transfected human monocytic thp-1 cells": 0.02376, "primary human cd34+ hemopoietic progenitor cells": 0.02376, "human red blood cells": 0.02376, "human hl60 leukemia cells": 0.02374, "hl60 human leukemia cells": 0.02374, "transfected human cells suggests": 0.02374, "human jurkat lymphoblastoid cells": 0.02373, "cultured human umbilical vein endothelial cells": 0.02372, "blast cells express lineage-specific transcription factors": 0.0237, "human promyelocytic leukemia cells": 0.0237, "human mononuclear cells isolated": 0.0237, "human breast cancer mcf-7 cells": 0.02369, "cultured human dermal endothelial cells": 0.02368, "peripheral human mononuclear cells": 0.02367, "human peripheral mononuclear cells": 0.02367, "human cd34+ erythroid progenitor cells": 0.02367, "lipopolysaccharide-stimulated human monocytic cells treated": 0.02365, "human leukemic cells studied": 0.02365, "cultured human endothelial cells": 0.02364, "human myeloblastic leukemia ml-1 cells": 0.02364, "ml-1 human myeloblastic leukemia cells": 0.02364, "resting human umbilical vein endothelial cells": 0.02362, "human promyeloid leukemia cells": 0.02361, "human myeloid leukemic cells": 0.0236, "human leukemia cells": 0.0236, "human primary haemopoietic cells": 0.02357, "e1a expression marks cells": 0.02356, "human purified cd34+ cells": 0.02354, "1a9-m cells expressing human bcl2": 0.02353, "human plasma cells": 0.02352, "tnf-treated human umbilical vein endothelial cells": 0.02351, "cytokine-stimulated human umbilical vein endothelial cells": 0.02351, "human umbilical arterial endothelial cells": 0.02351, "long-term human lymphoid cells": 0.0235, "human umbilical vein endothelial cells": 0.02349, "lncap human prostate cancer cells": 0.02348, "human myeloid u-937 cells": 0.02348, "human dermal microvessel endothelial cells": 0.02346, "human prostatic cancer lncap cells": 0.02344, "human cd34+ hematopoietic progenitor cells": 0.02344, "human leukemic k562 cells": 0.02344, "human cd34+ hematopoietic stem cells": 0.02343, "human aortic endothelial cells": 0.02343, "mature human monocytic cells": 0.02342, "bipotent human myeloid progenitor cells": 0.02342, "human endothelial cells": 0.02341, "human hematopoietic progenitor cells": 0.0234, "human cancer lncap cells": 0.02339, "transfected human erythroleukemia cells": 0.02336, "human thp-1 monocytic cells": 0.02335, "human monocytic thp-1 cells": 0.02335, "cells infiltrating human genital herpes lesions": 0.02334, "hematopoietic human erythroleukemia cells": 0.02333, "human myeloid cell nuclear differentiation antigen promoter": 0.02332, "human mammary epithelial cells": 0.02332, "human lymphoid cells": 0.02332, "human thp-1 macrophage cells": 0.02331, "undifferentiated human monocytic cells": 0.02331, "human myeloid cells": 0.02328, "human natural killer cells": 0.02328, "human hematopoietic cells": 0.02328, "ifn-gamma-treated human cells infected": 0.02327, "human nk cells": 0.02325, "human promonocytic u937 cells": 0.02325, "human u937 promonocytic cells": 0.02325, "human lymphoma cells": 0.02325, "human intestinal epithelial cells": 0.02325, "human bronchial epithelial cells": 0.02324, "u937 human monoblastic cells": 0.02323, "porphyromonas gingivalis lipopolysaccharide-stimulated human monocytic cells": 0.02323, "human leukemic cells": 0.02322, "human leukaemia cells carrying": 0.02322, "lipopolysaccharide-stimulated human monocytic cells": 0.02319, "k562 human erythroleukemia cells": 0.02318, "hiv-infected human monocytic cells": 0.02318, "thp-1 human monocytoid cells": 0.02317, "transfected human colonic carcinoma cell line ht29 activates transcription": 0.02316, "cells transcriptional activation": 0.02315, "human prostatic epithelial cells": 0.02315, "human monocytic cells": 0.02314, "human allergen-specific th2 cells": 0.02313, "human thp-1 promonocytic cells": 0.02313, "human k562 cells": 0.02313, "human tonsillar mononuclear cells": 0.02313, "human b-lymphocyte precursor cells": 0.02312, "u-937 human promonocytic cells": 0.02312, "human promonocytic u-937 cells": 0.02312, "human epithelial cells": 0.02311, "human mononuclear cells": 0.02311, "human th2 cells": 0.0231, "human naive cells": 0.02308, "human differentiated cells": 0.02306, "murine baf3 cells involves activation": 0.02305, "human dendritic cells": 0.02302, "human lymphoblastoid cells": 0.02302, "transcription factor ap-2 activates gene expression": 0.02297, "human glial cells": 0.02295, "cotransfected human cells": 0.02295, "human glomerular mesangial cells": 0.02295, "human erythroleukemia cells": 0.02295, "human accessory cells": 0.02294, "ad-transformed human cells": 0.02292, "human jurkat-t cells": 0.02292, "transcription factor activation protein": 0.02292, "human erythroleukemic cells": 0.02291, "human nk/t cells": 0.02291, "human t-lymphoblastoid cells": 0.02291, "human rhabdomyosarcoma cells": 0.02291, "keratinocyte-derived human cells": 0.02291, "human monoblastic cells": 0.02291, "human cells": 0.0229, "jurkat cells activation": 0.02266, "cell priming enhances il-4 gene expression": 0.02263, "helper cell cytokine gene expression": 0.02257, "affect protein kinase c-mediated gene transcription": 0.02253, "dna triplex formation selectively inhibits granulocyte-macrophage colony-stimulating factor gene expression": 0.02252, "fetal nucleated blood cells constitutively express important genes": 0.02246, "transcription factor gene expression": 0.02237, "mediate cell type-specific gene expression": 0.02228, "human monocytes induces immunoregulatory gene expression": 0.02213, "cells undergoing activation": 0.02206, "host cell gene expression": 0.02198, "pma-differentiated cells displayed agonist activity": 0.02193, "human immunodeficiency virus type-2 gene expression": 0.02186, "cell type-specific gene expression": 0.02183, "cell il3 gene expression": 0.0218, "human tumor necrosis factor alpha gene regulation": 0.02168, "thp-1 cell extracts identified gamma-ifn inducible dna binding activity": 0.02166, "dna binding protein nuclear factor": 0.0216, "glucocorticoid-resistant cells lacking endogenous functional receptor": 0.02155, "distinct dna binding specificities regulate differential gene expression": 0.02152, "adipocyte fatty acid binding protein gene": 0.02151, "cells activity": 0.02149, "tumor cells blocks apoptosis induced": 0.02136, "subclone wurzburg cells oxidant challenge elevated [ ca2+ ]": 0.02133, "high-proliferative potential colony-forming cells [ hpp-cfcs ]": 0.02125, "cultured endothelial cells induced cellular oxidant stress": 0.02113, "otf-2 protein enhanced dra gene transcription": 0.02109, "human granulocyte-macrophage colony-stimulating factor gene promoter": 0.02105, "activation protein 1-dependent transcriptional activation": 0.02099, "cell octamer-binding protein 1/octamer-binding factor": 0.02097, "cell protein binding": 0.02085, "fresh peripheral blood mononuclear cells ] tested": 0.02081, "protein kinase c-zeta stimulates leukemic cell differentiation": 0.02079, "nonspecific protein kinase inhibition inhibited nf-kappab activation": 0.02067, "daudi cells increased lmp1 mrna": 0.02062, "impaired transcription factor ap-1 dna binding activity": 0.02062, "pkc-zeta cells constitutively expressed mrna transcripts": 0.02062, "human interleukin-2 receptor alpha gene [": 0.02059, "freshly isolated cells show high levels": 0.02055, "human tumor necrosis factor alpha gene": 0.02053, "human endothelial cell activation": 0.02053, "leukemic myeloid progenitor cells expressed mrna": 0.02045, "human neutrophil gene expression": 0.02045, "lymphoid development epstein-barr virus-transforming protein latent infection membrane protein": 0.02045, "transcription factors stimulate gene expression": 0.02041, "hmba-induced cells expressed reduced levels": 0.0204, "extrathymic t-cell populations include cells expressing elevated levels": 0.02037, "human tumor necrosis factor alpha promoter region": 0.02035, "cos cells expressing gata-binding proteins": 0.02033, "human il-1beta gene expression": 0.02031, "cell line expressing cell surface mu/kappa": 0.02029, "cells induced robust phosphorylation": 0.02028, "mouse interleukin-2 receptor alpha gene expression": 0.02028, "human beta-globin gene expression": 0.02028, "major histocompatibility complex class ii gene expression observed": 0.02028, "k562 cells constitutively expressed c-myb mrna": 0.02026, "human b29 gene expression": 0.02022, "nk cells induce mhc class ii molecules": 0.02021, "anti-cd15 cross-linked cells demonstrated enhanced levels": 0.02013, "mouse thymoma line el-4 cells": 0.02013, "human nk cell activity": 0.01991, "d5 tumor cells induced": 0.01989, "ut-7 cells expressed detectable levels": 0.01988, "human mhc class ii gene transcription": 0.01988, "human myeloid cell nuclear differentiation antigen": 0.01981, "cell receptor engagement activates transcription factors important": 0.01977, "untreated ns-meg cells expressed mrna": 0.01973, "cells proteins": 0.01971, "monocytic thp-1 cells tnf-alpha induced": 0.0197, "cells constitutively contained high levels": 0.01966, "induced cells demonstrate": 0.01965, "latent membrane protein gene promoter-binding proteins": 0.01965, "jurkat cells induced": 0.01963, "inhibit stat-dependent early response gene expression induced": 0.01959, "active v-abl protein tyrosine kinase blocks immunoglobulin light-chain gene rearrangement": 0.01956, "normal peripheral blood mononuclear cells": 0.01954, "human t-cell receptor delta gene enhancer": 0.01947, "epstein-barr virus-transforming protein latent infection membrane protein": 0.0194, "stimulated primary murine bone marrow cells": 0.01938, "nuclear translocation protected cells": 0.01937, "native human erythrocyte ndp kinase protein inhibited": 0.01932, "immediate-early activation gene expression": 0.01932, "cultured corneal endothelial cells increased": 0.01931, "cell 110-kda nuclear protein": 0.01931, "creb binding protein increase transcription": 0.0193, "cells tested express tafii105 mrna": 0.01929, "activated blood mononuclear cells": 0.01925, "hiv-1 infects resting peripheral blood mononuclear cells": 0.01924, "primary adult t-cell leukemia cells": 0.01924, "cell antigen receptor-stimulated protein tyrosine kinases": 0.01921, "cell antigen receptor-induced protein tyrosine kinases": 0.01921, "il-2-induced monocyte-derived nuclear protein confers reporter gene": 0.0192, "tumor necrosis factor gene expression": 0.01919, "leukemia cells inhibited interleukin-2": 0.01918, "induced k562 cells": 0.01915, "u-937 cells induced": 0.01912, "parathyroid hormone-related protein gene promoter": 0.01911, "tissue culture cells expressing ebv": 0.01911, "cells display high levels": 0.0191, "cells expressing mhc class ii": 0.01908, "cells induced il-5": 0.01906, "cycloheximide/polyinosinic-polycytidylic acid treated hela s3 cells": 0.01906, "raji cells induced": 0.01905, "myeloid cells induces ifn production": 0.01905, "cells lack active nf-kappa": 0.01904, "k562 cells increases gamma-globin mrna": 0.01904, "pre-b cells induced": 0.01903, "northern analysis demonstrated increased il-2ralpha gene expression": 0.01903, "vivo isolated peripheral blood mononuclear cells": 0.01902, "b7-transfected cho cells induced": 0.01901, "cells il-10 stimulates tyrosine phosphorylation": 0.01899, "activated nk cells involves cytotoxic granules": 0.01899, "cell interleukin-2 receptor expression": 0.01896, "induced ml-1 cells": 0.01894, "activated jurkat cells": 0.01894, "jurkat cells activated": 0.01894, "cells induced": 0.01892, "cells increases camp levels": 0.01889, "normal cells stimulated": 0.01889, "cells exhibit enhanced il-2 secretion": 0.01889, "u937 cells increased": 0.01888, "lymphoma cells expressed b-cell": 0.01885, "atl-16t cells express mrna": 0.01884, "human platelet/endothelial cell adhesion molecule-1 promoter": 0.01884, "nk cells involved transcriptional": 0.01883, "cells express mrna": 0.01883, "human acute monocytic leukemia cell line": 0.01881, "hemin-treated k562 cells undergoing erythroid differentiation": 0.0188, "htlv-i-transformed peripheral blood mononuclear cells demonstrate": 0.01877, "control resting cells contained low": 0.01876, "rar alpha infected cells": 0.01875, "activated endothelial cells": 0.01874, "normal thymic epithelial cells treated": 0.01874, "human monocytic leukemia cell line thp-1 differentiate": 0.01872, "protein tyrosine kinase activity increased": 0.01871, "human t-cell lymphoma cell line": 0.01868, "primary peripheral blood mononuclear cells": 0.01868, "bone marrow cells express nf-kappab": 0.01868, "human chronic myelogenous leukemia cell line rwleu-4": 0.01867, "transcription factor nf-kappa b. xenogeneic human serum promotes leukocyte adhesion": 0.01866, "increased interfollicular bcl-6+/cd3+ cells": 0.01865, "immune system cells plays": 0.01865, "human proximal sequence element-binding transcription factor": 0.01864, "mature normal myeloid cells": 0.01863, "beta-globin-expressing murine erythroid leukemia cells": 0.01862, "peripheral blood mononuclear cells isolated": 0.01861, "tissue factor gene expression": 0.01861, "murine erythroid leukemia cells": 0.01861, "adult t-cell leukemia cells": 0.01859, "normal plasma cells": 0.01859, "cells expressing mutated receptors": 0.01859, "activated nk cells": 0.01858, "m-tat/gm-csf cells increased": 0.01858, "human monocytic leukemia cell line thp-1 differentiates": 0.01857, "cem cells displayed growth similar": 0.01855, "u937 cells activated": 0.01855, "cells increased": 0.01855, "syncytia lack activated cells": 0.01854, "normal primitive myeloid progenitor cells": 0.01854, "human t-cell leukemia virus type ii rex gene": 0.01854, "bone marrow-derived mip-1 alpha/gos19 inhibits primitive hematopoietic stem cells": 0.01854, "hela cells activated": 0.01853, "distinct mhc class ii-negative cells": 0.01852, "c/ebp-epsilon expression plasmid increased cell growth": 0.01852, "normal cd34+ bone marrow cells": 0.01851, "endothelial cells [": 0.01851, "detect residual pml/rar alpha mrna-containing cells": 0.01847, "normal myeloid progenitor cells": 0.01847, "normal bone marrow cells": 0.01847, "single tumor cells derived": 0.01847, "activated mononuclear cells": 0.01844, "lymphokine activated killer cells": 0.01842, "human monoblastic leukemia cell line u937": 0.01842, "ns-meg cells undergo terminal differentiation": 0.01842, "factor promotes il-4 gene expression": 0.01842, "transfected cells identified dissociated glucocorticoids": 0.01841, "hela cells hiv-1 tat suppressed": 0.01841, "dimethyl sulfoxide-differentiated hl-60 leukemia cells stimulated": 0.0184, "normal lymphoid cells": 0.01839, "stimulated il-2 secreting cells": 0.01839, "hematopoietic cells [": 0.01838, "induction specific dna binding protein": 0.01837, "b-cell chronic lymphocytic leukemia cells": 0.01836, "normal myeloid cells": 0.01835, "activated th1 cells": 0.01835, "jurkat cells constitutively expressing tax": 0.01835, "normal hematopoietic cells": 0.01834, "mouse myeloid leukemia m1 cells": 0.01834, "neural cells nf-kappa": 0.01834, "vivo dimethyl sulfate footprinting erythroid cells expressing": 0.01833, "cells nf-kappa": 0.01832, "purified early hematopoietic progenitor cells": 0.01832, "cells studied expressed": 0.01832, "activated u1 cells": 0.01832, "activated ht-2 cells": 0.0183, "jurkat cell extract contained pebp2 site-binding protein": 0.01829, "alpha b5a cells": 0.01828, "pma/pha stimulated tax transfected cells correlate": 0.01827, "activated ln cells": 0.01827, "transfected tissue culture cells": 0.01827, "infected cells undergo apoptosis": 0.01826, "cells induces ige synthesis": 0.01824, "ecv304 cells activated": 0.01824, "cells inhibited": 0.01824, "activated pth cells": 0.01824, "human promyeloid leukemia cell line hl60": 0.01823, "target cell hla-dr expression induced": 0.01823, "activated cells": 0.01823, "cells activated": 0.01823, "primary adult erythroid cells": 0.01821, "normal progenitor cells undergoing": 0.0182, "group ii cid cells": 0.0182, "peripheral blood mononuclear cells exposed": 0.0182, "quiescent simian peripheral blood mononuclear cells": 0.01819, "human leukemic cell line model": 0.01818, "human promyelocytic leukemia cell line": 0.01818, "u937 cells undergoing apoptosis": 0.01817, "jurkat cells demonstrated": 0.01816, "% er positive cells": 0.01816, "fc gamma riia stimulated cells": 0.01815, "resting jurkat cells express fas": 0.01815, "resting peripheral blood mononuclear cells": 0.01815, "quiescent peripheral blood mononuclear cells": 0.01814, "stimulating peripheral blood mononuclear cells": 0.01814, "pre-b cell line up-regulated cd19 expression": 0.01814, "ut-7 epo cells expressed alpha-globin": 0.01813, "cell specific transcription factor bsap": 0.01813, "primary blood mononuclear cells": 0.01813, "human leukemia cell line ut-7/gm": 0.01812, "inhibits nf-kappab-dependent reporter gene expression induced": 0.01812, "human leukemic cd4+ t-lymphocyte cell line": 0.01811, "normal lymph node cells": 0.01811, "acute myeloid leukemia blast cells": 0.0181, "freshly isolated primary nk cells": 0.01809, "cells enhance il-2 secretion": 0.01809, "human leukemia cell line": 0.01808, "infected human monocytic cell line u1": 0.01808, "jurkat cells stimulated": 0.01808, "mutant jurkat cells": 0.01808, "cells lines": 0.01808, "stimulated jurkat cells": 0.01808, "fresh peripheral blood mononuclear cells": 0.01807, "il-2-dependent cells [ kit225": 0.01807, "positive erythroid nucleated cells expressing": 0.01806, "murine basic helix-loop-helix transcription factor gene expressed": 0.01805, "unfractionated peripheral blood mononuclear cells": 0.01804, "phytohemagglutinin-activated peripheral blood mononuclear cells": 0.01804, "increased il-6 protein expression": 0.01803, "nonmobilized peripheral blood mononuclear cells": 0.01803, "phorbol ester-activated jurkat cells": 0.01802, "phorbol ester-treated jurkat cells": 0.01802, "peripheral blood mononuclear cells": 0.01802, "transcription factor activator protein": 0.01801, "specific cytokine-producing effector cells": 0.01801, "cells [": 0.018, "human monocyte cell line thp-1": 0.018, "cells undergoing megakaryocytic differentiation": 0.018, "adult globin expressing cells displayed": 0.018, "xp-d cells contained reduced amounts": 0.01799, "cells reporter construct": 0.01798, "pkc-zeta cells expressed": 0.01798, "isolated tumor cells": 0.01798, "camp response element binding protein": 0.01797, "normal prickle cells": 0.01797, "normal mesothelial cells": 0.01797, "cells expressed cd34": 0.01797, "virus-host cell protein interaction": 0.01796, "normal cells": 0.01796, "human monocytic cell line u937": 0.01795, "early erythroid progenitor cells": 0.01794, "human il-5 gene transcription": 0.01794, "cells expressed p40": 0.01794, "peripheral blood resting cells": 0.01794, "lin- murine bone marrow progenitor cells": 0.01793, "peripheral blood stem cells": 0.01793, "form myeloid cells": 0.01793, "antigen presenting cells interacts": 0.01793, "human leukemic cell line k562": 0.01793, "human monocytic cell line thp-1 mimics pam": 0.01792, "isolated white blood cells": 0.01791, "hl-60/vinc/r cells demonstrated translocation": 0.0179, "human breast carcinoma cell line": 0.01789, "monoblastoid cells undergoing tnf-alpha-induced apoptosis": 0.01789, "monoblastoid cells undergoing tnf-alpha-inuced apoptosis": 0.01788, "promonocytic cells undergoing apoptosis": 0.01788, "cells expressed": 0.01788, "stimulated endothelial cells": 0.01788, "endothelial cells stimulated": 0.01788, "peripheral blood polymorphonuclear cells": 0.01788, "gata-1.05 mutant hematopoietic progenitor cells": 0.01788, "cell leukemia virus type i-transformed human": 0.01787, "% positive cells": 0.01787, "mutant leukemic cells resistant": 0.01787, "human cell line model": 0.01786, "u937 monocytic cells results": 0.01786, "nonpituitary human prolactin gene transcription": 0.01785, "control u937 cells": 0.01784, "single tumor cells": 0.01784, "nk cells induce hla-dr": 0.01784, "important target cells": 0.01783, "human monocytic cell line thp-1": 0.01783, "human stomach cancer cell line": 0.01783, "alveolar type ii-like cells": 0.01782, "protein expression increased 2-3-fold": 0.01782, "human burkitt lymphoma cell line bl60": 0.01781, "peripheral blood cells": 0.01781, "cells specific": 0.01781, "human leukemic cell line cem": 0.0178, "adult red blood cells": 0.0178, "parental u937 cells stimulated": 0.0178, "primary leukemia cells": 0.0178, "murine bone marrow cells": 0.0178, "human lymphoid cell line": 0.0178, "activation block cytokine gene transcription": 0.01779, "cell transcription factor pu.1 binds": 0.01778, "cell activation factor nf-atc": 0.01776, "control cells cultured": 0.01776, "human hematopoietic cell line": 0.01776, "nkl human nk cell line": 0.01775, "term infant cord blood mononuclear cells": 0.01774, "cell-type-specific interleukin-2 receptor alpha-chain gene expression": 0.01774, "lineage cells induces": 0.01774, "cd4 cells induces": 0.01774, "acute promyelocytic leukemia cells": 0.01773, "human promonocytic cell line u937": 0.01773, "u-937 myeloid leukemia cells": 0.01773, "human promonocytic u937 cell line": 0.01773, "hl-60 promyelocytic leukemia cells correlates": 0.01773, "human nk cell line": 0.01773, "early genes upregulate interleukin-6 gene expression": 0.01773, "% mature cells": 0.01773, "complement receptor-1 cell surface protein": 0.01772, "mouse bone marrow cells": 0.01772, "murine ba/f3 cells transfected": 0.01772, "cells express multiple isotypes": 0.01772, "hybrid cells show": 0.01772, "lymphocyte jurkat cells": 0.01771, "primary erythroid cells": 0.01771, "cells identified": 0.01771, "early hematopoietic progenitor cells": 0.01771, "phorbol myristate acetate-stimulated hela cells": 0.01771, "lps-stimulated human monocytic cell line": 0.0177, "human monocytic cell line mono mac": 0.0177, "cultured blood mononuclear cells": 0.0177, "central nervous system pyramidal cells": 0.01769, "stromal cells induce tcell survival": 0.01769, "human interleukin-1 beta promoter confers preferential transcriptional activity": 0.01768, "pancreatic beta cells": 0.01768, "murine myeloid cells": 0.01768, "phorbol 12-myristate 13-acetate-differentiated u-937 cells": 0.01767, "takayasu arteritis activate endothelial cells": 0.01767, "differentiated hl-60 promyelocytic leukemia cells": 0.01766, "human erythroleukemia cell line k562": 0.01766, "immunomodulatory cytokine il-4 affects cells": 0.01766, "generate viable mature definitive erythroid cells": 0.01766, "il-2r alpha cell surface expression": 0.01765, "ldl receptor gene expression": 0.01765, "induces hl-60 cells": 0.01765, "macrophage/monocyte type cells": 0.01765, "acute myeloblastic leukemia cells": 0.01765, "human nkl cell line correlates": 0.01764, "cells expressing osteoclast markers differentiate": 0.01764, "nf-kappab protects ebv-infected cells": 0.01764, "early lymphoid cells": 0.01763, "acute leukemia cells": 0.01763, "human monocytic cell line bf24": 0.01763, "lymphoblastic leukemia cells suggested": 0.01763, "aiolos transcription factor controls cell death": 0.01763, "retinoic acid receptor alpha blocks myeloid cell differentiation": 0.01763, "x-ray-treated human colonic carcinoma cell line": 0.01763, "human myelomonocytic cell line u-937": 0.01762, "t47d mammary tumor cells": 0.01762, "early transfected cells": 0.01762, "class ii-negative hela cells": 0.01762, "erythroid cells expressing": 0.01762, "human monocytic cell line": 0.01762, "k562 cells express endogenous wt1": 0.01761, "human embryonal carcinoma cell line n-tera2": 0.01761, "human major histocompatibility complex class ii-associated invariant-chain gene": 0.01761, "myeloid cells undergo terminal neutrophilic maturation": 0.01761, "human cell line k562": 0.01761, "adult erythroid mel cells": 0.0176, "bone marrow-derived erythroid progenitor cells": 0.0176, "u937 cells involved": 0.0176, "thp-1 monocytic leukemia cells": 0.0176, "tnf-alpha- stimulated thp-1 cells": 0.0176, "anti-cd3-stimulated cord blood mononuclear cells": 0.0176, "lps-stimulated control cells": 0.01759, "% apoptotic cells": 0.01759, "human monoblast cell line u-937": 0.01759, "mature red blood cells": 0.01759, "professional antigen presenting cells": 0.01759, "activate endothelial cells": 0.01758, "cell antigen receptor complex induction": 0.01758, "transfected jurkat t-leukemia cells": 0.01758, "lymphoid jurkat cells": 0.01758, "lps -and zymosan-treated cells": 0.01757, "antigen presenting cells": 0.01757, "jeg-3 human choriocarcinoma cell line supernatants": 0.01757, "th2 cells induce humoral": 0.01757, "ifn-gamma treated u937 cells": 0.01757, "cells expressing exogenous bcl-2": 0.01757, "cells form 7-": 0.01757, "transfected jurkat cells": 0.01756, "hiv-1 iiib-infected monocytoid cells": 0.01756, "blood mononuclear cells separated": 0.01756, "mature myeloid cells suggests": 0.01755, "purified hematopoietic progenitor cells": 0.01755, "% cd56+ cells": 0.01755, "hl-60 cells constitutively expressing": 0.01755, "adult erythroid cells": 0.01755, "tolerant cells show": 0.01755, "nucleated fetal blood cells": 0.01754, "cells form": 0.01754, "myeloid leukemia cells": 0.01753, "fetal globin expressing cells": 0.01753, "human lymphoblastoid cell line im-9": 0.01752, "fetal blood cells": 0.01752, "lymphoid cells expressing e2a-hlf": 0.01752, "primary lymphoid cells": 0.01752, "nonlymphoid cells trans-activated reporter plasmids": 0.01752, "control cells": 0.01752, "early stage cells": 0.01752, "pax-5-deficient pro-b cells demonstrated": 0.01751, "cells expressing wild-type tdag51": 0.01751, "% cd68+ cells": 0.01751, "tumor cells triggers": 0.01751, "human lymphoblastoid cell line": 0.0175, "microdissected ovarian tumor cells": 0.0175, "promonocytic leukemia cells u937": 0.0175, "% cd3+ cells": 0.01749, "ebv infected cells": 0.01749, "il-2 secreting el4 cells": 0.01749, "thromboxane receptor gene expression": 0.01749, "inhibit hematopoietic stem cells": 0.01749, "cells hiv-1 multiplication": 0.01749, "u937 cells demonstrate": 0.01749, "lymphoblastoid cells stimulated": 0.01749, "% dead cells": 0.01748, "antigen handling cells": 0.01748, "adult cd34+ bone marrow cells": 0.01748, "dividing immature single positive cells": 0.01748, "ifn-u937 cells reduced interassay variation": 0.01747, "cells contained large amounts": 0.01747, "blood mononuclear cells": 0.01747, "preactivated primary nk cells": 0.01747, "fresh primary leukemic cells": 0.01746, "p16-negative human acute lymphoblastic leukemia cell lines": 0.01746, "cell lineage-specific activator protein": 0.01746, "u1 cells stimulated": 0.01746, "transfected erythroid cells": 0.01746, "primary nk cells": 0.01745, "cells expressing p85 mutants": 0.01745, "examined bone marrow cells": 0.01745, "burkitt tumor cells": 0.01745, "human t-lymphocyte cell line": 0.01745, "tissue structural cells": 0.01744, "helper cells results": 0.01744, "rodent thermosensitive mutant cells": 0.01744, "transcription factor nf-kappa b. transcriptional activation": 0.01743, "cells provide compelling evidence": 0.01743, "polymorphonuclear cells stimulated": 0.01743, "human megakaryocytic cell line": 0.01743, "purified hematopoietic cells": 0.01743, "daudi cells stimulated": 0.01743, "transfected target cells": 0.01742, "primary leukemic cells": 0.01742, "u937 cells express": 0.01742, "mouse th2 d10 cells": 0.01742, "-dependent murine pro-b cells": 0.01742, "immunostained tumor cells": 0.01741, "hl-60 leukemia cells": 0.0174, "freshly isolated leukemic cells": 0.0174, "epo-dependent human cell line": 0.0174, "cell type specific gene": 0.0174, "t-cell oncogenic protein hox11 activates aldh1 expression": 0.0174, "murine multipotential fdcp-mix a4 cells": 0.0174, "mammalian cells express": 0.0174, "mutant es cells": 0.0174, "human astroglioma cell line crt": 0.0174, "tumor cells": 0.01739, "transformed erythroid progenitors cells": 0.01739, "human monoblastic cell line": 0.01739, "embryonal carcinoma cells demonstrate": 0.01739, "human pro-monocytic cell line": 0.01739, "human nk-like cell line": 0.01739, "cd34+cd71+ cells stimulated": 0.01738, "sickle red blood cells": 0.01738, "hl60 promyelocytic leukemia cells": 0.01738, "k562 leukemia cells": 0.01737, "receptor-negative s49 murine thymoma cells": 0.01737, "stimulated cells": 0.01736, "il-3-dependent murine pro-b cells": 0.01736, "mutant cells": 0.01736, "cells stimulated": 0.01736, "viable white blood cells": 0.01736, "human t-cell lymphotrophic virus type-i tax gene induces secretion": 0.01735, "u-937 leukemia cells": 0.01735, "astrocytic glial cells support tar-independent transactivation": 0.01735, "tax expressing cells": 0.01735, "htlv-i tax expression vector induced galectin-3 expression": 0.01734, "erythroid cell transcription factor ef1": 0.01734, "murine pro-b cells": 0.01734, "cells enhanced": 0.01734, "murine macrophage-like cells": 0.01734, "mature erythroid cells": 0.01734, "murine erythroleukemia cells": 0.01734, "target cells leads": 0.01733, "infected cd4+ cells capable": 0.01733, "b-cll cells results": 0.01732, "pre-b leukemia cells nalm-6": 0.01732, "adult hematopoietic cells": 0.01732, "white blood cells": 0.01732, "murine thymoma cells": 0.01732, "murine mast cells": 0.01731, "2-lumisterol3 prime nb4 leukemia cells": 0.01731, "murine haemopoietic cells": 0.01731, "nfs-60 cells constitutively expressing": 0.01731, "murine ba/f3 cells": 0.01731, "cells constitutively expressing": 0.0173, "monocytic thp-1 cells transfected": 0.0173, "embryonic/fetal erythroid k562 cells": 0.0173, "cells binds": 0.0173, "cells lacking dna-binding alf1": 0.0173, "phorbol ester-induced cells": 0.0173, "phorbol ester-stimulated cells": 0.0173, "red blood cells": 0.0173, "cells results": 0.01729, "murine cells": 0.01729, "b-cll cells bind il-10": 0.01729, "pma -or ra-differentiated u937 cells": 0.01728, "cells lacking gamma": 0.01728, "immune cells infiltrating": 0.01728, "cells involved": 0.01728, "mouse mpc11 plasmacytoma cells": 0.01728, "erythroid k562 cells": 0.01728, "protects bovine pulmonary artery endothelial cells": 0.01728, "unstimulated jurkat cells": 0.01728, "r7-57 reporter cells": 0.01728, "putative hematopoietic stem cells": 0.01728, "primary cd8+ t-pll cells": 0.01728, "nef protein down-regulates transcription factors nf-kappa": 0.01727, "hematopoietic cells tested": 0.01727, "nm ra primed cells": 0.01727, "isolated lung cells": 0.01727, "central nervous system-derived cells express": 0.01727, "bound nk cells": 0.01727, "reporter cells": 0.01727, "human corticotropin-releasing hormone gene promoter": 0.01726, "cells important": 0.01726, "cells express dephosphorylated prb": 0.01726, "mouse erythroleukemia cells": 0.01726, "erythroid precursor cells": 0.01725, "blood cells": 0.01725, "fused ht-2 cells expressing": 0.01725, "cells expressing cd40": 0.01725, "untreated jurkat cells": 0.01725, "c. pneumoniae-infected endothelial cells": 0.01725, "cell death specification protein": 0.01725, "serum-starved mm patient cells": 0.01724, "differentiated plasma cells": 0.01724, "human myeloid leukemia cell lines": 0.01724, "mouse el-4 cells": 0.01724, "mononuclear cells isolated": 0.01724, "mouse l929 cells": 0.01723, "pha-activated peripheral mononuclear cells": 0.01723, "primary cells mdhm-induced elevation": 0.01723, "human t-cell leukemia virus-encoded tax protein": 0.01723, "increased thromboxane receptor gene transcription": 0.01723, "mouse hepa-1 cells": 0.01722, "apl cells express pml-rar": 0.01722, "nuclear protein binding sites": 0.01722, "leukemic myeloid cells influences": 0.01722, "non-t immune cells": 0.01722, "early passage cells": 0.01722, "hela cells selectively stimulates": 0.01721, "rat vascular smooth muscle cells": 0.01721, "mouse cells": 0.01721, "hiv-1 demonstrate normal late gene expression": 0.01721, "human t-cell leukemia virus type 1-infected human": 0.01721, "lymphoma cells transfected": 0.01721, "hela cells treated": 0.01721, "cultured corneal endothelial cells": 0.01721, "vascular endothelial cells": 0.01721, "myc-associated zinc finger protein binding site": 0.01721, "peripheral mononuclear cells": 0.01721, "cyclic-amp-responsive element binding protein/activation transcription factor family": 0.01721, "heme-treated friend leukemia cells": 0.0172, "gamma delta cells": 0.0172, "immature erythroid cells": 0.0172, "immune cells": 0.0172, "cos cells expressing squirrel monkey fkbp51": 0.01719, "tax-expressing jurkat cells": 0.01719, "cultured endothelial cells": 0.01719, "transfected nonlymphoid hela cells": 0.01719, "malignant lymphocytic cells treated": 0.01719, "cd4+ infected t-lymphoid cells": 0.01718, "bzlf 1-expressing r59z activator cells": 0.01718, "jurkat t-leukemia cells": 0.01717, "stat6-expressing jurkat cells": 0.01717, "primary rodent cells": 0.01717, "zap-70/syk-deficient jurkat cells": 0.01717, "lps tolerant cells": 0.01717, "u937 cells transfected": 0.01717, "jurkat cells downmodulates": 0.01717, "nef+ jurkat cells": 0.01717, "erythroid progenitor cells": 0.01717, "jurkat cells co-expressed": 0.01717, "tnf-alpha-stimulated jurkat cells": 0.01717, "uv-irradiated jurkat cells": 0.01717, "transfected u937 cells": 0.01717, "jurkat cells": 0.01716, "avian cells express": 0.01716, "hl-60 cells treated": 0.01716, "modified hematopoietic stem cells": 0.01716, "physiological target cells": 0.01715, "transgenic bone marrow cells": 0.01715, "myeloid cells leads": 0.01715, "infected cells failed": 0.01715, "transfected hela cells": 0.01715, "mature lymphoid cells": 0.01715, "myeloid leukemic cells": 0.01715, "retinoic acid activates interferon regulatory factor-1 gene expression": 0.01714, "glioblastoma cells express": 0.01714, "leukemia cells": 0.01714, "endothelial cells exposed": 0.01714, "primary hemopoietic cells": 0.01714, "infected u937 cells": 0.01713, "gst-pi-positive plasma cells": 0.01713, "primary t-all cells": 0.01713, "u937 histiocytic lymphoma cells": 0.01713, "u937 cells infected": 0.01713, "ms-5 stromal cells expressing": 0.01713, "cells lack markers": 0.01712, "m. tuberculosis-infected cells": 0.01712, "major glial cells": 0.01712, "cells express tcrzeta": 0.01712, "freshly isolated b-cll cells": 0.01711, "lymphocyte stem cells": 0.01711, "cultured m-tat cells long term": 0.01711, "untreated hl-60 leukemic cells": 0.01711, "transduced hematopoietic stem cells": 0.0171, "differentiating erythroid cells": 0.0171, "susceptible target cells": 0.0171, "lymphoid cells correlates": 0.0171, "epo-dependent hcd57 erythroid cells": 0.0171, "primary cells": 0.0171, "igg+ plasma cells": 0.0171, "human tumor cell lines": 0.0171, "human leukemia cell lines hl-60": 0.0171, "class ii major histocompatibility complex mutant cell line clone-13": 0.0171, "human il-2 receptor alpha chain promoter": 0.0171, "cells express": 0.01709, "similarly treated cho/cd14 cells": 0.01709, "proliferating erythroid cells": 0.01709, "nef expressing cells": 0.01709, "purified cd34+ cells": 0.01709, "immature bone marrow cells": 0.01709, "gata-1 -mutant embryonic stem cells": 0.01709, "r59z activator cells": 0.01708, "transfected k562 cells": 0.01708, "sensitized target cells": 0.01708, "class ii genes encode cell surface proteins": 0.01708, "k562 cells transfected": 0.01708, "effector cells characterized": 0.01708, "igm-secreting plasma cells": 0.01708, "cho cells expressing": 0.01708, "hcd57 erythroid cells": 0.01708, "human b-cell specific transcription factor": 0.01708, "hxbp-1 dna target sequence decreased dr alpha promoter activity": 0.01708, "s194 plasma cells": 0.01708, "freshly isolated cells": 0.01708, "definitive erythroid cells": 0.01708, "plasma cells": 0.01707, "activate cells": 0.01707, "quiescent endothelial cells": 0.01707, "cells derived": 0.01707, "htlv-i infected cells": 0.01706, "protein tyrosine kinase activation": 0.01706, "lymphoid precursor cells": 0.01706, "thp-1 cells transfected": 0.01706, "cd16- nk precursor cells": 0.01706, "erythropoietin-stimulated erythroid cells": 0.01706, "infected monocytic cells": 0.01705, "eliminate pu.1 binding decrease m-csf receptor promoter activity": 0.01705, "human androgen receptor gene": 0.01705, "erythroid cells": 0.01705, "malignant lymphoid cells": 0.01705, "differentiated myeloid cells isolation": 0.01705, "cultures lacking fresh antigen-presenting cells": 0.01705, "tg epsilon26 fetal liver cells": 0.01704, "lps-stimulated cmv transfected cells": 0.01704, "androgen-sensitive prostate cancer lncap cells": 0.01704, "cells expressing cd40l": 0.01704, "activator cells": 0.01704, "human erythropoietin receptor gene": 0.01703, "acute promyelocytic cells": 0.01703, "cells isolated": 0.01703, "wild-type cem cells": 0.01703, "cells expressing p45": 0.01703, "cd4+ cells correlates": 0.01702, "promyelomonocytic leukemic hl-60 cells": 0.01702, "rat embryonal fibroblast ref52 cells": 0.01702, "arterial endothelial cells": 0.01702, "hiv-protease expressing cells": 0.01702, "hematopoietic precursor cells": 0.01702, "porcine aortic endothelial cells": 0.01702, "human thromboxane receptor gene": 0.01701, "lymphoid cells transformed": 0.01701, "cells expressing": 0.01701, "monocytic u937 cells": 0.01701, "cells mediated": 0.01701, "target cells": 0.01701, "nerve cells provide": 0.01701, "cell lines lif increased nf-kb activity": 0.01701, "expressing cells": 0.01701, "u937 monocytic cells": 0.01701, "cultured cells leads": 0.017, "allogeneic endothelial cells": 0.017, "leukemic cells carrying": 0.017, "cells provide": 0.017, "lymphoma precursor cells": 0.017, "nk cells occurs": 0.017, "immature hematopoietic ba/f3 cells": 0.01699, "preleukaemic clone cells": 0.01699, "ikappabalpha transfected cells": 0.01699, "human multiple myeloma cell lines represent": 0.01699, "lymphoid progenitor cells": 0.01699, "exist progenitor cells common": 0.01699, "adt treated wurzburg cells": 0.01699, "hu treated cells": 0.01698, "cytokine-stimulated endothelial cells": 0.01698, "monocytic cells involves cooperation": 0.01698, "wild-type es cells": 0.01697, "immature hematopoietic cells": 0.01697, "cells infiltrating affected joints": 0.01697, "mo t-lymphoid htlv-ii infected cells": 0.01697, "lncap cells treated": 0.01697, "infected u1 monocytoid cells": 0.01697, "target specific dna binding protein": 0.01697, "naive cd4+ cells": 0.01697, "t-cell receptor gene activation": 0.01697, "lps-treated endothelial cells": 0.01697, "u937 cells acts": 0.01696, "late stage cells": 0.01696, "cd11b+ bone marrow cells": 0.01696, "gm-csf-responsive bone marrow cells": 0.01696, "u373 mg astrocytoma cells due": 0.01695, "myeloid progenitor cells": 0.01695, "bone marrow cells": 0.01695, "colon cancer cells": 0.01695, "selected infected cells": 0.01695, "patient cells": 0.01695, "breast carcinoma cells": 0.01695, "cd56+ cd16+ natural killer cells": 0.01695, "endothelial cells": 0.01695, "hematopoietic progenitor cells": 0.01694, "adult cells": 0.01694, "active ocim1 cells": 0.01694, "hela cervical carcinoma cells": 0.01694, "cells contained": 0.01694, "hematopoietic stem cells": 0.01694, "apoptotic vascular smooth muscle cells": 0.01694, "ra synovial cells": 0.01693, "lymphoblastoid cells infected": 0.01693, "ach-2 cells treated": 0.01693, "tax transformed cells": 0.01693, "u937 cells differentiated": 0.01693, "wild-type cells": 0.01693, "er-positive human breast cancer cell lines": 0.01693, "u937 cells transduced": 0.01693, "multidrug-resistant hl-60 cells confers": 0.01692, "neoplastic lymphoid cells": 0.01692, "prestimulated thp-1 monocytic cells": 0.01692, "bcl-2 protects cells": 0.01692, "yj cells treated": 0.01692, "cells bound": 0.01692, "er- cells tested": 0.01692, "epidermal basal cells": 0.01692, "b95-8 lymphoid cells": 0.01692, "single cd34+thy-1+ cells": 0.01691, "treated cells": 0.01691, "cells treated": 0.01691, "cd34+thy-1+ single cells": 0.01691, "myeloid blast cells": 0.01691, "-negative lymphoid cells": 0.01691, "unstimulated nk cells": 0.01691, "mnda positive cells": 0.01691, "infected u1 cells": 0.0169, "leukemic hl60 cells": 0.0169, "thp-1 monocytic cells": 0.0169, "transfected eosinophil-committed hl-60-c15 cells": 0.0169, "human breast cancer cell lines": 0.0169, "monocytic thp-1 cells": 0.0169, "transfected nonlymphoid cells": 0.01689, "cd36 transfected cells": 0.01689, "human il-5 gene promoter": 0.01689, "pml-rar positive cells": 0.01689, "tpa-treated hl-60 cells exposed": 0.01689, "cells tested": 0.01689, "differentiated embryonic stem cells": 0.01689, "cells studied": 0.01688, "t-derived lymphoid cells": 0.01688, "translocation cells proliferate": 0.01688, "hc11 mammary epithelial cells": 0.01688, "spi-1 transfected cells": 0.01688, "cancer cells": 0.01688, "memory th2 cells": 0.01688, "antigen-responsive lymphoid cells": 0.01688, "hiv-1-infected myeloid cells": 0.01688, "parental u937 cells": 0.01688, "stat protein binding site": 0.01688, "differentiating myeloid cells": 0.01688, "transfected cl-01 cells": 0.01688, "cell protein tcf-1": 0.01688, "cells suggests": 0.01688, "inflammatory cells": 0.01687, "lymphoid cells": 0.01687, "monocytic cells exposed": 0.01687, "m2 leukemic blast cells": 0.01687, "positive cells": 0.01687, "transfected nih-3t3 cells": 0.01686, "autologous thymic epithelial cells": 0.01686, "l132 cells transfected": 0.01686, "ar-5 cells transfected": 0.01686, "untreated u937 cells": 0.01686, "gene transcription activation": 0.01686, "cells play": 0.01686, "cos-7 cells transfected": 0.01686, "myb-transformed hematopoietic cells": 0.01686, "transfected cos cells": 0.01686, "kg1 dendritic-like cells include morphology": 0.01686, "bone marrow-derived cells": 0.01686, "unstimulated hela cells": 0.01686, "transfected skw6.4 cells": 0.01686, "mammary epithelial cells": 0.01686, "m2-type leukemic blast cells": 0.01686, "intestinal epithelial cells initiate": 0.01685, "hl-60 cells transduced": 0.01685, "p45 megakaryocytic lineage cells": 0.01685, "ra-resistant hematopoietic cells": 0.01685, "cells transfected": 0.01685, "transfected cells": 0.01685, "series resistant cells": 0.01685, "polarized intestinal epithelial cells": 0.01685, "affected cells": 0.01684, "leu-7+ natural killer cells": 0.01684, "nonproliferating hematopoietic cells": 0.01684, "lymphoma cells ri-i": 0.01684, "adult beta-globin gene activator protein eklf": 0.01684, "infiltrating leukemic cells": 0.01684, "cells influences constitutive": 0.01684, "cells uniformly lack alpha-": 0.01684, "macrophage-like pma-differentiated u937 cells": 0.01683, "uninduced u937 cells": 0.01683, "c/ebpalpha-deficient hematopoietic cells": 0.01683, "vitro-differentiated bcl-xl-/- embryonic stem cells fail": 0.01683, "monocytoid u937 cells": 0.01683, "pparalpha activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression": 0.01683, "thp-1 cells exposed": 0.01683, "megakaryocytic lineage cells": 0.01683, "natural killer cells": 0.01683, "myeloid cells": 0.01683, "u937 cells cotransfected": 0.01682, "hematopoietic cells": 0.01682, "alveolar epithelial cells": 0.01682, "monocytic hl60 cells": 0.01682, "k562 cells synthesized hb": 0.01682, "differentiated thp-1 cells": 0.01682, "stable chromatin-integrated yeast cells": 0.01682, "il-12-stimulated nk cells": 0.01682, "cemxl74 cells infected": 0.01682, "rheumatoid synovial cells up-regulates vcam-1": 0.01682, "human peripheral blood mononuclear cell responses": 0.01681, "parental mpc11 cells carrying": 0.01681, "lipopolysaccharide-stimulated u937 cells": 0.01681, "co-cultured bronchial epithelial cells": 0.01681, "gata-1 -red cells": 0.01681, "render yeast cells resistant": 0.01681, "nonresident vascular wall cells": 0.01681, "lymphoma rael cells": 0.01681, "dendritic antigen-presenting cells point": 0.01681, "gata-1 -erythroid cells": 0.01681, "infected cell monolayers demonstrated vector expression": 0.01681, "cells infected": 0.01681, "il-2-preactivated nk cells": 0.01681, "th1 cells lack": 0.01681, "ifn-activated nk cells": 0.01681, "hiv-infected u937 cells": 0.01681, "infected cells": 0.01681, "parental hl-60 cells": 0.01681, "fresh leukemic cells": 0.01681, "undifferentiated non-prl-secreting endometrial stromal cells": 0.0168, "promyelocyte stage cells": 0.0168, "membrane protein gene similar": 0.0168, "cd4+ cd8int/- cells": 0.0168, "il-10-pretreated u937 cells": 0.0168, "human cd36 gene promoter": 0.0168, "intestinal epithelial cells": 0.0168, "human 15-lipoxygenase gene promoter": 0.0168, "viable u937 cells": 0.0168, "pma-stimulated u937 cells": 0.0168, "lymphoma cells": 0.0168, "atl leukemic cells": 0.01679, "t-lineage cells leads": 0.01679, "cells gr": 0.01679, "untreated hl-60 cells": 0.01679, "female somatic cells": 0.01679, "bronchial epithelial cells": 0.01679, "promonocytic thp-1 cells require prestimulation": 0.01679, "parental k562 cells": 0.01679, "k562 stem cells": 0.01679, "leukemic atll cells": 0.01679, "nk cells": 0.01679, "promonocytic u937 cells": 0.01679, "gc cells": 0.01679, "cd4+ cells": 0.01679, "u937 promonocytic cells": 0.01679, "vascular smooth muscle cells": 0.01679, "cells failed": 0.01679, "monoblast-like u937 cells": 0.01678, "mac-1 cell surface antigen expression": 0.01678, "monoblastoid u937 cells": 0.01678, "bcl-2-overexpressed u937 cells": 0.01678, "human multiple myeloma cell lines": 0.01678, "cd4 cells": 0.01678, "m2-type leukemic cells": 0.01678, "hiv1-infected u937 cells": 0.01678, "u1 monocytic cells": 0.01678, "interferon-gamma-treated u937 cells": 0.01678, "hcd57 cells correlated": 0.01678, "lineage cells": 0.01678, "pma-differentiated u937 cells": 0.01678, "pml-rar-containing leukemic cells": 0.01678, "uncultured leukemic cells": 0.01677, "m0/m1 leukemic cells": 0.01677, "human crh gene promoter": 0.01677, "untreated k562 cells": 0.01677, "render cells sensitive": 0.01677, "cells leads": 0.01677, "human delta-globin gene promoter": 0.01677, "u937 cells": 0.01677, "stromal cells stimulate": 0.01676, "leukemic cells": 0.01676, "hela nonpituitary cells": 0.01676, "thymic epithelial cells": 0.01676, "mature myelomonocytic cells": 0.01676, "cells responsive": 0.01676, "responsive cells": 0.01676, "immature cells differentiated": 0.01676, "untreated thp-1 cells": 0.01675, "nonimmune hela cells": 0.01675, "stage cells": 0.01675, "atl cells constitutively": 0.01675, "mature immunocompetent cells": 0.01675, "cells correlated": 0.01675, "differentiated hl60 cells": 0.01675, "nuclear protein complexes binding": 0.01675, "vitro-differentiated embryonic stem cells": 0.01675, "mammalian cells": 0.01675, "cells due": 0.01675, "breast cancer exhibit abnormal protein expression": 0.01675, "jak-1-deficient hela cells": 0.01675, "airway epithelial cells": 0.01675, "cell activation genes": 0.01674, "utilized thp-1 cells": 0.01674, "hela cells": 0.01674, "epitope peptide-loaded dendritic cells": 0.01674, "developing th2 cells": 0.01674, "mature monocyte/macrophage-like cells": 0.01674, "cells remain poorly understood": 0.01674, "hiv-infected monocytic cells": 0.01673, "polarized il-4-producing th2 cells": 0.01673, "cells resulting": 0.01673, "h. cd38+ cells committed": 0.01673, "t. parva-infected cells": 0.01673, "il-13r alpha1-positive thp-1 cells": 0.01673, "mm cells": 0.01672, "peripheral-blood mononuclear cells": 0.01672, "transduced stem cells": 0.01672, "mature cells": 0.01672, "modified cells acting": 0.01672, "nonerythroid hl-60 cells": 0.01672, "erythroleukemia k562 cells": 0.01672, "kit225 cells cultured": 0.01672, "generate benzidine-positive cells": 0.01672, "drosophila schneider cells": 0.01672, "embryonic stem cells": 0.01672, "k562 cells acquired": 0.01672, "cells mature": 0.01672, "monocyte-like hl-60 cells": 0.01672, "uninduced thp-1 cells": 0.01672, "cell cycle-dependent transcription factor": 0.01672, "pdbu-treated hl-60 cells": 0.01671, "cells sensitive": 0.01671, "kb cells": 0.01671, "adenovirus-transformed cells correlates": 0.01671, "cell transcription factor": 0.01671, "cultured mcf-7 cells": 0.01671, "resting raji cells": 0.01671, "cells exhibit defects": 0.0167, "cells remains": 0.0167, "vascular cells": 0.0167, "pre-b cells transformed": 0.0167, "transformed pre-b cells": 0.0167, "differentiating thp-1 cells": 0.0167, "variant cells": 0.0167, "parental hl60 cells": 0.0167, "rare interfollicular zone cells": 0.0167, "multidrug-resistant hl-60 cells": 0.0167, "androgen-responsive prostate tumour cells": 0.01669, "thp-1-hgh-transfected cells cultured": 0.01669, "exocrine precursor cells bud": 0.01669, "series cells grown": 0.01669, "atopic th2 cells": 0.01669, "e1a render cells vulnerable": 0.01669, "cd40 cells": 0.01669, "cultured h-rs cells": 0.01669, "monocytic cells": 0.01669, "serum-free grown hl60 cells": 0.01669, "conventional b-2 cells": 0.01669, "cem-c7 cells cultured": 0.01669, "embryonic cardiac cells": 0.01669, "drosophila cells": 0.01669, "platelet-like k562 cells": 0.01669, "transcription factor nuclear factor kappa": 0.01669, "bona fide th2 cells": 0.01669, "hl-60 cells": 0.01669, "lp mononuclear cells": 0.01669, "living k562 cells": 0.01668, "promyelocytic hl60 cells": 0.01668, "aml1a-transfected k562 cells": 0.01668, "follicular dendritic cells": 0.01668, "memory cells": 0.01668, "gamma-globin-expressing k562 cells": 0.01668, "represent immunoregulatory cells": 0.01668, "marrow progenitor cells": 0.01668, "cells correlates": 0.01668, "committed progenitors cells": 0.01668, "cns-derived cells tat": 0.01668, "cells cultured": 0.01668, "thp-1 monocyte/macrophage cells": 0.01668, "cells involves": 0.01668, "cells displayed": 0.01668, "promonocytic thp-1 cells": 0.01668, "germinal center cells": 0.01668, "influence cells": 0.01668, "cultured cells": 0.01668, "ebv-infected epithelial cells": 0.01668, "viral structural protein expression": 0.01667, "thymus stromal cells": 0.01667, "raw264.7 macrophage cells": 0.01667, "pha-activated mononuclear cells": 0.01667, "abnormal blast cells": 0.01667, "gastric epithelial cells": 0.01667, "splenic precursor cells": 0.01667, "cell antigen receptor-induced erk2 kinase activation": 0.01667, "acinar epithelial cells": 0.01667, "series cells": 0.01667, "pituitary endocrine cells": 0.01667, "k562 cells": 0.01667, "plb-985 cells represent": 0.01667, "undifferentiated embryocarcinoma f9 cells": 0.01667, "u-937 promonocytic cells": 0.01667, "thymic dendritic cells": 0.01667, "immature cells expresses cd21": 0.01667, "autologous dendritic cells": 0.01667, "prestimulated thp-1 cells": 0.01667, "cells recognized ie-1": 0.01667, "u-937 monocyte-like cells": 0.01667, "il-10 arrested cells": 0.01667, "protein kinase a. activation": 0.01666, "mononuclear cells": 0.01666, "developing th1 cells": 0.01666, "camp-activated th2 cells": 0.01666, "tpa-treated u-937 cells": 0.01666, "pma-treated thp-1 cells": 0.01666, "unstimulated u1 cells": 0.01666, "lps-activated thp-1 cells": 0.01666, "circulating dendritic cells": 0.01666, "dna-transfected u-937 cells": 0.01666, "tnf-stimulated cells blocks": 0.01666, "cells reveals": 0.01666, "transformed cells depends": 0.01665, "decidualized endometrial stromal cells": 0.01665, "gastric carcinoma cells": 0.01665, "spontaneous m2 blast cells": 0.01665, "epithelial cells": 0.01665, "cells occurs": 0.01665, "tpa-differentiated u-937 cells": 0.01665, "il-4-secreting th2 cells": 0.01665, "thp-1 cells": 0.01665, "multipotential hemopoietic stem cells": 0.01665, "u-937 cells": 0.01664, "colony-forming unit-granulocyte-macrophage progenitor cells": 0.01664, "precursor cells": 0.01664, "immune/inflammatory effector cells": 0.01664, "th2 cells": 0.01664, "resistant icr27tk.3 cells": 0.01664, "erythroid/megakaryocytic bipotential progenitor cells": 0.01664, "cytokine-producing effector cells": 0.01664, "foreign body giant cells": 0.01664, "cells prepared": 0.01663, "cd19 cross-linked blin-1 cells": 0.01663, "malignant cells": 0.01663, "parental ut-7 cells": 0.01663, "effector cells": 0.01663, "nb4 apl cells": 0.01663, "immature myelomonocytic cells": 0.01663, "cells differentiate": 0.01663, "rheumatoid synovial cells": 0.01663, "ut-7 epo cells": 0.01663, "apoptotic peer cells": 0.01663, "granulocyte-macrophage colony-stimulating factor receptor alpha gene": 0.01663, "polarized th1 cells": 0.01662, "naive cells": 0.01662, "hiv-1-infected promonocytic u1 cells": 0.01662, "cells reconstituted": 0.01662, "cotton-top tamarin b95-8 cells": 0.01662, "immature neutrophilic cells": 0.01662, "category iii cells": 0.01662, "cells exposed": 0.01662, "htlv-i-positive mt-2 cells": 0.01662, "lmp1- tumour cells": 0.01662, "measure protein tyrosine kinase activity": 0.01662, "thyroid cells": 0.01662, "multipotential progenitor cells": 0.01661, "intact cells": 0.01661, "undifferentiated cells": 0.01661, "mt-2 cells": 0.01661, "untreated ht-2 cells": 0.01661, "differentiated cells": 0.01661, "hl-60/vinc/r cells respond": 0.01661, "u-373 mg cells": 0.01661, "cells occur": 0.01661, "lymphokine-activated killer cells": 0.01661, "ifn-gamma induced irf-1 gene expression": 0.01661, "transplanted cells": 0.01661, "u373 mg cells": 0.01661, "cells deficient": 0.01661, "alveolar cells": 0.01661, "cd34+ progenitor cells": 0.0166, "t-lymphocyte-depleted spleen cells": 0.0166, "protein tyrosine kinase activity": 0.0166, "okadaic acid-induced cells": 0.0166, "rare bcl-2+ cells": 0.0166, "cells exhibit": 0.0166, "maintain polarized t-helper cells": 0.0166, "tyrosine protein kinase activity": 0.0166, "apoptotic vsmc-myc cells": 0.0166, "transduced cells": 0.0166, "cells shows": 0.0166, "e1c3 cells restored": 0.0166, "cem c1 cells": 0.01659, "tumour cells": 0.01659, "prime nb4 cells": 0.01659, "spleen cells": 0.01659, "xp-d lymphoblastoid cells": 0.01659, "autologous cells pulsed": 0.01659, "cells correlate": 0.01659, "helper cells": 0.01659, "immature cells": 0.01659, "gh4c1 pituitary cells": 0.01659, "individual viable cells": 0.01659, "ebv-infected lymphoblastoid cells": 0.01659, "preleukemic clonal cells": 0.01659, "class ii major histocompatibility complex gene transcription": 0.01659, "cells transformed": 0.01659, "serum-grown hl60 cells": 0.01659, "cells subsets": 0.01659, "jun/fos early response gene expression": 0.01659, "apoptotic cells": 0.01659, "il-13r alpha1-negative daudi cells": 0.01659, "transformed cells": 0.01659, "lytic cycle-induced cells": 0.01658, "low pkc protein expression": 0.01658, "gm-csf-responsive progenitor cells": 0.01658, "dimethyl sulfoxide-induced mel cells": 0.01658, "fusing lymphoblastoid cells": 0.01658, "bronchial cells": 0.01658, "peptide-loaded dendritic cells": 0.01658, "progesterone receptor-bearing cells": 0.01658, "well-differentiated th1 cells": 0.01658, "hepatic htc cells": 0.01658, "cd1+relb+ dendritic cells": 0.01658, "hl60 cells": 0.01658, "brain cells": 0.01658, "neonatal cells": 0.01658, "uncultured cells recovered": 0.01658, "renal cell carcinoma-derived gangliosides suppress nuclear factor-kappab activation": 0.01658, "rare cells": 0.01658, "non-clonal progenitor cells": 0.01658, "resting cells": 0.01657, "pma-stimulated u1 cells": 0.01657, "protect mcf-fas cells": 0.01657, "protect virus-infected cells": 0.01657, "raji cells": 0.01657, "dendritic cells": 0.01657, "il-5-stimulated cells underwent autophosphorylation": 0.01657, "unstimulated sp-b21 cells": 0.01657, "camp regulatory element binding protein": 0.01657, "quiescent haemopoietic cells": 0.01657, "world primate cells": 0.01657, "bl cells": 0.01657, "mouse-repopulating stem cells": 0.01657, "targeted erythroleukemia cells": 0.01657, "recovered cells": 0.01657, "human lymphoid cell lines": 0.01657, "sensitized red cells": 0.01656, "atra-induced cd38+ cells": 0.01656, "stem cells": 0.01656, "th1 cells": 0.01656, "dex-resistant cem cells": 0.01656, "protect cells": 0.01656, "unstimulated cells": 0.01656, "u1 promonocytic cells": 0.01656, "quiescent cells": 0.01656, "cells showing": 0.01656, "lymphoblastoid cells": 0.01656, "pre-b cells": 0.01656, "squirrel monkey cells": 0.01656, "progenitor cells": 0.01656, "cells triggers": 0.01656, "il-2-secreting cells consisting": 0.01656, "parental cells": 0.01656, "c57mg fibroblast cells": 0.01656, "red cells sensitized": 0.01656, "cem c7 cells": 0.01656, "transduce human hematopoietic cell lines": 0.01656, "neoplastic epidermal cells": 0.01655, "apl cells": 0.01655, "cd8+ cells": 0.01655, "fibroblast cells": 0.01655, "cells apc": 0.01655, "cd56+ cells": 0.01655, "cem cells": 0.01655, "stromal cells": 0.01655, "induced endothelial cell activation": 0.01655, "igm+ igd+ cl-01 cells": 0.01655, "lymphocytic cells": 0.01654, "32p-labeled ht-2 cells": 0.01654, "atl cells overexpressed": 0.01654, "cells developing": 0.01654, "untreated cells": 0.01654, "promyelocytic cells": 0.01654, "cd45 -t cells": 0.01654, "interfollicular bcl-6+ cells": 0.01654, "pkc-zeta cells": 0.01654, "-positive cells": 0.01654, "unseparated lavage cells": 0.01654, "interfollicular bcl-6+/cd3+ cells": 0.01654, "airway cells": 0.01654, "cells differ": 0.01654, "placental cells": 0.01654, "e2-stimulated er+ cells": 0.01654, "nb4 cells pulse-exposed": 0.01654, "neoplastic myelomonocytic cells": 0.01654, "u1 cells": 0.01654, "fcgamma receptor-mediated mitogen-activated protein kinase activation": 0.01653, "calyculin a-treated cells": 0.01653, "prostate cells": 0.01653, "e1a-positive sarcoma cells": 0.01653, "protects cells": 0.01653, "cd36-producing cho cells": 0.01653, "cells harbor": 0.01653, "intrafollicular cd57+ cells": 0.01653, "human myeloid cell lines": 0.01653, "blast cells": 0.01653, "smooth muscle cells": 0.01653, "nb4 cells": 0.01653, "olfactory neuronal cells": 0.01653, "b104 cells": 0.01653, "t3-unresponsive jeg-3 cells": 0.01653, "lps-stimulated thp-1-hgh cells": 0.01653, "mono mac-6 cells": 0.01652, "cells overexpressed": 0.01652, "dna binding protein complexes": 0.01652, "abundant cells": 0.01652, "cho cells": 0.01652, "eliminate unwanted cells": 0.01652, "erythroblastic hel cells": 0.01652, "lps-stimulated cells": 0.01652, "cells infiltrating": 0.01652, "lavage cells": 0.01652, "interfollicular cells": 0.01652, "gamma/delta tcr+ cells": 0.01652, "m4 cells": 0.01652, "e1c3 cells utilizing": 0.01652, "tpa-treated hl-60/vinc cells": 0.01652, "nwp cells": 0.01652, "synovial cells": 0.01652, "ifn-inducible gene products regulate cell growth": 0.01652, "targeted cells": 0.01652, "adherent cells": 0.01652, "fresh atl cells": 0.01651, "t-lymphocyte cells": 0.01651, "avian cells": 0.01651, "render cells": 0.01651, "ut-7 cells": 0.01651, "multipotent eml cells": 0.01651, "daudi cells": 0.01651, "rodent cells": 0.01651, "polymorphonuclear cells": 0.01651, "ht-2 cells": 0.01651, "epo-independent hcd57-srei cells": 0.01651, "eklf-/- es cells": 0.01651, "eth1 cells": 0.01651, "tolerant cells": 0.01651, "myb-transformed hemopoi-etic cells": 0.01651, "s107 plasmacytoma cells": 0.01651, "primitive cells": 0.01651, "monocytoid cells": 0.01651, "cd68+ cells": 0.01651, "uninduced cells": 0.01651, "egr-1-expressing ramos cells": 0.01651, "cells representative": 0.01651, "tpo-treated ut-7/gmt cells": 0.01651, "self-renewing b-1 cells": 0.0165, "cd30+ cells": 0.0165, "jcam cells": 0.0165, "endometrial cells": 0.0165, "neuronal cells": 0.0165, "dnd39 cells": 0.0165, "parent ut-7/gm cells": 0.0165, "anti-cd3/il-2-activated ln cells": 0.0165, "neoplastic cells": 0.0165, "myd88-/- th1-developing cells": 0.0165, "cells fail": 0.0165, "raw264.7 macrophage-like cells": 0.0165, "huh7 hepatoma cells": 0.0165, "lipid-laden foam cells": 0.0165, "red cells": 0.0165, "il-6-stimulated 1a9-m cells": 0.0165, "epidermal cells": 0.0165, "preincubated cells": 0.0165, "bq-treated dead cells": 0.0165, "il-3-dependent pro-b cells": 0.0165, "control-transduced pre-t cells": 0.0165, "atra-treated kasumi-1 cells": 0.0165, "glucocorticoid-resistant cem-c1 cells": 0.0165, "ag-pulsed accessory cells": 0.0165, "interferon consensus sequence binding protein": 0.0165, "lck-negative jcam1 cells": 0.0165, "cells preincubated": 0.0165, "hl-60/vinc cells": 0.0165, "om10.1 cells": 0.0165, "lncap cells": 0.0165, "b95-8 cells": 0.0165, "eosinophilic cells": 0.0165, "cells progress": 0.01649, "eosinophil-committed hl-60-c15 cells": 0.01649, "cml cells": 0.01649, "transforms haematopoietic cells": 0.01649, "accessory cells": 0.01649, "macrophage-like cells": 0.01649, "responding cells": 0.01649, "mel cells": 0.01649, "ra-resistant uf-1 cells": 0.01649, "cells differentiating": 0.01649, "hiv-1-infected cells": 0.01649, "hel cells": 0.01649, "unresponsive cells": 0.01649, "plasmacytoma cells": 0.01649, "glial cells": 0.01649, "cd3+ cells": 0.01649, "cells responding": 0.01649, "distinguishes b-cll cells": 0.01649, "prostatic cells": 0.01649, "rescue cells": 0.01649, "nonerythroid nih3t3 cells": 0.01649, "ebv-negative cells": 0.01649, "differentiating cells": 0.01649, "pro-b cells": 0.01649, "myelomonoblastic plb-985 cells": 0.01649, "double-positive cells": 0.01649, "leukaemic cells": 0.01649, "multipotential cells": 0.01649, "nonepithelial cells": 0.01649, "androgen insensitive human prostatic carcinoma cell lines": 0.01649, "cells committed": 0.01649, "hl-60/vinc/r cells": 0.01649, "megakaryocytic cells": 0.01649, "nonlymphoid cells": 0.01648, "hepatoma cells": 0.01648, "proliferating cells": 0.01648, "pre-t cells": 0.01648, "primed cells": 0.01648, "osteoclast-like cells": 0.01648, "non-irradiated ht29 cells": 0.01648, "cells belonging": 0.01648, "t-helper cells": 0.01648, "foam cells": 0.01648, "trap+ cells": 0.01648, "cd1a- cells": 0.01648, "t-lymphocytic ach-2 cells": 0.01648, "adenovirus-transformed cells": 0.01648, "hdlm-1 cells": 0.01648, "nonstimulated cells": 0.01648, "ductal cells": 0.01648, "kit225 cells": 0.01648, "hcd57-srei cells": 0.01648, "es cells": 0.01648, "ut-7/gm cells": 0.01648, "ilt-mat cells": 0.01648, "hiv-infected cells": 0.01648, "ut-7/gmt cells": 0.01648, "1a9-m cells": 0.01648, "m1 cells": 0.01648, "cll cells": 0.01648, "detectable nf-at protein expression": 0.01648, "3t3-l1 cells": 0.01648, "hemopoietic cells": 0.01648, "il-2+ cells": 0.01648, "myelomonocytic cells": 0.01648, "c81-66-45 cells": 0.01648, "namalwa cells": 0.01648, "trophoblast cells": 0.01648, "wurzburg cells": 0.01648, "cadmium-pretreated cells": 0.01648, "uninfected cells": 0.01648, "hel/s cells": 0.01648, "viable cells": 0.01648, "cl-01 cells": 0.01648, "tax-expressing cells": 0.01648, "cd34+ cells": 0.01648, "ach2 cells": 0.01648, "ebv-transformed cells": 0.01648, "myelomonoblastic cells": 0.01647, "neutrophilic cells": 0.01647, "aggregated cells": 0.01647, "progenitor/precursor cells": 0.01647, "ra-resistant cells": 0.01647, "bal cells": 0.01647, "a1-vdr cells": 0.01647, "cd45ra+ cells": 0.01647, "t-lymphoid cells": 0.01647, "kasumi-1 cells": 0.01647, "cells immortalized": 0.01647, "p-lps-treated cells": 0.01647, "senescent cells": 0.01647, "mitogen-stimulated cells": 0.01647, "epo-independent cells": 0.01647, "non-lymphoid cells": 0.01647, "b-cll cells": 0.01647, "melanoma cells": 0.01647, "eukaryotic cells": 0.01647, "monocyte/macrophage cells": 0.01647, "reed-sternberg cells": 0.01647, "ebna-2-positive cells": 0.01647, "ebv-infected cells": 0.01647, "m-tat/gm-csf cells": 0.01647, "immunocompetent cells": 0.01647, "immortalized cells": 0.01647, "nonerythroid cells": 0.01647, "hcd57 cells": 0.01647, "rs cells": 0.01647, "cells enter": 0.01647, "promonocytic cells": 0.01647, "el-4 cells": 0.01647, "non-b cells": 0.01647, "t/nk cells": 0.01647, "s49 cells": 0.01647, "dendritic-like cells": 0.01647, "molt-4 cells": 0.01647, "b-lymphocyte cells": 0.01647, "atl cells": 0.01647, "nih3t3 cells": 0.01647, "m-tat/epo cells": 0.01647, "class iii gene transcription factor tfiiib": 0.01647, "er- cells": 0.01647, "dead cells": 0.01647, "cells proliferate": 0.01647, "giant cells": 0.01647, "interphase cells": 0.01647, "nonpermissive cells": 0.01647, "foreign cells": 0.01647, "hl-60-c15 cells": 0.01647, "cells serves": 0.01647, "ro-vdr cells": 0.01647, "monocyte-macrophage cells": 0.01647, "b-2 cells": 0.01647, "haematopoietic cells": 0.01647, "rb-defective cells": 0.01646, "cells co-transfected": 0.01646, "antigen-presenting cells": 0.01646, "akata cells": 0.01646, "cells delivers": 0.01646, "om-10.1 cells": 0.01646, "eklf-/- cells": 0.01646, "virus-exposed cells": 0.01646, "mcf-fas cells": 0.01646, "non-t cells": 0.01646, "cos-1 cells": 0.01646, "unit-erythroid cells": 0.01646, "endotoxin-stimulated cells": 0.01646, "inappropriate cells": 0.01646, "pyramidal cells": 0.01646, "dividing cells": 0.01646, "dex-resistant cells": 0.01646, "pre-monocytic cells": 0.01646, "ctll-2 cells": 0.01646, "self-reactive cells": 0.01646, "pth cells": 0.01646, "vitd3-treated cells": 0.01646, "eth2 cells": 0.01646, "lak cells": 0.01646, "raw264.7 cells": 0.01646, "il-4-stimulated cells": 0.01646, "dmso-treated cells": 0.01646, "ba/f3 cells": 0.01646, "ach-2 cells": 0.01646, "e1a-negative cells": 0.01646, "e1c3 cells": 0.01646, "im-9 cells": 0.01646, "eml cells": 0.01646, "cos-7 cells": 0.01646, "sublining cells": 0.01646, "hacat cells": 0.01646, "p3hr1 cells": 0.01646, "t-lineage cells": 0.01646, "hit-t15 cells": 0.01646, "steroid-responsive cells": 0.01646, "non-malignant cells": 0.01646, "ecv304 cells": 0.01646, "maturing cells": 0.01646, "e1a-positive cells": 0.01646, "tnf-alpha-stimulated cells": 0.01646, "cref cells": 0.01646, "yj cells": 0.01646, "monoblastoid cells": 0.01646, "il-7-treated cells": 0.01646, "dox-treated cells": 0.01646, "ocim1 cells": 0.01646, "mast cells": 0.01646, "hs-72 cells": 0.01646, "h9 cells": 0.01646, "hyon cells": 0.01646, "hl60r cells": 0.01646, "gm-csf-stimulated cells": 0.01646, "cem-c7 cells": 0.01646, "nonmyeloid cells": 0.01646, "il-12-stimulated cells": 0.01646, "cells drives": 0.01646, "p3hr-1-infected cells": 0.01646, "htlv-i-transformed cells": 0.01646, "bcl-6+ cells": 0.01646, "nkl cells": 0.01646, "nontolerant cells": 0.01646, "pha-activated cells": 0.01646, "infectable cells": 0.01646, "neuroendocrine cells": 0.01646, "cells manifests": 0.01646, "null cells": 0.01646, "lps-treated cells": 0.01646, "cd3-cd16+ cells": 0.01646, "permeabilized cells": 0.01646, "anergic cells": 0.01646, "fusing cells": 0.01646, "non-epithelial cells": 0.01646, "langerhans cells": 0.01646, "el4 cells": 0.01646, "x-ray-treated cells": 0.01646, "cells contrasts": 0.01646, "non-irradiated cells": 0.01646, "h-rs cells": 0.01646, "pdbu-treated cells": 0.01646, "anti-cd3-stimulated cells": 0.01646, "ns-meg cells": 0.01646, "b-1 cells": 0.01646, "blin-1 cells": 0.01646, "virus-infected cells": 0.01646, "cho/cd14 cells": 0.01646, "b-lymphoid cells": 0.01646, "l929 cells": 0.01646, "serum-starved cells": 0.01646, "cemxl74 cells": 0.01646, "2m-1 cells": 0.01646, "ml-1 cells": 0.01646, "nucleated cells": 0.01646, "tonsillar cells": 0.01646, "nonhematopoietic cells": 0.01646, "plb-985 cells": 0.01646, "uf-1 cells": 0.01646, "non-erythroid cells": 0.01646, "s107 cells": 0.01646, "hl-60r cells": 0.01646, "unprimed cells": 0.01646, "p53-null cells": 0.01646, "cells arrested": 0.01645, "interferon-treated cells": 0.01645, "nk/lgl cells": 0.01645, "virus-transformed cells": 0.01645, "ctll-r8 cells": 0.01645, "non-monocytic cells": 0.01645, "ig-secreting cells": 0.01645, "fdcp-2 cells": 0.01645, "il-2-producing cells": 0.01645, "hela-tat cells": 0.01645, "jr-st cells": 0.01645, "gamma-positive cells": 0.01645, "insect cells": 0.01645, "lps-responsive cells": 0.01645, "gcr-beta-immunoreactive cells": 0.01645, "hh514-16 cells": 0.01645, "km-h2 cells": 0.01645, "platelet-progenitor cells": 0.01645, "hla-dr+ cells": 0.01645, "cells nearby": 0.01645, "ar-5 cells": 0.01645, "m-tat cells": 0.01645, "receptor-containing cells": 0.01645, "beas-2b cells": 0.01645, "cho-cd14 cells": 0.01645, "non-proliferating cells": 0.01645, "il-10-treated cells": 0.01645, "bcl-2-transduced cells": 0.01645, "cess cells": 0.01645, "rwleu-4 cells": 0.01645, "nk3.3 cells": 0.01645, "mo7e cells": 0.01645, "ifn-u937 cells": 0.01645, "ifn-gamma-treated cells": 0.01645, "lineage-positive cells": 0.01645, "acyclovir-treated cells": 0.01645, "a/r-tolerant cells": 0.01645, "il-6-treated cells": 0.01645, "mononucleated cells": 0.01645, "ald-treated cells": 0.01645, "rela-overexpressing cells": 0.01645, "g1/g0 cells": 0.01645, "cv-1 cells": 0.01645, "ebv-b cells": 0.01645, "nonmacrophage cells": 0.01645, "bl-2 cells": 0.01645, "myeloblast cells": 0.01645, "ifn-gamma-producing cells": 0.01645, "balb/c3t3 cells": 0.01645, "tap1-/- cells": 0.01645, "e1a-immortalized cells": 0.01645, "steroid-treated cells": 0.01645, "dep-pah-activated cells": 0.01645, "pma-treated cells": 0.01645, "cemx174 cells": 0.01645, "pma/bt2camp-treated cells": 0.01645, "c5mj2 cells": 0.01645, "helas3 cells": 0.01645, "ciita-expressing cells": 0.01645, "plb-iiib cells": 0.01645, "aa2 cells": 0.01645, "benzidine-positive cells": 0.01645, "non-expressing cells": 0.01645, "gcrbeta-immunoreactive cells": 0.01645, "c12 cells": 0.01645, "htlv-1-transformed cells": 0.01645, "polymorphonucleate cells": 0.01645, "hemoglobin-producing cells": 0.01645, "non-hematopoietic cells": 0.01645, "hemoglobin-positive cells": 0.01645, "erythroid-lineage cells": 0.01645, "anergized cells": 0.01645, "tur cells": 0.01645, "leishmania-infected cells": 0.01645, "mesenchymal cells": 0.01645, "c3/5 cells": 0.01645, "mnda-expressing cells": 0.01645, "cos7 cells": 0.01645, "acla-treated cells": 0.01645, "nih-3t3 cells": 0.01645, "theileria-infected cells": 0.01645, "il-2-deprived cells": 0.01645, "il-2-stimulated cells": 0.01645, "non-il-2-secreting cells": 0.01645, "hsv-infected cells": 0.01645, "hit cells": 0.01645, "bfu-e-derived cells": 0.01645, "apoptosisprone cells": 0.01645, "living cells": 0.01645, "tpa-activated cells": 0.01645, "atl-16t cells": 0.01645, "igm-secreting cells": 0.01645, "hpp-47.10 cells": 0.01645, "untransfected cells": 0.01645, "macrophagelike cells": 0.01645, "jy25 cells": 0.01645, "retrodifferentiated cells": 0.01645, "calcineurin-stimulated cells": 0.01645, "icrf-193-treated cells": 0.01645, "glycation-induced cells": 0.01645, "nef-expressing cells": 0.01645, "anthracycline-treated cells": 0.01645, "m-tat/scf cells": 0.01645, "hd6 cells": 0.01645, "erythroleukaemia cells": 0.01645, "p19 cells": 0.01645, "mcd14-expressing cells": 0.01645, "l540 cells": 0.01645, "cvz-resistant cells": 0.01645, "stem/progenitor cells": 0.01645, "nonhepatic cells": 0.01645, "nonrelated cells": 0.01645, "etoposide-treated cells": 0.01645, "myelo-monocytic cells": 0.01645, "neighboring cells": 0.01645, "jpx9 cells": 0.01645, "tat-expressing cells": 0.01645, "ifna-producing cells": 0.01645, "hbsag-reactive cells": 0.01645, "cd4+cd45r0+ cells": 0.01645, "vsmc-myc cells": 0.01645, "skw6.4 cells": 0.01645, "rh:33 cells": 0.01645, "matrix-adherent cells": 0.01645, "csa-treated cells": 0.01645, "fmol/million cells": 0.01645, "dl337-infected cells": 0.01645, "ra-treated cells": 0.01645, "ifn-alpha-treated cells": 0.01645, "nonthymocyte cells": 0.01645, "bja-b cells": 0.01645, "cos cells": 0.01645, "bcp-all cells": 0.01645, "u9-iiib cells": 0.01645, "igg-positive cells": 0.01645, "e1a-expressing cells": 0.01645, "htlv-infected cells": 0.01645, "jpx-9 cells": 0.01645, "non-il-2-producing cells": 0.01645, "s194 cells": 0.01645, "hb-synthesizing cells": 0.01645, "2d3-responsive cells": 0.01645, "il-2-treated cells": 0.01645, "wt19 cells": 0.01645, "phorbol-di-butyrate-treated cells": 0.01645, "baf3 cells": 0.01645, "icr27tk.3 cells": 0.01645, "fva cells": 0.01645, "hpv-transformed cells": 0.01645, "cells": 0.01644, "human mm cell lines": 0.01643, "functional rb rescues ifn-gamma-induced class ii gene expression": 0.01643, "surface protein expression": 0.01642, "decreased p65-rela protein expression": 0.01642, "mitogen-activated protein kinase activation": 0.01642, "human colon carcinoma cell lines": 0.01641, "tumor necrosis factor receptor-associated death domain protein": 0.01639, "human monocytic cell lines": 0.01639, "ebv protein expression": 0.01638, "zinc finger protein binding region": 0.01638, "cell specific expression": 0.01636, "il-3/adenovirus e4 promoter binding protein": 0.01636, "il-2 gene promoter activity": 0.01635, "cell lines bearing human": 0.01635, "rela induced jagged1 gene expression": 0.01634, "e1a oncogene expression increases mammalian cell susceptibility": 0.01633, "tcf-1 alpha binding site diminished enhancer activity": 0.01632, "increased delta globin gene expression": 0.01632, "gene product increased expression": 0.01631, "significant e2a protein expression": 0.01631, "human myeloid cell differentiation": 0.0163, "increased il-4 gene expression": 0.01628, "primary human adult erythroid cell": 0.01628, "stat6 inhibits human interleukin-4 promoter activity": 0.01628, "activated viral gene expression": 0.01628, "nf-kappa b-dependent cytokine gene expression": 0.01626, "activator protein-1 transcription factor expression": 0.01624, "c-jun protein expression": 0.01621, "ribosomal protein gene promoters": 0.0162, "cross-linking cd40 supports nf-kappa b-dependent gene expression": 0.0162, "macrophage transcription factor pu.1 directs tissue-specific expression": 0.0162, "human neuroblastoma cell lines": 0.01619, "human myelomonocytic cell lines": 0.01619, "dm regulated il-2r alpha gene expression": 0.01617, "human epo-dependent cell lines": 0.01617, "human t-cell fk506-binding protein": 0.01617, "matrix attachment region binding protein": 0.01616, "modulating cell activation induced": 0.01616, "human cell lines": 0.01615, "tumor necrosis factor receptor expression": 0.01614, "switch region binding protein": 0.01614, "inducing tal-1 protein expression": 0.01613, "intracellular protein expression": 0.01613, "exhibit strong tcl1 protein expression": 0.01612, "cell receptor beta genes": 0.01612, "human myeloid zinc finger protein": 0.01611, "specific protein binding sites": 0.0161, "human peripheral blood mononuclear cell": 0.01609, "c-fos protein expression": 0.01609, "p65 protein expression": 0.01609, "type ii ifns suppress il-4/il-13-inducible gene expression": 0.01606, "mab activates hiv-1 gene expression": 0.01606, "inosine-5'-monophosphate dehydrogenase type ii gene expression": 0.01605, "specific dna protein complex formation": 0.01605, "retinoblastoma protein expression leads": 0.01604, "human intestinal epithelial cell inflammatory responses": 0.01602, "specific transcription factor binding sites": 0.016, "ccaat enhancer binding protein alpha": 0.01598, "cell surface marker expression": 0.01597, "mechanism restricting hiv-1 gene expression": 0.01595, "endogenous nf-kappa b1 gene expression": 0.01594, "inducible il-2r alpha gene expression": 0.01593, "increased beta-globin gene expression": 0.01593, "human nk cell membrane-bound lt signals": 0.01592, "transcription factor regulates expression": 0.01592, "human b-cell transcription factor oct-2": 0.01592, "octamer site-mediated immunoglobulin gene promoter activity": 0.01592, "vascular cell adhesion molecule-1 gene": 0.0159, "il-4 gene expression levels": 0.01588, "cell cycle regulated histone h4 gene": 0.01587, "erythroid-specific gata-1 transcription factor gene": 0.01587, "c-rel protein expression": 0.01586, "diminished cell surface expression": 0.01586, "impdh type ii gene expression": 0.01585, "stimulates il-2r alpha gene expression": 0.01585, "type ii il-1r gene expression": 0.01585, "increased natural killer cell activity correlates": 0.01584, "ifn-gamma-induced mhc class ii gene expression": 0.01584, "ltr-directed gene expression increased": 0.01584, "type ii gene expression": 0.01583, "protein latency expression": 0.01582, "bcl-6 protein expression": 0.01582, "p53 protein expression": 0.01582, "differential nf-kappa b-mediated gene expression": 0.01582, "nuclear transcription protein": 0.01581, "transcription factor expression vectors": 0.01581, "cat reporter gene suggesting increased activity": 0.01581, "rb protein expression": 0.0158, "distal nf-kappab transcription factor binding sites": 0.0158, "mhc class ii gene expression": 0.01579, "dna-binding eukaryotic transcription factors tata-binding protein": 0.01579, "transcription factor expression plasmids": 0.01578, "elements regulating il-4 gene expression": 0.01578, "cytokine-stimulated cell surface expression": 0.01575, "induce cellular cd23 gene expression": 0.01574, "rap1 protein expression": 0.01574, "tcl1 protein expression": 0.01573, "camp-responsive element binding protein": 0.01573, "human c-jun protein": 0.01573, "t-lymphocytes activated gene expression": 0.01573, "cell surface expression": 0.01572, "ikappabbeta protein expression": 0.01572, "host cell gene encoding": 0.01572, "human immunodeficiency virus-1 tat protein": 0.01572, "cox-2 protein expression": 0.01572, "pan/e2a protein expression": 0.01571, "er-alpha protein expression": 0.01571, "protein expression": 0.0157, "cell membrane ig expression": 0.0157, "b-cell specific gene expression": 0.01569, "nf-kappa b1 gene expression": 0.01568, "il-2 induces gene expression": 0.01568, "potential ets transcription factor binding sites": 0.01567, "cd4 gene transcription start site": 0.01565, "downregulates mip-1 alpha gene expression": 0.01564, "nf-kappa b-mediated gene expression": 0.01562, "nf-kappa b-dependent gene expression": 0.01562, "major histocompatibility complex class ii gene promoter dra": 0.01561, "cell antigen receptor complex": 0.01561, "eosinophil-specific granule protein gene": 0.01561, "cell membrane expression": 0.0156, "nuclear factor kappa b/rel nuclear activity": 0.0156, "early growth response-1 gene expression": 0.0156, "insulin gene transcription factor": 0.01559, "activated irf-1 gene expression": 0.01558, "transcription factor gene families": 0.01555, "lim-only protein gene": 0.01555, "mediate high level gene expression": 0.01555, "alpha gene expression": 0.01555, "nf kappa b-dependent gene expression": 0.01553, "nf kappa b-mediated gene expression": 0.01553, "insulin gene promoter activity": 0.0155, "lymphoid specific gene expression": 0.0155, "potential transcription factor binding sites": 0.0155, "human leukemic cell clone cem c7": 0.01549, "human neutrophil-mediated tumor cell cytostasis": 0.01549, "class ii gene expression": 0.01549, "measured nucleoprotein dna-binding activities regulating gene expression": 0.01548, "cem human leukemic cell clone": 0.01548, "human cd34+ cord blood cell": 0.01548, "observed gene expression pattern": 0.01547, "increase gene expression": 0.01547, "normal cell cycle activation program": 0.01546, "drosophila toll protein signals activation": 0.01546, "human transcription factor sp1": 0.01546, "sry protein dna binding ability": 0.01542, "unique human protein": 0.01542, "human protein recognized": 0.01542, "human ets-1 protein": 0.01541, "epstein-barr virus gene expression": 0.01541, "superantigens activate hiv-1 gene expression": 0.01541, "specific nuclear protein complex": 0.0154, "activate hiv-1 ltr-dependent gene expression": 0.0154, "ebna gene promoter activity": 0.01539, "activate hiv-1 gene expression": 0.01538, "protein phosphatase inhibitor okadaic acid secreted high levels": 0.01538, "human impdh type ii gene": 0.01537, "decreased human cell lysates": 0.01537, "human mhc hla-dra class ii gene": 0.01537, "th2- specific gene expression remains": 0.01536, "transcription factor nuclear factor kappab": 0.01535, "human rar alpha expression": 0.01533, "caenorhabditis elegans cell death gene ced-3": 0.01533, "hsf2-beta inhibits hemin-induced heat shock gene expression": 0.01532, "human tfiid protein shares": 0.01532, "mzf-1 activates cat reporter gene expression": 0.01531, "human cytomegalovirus ie2 protein": 0.01529, "human tcf-1 protein": 0.01528, "human sr 31747a-binding protein": 0.01527, "human tfiid protein": 0.01526, "human c/ebp-epsilon protein": 0.01526, "regulate inducible t-cell gene expression": 0.01524, "regulating inducible t-cell gene expression": 0.01523, "human bactericidal/permeability-increasing protein": 0.01522, "induced dra expression involves activation": 0.01522, "human swi2 protein": 0.01522, "human tr2 orphan receptor response element": 0.01522, "human protein": 0.01521, "transcription factor nuclear factor": 0.01521, "ikk complex-associated protein inhibited stimulus-mediated transcription": 0.0152, "human myeloid-cell-specific c/ebp-epsilon transcription factor": 0.0152, "dna binding protein nf-kb": 0.01519, "androgen receptor gene transcription": 0.01517, "primary human cell": 0.01517, "activate reporter gene expression": 0.01517, "tyrosine-phosphorylated dna binding protein": 0.01516, "il-1 beta gene expression": 0.01516, "virus gene expression": 0.01516, "human t-cell receptor beta-chain core promoter": 0.01514, "cyclic amp response element-binding protein nuclear complexes": 0.01514, "human granulocyte macrophage-colony stimulating factor promoter involved": 0.01513, "control tnf-alpha gene expression": 0.01512, "cell activation-induced fasl expression": 0.01512, "inhibits tnf gene expression": 0.01512, "human class ii transplantation gene": 0.01511, "human transcription factor": 0.01511, "inhibits cd4 gene expression": 0.01511, "augment human alpha-globin promoter activity": 0.01511, "latent membrane protein 1-driven activation": 0.01511, "human mip-1 alpha gene": 0.0151, "human umbilical vein endothelial cell": 0.0151, "active human tata binding factor": 0.0151, "high level gene expression": 0.0151, "human dr alpha gene": 0.01509, "specific gene expression": 0.01508, "interferon regulatory factor family transcription factor": 0.01508, "regulating cd95 ligand gene expression": 0.01507, "interferon alpha regulated nuclear protein expressed": 0.01506, "92-kda dna binding protein": 0.01505, "dna binding protein": 0.01504, "regulating hiv-1 gene expression": 0.01504, "cmv induces il-6 gene expression": 0.01503, "induce transcription factor activation": 0.01502, "regulating cellular gene expression": 0.01502, "tax stimulates rna polymerase iii-dependent gene expression": 0.01502, "accessible human cell model": 0.01501, "low level rag gene expression": 0.01501, "cell growth-regulated expression": 0.01501, "cell stimulation-induced expression": 0.01501, "regulating il-2 gene expression": 0.015, "cell expression": 0.015, "t-cell nuclear protein complex": 0.01498, "human renal cell carcinomas": 0.01498, "enhances beta-globin reporter gene expression": 0.01496, "cell lines expressed increased levels": 0.01496, "e1a gene expression induces susceptibility": 0.01496, "janus kinase-1-deficient cell line u4a expresses hla-dr alpha mrna": 0.01496, "transcription factor binding sites downstream": 0.01495, "suppress hiv-1 ltr-driven gene expression": 0.01495, "transcriptional regulatory proteins binding distinct c-fos/c-jun promoter elements": 0.01494, "human renal cell carcinoma": 0.01494, "inducible transcription factor binding sites": 0.01492, "mitogen-activated protein kinase family members extracellular-regulated kinase": 0.01492, "human immunoglobulin heavy-chain gene enhancer": 0.01492, "activate target gene expression": 0.01491, "proteins regulating gene transcription": 0.0149, "enhances intercellular adhesion molecule-1 gene expression": 0.01489, "nf-kappab protein activity": 0.01489, "tp1 promoter steel factor affects scl expression": 0.01489, "cell gene cd21": 0.01486, "cell cycle-associated gene": 0.01485, "s9a inhibited tnf-alpha promoter-driven reporter gene activity": 0.01484, "mzf-1 represses cat reporter gene expression": 0.01483, "mechanisms underlying endothelial cell activation": 0.01483, "human b-lymphocyte cell cycle": 0.01482, "human epsilon-globin-encoding gene [ cao": 0.01482, "activate hiv gene expression": 0.01481, "human tcr beta gene uncovers": 0.0148, "human squamous cell carcinomas": 0.01479, "ebf binding sites diminished b29 promoter activity": 0.01478, "inhibits gpc91-phox gene expression": 0.01478, "inhibits gene expression": 0.01477, "hiv-1 ltr-driven gene expression": 0.01477, "gene activation induced": 0.01476, "fasl versus cytokine gene expression": 0.01476, "hiv-1 gene expression": 0.01476, "human neutrophils express gh-n gene transcripts": 0.01475, "activates nuclear calcium/calmodulin-dependent protein kinase ii": 0.01475, "host cell transcription factors": 0.01475, "nuclear inhibitory protein repressor element": 0.01475, "cellular gene expression": 0.01474, "protein binding sites": 0.01474, "adipocyte fatty acid binding protein": 0.01473, "cell antigen receptor-induced mapk activation": 0.01473, "cell surface activation markers": 0.01473, "activating viral gene expression": 0.01473, "il-2 gene expression": 0.01472, "il-4 activates gene expression": 0.01472, "transcription factor nf kappa b. macrophage-colony-stimulating factor": 0.01472, "stimulates viral gene expression": 0.01471, "inhibit cytokine-induced endothelial cell activation": 0.0147, "human il-5 promoter/enhancer luciferase gene construct transfected": 0.0147, "study globin gene expression": 0.0147, "regulates cytokine gene expression": 0.01469, "nk cell activation early": 0.01469, "sp1 site mediates monocytic specific promoter activity": 0.01467, "induce erythroid-specific gene expression": 0.01466, "cell ag receptor complex": 0.01466, "regulating eotaxin gene expression and/or mediating": 0.01465, "inducible mhc class ii gene activation": 0.01465, "il-6 mrna expression involves activation": 0.01465, "mzf-1 represses reporter gene expression": 0.01465, "gene activation pathway": 0.01464, "transcription factor binding sites": 0.01463, "binding ga-binding protein alpha": 0.01463, "mechanisms regulating gene expression": 0.01462, "human cell partner": 0.01462, "cell antigen receptor-induced activation": 0.01461, "epstein-barr virus rta protein activates lytic cycle genes": 0.01461, "enhanced gene expression": 0.01461, "receptor protein increased": 0.0146, "estrogen decreases tnf gene expression": 0.0146, "enhanced hiv-1 ltr-mediated reporter gene activity": 0.0146, "gene expression required": 0.0146, "prostatic spermine binding protein mrna": 0.01459, "cell receptor complex": 0.01458, "human t-cell leukemia virus-infected human": 0.01458, "th2 cytokine gene expression": 0.01456, "c5a-induced reporter gene expression": 0.01456, "cell transcription factors": 0.01455, "gene expression involved": 0.01455, "human putative lymphocyte g0/g1 switch gene homologous": 0.01454, "reporter gene expression": 0.01454, "cell activation induces": 0.01453, "human il-5 promoter/enhancer-luciferase gene construct transfected": 0.01451, "viral gene expression": 0.0145, "mast cell activation signals": 0.0145, "19-bp nuclear factor binding site": 0.0145, "isolated human mcm gene promoters": 0.01448, "early gene expression": 0.01448, "cell activation signals": 0.01448, "functional protein binding sequences": 0.01447, "cell specific activity": 0.01447, "adult globin gene expression": 0.01447, "human granulocyte colony-stimulating factor receptor": 0.01445, "consensus ah receptor dna binding site": 0.01444, "sp1 regulate tf gene expression": 0.01444, "human putative lymphocyte g0/g1 switch gene": 0.01444, "gm-csf-induced proinflammatory cytokine gene expression": 0.01443, "leukemic cell line jurkat induced": 0.01443, "cytokine gene expression differs": 0.01442, "gal4 dna binding domain activated transcription": 0.01442, "cell activation results": 0.01442, "unrearranged tcr delta gene expression": 0.0144, "ebv gene expression": 0.0144, "gene expression level": 0.01439, "il-2 gene promoter region": 0.01439, "regulatory gene expression": 0.01438, "protein kinase a-related camp response elements": 0.01438, "gm-csf-induced cytokine gene expression": 0.01437, "activate lymphokine gene expression": 0.01437, "differential gene expression regulated": 0.01437, "retinoic acid receptor alpha gene": 0.01437, "cytokine gene expression": 0.01436, "activates irf-1 gene expression": 0.01435, "inhibit lck gene expression": 0.01435, "human malignant melanoma study nm23 expression": 0.01435, "examined chemokine gene expression": 0.01435, "activate gene expression": 0.01434, "msr promoter-reporter gene construct demonstrated decreased activity": 0.01434, "low nm23.h1 gene expression": 0.01434, "erythroid gene expression": 0.01433, "inducible pb1 nuclear protein complex": 0.01433, "regulates inducible gene expression": 0.01433, "htlv-i ltr gene expression": 0.01433, "mutated human retinoic acid receptor alpha": 0.01432, "spi-b gene expression increases": 0.01431, "c-cerba/thyroid hormone receptor regulate erythroid cell growth": 0.01431, "gp120 enhances icam-1 gene expression": 0.0143, "regulating leukocytes gene expression": 0.0143, "activates rantes gene expression": 0.0143, "small gtp-binding protein rho potentiates ap-1 transcription": 0.0143, "human platelet-activating factor receptor": 0.0143, "gm-csf receptor alpha promoter activity": 0.0143, "cell activation pathways": 0.01429, "regulate inducible gene expression": 0.01429, "lps-lps binding protein complexes": 0.01428, "gene expression mediated": 0.01428, "activation protein": 0.01427, "protein activation": 0.01427, "regulate globin gene expression": 0.01426, "csa inhibited il-2 gene transcription": 0.01426, "high-affinity lps binding protein membrane cd14": 0.01426, "cell activation markers icam-1": 0.01425, "impaired immunoglobulin gene expression": 0.01424, "human il-2 gene": 0.01424, "c-jun gene expression": 0.01424, "controls gene expression": 0.01423, "dominant negative c/ebp protein lip inhibited hiv-1 mrna": 0.01423, "endogenous 5-lipoxygenase activity modulates platelet-activating factor induced arachidonic acid release": 0.01423, "pwm regulates egr-1 gene expression": 0.01422, "regulating alpha2 integrin gene expression": 0.01421, "regulate late gene expression": 0.01421, "cmv transactivators enhance hiv-2 gene expression": 0.0142, "downregulates cytokine-induced tnf gene expression": 0.0142, "ras protein activity": 0.01419, "up-regulated monocyte gene expression": 0.01419, "comments ] glucocorticoid receptor regulates expression": 0.01419, "hiv gene expression": 0.01418, "mediate il-12-induced gene expression": 0.01418, "regulating hbv gene expression transcription-independent turnover": 0.01418, "mediating il-6 gene expression": 0.01418, "protein-coupled transcription factor activation": 0.01417, "il-4 gene expression": 0.01417, "gene encoding human inosine- 5'-monophosphate dehydrogenase": 0.01417, "transcription factor activation": 0.01416, "gamma-interferon mediated cell activation": 0.01414, "basal gene expression": 0.01414, "ifn-gamma activation site-like dna sequence element": 0.01414, "transcription factor egr-1 activity down-regulates fas": 0.01414, "monocyte gene expression": 0.01413, "normal mouse bone marrow generates hematopoietic growth factor-dependent cell lines frozen": 0.01413, "cell antigen receptor stimulation": 0.01412, "c-fos gene expression": 0.01411, "okadaic acid-induced il-6 gene expression": 0.01411, "fibroblasts pilot gene expression": 0.01411, "human il-5 promoter/enhancer-luciferase gene construct": 0.0141, "hematopoietic gene expression": 0.0141, "affect gene expression": 0.0141, "tumor necrosis factor alpha gene": 0.01408, "down-regulate cd4 gene expression": 0.01408, "immunoglobulin heavy-chain gene expression": 0.01408, "endothelial cell activation": 0.01408, "enhance replicative gene expression": 0.01408, "thromboxane receptor gene promoter": 0.01407, "cd4 gene expression": 0.01406, "uncharacterized transcription factor called cd28 response complex": 0.01406, "tnf gene expression": 0.01406, "regulate adenoviral gene expression": 0.01406, "distinctive gene expression patterns": 0.01405, "nuclear factor kappab activation attenuates apoptosis resistance": 0.01405, "ifn-gamma gene expression": 0.01405, "human peripheral leukocytes ] [ regulatory effect": 0.01405, "human retinoic acid receptor alpha": 0.01405, "regulates gene expression": 0.01405, "cell activation events": 0.01404, "cell binding sites": 0.01404, "hla-dmb gene expression functions": 0.01404, "immunoglobulin gene expression": 0.01404, "tnf-alpha gene expression": 0.01404, "inducing jagged1 gene expression": 0.01404, "block ifn-stimulated gene expression": 0.01403, "gene expression patterns": 0.01403, "gal4-eed fusion protein represses transcription": 0.01402, "inducing socs-1 gene expression": 0.01402, "transcription factor stat1 activity": 0.01401, "regulate retinoid-mediated gene expression": 0.01401, "regulating rag gene expression": 0.01401, "regulate gene expression": 0.014, "early t-cell gene activation": 0.014, "csa inhibits lymphocyte gene activation": 0.014, "regulating gene expression": 0.014, "inducible gene expression": 0.014, "il-1 gene expression": 0.014, "repress late gene expression": 0.01399, "increased c-jun gene transcription": 0.01398, "stimulate bcl-xl gene expression": 0.01397, "human interleukin-2 receptor beta-chain promoter": 0.01397, "globin gene expression": 0.01397, "altered gene expression": 0.01397, "cell-specific gene expression": 0.01397, "htlv-i gene expression": 0.01397, "interleukin-2 gene expression": 0.01396, "induced stat6 dna binding activity": 0.01396, "activating differentiation-linked gene expression": 0.01396, "influence gene expression": 0.01395, "cell dexamethasone binding assay": 0.01395, "interleukin 2-directed gene expression": 0.01395, "camp-dependent protein kinase specific inhibitor h-89": 0.01395, "activator protein 1-mediated transcription": 0.01394, "il-6 gene expression": 0.01394, "blin-1 pre-b cell line expressing low levels": 0.01394, "human gene encoding lbr": 0.01394, "human gene therapy protocols": 0.01394, "human fetal globin expression": 0.01392, "cell antigen receptor function": 0.01392, "late gene expression": 0.01392, "oct-2 gene expression": 0.01392, "protein products mediate monocyte binding": 0.01392, "differential gene expression": 0.01392, "nk cell activation": 0.01392, "il-2 receptor alpha chain gene": 0.01391, "human gene encoding": 0.01391, "cd4 cell activation": 0.01391, "prostaglandin e2 up-regulates hiv-1 long terminal repeat-driven gene activity": 0.01391, "suppress il-4/il-13-inducible gene expression": 0.01391, "cat gene expression": 0.0139, "promote lymphokine gene expression": 0.0139, "il-10 prevents human monocyte nf-kappab activation": 0.0139, "lps-induced tf gene expression": 0.01389, "human monocyte-derived macrophages inhibited mmp-9 gelatinolytic activity": 0.01389, "gm-csf gene expression": 0.01389, "human erythroid alas gene": 0.01389, "cytochrome p4501a1 gene expression": 0.01388, "tissue-specific gene expression": 0.01388, "activate nf-kappa b-mediated gene transcription": 0.01388, "b-lymphocyte cell cycle activation": 0.01388, "egr-1 gene expression": 0.01388, "developmental stage-specific gene expression": 0.01388, "alter gene expression": 0.01387, "vcam-1 gene expression": 0.01387, "controlled gene expression": 0.01387, "peripheral blood mononuclear cell gcr binding affinities": 0.01387, "transactivate gene expression": 0.01386, "cytomegalovirus modulates interleukin-6 gene expression": 0.01386, "cd23 gene expression": 0.01386, "chemokine gene expression": 0.01385, "cell activation resulting": 0.01385, "decidual prl gene expression": 0.01385, "gata-3 represses gp91phox gene expression": 0.01385, "beta-catenin alters gene expression": 0.01385, "il-5 gene expression": 0.01385, "modulating perforin gene expression": 0.01385, "triggers nfkappab-mediated gene expression": 0.01384, "eosinophil gene expression": 0.01384, "activating transcription factor/camp response element binding": 0.01383, "replicative gene expression": 0.01383, "cd19 gene expression": 0.01383, "nonpituitary prl gene expression": 0.01383, "c5a-induced il-8 gene expression": 0.01383, "lt gene expression": 0.01382, "beta-globin gene expression": 0.01382, "junb gene expression": 0.01382, "-induced gene expression": 0.01382, "repress homeotic gene expression": 0.01382, "e2a-hlf chimeric protein induced t-cell apoptosis": 0.01382, "ig gene expression ceases": 0.01382, "il-8 gene expression": 0.01382, "cellular binding protein": 0.01381, "steroid-induced monokine gene expression": 0.01381, "protein activity": 0.01381, "cell receptor signaling pathways": 0.01381, "cell nuclear proteins": 0.01381, "gamma-globin promoter/luciferase gene expression": 0.01381, "interferon-gamma gene expression": 0.0138, "subsequent cell activation": 0.0138, "human inducible nitric oxide synthase gene": 0.0138, "targeting nfat-1-dependent gene expression": 0.0138, "construct suppressed reporter gene activity driven": 0.0138, "tf gene expression": 0.0138, "fos gene expression": 0.0138, "dra gene expression": 0.01379, "il-13 gene expression": 0.01379, "irf-1 gene expression": 0.01379, "bhlh heterodimer-dependent gene expression": 0.01379, "repress gene expression": 0.01379, "erythroid-specific gene expression": 0.01379, "drosophila extra sex combs gene displays transcriptional repressor activity": 0.01379, "il-4-induced gene expression": 0.01379, "usf2 up-regulate gene expression": 0.01379, "alters gene expression": 0.01379, "alpha-globin gene expression": 0.01378, "uv-induced cyp1a1 gene expression": 0.01378, "mononuclear cell activation": 0.01378, "hla-dra gene expression": 0.01378, "proteins inhibit tumor cell proliferation": 0.01378, "bak gene expression": 0.01378, "thymocyte-specific gene expression": 0.01378, "eed-restricted homeotic gene expression": 0.01377, "nf-kappab-dependent gene expression": 0.01377, "cell activation occurs": 0.01377, "hiv-2 gene expression": 0.01377, "megakaryocytic gene expression": 0.01377, "host cell activation": 0.01377, "igh gene expression": 0.01377, "b29 gene expression": 0.01377, "-2 gene expression": 0.01376, "myeloid-cell-specific gene expression": 0.01376, "tsc2 gene expression": 0.01376, "determining specific gene activation": 0.01376, "c5a-induced interleukin-8 gene expression": 0.01376, "cd3-epsilon gene expression": 0.01376, "nuclear transcription factor kappa beta": 0.01376, "gata-3 gene expression": 0.01376, "elk-1 gene expression": 0.01376, "nf-kappab transcription factor binding": 0.01376, "human tumor necrosis factor alpha": 0.01375, "ifnalpha-induced gene expression": 0.01375, "lymphocyte-specific gene expression": 0.01375, "sv40 gene expression": 0.01375, "rantes gene expression": 0.01375, "kappab-dependent gene expression": 0.01375, "il-4/il-13-induced il-1r gene expression": 0.01375, "interleukin-8 gene expression": 0.01374, "eukaryotic gene expression": 0.01374, "pml-rar gene expression": 0.01374, "ngal gene expression": 0.01374, "sr-bp gene expression": 0.01374, "human nm23-h2 gene product": 0.01374, "cd28 response complex transcription factor": 0.01374, "lyn gene expression": 0.01374, "il-1r gene expression": 0.01374, "tumor-suppressor gene expression": 0.01374, "il-13-induced gene expression": 0.01374, "il3 gene expression": 0.01374, "osm gene expression": 0.01373, "neutrophil-specific gene expression": 0.01373, "myeloid-specific gene expression": 0.01373, "gp91phox gene expression": 0.01373, "vascular-specific gene expression": 0.01373, "stat5-mediated gene expression": 0.01373, "il-9 gene expression": 0.01373, "il-4-inducible gene expression": 0.01373, "pim-1 gene expression": 0.01373, "nfat-1-mediated gene expression": 0.01373, "p27kip1 gene expression": 0.01373, "kappab-driven gene expression": 0.01373, "bcd gene expression": 0.01373, "il-4/il-13-induced gene expression": 0.01373, "ltr-directed gene expression": 0.01373, "aldh1 gene expression": 0.01373, "stat6-dependent gene expression": 0.01373, "dc-ck1 gene expression": 0.01373, "pafr gene expression": 0.01373, "tcr-inducible gene expression": 0.01373, "cell antigen receptor signals": 0.01373, "perforin gene expression": 0.01373, "hepor gene expression": 0.01373, "il-4-specific gene expression": 0.01373, "ifn-stimulated gene expression": 0.01373, "hsp gene expression": 0.01373, "gene expression": 0.01372, "cell receptor alpha enhancers": 0.01371, "hiv-1 ltr-driven reporter gene activity": 0.01371, "human b7.1 gene regulated": 0.01371, "transcription factor activity": 0.0137, "human il-4 gene": 0.01369, "crucial mhc class ii gene regulatory factor": 0.01369, "lymphocytes induce protein tyrosine phosphorylation": 0.01369, "cell receptor signal transduction cascade csa resistant": 0.01368, "recombinant il-2 increased nf-kappab binding activity": 0.01368, "primary nuclear transcription factors binding": 0.01366, "stimulation il-2 gene transcription": 0.01366, "pro-coagulant protein tissue factor": 0.01366, "human beta-globin gene locus": 0.01366, "500-bp human il-5 gene segment": 0.01365, "cell receptor gamma enhancer": 0.01363, "human bcl-2 gene": 0.01363, "distinct nuclear protein complexes": 0.01362, "cell type-specific activation": 0.01362, "ah receptor deficient c12 cell lines": 0.01362, "e2a gene encodes transcription factors": 0.01362, "cell receptor alpha": 0.01362, "t-helper cell activation": 0.0136, "class ii transcriptional mutant cell lines": 0.01359, "human ada lcr-directed transgene expression": 0.01358, "human cd4 gene": 0.01357, "cell activation": 0.01357, "human tnf-alpha gene": 0.01356, "parallel mitogen-activated protein kinase signaling pathways mediated": 0.01355, "human g0/g1 switch gene": 0.01354, "enhance il-1-induced nf-kappa b-dependent gene transcription": 0.01353, "regulate nf-kappa b-mediated gene transcription": 0.01353, "human t-lymphocyte gata-3 factors mediate transcription": 0.01351, "il-2r alpha gene transcription involves": 0.01351, "c/ebp beta blocked tnf alpha promoter activation": 0.01351, "antioncogenic transcription factor interferon regulatory factor": 0.01351, "human pml expression": 0.01351, "il-2 receptor alpha expression": 0.0135, "human tcf-1 gene encodes": 0.0135, "protein binding regions": 0.0135, "monocytic thp-1 cell line increased": 0.01349, "natural killer cell activity": 0.01349, "human ige germline gene": 0.01349, "human beta-globin expression": 0.01349, "protein factor present": 0.01348, "cell surface t-cell receptor": 0.01347, "human cytomegalovirus ul44 gene coding": 0.01347, "human interleukin-2 gene": 0.01347, "nk cell activity": 0.01346, "site mediates human immunodeficiency virus type": 0.01346, "lps binding protein": 0.01345, "human b29 gene lacks": 0.01344, "epidermal growth factor receptor displayed increased tyrosine phosphorylation": 0.01344, "activated jurkat cell line": 0.01343, "tumour necrosis factor alpha expression": 0.01343, "human beta-globin gene cluster depends": 0.01343, "endogenous nf-kappa b-dependent granulocyte-macrophage colony stimulating factor gene": 0.01342, "human chromosomal il-16 gene": 0.01341, "transfected cell lines expressed elevated levels": 0.01341, "human gm-csf gene": 0.01341, "human il-16 gene consists": 0.0134, "protein tyrosine kinase inhibitor genistein": 0.0134, "human ciita gene": 0.01339, "gm-csf receptor alpha promoter pu.1 site": 0.01337, "tata box binding protein": 0.01337, "myeloid cell nuclear differentiation antigen": 0.01335, "eosinophil granule major basic protein promoter": 0.01335, "glucocorticoid receptor positive cell population": 0.01334, "human cd19 gene": 0.01334, "human beta-globin gene": 0.01334, "human epor gene": 0.01334, "pml/rar alpha hybrid protein induced": 0.01334, "human aml1 gene": 0.01333, "transcription protein": 0.01333, "interleukin-10 inhibits interferon-gamma-induced intercellular adhesion molecule-1 gene transcription": 0.01332, "pebp2 alpha/aml-1-related factor increases osteocalcin promoter activity": 0.01332, "diverged human homeobox gene": 0.01332, "human cd14 gene": 0.01332, "human pax-5 gene": 0.01332, "box binding protein": 0.01332, "human gamma-globin gene": 0.01332, "cellular gene activation": 0.01331, "human irf-1 gene": 0.01331, "human il-13 gene": 0.01331, "human c-fes gene": 0.01331, "human tf gene": 0.01331, "human irf-2 gene": 0.0133, "ecs-dependent luciferase reporter gene activation": 0.0133, "interleukin-2 receptor alpha chain expression": 0.0133, "human homeobox gene": 0.01329, "mouse tnf-alpha gene displayed weak activity": 0.01329, "nf-kappab dna binding activity required": 0.01329, "il-2 gene activation": 0.01329, "human alpha-globin gene": 0.01329, "human b29 gene": 0.01329, "human cd5 gene": 0.01328, "human gata-3 gene": 0.01328, "human interleukin-4 gene": 0.01328, "human gata3 gene": 0.01328, "cell receptor transgenic mice": 0.01328, "mitogen-activated protein kinase pathway": 0.01327, "lymphocytes expressing human t-cell leukemia virus type": 0.01326, "human interleukin-6 gene": 0.01326, "human zeta-globin gene": 0.01326, "human b7.1 gene": 0.01326, "human interleukin-1beta gene": 0.01326, "nf-kappa b-mediated gene transcription": 0.01325, "human proenkephalin gene": 0.01325, "human cd3epsilon gene": 0.01325, "human carboxylesterase gene": 0.01325, "human epsilon-globin gene": 0.01325, "cell growth factor": 0.01325, "human lim-hox gene": 0.01325, "human dpa gene": 0.01325, "human epsilon-globin-encoding gene": 0.01325, "human eotaxin gene": 0.01325, "human delta-globin-encoding gene": 0.01325, "human lox-1 gene": 0.01325, "human lcr/gamma-globin gene": 0.01325, "human pro-interleukin-1beta gene": 0.01325, "human c/ebpepsilon gene": 0.01325, "human retinoblastoma gene": 0.01325, "human ifna2 gene": 0.01325, "human fosb gene": 0.01325, "human gene": 0.01324, "protein binding properties": 0.01322, "glucocorticoid receptor mrna expression": 0.01322, "transcription activator protein-2 binding site": 0.0132, "sp1/ap-2 site decreased promoter activity": 0.0132, "vivo protein binding": 0.0132, "transcription factors nuclear factor kappab": 0.01319, "primary human lymphocyte activation": 0.01318, "alpha gene transcription": 0.01318, "c3a induce nuclear factor kappab activation": 0.01317, "epstein-barr virus replicative gene transcription": 0.01315, "inducible early growth response protein egr-1": 0.01314, "bioactive macrophage colony-stimulating factor protein": 0.01313, "human ip-10 promoter region": 0.01313, "cyclosporin a-sensitive tumor necrosis factor-alpha gene transcription": 0.01312, "class ii gene transcription": 0.01312, "cell cycle-stimulatory activity": 0.01312, "cell activity": 0.01311, "positive transcription factor binding": 0.01311, "constitutive binding protein": 0.01311, "reporter gene activation": 0.01311, "kappa b-alpha inhibits transcription factor nf-kappa": 0.0131, "ebna2-oestrogen receptor fusion protein": 0.0131, "mip-1 alpha nuclear protein": 0.0131, "protein kinase inhibitor h-7 blocks accumulation": 0.01309, "cell receptor stimulation": 0.01309, "cell receptor signaling": 0.01309, "mip1 alpha nuclear protein": 0.01308, "adult t-cell leukemia cell line": 0.01307, "human 15-lo promoter region": 0.01307, "early gene activation": 0.01305, "human t-cell lymphotrophic virus-1 tax transactivator-induced luciferase activity": 0.01305, "induce reporter gene transcription": 0.01304, "gata-1 binding transcription factor": 0.01304, "human activation antigen cd69": 0.01304, "ige germline promoter reporter gene constructs carrying point mutations": 0.01303, "gene transcriptional activity": 0.01303, "kda protein factor": 0.01303, "octamer binding protein": 0.01303, "human interleukin-7 receptor complex": 0.01302, "nuclear transcription factor nf-kappa": 0.013, "yb-1 expression plasmid increases htlv-i basal transcription": 0.01299, "stat protein binding": 0.01298, "creb binding protein": 0.01298, "guanine nucleotide binding protein": 0.01298, "nf-kappa b/rel transcription factor family involved": 0.01297, "protein binding characteristics": 0.01297, "fk506 binding protein fkbp": 0.01296, "display constitutive nf-kappab dna binding activity": 0.01296, "polyomavirus enhancer-binding protein 2/core-binding factor": 0.01296, "ubiquitous protein neg-2 binding": 0.01296, "mitogen-activated protein kinase kinase": 0.01294, "epstein-barr virus nuclear protein": 0.01293, "receptor expression induces apoptosis": 0.01292, "ccaat binding protein nf-y": 0.01291, "protein kinase c-zeta mediates nf-kappa": 0.01291, "receptor alpha chain gene": 0.01291, "activator protein-1-responsive gene activation": 0.0129, "inhibit il-2 gene transcription": 0.0129, "ccaat/enhancer binding protein epsilon": 0.01289, "increased protein kinase": 0.01289, "cre binding protein": 0.01288, "granulocyte-macrophage colony-stimulating factor promoter activity": 0.01286, "rhombotin-2 binding ets transcription factor": 0.01286, "cle0 binding protein": 0.01286, "tumor necrosis factor receptor signaling pathway": 0.01285, "activation and/or expression": 0.01284, "tissue-specific transcription factor binding": 0.01284, "lymphocyte gene activation": 0.01284, "host cell transcription": 0.01283, "up-regulate protein binding": 0.01283, "e2f-1 binding protein": 0.01283, "ccaat/enhancer binding protein": 0.01282, "e1 binding protein": 0.01282, "cell antigen receptor": 0.01282, "reduces transcription factor binding": 0.01282, "protein kinase a/protein kinase": 0.01282, "immunosuppressant binding protein": 0.01282, "tumor necrosis factor alpha activation": 0.01281, "microb binding protein": 0.01281, "maltose binding protein": 0.0128, "e2f-i binding protein": 0.0128, "murine b-cell lymphoma cell line a20": 0.0128, "tata-box binding protein": 0.0128, "guanylate binding protein": 0.0128, "increased oestrogen receptor expression": 0.0128, "lps-lps binding protein": 0.0128, "cyclic nucleotide-dependent protein kinase inhibitor ha-1004": 0.0128, "60-kda protein binding": 0.0128, "protein binding": 0.01279, "binding protein": 0.01279, "affect nf-kappab dna binding activity": 0.01279, "human genomic dna sequence upstream": 0.01278, "control tnf-alpha gene transcription": 0.01275, "cell receptor induces": 0.01275, "cell restricted cytoplasmic factor": 0.01275, "mediate gene activation": 0.01274, "non-il-5-producing cell line activated": 0.01273, "nfil-2b nuclear protein complexes": 0.01273, "nonspecific serine/threonine protein kinase inhibitor staurosporine": 0.01273, "cell type oct-2 proteins": 0.01273, "il-2 promoter [ distal nuclear factor": 0.01273, "cell receptor coengagement and/or exposure": 0.01272, "nuclear protein complexes": 0.01272, "human immunodeficiency virus type-1 transcription": 0.01271, "cell line activated": 0.01271, "human immunodeficiency virus transcription": 0.0127, "ifn-gamma-induced reporter gene activity": 0.0127, "cd16 ligands induces nfat-like dna binding activity": 0.0127, "enhanced il-4 gene transcription": 0.0127, "regulates il-2 gene transcription": 0.01269, "transcription factor binding": 0.01268, "nf-kappa b-independent hiv promoter domain activity": 0.01267, "reporter gene activity": 0.01265, "tfiia expression vectors enhanced tax-activated transcription": 0.01265, "serine/threonine protein kinase inhibitor h-7": 0.01265, "myelomonocytic cell specific genes": 0.01264, "cd4 gene activation": 0.01263, "increased glucocorticoid receptor binding sites": 0.01263, "detectable nf-kappab dna binding activity": 0.01262, "cell lymphotropic virus type i. nf-kappa": 0.01262, "proteasome inhibitor mg-132 blocked tnf -and lps-stimulated u-937 cell adhesion": 0.01262, "nuclear transcription factor kappa": 0.01261, "nuclear transcription factor-kappab activation": 0.0126, "increased cd38 protein levels": 0.0126, "selectively inhibits transcription factor nf-kappab [": 0.0126, "interferon beta gene transcription": 0.0126, "human interleukin-9 receptor alpha chain": 0.01259, "tnf alpha induces cell differentiation": 0.01259, "monocyte cell lines induced": 0.01258, "protein levels increased": 0.01258, "human b-cell activation": 0.01257, "activated protein kinase": 0.01257, "protein shows significant sequence similarities": 0.01257, "stimulate il-2 gene transcription": 0.01256, "cis-elements bound specific protein factors": 0.01255, "induce cd4 gene transcription": 0.01255, "turn affect neutrophil-to-tumor cell binding": 0.01254, "globin gene activation": 0.01254, "phorbol myristate acetate induced egr-1 mrna expression": 0.01254, "human lymphocyte activation": 0.01252, "nuclear transcription factor c/ebp beta": 0.01252, "protein kinase inhibitor": 0.01252, "cell surface receptor": 0.01252, "cell type-specific enhancer region": 0.01251, "acute myeloid leukemia m2-type cell line": 0.01251, "androgen-bound receptor protein": 0.01251, "regulated fork head domain transcription factor family": 0.0125, "derived protein sequence": 0.0125, "epstein-barr virus membrane protein expressed": 0.0125, "notch receptor protein": 0.0125, "defective il-2 gene transcription": 0.0125, "mitogen-activated protein kinase family": 0.01249, "receptor protein": 0.01249, "gm-csf gene activation": 0.01247, "maximal gene activation": 0.01247, "thrombin receptor mrna expression": 0.01247, "tnf alpha gene promoter": 0.01247, "major inducible protein complex": 0.01247, "gene activation identical": 0.01247, "cell nuclear factors": 0.01246, "nf-kappab sites reduced il-1alpha promoter activity": 0.01246, "gene activation shows": 0.01245, "autologous lymphoblastoid cell line stimulation": 0.01245, "infected promonocytic u1 cell line show": 0.01245, "nuclear membrane protein related": 0.01245, "transcription factor consensus sequence oligonucleotides": 0.01244, "ox ldl enhanced dna binding activity": 0.01244, "retinoic acid-resistant acute promyelocytic leukemia cell line": 0.01244, "express ap-1 dna binding activity": 0.01242, "efficient gene activation": 0.01242, "nf-kappab dna binding activity": 0.01241, "salicylates affect cytokine gene transcription": 0.0124, "true protein kinase c-mediated signal transduction event": 0.0124, "tax transfected jurkat cell line": 0.01239, "vitro activated normal human lymphocytes": 0.01239, "induces tf gene transcription": 0.01239, "u2 snrna-encoding gene activation": 0.01239, "hiv-1 gene transcription": 0.01239, "purified protein derivative induced": 0.01239, "class ii mutant cell lines": 0.01239, "immediate-early activation gene": 0.01238, "fasl gene activation": 0.01237, "il-2 gene transcription": 0.01236, "mature monocytic leukemia cell line thp-1": 0.01236, "murine myeloid precursor cell line": 0.01236, "irf-1 gene activation": 0.01236, "stat1-dependent gene activation": 0.01236, "nitric oxide synthase regulates nuclear factor kappab activity": 0.01235, "transforming growth factor beta suppressed activation": 0.01235, "cd3 complex induced expression": 0.01234, "receptor alpha gene": 0.01234, "thromboxane receptor promoter activity": 0.01234, "mitogen-activated protein kinase signaling cascade": 0.01234, "leukemia cell line jurkat": 0.01234, "human recombinant tumor necrosis factor": 0.01233, "recombinant human tumor necrosis factor": 0.01233, "cell receptor gamma": 0.01231, "reduced oct-1 dna binding activity": 0.01231, "ifn-gamma induced hla class ii antigens expression": 0.0123, "cell-cycle gene activation": 0.0123, "alpha protein levels": 0.0123, "vascular cell adhesion molecule-1 genes": 0.01229, "gene activation": 0.01229, "lymphoblastoid cell lines induced": 0.01229, "1311-base pair human tumor necrosis factor": 0.01228, "increased nf-kappab binding activity": 0.01227, "cell cycle regulated histone h4 genes": 0.01226, "il-2 involves p38 mitogen-activated protein kinase": 0.01226, "complex regulatory protein network": 0.01226, "hl-60 myeloid leukemia cell line": 0.01226, "stem cell factor": 0.01226, "ag receptor cross-linking induces transient expression": 0.01226, "philadelphia chromosome-positive chronic myelogenous leukemia cell line": 0.01225, "neutrophil-like hl60 cell binding": 0.01224, "nf-kappa b/rel protein family": 0.01224, "tax transformed mouse fibroblastic cell line": 0.01223, "multiple transcription start site region": 0.01223, "epstein-barr virus oncoprotein latent infection membrane protein": 0.01223, "acute lymphoblastic leukemia cell line reh": 0.01223, "enhanced dna binding activity": 0.01222, "thp-1 myeloid leukemia cell line": 0.01222, "normal human peripheral blood lymphocytes stimulated": 0.01221, "induce gene transcription": 0.01221, "murine fdc-p1-derived cell line wt-19 transfected": 0.01221, "heat activation step promoted dna binding": 0.0122, "human gm-csf receptor alpha": 0.01219, "cellular transcription factor nuclear factor-kappa": 0.01219, "hl-60 cell differentiation induced": 0.01219, "p38 mitogen-activated protein kinase mediates signal integration": 0.01218, "cell leukemia-derived factor": 0.01218, "reporter gene transcription": 0.01217, "wild type cell line": 0.01217, "suppress cytokine gene transcription": 0.01217, "protein tyrosine kinase activities p56lck": 0.01216, "mutant jak1-deficient hela cell line": 0.01216, "melana/mart1+ mm cell line enhanced": 0.01216, "specific protein kinase": 0.01215, "class ii major histocompatibility complex-negative cell lines": 0.01215, "cell factor": 0.01214, "immunoblot analysis identified fli-1 protein": 0.01212, "early gene transcription": 0.01212, "cell receptor alpha/delta locus": 0.01212, "nf-at protein complex": 0.01212, "intracellular il-2 receptor expression": 0.01211, "igg fc receptor type ic gene": 0.01211, "negative regulatory protein kinase glycogen synthase kinase-3beta": 0.01211, "-1 transcription factor genes": 0.01211, "toxins affected kappab binding activity induced": 0.0121, "binds nuclear protein": 0.0121, "expressed pou domain transcription factor oct-1": 0.0121, "cell receptor involvement": 0.0121, "class ii major histocompatibility complex gene hla-dra": 0.01209, "fcr-mediated nuclear factor activation": 0.01208, "hiv infected u937 cell line": 0.01208, "human mineralocorticoid receptor hormone-binding domain": 0.01207, "termed nuclear inhibitory protein": 0.01207, "inhibit gm-csf gene transcription": 0.01207, "ah receptor recognizes dna binding sites": 0.01206, "protein tyrosine kinase inhibitors": 0.01206, "nf kappa b/rel transcription factor family": 0.01205, "cell surface proteins": 0.01205, "multiple nuclear factor binding motifs": 0.01205, "ligation induces protein tyrosine phosphorylation": 0.01204, "dna protein interactions": 0.01203, "major human class ii genes": 0.01203, "increased viral protein secretion": 0.01203, "macrophage tissue factor expression": 0.01203, "class ii major histocompatibility complex gene dpa": 0.01203, "human retinoid-x receptor alpha": 0.01202, "vcam-1 promoter reporter gene constructs": 0.01202, "cell nuclear extracts demonstrated": 0.01202, "protein tyrosine kinase zap-70 plays": 0.01202, "human beta-globin dominant control region function": 0.01202, "murine macrophage cell line raw": 0.01201, "predicted protein sequence": 0.01201, "control cell line": 0.012, "kappa b-alpha protein levels": 0.012, "murine p388d1 macrophage cell line": 0.012, "lymphoblastic tumor cell line": 0.01199, "cytokine gene transcription": 0.01199, "cell receptor cross-linking": 0.01198, "hl-60 promyelocytic leukemia cell line": 0.01198, "jurkat cd4+ cell line": 0.01198, "similar dna binding activity": 0.01198, "alkaline phosphatase restores nfatp dna binding activity": 0.01197, "impaired ap-1 dna binding activity": 0.01197, "comparative analysis identifies conserved tumor necrosis factor receptor-associated factor": 0.01197, "protein kinase c-independent mechanism": 0.01196, "kda sterol regulatory element binding factor": 0.01195, "epstein-barr virus transformed lymphoid cell lines": 0.01195, "growth-factor-dependent myeloid cell line derived": 0.01195, "high level cd19 promoter expression": 0.01195, "epstein-barr virus oncogene product latent membrane protein": 0.01195, "cd28 adhesion molecules induces long-term nuclear expression": 0.01194, "cell line cess demonstrated": 0.01194, "metabolized transcription factor proteins": 0.01194, "phorbol ester-sensitive protein kinase c.": 0.01193, "sm protein sequence": 0.01193, "gata-1 regulate red cell genes": 0.01193, "cell membrane proteins": 0.01193, "cell line demonstrated": 0.01193, "inhibit lipopolysaccharide-induced gene transcription": 0.01192, "transcription factor proteins": 0.01192, "target gene transcription": 0.01192, "jnk inhibited il-2 promoter activation": 0.01192, "ebv nuclear protein": 0.01192, "gene silencing activity": 0.0119, "human il-2r alpha promoter": 0.0119, "activates gene transcription": 0.0119, "flanking region augments alpha-globin promoter activity": 0.01189, "cell cycle regulating proteins": 0.01189, "nf-at dna binding activity": 0.01189, "cell antigen receptor/cd3 complex": 0.01189, "class ii-positive nonlymphoid glioblastoma cell line": 0.01189, "ap-1 transcription factor complex": 0.01189, "induced nuclear expression": 0.01189, "murine pre-b cell line": 0.01189, "dna binding activity mediated": 0.01189, "murine ra-inducible mpro promyelocyte cell line": 0.01188, "endocrine cell type-specific complex formation": 0.01188, "full gene activity": 0.01188, "il-4 inhibited lps-induced ap-1 binding activity": 0.01187, "transcription factors regulates activity": 0.01187, "cell ag receptor": 0.01187, "gamma gene transcription": 0.01187, "c-jun gene transcription": 0.01187, "inhibits monocyte tissue factor activation": 0.01186, "specific protein inhibitor": 0.01186, "mutant cell line": 0.01185, "v-abl protein tyrosine kinase triggers high-frequency rearrangement": 0.01185, "murine pro-b cell line baf3": 0.01184, "murine macrophage-like cell line raw": 0.01184, "inducible protein complex": 0.01184, "renal cell carcinoma patients exhibit": 0.01184, "phorbol ester nonresponsive atypical protein kinase": 0.01184, "murine pro-b cell line ba/f3": 0.01184, "gene activity": 0.01183, "transcription factor genes": 0.01183, "tissue factor expression": 0.01182, "n9 murine microglial cell line": 0.01182, "regulates il-5 gene transcription": 0.01182, "protein tyrosine kinase dependent": 0.01182, "glucocorticoid receptor regulates expression": 0.01181, "inducible oct-2 dna binding activity": 0.01181, "vitro synthesized human glucocorticoid receptor": 0.0118, "cd3/t cell receptor": 0.0118, "affect dra gene transcription": 0.0118, "il-4 gene transcription": 0.0118, "fetal erythroid cell line": 0.0118, "c-fos proteins mediated anti-cd19 induced ap-1-binding activity": 0.01179, "data suggest ap-1 regulated cytokine mrna expression": 0.01179, "protein kinase c-activating phorbol ester": 0.01179, "cell receptor": 0.01179, "kappa gene promoter": 0.01178, "ap-1-binding sites influence il-2 promoter activity": 0.01178, "multifunctional ca2+/calmodulin-dependent protein kinase ii": 0.01178, "c5a induced kappab binding activity": 0.01177, "group iii ebv genome carrying cell lines": 0.01177, "porcine vascular endothelial cell line piec": 0.01177, "calcium/calmodulin-dependent protein kinase ii downregulates": 0.01177, "nef protein inhibits nf-kappa": 0.01177, "ap-1 dna binding activity": 0.01177, "peripheral blood mononuclear cell glucocorticoid receptors": 0.01176, "delayed il-2 receptor expression": 0.01176, "cd14 positive monocytic cell line mono mac": 0.01176, "mouse thymocyte cell line": 0.01175, "protein kinase c-activating phorbol esters": 0.01175, "mouse plasmacytoma cell line": 0.01175, "constitutive dna binding activity consisting": 0.01175, "human myeloid nuclear differentiation antigen": 0.01175, "tnf receptor surface expression": 0.01174, "jun protein complex": 0.01174, "b104 cell growth induced": 0.01174, "nuclear dna-binding protein": 0.01174, "hematopoietic gene transcription": 0.01173, "beta globin gene upstream element": 0.01173, "mouse granulocyte/macrophage colony-stimulating factor gene": 0.01173, "nuclear protein extracts": 0.01172, "p65 dna binding activity": 0.01172, "truncated beta gene promoter": 0.01172, "er-negative breast cancer cell line": 0.01172, "protein kinase c-dependent signals": 0.01171, "transcriptional regulatory protein nf-kappab": 0.01171, "mouse t-lymphoma cell line": 0.01171, "activated normal human lymphocytes": 0.01171, "monocytic cell line u937 calcineurin": 0.01171, "human mhc class ii genes": 0.0117, "human stat proteins activated": 0.0117, "regulate ar gene transcription": 0.0117, "activate protein kinase c.": 0.0117, "sterol dependent ldl-receptor gene transcription": 0.01169, "tap-deficient cell lines lacking antigenic er peptides derived": 0.01169, "parallel mitogen-activated protein kinase pathways": 0.01169, "ifn-gamma gene transcription": 0.01169, "gata-1 dna binding activity": 0.01168, "ap-1 transcription factor family demonstrated": 0.01168, "tnf-alpha gene transcription": 0.01168, "suppresses insulin gene transcription": 0.01168, "enhance il-4-induced gene transcription": 0.01168, "human androgen receptor assay": 0.01167, "uninfected jurkat cell line": 0.01167, "tissue factor gene": 0.01167, "enhance dra gene transcription": 0.01167, "il-2 receptor expression": 0.01167, "thp-1 mature monocytic cell line": 0.01166, "human immunodeficiency virus promoter": 0.01165, "constitutive dna binding activity": 0.01165, "constitutively express functional human immune deficiency virus type": 0.01165, "model monocytic cell line": 0.01165, "cell line jurkat j6": 0.01165, "nfat dna binding activity": 0.01164, "histone h4 gene transcription": 0.01164, "inducing gene transcription": 0.01164, "cell line jurkat": 0.01164, "regulate gene transcription": 0.01164, "phorbol ester-responsive protein kinase": 0.01164, "regulating gene transcription": 0.01163, "pge2 induces specific binding activity": 0.01163, "myeloid leukemic cell line": 0.01163, "mitogen-activated protein kinase pathways": 0.01163, "ebv producer cell line b95.8": 0.01163, "infected monocyte/macrophage-like cloned cell line": 0.01162, "tpa activates protein kinase": 0.01161, "globin gene transcription": 0.01161, "cell-specific gene transcription": 0.0116, "t-cell receptor gene rearrangement": 0.0116, "z29 strain increased hiv promoter activity": 0.0116, "human expressed sequence tag isolated": 0.0116, "v-abl protein tyrosine kinase": 0.01159, "lymphocyte-specific protein tyrosine kinase": 0.01159, "interleukin-2 gene transcription": 0.01159, "identical steroid hormone receptor expression": 0.01158, "il-6 gene transcription": 0.01158, "cell line lacking stat3": 0.01157, "derived b-lymphoblastoid cell line": 0.01157, "lck-defective cell line derived": 0.01157, "cell line nk3.3 derived": 0.01157, "rat macrophage cell line r2": 0.01157, "represses vcam-1 gene transcription": 0.01157, "control basal human t-cell lymphotropic virus type": 0.01156, "protein tyrosine kinase": 0.01156, "higher-order protein complex": 0.01156, "tyrosine protein kinase": 0.01156, "activated human peripheral blood lymphocytes": 0.01156, "vitamin d-resistant cell nuclear extract contained": 0.01156, "monocytic u937 cell line differs": 0.01156, "cell line derived": 0.01156, "human motor activity": 0.01155, "plasma cell line": 0.01155, "icam-1 promoter luciferase reporter gene": 0.01155, "protein complex": 0.01155, "binding activity induced": 0.01155, "stimulate gene transcription": 0.01155, "epstein-barr virus latent membrane protein lmp1": 0.01154, "epithelial cell line transfected": 0.01154, "receptor beta chain [ il-2rbeta ] extracellular domain fused": 0.01154, "erythroid cell line": 0.01154, "activate mitogen-activated protein kinase": 0.01154, "phorbol ester treated myeloid cell lines": 0.01154, "pu.1 dna binding activity": 0.01154, "ferritin h-chain gene promoter regulation": 0.01153, "gm-csf gene transcription": 0.01153, "oct-2 dna binding activity": 0.01153, "corticosteroid receptors [ human glucocorticoid receptors": 0.01153, "infected monocytic cell line": 0.01153, "selectively increased cell regulatory properties": 0.01153, "monocytic cell type-specific transcriptional induction": 0.01153, "hhv-6 upregulates zebra gene transcription": 0.01152, "myeloid cell lines expressed": 0.01152, "protein kinase c-mediated pathways": 0.01152, "oct-1 dna binding activity": 0.01152, "granulocyte colony-stimulating factor receptor promoter": 0.01151, "infected autologous lymphoblastoid cell line": 0.01151, "mediates epstein-barr virus latent membrane protein": 0.01151, "multi-protein hematopoietic-specific transcription factor complex": 0.01151, "bcl-2 protein inhibits bufalin-induced apoptosis": 0.01151, "vcam-1 gene transcription": 0.0115, "cd4-positive lymphocyte cell line": 0.0115, "gcs up-regulate cytokine receptor expression": 0.0115, "insulin gene transcription": 0.0115, "relb protein nuclear localization": 0.0115, "hematopoietic precursor cell line": 0.0115, "hybrid protein pml/rar alpha present": 0.0115, "tnf mrna expression induced": 0.0115, "lymphocyte cell line libraries": 0.0115, "increased stat1 binding activity": 0.0115, "cell line expressing": 0.01149, "monocytic cell line u937": 0.01149, "cell nuclear extracts bound": 0.01149, "il-5 gene transcription": 0.01149, "human il2 upstream enhancer region": 0.01149, "u937 monocytic cell line": 0.01149, "il-1beta gene transcription": 0.01149, "specific transcription factor complexes": 0.01149, "glucocorticoid receptor expression": 0.01148, "lymphocyte cell line": 0.01148, "tumor necrosis factor alpha [ tnf-alpha ]": 0.01148, "interferon-induced transcription factor complex isgf3": 0.01148, "hla-dr/-dq positive parental cell line": 0.01148, "bsap-stimulated cd19 gene transcription": 0.01147, "cell lines expressed vitamin": 0.01147, "increased cell apoptosis": 0.01147, "leukemic cell line k562": 0.01147, "nf-kb dna binding activity": 0.01147, "kappab dna binding activity": 0.01147, "u937 macrophage cell line": 0.01146, "continuous myeloid cell line presenting": 0.01146, "macrophage cell line u937": 0.01146, "bone marrow-derived stromal cell line": 0.01146, "epo-inducible tal1 dna binding activity": 0.01146, "cell cycle control kinase cdc2": 0.01146, "soluble nuclear protein": 0.01146, "inhibited vascular cell adhesion molecule": 0.01146, "beta-globin gene transcription": 0.01145, "il-6 gene promoter stimulated": 0.01145, "t-cell activation response element": 0.01145, "promoter mediates endothelial icam-1 expression": 0.01145, "transcription factor complex": 0.01145, "initial viral latent gene promoter": 0.01145, "cell mediated immune response": 0.01144, "unidentified ets family protein binds": 0.01144, "murine cyclin-dependent kinase inhibitor gene p27kip1": 0.01144, "alpha expression increased events distal": 0.01144, "ig gene transcription": 0.01144, "epstein-barr virus oncoprotein latent membrane protein": 0.01143, "blocking gene transcription": 0.01143, "tf gene transcription": 0.01143, "stat5a dna binding activity": 0.01143, "hematopoietic progenitor cell line": 0.01143, "camp -and protein kinase": 0.01143, "sequence-specific dna binding activity": 0.01143, "related protein c/ebp alpha": 0.01143, "stat1-dependent gene transcription": 0.01142, "human monocyte il-1 receptor antagonist": 0.01142, "cellular gene regulatory molecules induced": 0.01142, "dra gene transcription": 0.01142, "il-1alpha gene transcription": 0.01142, "tnf- and/or anti-fas- induced cell death": 0.01141, "interleukin-1 gene transcription": 0.01141, "growth factor-dependent cell lines expressing": 0.01141, "infected promonocytic cell line u1": 0.01141, "tcr-mediated gene transcription": 0.01141, "ngf-responsive rat pheochromocytoma cell line": 0.01141, "camp-dependent protein kinase activities": 0.0114, "steroid hormone receptor expression": 0.0114, "cell leukemia virus type": 0.0114, "fibronectin-induced interleukin-beta gene transcription": 0.0114, "control beta-actin gene promoter": 0.01139, "trna gene transcription": 0.01139, "individual protein factors bind": 0.01139, "nuclear transcription factor kb": 0.01139, "ebna gene transcription": 0.01139, "ebv genome positive lymphoid cell lines": 0.01139, "infected promyelocyte cell line om10.1": 0.01139, "mbp gene transcription": 0.01139, "sickle cell anemia patients": 0.01139, "cepsilon gene transcription": 0.01138, "monocytic cell line thp-1": 0.01138, "stat1 alpha protein bound": 0.01138, "dna binding activity indistinguishable": 0.01138, "thp-1 monocytic cell line": 0.01138, "interleukin-1beta gene transcription": 0.01138, "stat-mediated gene transcription": 0.01137, "cell line tested": 0.01137, "cyclic-amp responsive element binding factor": 0.01137, "thp-1 mononuclear phagocyte cell line": 0.01137, "tnf increased vcam-1 protein": 0.01136, "redox-dependent gene transcription": 0.01136, "nuclear tal1 protein": 0.01136, "human rel family proteins": 0.01136, "alpha/mad-3 gene transcription": 0.01136, "rag gene transcription": 0.01136, "carboxylesterase gene transcription": 0.01136, "ldl-receptor gene transcription": 0.01136, "proil-1beta gene transcription": 0.01136, "inhibits tumor cell apoptosis": 0.01136, "hla-dm gene transcription": 0.01136, "lymphoid cell line": 0.01135, "gene transcription": 0.01135, "potent protein phosphatase inhibitor": 0.01135, "beta globin gene flanking region": 0.01135, "nfatx1 dna binding activity": 0.01135, "phase-specific dna binding activity": 0.01134, "hemin-induced dna binding activity": 0.01134, "activates protein kinase": 0.01134, "nf-il-6 dna binding activity": 0.01134, "pif dna binding activity": 0.01134, "monocyte cell line": 0.01134, "il-10 inhibits nuclear factor-kappa b/rel nuclear activity": 0.01134, "cell cycle-related proteins": 0.01134, "murine gm-csf gene promoter": 0.01133, "dna binding activity": 0.01133, "cell proteins": 0.01133, "cell enhancer sites": 0.01133, "inhibited ap-1 binding activity": 0.01132, "infected promonocytic cell line": 0.01132, "histamine induced mrna expression": 0.01132, "hematopoietin receptor superfamily lacking intrinsic kinase activity": 0.01132, "ebv latent infection membrane protein lmp1": 0.01132, "nf-kappab transcription factor family": 0.01131, "myeloid cell line": 0.01131, "hematopoietic cell line": 0.01131, "egr-1 mrna expression induced": 0.01131, "monocytoid u937 cell line": 0.01131, "natural killer cell line": 0.01131, "vitamin d-responsive cell line": 0.01131, "cytokine receptor expression": 0.01131, "il-2 gene promoter": 0.01131, "ikappab-alpha protein levels decreased": 0.0113, "vitamin d-resistant cell line": 0.0113, "affect mitogen-activated protein kinase": 0.0113, "infected survivor cell line": 0.0113, "human interferon regulatory factor": 0.0113, "steel factor affects scl expression": 0.0113, "myeloid differentiation primary response gene": 0.01129, "nk cell line nk92": 0.01129, "nuclear protein hmg-i": 0.01129, "normal human peripheral blood lymphocytes": 0.01129, "cell type-specific genes": 0.01129, "infected cell line": 0.01129, "promonocytic cell line u937": 0.01128, "u937 promonocytic cell line": 0.01128, "epstein-barr virus latent membrane protein": 0.01128, "lymphoma cell line": 0.01128, "parent cell line u937": 0.01127, "constitutively activated tumor necrosis factor receptor": 0.01127, "membrane receptor expression": 0.01127, "neutrophil-endothelial cell adhesion induced": 0.01127, "cell growth-related genes": 0.01127, "apoptosis sensitive cell lines": 0.01126, "nuclear egr1 protein": 0.01126, "cell responses induced": 0.01126, "plzf nuclear protein": 0.01126, "pro-monocytic cell line u937": 0.01126, "cell surface induced": 0.01126, "monoblastoid u937 cell line": 0.01126, "monocytic cell line u1": 0.01126, "receptor gene constructs": 0.01126, "monoblastoid cell line u937": 0.01126, "auxiliary nuclear protein": 0.01125, "multipotent progenitor cell line transformed": 0.01125, "lps stimulated vascular cell adhesion molecule": 0.01125, "monocytic cell line mono mac": 0.01125, "important transcription factor nf kappa": 0.01125, "41-kda nuclear protein": 0.01125, "bcr1 type-pml/rar alpha fusion protein": 0.01124, "cell leukemia induced": 0.01124, "cell cycle-controlling genes": 0.01124, "leukemic cell line": 0.01124, "nuclear protein": 0.01124, "proinflammatory transcription factor nuclear factor-kappab": 0.01124, "cell cycle-associated genes": 0.01124, "e. chaffeensis induces potent proinflammatory cytokine mrna expression": 0.01124, "protein kinase a-dependent fashion": 0.01124, "protein synthesis inhibitor cycloheximide": 0.01123, "cell genes": 0.01123, "human t-cell line jurkat carrying": 0.01122, "murine gammac promoter gene": 0.01122, "increased tumor cell killing": 0.01122, "human gata3 transcription unit": 0.01121, "plzf-rar alpha fusion protein": 0.01121, "stimuli affect mitogen activated protein": 0.01121, "alpha expression increased constitutive": 0.0112, "cell type and/or differentiation step": 0.0112, "erythroleukemia cell line k562": 0.0112, "lr1-dna binding activity increased": 0.0112, "phosphorylated p42/p44 mitogen-activated protein kinase": 0.01119, "and/or protein kinase": 0.01119, "eukaryotic transcription factor nuclear factor-kappa": 0.01119, "mycobacterium tuberculosis -induced interleukin-2 receptor expression": 0.01119, "related paired domain protein pax-1": 0.01119, "genomic lmp1 dna fragments enhanced lmp1 expression": 0.01119, "transcription activation function": 0.01118, "dibutyryl camp inhibited cell growth": 0.01118, "hl-60 cell line": 0.01118, "monocytic cell line mm6": 0.01118, "cyclic amp response element-binding protein": 0.01118, "increased binding activity": 0.01118, "induced 24-hydroxylase mrna expression": 0.01117, "gata factor expression": 0.01117, "cell nfat complex": 0.01117, "transcription factor nuclear factor-kappab": 0.01117, "recombinant human soluble dimeric tnf receptor": 0.01117, "monocytic cell line": 0.01117, "human epsilon germline transcription": 0.01116, "murine thy-1 gene promoter": 0.01116, "transcription factor nuclear factor-kappa": 0.01116, "erythroleukemic cell line k562": 0.01116, "stress- activated protein kinases": 0.01115, "protein synthesis inhibitor anisomycin": 0.01115, "cell-specific transcription factor tcf-1 alpha plays": 0.01115, "inhibit phytohemagglutinin-induced peripheral blood mononuclear cell proliferation": 0.01115, "k562 cell line": 0.01115, "transformed t-lymphocyte cell line": 0.01114, "cellular protein tyrosine kinases": 0.01114, "specific protein interactions": 0.01114, "protein synthesis inhibitor": 0.01114, "u-373 mg glioblastoma cell line": 0.01114, "75-kda hematopoietic cell-specific intracellular signaling protein": 0.01114, "u-937 monoblastic cell line": 0.01114, "macrophage colony-stimulating factor gene": 0.01114, "nf-kappab-like nuclear transcription factor": 0.01114, "cell growth induction": 0.01114, "undifferentiated scc cell line": 0.01113, "cell line thp-1": 0.01113, "macrophage cell line": 0.01113, "cell line occurs": 0.01113, "nuclear transcription factor": 0.01113, "leukemia cell lines transient overexpression": 0.01113, "thp-1 cell line": 0.01113, "human t-cell receptor": 0.01113, "suggest monocyte mcp-1 expression induced": 0.01113, "influence tcr-induced protein tyrosine phosphorylation": 0.01113, "lipopolysaccharide-induced interleukin-1 beta protein production": 0.01113, "putative protein kinase": 0.01113, "hiv enhancer-binding protein nf-kappa": 0.01113, "u-937 cell line": 0.01113, "s6 protein demonstrated stimulation": 0.01112, "nb4 apl cell line": 0.01112, "% human serum expressed ppargamma mrna": 0.01112, "cell lines expressing antisense egr-1 rna": 0.01112, "mink cell focus-forming murine leukemia virus": 0.01111, "leucine zipper protein family suggests c-myb": 0.0111, "transcription factor nf-kappa b. hiv-1-infected individuals": 0.0111, "ut-7 cell line exhibits": 0.01109, "extracellular signal-regulated protein kinase": 0.01109, "cd28 cell surface molecule delivers costimulatory signals essential": 0.01109, "erythroid transcription factor p45 nf-e2 mrna": 0.01109, "granulocyte-macrophage colony-stimulating factor gene": 0.01108, "cell proliferation response": 0.01108, "myeloid-committed eosinophil cell line": 0.01108, "human il4 promoter-mediated transcription": 0.01108, "il-1 receptor-associated protein kinase": 0.01108, "constitutive mhc class ii mrna expression": 0.01107, "inducible protein kinase": 0.01107, "camp response element-binding protein": 0.01107, "serum-independent hl60 cell line": 0.01107, "protein kinase c.": 0.01107, "cd34+ myelomonocytic cell line kg1 differentiates": 0.01107, "box1 motif abrogated il-9-induced cell proliferation": 0.01107, "key transcription factor mediating il-2-induced t-cell proliferation": 0.01107, "p50 subunit gene promoter underlies self-perpetuation": 0.01107, "apoptotic cell death induced": 0.01107, "human il4 transcription": 0.01107, "vitamin d-resistant cell nuclear extract": 0.01106, "cell lines lacking oct-2 results": 0.01106, "cell cycle arrest induced": 0.01106, "cell line raji": 0.01106, "nk cell-induced hla-dr alpha mrna expression": 0.01105, "cyclic amp-dependent protein kinase": 0.01105, "mitogen-activated protein kinase cascade": 0.01105, "lymphoblastoid cell line": 0.01105, "pge2 inhibited cell proliferation": 0.01105, "hybridoma cell line": 0.01105, "androgen receptor gene mutations": 0.01104, "promoter activity induced": 0.01104, "plasma cell pathway": 0.01104, "parental cell line": 0.01104, "human beta-globin locus control region": 0.01104, "retinoid-resistant promyelocytic cell line": 0.01104, "lymphocytic cell line ach-2": 0.01104, "kappa b-specific dna binding proteins": 0.01104, "induced promoter activity": 0.01104, "pre-b cell line": 0.01104, "tnfri death domain interacting protein tradd": 0.01104, "ifn-gamma receptor alpha-chain expression": 0.01103, "-associated death domain protein tradd": 0.01103, "increased protein turnover-degradation correlate": 0.01103, "lps induces nuclear expression": 0.01103, "fva cell nuclear extracts": 0.01103, "apl cell line": 0.01103, "cell nuclear extracts": 0.01102, "dna affinity-purified protein": 0.01102, "hiv-infected myelomonocytic cell line om-10.1": 0.01102, "mn-sod rna protein levels": 0.01102, "nuclear cell extracts": 0.01102, "cell line potentiates": 0.01102, "b104 cell death induced": 0.01102, "il-2 independent cell lines": 0.01102, "early g1 cell cycle regulatory function": 0.01102, "avian erythroblast cell line hd6": 0.01102, "lymphocytic cell line": 0.01102, "cell line b104": 0.01102, "classical protein kinase": 0.01102, "mitogen-activated protein p38 kinase": 0.01101, "enhanced il-1 beta mrna expression": 0.01101, "calcineurin protein kinase": 0.01101, "rxr alpha expression increased": 0.01101, "p38 mitogen-activated protein kinase": 0.01101, "nb4 cell line": 0.01101, "cell line nb4": 0.01101, "transcriptional transactivator protein designated hbxag": 0.011, "cell line expresses": 0.011, "cell line influences": 0.011, "-dependent cell line": 0.011, "distinct cell surface receptors": 0.011, "androgen-dependent lncap cell line": 0.011, "estrogen receptor expression": 0.011, "human glucocorticoid receptor": 0.01099, "myelomonocytic specific tyrosine kinase hck gene": 0.01099, "t-lymphocyte cell line": 0.01099, "daudi cell line": 0.01099, "cell line bjab": 0.01099, "resultant cell line": 0.01099, "cell element": 0.01099, "tumor necrosis factor alpha-mediated activation": 0.01099, "c-jun protein levels": 0.01099, "gammac chain gene promoter depends": 0.01099, "lncap cell line": 0.01099, "erythroleukemia cell line": 0.01098, "sh-sy5y neuroblastoma cell line": 0.01098, "p38alpha mitogen-activated protein kinase": 0.01098, "human t-cell line jurkat": 0.01098, "lt-producing c81-66-45 cell line": 0.01098, "janus protein kinase": 0.01097, "multipotential cell line": 0.01097, "n9 microglial cell line": 0.01097, "important nf-kappab binding activity": 0.01097, "camp response element-binding protein/activation transcription factor": 0.01097, "cell tyrosine kinase zap-70": 0.01097, "ebv-transformed cell line": 0.01097, "inhibited cell growth": 0.01097, "myelomonocytic cell line": 0.01097, "cultures decreased il-2 promoter activation": 0.01097, "glioblastoma cell line": 0.01097, "cloned tcf-1 alpha protein": 0.01097, "promyelocyte cell line": 0.01097, "human udg promoter sequences": 0.01096, "nf-kappa b-like binding activity": 0.01096, "cytokines cell cycle analysis": 0.01096, "microb dna motif decreased transcriptional activity": 0.01096, "cell line namalwa": 0.01096, "hepatoma cell line": 0.01096, "ca2+/calmodulin-dependent protein kinase iv": 0.01096, "stroma cell line": 0.01096, "mitogen-activated protein kinase cascades": 0.01095, "erythroblast cell line hd6": 0.01095, "reduced nf-kappab binding activity": 0.01095, "npc cell line hk666": 0.01095, "fourth cell line": 0.01095, "lymphoblast cell line msb": 0.01095, "mitogen-activated protein kinase erk2": 0.01095, "cell line ach-2": 0.01095, "nk cell induced cytolysis": 0.01095, "cell line el-4": 0.01095, "t-all cell line": 0.01095, "promonocytic cell line": 0.01095, "cytokine-dependent cell line m-tat": 0.01095, "ach-2 cell line": 0.01095, "astrocytoma cell line": 0.01095, "interferon-gamma promoter mediates selective expression": 0.01095, "non-lymphoid cell line": 0.01095, "thymoma cell line": 0.01095, "gliadin peptide-hla class ii molecule-t cell interactions": 0.01095, "monocyte/macrophage cell line": 0.01095, "promonocyte cell line": 0.01094, "cell line hsb-2": 0.01094, "t-leukemia cell line": 0.01094, "ciita-deficient cell line": 0.01094, "ucsd-aml1 cell line": 0.01094, "physiological cell death pathway": 0.01094, "megakaryoblastic/erythroid cell line": 0.01094, "cell line hpb.all": 0.01094, "cell line el4": 0.01094, "cell line ht93a": 0.01094, "yj cell line": 0.01094, "nk3.3 cell line": 0.01094, "cell line rpmi": 0.01094, "hacat cell line": 0.01094, "apl-derived cell line": 0.01094, "yt cell line": 0.01094, "cell line k46": 0.01094, "htlv-ii-bearing cell line": 0.01094, "zr-75-1 cell line": 0.01094, "htlv-1-transformed cell line": 0.01094, "myelomocytic cell line": 0.01094, "responder cell line": 0.01094, "cytokine-dependent cell line": 0.01094, "cell line ctll2": 0.01094, "hiv-1 nef protein inhibits": 0.01094, "t-lymphocytic cell line": 0.01094, "absent p65 protein levels": 0.01094, "cell line skw6.4": 0.01094, "im-9 cell line": 0.01094, "b-lymphoblastoid cell line": 0.01094, "additional protein factors": 0.01093, "functional nf-at1 transcription factor complexes": 0.01093, "regulated gpix promoter expression": 0.01093, "cell line": 0.01093, "costimulation-induced mitogen-activated protein kinase": 0.01093, "inhibits terminal cell differentiation": 0.01092, "mitogen-activated protein kinase": 0.01092, "tnf alpha gene induction": 0.01092, "restricted protein kinase": 0.01091, "oct factor gene": 0.01091, "specific dna binding proteins": 0.01091, "twhf extract human t-cell leukemia virus type": 0.01091, "gene erythroid promoter": 0.01091, "human monocyte binding": 0.0109, "mouse cell lines suggests": 0.0109, "induce class ii mhc antigen expression": 0.0109, "kappa b-like site binding complexes": 0.0109, "alpha inhibitory protein": 0.0109, "potent acid activation region": 0.01089, "serine/threonine protein kinase": 0.01089, "sig-crosslinking-induced protein tyrosine phosphorylation": 0.01089, "dna consensus binding site recognized": 0.01089, "ap-1 enhancer factor activity": 0.01089, "crucial proximal human il-4 promoter": 0.01089, "prolonged protein kinase": 0.01089, "two-phase neutrophil-endothelial cell adhesion response": 0.01088, "double-stranded rna-dependent protein kinase": 0.01088, "human il-1alpha promoter involved": 0.01088, "il-10 receptor expression": 0.01088, "ifn-stimulated gene factor": 0.01088, "cell receptor-cd3 complex": 0.01088, "transcription factor nf-kappab regulation": 0.01088, "htlv-i infected human t-cell line": 0.01088, "inducible nuclear factor binding": 0.01087, "protein tyrosine phosphorylation": 0.01087, "ribosomal protein s6 kinase": 0.01087, "cell receptor/cd3 complex": 0.01087, "protein phosphatase inhibitor": 0.01087, "protein increased": 0.01087, "human acute lymphoblastic t-cell line": 0.01086, "nuclear nf-kappab proteins binding": 0.01086, "human uterine thromboxane receptor cdna": 0.01085, "estrogen receptor gene": 0.01085, "constitutively expressed sp1 protein": 0.01085, "mouse myeloid cell lines": 0.01085, "sh2 domain leukocyte protein": 0.01085, "prominent protein kinase cascades": 0.01084, "early myeloid cell lines": 0.01084, "camp-dependent protein kinase": 0.01084, "viral protein tax induces": 0.01084, "p50 steady-state protein levels": 0.01084, "complex demonstrated predominant expression": 0.01083, "protein kinase raf-1": 0.01083, "lymphoid jurkat cell lines": 0.01083, "transcription factors regulates genes involved": 0.01083, "lymphoid leukemia cell lines": 0.01082, "cell growth regulators [": 0.01082, "protein kinase cascades": 0.01082, "myeloid cell lines confers resistance": 0.01082, "pathogenic retrovirus human t-cell leukemia virus type": 0.01082, "ca2+/calmodulin-dependent protein kinase": 0.01082, "protein kinase calpha": 0.01081, "stress-activated protein kinase": 0.01081, "protein kinase c-alpha": 0.01081, "inducible transcription factor nf-kappa": 0.01081, "cell proliferation and/or differentiation": 0.01081, "protein kinase c-dependent": 0.0108, "protein kinase a-independent": 0.0108, "calcium/calmodulin-dependent protein kinase": 0.0108, "alpha-associated protein kinase": 0.0108, "nm23/ndp kinase protein": 0.0108, "il-1ri-associated protein kinase": 0.0108, "increased gp91phox mrna expression": 0.0108, "inhibited agonist-induced monocytic cell adhesion": 0.0108, "p21-activated protein kinase": 0.0108, "protein kinase c-zeta": 0.0108, "receptor-associated protein kinase": 0.0108, "prominent protein kinase": 0.0108, "induce target cell apoptosis": 0.01079, "plzf-rar alpha expression blocks terminal differentiation": 0.01079, "protein kinase": 0.01078, "androgen receptor gene leading": 0.01078, "epo receptor expression": 0.01078, "ebv-negative primary effusion lymphoma cell lines": 0.01078, "interleukin-2 receptor alpha-chain gene": 0.01078, "related il-6-mediated autocrine tumor cell growth": 0.01078, "murine cdna encoding transcription factor nfatc": 0.01078, "monocytoid leukemia cell lines u937": 0.01078, "myeloid leukemia cell lines": 0.01078, "thymidine kinase mrna expression": 0.01077, "effect required surface expression": 0.01077, "control cell lines": 0.01077, "mhc class ii transcription factor rfx": 0.01077, "cloned human genes encoding cyclophilin b-binding-proteins": 0.01077, "octamer binding transcription factors": 0.01076, "k562 cell induced": 0.01076, "human t-cell leukemia virus type": 0.01075, "gata-binding protein family members": 0.01075, "specific nfat binding activity": 0.01075, "reported human nrf-1/alpha-pal factor": 0.01075, "human p40 promoter regions": 0.01074, "constitutively expressed transcription factor sp1": 0.01074, "normal human monocytes activated": 0.01074, "nuclear factor kappab binding": 0.01073, "hmg protein family regulates": 0.01073, "host transcription factor nf-kappa": 0.01073, "tat protein constitutively expressed": 0.01072, "early growth response gene": 0.01072, "cell growth [": 0.01072, "rxr alpha protein": 0.01072, "cell lymphotropic virus type": 0.01072, "induce myeloid cell differentiation": 0.01071, "oligonucleotides inhibited cell adhesion": 0.01071, "thromboxane receptor gene promoter/chloramphenicol acetyltransferase": 0.01071, "gene regulatory proteins": 0.01071, "differentiation stage-specific dna-binding protein": 0.01071, "increased hil-5 promoter activity": 0.0107, "interleukin-10 receptor expression": 0.0107, "inhibited rantes mrna expression dose": 0.0107, "small maf family protein": 0.0107, "helper cell differentiation system": 0.0107, "ga-binding protein factors": 0.01069, "cell nuclear extract": 0.01069, "human beta-globin promoter chromatin structure": 0.01069, "normal cell growth": 0.01069, "increased crh promoter activity": 0.01069, "stimulated human peripheral blood lymphocytes": 0.01069, "epstein-barr virus protein ebna2 acts": 0.01069, "protein factors": 0.01068, "host nk cell response": 0.01068, "il-2r alpha protein": 0.01068, "il-2-alpha receptor expression": 0.01068, "cytosolic inhibitor protein ikappab-alpha": 0.01068, "ap-1 transcription factor family": 0.01068, "receptor expression": 0.01067, "pou domain transcription factor oct-2": 0.01067, "cipro enhanced il-2 gene induction": 0.01067, "human il-4 receptor alpha-chain": 0.01067, "duffy chemokine receptor gene": 0.01067, "heterologous promoter restores expression": 0.01066, "nf-kappa b/rel protein": 0.01066, "ba-induced cell growth inhibition": 0.01066, "protein family member": 0.01066, "activated stat-3 protein associates": 0.01065, "tumor cell lines": 0.01065, "cell tumor lines": 0.01065, "generate mature hela cell mrna": 0.01064, "epstein-barr virus bzlf1 transactivator protein": 0.01064, "nuclear kappab dna-binding activity induced": 0.01064, "oestrogen receptor gene polymorphisms": 0.01064, "human il-4 receptor": 0.01064, "scl protein levels": 0.01063, "transcriptional regulatory protein": 0.01063, "induced maximal hiv-1 expression": 0.01063, "progesterone receptor gene": 0.01063, "human paf receptor transcript": 0.01062, "cell type specific": 0.01062, "lmp-1 protein levels": 0.01062, "putative nf-kappab binding site identified": 0.01062, "b-cell specific transcription factor": 0.01062, "cell lines stimulated": 0.01062, "ebv carrying cell lines": 0.01061, "glucocorticoid receptor ] [ effect": 0.01061, "glucocorticoid-sensitive human leukemic t-cell line": 0.01061, "interferon-gamma-induced nuclear binding factor": 0.01061, "bcl-6 protein levels": 0.0106, "human leukocytes ] [": 0.0106, "androgen receptor gene": 0.0106, "nuclear receptor peroxisome proliferator-activated receptor gamma": 0.0106, "ap-2-like nuclear factor binding": 0.0106, "lipoprotein-lipopeptide-induced immune cell signaling events": 0.0106, "preserving ikappab-alpha protein levels": 0.0106, "pou domain protein pit-1": 0.01059, "alpha protein": 0.01059, "223-amino acid protein": 0.01059, "intact human il-4 promoter": 0.01059, "apoptosis suppressor protein bcl-2": 0.01059, "nuclear factor binding": 0.01059, "il-2-induced il-2r alpha promoter activity": 0.01059, "hematopoietic cell lines examined": 0.01058, "ap-1 transcription factor complexes": 0.01058, "vitellogenin gene b1 promoter shows": 0.01058, "cell-specific transcriptional promoter activity mediated": 0.01058, "ikappab-alpha protein levels": 0.01058, "fork head domain protein": 0.01058, "endothelial cell conditioned medium induces oxidant stress leading": 0.01058, "murine melanoma cell lines": 0.01058, "murine t-all cell lines": 0.01057, "inhibitory protein mad3/i kappa": 0.01057, "protein dimerization domain": 0.01057, "induce monocytic cell differentiation": 0.01057, "stat5b proteins form distinct fc gamma ri gas binding patterns": 0.01057, "pleiotropic transcription factor nf-kappa": 0.01057, "de novo viral protein synthesis occurs": 0.01057, "duffy antigen/chemokine receptor gene": 0.01056, "cell-specific blk gene promoter": 0.01056, "common dna binding site": 0.01056, "multifunctional domain protein": 0.01056, "transcriptional activator protein": 0.01056, "thromboxane receptor gene": 0.01056, "eukaryotic transcription factor nf-kappa": 0.01055, "human cytomegalovirus binding": 0.01055, "receptor complex binding": 0.01055, "multi-functional domain protein": 0.01055, "expressed tax protein": 0.01054, "myeloid differentiation protein": 0.01054, "putative protein expressed": 0.01054, "control cell differentiation": 0.01054, "receptor alpha-chain gene": 0.01054, "murine cell lines": 0.01054, "kappay element reporter gene": 0.01054, "selected myeloid leukemic cell lines": 0.01054, "cell surface molecule cd28 binds": 0.01054, "human c-type lectin leukocyte receptor aim/cd69": 0.01053, "transcription factor nf-kappa": 0.01053, "thyrotropin receptor gene": 0.01053, "protein phosphorylation pattern": 0.01053, "ah receptor gene": 0.01053, "similar structural protein sequences": 0.01053, "phorbol ester-induced mononuclear cell differentiation": 0.01053, "enhance cytoplasmic inhibitory ikbalpha protein degradation correlates": 0.01053, "il-6 gene promoter": 0.01053, "vitro immortalized lymphoblastoid cell lines": 0.01052, "t-cell transcription factor blocked": 0.01052, "human estrogen receptor": 0.01052, "transcription factors binding": 0.01052, "tyrosine kinase activity induced late": 0.01052, "receptor gene scya3r": 0.01052, "tnf/neuron growth factor receptor family": 0.01051, "epstein-barr virus sm protein": 0.01051, "er-negative mda-mb-231 breast cancer cell lines": 0.01051, "cell inhibits il-2 secretion": 0.01051, "mouse pro-b cell lines": 0.01051, "long-term cell lines derived": 0.01051, "ets protein family": 0.01051, "protein increase": 0.01051, "jnk1 protein levels": 0.01051, "receptor gene": 0.01051, "integrin gene promoter": 0.0105, "inhibitor protein i-kb": 0.0105, "viral protein induces": 0.0105, "distinct cell type-specific complexes": 0.0105, "erk2 protein levels": 0.0105, "inhibits early mrna expression": 0.0105, "human il-4 promoter exists": 0.0105, "xenopus laevis vitellogenin gene b1 promoter": 0.0105, "epstein-barr virus zebra protein": 0.01049, "gata family protein": 0.01049, "inhibitor protein": 0.01049, "specific cell targets results": 0.01048, "inhibit c-jun induced expression": 0.01048, "gp ib alpha promoter activity": 0.01048, "protein motif": 0.01048, "% cell type specificity": 0.01048, "protein complexes act": 0.01048, "reduced il-2 mrna expression": 0.01047, "nuclear factor e1-binding site": 0.01047, "pou domain transcription factor": 0.01047, "kappa b-alpha protein acts": 0.01047, "protein levels": 0.01047, "nf-kappab binding activity correlated": 0.01047, "tissue-specific rna polymerase ii transcription factor": 0.01047, "adaptor protein cbl [": 0.01047, "required de novo protein synthesis": 0.01047, "ikappab kinase complex activation": 0.01046, "human il-3 proximal promoter": 0.01046, "mouse cell lines": 0.01046, "increase class ii expression": 0.01046, "human genomic sterol regulatory element": 0.01046, "high mobility group protein i/y": 0.01046, "endothelial cell surface adhesion molecules": 0.01045, "insulin gene promoter": 0.01045, "vitro cell culture system": 0.01045, "promoter expression": 0.01045, "distinct dna binding proteins": 0.01045, "vcam-1 gene promoter": 0.01045, "specific binding activity": 0.01044, "cell-type specific transcription factor gata-1": 0.01044, "binding activity specific": 0.01044, "transcription factor activated": 0.01044, "transcription factor nf kappa": 0.01044, "high mobility group protein": 0.01044, "primary human peripheral blood lymphocytes": 0.01043, "cck-8 induced il-2 expression": 0.01043, "human il-4 promoter": 0.01043, "mitogen-activated protein kinase-targeted hematopoietic tyrosine phosphatase": 0.01043, "inhibits hla class ii constitutive expression": 0.01043, "tumor necrosis factor/nerve growth factor receptor superfamily": 0.01043, "cellular protein synthesis": 0.01043, "vitellogenin gene b1 promoter": 0.01042, "stat transcription factor family": 0.01042, "protein phosphorylation patterns": 0.01042, "stimulates human immunodeficiency virus type 1-long terminal repeat": 0.01042, "hematopoietic-specific ets family transcription factor": 0.01042, "cell pathway": 0.01041, "tumor cell differentiation": 0.01041, "c-rel protein complexes": 0.01041, "protein tyrosine phosphatase inhibitors": 0.01041, "myeloid precursor cell lines hl60": 0.01041, "inhibited gata-3 promoter activity": 0.01041, "lymphocyte activation enhances binding": 0.01041, "jurkat cell lines": 0.01041, "expression levels increase": 0.0104, "beta-globin gene promoter": 0.0104, "cell lines bearing dqa1*0501/dqb1*0201 heterodimers": 0.0104, "cell complementary dna": 0.0104, "inhibited nuclear nf-kappab activity": 0.0104, "myeloid cell lines u937": 0.0104, "leukemia cell lines": 0.0104, "ets transcription factor family": 0.0104, "cell antigen receptors": 0.0104, "cell cycle analysis": 0.01039, "mrna expression levels": 0.01039, "estrogen-dependent lymphoblastoid cell lines expressing": 0.01039, "il-13-treated human peripheral monocyte nuclear extracts": 0.01039, "cell cultures increased": 0.01039, "monocytic cell lines studied": 0.01038, "cell-specific transcriptional coactivator protein": 0.01038, "fragmentation required ongoing protein synthesis": 0.01038, "purified human peripheral-blood granulocytes express constitutively significant levels": 0.01038, "transcription factor effects": 0.01038, "thy-1 gene promoter resembles": 0.01038, "59-kda protein [ tai": 0.01037, "increase alpha-globin promoter activity": 0.01037, "gata-1 expression involves additional regulatory factors": 0.01037, "herpes simplex virus vp16 protein": 0.01036, "immediate-early activation genes family": 0.01036, "stimulate nf-kappab binding activity": 0.01036, "bzlf1 gene promoter": 0.01036, "hla-dra gene promoter": 0.01036, "normal protein mds1/evi1": 0.01035, "p40 gene promoter": 0.01035, "important transcription factor required": 0.01035, "isolated human peripheral blood lymphocytes": 0.01035, "forkhead protein family": 0.01035, "x-linked human androgen receptor": 0.01035, "cd36 gene promoter": 0.01034, "beta-casein gene promoter": 0.01034, "protein phosphatase type": 0.01034, "impaired rna transcription activity": 0.01034, "genes encoding transcription factors": 0.01034, "human c-c chemokine receptor": 0.01034, "protein family": 0.01034, "human intestinal receptor": 0.01033, "human colony-stimulating factor-1 receptor": 0.01033, "helper cell cytokine production plays": 0.01033, "molecules induced cyclin e-associated kinase activity": 0.01033, "human fibronectin receptor": 0.01032, "cpo gene promoter": 0.01032, "cell growth regulation": 0.01032, "human il-5 receptor": 0.01032, "cell lines derived": 0.01032, "plasma cell lines": 0.01032, "multiple myeloma cell lines": 0.01032, "nuclear receptor proteins results": 0.01032, "induces stress-activated protein kinases": 0.01032, "cell culture experiments demonstrated": 0.01032, "human tnf promoter": 0.01032, "1.4-kb human tnf-alpha promoter": 0.01031, "gene family member nfatc [": 0.01031, "human ifn-gamma promoter": 0.01031, "expressed adaptor protein": 0.01031, "agents tested induced expression": 0.01031, "specific stat protein": 0.01031, "distinct protein heterodimers encoded": 0.01031, "reduced ap-1 binding activity": 0.01031, "specific transcription factor functions": 0.01031, "erythroid cell lines": 0.0103, "-binding protein complexes": 0.0103, "janus protein tyrosine kinases": 0.0103, "hematopoietic cell lines k562": 0.0103, "gene promoter": 0.0103, "extracellular hiv-1 tat protein": 0.0103, "kappa b-dependent il-6 promoter activity": 0.0103, "human progesterone receptor": 0.0103, "induce nf-kappa b/rel nuclear activity": 0.0103, "human mineralocorticoid receptor": 0.0103, "human tnf-alpha promoter": 0.0103, "vitro transcription activity": 0.01029, "stat protein phosphorylation": 0.01029, "rel transcription factor family": 0.01029, "specific protein substrates": 0.01029, "hematopoietic cell specific molecules": 0.01028, "cellular dna-binding protein": 0.01028, "activates transcription factor nf-kappab": 0.01028, "interferon gamma induces class ii expression": 0.01028, "human t-cell line iarc": 0.01028, "kappa b-binding protein": 0.01028, "cell proliferative response": 0.01028, "heterodimeric receptor induces activation": 0.01028, "kappa b-alpha protein": 0.01028, "thrombin receptor activation peptide": 0.01027, "hematopoietic precursor cell lines": 0.01027, "human androgen receptor": 0.01027, "human t-cell line": 0.01027, "low mobility ap-1 binding activity": 0.01027, "similar transcription activity": 0.01027, "cell lines expressing": 0.01026, "dominant-negative mutant tumor necrosis factor receptor": 0.01026, "cell p50 nf-kappa": 0.01026, "apoptosis suppressor protein bcl-xl": 0.01025, "kappa b-like protein": 0.01025, "human full-length il-1beta promoter": 0.01025, "murine macrophage inflammatory protein": 0.01025, "nf-kappab/rel transcription factor family": 0.01025, "e2f dna binding site": 0.01025, "pro-inflammatory protein tumor necrosis factor-alpha": 0.01025, "lymphocyte cell lines": 0.01025, "protein complexes": 0.01024, "lef/tcf transcription factor family": 0.01024, "human kruppel-related zinc finger proteins": 0.01024, "il-2 receptor activation": 0.01024, "scl protein observed": 0.01024, "distinct e2f dna-binding protein": 0.01023, "human ige germline promoter": 0.01023, "sp1 sites mediated basal expression": 0.01023, "transcription factor family": 0.01023, "human icam-1 promoter": 0.01023, "pel cell lines suggests": 0.01023, "p60 protein expressed": 0.01023, "human toll-like receptor": 0.01022, "syk protein tyrosine kinases sit recruits": 0.01022, "unidentified fc gamma ri gas dna-binding protein": 0.01022, "potent transactivator protein termed tax": 0.01022, "high-affinity cell surface receptors": 0.01022, "human tsh receptor": 0.01022, "gal4 dna binding site": 0.01021, "intracellular il-2 protein": 0.01021, "transcription factor nf-kappab involves proteasome-mediated processing": 0.01021, "expressed rp1 protein": 0.01021, "functional hiv tat protein": 0.01021, "heat shock protein glycoprotein 96-chaperoned antigenic peptides": 0.01021, "leukemic cell lines u-937": 0.01021, "suppress il-2 promoter activation": 0.01021, "serine/threonine protein phosphorylation": 0.01021, "0.1-10 micromol/l enhanced nk cell-mediated k562 cancer cell killing": 0.0102, "human ah receptor": 0.0102, "il-1 beta protein": 0.0102, "cell leukemia virus": 0.0102, "protein expressed": 0.0102, "cell lines examined": 0.0102, "colon cancer cell lines": 0.0102, "cell il-2 production": 0.01019, "mutant tax protein deficient": 0.01019, "drosophila developmental control protein": 0.01019, "activated human lymphocytes": 0.01019, "cell lines contained": 0.01019, "human fas promoter": 0.01019, "express functional retinoblastoma protein": 0.01019, "erythroid progenitor cell differentiation": 0.01019, "human gata-3 proteins play": 0.01019, "early regulatory protein": 0.01019, "human receptor": 0.01018, "cell co-cultures increased": 0.01018, "t-cell receptor activation": 0.01018, "dna binding site": 0.01018, "c-jun delta-domain inhibits neuroendocrine promoter activity": 0.01018, "decreased gag protein synthesis": 0.01018, "t-cell transcription factor nf-at": 0.01017, "-associated protein tyrosine kinases": 0.01017, "mouse mammary tumor virus env gene": 0.01017, "myelomonocytic cell lines studied": 0.01017, "protein tyrosine kinases p56lck": 0.01016, "viral integral membrane protein": 0.01016, "cyclosporin-sensitive dna-binding protein required": 0.01016, "tnf alpha induced activation": 0.01016, "nf-kappab binding activity": 0.01016, "lipopolysaccharide-free cell culture system leads": 0.01016, "cell lines lacking jak3": 0.01015, "high gata-1 binding activity": 0.01015, "human gm-csf promoter": 0.01015, "il-2-independent cell lines tested": 0.01015, "rap1 protein phosphorylation": 0.01015, "cell surface molecules required": 0.01015, "multicopy nfat -and il-2 promoter-beta-galactosidase reporter gene constructs": 0.01015, "htlv-i-bearing cell lines tested": 0.01015, "daughter cell analysis": 0.01014, "alpha-tocopherol inhibits agonist-induced monocytic cell adhesion": 0.01014, "cell lines tested": 0.01014, "human toll signaling pathway": 0.01014, "antisense oligonucleotides inhibits cell adhesion": 0.01014, "cell lines bearing htlv-i": 0.01014, "human monoclonal antibody specific": 0.01014, "cell sorter analysis": 0.01014, "enhanced protein degradation": 0.01014, "cell surface paf receptors": 0.01013, "early activator protein": 0.01013, "cell antigen-specific signaling responses": 0.01013, "hiv-1 tat downregulates mip-1 alpha expression": 0.01013, "c-jun early response gene": 0.01013, "increased basal level expression": 0.01013, "tcr-stimulated protein tyrosine kinases": 0.01013, "growth factor-stimulated cell proliferation": 0.01013, "cell response": 0.01013, "lps increased nf-kappab dna binding": 0.01013, "cell lines studied": 0.01013, "nonreceptor protein tyrosine kinases": 0.01013, "tumor cell growth": 0.01012, "stable jurkat cell clones provide": 0.01012, "camp- stimulated il-5 promoter activation": 0.01012, "non-irradiated transfected cell lines": 0.01012, "cytotoxicity markers assessed include tumor cell killing": 0.01012, "lymphoid cell lines": 0.01012, "protein tyrosine kinases": 0.01011, "monocyte cell lines": 0.01011, "c/ebp alpha expression vector demonstrate": 0.01011, "unconventional cell surface receptors": 0.01011, "plasma cell differentiation acetylation": 0.01011, "thp-1 macrophage cell lines": 0.01011, "activated il-2 receptor complexes increased": 0.01011, "human il-1beta promoter": 0.01011, "cell surface receptors": 0.0101, "cell mediated immune responses": 0.0101, "cell lines lacking p56": 0.0101, "alpha-tocopheryl succinate inhibits monocytic cell adhesion": 0.0101, "specific cell fate development": 0.0101, "transfected cell lines": 0.0101, "platelet endothelial cell adhesion molecules": 0.0101, "protein phosphorylation": 0.0101, "cytokine genes lack respective binding sites": 0.0101, "transcription factor expressed": 0.01009, "proteins inhibit dna binding": 0.01009, "viral encoded protein tax": 0.01009, "bufalin treatment activated activator protein-1 transcriptional activity": 0.01009, "induce nf-kb binding activity": 0.01009, "transcription factor nf-kappab plays": 0.01009, "expressed transcription factor": 0.01009, "myeloid cell lines": 0.01008, "transcription activation": 0.01008, "purified jurkat protein": 0.01008, "cell type-specific oct factors": 0.01008, "epstein-barr virus-immortalized lymphoblastoid cell lines": 0.01008, "expression level induced": 0.01008, "cell signaling pathways": 0.01008, "single viral immediate-early protein": 0.01008, "monoclonal anti-endothelial cell antibodies": 0.01008, "increases ap-1 binding activity": 0.01007, "hematopoietic cell lines": 0.01007, "identified dre 1-binding protein": 0.01007, "erythroid cell differentiation": 0.01007, "human gamma-globin promoter": 0.01006, "human t-cell lymphotropic virus type": 0.01006, "infected cell lines": 0.01006, "leukemia/b lymphoma cell lines": 0.01006, "factor binding sites": 0.01006, "tax protein induces": 0.01006, "characterized human genomic dna clones": 0.01005, "cell lymphoma lines": 0.01005, "cell separation experiments suggest": 0.01005, "2.5-fold enhanced protein secretion": 0.01005, "zinc finger transcription factor required": 0.01005, "nk cell lines": 0.01005, "tyrosine kinase abrogate gp120-mediated icam-1 expression": 0.01005, "vitro glucocorticoid receptor binding studies": 0.01005, "lymphoma cell lines": 0.01005, "human tf promoter": 0.01005, "-kappa b/rel nuclear activity induced": 0.01005, "glucocorticoid receptor activation": 0.01005, "human gammac promoter": 0.01005, "nk cell inhibitory receptors": 0.01004, "fn-induced il-1beta protein production": 0.01004, "56-59-kilodalton protein identified": 0.01004, "regulate transcription factor function": 0.01004, "resting monocytes contained nuclear factors binding": 0.01004, "identified nb protein": 0.01004, "scl protein production": 0.01004, "transcription factor c/ebp beta": 0.01004, "macrophage migration inhibitory related protein": 0.01004, "hiv-1 tat protein": 0.01003, "cell lines lacking capability": 0.01003, "increased hiv rna expression": 0.01003, "il-2 promoter activation": 0.01003, "bacterial protein icsa binds n-wasp": 0.01003, "basal transcription activity": 0.01003, "cell receptor-bearing lymphocytes": 0.01003, "gamma interferon activation site": 0.01003, "large protein ligand": 0.01002, "cell differentiation mediated": 0.01002, "suppress myeloid cell differentiation": 0.01002, "human cd44 promoter": 0.01002, "il-10 induced c-fos expression": 0.01002, "human elk-1 promoter": 0.01002, "oxidative-stress sensitive transcription factor nf-kappab": 0.01002, "essential 40-kda protein termed tax": 0.01002, "transformed human lymphocyte line": 0.01002, "low nuclear expression": 0.01002, "human il-2rbeta promoter": 0.01001, "specific transcription factor": 0.01001, "mature myelomonocytic cell lines": 0.01001, "protein synthesis inhibitors differ": 0.01001, "human il4 promoter": 0.01001, "cell sites": 0.01001, "malignant cell cytokine production": 0.01001, "leukemic cell lines": 0.01001, "cloned cell lines": 0.01001, "human inos promoter": 0.01, "human tcr alpha enhancer": 0.01, "bone marrow-derived macrophages binding activity": 0.01, "nonmonocytic cell lines hela": 0.01, "human interleukin-3 promoter": 0.01, "human mcm6 promoter": 0.01, "reduced clonogenic cell growth": 0.01, "region gene segments": 0.01, "induces increased expression": 0.01, "human gata-1 genes": 0.00999, "distal promoter element regulate transcriptional induction": 0.00999, "alters immune cell function": 0.00999, "class ii promoter-specific dna binding factors": 0.00999, "human collagenase-1 promoter": 0.00999, "interleukin-6 promotes multiple myeloma cell growth": 0.00999, "human cd95l promoter": 0.00999, "gene marks patients": 0.00998, "rex protein production": 0.00998, "hiv long terminal repeat reporter gene construct": 0.00998, "normal human monocytes m-csf induces": 0.00998, "cell factors": 0.00998, "dna sequence binding affinity profile": 0.00997, "human promoter": 0.00997, "show minimal constitutive virus expression": 0.00997, "mature cell lines": 0.00997, "activates nuclear expression": 0.00997, "enhanced binding activity": 0.00997, "hiv-1 ltr promoter activity": 0.00997, "multiple serine-specific protein kinases": 0.00997, "malignant lymphocytic cell lines": 0.00997, "cellular response gene inducibility": 0.00997, "lmp1-induced cell size increase": 0.00997, "viral trans-activator tax protein": 0.00997, "simian cell lines bearing stlv-i": 0.00996, "cell size increase": 0.00996, "identified transcription initiation site": 0.00996, "autologous lymphoblastic cell lines pulsed": 0.00996, "natural killer gene complex": 0.00996, "type ii interferons induce expression": 0.00996, "estrone potentiates myeloid cell differentiation": 0.00996, "induce sustained cell proliferation": 0.00996, "helper cell mrna": 0.00995, "human b-cell line im-9": 0.00995, "spontaneous ebv-transformed lymphoblastoid cell lines": 0.00995, "activate human immunodeficiency virus type": 0.00995, "mutant mice lacking functional ikaros transcription factors": 0.00995, "human immunoglobulin genes": 0.00995, "tumor-derived cell lines correlates": 0.00995, "erythroid transcription factor erythroid factor-1": 0.00995, "human germinal centers expressed bcl-6 mrna": 0.00994, "monocytic cell lines": 0.00994, "entire interleukin-2 enhancer show bimodal expression patterns": 0.00994, "vzv ie62 protein coding sequences": 0.00994, "phytohemagglutinin-stimulated normal human lymphocytes": 0.00994, "vzv ge protein coding sequences": 0.00994, "cell lines hl-60": 0.00994, "human b-cell line": 0.00993, "gamma activation site": 0.00993, "normal human lymphocytes": 0.00993, "identified transcription factor nf-il4": 0.00993, "b-cell lineage-specific transcription factor present": 0.00993, "macrophage transcription factor pu.1 binds": 0.00993, "shp1 protein tyrosine phosphatase": 0.00993, "alpha gene enhancer": 0.00993, "hgata-3 transcriptional activation domain abolished gata-dependent hiv-1 trans-activation": 0.00993, "il-2 promoter cd28 response element/ap-1 sequence": 0.00993, "heat shock induced virus activation": 0.00993, "nuclear nf-kb binding proteins": 0.00992, "vitro protein truncation test": 0.00992, "induces rapid apoptotic cell death": 0.00992, "22-kda c-terminal sp1 protein fragment": 0.00992, "tcl1 gene sequence": 0.00992, "immune cell function": 0.00992, "human major histocompatibility complex": 0.00992, "interleukin-1 stimulated u-937 cell adhesion": 0.00992, "induce increased expression": 0.00991, "oxidative stress suppresses transcription factor activities": 0.00991, "hiv-1-encoded nef protein inhibits": 0.00991, "single cell assay": 0.00991, "protein synthesis inhibitors": 0.00991, "gtp-binding protein function": 0.00991, "purified protein derivative": 0.00991, "cell lines bearing dqa1*0201/dqb1*0201": 0.00991, "huvecs contained endothelial nos protein": 0.00991, "t-cell transcription factor nfat": 0.00991, "protein tyrosine phosphatase": 0.00991, "cell lines bearing dqa1*0201": 0.00991, "t-cell protein recognized": 0.00991, "erythroid progenitor cell growth": 0.0099, "human alpha-like globin genes": 0.0099, "lymphoid cell differentiation relies": 0.0099, "macrophage cell lines": 0.0099, "consensus dna binding sequence": 0.0099, "increased expression results": 0.0099, "epithelial cell lines": 0.0099, "cdna fusion protein": 0.00989, "human u2 small nuclear rna": 0.00989, "gene sequence": 0.00989, "comments ] hiv-1 vpr suppresses immune activation": 0.00989, "nf-kappa b/rel activation induced": 0.00989, "normal cell population": 0.00989, "hemopoietic myeloid cell differentiation": 0.00989, "htlv-i-transformed human lymphocyte line": 0.00989, "transactivates latent membrane protein lmp1": 0.00988, "human ciita coding sequence": 0.00988, "mutant myc protein capable": 0.00988, "long-term cell lines": 0.00988, "inhibited h2o2 induced activation": 0.00988, "endogenous murine protein": 0.00988, "inducible protein involved": 0.00988, "tat protein enhanced": 0.00988, "viral protein tax": 0.00988, "cytokine receptor activation": 0.00988, "normal human monocytes stimulated": 0.00988, "protein production": 0.00988, "cell lines leading": 0.00987, "heterozygous cell lines nb4": 0.00987, "primary human blood lymphocytes": 0.00987, "peripheral blood mononuclear cell cultures": 0.00987, "sp1 transcription factor binds": 0.00987, "bcl-2 protein decreased": 0.00987, "ebv-transformed lymphoblastoid cell lines ebna-5": 0.00987, "promote intestinal epithelial cell apoptosis": 0.00987, "cell specific fashion": 0.00987, "activated cell destroys": 0.00986, "cell type-specific increase": 0.00986, "x1 box dna-binding protein rfx": 0.00986, "reporter gene analysis reveals": 0.00986, "tumor suppressor protein": 0.00986, "elevated e2a protein concentrations": 0.00986, "cell lines deficient": 0.00986, "normal cell cycle": 0.00986, "il-2r alpha expression demonstrated": 0.00986, "c-jun protein isolated": 0.00986, "antisense cell lines": 0.00986, "ebv-transformed lymphoblastoid cell lines": 0.00985, "lymphocytes induces expression": 0.00985, "cell surface antigen a6h": 0.00985, "transcription factor nfatp inhibits": 0.00985, "cell lines exhibit": 0.00985, "cell-specific protein involved": 0.00984, "maintain ebv-positive npc cell lines": 0.00984, "tcf-1 alpha binding site juxtaposed": 0.00984, "myeloid cell differentiation": 0.00984, "transformed cell lines": 0.00984, "cell-specific tyrosine kinase gene": 0.00983, "eosinophil granule major basic protein": 0.00983, "immortalised lymphoblastoid cell lines": 0.00983, "inhibited nuclear factor-kappab activation": 0.00983, "glucocorticoid response element binding": 0.00983, "derivative tcp succinate prevents monocytic cell adhesion": 0.00983, "chronic human immunodeficiency virus type": 0.00983, "multiple tumor necrosis factor receptor": 0.00982, "tcf-1 alpha binding site": 0.00982, "specific nuclear binding sites": 0.00982, "bl cell lines": 0.00982, "peptide-pulsed lymphoblastic cell lines": 0.00982, "ebv-negative b-lymphoma cell lines bjab": 0.00982, "nf-kappa b-activating cytokine tumor necrosis factor alpha": 0.00982, "cell-specific cell surface molecule cd19": 0.00982, "potential amphipatic alpha-helical protein segments": 0.00982, ":29038 ] hiv-1 envelope glycoproteins induce activation": 0.00982, "cell surface interactions": 0.00981, "major gc-box binding activity a1": 0.00981, "induced c-fos expression": 0.00981, "-induced hl-60 cell differentiation": 0.00981, "essential regulatory protein": 0.00981, "individual cell lines": 0.00981, "lymphoblastoid cell lines": 0.00981, "myeloid cell specific": 0.00981, "c-fos expression induced": 0.00981, "parental cell lines": 0.00981, "uninduced myelomonocytic cell lines": 0.0098, "identified transcription start site": 0.0098, "compatible protein interactions": 0.0098, "high spi-1-dna binding activity": 0.0098, "c-fos protein synthesis": 0.0098, "cell proliferation involves cyclin e-mediated inactivation": 0.0098, "gata-1 protein level": 0.00979, "cellular tip-associated protein": 0.00979, "e2a protein required": 0.00979, "poz-mediated protein interactions": 0.00979, "natural killer cell receptors cluster": 0.00979, "protein antigen": 0.00979, "lymphocytic cell lines": 0.00979, "vitamin d3 treated maturing cell cultures": 0.00979, "sufficient th2 cell differentiation": 0.00979, "ecdysone-inducible drosophila transcription factor required": 0.00979, "limit blood cell formation": 0.00978, "erythroid cell growth": 0.00978, "activate heat shock transcription factor": 0.00978, "megakaryoblastic permanent cell lines": 0.00978, "abnormal nf-at binding activity": 0.00978, "oncogenic e2a-hlf fusion protein reversed": 0.00978, "cellular protein": 0.00978, "calcium-dependent induced gene product": 0.00977, "recombinant fusion protein": 0.00977, "binding nuclear proteins": 0.00977, "human peripheral blood lymphocytes": 0.00977, "nuclear proteins binding": 0.00977, "ebv-positive b-lymphoblastoid cell lines": 0.00977, "nuclear binding proteins": 0.00977, "increased surface expression": 0.00977, "pparalpha activators decreased cytokine-induced vcam-1 mrna expression": 0.00977, "cell culture system": 0.00977, "cell lines daudi": 0.00976, "t-lymphocyte cell lines": 0.00976, "cell lines yields": 0.00976, "daudi cell lines": 0.00976, "transcription factor function": 0.00976, "viral protein directs progenitors": 0.00976, "chemical-induced erythroleukemia cell lines": 0.00976, "cell lymphomas commonly display multiple somatic mutations clustering": 0.00976, "monocytoid cell lines": 0.00976, "atl-1k cell lines": 0.00976, "activated normal human": 0.00976, "mouse delta protein": 0.00976, "ubiquitous protein involved": 0.00976, "regulate cell differentiation": 0.00975, "autologous peripheral blood stem cell transplantation": 0.00975, "myelomonocytic cell lines arrested": 0.00975, "human t-cell lines jurkat": 0.00975, "inhibit leukocyte-endothelial cell interaction": 0.00975, "tnf-alpha protein presence": 0.00975, "continuous t-leukemia cell lines": 0.00975, "antigen receptor response element": 0.00975, "monocytic/myeloid leukemia-derived cell lines": 0.00975, "glial cell lines": 0.00975, "plasmacytoma cell lines": 0.00975, "cellular transcription factor e2f": 0.00975, "cell lines fail": 0.00975, "nf kappa b/rel binding site": 0.00975, "vitro binding activity": 0.00975, "hiv-1-infected cell lines": 0.00975, "natural killer cell receptors": 0.00975, "maximal il-2 promoter activity": 0.00975, "functional il-6 protein": 0.00975, "thymocyte-thymic epithelial cell interaction leads": 0.00974, "constitutive nuclear expression": 0.00974, "surface mhc class ii expression": 0.00974, "human mzf-2 proteins": 0.00974, "cell transcriptional events": 0.00974, "erythroleukemia cell lines": 0.00974, "normal cell types": 0.00974, "icam-1 surface protein": 0.00974, "il-2 promoter cd28 response element": 0.00974, "altered cell cycle regulation": 0.00974, "fibroblastic cell lines": 0.00974, "ad12 e1a-transfected cell lines": 0.00974, "il-2-dependent cell lines": 0.00973, "fas/fasl interaction initiates cell death": 0.00973, "hemopoietic cell lines": 0.00973, "nonlymphoid cell lines": 0.00973, "decreased cell proliferation": 0.00973, "nf-kappab transcription factor": 0.00973, "activator protein-1 binding activity": 0.00973, "neuroblastoma cell lines": 0.00973, "transcription factor nf-kappab": 0.00973, "endothelial cell adhesion molecules": 0.00973, "ap-1 protein c-jun": 0.00973, "sense cell lines": 0.00973, "myelomonocytic cell lines": 0.00973, "peripheral blood mononuclear cell compartment": 0.00973, "transfected jurkat cell clones": 0.00973, "cro-ap/5 cell lines": 0.00973, "protein synthesis leads": 0.00973, "reduced u-937 cell adhesion": 0.00973, "htlv-i-infected cell lines": 0.00973, "protein synthesis independent": 0.00973, "activated il-2 expression": 0.00973, "tax-expressing cell lines": 0.00973, "lck-deficient cell lines": 0.00972, "adult-t-cell-leukemia cell lines": 0.00972, "pleiotropic cellular transcription factor": 0.00972, "cell lines af10": 0.00972, "finger transcription factor required": 0.00972, "induce il-2r alpha expression": 0.00972, "nonhematopoietic cell lines nih": 0.00972, "ebna-2-positive cell lines": 0.00972, "non-b cell lines": 0.00972, "ebv-infected cell lines": 0.00972, "atl cell lines": 0.00972, "du-145 cell lines": 0.00972, "cytoplasmic protein extracts": 0.00972, "t-all cell lines": 0.00972, "cell lines kg-1": 0.00972, "hexameric receptor binding sites": 0.00972, "m10-expressing cell lines": 0.00971, "unidentified estrogen receptor-related 29-kda protein selectively recognized": 0.00971, "b-lymphoblastoid cell lines": 0.00971, "single cell type": 0.00971, "ribosomal protein sequences": 0.00971, "nonhematopoietic cell lines": 0.00971, "non-erythroid cell lines": 0.00971, "b-lymphoid cell lines": 0.00971, "hl-60 cell differentiation": 0.00971, "gm-csf-responsive cell lines": 0.00971, "late-myeloblast-like cell lines": 0.00971, "epo-dependent cell lines": 0.00971, "bone marrow cell clonogenic function": 0.00971, "cell type specificity influence": 0.00971, "nonmyeloid cell lines": 0.00971, "transcription factor dna-binding activities": 0.00971, "il-2-independent cell lines": 0.00971, "t-cell protein": 0.00971, "h-rs cell lines": 0.00971, "monocyte/macrophage-like cell lines": 0.00971, "mast cell lines": 0.00971, "erythroid/megakaryocytic cell lines": 0.00971, "receptor binding sites": 0.00971, "glia cell lines": 0.00971, "immortal cell lines": 0.00971, "myeloma cell lines": 0.00971, "atl-derived cell lines": 0.00971, "regulate lps/ifn-gamma induced expression": 0.00971, "enhanced il-1beta mrna expression": 0.00971, "human t-cell leukemia virus types": 0.0097, "monocytic cell differentiation": 0.0097, "maeca induced ec expression": 0.0097, "perforin-expressing cell lines": 0.0097, "glial-derived cell lines": 0.0097, "jurkat-tat cell lines": 0.0097, "viral protein epitopes": 0.0097, "rb-transformed cell lines": 0.0097, "mm-derived cell lines": 0.0097, "fibrosarcoma cell lines": 0.0097, "tpa-induced mononuclear cell differentiation": 0.0097, "cancerous cell lines": 0.0097, "hil-5-responsive cell lines": 0.0097, "htlv-i immortalized tax-expressing human t-lymphocyte line": 0.0097, "erythroleukemic cell lines": 0.0097, "class ii gene regulation": 0.0097, "htlv-i-bearing cell lines": 0.0097, "hematopoetic cell lines": 0.0097, "serum-activated cell lines": 0.0097, "distinct lymphoid-specific protein": 0.0097, "v3-bh10 enhanced il-2-induced mrna expression": 0.00969, "require de novo protein synthesis": 0.00969, "mutant nm23-h2his protein": 0.00969, "cell lines": 0.00969, "active phosphorylated creb protein": 0.00969, "augments cd28-induced il-2 promoter activity": 0.00969, "cd28 cell surface molecule": 0.00968, "hepor transcription activity depends": 0.00968, "cellular transcription factor": 0.00968, "analyze transcription activity": 0.00968, "human p40 genes": 0.00968, "il-2 mrna expression": 0.00968, "protein sequences": 0.00968, "mutant protein": 0.00968, "pebp2beta smmhc chimeric fusion protein": 0.00967, "distinct transcription factor families": 0.00967, "140-kda protein designated sp140": 0.00967, "vascular cell adhesion molecule": 0.00967, "soluble cd40l fusion protein up-regulated": 0.00967, "retinoid-induced u-937 cell differentiation": 0.00967, "agammaglobulinemia tyrosine kinase gene": 0.00967, "cell growth inhibitors": 0.00967, "human eosinophils involves jak2 tyrosine kinase": 0.00967, "distinct stat3-like protein": 0.00967, "induced icam-1 expression": 0.00967, "derived 103-amino-acid basic protein": 0.00967, "major basic protein": 0.00966, "th2 cell differentiation": 0.00966, "u-937 cell differentiation": 0.00966, "lymphoid-specific protein binds": 0.00966, "host cell differentiation": 0.00966, "cell adhesion molecule icam-1": 0.00966, "normal cell counterparts microdissected": 0.00965, "basal total white blood cell": 0.00965, "estrogen receptor-related 27-kda heat shock protein": 0.00965, "ubiquitous transcription factor involved": 0.00965, "ebv-encoded latent membrane protein": 0.00965, "regulatory tat protein": 0.00965, "prdii element increased transcription": 0.00965, "protein synthesis correlates": 0.00964, "protein phosphatase inhibitors": 0.00964, "protein required": 0.00964, "il-10 prevented ifn-gamma-induced binding activity": 0.00964, "nf-at dna binding complex": 0.00964, "human monocytic line mono mac": 0.00964, "peripheral blood mononuclear cell": 0.00964, "heat shock protein association": 0.00964, "suppress cell differentiation": 0.00964, "enhances human immunodeficiency virus type": 0.00964, "gene regulation suggests distinct biological roles": 0.00964, "ra receptor activation": 0.00964, "cell cycle signaling": 0.00964, "induced fas expression": 0.00963, "human genes": 0.00963, "viral immediate-early protein": 0.00963, "il-4 affects binding activity": 0.00963, "enhanced p40 mrna expression": 0.00963, "protein tyrosine phosphatases": 0.00963, "main transcription factor involved": 0.00963, "proteins activated transcription": 0.00962, "viral protein vp16": 0.00962, "dna-binding protein gata-1": 0.00962, "erythroid transcription factor gata-1": 0.00962, "protein binds": 0.00962, "suppressed nfkappab binding activity": 0.00962, "protein tyrosine phosphorylation-dependent event": 0.00962, "erythroid alas precursor protein": 0.00961, "chimeric fusion protein": 0.00961, "comments ] inducible expression": 0.00961, "cell mutant derived": 0.00961, "single major transcription start site": 0.00961, "induced differential expression": 0.00961, "cell adhesion assays": 0.00961, "putative zinc finger protein": 0.00961, "transcription activity": 0.00961, "helper cell differentiation": 0.00961, "cyclic amp-dependent protein kinases": 0.00961, "protein results": 0.00961, "vitro undergo constitutive cell death": 0.0096, "human peripheral leukocytes ]": 0.0096, "phorbol ester-inducible transcription factor ap1": 0.0096, "mammalian 27-kda heat shock protein": 0.0096, "hl60 cell differentiation": 0.0096, "potential ap-1 binding site plays": 0.0096, "important immunoregulatory protein": 0.0096, "il-4-activated transcription factor signal transducer": 0.0096, "hu regulates c-jun mrna expression": 0.0096, "latent membrane protein lmp2": 0.0096, "hepatic pcd/dcoh protein level": 0.0096, "de novo protein synthesis": 0.00959, "mouse tcf-1 protein": 0.00959, "latent membrane protein": 0.00959, "protein involved": 0.00959, "staphylococcus aureus replication initiation protein": 0.00958, "vitro translated spi-b protein": 0.00958, "cell surface recognition events": 0.00958, "control programmed cell death": 0.00958, "specific cell types": 0.00958, "tnf-alpha gene induced": 0.00958, "nuclear c-rel expression": 0.00958, "dendritic cell differentiation": 0.00958, "transcription factor e2f binds": 0.00958, "ebv lmp-1 protein": 0.00958, "b-cell-specific activator protein": 0.00957, "octamer-binding protein otf-2 demonstrate": 0.00957, "increases il-4 promoter activity": 0.00957, "cell inhibitory activities present": 0.00957, "granulocyte-colony-stimulating factor receptor mrna": 0.00957, "tumor necrosis factor receptor-associated factor": 0.00957, "enhanced mrna expression": 0.00957, "exogenous recombinant tat protein": 0.00957, "human t-cell leukemia virus type-i": 0.00957, "il-2 promoter activity": 0.00957, "timp-1 upregulation induced expression": 0.00957, "cell differentiation contributes": 0.00956, "inflammatory cytokine expression [": 0.00956, "nk cell-target cell interaction": 0.00956, "nuclear nf-kb expression": 0.00956, "stat6 protein present": 0.00956, "cell precursor acute lymphoblastic leukemia": 0.00956, "increased c-jun expression": 0.00956, "cytosolic phospholipase a2 suppressed interleukin-1beta protein": 0.00956, "plasma cell formation": 0.00956, "scl protein synthesis": 0.00956, "human gm-csf element": 0.00956, "human sequence": 0.00956, "tumor necrosis factor receptor-activated factor": 0.00956, "overexpression induced transcriptional activation": 0.00955, "optimal cell differentiation": 0.00955, "molecular mechanisms regulating human immunodeficiency virus": 0.00955, "dna binding proteins": 0.00955, "vitro translated mad-3 protein": 0.00955, "human t-cell leukemia virus": 0.00955, "id3 cell cycle function": 0.00955, "depressed peripheral white blood cell": 0.00955, "increased monocyte tf expression": 0.00954, "inducible dna-binding protein": 0.00954, "ar protein decreased": 0.00954, "transcription factor ifn regulatory factor-1": 0.00954, "high c-myc mrna expression": 0.00954, "transcription factor required": 0.00954, "g-csf receptors lack intrinsic tyrosine kinase activity": 0.00954, "isolated ets-1 protein": 0.00954, "[ ca2+ ] i. proteolytic activity": 0.00954, "viral protein": 0.00954, "myeloid-associated growth factor receptor transcripts": 0.00954, "protein tyrosine kinase-": 0.00954, "cell functional responses": 0.00954, "pml/rar alpha fusion gene resulting": 0.00954, "putative hematopoietic transcription factor scl": 0.00953, "suppress malignant cell growth": 0.00953, "induced gene products": 0.00953, "stimulate human immunodeficiency virus type": 0.00953, "zinc-binding potential transcription factor": 0.00953, "inhibit monocytic cell adhesion": 0.00953, "classical c-fos promoter serum response element": 0.00953, "protein tyrosine": 0.00953, "early protein": 0.00953, "ribosomal protein s6 serine/threonine kinases": 0.00953, "cell type dependent": 0.00953, "activate mitogen-activated protein": 0.00952, "cell signal transduction": 0.00952, "il-2 promoter response element": 0.00952, "ap-1 binding activity": 0.00952, "zinc finger transcription factor gata-1": 0.00952, "study il-6 promoter activity": 0.00952, "cell lymphotropic virus": 0.00952, "decreased bcl-6 mrna expression": 0.00952, "critical cell function": 0.00952, "purified protein fractions": 0.00952, "cell immunoglobulin production": 0.00951, "primary response gene": 0.00951, "glutathione s-transferase-tax1 fusion protein": 0.00951, "immediate-early major tegument protein": 0.00951, "cell growth transformation": 0.00951, "require protein synthesis": 0.00951, "fasl expression induced": 0.0095, "murine transcription factor": 0.0095, "cell expressed": 0.0095, "ikaros/lyf-1 transcription factor motifs": 0.0095, "kda id-3 protein termed id-3l": 0.0095, "ebv sm protein": 0.0095, "neuroblastoma cell differentiation": 0.0095, "promote cd4 cell proliferation": 0.0095, "blood cell development": 0.0095, "nk cell membrane extracts": 0.0095, "72-kilodalton major immediate-early protein": 0.00949, "72-kda major immediate-early protein": 0.00949, "sp1 transcription factor bound": 0.00949, "cell cycle regulation": 0.00949, "mitogen-activated protein kinases erk1": 0.00949, "important cell membrane constituents": 0.00949, "promoter activity stimulated": 0.00949, "major immediate-early protein ie1": 0.00949, "transcription factor involved": 0.00949, "cell surface mu heavy chain": 0.00948, "induced hsp70 expression": 0.00948, "ebv zebra protein": 0.00948, "nfat gene family members characterized": 0.00948, "kd tumor necrosis factor receptor": 0.00948, "induced mip-1alpha expression": 0.00948, "nuclear receptor proteins": 0.00948, "il-4 promoter activation": 0.00948, "nuclear tcf-1 expression": 0.00948, "cd16- myeloid/natural killer cell acute leukemia": 0.00948, "mouse il-2r alpha gene": 0.00947, "nf-kappab dna binding increased": 0.00947, "regulate im-9 cell growth": 0.00947, "cell transmembrane signaling": 0.00947, "ki-67 cell cycle antigen": 0.00947, "decreased tf mrna expression": 0.00947, "mitogen-activated protein kinases": 0.00947, "cell type specificity": 0.00947, "mutated recombinant xpb protein": 0.00947, "cell surface molecule": 0.00946, "reduced mrna expression": 0.00946, "il-6-mediated mm cell growth": 0.00946, "cell assay": 0.00946, "important transcription factor": 0.00946, "continuous nuclear expression": 0.00946, "adhesion protein mac-1": 0.00946, "beta cell glucose toxicity": 0.00946, "cell differentiation": 0.00946, "gene transcriptional inhibition": 0.00946, "kda heat shock protein": 0.00945, "regulating cell growth": 0.00945, "sm protein derived": 0.00945, "observed cell type-specific permissiveness": 0.00945, "il-10 receptor activation": 0.00945, "human immunodeficiency virus enhancer": 0.00945, "mm cell growth": 0.00945, "fusion protein e2a-hlf": 0.00945, "virion-associated regulatory protein": 0.00944, "ongoing protein synthesis": 0.00944, "mhc class ii antigens expression": 0.00944, "hiv-1 expressing ikappab-alphas32/36a down-regulates viral expression": 0.00944, "decreased tissue-specific promoter activity": 0.00944, "cell leukemia virus-i tax leads": 0.00944, "encoded transactivator protein tax": 0.00944, "pml/raralpha fusion protein": 0.00943, "nf-kappa b/rel nuclear activity": 0.00943, "decreased class ii expression": 0.00943, "regulatory protein": 0.00943, "neural cell adhesion molecule": 0.00943, "cell type-specific enhancer": 0.00943, "tax-stimulated nuclear expression": 0.00943, "induced fra-1 expression": 0.00943, "protein level": 0.00943, "viral transcription factor": 0.00943, "c/ebpalpha mrna expression decreased": 0.00943, "human antigen-specific cd4+ t-cell lines": 0.00943, "protein kinases p56": 0.00943, "ets transcription factor related": 0.00943, "t-helper cell dysfunctions observed": 0.00943, "related octamer-binding protein": 0.00943, "major histocompatibility complex class ii dra promoter occupancy mediated": 0.00943, "cell cycle control": 0.00942, "induced rar-beta expression": 0.00942, "induced raldh2 expression": 0.00942, "nuclear transcription factors ap-1": 0.00942, "cell specific": 0.00942, "reduced il-13 promoter activity": 0.00942, "nuclear expression": 0.00942, "early transcription factor": 0.00942, "m-tat/epo cell culture decreased": 0.00942, "major ccaat/enhancer-binding protein": 0.00942, "extracellular matrix protein fibronectin": 0.00942, "stress-activated protein kinase/c-jun nh2-terminal kinases": 0.00942, "intracellular signal-transducing protein stat6": 0.00942, "nuclear run-on experiments demonstrated decreased transcription": 0.00942, "major coat protein": 0.00942, "estrogen binding activity": 0.00941, "cytolytic effector cell function": 0.00941, "-230 reduced promoter activity": 0.00941, "transduced pml/rar alpha fusion gene": 0.00941, "protein synthesis": 0.00941, "induced expression": 0.00941, "macrophage inflammatory protein": 0.0094, "culture protein filtrates": 0.0094, "affect cell proliferation": 0.0094, "elk-1 fusion protein": 0.0094, "identified pre-i binding factor pos-1": 0.0094, "cytokine-induced human immunodeficiency virus type": 0.0094, "influence cell growth": 0.0094, "cell surface hla-dr antigens": 0.0094, "cytokine gene induction": 0.00939, "human gasd element": 0.00939, "stat1 binding activity": 0.00939, "nuclear factor kappa b. oxidoreductive regulation": 0.00939, "human monocyte nuclear factor-kappab": 0.00939, "human peripheral blood monocytes bind": 0.00939, "cell activation-induced apoptosis": 0.00939, "cellular glucocorticoid receptor levels increased": 0.00939, "mhc class ii-silenced cell hybrids": 0.00939, "major protein": 0.00939, "human serum-inducible element": 0.00939, "lymphocyte cytosolic protein": 0.00939, "leukemia-associated fusion protein aml1/mds1/evi1": 0.00939, "microglial cell stimulation": 0.00939, "interleukin-12 fusion protein": 0.00938, "transcriptional activator nf-kappa b. activation": 0.00938, "small basic protein": 0.00938, "human class ii trans-activator constructs lacking": 0.00938, "fusion protein aml1/mds1/evi1": 0.00938, "oxovanadium-iv enhanced cell death": 0.00938, "inducible transcription factor ap-1": 0.00938, "s49 cell apoptosis": 0.00938, "impaired il-9-induced cell growth": 0.00938, "integral membrane protein": 0.00938, "rfx5 fusion protein": 0.00938, "growth factor receptor engagement leads": 0.00937, "mhc class ii expression plays": 0.00937, "gad-creb fusion protein": 0.00937, "cell permeable inhibitory peptide": 0.00937, "protein related": 0.00937, "major histocompatibility complex class ii invariant chain promoter": 0.00937, "induce programmed cell death": 0.00937, "cell receptors": 0.00937, "ews/fli-1 fusion protein": 0.00937, "erythroid protein": 0.00937, "gamma interferon-induced class ii transactivator expression": 0.00937, "gst-ebna-2 fusion protein": 0.00937, "chemokines monocyte chemoattractant protein": 0.00937, "gp39-cd8 fusion protein": 0.00937, "related protein": 0.00937, "stress-activated protein kinases": 0.00937, "il-6 protein secretion": 0.00937, "activator protein": 0.00936, "cgmp-dependent protein kinases": 0.00936, "cell stimulation": 0.00936, "cell apoptosis": 0.00936, "single protein fraction": 0.00936, "cell signaling": 0.00936, "cd4 promoter activation": 0.00936, "sequence-specific dna-binding protein": 0.00936, "fusion protein": 0.00936, "dna binding region": 0.00936, "activating protein-1 binding activity": 0.00936, "protein dimerization domains": 0.00936, "divergent protein kinases": 0.00936, "cell effector function": 0.00935, "htlv-i tax protein": 0.00935, "transient expression analysis": 0.00935, "immediate-early gene induced": 0.00935, "productive human immunodeficiency virus type": 0.00935, "integrated human immunodeficiency virus type": 0.00935, "multimerized region ii sequence elements enhanced": 0.00935, "wild-type id3 protein": 0.00935, "shigella flexneri icsa protein promotes actin nucleation": 0.00935, "reduced promoter activity": 0.00935, "normal human peripheral blood": 0.00934, "nf-kappa b2 p100 gene product": 0.00934, "constitutive tnf mrna expression": 0.00934, "transcription factor products play": 0.00934, "inhibit mip-1 alpha expression": 0.00934, "protein kinases": 0.00934, "affect er mrna expression": 0.00934, "cell products il-2": 0.00934, "ctll-2 transformed cell growth": 0.00934, "eukaryotic transcription regulatory factor": 0.00934, "active v-abl protein interferes": 0.00934, "sickle cell disease": 0.00934, "principal epo-responsive cell type": 0.00933, "endogenous c-fos mrna expression": 0.00933, "purified human p65 nf-kappa": 0.00933, "human leukocytes ] random migration": 0.00933, "constitutive transcription factor sp1": 0.00933, "constitutive mhc class ii expression": 0.00933, "wild-type hlf protein": 0.00933, "heat shock protein reacts": 0.00933, "stimulate factor activity": 0.00933, "scl protein displays cell-specific heterogeneity": 0.00933, "cd2 receptor activation": 0.00933, "human immunodeficiency virus long terminal repeat": 0.00933, "nf-at protein": 0.00933, "human immunodeficiency virus type": 0.00933, "leukemic cell proliferation": 0.00933, "principal dna-binding protein": 0.00932, "cyclic amp response element binding": 0.00932, "functional promoter activity": 0.00932, "long-term lymphoblastoid cell proliferation": 0.00932, "interferon-gamma activation site-like sequence upstream": 0.00932, "major cell wall component": 0.00932, "nuclear-located kruppel-type zinc finger protein": 0.00932, "active transcription factor creb": 0.00932, "cell functional phenotype": 0.00932, "binding factor ii functions": 0.00932, "cytokine mrna expression": 0.00932, "jurkat cell clones": 0.00932, "major transcription initiation site": 0.00932, "zinc finger transcription factor egr-1": 0.00932, "cell growth exert": 0.00932, "protein termed bp1": 0.00931, "tumor necrosis factor receptor superfamily": 0.00931, "increased raf-1 kinase activity maximum 3.3-fold": 0.00931, "lymphocyte protein": 0.00931, "steroid binding activity": 0.00931, "kda glial labile repressor protein": 0.00931, "encoded tax protein": 0.00931, "protein activates": 0.00931, "-72 abolished basal promoter activity": 0.00931, "gata-1 factor binding motifs": 0.00931, "transcription factor activator protein-1": 0.00931, "wild type cell": 0.0093, "endothelial cell surface": 0.0093, "specific binding site": 0.0093, "protein component": 0.0093, "lymphocyte glucocorticoid receptor binding parameters": 0.0093, "clonal cell growth": 0.0093, "increased lmp1 expression": 0.0093, "inducing cell proliferation": 0.0093, "erythroid cell development": 0.0093, "extracellular matrix protein tenascin": 0.0093, "major histocompatibility class ii gene dra": 0.0093, "multiple cell culture": 0.0093, "90-kda heat shock protein": 0.0093, "ap-1 enhancer activity induced": 0.00929, "c/ebp alpha regulate expression": 0.00929, "activation-dependent cell surface markers cd25": 0.00929, "phoq protein contained": 0.00929, "pituitary cell system": 0.00929, "il-2 induces bcl-2 expression": 0.00929, "viral gene effects": 0.00929, "gata1 erythroid transcription factor": 0.00929, "dendritic cell function": 0.00929, "monocyte chemoattractant protein": 0.00929, "lam -and lps-inducible il-6 promoter activity": 0.00929, "slp-76 linker protein interacts": 0.00929, "effective antigen-presenting cell function": 0.00928, "putative additional lymphoid-specific transcription factor": 0.00928, "prevents synergistic promoter activation": 0.00928, "major transcription factor": 0.00928, "hematopoietic cell-specific transcription factor": 0.00928, "cell ig production": 0.00928, "cd8 cell surface antigens": 0.00928, "cell transfectants expressing wild-type": 0.00928, "c-jun protein": 0.00928, "termed octamer-associated protein": 0.00928, "inducible egr-1 protein recognizes": 0.00928, "molecular mechanisms regulating human granulocyte apoptosis": 0.00928, "site-specific activators cyclic amp-responsive element-binding protein": 0.00928, "myc-associated zinc finger protein": 0.00928, "antigen-presenting cell type": 0.00928, "extracellular matrix protein": 0.00928, "myeloid-specific zinc finger protein": 0.00928, "consensus sequence-binding protein": 0.00928, "transcription factor e2f activates": 0.00927, "transduce cell survival signals": 0.00927, "cell transformation assays": 0.00927, "zinc finger protein": 0.00927, "active v-abl protein": 0.00927, "cell receptor-derived type": 0.00927, "gene nuclear topography": 0.00927, "cell surface molecules": 0.00927, "cd2-mediated interleukin-2 promoter activation": 0.00927, "megakaryocytic cell surface markers": 0.00927, "receptor binding studies indicating": 0.00927, "jurkat cell model": 0.00926, "truncated tat protein": 0.00926, "large 67-kda precursor protein": 0.00926, "cell surface events": 0.00926, "cell type": 0.00926, "cell type-specific regulation": 0.00926, "dna-binding protein": 0.00926, "erythroid transcription factor": 0.00926, "heat shock protein": 0.00926, "islet cell antibodies": 0.00926, "antisense myb rna expression suppresses hm-induced differentiation": 0.00926, "control ig gene class switch recombination": 0.00926, "cell proliferation correlates": 0.00925, "tumor cell nuclei": 0.00925, "wild-type protein": 0.00925, "reporter gene experiments demonstrated": 0.00925, "gm-csf receptor alpha promoter": 0.00925, "30-kd protein product": 0.00925, "myeloid transcription factor pu.1": 0.00925, "p/i-inducible fas promoter activation": 0.00925, "ligand activated transcription factors": 0.00925, "protein extracts": 0.00924, "putative cell-specific transcription factor": 0.00924, "protein product": 0.00924, "protein degradation": 0.00924, "activating cell proliferation": 0.00924, "cell adhesion molecules cd62e": 0.00924, "cytoplasmic protein": 0.00924, "androgen receptor binding assay": 0.00924, "protein truncation test": 0.00924, "red cell production": 0.00924, "cell-specific activating protein": 0.00924, "hematopoietic transcription factor pu.1": 0.00924, "class ii major histocompatibility complex surface proteins": 0.00924, "ad5 e1a protein localized": 0.00924, "affected b29 minimal promoter activity": 0.00924, "protein bound": 0.00924, "tumor necrosis factor induced apoptosis": 0.00924, "receptor activation": 0.00924, "transactivator protein tax": 0.00923, "cell surface maturation-specific antigens": 0.00923, "interferon alpha selectively affects expression": 0.00923, "c5a-induced kappab binding activity": 0.00923, "restricted mrna expression pattern": 0.00923, "kappa immunoglobulin light chain gene": 0.00923, "hiv-1-encoded nef protein suggested": 0.00923, "immunoglobulin kappa light chain gene": 0.00923, "tcr alpha joining gene segments": 0.00922, "p75 tumor necrosis factor receptor": 0.00922, "nf-kappa b-directed luciferase activity increased": 0.00922, "small mitochondrial protein": 0.00922, "epstein-barr virus-encoded transactivator protein bzlf1": 0.00922, "nf-at transcription factor": 0.00922, "stat protein heterocomplexes exist prior": 0.00922, "stimulate cell proliferation": 0.00922, "mediate maximal il-2rbeta promoter activity": 0.00922, "nfkappab binding activity": 0.00922, "activated human monocytes": 0.00922, "protein structure": 0.00922, "cell surface antigens": 0.00922, "human activated monocytes": 0.00922, "cell surface markers": 0.00922, "cell activating signals": 0.00921, "subsequent monocytic cell adhesion": 0.00921, "cell adhesion molecules": 0.00921, "cell cultures stimulated": 0.00921, "ap-1 protein": 0.00921, "soluble tat protein": 0.00921, "transcription factor families ap-1": 0.00921, "suppress core promoter activity": 0.00921, "-10 inhibits nuclear factor kappa": 0.00921, "comments ] hiv enhancer activity": 0.00921, "recombinant zebra protein": 0.00921, "cell regulation": 0.00921, "transcription factor activities": 0.00921, "induces cell maturation": 0.00921, "high-affinity dehydroepiandrosterone binding activity": 0.00921, "tumor necrosis factor receptor": 0.0092, "serine/threonine-specific protein phosphatase": 0.0092, "recombinant hbxag protein": 0.0092, "es cell system": 0.0092, "enhancer binding proteins isolated": 0.0092, "gene termed class ii transactivator": 0.0092, "natural bacterial cell wall breakdown product": 0.0092, "recombinant mzf-1 protein": 0.0092, "recombinant c/ebpbeta protein": 0.0092, "epstein-barr virus dna polymerase activity": 0.0092, "protein heterodimers": 0.0092, "cyclosporin a-binding protein cyclophilin": 0.0092, "mammalian protein bsap recognizes": 0.0092, "mammalian homeodomain protein": 0.00919, "gata-1 controls cell survival": 0.00919, "activated hiv expression": 0.00919, "platelet glycoprotein ib alpha gene": 0.00919, "soluble protein ag enter apc": 0.00919, "lymphoid-specific transcription factor oct-2a plays": 0.00919, "13-kb human c-fes locus contained positive cis-acting elements": 0.00919, "tax transforming protein": 0.00919, "protein antigens": 0.00919, "recombinant otf-2 protein": 0.00919, "mononuclear leukocyte glucocorticoid receptor binding characteristics": 0.00919, "c-jun mrna expression": 0.00919, "human c-fes transgene exhibits high levels": 0.00919, "initial increased expression": 0.00919, "induced transcriptional activation": 0.00919, "induce high level expression": 0.00918, "hgm-csf-mediated cell growth": 0.00918, "distinct cell types depends": 0.00918, "inhibits t-cell interleukin-2 expression": 0.00918, "alpha chain gene": 0.00918, "tumor cell infiltration": 0.00918, "single cell level": 0.00918, "il-9-mediated cell growth": 0.00918, "il-2-driven cell growth": 0.00918, "increased cd23 expression": 0.00918, "il-1ra protein secretion": 0.00918, "nf-il6 binding activity": 0.00918, "mediating gata-1-induced erythroid cell survival": 0.00918, "early pro-b cell stage": 0.00918, "il-2r alpha expression correlated": 0.00917, "ca2+/calmodulin-dependent protein phosphatase": 0.00917, "cell extracts derived": 0.00917, "recombinant protein": 0.00917, "terminal protein": 0.00917, "increased ikappab expression": 0.00917, "total protein content": 0.00917, "cell growth": 0.00917, "cell clones expressing": 0.00917, "tumor cell types": 0.00917, "a-myb transcription factor plays central": 0.00916, "il-5 promoter activation": 0.00916, "p65 protein": 0.00916, "major transcription start site": 0.00916, "cell function": 0.00916, "exogenous tat protein": 0.00916, "zinc finger transcription factor": 0.00916, "cell activator oct-2 functions": 0.00916, "reduced red cell survival": 0.00916, "increased c-myb expression": 0.00916, "protein secretion": 0.00915, "lymphoid-specific immunoglobulin mu heavy chain gene enhancer": 0.00915, "heat shock transcription factor": 0.00915, "lacked detectable cd14 cell surface": 0.00915, "cell type-specific tfiid subunit related": 0.00915, "cell surface enzyme immunoassays": 0.00915, "nf-y binding activity": 0.00915, "alpha subunit expression": 0.00915, "c-fos protein": 0.00915, "cell system": 0.00915, "bcl-2 protein": 0.00915, "mutated apc protein": 0.00914, "cell proliferative signals": 0.00914, "protein phosphatase": 0.00914, "single transcription initiation site": 0.00914, "t-cell-directed tal-1 expression induces t-cell malignancies": 0.00914, "full-length sp1 transcription factor": 0.00914, "mouse spleen cell hybrids": 0.00914, "putative p13mtcp1 protein": 0.00914, "ik protein plays": 0.00913, "active transcription factor": 0.00913, "hiv-1 promoter transcription": 0.00913, "downstream parathyroid hormone-related protein": 0.00913, "stem cell proliferation": 0.00913, "cell development tested": 0.00913, "homodimeric stat1 protein": 0.00913, "cell surface cd4": 0.00913, "concomitant cell proliferation": 0.00913, "induce cell lysis": 0.00912, "vascular cell adhesion molecule-1": 0.00912, "protein plays": 0.00912, "gata-1 protein": 0.00912, "estrogen receptor-related protein": 0.00912, "lineage limited transcription factor nf-e2": 0.00912, "protein interacts": 0.00912, "lymphocyte glucocorticoid receptor binding": 0.00912, "cell adhesion include paxillin": 0.00912, "adult alpha-globin promoter activity": 0.00912, "c-fos sense mrna expression": 0.00911, "40-kd tax protein": 0.00911, "human t-lymphotropic virus type": 0.00911, "activated ras expression": 0.00911, "sh2 domain-containing leukocyte protein": 0.00911, "tnf alpha expression": 0.00911, "ubiquitous protein oct-1": 0.00911, "human t-cell-leukemia virus type": 0.00911, "human t-lymphotrophic virus type": 0.00911, "cell surface immunoglobulin": 0.00911, "transforming protein lmp1": 0.00911, "basal transcription factor tfiih": 0.00911, "cross-linking cell surface cd3": 0.00911, "vitamin d-binding protein": 0.00911, "latent membrane protein-1 induces cyclin d2 expression": 0.0091, "minimal promoter exhibits b-cell-specific activity": 0.0091, "transcription factor ap-1": 0.0091, "stat1 protein starting": 0.0091, "amino acid long human tramp": 0.0091, "stp-c488 induced nf-kappab activation": 0.0091, "tax protein": 0.0091, "optimal il-4 promoter activity": 0.0091, "ap-1 transcription factor": 0.0091, "transcription factor regulated": 0.0091, "gr protein": 0.0091, "mrna expression pattern": 0.0091, "single transcription factor": 0.0091, "nuclear nf-kappab dna-binding activity": 0.0091, "stimulates immunoglobulin promoter activity": 0.0091, "mouse mammary tumor virus-long terminal repeat dna binding": 0.00909, "inducible c1 protein": 0.00909, "nf-il-6 binding activity": 0.00909, "cell-b cell interactions": 0.00909, "stat3 protein": 0.00909, "tnf gene induction": 0.00909, "ap-1-dna binding activity": 0.00909, "arre-2 binding activity": 0.00909, "nf-il-2b binding activity": 0.00909, "e2f-dna binding activity": 0.00909, "p50 protein": 0.00909, "functional t-cell receptor signaling pathway": 0.00909, "lr1-dna binding activity": 0.00909, "absent mhc class ii expression": 0.00909, "receptor alpha chain/cd25 promoter": 0.00909, "tnf-alpha protein": 0.00908, "promote erythroid cell survival": 0.00908, "camp response element site": 0.00908, "natural killer cell development": 0.00908, "cell proliferation rates": 0.00908, "potential nf-kappab binding sequence": 0.00908, "abolish il-9-induced cell proliferation": 0.00908, "mononuclear blood cell": 0.00908, "basic helix-loop-helix protein": 0.00908, "binding activity": 0.00908, "protein lacking": 0.00908, "lipid transfer protein": 0.00908, "inhibitory protein": 0.00908, "basal transcription factor": 0.00907, "hematopoietic transcription factor belonging": 0.00907, "nf-kappab nuclear activation": 0.00907, "scl protein size": 0.00907, "nf-kappab1 p105 precursor protein": 0.00907, "nfat gene family member nfatc": 0.00907, "multiple endothelial gene products required": 0.00907, "b-cell-specific pu.1 transcription factor": 0.00907, "c/ebp epsilon protein": 0.00907, "chimeric ebna2 protein": 0.00907, "human cd3epsilon transgenic mouse lines": 0.00907, "augment coactivator protein recruitment": 0.00907, "stat1 protein": 0.00907, "pp52 leukocyte protein": 0.00907, "c-fos mrna expression": 0.00907, "cell type-specific alternative messenger rna splicing": 0.00907, "nfat protein": 0.00907, "myeloid cell development": 0.00907, "repress basal promoter activity": 0.00906, "protein release": 0.00906, "vdr protein": 0.00906, "nf-kappa b-dependent il-6 expression": 0.00906, "hla class ii expression": 0.00906, "gamma-interferon inducible protein": 0.00906, "endothelial cell adhesive properties": 0.00906, "nf-kappab activation induced": 0.00906, "primary human lymphocytes": 0.00906, "ifn-gamma-induced mhc class ii expression": 0.00906, "gammac basal promoter activity": 0.00906, "pathway inhibits nf-kappab transcription": 0.00906, "human genomic dna": 0.00906, "pml/rar-alpha hybrid protein": 0.00906, "lineage-restricted transcription factor gata-1": 0.00905, "e1a gene products inhibited ifn-mcp": 0.00905, "increased expression": 0.00905, "large protein": 0.00905, "truncated nm23-h2 protein": 0.00905, "htlv-i-negative human t-cell lines": 0.00905, "activate nf-kappa b. phorbol activation": 0.00905, "full-length scl protein": 0.00905, "detectable nfatc protein": 0.00905, "normal circulating human monocytes": 0.00905, "kappa light chain gene enhancers depends": 0.00905, "porcine mhc class ii expression": 0.00905, "transcription factor e2f-1 plays": 0.00905, "redox sensitive cytosolic transcription factor": 0.00905, "strong c-myc mrna expression": 0.00905, "abundant chromosomal protein hmg-1 belongs": 0.00904, "t-cell-specific ets protein elf-1": 0.00904, "key immediate-early protein": 0.00904, "kd protein": 0.00904, "stat protein pairs": 0.00904, "drosophila toll protein": 0.00904, "mutated k-ras protein": 0.00904, "human t-cell lines": 0.00904, "mature protein": 0.00904, "il-12 induced nuclear factors nf-kappa": 0.00904, "drosophila runt protein": 0.00904, "lineage-specific transcription factor gata-1": 0.00904, "subsequent protein conjugation": 0.00904, "regulating lps-triggered gene induction": 0.00904, "nk cell development": 0.00904, "tax expression promotes n-terminal phosphorylation": 0.00904, "basic domain-helix-loop-helix protein": 0.00904, "mitogen-activated protein kinase-1 extracellular-regulated kinase-kinase": 0.00904, "freshly isolated normal human thymocytes": 0.00904, "neutrophil-mediated tumor cell cytostasis": 0.00904, "shp2 interacting transmembrane adaptor protein": 0.00904, "inducible protein": 0.00904, "binding factor ii": 0.00903, "blocked il-10 mediated c-fos expression": 0.00903, "il-9-induced cell proliferation": 0.00903, "hematopoietic transcription factor": 0.00903, "truncated protein": 0.00903, "protein products": 0.00903, "protein coding exons": 0.00903, "uncontrolled cell proliferation": 0.00903, "mechanisms regulating human immunodeficiency virus": 0.00903, "granulosa cell tumor": 0.00903, "mast cell proliferation": 0.00903, "nk cell mediated cytolysis": 0.00903, "variant id-3l protein": 0.00903, "low cd4+ cell counts": 0.00903, "core promoter activity": 0.00903, "protein dependent": 0.00903, "basic protein": 0.00903, "transcription factor aiolos interacts": 0.00903, "hiv promoter activity": 0.00903, "promoter activation": 0.00902, "cell-specific protein neg-1": 0.00902, "transcription factor suggested": 0.00902, "ndp kinase expression serves": 0.00902, "bk virus plasmid expression vector": 0.00902, "protein hlf fused": 0.00902, "protein species": 0.00902, "protein selectively": 0.00902, "endogenous protein": 0.00902, "response element binding": 0.00902, "interleukin-9-mediated cell proliferation": 0.00902, "gr mrna expression": 0.00902, "lef-1 hmg protein": 0.00902, "ebna2 positive cell extracts": 0.00902, "hgm-csf-dependent cell proliferation": 0.00902, "creb binding site oligonucleotides demonstrate": 0.00902, "il-4 promoter activity": 0.00902, "chimeric gal4-hsf3 protein": 0.00902, "stem cell factor-dependent erythroid progenitors": 0.00902, "transcription factor gata-1": 0.00901, "gata-1 transcription factor": 0.00901, "mhc class ii expression": 0.00901, "chimeric protein": 0.00901, "upregulate c-fos promoter activity": 0.00901, "il-2-induced il-6 mrna expression": 0.00901, "cell proliferation": 0.00901, "hybrid cd8-nef protein": 0.00901, "ubiquitin protein ligase e3": 0.00901, "transcription factor sp1": 0.00901, "inducing g1 cell cycle arrest": 0.00901, "sp1 transcription factor": 0.00901, "alpha tcr gene": 0.00901, "nf-kappab binding site": 0.00901, "kda stat5b protein": 0.00901, "cell-specific protein": 0.00901, "critical transcription factor": 0.00901, "complement receptor-1 cell-surface protein": 0.00901, "5-lox activating protein": 0.00901, "lymphoid cell resistance": 0.00901, "cell distribution studies": 0.00901, "tcr alpha gene": 0.00901, "hiv-1 antigen expression": 0.009, "total human dna": 0.009, "bzlf1 expression precedes rampant virus replication": 0.009, "gr expression levels": 0.009, "transcription factors nuclear factor-kappa": 0.009, "decreased adhesion molecule expression": 0.009, "tegument protein encoded": 0.009, "agonist-induced monocytic cell adhesion": 0.009, "tat protein amplifies": 0.009, "mutated rar alpha gene": 0.00899, "activation modified proteins": 0.00899, "ndp kinase expression": 0.00899, "activating protein": 0.00899, "synthesized p105 protein": 0.00899, "tat protein": 0.00899, "bacterial cell wall components plays": 0.00899, "il-6 protein": 0.00899, "putative transcription factor": 0.00899, "cell contact-delivered signals": 0.00899, "fc gamma receptors activates hiv-1 long terminal repeat-driven transcription": 0.00899, "shp2-interacting transmembrane adaptor protein": 0.00899, "isolated human lymphocytes": 0.00899, "c/ebp epsilon mrna expression": 0.00899, "p38 mitogen-activated protein": 0.00899, "monocytic cell adhesion": 0.00898, "ets protein elf-1": 0.00898, "ubiquitous octamer-binding protein": 0.00898, "basal promoter activity": 0.00898, "epidermal growth factor receptor": 0.00898, "dpm mg-1 cytosol protein": 0.00898, "lytic cycle infectious progeny virus expression": 0.00898, "urinary protein excretion": 0.00898, "mtetra-induced il-6 mrna expression depends": 0.00898, "human peripheral blood monocytes exposed": 0.00898, "ets protein spi-b": 0.00898, "mutant cell": 0.00898, "cell signals": 0.00898, "encoded protein": 0.00897, "foam cell formation": 0.00897, "shuttling transcription factor nfat": 0.00897, "octamer-binding protein oct-2a": 0.00897, "hiv-1 gene regulation": 0.00897, "hsv-2 vp16 protein": 0.00897, "il-2r alpha gene contribute": 0.00897, "protein encoded": 0.00897, "transcription factors induced": 0.00897, "oncogenic ets transcription factor fli-1": 0.00897, "unique protein": 0.00897, "nuclear transcription factors": 0.00897, "epithelial cell fusion partner": 0.00897, "serine/threonine protein phosphatases": 0.00897, "32-34 kda protein": 0.00897, "target cell uptake": 0.00897, "cell surface glycoprotein": 0.00897, "protein fractions enriched": 0.00897, "transcription factor stat1": 0.00896, "precursor protein": 0.00896, "il-10-stimulated stat protein": 0.00896, "transcription factor nfat": 0.00896, "peripheral human lymphocytes": 0.00896, "hxbp-1 protein acts": 0.00896, "oct-2 protein": 0.00896, "lacked jak3 protein": 0.00896, "freshly derived cell populations": 0.00896, "mammalian transcription factor": 0.00896, "enhance il-1beta promoter activity": 0.00896, "ifn-gamma activation site-like sequence": 0.00896, "cultured nk cell population": 0.00896, "affected promoter activity": 0.00896, "rabbit 59-kda protein reacts": 0.00896, "stat1 transcription factor": 0.00896, "c-fos promoter activity": 0.00896, "adult beta globin gene contribute": 0.00895, "oct-1 protein": 0.00895, "normal human monocytes": 0.00895, "stat protein": 0.00895, "factor binding motifs": 0.00895, "ifn-gamma activation sequence": 0.00895, "affect promoter activity": 0.00895, "cell-specific transcription factor interacting": 0.00895, "active transcriptional activation domain": 0.00895, "cell population accumulates phenotypic markers": 0.00895, "creb protein": 0.00895, "ets-1 protein": 0.00895, "cysteine-rich secreted protein": 0.00895, "tnf alpha gene": 0.00895, "migration protein cd44": 0.00895, "kda protein": 0.00895, "purified human nf-kappa": 0.00894, "nf-kappa b1 gene encodes": 0.00894, "critical egr family binding element": 0.00894, "key protein": 0.00894, "cell precursor acute leukemias": 0.00894, "u-937 cell adhesion": 0.00894, "cell proliferative responses": 0.00894, "nf-kappab activation pathway": 0.00894, "protein translation start atg": 0.00894, "jun protein": 0.00894, "cell survival mechanisms": 0.00894, "cat protein": 0.00894, "inducible transcription factor": 0.00894, "immediate-early trans-activator protein": 0.00894, "adaptor protein functioning": 0.00894, "binding site demonstrated": 0.00894, "inhibited long-term beta-globin gene silencing": 0.00894, "increased hiv enhancer activity": 0.00894, "erythroid cell survival": 0.00893, "e1a protein": 0.00893, "mhc class ii gene silencing": 0.00893, "ets protein": 0.00893, "protein components": 0.00893, "transcription factor aml1 fused in-frame": 0.00893, "otf-1-enriched protein fractions": 0.00893, "cyclophilin b-binding protein": 0.00893, "resting human peripheral blood monocytes": 0.00893, "htlv-1 transactivator protein": 0.00893, "predicted hb9 protein": 0.00893, "cell cycle entry events": 0.00893, "interferon-gamma activation sequence mediates": 0.00893, "intermediate filament protein vimentin": 0.00893, "icam-1 mrna expression": 0.00893, "conserved transcription factor": 0.00893, "c-rel protein": 0.00893, "predominant stat transcription factor": 0.00893, "linker protein slp-76": 0.00893, "ubiquitous protein": 0.00892, "egr-1 protein": 0.00892, "zinc-finger transcription factor encoded": 0.00892, "chloramphenicol acetyltransferase reporter gene system": 0.00892, "mycobacterium tuberculosis cell wall component lipoarabinomannan": 0.00892, "scl protein": 0.00892, "major sp1 binding site": 0.00892, "ciita protein": 0.00892, "human immunodeficiency virus infection": 0.00892, "110-130-kda nfatp protein": 0.00892, "protein fractions": 0.00892, "recombinant human tshr extracellular domain": 0.00892, "jurkat cell lysates": 0.00892, "nef protein down-regulates": 0.00891, "immediate-early brlf1 protein": 0.00891, "oleic acid inhibits endothelial activation": 0.00891, "augments interleukin-2 promoter activity": 0.00891, "tpl-2 induces il-2 expression": 0.00891, "potential transcriptional activation elements": 0.00891, "protein fraction": 0.00891, "human peripheral monocytes stimulated": 0.00891, "shigella icsa protein": 0.00891, "oncogenic protein fli-1": 0.00891, "leukocyte cell membranes mediate": 0.00891, "b-cell-specific transcription factor bsap": 0.00891, "tnf promoter activity": 0.00891, "protein predicted": 0.00891, "plasmodium vivax erythrocyte-binding protein": 0.00891, "predicted protein": 0.00891, "c-myc protein": 0.00891, "bzlf1 trans-activator protein": 0.00891, "inhibited lps-induced e-selectin expression": 0.00891, "heat-shock protein hsp90": 0.00891, "helix-loop-helix protein id3": 0.00891, "mg protein": 0.00891, "il-6 mrna expression": 0.0089, "sea urchin protein tsap": 0.0089, "wild-type zap-70 induced constitutive activation": 0.0089, "protein synthesis-independent appearance": 0.0089, "high cell turnover": 0.0089, "proteasome inhibitor mg132 abolished dopamine-induced transcriptional activation": 0.0089, "protein e2a": 0.0089, "503-amino-acid-long acidic protein": 0.0089, "activated primary human": 0.0089, "platelet-activating factor stimulates transcription": 0.0089, "induces il-2 expression": 0.0089, "u937 myeloid cell models": 0.0089, "chimeric transcription factor": 0.0089, "erythrocyte duffy protein": 0.0089, "protein reduces": 0.0089, "cell-specific transcription factor": 0.0089, "tumor-suppressor protein prb": 0.0089, "nonpermissive monocyte-like u-937 cell cultures infected": 0.0089, "cell ige synthesis": 0.0089, "ikappabalpha protein": 0.0089, "erythroid cell cultures": 0.0089, "e2a protein": 0.0089, "kappa light chain gene": 0.0089, "il-1beta protein": 0.0089, "ubiquitous transcription factor nf-y": 0.00889, "mitogen-activated protein": 0.00889, "pu.1 mrna expression": 0.00889, "hematopoietic cell lineage commitment": 0.00889, "cd4 cell number": 0.00889, "octamer transcription factor": 0.00889, "gp41 envelope protein": 0.00889, "human anti-porcine t-cell immune responses": 0.00889, "induce cd8 antigen expression": 0.00889, "shc adaptor protein": 0.00889, "full-length protein": 0.00889, "grb2-associated tyrosine-phosphorylated protein": 0.00889, "transactivator protein": 0.00889, "recovered protein": 0.00889, "80-kda tyrosine-phosphorylated protein": 0.00889, "adaptor protein cbl-b": 0.00889, "prb protein": 0.00889, "eosinophil cationic protein": 0.00889, "synthesized protein": 0.00889, "sh2 domain-containing protein": 0.00888, "nfat promoter activity": 0.00888, "unknown protein": 0.00888, "p53 protein": 0.00888, "grb2-related adaptor protein": 0.00888, "transcription factor generation": 0.00888, "protein substrate": 0.00888, "massive monocyte cell death": 0.00888, "80-kd stat5a protein": 0.00888, "malignant human b-cell lines": 0.00888, "c-myc protooncogene mrna expression": 0.00888, "mature burkitt lymphoma cell raji": 0.00888, "oxidative stress enhances nuclear factor kappa": 0.00888, "helper cell level": 0.00888, "myeloid cell markers": 0.00888, "fatty acid-binding protein": 0.00888, "calycin protein superfamily": 0.00888, "c-myb protein": 0.00888, "enhances promoter activity": 0.00888, "bcl-6 protein": 0.00888, "latent transcription factor": 0.00888, "yy-1 protein": 0.00888, "vitro binding site selection procedure": 0.00888, "cell surface igm": 0.00887, "ces-2 cell-death specification protein": 0.00887, "b-cell-specific transcription factor pu.1/spi-1": 0.00887, "gm-csf transcription initiation site": 0.00887, "inhibited cd23 expression": 0.00887, "protein families": 0.00887, "monocyte/b-cell-specific transcription factor pu.1": 0.00887, "ikappab-alpha protein": 0.00887, "platelet/endothelial cell adhesion molecule-1": 0.00887, "40-kda transforming protein": 0.00887, "rb protein": 0.00887, "platelet-endothelial cell adhesion molecule-1": 0.00887, "responsive elements regulating expression": 0.00887, "polyomavirus enhancer-binding protein": 0.00887, "ebv induces il-12 expression": 0.00887, "cd19 protein": 0.00887, "cell-enriched transcription factor oct-2": 0.00887, "calcium-dependent immediate-early gene induction": 0.00887, "human t-cell clones stimulated": 0.00887, "transmembrane protein": 0.00887, "functional ets binding site": 0.00886, "cell lineage-independent manner": 0.00886, "vzv ie62 protein": 0.00886, "b-cell-specific transcription factor": 0.00886, "human t-cell lymphotropic virus": 0.00886, "lymphoid-specific ets transcription factor": 0.00886, "encoded transcription factor": 0.00886, "increase gm-csf expression": 0.00886, "50-kda hlp-1 protein": 0.00886, "transcription factor reveals": 0.00886, "transcription factor pu.1": 0.00886, "adaptor protein": 0.00886, "50-kda protein nfkb1": 0.00886, "tetracycline trans-activator protein": 0.00886, "il-2r alpha expression": 0.00886, "protein recruitment": 0.00886, "translated protein": 0.00886, "unique transcription factor": 0.00886, "protein phosphatases": 0.00886, "junb protein": 0.00886, "activator protein-1 [ ap-1 ] site": 0.00886, "protein traf1": 0.00886, "lineage-restricted ets transcription factor": 0.00886, "inducible promoter activity": 0.00885, "anti-apoptotic protein bcl-xl": 0.00885, "regulates cell cycle progression": 0.00885, "abundant nucleolar protein": 0.00885, "il-8 gene induction": 0.00885, "human erythroid alas mrna": 0.00885, "viral gene regulatory mechanisms": 0.00885, "tcf-1 alpha binding element": 0.00885, "potential tfiid binding site": 0.00885, "helix-turn-helix transcription factor oct-1": 0.00885, "sig-crosslinking-induced egr-1 mrna expression": 0.00885, "cell cycle controls": 0.00885, "single critical c-myb binding site": 0.00885, "single-chain protein": 0.00885, "oct-2 transcription factor": 0.00885, "tnf-alpha transcription start site": 0.00885, "rex protein": 0.00885, "bioactive m-csf protein": 0.00885, "unidentified pos-binding protein": 0.00885, "double-stranded rna-binding protein": 0.00885, "dendritic cell level": 0.00885, "immediate-early protein": 0.00885, "erythroid-specific protein": 0.00884, "induce hiv-1 expression": 0.00884, "conserved c4 zinc finger dna binding domain": 0.00884, "hela cell extracts": 0.00884, "cytosolic protein": 0.00884, "fasl protein": 0.00884, "abundant protein": 0.00884, "p24 gag protein": 0.00884, "augment interleukin-2 promoter activity": 0.00884, "protein ag": 0.00884, "n-terminal acidic transcriptional activation domain": 0.00884, "cell il-5 synthesis": 0.00884, "transcription factor oct-1": 0.00884, "srg3 protein associates": 0.00884, "stat transcription factor": 0.00884, "tf protein": 0.00884, "cell volume decreased": 0.00884, "undefined 84-kda protein": 0.00884, "egr-1 mrna expression": 0.00884, "cell surface antigenes cd33": 0.00884, "transcription factor creb": 0.00884, "stress-responsive hsp70 protein": 0.00884, "cell culture systems": 0.00884, "hiv-1 long terminal repeat promoter region": 0.00884, "nef protein": 0.00884, "17beta-hsd iv mrna expression": 0.00884, "tradd protein": 0.00883, "rb-related protein p107": 0.00883, "cell surface glycoproteins": 0.00883, "death-inducing protein shares": 0.00883, "lymphocyte gr receptor binding parameters": 0.00883, "split protein": 0.00883, "syk kinases-interacting protein": 0.00883, "in-vitro-translated 20-kda protein": 0.00883, "t-cell-expressed cytokines [ human interleukin-2": 0.00883, "relb protein": 0.00883, "lymphoid-specific transcription factor oct-2a": 0.00883, "sensitizing target cell lysis": 0.00883, "lymphoid-specific oct2b protein": 0.00883, "prevented cd4+ cell depletion": 0.00883, "ets transcription factor": 0.00882, "hs transcription factor": 0.00882, "yeast cell wall derivative": 0.00882, "unphosphorylated 27-kda protein": 0.00882, "augmented asm promoter activity": 0.00882, "mue3-binding protein tfe3": 0.00882, "cell costimulatory molecule": 0.00882, "protein translocated": 0.00882, "transdominant rev protein": 0.00882, "pertussis-toxin-sensitive gi/go protein": 0.00882, "anti-apoptotic protein eib19k": 0.00882, "abl sh3-interacting protein": 0.00882, "target cell lysis": 0.00882, "transactivating protein": 0.00882, "il-1beta mrna expression": 0.00882, "proapoptotic nip-2 protein": 0.00882, "bone marrow cell survival": 0.00882, "rel-related 65-kd protein": 0.00882, "pml/rar-alpha protein": 0.00882, "cell membrane fractions": 0.00882, "c-myc mrna expression": 0.00882, "protein dimerization": 0.00882, "tumor necrosis factor receptor-associated proteins tradd": 0.00882, "related cell types": 0.00882, "vcam-1 mrna expression": 0.00882, "rel-related nf-kappa b2 gene": 0.00882, "sr 31747a-binding protein": 0.00882, "increased transcriptional activation": 0.00882, "48-kda isgf3gamma protein": 0.00882, "sh2/sh3 adapter protein": 0.00882, "cytokine-inducible sh2-containing protein": 0.00882, "tcf-1 protein": 0.00882, "tax1 protein": 0.00882, "bzlf1 protein": 0.00882, "ikk complex-associated protein": 0.00882, "globin promoter activity": 0.00882, "ar protein": 0.00882, "tissue-specific transcription factor": 0.00881, "putative transcriptional activation domain": 0.00881, "1,25-dihydroxyvitamin d3-responsive protein": 0.00881, "fos gene family members": 0.00881, "pma-induced cell adhesion": 0.00881, "raf-1 protein": 0.00881, "transcription factor stat6": 0.00881, "th1 cell development": 0.00881, "diminished lps-induced endothelial cell adhesiveness": 0.00881, "tfiid protein": 0.00881, "protein footprint": 0.00881, "gata-3 protein": 0.00881, "somatic cell fusion": 0.00881, "trans-activating protein": 0.00881, "general transcription factor": 0.00881, "helix-loop-helix protein": 0.00881, "human type ii interleukin-1 fused": 0.00881, "dendritic cell development": 0.00881, "cell leukemia virus-1": 0.00881, "ubiquitous transcription factor": 0.00881, "ap-1 binding proteins required costimulation": 0.00881, "sry-related protein sox-4": 0.00881, "cell surface ganglioside": 0.00881, "ankyrin protein": 0.00881, "35s-methionine labelled protein": 0.00881, "specific cellular activation signals": 0.00881, "specific gene regulatory": 0.00881, "protein stabilization": 0.00881, "tegument protein vp22": 0.00881, "transcription factor ciita": 0.00881, "induce il-2 expression": 0.00881, "transcription factor egr-1": 0.00881, "gata-binding protein": 0.0088, "-inducible protein": 0.0088, "zebra protein": 0.0088, "pml/rar alpha expression": 0.0088, "85-kda protein": 0.0088, "pituitary transcription factor pit-1": 0.0088, "dna sequence element termed": 0.0088, "promote human immunodeficiency virus replication": 0.0088, "ccaat/enhancer-binding protein": 0.0088, "pituitary transcription factor pit-1b": 0.0088, "transcription factor nfkappab": 0.0088, "peripheral blood human monocytes": 0.0088, "transcription factor nf-kb": 0.0088, "integrin-dependent cell adhesion": 0.0088, "strong promoter activity": 0.0088, "cell clone recognized": 0.0088, "transcription factor oct-2a": 0.0088, "protein glycation": 0.0088, "rev protein": 0.0088, "human peripheral blood monocytes": 0.0088, "surfactant protein": 0.0088, "anti-cd40 mab induced activation": 0.0088, "distinct cytokine expression patterns": 0.0088, "rap1 protein": 0.0088, "p13mtcp1 protein": 0.0088, "transcription factors selectively regulating cytokine production": 0.0088, "positive cell population": 0.0088, "leukaemia-associated e2a-hlf chimaeric transcription factor": 0.0088, "interleukin-2 promoter activity": 0.0088, "v-abl protein": 0.00879, "protein bcl-3": 0.00879, "platelet-activating factor induced arachidonic acid release": 0.00879, "oct2 protein": 0.00879, "lymphocyte-specific protein": 0.00879, "hbxag protein": 0.00879, "cell subsets isolated": 0.00879, "-2 gene induction": 0.00879, "activated hla-dra expression": 0.00879, "transcription factor requirement": 0.00879, "rel-a protein": 0.00879, "independent transcriptional activation domain": 0.00879, "duffy protein": 0.00879, "hairy cell leukemia": 0.00879, "phoq protein": 0.00879, "cell surface": 0.00879, "il-6 promoter activity": 0.00879, "lps-mediated saa gene induction": 0.00879, "il-2r beta membrane expression": 0.00879, "msr protein": 0.00879, "sry protein": 0.00879, "ets-related protein": 0.00879, "bcl-3 protein": 0.00879, "retinoic acid receptor type alpha": 0.00879, "tegument protein": 0.00879, "cell cycle regulated": 0.00879, "ras-related protein": 0.00879, "defective transcription factor": 0.00879, "oct1 protein": 0.00879, "mzf-1 protein": 0.00879, "plzf-rar alpha expression": 0.00879, "aa protein": 0.00879, "pml-rar alpha expression": 0.00879, "target cell genome": 0.00879, "mad3 protein": 0.00879, "il2r alpha expression": 0.00879, "cell leukemia virus-i": 0.00878, "musculin protein": 0.00878, "inhibited immune activation pathways": 0.00878, "protein tbp": 0.00878, "fas promoter activity": 0.00878, "gene regulatory elements": 0.00878, "c-maf protein": 0.00878, "pilot protein": 0.00878, "protein partners": 0.00878, "her-2/neu protein": 0.00878, "nf-ya protein": 0.00878, "maintain erythroid cell viability": 0.00878, "cell prolymphocytic leukemia": 0.00878, "swi3 protein": 0.00878, "tax1 activated expression": 0.00878, "protein co-migrating": 0.00878, "stress-activated protein": 0.00878, "tat-binding protein": 0.00878, "interleukin-6 protein": 0.00878, "vpr protein": 0.00878, "erythroid-specific transcription factor nf-e1": 0.00878, "leader protein": 0.00878, "p48 protein": 0.00878, "bone marrow progenitor cell compartment": 0.00878, "cell responses": 0.00878, "maximal il-2rbeta promoter activity": 0.00878, "erp protein": 0.00878, "retinoblastoma protein": 0.00878, "critical cell cycle checkpoint": 0.00877, "socs-3 protein": 0.00877, "mzf protein": 0.00877, "alpha expression": 0.00877, "gal4-k protein": 0.00877, "fk506-binding protein": 0.00877, "105-kd protein": 0.00877, "receptor-interacting protein": 0.00877, "nm23h2 protein": 0.00877, "protein synthesis-dependent": 0.00877, "paired daughter cell culture": 0.00877, "cmat protein": 0.00877, "mycobacterial cell wall component mannose-capped lipoarabinomannan": 0.00877, "camp-response-element-binding protein": 0.00877, "mar-binding protein": 0.00877, "80-kda protein": 0.00877, "ctcf protein": 0.00877, "early-lytic-cycle protein": 0.00877, "id1 protein": 0.00877, "tetrahydrocortisol inhibited expression": 0.00877, "promoter-binding protein": 0.00877, "non-fusion protein": 0.00877, "72-kda protein": 0.00877, "170-kd protein": 0.00877, "cut/cdp protein": 0.00877, "nf90 protein": 0.00877, "protein module": 0.00877, "prion protein": 0.00877, "coup protein": 0.00877, "defined acidic transcriptional activation domain": 0.00877, "protein synthesis-independent": 0.00877, "amino-acid protein": 0.00877, "tata-binding protein": 0.00877, "lps-binding protein": 0.00877, "i-factor/nm23 protein": 0.00877, "ppargamma mrna expression": 0.00877, "33-kda protein": 0.00877, "phosphotyrosine-containing protein": 0.00877, "cre-binding protein": 0.00877, "poz/zinc-finger protein": 0.00877, "anti-apoptosis protein": 0.00877, "cytosolic-anchoring protein": 0.00877, "40-kda protein": 0.00877, "gi protein": 0.00877, "lef-1-interacting protein": 0.00877, "grb2-related protein": 0.00877, "120-kda protein": 0.00877, "dual-function protein": 0.00877, "97-kda protein": 0.00877, "47-kda protein": 0.00877, "95-kda protein": 0.00877, "92-kda protein": 0.00877, "protein trans-factors": 0.00877, "ige-binding protein": 0.00877, "vdre-binding protein": 0.00877, "65-kd protein": 0.00877, "srg3 protein": 0.00877, "14-kd protein": 0.00877, "nfat3 protein": 0.00877, "130-kd protein": 0.00877, "ubiquitin-carrier protein": 0.00877, "protein vital": 0.00877, "homeodomain-containing protein": 0.00877, "70-kda protein": 0.00877, "marcks-related protein": 0.00877, "hbx protein": 0.00877, "fmol/mg protein": 0.00877, "bactericidal/permeability-increasing protein": 0.00877, "75-kd protein": 0.00877, "32.2-kda protein": 0.00877, "ga-binding protein": 0.00877, "inflammatory cell infiltration score": 0.00877, "ap-1-related protein": 0.00877, "105-kda protein": 0.00877, "nfil3 protein": 0.00877, "56-kda protein": 0.00877, "taxreb protein": 0.00877, "karyophilic protein": 0.00877, "mnp protein": 0.00877, "110-kda protein": 0.00877, "14.3-kda protein": 0.00877, "c-reactive protein": 0.00877, "tract-binding protein": 0.00877, "e1a-binding protein": 0.00877, "soluble tumor necrosis factor receptors inhibit phorbol myristate acetate": 0.00877, "195-kd protein": 0.00877, "aldh1 protein": 0.00877, "icp27 protein": 0.00877, "v-fos protein": 0.00877, "integral protein": 0.00877, "phorbol esters induce expression": 0.00876, "nh2-terminal amino acid sequence analysis identified": 0.00876, "v-myb reduces mrp14 promoter activity": 0.00876, "nuclear dna binding": 0.00876, "ap-1 binding proteins contained c-jun": 0.00876, "major histocompatibility complex class ii promoter": 0.00876, "cell leukemia": 0.00876, "protein": 0.00876, "cd14 mrna expression": 0.00876, "transcription factor nf-atc": 0.00876, "gene induction": 0.00875, "pma induced activity suggesting": 0.00875, "extensive inflammatory cell infiltration": 0.00875, "il-2r beta chain expression": 0.00875, "homotypic cell adhesion": 0.00875, "transcription factor recruitment": 0.00875, "integrin-mediated cell adhesion": 0.00875, "transcription factor junb": 0.00875, "tf mrna expression": 0.00875, "glucocorticoid receptor binding characteristics": 0.00875, "vcam-1-mediated cell adhesion": 0.00875, "il-13 mrna expression": 0.00875, "inhibited cd26 expression": 0.00875, "polyomavirus transcription factor t-antigen": 0.00875, "human cd4+ lymphocytes": 0.00875, "identified natural dna response element": 0.00874, "transcription factor aml1": 0.00874, "diffuse large cell lymphoma": 0.00874, "red cell development": 0.00874, "isolated human membrane system": 0.00874, "mediates programmed cell death": 0.00874, "human cd4 lymphocytes": 0.00874, "cell adhesion": 0.00874, "nf-kappa b1 gene": 0.00874, "transcription factor nfat-1": 0.00874, "gm-csf promoter activity": 0.00874, "] dexamethasone binding sites": 0.00874, "ap1 transcription factor": 0.00874, "transcription factor pax-5": 0.00874, "multifunctional yy1 transcription factor": 0.00874, "inhibited expression": 0.00874, "hla-dra mrna expression": 0.00874, "transcription factor requirements": 0.00874, "transcription factor ap1": 0.00874, "study cd14 gene regulation": 0.00874, "antigen receptor signals prolong nf-kappa b-dna interaction": 0.00873, "nuclear binding factors include": 0.00873, "transcription factor vp16": 0.00873, "cell level": 0.00873, "cell cycle progression hemoglobin switching": 0.00873, "il4 transcription initiation site": 0.00873, "ets gene family encodes": 0.00873, "transfected reporter gene construct": 0.00873, "transcription factor nf-e2": 0.00873, "activated igkappa expression": 0.00873, "cd4+ cd8int/- cell population": 0.00873, "e-box-dependent reporter gene function": 0.00873, "activate blk promoter transcription": 0.00873, "ets-related transcription factor elf-1": 0.00873, "purine-box/antigen receptor response element": 0.00873, "cd44 mrna expression": 0.00872, "nfatc transcription factor": 0.00872, "rar alpha gene": 0.00872, "lymphocyte-specific transcription factor oct2": 0.00872, "erythroid cell fate": 0.00872, "cell types examined": 0.00872, "transcription factor nfatc": 0.00872, "chicken nf-m transcription factor": 0.00872, "leukemic cell transformation": 0.00872, "cd11b promoter activity": 0.00872, "nk cell nfat": 0.00872, "lymphoid-specific transcription factor oct2": 0.00872, "mnp-1 transcription factor": 0.00872, "tissue-specific promoter activity": 0.00872, "activated dna binding similar": 0.00872, "a-myb transcription factor": 0.00872, "transcription factor e2f": 0.00872, "cell cdna library": 0.00872, "zinc-finger transcription factor": 0.00871, "major cell reservoir": 0.00871, "bhlh transcription factor": 0.00871, "il-1ra mrna expression": 0.00871, "cell biological properties": 0.00871, "endothelial cell glutathione": 0.00871, "diabetic nephropathy show increased activation": 0.00871, "undergoing apoptotic cell death": 0.00871, "-binding transcription factor": 0.00871, "cell repertoire development": 0.00871, "sp1 binding site mutants": 0.00871, "[ cortisone-resistant bronchial asthma ] [ cortisone-resistant bronchial asthma ]": 0.00871, "viral gene regulation": 0.00871, "t-cell-specific transcription factor": 0.00871, "transient expression assay": 0.00871, "transcription factor bsap": 0.00871, "il-2r alpha gene": 0.00871, "normal human pulmonary alveolar macrophages": 0.00871, "alter cell phenotype": 0.00871, "basal cell carcinomas": 0.00871, "class ii expression": 0.00871, "activation-dependent scm-1 promoter activity": 0.0087, "constitutive virus expression": 0.0087, "cell model systems": 0.0087, "human t-cell acute lymphoblastic leukemia": 0.0087, "nk cell functions": 0.0087, "cell leukemia/lymphoma development": 0.0087, "transcription factor sp-1": 0.0087, "cell cytokine": 0.0087, "cell membrane phospholipids": 0.0087, "gata-3 transcription factor": 0.0087, "spi-b transcription factor": 0.0087, "functional rbp binding site": 0.0087, "il-1beta promoter activity": 0.0087, "c/ebp-epsilon transcription factor": 0.0087, "leukemic u937 cell": 0.0087, "cell neoplasms expressing mnda": 0.0087, "transcription factor ap-2": 0.0087, "htlv-1 transformed human lymphoid lines": 0.0087, "transcription factor gata-3": 0.0087, "c/ebp proteins activate transcription": 0.0087, "gata-2 transcription factor": 0.0087, "apoptotic cell death program": 0.00869, "transcription initiation site": 0.00869, "mature human lymphocytes": 0.00869, "lymphoid-specific transcription factor": 0.00869, "surface antigen expression": 0.00869, "plasma cell": 0.00869, "pituitary-specific transcription factor": 0.00869, "interferon-gamma activation sequence": 0.00869, "il-12p40 mrna expression": 0.00869, "oct2 transcription factor": 0.00869, "cell development": 0.00869, "cdc2 mrna expression": 0.00869, "e2f-1 transcription factor": 0.00869, "cell hybridoma model a1.1": 0.00869, "activation-induced fasl promoter activity": 0.00869, "anti-apoptotic transcription factor": 0.00869, "transcription factor c/ebpalpha": 0.00869, "litaf mrna expression": 0.00869, "pleiotropic transcription factor": 0.00869, "increase expression": 0.00869, "lineage-restricted transcription factor": 0.00869, "dq alpha gene": 0.00869, "transcription factor stat-3": 0.00869, "transcription factor nfat1": 0.00869, "transcription factor iia": 0.00869, "dna-binding site abolished binding": 0.00869, "transcription factor elk-1": 0.00869, "transcription factor mef2c": 0.00868, "mrna expression": 0.00868, "nf-kappa b-dependent gene": 0.00868, "class ii gene transactivator": 0.00868, "somatic cell hybridization approach": 0.00868, "acute promyelocytic leukemia pml-retinoic acid receptor alpha": 0.00868, "winged-helix transcription factor trident": 0.00868, "ets-related transcription factor": 0.00868, "proliferation-specific transcription factor e2f1": 0.00868, "cell culture": 0.00868, "eukaryotic transcription factor": 0.00868, "lymphocyte-specific transcription factor": 0.00868, "gzero/g1 cell cycle phase": 0.00868, "transcription factor jun-b": 0.00868, "mediating cell death": 0.00868, "steroid-mediated cell death occurs": 0.00867, "nfil3/e4bp4 transcription factor": 0.00867, "undifferentiated spindle-shaped basal cell epitheliomas": 0.00867, "e2a-pbx1 initiates programmed cell death": 0.00867, "nfat gene family": 0.00867, "acetylated transcription factor": 0.00867, "lt promoter activity": 0.00867, "interleukin-4-induced transcription factor": 0.00867, "t-helper cell cytokines": 0.00867, "hiv-1-induced cell fusion": 0.00867, "early growth response-1 gene": 0.00867, "transcription factor spi-1/pu.1": 0.00867, "isotype-specific transcription factor": 0.00867, "transcription factor rfx1": 0.00867, "impair human immunodeficiency virus replication": 0.00867, "ligand-activated transcription factor": 0.00867, "response element complex formation": 0.00867, "interleukin-4-dependent transcription factor nf-il4": 0.00867, "human cd36 mediates signal transduction events": 0.00867, "promoter sequence analysis": 0.00867, "hugata-3 transcription factor": 0.00867, "prevents cell death": 0.00867, "transcription factor rbp-jkappa": 0.00867, "transcription factor mibp1": 0.00867, "octamer-binding site reduces transcription": 0.00867, "activate nuclear factor kappa": 0.00867, "lps stimulated vcam-1 expression": 0.00867, "key vdr target gene involved": 0.00867, "transcription factor tfiia": 0.00867, "cell membrane": 0.00867, "il-4/il-13-inducible transcription factor": 0.00866, "transcription factor nf-chi": 0.00866, "alpha1 promoter activates transcription": 0.00866, "prolactin-induced transcription factor": 0.00866, "gene rearrangements inhibits development": 0.00866, "saf-like transcription factor": 0.00866, "nf-at/ap-1 transcription factor": 0.00866, "transcription factor iid": 0.00866, "astrocyte-derived kappa b-binding factors activate transcription": 0.00866, "bzlf1-encoded transcription factor": 0.00866, "tsh-r expression levels": 0.00866, "redox-sensitive transcription factor": 0.00866, "cell types tested": 0.00866, "cd40 signaling downregulates bcl-6 expression": 0.00866, "transcription factor pertinent": 0.00866, "distinct nf-kappab activation mechanism": 0.00866, "aml1-related transcription factor": 0.00866, "g1 cell cycle progression": 0.00866, "il-3 mediates cell survival": 0.00866, "transcription factor hiv-tf1": 0.00866, "pebp2/cbf transcription factor": 0.00866, "cloned mouse embryonic ectoderm development gene": 0.00866, "ap-2-like transcription factor": 0.00866, "maz transcription factor": 0.00866, "world primate cell extracts": 0.00866, "cell fusion": 0.00866, "hormone-activated transcription factor": 0.00866, "transcription factor atf2": 0.00866, "usf-related transcription factor": 0.00866, "transcription factor yb-1": 0.00866, "distinct dna binding complexes": 0.00866, "inducible virus expression": 0.00866, "36-kda transcription factor": 0.00866, "target cell sensitization": 0.00866, "ngfi-b/nur77-related transcription factor": 0.00866, "mgf-stat5-like transcription factor": 0.00866, "transcription factor": 0.00865, "expression levels": 0.00865, "nf-kappab activation response": 0.00865, "monocytic cell lineage": 0.00865, "controls cell fate decisions": 0.00865, "dominant-negative mutant tnfri inhibited ec activation": 0.00865, "suppressing promoter activity": 0.00865, "human immunodeficiency virus replication": 0.00865, "il-2 control il-2 receptor alpha": 0.00865, "tf promoter activity": 0.00864, "precursor cell common": 0.00864, "normal human alveolar macrophages": 0.00864, "dr alpha gene": 0.00864, "lymphoid cell types": 0.00864, "cell clones immortalized": 0.00864, "tumor necrosis factor genes": 0.00864, "bik promotes cell death": 0.00863, "zebra activation region": 0.00863, "target cell": 0.00863, "bipotential myelomonoblastic cell population capable": 0.00863, "myeloid cell features": 0.00863, "deliver enhancer binding proteins": 0.00863, "multiple cellular dna-binding transcription factors": 0.00863, "ap1 binding site upstream": 0.00863, "hla-dra promoter activity": 0.00863, "t-cell antigen receptor element": 0.00863, "human immunodeficiency virus vpr product": 0.00863, "pma-induced promoter activity": 0.00863, "human cytomegalovirus induces interleukin-8 production": 0.00862, "ebv-b cell clones": 0.00862, "full promoter activity": 0.00862, "nk cell lineages": 0.00862, "key cell cycle regulators": 0.00862, "alpha-globin promoter activity": 0.00862, "cell lymphoid malignancies": 0.00862, "cell cycle time": 0.00862, "cell clone sp-b21": 0.00861, "reporter gene assays reveal": 0.00861, "nuclear nf-kappab activity": 0.00861, "gata-3 promoter activity": 0.00861, "nf-kappab-dependent promoter activity": 0.00861, "zeta 2-globin promoter activity": 0.00861, "elk-1 promoter activity": 0.00861, "-2 promoter activity": 0.00861, "cell blasts treated": 0.00861, "human class ii mhc ag": 0.00861, "induce lytic ebv expression": 0.00861, "cell cycle regulator e2f": 0.00861, "activated human polymorphonuclear leukocytes": 0.00861, "il-2 promoter factor": 0.00861, "alpha gene": 0.00861, "suggesting phosphorylation required antecedent activation": 0.00861, "regulate cell survival": 0.00861, "macrophage cell lineage": 0.00861, "cell clone ar-5": 0.00861, "genetic program mediating normal t-cell activation": 0.0086, "hematopoietic cell types": 0.0086, "leukemic cell contamination decreases": 0.0086, "cell clone": 0.0086, "c/ebp gene family": 0.0086, "msr promoter activity": 0.0086, "single cell layer": 0.0086, "nf-kappa b-independent transcriptional activation": 0.0086, "endothelial cell gssg/gsh": 0.0086, "cell clones": 0.0086, "nk cell lysis": 0.0086, "expressed replicative gene products": 0.0086, "myeloid cell types": 0.0086, "apoptotic cell death": 0.0086, "burkitt lymphoma raji cell": 0.0086, "activation region": 0.00859, "plasmacytoma cell extracts": 0.00859, "prototype class ii gene": 0.00859, "tcr alpha enhancer activity": 0.00859, "support cell survival": 0.00859, "mammalian cell transfection": 0.00859, "dependent reporter gene construct": 0.00859, "cell types suggested": 0.00859, "pma-activated promoter activity": 0.00859, "cellular tyrosine hydroxylase gene": 0.00859, "hil-5 promoter activity": 0.00859, "induce luciferase expression related": 0.00859, "primary binding site": 0.00859, "rantes promoter activity": 0.00859, "cell cycle arrest": 0.00859, "prevent gc-induced cell death": 0.00859, "high-level promoter activity": 0.00859, "individual cell cycle phases": 0.00859, "kappa b-like site mediated lps induction": 0.00859, "minor transcription start site": 0.00859, "zeta-globin promoter activity": 0.00858, "purified normal human": 0.00858, "il-9 promoter activity": 0.00858, "mononuclear cell priming cultures": 0.00858, "blk promoter activity": 0.00858, "cytotoxic nk cell granules": 0.00858, "myeloid-specific promoter activity": 0.00858, "constitutively aggregated pseudo-tumor necrosis factor receptor": 0.00858, "hepor promoter activity": 0.00858, "cxcr4 promoter activity": 0.00858, "ea-d promoter activity": 0.00858, "normal human lung fibroblasts": 0.00858, "core binding factor": 0.00858, "cell replication": 0.00858, "activated human cd4": 0.00858, "monocyte-specific promoter activity": 0.00858, "bamhi-q promoter activity": 0.00858, "tnf-alpha-inducible promoter activity": 0.00857, "cell controls": 0.00857, "core ets binding site": 0.00857, "restricts promoter activity": 0.00857, "lymphoid specific gene": 0.00857, "glucocorticoid receptor binding": 0.00857, "cell cycle kinetics": 0.00857, "ebna-2-positive cell extracts": 0.00857, "human glucocorticoid receptors": 0.00857, "myeloid cell precursors": 0.00857, "endothelial cell": 0.00857, "tgf-beta-inducible promoter activity": 0.00857, "cytokine gene regulation": 0.00857, "receptor binding studies": 0.00857, "lymphocyte-specific immunoglobulin mu heavy-chain gene intronic enhancer": 0.00856, "malignant cell population": 0.00856, "prepared somatic cell hybrids": 0.00856, "human platelets activated": 0.00856, "enhanced surface expression": 0.00856, "cell phenotype": 0.00856, "common progenitor cell": 0.00856, "common stem cell": 0.00856, "promoter activity": 0.00856, "cell type-specific differences": 0.00855, "reduced receptor binding": 0.00855, "nf-at activation induced": 0.00855, "intrinsic transcriptional activation domain": 0.00855, "efficient long-term lymphoblastoid cell outgrowth": 0.00855, "cell number": 0.00855, "class ii gene": 0.00855, "unlabeled nf-at binding site": 0.00854, "cell extracts": 0.00854, "nk cell cytotoxicity": 0.00854, "cat reporter gene constructs": 0.00854, "adenomatous polyposis coli-binding eb1-like gene family": 0.00854, "jun gene family": 0.00854, "cell type-specific pattern": 0.00854, "cell ig secretion": 0.00854, "monocytic specific expression": 0.00854, "flow cytometric cell sorting": 0.00854, "il-4 inhibits lps-induced expression": 0.00854, "cell cycle variation": 0.00854, "gene domain": 0.00854, "b104 cell death": 0.00854, "leukemic cell infiltration": 0.00854, "diverse host cell types": 0.00854, "tpa-resistant u-937 cell variant": 0.00853, "t-cell apoptosis ] [ ngfi-b/nur77 family involved": 0.00853, "il-2-mediated cell cycle progression": 0.00853, "hlf consensus binding site": 0.00853, "transcription start site": 0.00853, "eventual programmed cell death": 0.00853, "clathrin assembly lymphoid myeloid leukemia gene": 0.00853, "inhibit stimuli-induced hiv-1 expression": 0.00853, "nf-at-binding site directs transcription": 0.00853, "renal cell carcinomas": 0.00853, "ikaros gene family": 0.00853, "low surface icam-1 expression": 0.00853, "ets gene family": 0.00853, "myeloid pu.1 binding site": 0.00853, "myelomonocytic lineage specific gene": 0.00853, "responsive cell types": 0.00853, "expression plasmids encoding regions": 0.00853, "glucocorticoid-induced cell death": 0.00853, "vitro tyrosine kinase activity": 0.00852, "constitutively increased nf-kappab activity": 0.00852, "cell cycle progression": 0.00852, "ifn-induced nk cell killing": 0.00852, "cell cycle prior": 0.00852, "cell hybridoma leads": 0.00851, "mediate cell": 0.00851, "programmed cell death": 0.00851, "increased rar beta/rxr dna binding": 0.00851, "il-10 induces c-fos expression": 0.00851, "nk cell killing": 0.00851, "il-10 inhibits ifn-gamma-induced icam-1 expression": 0.00851, "rescue fas-induced cell death": 0.00851, "fibroblast cell transformation": 0.00851, "mature cell types": 0.0085, "mononuclear cell cultures": 0.0085, "a6h transduced ap-1 activation pathway": 0.0085, "single c-myb binding site": 0.0085, "circulating human lymphocytes": 0.0085, "polymerized mutated nf-kappab binding sequence": 0.0085, "pb mononuclear cell populations": 0.0085, "tsp gene family": 0.0085, "cancer cell": 0.0085, "promote cell cycle": 0.0085, "cell type-specific subunit": 0.0085, "total cell lysates": 0.00849, "natural host cell": 0.00849, "basal cell epitheliomas": 0.00849, "renal cell carcinoma": 0.00849, "potential stati dna binding elements": 0.00849, "expression patterns suggest": 0.00849, "monocytic cell maturation": 0.00849, "nk cell cytolytic programs": 0.00849, "traf6 inhibited rankl-mediated nf-kappab activation": 0.00849, "cloned human nur77 beta cdna": 0.00848, "diffuse large cell subtype": 0.00848, "reporter gene encoding chloramphenicol acetyl transferase": 0.00848, "nk cell granules": 0.00848, "lymphocyte gene regulation": 0.00848, "human er mrna": 0.00848, "mouse thymus cdna expression library": 0.00848, "tnfrp55-/-mutant mice lack expression": 0.00848, "activated human neutrophils": 0.00848, "vitro expression assays": 0.00848, "reporter gene assays": 0.00848, "pre-b cell stage": 0.00848, "activation-induced cell death": 0.00848, "b-cll cell death": 0.00848, "examined erythroid markers expression": 0.00848, "mononuclear cell reaction": 0.00847, "bacterial cell wall": 0.00847, "t-lymphocyte cell lineage": 0.00847, "ang ii stimulated nf-kappab activation": 0.00847, "promote cell survival": 0.00847, "cell tropic strain": 0.00847, "transcriptional activation domain": 0.00847, "apparent non-cell-type-specific expression suggest": 0.00847, "human hla-dq class ii subset": 0.00847, "transcription site": 0.00847, "cell types responsible": 0.00847, "mantle cell lymphoma": 0.00847, "glucocorticoid-evoked cell death": 0.00846, "tramp-induced cell death": 0.00846, "m2 leukemic cell context": 0.00846, "cell hybrids carrying": 0.00846, "reduced tr75 surface expression": 0.00846, "somatic cell hybrid panels": 0.00846, "necrotic cell death": 0.00846, "lung cell types": 0.00846, "normal expression": 0.00846, "interferon-beta mediates stromal cell rescue": 0.00846, "germinal center cell origin": 0.00846, "somatic cell hybrid": 0.00845, "nf-kappa b-like nuclear factor": 0.00845, "cell death": 0.00845, "affinity cvz binding site": 0.00845, "cell cycle entry": 0.00845, "well-known il-2-dependent cell transformation": 0.00845, "large cell lymphomas": 0.00845, "inducing transforming growth factor-beta expression": 0.00845, "natural killer cell": 0.00845, "bind specific transcription factors": 0.00845, "human th2-type lymphocytes": 0.00844, "induce cytokine expression": 0.00844, "core srf binding site": 0.00844, "multiple p21ras effector pathways regulate nuclear factor": 0.00844, "t-cell antigen receptor-cd3 complex signaling pathway": 0.00844, "consensus binding site": 0.00844, "nuclear factor nf-kappa": 0.00844, "low affinity specific binding sites": 0.00844, "dra gene regulatory sequences": 0.00844, "host cell genome": 0.00843, "purified human peripheral blood": 0.00843, "alpha promoter region": 0.00843, "cellular tumor necrosis factor receptor-associated factors": 0.00843, "type ii estrogen binding sites": 0.00843, "downstream binding factor": 0.00843, "nuclear factors binding": 0.00843, "pro-b cell stage": 0.00842, "c-fos promoter sis-inducible element ifn-gamma-activated sequence-binding complexes": 0.00842, "cell lymphoma": 0.00842, "dna binding assays identified": 0.00842, "major histocompatibility complex class ii genes": 0.00842, "intestinal epithelial cell": 0.00842, "myeloblastic leukemic ml-1 cell": 0.00842, "distinct cellular transcription factors": 0.00842, "-induced human monocyte tnf-alpha production": 0.00842, "socs/ ssi/cis gene family": 0.00842, "human im-9 lymphocytes": 0.00842, "cd4+ cell counts": 0.00842, "sp1 binding site adjacent": 0.00842, "cd4- cd8+ cell populations": 0.00842, "repeated cold-air exposures increase human triiodothyronine": 0.00842, "human factors yy1": 0.00842, "src gene family": 0.00842, "oligonucleotides reduced c-jun expression": 0.00842, "regulating cell fate decisions": 0.00842, "host cell types": 0.00842, "affects cell survival": 0.00842, "human cd4+ t-cell clones recovered": 0.00842, "class ii major histocompatibility complex genes": 0.00842, "cd69 promoter-based reporter gene constructs": 0.00841, "hl60 cell variants": 0.00841, "normal human subjects": 0.00841, "human rxr alpha": 0.00841, "human ikappab alpha": 0.00841, "ifn-gamma decreased basal expression": 0.00841, "nk cell": 0.00841, "protein-binding eb1 gene family": 0.00841, "epithelial cell malignancies": 0.00841, "cell cycle machinery": 0.0084, "nf-kappa b/rel transcription factors": 0.0084, "asa inhibited nf-kappab activation": 0.0084, "support human immunodeficiency virus": 0.0084, "discrete cell basis": 0.0084, "eb1-like gene family": 0.0084, "cd40-mediated cell survival proceeds": 0.0084, "human rar alpha": 0.0084, "leukemic cell contamination": 0.0084, "cell lineage": 0.0084, "cell blasts up-regulates fas": 0.0084, "human lymphocytes": 0.0084, "transient expression system": 0.0084, "cell wall derivatives": 0.0084, "full cell cycle": 0.0084, "nf-kb binding site leads": 0.0084, "cell transformation": 0.0084, "human cdnas encoding kruppel-type zinc finger domains": 0.00839, "cell lysates prepared": 0.00839, "cell immunoglobulin": 0.00839, "molecular mechanisms underlying selective expression": 0.00839, "diverse cell lineages": 0.00839, "inhibited nf-kappab activation": 0.00839, "cd30 induces hiv expression": 0.00839, "vivo hiv-1 expression": 0.00839, "increased dna binding": 0.00839, "total cell lipids": 0.00839, "nf-kappa b-related transcription factors": 0.00839, "-150 ap-1 binding site": 0.00839, "stem cell disorders": 0.00839, "abolished factor binding": 0.00838, "cell tumors": 0.00838, "human pebp2 alpha": 0.00838, "-induced adhesion molecule expression": 0.00838, "lncap cell variant": 0.00838, "differentiated cell types": 0.00838, "human lipopolysaccharide-stimulated peripheral blood mononuclear leukocytes": 0.00838, "reporter gene constructs driven": 0.00838, "nf-kappa b/rel/nfat transcription factors": 0.00838, "human factors": 0.00838, "single binding site": 0.00838, "ap-1 binding site": 0.00838, "virus expression": 0.00838, "interspecies somatic cell hybrids": 0.00838, ":735 ] initiation binding repressor [": 0.00838, "leukemic cell": 0.00838, "cell harvester correlated": 0.00838, "il-1 beta expression": 0.00838, "u937 cell": 0.00838, "cd56+ cell populations": 0.00838, "il-4 gene regulation": 0.00838, "nf-kappa b-like transcription factors": 0.00838, "nm23 gene family": 0.00838, "hiv-1 accessory gene product vpr": 0.00837, "influence cell fate decisions": 0.00837, "regulate cell division": 0.00837, "cell cycle exit": 0.00837, "somatic cell hybrids": 0.00837, "human lysosomal acid lipase": 0.00837, "human il-4r alpha": 0.00837, "rhombotin gene family": 0.00837, "lps-stimulated whole-blood cell cultures": 0.00837, "transcription factors nf-kappa": 0.00837, "endogenous tyrosine amino transferase gene": 0.00837, "cell population": 0.00837, "immediate/early gene family": 0.00837, "cell-type specific expression": 0.00837, "total cell gelatinase": 0.00837, "cell cycle behavior": 0.00837, "induced kappab-dependent reporter activity": 0.00837, "cell recognition": 0.00837, "basal level gr expression": 0.00837, "transcription factors gabp alpha": 0.00836, "human t-cell clones reactive": 0.00836, "cell release": 0.00836, "p50 dna binding domain": 0.00836, "transformed cell types": 0.00836, "zpcat reporter gene constructs": 0.00836, "demonstrate cytokine gene specificity": 0.00836, "human immunodeficiency virus tat": 0.00836, "cell cycle perturbation": 0.00836, "cell restricted coactivator": 0.00836, "human umbilical vein ec provide costimulatory signals": 0.00836, "helper cell subsets": 0.00836, "human class ii transactivator": 0.00836, "increased transcriptional activity": 0.00836, "activated nuclear factor": 0.00835, "apoptotic cell bodies": 0.00835, "cell thymic progenitors": 0.00835, "acute myeloid leukemia gene": 0.00835, "heterologous cell types": 0.00835, "vitro globin gene switching model": 0.00835, "reporter gene constructs": 0.00835, "large cell": 0.00835, "nuclear factor activated": 0.00835, "human monocytes stimulated": 0.00835, "cell functions": 0.00835, "identified human placental cdna": 0.00835, "il-4 induces expression": 0.00835, "inhibit ca2+ mobilization dependent expression": 0.00835, "glucocorticoid-induced cell lysis": 0.00834, "t3 nuclear receptor sites": 0.00834, "il-4 gene share high homology": 0.00834, "squamous cell carcinomas": 0.00834, "putative e2f binding site": 0.00834, "detectable cell toxicity": 0.00834, "cell cycle": 0.00834, "hiv ltr-driven luciferase expression constructs": 0.00834, "diverse cell types": 0.00834, "lipopolysaccharide-induced tyrosine kinase activation": 0.00833, "erythrocytic lineages share specific transcription factors": 0.00833, "human nf-kappa": 0.00833, "stimulate human immunodeficiency virus": 0.00833, "cellular activation and/or differentiation": 0.00833, "reporter gene construct": 0.00832, "human il-7r alpha": 0.00832, "cd40 lacks intrinsic tyrosine kinase activity": 0.00832, "thrombin activates endothelial icam-1 expression": 0.00832, "cell survival": 0.00832, "inflammatory effector gene products similar": 0.00832, "proximal ghf-1/pit-1 binding site": 0.00832, "high expression level": 0.00832, "cellular proteins binding": 0.00832, "il-2 gene transactivation": 0.00832, "il-4 gene control": 0.00831, "guanine nucleotide binding factor": 0.00831, "aiolos induces bcl-2 expression": 0.00831, "common binding site": 0.00831, "nontransformed t-lineage cell populations": 0.00831, "kappa b-alpha gene": 0.00831, "dna binding basic domain": 0.00831, "affect gene regulation": 0.00831, "human dr alpha": 0.00831, "kappa b-binding activity constitutively expressed": 0.0083, "tyrosine kinase activation": 0.0083, "red cell progenitors": 0.0083, "rabbit beta globin gene": 0.0083, "dimeric gata-1 binding site": 0.0083, "cell hybrid": 0.0083, "spleen lymphocytic cell": 0.0083, "specific expression": 0.0083, "steroid/thyroid hormone nuclear receptor family": 0.0083, "squamous cell carcinoma": 0.0083, "induce multiple gene reporters": 0.0083, "tumor necrosis factor induces nf-kappa": 0.0083, "elements restricting expression": 0.0083, "c-jun n-terminal kinase activation": 0.0083, "down-regulate adhesion molecule expression": 0.0083, "cell nuclei": 0.0083, "human immune system": 0.0083, "whole-blood cell cultures": 0.0083, "cell stimuli": 0.0083, "normal gene": 0.0083, "low nuclear stat6 activity": 0.0083, "base pair il-5 gene segment upstream": 0.0083, "regulate cd95 ligand expression": 0.00829, "nfat activation induced": 0.00829, "constitutively expressed nuclear factor": 0.00829, "mast cell lineages": 0.00829, "cell specificity repertoire": 0.00829, "human cd4+ t-cell clones": 0.00829, "cell cultures": 0.00829, "nonendocrine cell lineages": 0.00829, "human th2 lines": 0.00829, "cell cycle-dependent initiation": 0.00829, "bzlf 1-containing cell lysates": 0.00829, "mast cell populations": 0.00829, "sp1 binding site": 0.00829, "human monocytes suggesting": 0.00829, "mononuclear cell": 0.00828, "vitamin d-mediated gene regulation": 0.00828, "htlv-1 tax induces expression": 0.00828, "vitamin d-dependent gene regulation": 0.00828, "t-lymphocyte cell types": 0.00828, "freshly isolated human monocytes decreases": 0.00828, "adhesion molecule expression": 0.00828, "gal4 dna binding domain reveals": 0.00828, "cell mass": 0.00827, "glial cell origin": 0.00827, "inhibited nf-kappa b-dependent transcription": 0.00827, "mhc antigen expression": 0.00827, "nk/t cell progenitors": 0.00827, "cell lineages": 0.00827, "cell populations": 0.00827, "heat shock proteins shows typical native receptor characteristics": 0.00826, "precursor cell": 0.00826, "gal4 dna binding sites": 0.00826, "agents induce expression": 0.00826, "binding site leads": 0.00826, "neuroendocrine cell characteristics": 0.00826, "cell leukemias": 0.00826, "host cell": 0.00826, "specific human inflammatory pathologies": 0.00826, "normal mature human": 0.00826, "cell lysis": 0.00825, "cell localization": 0.00825, "common gamma chain gene": 0.00825, "plap reporter gene derived": 0.00825, "gc-mediated cell processes": 0.00825, "tnf-alpha promoter element kappa": 0.00825, "future clinical gene therapy trials": 0.00825, "cell stage-specific distribution": 0.00825, "cell redox status": 0.00825, "cell maturation": 0.00825, "inhibited hiv-1 ltr activity": 0.00825, "cell hybridomas respond": 0.00825, "mutant inhibited tcr-induced activation": 0.00825, "cell progenitors": 0.00825, "resting normal human pbl": 0.00825, "human neutrophils [": 0.00825, "early viral proteins and/or viral dna": 0.00824, "human class ii isotypes": 0.00824, "polymerized nf-kappab binding sequence ligated": 0.00824, "ras pathway activation": 0.00824, "cell coactivator obf-1/bob1/oca-b": 0.00824, "uninfected cell extract": 0.00824, "nfat binding site": 0.00824, "human monocyte/neutrophil elastase inhibitor": 0.00824, "cell costimulation": 0.00824, "human blood monocytes": 0.00824, "reporter gene experiments": 0.00824, "lymphoblastoid cell outgrowth": 0.00824, "human myeloid differentiation": 0.00824, "cell progression": 0.00824, "activated human": 0.00824, "human immunodeficiency virus entry": 0.00824, "lmp1 expression induces phenotypic": 0.00824, "trypan blue exclusion cell counting": 0.00824, "im-9 cell cytosol": 0.00824, "gal4 dna binding domain fused": 0.00824, "ciita-transfected cell hybrids": 0.00823, "reduced nf-kb binding proteins": 0.00823, "cell division controlled": 0.00823, "nonmyeloid cell types": 0.00823, "cell cytosol": 0.00823, "b-lineage-specific gene expressed": 0.00823, "il-4 luciferase reporter gene": 0.00823, "nucleolin cdna expression construct": 0.00823, "mol cell biol": 0.00823, "detect red cell": 0.00823, "dna binding sites": 0.00823, "nonhematopoietic cell types": 0.00823, "cell components": 0.00823, "non-erythroid cell types": 0.00823, "ccaat binding factor nf-y": 0.00823, "cell responsiveness": 0.00822, "t- cell mitogens": 0.00822, "cell types": 0.00822, "basophil cell distribution": 0.00822, "cell systems": 0.00822, "low level expression": 0.00822, "macaque cell lysates": 0.00822, "cell hybrids": 0.00822, "cell nucleus": 0.00822, "stromal cell rescue": 0.00822, "normal human neutrophils": 0.00822, "nf-kappab binding sequence": 0.00822, "cell origin": 0.00822, "cell v-atpase content": 0.00822, "intact cell": 0.00822, "il-1 beta gene": 0.00822, "granulocyte-macrophage colony-stimulating factor stimulates jak2 signaling pathway": 0.00821, "cell migration": 0.00821, "ii binding proteins": 0.00821, "cell subtractive library": 0.00821, "leucine zipper dna binding motif": 0.00821, "620-bp human gm-csf promoter-luciferase reporter construct": 0.00821, "cell subsets": 0.00821, "cell extract": 0.00821, "cd40 antigen expression": 0.00821, "octamer-dna binding proteins distinct": 0.00821, "mangabey cell lysates": 0.00821, "related retinoic acid receptor alpha": 0.0082, "cell lysates": 0.0082, "systemic lupus erythematosus ] [ estrogen receptor content": 0.0082, "sickle cell anemia": 0.0082, "cell count 2-6 mil": 0.0082, "canonical tfiid binding site suppresses": 0.0082, "cell immunity": 0.0082, "gm-csf-responsive progenitor cell": 0.0082, "cell malignancies": 0.0082, "dna binding ets domain": 0.0082, "human cdna clone encoding": 0.0082, "mouse osteopontin gene promoters": 0.0082, "predominant factor binding": 0.0082, "ccaat-box binding factor nf-y": 0.0082, "acinar cell damage": 0.0082, "tnf stimulated expression": 0.0082, "il-2r beta expression": 0.00819, "interferon beta expression": 0.00819, "cell blasts pulsed": 0.00819, "cell precursors": 0.00819, "cell hybridoma": 0.00819, "gc box binding proteins bteb2": 0.00819, "n-acetyl-l-cysteine inhibits primary human": 0.00819, "human immunodeficiency virus transmission": 0.00819, "cell library": 0.00819, "suppresses nf-kappab expression": 0.00819, "cell damage": 0.00819, "cell cytotoxicity": 0.00819, "autologous antigen-presenting cell": 0.00818, "transient expression assays": 0.00818, "cell subclones": 0.00818, "stem cell": 0.00818, "enhanced gr expression": 0.00818, "cell activators": 0.00818, "epstein-barr virus latent membrane protein-1 triggers ap-1 activity": 0.00818, "cell separation": 0.00818, "expression suggest": 0.00818, "th1 cell": 0.00818, "cell reactivity": 0.00818, "additional binding site": 0.00818, "reporter gene mediated": 0.00817, "cell adaptor": 0.00817, "cell supernatants": 0.00817, "cell cytoplasm": 0.00817, "ebv immediate-early gene transcripts": 0.00817, "transcription proteins stat3": 0.00817, "pre-b cell": 0.00817, "cref cell killing": 0.00817, "heterologous dna binding domain": 0.00817, "cell contact": 0.00817, "cd16- counterpart cell": 0.00817, "human peripheral blood mononuclear precursors": 0.00816, "il-4 similarly affect il-6 expression": 0.00816, "distinct expression patterns": 0.00816, "cell killing": 0.00816, "blocks human lymphocyte proliferation": 0.00816, "apl cell": 0.00816, "vivo expression studies": 0.00816, "b-cell antigen receptor complex": 0.00816, "aim activation pathway regulate": 0.00816, "mycobacterial cell wall": 0.00816, "cell commitment": 0.00816, "cell lymphomas": 0.00816, "human b-lymphocyte precursors [": 0.00816, "red cell viability": 0.00816, "giant cell arteritis": 0.00815, "inhibited transcription activated": 0.00815, "cell wall": 0.00815, "control tal-1 expression": 0.00815, "platelet-activating factor binding": 0.00815, "induce enzyme expression": 0.00815, "cell fusions": 0.00815, "dna binding nf-kappa": 0.00815, "schizosaccharomyces pombe mc mating type gene": 0.00815, "cell prolymphocytic leukaemia": 0.00815, "active globin gene promoters": 0.00815, "human immunodeficiency virus 1-induced": 0.00814, "cell blasts": 0.00814, "cell factor-1": 0.00814, "macrophage gene regulation": 0.00814, "human immunodeficiency virus type-1": 0.00814, "hiv-1 genome expression": 0.00814, "sickle cell": 0.00814, "canonical egr-1 binding site": 0.00814, "activation signal hb24 mrna": 0.00814, "c-rel-expressing cell monolayers": 0.00814, "sequence demonstrated binding": 0.00814, "32pi-labeled stat5 binding site": 0.00814, "ets-1 binding site": 0.00813, "lining cell depth": 0.00813, "oxidative stress induced catalase activity": 0.00813, "human immunoglobulin heavy-chain enhancer": 0.00813, "human immunodeficiency virus": 0.00813, "human pre-b-cell lines": 0.00813, "nuclear factor ms-2 [": 0.00813, "cell nfatc": 0.00813, "il-6-responsive gene elements": 0.00813, "cell toxicity": 0.00813, "differential gene regulation": 0.00813, "cell autonomous coregulation": 0.00813, "cell selectivity": 0.00813, "cell mitogens": 0.00813, "disease expression": 0.00813, "cell subpopulations": 0.00813, "interferon-gamma-induced factor binding": 0.00813, "fas ligand expression": 0.00812, "cell morphology": 0.00812, "fluorescence-activated cell sorter": 0.00812, "cell volume": 0.00812, "human haematopoietic lines": 0.00812, "ifn-beta promoter transcription": 0.00812, "cell cytoskeleton": 0.00812, "human peripheral blood leukocytes": 0.00812, "cell cycling": 0.00812, "lymphoid-enhancer binding factor": 0.00812, "cell hybridomas": 0.00812, "cell preparations": 0.00812, "inhibit cytokine expression": 0.00812, "asymmetric cell division": 0.00812, "cell mitogenesis": 0.00811, "basophil cell return": 0.00811, "cell viability": 0.00811, "binding factor": 0.00811, "neoplastic cell": 0.00811, "interleukin-2 [ il-2 ] -dependent ht-2 line": 0.00811, "cell type-specific": 0.00811, "macrophage-like cell": 0.00811, "cell fate": 0.00811, "cell immortalization": 0.00811, "normal human igg": 0.00811, "nfat-controlled luciferase gene system distinguishes cif": 0.00811, "pu.1 induces expression": 0.00811, "resting normal human": 0.00811, "heterodimeric activator protein-1 transcription complex": 0.00811, "ets binding site": 0.0081, "cell suicide": 0.0081, "gene enhancer": 0.0081, "cell res": 0.0081, "cell unresponsiveness": 0.0081, "mhc i+/mhc iibright/cd83+/cd86+/cd14- surface ag expression": 0.0081, "cell cycles": 0.0081, "cell type-": 0.0081, "human leukemia/lymphoma lines": 0.0081, "increased ap-1 dna-binding activity": 0.0081, "normal human eosinophils": 0.0081, "cell zone": 0.0081, "human monocytic differentiation": 0.0081, "cell dysregulation": 0.0081, "cell hypoactivity": 0.0081, "cell follicles": 0.0081, "cell receptor-": 0.0081, "cell source": 0.0081, "cell receptor-beta": 0.0081, "cell homeostasis": 0.0081, "cell specification": 0.0081, "ikaros binding site": 0.0081, "cell neoplasms": 0.0081, "-20 gata binding site": 0.0081, "primary cultured human erythroid precursors": 0.00809, "viral gene transactivation": 0.00809, "control hla-dq expression": 0.00809, "natural cytotoxicity programs regulates ap-1 expression": 0.00809, "primary human monocytes": 0.00809, "receptor binding defect": 0.00809, "estrogen receptor binding": 0.00809, "dna binding studies demonstrated": 0.00809, "cell nhl": 0.00809, "stat6 binding site": 0.00809, "unrecognized composite binding site": 0.00809, "cell sensitization": 0.00809, "cell triggering": 0.00809, "cell deficit": 0.00809, "cell division": 0.00808, "cell repertoire": 0.00808, "cell sorting": 0.00808, "cell communication": 0.00808, "cell divisions": 0.00808, "il-2 binding analysis demonstrated": 0.00808, "cell anergy": 0.00808, "cell antigen-receptor": 0.00808, "macrophage colony-stimulating factor receptor": 0.00808, "cell pigmentation": 0.00808, "oct-2a binding site": 0.00808, "cell areas": 0.00808, "cell biology": 0.00808, "cell neoplasia": 0.00808, "c-jun nh2-terminal kinase activation": 0.00808, "kappa b-specific binding factors present": 0.00808, "gata binding site": 0.00808, "cell counting": 0.00808, "cell surfaces": 0.00808, "box binding proteins enhance": 0.00808, "receptor heterodimer blocks nfatp/ap-1 complex formation": 0.00808, "antigen-presenting cell": 0.00808, "family transcription factors": 0.00807, "cell shape": 0.00807, "cell specific-transcription": 0.00807, "gal4 dna binding domain": 0.00807, "cell harvester": 0.00807, "transcription factors regulate apoptosis": 0.00807, "cell type-specificity": 0.00807, "early gene c-jun": 0.00807, "vitro stimulated human tonsil": 0.00807, "cell area": 0.00807, "freshly isolated human monocytes": 0.00807, "cell hyperreactivity": 0.00807, "cell immunopoiesis": 0.00807, "cell leukemia/lymphoma": 0.00807, "cell hemoglobinization": 0.00807, "high basal expression": 0.00807, "unlabeled ap1 binding site": 0.00806, "identified fkhrl1 gene": 0.00806, "human peripheral blood neutrophils": 0.00806, "cell": 0.00806, "weak binding site": 0.00806, "identified fas-regulatory gene": 0.00806, "binding site selection": 0.00806, "normal human epidermal keratinocytes": 0.00806, "human growth hormone": 0.00806, "ionomycin induced synergistic activation": 0.00806, "hiv-1 nef expression": 0.00806, "zebra activation domain swap constructs": 0.00806, "myb-like dna binding domain": 0.00805, "reporter gene regulated": 0.00805, "hiv-1 tat gene": 0.00805, "nf-kappab directs expression": 0.00805, "open binding site": 0.00805, "endogenous il-2 gene": 0.00805, "yy-1 binding site": 0.00805, "cytokine-induced hiv-1 expression": 0.00805, "tnf-stimulated nuclear factor-kappab activation": 0.00805, "high-affinity binding site": 0.00805, "purified human monocytes": 0.00804, "dna binding domain": 0.00804, "il-2rbeta dna binding motif": 0.00804, "normal human tonsils": 0.00804, "nuclear factor kappa": 0.00804, "negative regulation required zta dna-binding activity": 0.00804, "tf antigen expression": 0.00804, "fosb gene suggest": 0.00804, "human acute myeloid leukemia": 0.00803, "human immunodeficiency virus-induced apoptosis": 0.00803, "nuclear factor-kappab activation": 0.00803, "major physiological human glucocorticoid": 0.00803, "interleukin-10 inhibits expression": 0.00803, "il-2r beta gene": 0.00803, "binding site contributes": 0.00803, "icer inhibits calcineurin-mediated expression": 0.00803, "eklf binding site": 0.00803, "understand gata3 gene regulation": 0.00803, "basal level expression": 0.00803, "upregulate hiv-1 expression": 0.00803, "increase dna binding": 0.00803, "tcr-stimulated cd95 ligand expression": 0.00802, "cd5 surface expression correlated": 0.00802, "e47 induce efficient expression": 0.00802, "functional receptor proteins remains": 0.00802, "form multiple dna binding homo-": 0.00802, "human monocytes isolated": 0.00802, "repress il-2 expression": 0.00802, "infects normal human": 0.00802, "induced dna-binding activity": 0.00802, "inhibit inflammatory mediator expression": 0.00802, "il-2r regulation gene": 0.00802, "sp binding site": 0.00801, "specific dna binding capacity": 0.00801, "transfected reporter gene": 0.00801, "tnf-alpha-induced hiv-1 expression": 0.00801, "single viral gene": 0.00801, "peripheral blood-derived human monocytes": 0.00801, "control expression": 0.00801, "vitamin d-responsive element-regulated reporter gene": 0.00801, "nf-e2 binding site": 0.00801, "pervanadate induced activation": 0.00801, "p53 tumor suppressor gene": 0.008, "reporter luciferase gene vectors": 0.008, "mouse il-4 gene": 0.008, "activated il-2 receptor complexes": 0.008, "tcr/cd3 induced activation": 0.008, "e2f binding site": 0.008, "dna binding motif": 0.008, "increase transcriptional activity": 0.008, "human cd36-specific antibody okm5": 0.008, "preferred spi-b binding site": 0.00799, "promoter sequence polymorphisms identified": 0.00799, "fos inhibits nf-at dna binding": 0.00799, "human dendritic cell-based assay": 0.00799, "multiple transcription factors required": 0.00799, "sla-dq antigen expression": 0.00799, "c2h2 zinc finger gene encoding": 0.00799, "alpha,25-dihydroxyvitamin d3-mediated gene regulation": 0.00799, "human peripheral monocytes": 0.00799, "granulocyte colony-stimulating factor receptor": 0.00799, "normal t-cell activation": 0.00798, "purified quiescent human blood": 0.00798, "soluble cd40 ligand stimulated fibroblast activation": 0.00798, "tumor suppressor gene brca1": 0.00798, "allergen-specific human t-cell clones": 0.00798, "activation induced": 0.00798, "normal human": 0.00798, "human normal": 0.00798, "ap-2 binding site": 0.00798, "hiv-1 expression": 0.00798, "gata-3 binding site": 0.00798, "igh gene regulation": 0.00798, "bp1 binding site": 0.00797, "htlv-1 gene regulation": 0.00797, "ltr reporter gene": 0.00797, "c. albicans enhance hiv expression": 0.00797, "yy1 binding site": 0.00797, "receptor binding specificity": 0.00797, "pip binding site": 0.00797, "high constitutive expression": 0.00797, "nitric oxide selectively reduces endothelial expression": 0.00797, "granulocyte/macrophage colony-stimulating factor basic promoter": 0.00797, "developmental control gene": 0.00797, "detect ebv replicative gene products": 0.00796, "ick-1 binding site": 0.00796, "glutamine-rich activation domain present": 0.00796, "cellular expression": 0.00796, "e1a gene demonstrated": 0.00796, "transcriptional regulator nuclear factor": 0.00796, "central tumor suppressor gene": 0.00796, "human lymphocyte proliferation": 0.00796, "cyclin e-dependent kinase activity mediates rb inactivation": 0.00796, "theileria annulata induces expression": 0.00796, "turn induces expression": 0.00795, "nf-kappab/rel binding site": 0.00795, "sp6 kappa promoter kappay element": 0.00795, "rbp-jkappa binding site": 0.00795, "hormone-mediated gene regulation": 0.00795, "atf binding site": 0.00795, "adjacent promoter proximal ap-1-binding site": 0.00795, "tumor necrosis factor induced": 0.00795, "human cd3epsilon transgenic mice": 0.00795, "genes encoding proteins involved": 0.00795, "footprinted binding site": 0.00794, "cbf1/rbp-jkappa binding site": 0.00794, "transient expression experiments": 0.00794, "require tyrosine kinase activity": 0.00794, "sp1/egr-1 binding site": 0.00794, "nf-il6 enhanced expression": 0.00794, "atf/cre binding site": 0.00794, "early gene c-fos": 0.00794, "xenogeneic human serum promotes leukocyte adhesion": 0.00794, "cytokine tumor necrosis factor alpha": 0.00794, "beta gene": 0.00794, "il-2 expression": 0.00794, "19-bp binding site": 0.00794, "-1 surface expression": 0.00794, "human t-cell clone": 0.00794, "transformation-associated viral genes demonstrate marked sequence divergence": 0.00793, "expressed transcription factors": 0.00793, "inhibited low shear-induced activation": 0.00793, "transcription factors expressed": 0.00793, "monocytic ikappab kinase signalsome activation": 0.00793, "nuclear run-on transcription assays": 0.00793, "tumor necrosis factor-alpha-induced nf-kappa b1 transcription": 0.00793, "binding site": 0.00793, "activated erythropoietin receptor inhibits apoptosis": 0.00793, "human immunodeficiency virus-1 long terminal repeat": 0.00793, "gene regulation": 0.00793, "human cytomegalovirus immediate-early enhancer": 0.00793, "potent gene regulatory": 0.00792, "icam-1 surface expression": 0.00792, "hiv rna expression": 0.00792, "p40 promoter region identified": 0.00792, "decreased kappab binding activities induced": 0.00792, "specific nuclear factor": 0.00792, "nuclear factor specific": 0.00792, "immunoglobulin heavy chain expression": 0.00791, "nf-kappab binding complex": 0.00791, "mbp promoter region identified": 0.00791, "initial receptor binding": 0.00791, "ligand expression": 0.00791, "cpg-rich island suggesting expression": 0.00791, "human immuno-deficiency virus": 0.00791, "surface marker expression": 0.00791, "stimulated bcl-xl expression": 0.00791, "cd40 surface expression": 0.00791, "activation domain present": 0.0079, "induce aim/cd69 cell-surface expression": 0.0079, "induces expression": 0.0079, "trp enhanced cd69 expression": 0.0079, "inhibit tumor necrosis factor-alpha-induced nf kappab activation": 0.0079, "bat box binding proteins dissociated": 0.0079, "chloramphenicol acetyltransferase expression constructs": 0.0079, "fragment confers cell-specific expression": 0.0079, "uv required expression": 0.0079, "induce beta-globin expression": 0.0079, "transcription factors termed signal transducers": 0.0079, "gata-2 binding element required": 0.00789, "mitogen-inducible gene product related": 0.00789, "nf-at expression vector": 0.00789, "gene products involved": 0.00789, "il-2 gene displays": 0.00789, "bat box binding proteins": 0.00789, "human peripheral blood burst-forming unit-erythroid": 0.00789, "nf-kappa b/rel binding sites": 0.00789, "cd28 surface expression": 0.00789, "mts1 tumor suppressor gene": 0.00789, "colony-stimulating factor receptor": 0.00788, "b-cell lymphoma/leukemia-2 gene product": 0.00788, "tax induced lt-293 activity": 0.00788, "mediates specific dna binding": 0.00788, "alpha2 integrin gene required": 0.00788, "tyrosine kinase enzymatic activity": 0.00788, "t-cell expression": 0.00788, "positive c-jun expression": 0.00788, "reporter gene analyses": 0.00788, "tumor suppressor gene": 0.00788, "il-13 induce expression": 0.00787, "gene transfection assays": 0.00787, "% xenogeneic human serum": 0.00787, "recombinant human il-2": 0.00787, "situ dna binding assay": 0.00787, "human granulocyte apoptosis": 0.00787, "decreases surface expression": 0.00787, "induced il-1beta promoter-driven cat activity": 0.00787, "gamma chain gene": 0.00787, "camp/pka activation pathway": 0.00787, "altered expression level": 0.00786, "m-csf regulates c-jun expression": 0.00786, "amplified c-erbb2 gene sequences": 0.00786, "human adenovirus type": 0.00786, "gene control": 0.00786, "activation pathway": 0.00786, "p21ras small gtp binding proteins participate": 0.00786, "interleukin-2 nfat-driven reporter gene": 0.00786, "pancreatic islet expression studies": 0.00786, "hiv gene therapy": 0.00785, "immediate-early gene product egr-1 regulates": 0.00785, "specific transcription factors": 0.00785, "human leukocyte antigen status": 0.00785, "induce cd69 expression": 0.00785, "t-cell receptor genes": 0.00785, "transforming growth factor-beta suppresses human": 0.00785, "htlv-i tax expression leads": 0.00785, "mc903 induce expression": 0.00785, "antisense expression constructs": 0.00785, "1.2-kb cdna encoding full-length human c/ebp-epsilon": 0.00785, "nuclear transcription studies": 0.00785, "cdna encoding human sr-bp shows": 0.00785, "erythroid-specific reporter expression": 0.00784, "enhanced tr75 expression": 0.00784, "undetected viral gene products": 0.00784, "monochloramine inhibits phorbol ester-inducible neutrophil respiratory burst activation": 0.00784, "tyrosine kinase activity": 0.00784, "distinct expression": 0.00784, "transcription proteins": 0.00784, "suppresses surface expression": 0.00784, "induce cd5 expression": 0.00784, "primary human bone marrow cultures": 0.00784, "heterologous beta-globin reporter gene": 0.00784, "decrease lps-induced nf-kappab dna binding": 0.00783, "viral gene products": 0.00783, "small human tissue samples": 0.00783, "dprl promoter/reporter gene constructs carrying": 0.00783, "expression vectors encoding": 0.00783, "enhanced expression": 0.00783, "gene inactivation studies": 0.00783, "gm-csf promoter cbf site tgtggtca": 0.00782, "induce cd38 expression": 0.00782, "human disease x-linked agammaglobulinemia": 0.00782, "chloramphenicol acetyltransferase reporter gene": 0.00782, "early gene products": 0.00782, "human peripheral blood": 0.00782, "vcam-1 surface expression": 0.00781, "induce isg expression": 0.00781, "low shear flow-induced haec vcam-1 expression": 0.00781, "granulocyte-macrophage colony-stimulating factor promoter": 0.00781, "mpl receptor binding": 0.00781, "gene reveal significant differences": 0.00781, "adenovirus gene therapy vectors": 0.00781, "induce sialoadhesin expression": 0.00781, ":29038 ] activation": 0.00781, "transcription initiation complex assembly": 0.00781, "ap-1 transcription complex": 0.00781, ":3632 ] activation": 0.00781, "reduced il-13r alpha1 expression": 0.00781, "increased glucocorticoid receptor beta": 0.0078, "inhibitors inhibited monocyte chemotactic activity": 0.0078, "chloramphenicol acetyl transferase reporter gene": 0.0078, "induce expression": 0.0078, "g. vaginalis lysates activated hiv long-terminal repeat transcription": 0.0078, "immunoglobulin mu heavy chain gene": 0.0078, "ifngamma-induced dna binding complexes": 0.00779, "receptor alpha chain induces cepsilon germline transcripts": 0.00779, "dor1 signaling increased [ ca2+ ]": 0.00779, "nuclear receptor family": 0.00779, "gene demonstrated": 0.00779, "cat reporter gene": 0.00779, "nf-kappab transcriptional activation": 0.00779, "il-2 gene": 0.00779, "tf expression data suggests": 0.00779, "gre-dependent luciferase reporter gene": 0.00779, "jurkat expression library": 0.00778, "reporter gene luciferase": 0.00778, "immunoglobulin heavy chain gene cluster": 0.00778, "luciferase reporter gene": 0.00778, "basal transcription complex": 0.00778, "encoding gene cloned": 0.00778, "simultaneous early expression": 0.00778, "cdna expression library prepared": 0.00778, "tcr/cd3 stimulation induces activation": 0.00778, "ebv genome expression": 0.00778, "cyclosporin a-sensitive nuclear factor-at response element": 0.00778, "additional upstream gene segments": 0.00778, "human transcriptional activators": 0.00778, "c-myb expression decreased": 0.00777, "tax1-inducible transcription factors identified": 0.00777, "important hiv transcription factors": 0.00777, "gene therapy vector": 0.00777, "hormone-activated receptor binding": 0.00777, "cdna encoding nuclear factor": 0.00777, "human enhancer": 0.00777, "tandem nf-kappa b/rel binding motif": 0.00777, "il-10 inhibited ifn-gamma-induced stat activation": 0.00777, "il-2 receptor alpha chain promoters": 0.00777, "pathways mediate cd23-triggered nf-kappab activation": 0.00777, "dna-protein binding complex formation": 0.00777, "transient and/or stage-specific expression": 0.00776, "human monocytes leads": 0.00776, "human adult blood": 0.00776, "sequences lack classical enhancer activity": 0.00776, "early human adult hematopoiesis": 0.00776, "positive c-fos expression": 0.00776, "interleukin-2 promoter/reporter gene construct": 0.00776, "e-selectin surface expression": 0.00775, "vitro kinase activity": 0.00775, "granulocyte-macrophage colony-stimulating factor mrna levels": 0.00775, "hiv-1 transcriptional activation": 0.00775, "primary human breast tumors": 0.00775, "identified human islet": 0.00775, "-alpha beta nls receptor complex": 0.00775, "intracellular binding proteins": 0.00774, "heterologous reporter gene": 0.00774, "proximal functional promoter region": 0.00774, "pge2-mediated activation effect": 0.00774, "decreased fasl expression": 0.00774, "epitope-tagged nucleolin expression constructs": 0.00774, "human autosomal recessive disease": 0.00774, "expression studies": 0.00774, "tissue expression": 0.00774, "reduced gralpha expression": 0.00774, "studied gata-1 expression": 0.00773, "human atherosclerotic disease": 0.00773, "tumor gene": 0.00773, "-oestrogen receptor fusion proteins complement": 0.00773, "tcr transcript expression": 0.00773, "natural endogenous gene regulated": 0.00773, "reduced expression": 0.00773, "murine bcl6 gene": 0.00773, "nf-kappab-controlled beta-globin reporter gene": 0.00772, "demonstrated increased htlv-1 transcription": 0.00772, "human disease syndromes": 0.00772, "id2 expression decreased": 0.00772, "fc gamma ri expression": 0.00772, "increase hiv-1 ltr transcription": 0.00772, "murine lck gene": 0.00772, "up-regulated surface expression": 0.00772, "human interferon beta": 0.00771, "mature human monocytes": 0.00771, "cat activity induced": 0.00771, "reporter gene strategy": 0.00771, "il-2 induce stat3 activation": 0.00771, "viral expression": 0.00771, "consensus sequence eliminate binding": 0.00771, "bcl-2 expression vector": 0.00771, "cd5 surface expression": 0.00771, "induced cat activity": 0.00771, "beta-globin reporter gene": 0.00771, "jun kinase activation": 0.00771, "ad2/ad12 hybrid e1a gene product harboring": 0.00771, "endogenous long terminal repeat transcriptional activity": 0.00771, "tax gene develop fibroblastic tumors": 0.0077, "high c-erb b-2 expression": 0.0077, "ap-2 expression construct": 0.0077, "functional expression": 0.0077, "restricted cytokine expression": 0.0077, "box region factor": 0.0077, "screen bacteriophage lambda cdna expression libraries": 0.0077, "high bcl-xl expression": 0.0077, "human il-2r beta": 0.0077, "gene encoding interleukin-2": 0.0077, "low shear-induced vcam-1 expression": 0.0077, "aml1 expression level": 0.0077, "cd25 surface expression": 0.00769, "pkc-induced nuclear nf-kb activity": 0.00769, "human b-cell development": 0.00769, "mouse e2a gene": 0.00769, "transcription-dependent surface expression": 0.00769, "helenalin inhibits nf-kappab activation": 0.00768, "freshly prepared human monocytes": 0.00768, "decreased mn-sod expression": 0.00768, "myeloid zinc finger gene": 0.00768, "general cellular transcription factors": 0.00768, "human immunodeficiency virus-infected monocytes": 0.00768, "tnf alpha activation": 0.00768, "ubiquitous cellular transcription factors": 0.00768, "increased il-2 transcription": 0.00768, "expression constructs": 0.00768, "lck promoter ets site": 0.00767, "b-cell activation [": 0.00767, "gene required": 0.00767, "cultured human monocytes": 0.00767, "re/ap construct expression": 0.00767, "supporting specific dna binding": 0.00767, "high wt1 expression": 0.00767, "high grbeta expression": 0.00767, "antisense myb rna expression": 0.00767, "modulates tumor necrosis factor alpha release": 0.00766, "ap-1 -binding activity increased": 0.00766, "p65 activation domain": 0.00766, "aberrant retinoic acid metabolism activation": 0.00766, "gene targeting studies": 0.00766, "related gene products": 0.00766, "surface expression": 0.00766, "tax expression vector": 0.00766, "myd88 gene results": 0.00766, "inhibit ikk kinase activity": 0.00766, "lytic regulatory gene bzlf": 0.00765, "stat1 alpha activation": 0.00765, "tcl1 gene involved": 0.00765, "c-jun expression plasmids": 0.00765, "constitutive expression c-fos": 0.00765, "murine fosb gene": 0.00765, "high expression": 0.00765, "additional distinct transcription factors": 0.00765, "human type": 0.00765, "human disease": 0.00765, "murine fra-1 gene": 0.00765, "decreased expression": 0.00765, "assay transcriptional activity": 0.00765, "reported nuclear factor designated saf": 0.00765, "increased dna-binding activity": 0.00765, "c-jun expression prior": 0.00764, "tcf-1 alpha binding motif": 0.00764, "prolactin-inducible interferon regulatory factor-1 gene": 0.00764, "transient expression data": 0.00764, "atherogenesis human ldl induces": 0.00764, "lac-z reporter gene": 0.00764, "tp1 promoter-reporter gene constructs": 0.00764, "specific dna binding": 0.00764, "respiratory burst activity induced": 0.00764, "tsc2 messenger rna expression": 0.00764, "human monocytes lead": 0.00764, "recombinant ebna-2 expression vectors": 0.00764, "nuclear factor nf-kappab": 0.00764, "steroid/thyroid hormone receptor response elements": 0.00764, "h-7-sensitive pathways regulate stat3 dna binding": 0.00763, "activate hla-dra expression": 0.00763, "mhc class ii-negative human": 0.00763, "hiv tat expression": 0.00763, "reporter gene driven": 0.00763, "human tr beta": 0.00763, "intrinsic transcriptional activation motifs": 0.00763, "mutated human ciita constructs": 0.00763, "t3-responsive reporter gene": 0.00762, "nf-kappab-responsive reporter gene": 0.00762, "important gene dorsal": 0.00762, "adult globin gene program": 0.00762, "ra-responsive reporter gene": 0.00762, "involved gene": 0.00762, "lacz reporter gene": 0.00762, "important immunoregulatory gene": 0.00762, "interferon regulatory factor-1 gene": 0.00762, "differential expression model": 0.00762, "mutant human cd40": 0.00762, "purified human peripheral": 0.00762, "human neutrophils stimulated": 0.00762, "calcium ionophore a23187 increased zp activity": 0.00762, "inhibited nfat activation": 0.00762, "nuclear proteins nf-kappa": 0.00762, "similar dna binding specificities mediated": 0.00762, "influence and/or limit expression": 0.00761, "wild-type gr gene": 0.00761, "expression level": 0.00761, "il-2 promoter region": 0.00761, "vitronectin receptor [ vr ]": 0.00761, "stimulate purified human cd4+": 0.00761, "human monocytes exposed": 0.00761, "regulating bcl-2 expression": 0.00761, "human t-cell lineages": 0.00761, "expression cdna cloning": 0.00761, "trans-dominant negative expression vectors": 0.00761, "alternative promoter site": 0.0076, "bacterial lipopolysaccharide-activated human blood": 0.0076, "regulates transcriptional activation mediated": 0.0076, "endothelial vcam-1 expression": 0.0076, "mouse cpo gene spans": 0.0076, "human monocytes differentiated": 0.0076, "human t-cell leukemias": 0.0076, "tax gene product": 0.0076, "constitutive tax expression": 0.0076, "immediate-early ebv zebra gene": 0.0076, "reporter gene": 0.0076, "protein-tyrosine kinase activation": 0.0076, "stimulate hiv expression": 0.0076, "mouse gata3 gene": 0.0076, "activate pag expression": 0.0076, "cdna expression library": 0.00759, "enhanced ap-1 transcriptional activity": 0.00759, "functional nuclear factor kb": 0.00759, "promoter proximal region upstream": 0.00759, "retinoic acid receptor alpha": 0.00759, "promyelocytic leukemia gene": 0.00759, "dysregulated cytokine expression": 0.00759, "transcriptional activation required": 0.00759, "nf-kappa b. activation": 0.00758, "cell-specific transcription factors involved": 0.00758, "specific steroid binding sites": 0.00758, "human blood platelets": 0.00758, "bcl-6 gene encoding": 0.00758, "affect lmp1 expression": 0.00758, "mouse inos gene": 0.00758, "alds induced qr activity": 0.00758, "transient expression analyses": 0.00758, "cytokine expression": 0.00758, "cellular factor induced": 0.00758, "lmp1 expression vector": 0.00758, "vd3 induced 24r-hydroxylase activity": 0.00758, "human monocyte/macrophage function": 0.00758, "fc gamma ric gene": 0.00757, "control transcription factors": 0.00757, "increased mrna encoding profibrotic growth factors": 0.00757, "nf-kappab transcription factors": 0.00757, "isoform expression patterns": 0.00757, "general transcription complex tfiid": 0.00757, "induce transcriptional activation": 0.00757, "cellular transcription factors interacting": 0.00757, "mouse osteocalcin gene": 0.00757, "retinoid-dependent granulocytic markers expression": 0.00756, "altered camp-induced gr expression": 0.00756, "unusual transcription element tar": 0.00756, "human vdr cdna mutated": 0.00756, "fc gamma ri gene": 0.00756, "activate expression": 0.00756, "transfected expression vectors": 0.00756, "human t-cell types": 0.00756, "tcr delta gene segments": 0.00756, "murine leukemia virus transcription": 0.00756, "human myeloperoxidase promoters suggested": 0.00756, "mouse perforin gene": 0.00756, "phorbol myristate acetate-inducible creb -or ap1-dependent transcriptional activity": 0.00756, "mouse gene": 0.00755, "inducible tnf-alpha expression": 0.00755, "human cytokine il-4": 0.00755, "immediate-early gene encoding": 0.00755, "early gene": 0.00755, "low expression": 0.00755, "-reporter gene constructs": 0.00754, "somatic gene therapy": 0.00754, "octamer binding proteins": 0.00754, "membrane expression": 0.00754, "gene therapy strategies": 0.00754, "human monocyte monokine synthesis": 0.00754, "cytokine receptor genes": 0.00754, "nuclear activity": 0.00753, "adult beta-globin expression": 0.00753, "human cd5 antigen": 0.00753, "h. human fibroblasts contained": 0.00753, "zap-70 affects multiple t-cell receptor signaling pathways": 0.00753, "il-2 receptor complex": 0.00753, "restricted hiv expression": 0.00753, "human er reduced": 0.00753, "adult globin gene": 0.00753, "rodent gene encoding": 0.00752, "gata-1 expression vectors": 0.00752, "cellular transcription factors": 0.00752, "elderly subjects contained serum response factor": 0.00752, "protease expression vector": 0.00752, "oct-2 expression vector": 0.00752, "beta-globin gene promoters": 0.00752, "peripheral human mononuclear leukocytes": 0.00752, "major susceptibility gene": 0.00752, "induced activity": 0.00752, "cd14+ adherent human monocytes": 0.00752, "increased nk activity": 0.00751, "target expression": 0.00751, "tax trans-activator induces nf-kappab activity": 0.00751, "activates interleukin-6 expression": 0.00751, "n-terminal activation domain": 0.00751, "hiv-1 envelope glycoproteins induce activation": 0.00751, "regulate inducible expression": 0.00751, "e-selectin gene exhibits marked differences": 0.00751, "early growth response genes c-fos": 0.00751, "b-1 lymphocytes constitutively express nuclear activated stat3": 0.0075, "tumor necrosis factor alpha decreases": 0.0075, "cpg island suggests expression": 0.0075, "human peripheral-blood monocytes": 0.0075, "hiv-1 vpr suppresses immune activation": 0.0075, "fli-1 expression vector shows": 0.0075, "single bipartite retinoic acid response element": 0.0075, "human cdnas encoding subunits": 0.0075, "gene encoding ebna": 0.0075, "hormone receptor proteins": 0.0075, "chain expression": 0.0075, "il-2 autocrine human": 0.0075, "major immediate-early gene": 0.0075, "region documented constitutive binding": 0.0075, "human tsp 1-chloramphenicol acetyltransferase constructs": 0.0075, "separable gene regulatory": 0.00749, "human hiv-1": 0.00749, "oct-1 binding proteins": 0.00749, "vertebrate gene encoding": 0.00749, "irf-1 gene promoters": 0.00749, "activates expression": 0.00749, "restricted expression pattern": 0.00749, "gene targeting experiments": 0.00749, "detectable tax expression": 0.00749, "full-length human ciita constructs": 0.00749, "constitutively expressed nuclear proteins": 0.00748, "follicular expression pattern": 0.00748, "lipopolysaccharide-stimulated human monocytes": 0.00748, "similar dna binding domains": 0.00748, "upregulated il-4 expression": 0.00748, "inhibit expression": 0.00748, "temporal expression pattern": 0.00748, "ad2/ad12 hybrid e1a gene products": 0.00748, "lymphocytes induces transcription": 0.00748, "putative mammalian sex-determining gene sry": 0.00748, "genomic tnf gene": 0.00748, "block activation-induced fas expression": 0.00748, "inducing icam-1 expression": 0.00748, "effector plasmid expressing human trx": 0.00748, "egr-1 expression vector": 0.00748, "inflammatory gene products": 0.00748, "vzv immune human donors": 0.00747, "binding peptide induced": 0.00747, "t-cell receptor complex": 0.00747, "multiple potential binding sites": 0.00747, "myh11 gene encoding": 0.00747, "mitogen-inducible gene encoding": 0.00747, "e2a-hlf fusion gene": 0.00747, "primary human nk": 0.00747, "oct-2a expression vector": 0.00747, "gene therapeutic agents": 0.00747, "attenuated nf-kappab dna binding": 0.00747, "binding complex similar": 0.00747, "major gene modulates": 0.00747, "tgf-beta gene promoters": 0.00747, "increased viral transcription": 0.00746, "controls th2-specific expression": 0.00746, "late expression patterns": 0.00746, "unrearranged tcr delta gene": 0.00746, "enhanced nuclear factor": 0.00746, "gene encoding": 0.00746, "primary human cd4+": 0.00746, "erythroid transcription factors gata-1": 0.00746, "human il-2": 0.00746, "ebna gene promoters": 0.00746, "important tissue-specific regulatory dna element present": 0.00745, "lps-induced nf-kappab dna binding": 0.00745, "cytokine gene cluster": 0.00745, "sle disease activity index system": 0.00745, "basic helix loop helix zipper transcription factors interact": 0.00745, "adult human bone marrow": 0.00745, "normal cd40-induced monocyte activation": 0.00745, "controls expression": 0.00745, "cellular activation signals": 0.00745, "c-jun expression": 0.00745, "jun activation domain": 0.00745, "endogenous thymocyte-specific gene called gig18": 0.00745, "ciprofloxacin increased cat activity": 0.00745, "target gene il-8": 0.00745, "cd11c gene promoters": 0.00745, "endothelial expression": 0.00745, "direct transgene expression": 0.00745, "oxidative stress stimulate transcriptional activation": 0.00744, "human class i-restricted cytotoxic": 0.00744, "c-fos gene products": 0.00744, "agents inhibited lps-induced tk activity": 0.00744, "putative tumour suppressor gene fhit": 0.00744, "examined expression": 0.00744, "human beta-globin yeast artificial chromosome transgene": 0.00743, "human monocytes": 0.00743, "chimeric tcr gene": 0.00743, "ifn-inducible gene promoters": 0.00743, "longer affected mn-sod expression": 0.00743, "decreased transcriptional activation": 0.00743, "monocyte tf expression": 0.00743, "potential nuclear factor": 0.00743, "incompetent human g-csfr mutant": 0.00743, "non-mammalian cytokine gene": 0.00743, "nuclear factor binds": 0.00742, "cytokine gene": 0.00742, "high affinity aldosterone binding sites": 0.00742, "ciita activation domain": 0.00742, "promoter site": 0.00742, "purified human sp1": 0.00742, "h2o2 treatment suppressed dna-binding activity": 0.00742, "product expression": 0.00742, "activation and/or differentiation stages": 0.00742, "final gene rearrangement events": 0.00742, "inducible il-2 receptor alpha chain": 0.00742, "secreted tumor necrosis factor alpha": 0.00742, "intermediate thymocyte cultures induces nf-kappab activity": 0.00742, "gene promoters": 0.00742, "primary human leukocytes": 0.00741, "inhibited il-2-induced activation": 0.00741, "purified human cd4+": 0.00741, "gm-csf-stimulated hiv expression": 0.00741, "b95-8 cytosol inhibited specific binding": 0.00741, "nf-kappa b-dependent activation": 0.00741, "tumor necrosis factor receptor-associated factors": 0.00741, "lymphoid-specific transcription complex": 0.0074, "tal-1 gene product": 0.0074, "ikappabalpha constitutive expression": 0.0074, "distinct transcription factors": 0.0074, "raf-1 activity promotes il-2 production": 0.0074, "nfat transcription factors bind": 0.0074, "constitutively express human c-mpl": 0.0074, "multiple human tissues": 0.0074, "endogenous gata-1 gene": 0.0074, "class ii-specific transcription factors rfx": 0.0074, "activate human platelets": 0.0074, "nef expression vector": 0.0074, "increased leukocyte microbicidal activity": 0.0074, "hiv expression": 0.0074, "dna sequence analysis": 0.0074, "negative-acting sequences repress enhancer activity": 0.0074, "heterologous activation domain": 0.0074, "th2-restricted il-4 expression": 0.0074, "yy1 class transcription factors": 0.00739, "regulated expression": 0.00739, "il-4 expression": 0.00739, "ifn-alpha/beta-induced transcription complex isgf3": 0.00739, "ebna-2 expression vector": 0.00739, "pml gene product": 0.00739, "cd15 increased cat activity": 0.00739, "related gene": 0.00739, "promyelocytic/retinoic acid receptor alpha": 0.00739, "retinoblastoma susceptibility gene product": 0.00739, "acidic activation domain": 0.00739, "distinct dna binding subunits": 0.00739, "jurkat human leukaemic t-cells": 0.00739, "block cd11b expression": 0.00739, "nf-y subunit expression": 0.00739, "bcl-6 gene product": 0.00739, "jak3 expression correlated": 0.00739, "human inflammatory diseases": 0.00739, "studied trident expression": 0.00739, "inhibited jnk activation": 0.00739, "gene therapy": 0.00739, "dna binding function": 0.00738, "exhibit inducible expression": 0.00738, "phase gene inducible": 0.00738, "-beta subunit expression": 0.00738, "negative expression": 0.00738, "reduced nf-kappab activation": 0.00738, "gene fusion": 0.00738, "fusion gene": 0.00738, "gamma/delta tcr+ pregnancy lymphocytes expressed progesterone receptor": 0.00738, "induces distinct stat6-dna binding complexes": 0.00738, "c-myb gene product": 0.00738, "-1 alpha-stimulated vcam-1 expression": 0.00738, "inducing nf-kb expression": 0.00738, "transcription factors required": 0.00738, "mitogen-inducible gene isolated": 0.00738, "distinctive expression pattern": 0.00738, "regulate insulin expression": 0.00738, "dna binding form": 0.00738, "oxidative stress dependent nf-kappab activation": 0.00738, "t-cell activation signals": 0.00737, "ebna2 expression vector": 0.00737, "fc gammar1 gene leads": 0.00737, "major transcription initiation sites": 0.00737, "cyclin d-associated kinase activity": 0.00737, "proximal c-jun tre-like promoter element": 0.00737, "important human mediator": 0.00737, "creb gene transcript": 0.00737, "tcr gene rearrangements": 0.00737, "erba target gene caii": 0.00737, "proximal binding element p0": 0.00737, "expression pattern": 0.00736, "possess distinct intrinsic dna binding affinities": 0.00736, "ifn inducible expression": 0.00736, "zinc finger transcription factors sp1": 0.00736, "human alpha-like globin promoters": 0.00736, "regulate epsilon germline expression": 0.00736, "nf-kappab dna binding": 0.00736, "ltr-driven cat expression vectors": 0.00736, "lymphoid cell-specific transcription factors ets-1": 0.00736, "variable vdr expression": 0.00736, "aml1 gene product": 0.00736, "functional promoter region": 0.00736, "transcription complex": 0.00736, "target gene": 0.00735, "stable e1a expression": 0.00735, "cd40l expression vector": 0.00735, "fgf-1-induced rel/kappab binding proteins": 0.00735, "contained potential binding sites": 0.00735, "transfected scl gene": 0.00735, "cyclin-like udg gene product": 0.00735, "eukaryotic transcription factors involved": 0.00735, "ciita expression plasmid": 0.00735, "factor proteins": 0.00735, "regulates fasl expression": 0.00735, "normal tnf-alpha activation": 0.00735, "activation domain requirements": 0.00735, "drosophila segment polarity gene armadillo": 0.00735, "lck gene product": 0.00735, "ap-1 transcription factors measured": 0.00735, "human genomic clones": 0.00735, "human primary t-lymphocytes": 0.00734, "egr1 expression vector": 0.00734, "spi-1 expression vector": 0.00734, "grbeta expression vector": 0.00734, "substantial constitutive nf-kappa b-binding activity": 0.00734, "gralpha expression vector": 0.00734, "specific binding sites": 0.00734, "transcription factors results": 0.00734, "gm-csf gene essential": 0.00734, "activated receptor-1 activation": 0.00734, "oct binding proteins": 0.00734, "human jurkat t-cells": 0.00734, "purified octamer transcription factors": 0.00734, "otf-2 expression vector": 0.00734, "hrs c-fos expression": 0.00734, "inhibitor hiv-1 transcription": 0.00734, "primary human t-lymphocytes": 0.00734, "tcr expression": 0.00733, "nf-kappab transcriptional activity": 0.00733, "sh2 domains enhanced basal nfat activity": 0.00733, "direct myeloid-specific expression": 0.00733, "transient short-term expression": 0.00733, "tre-dna binding proteins": 0.00733, "control transcriptional activity": 0.00733, "single gene trans-activation": 0.00733, "ap-1/c-jun expression vector": 0.00733, "immediate-early g1 phase gene": 0.00733, "transcriptional control activity": 0.00733, "bamhi zlf-1 gene product": 0.00733, "transcription factors involved": 0.00733, "c-fos expression": 0.00733, "bcl-2 expression": 0.00733, "empty expression vector": 0.00733, "egr-1 expression correlates": 0.00733, "endogenous c-myb expression": 0.00732, "m-csf receptor promoter": 0.00732, "neomycin resistance gene": 0.00732, "demonstrate membrane binding sites": 0.00732, "affect expression": 0.00732, "mediate hiv-2 enhancer activation": 0.00732, "hygromycin resistance gene": 0.00732, "human ebv oncogene": 0.00732, "chromosomes lacking xist expression": 0.00732, "glutamine-rich activation domain": 0.00732, "tcr gene rearrangement": 0.00732, "bacterial chloramphenicol acetyltransferase gene": 0.00732, "expression vector": 0.00732, "putative nuclear localization sequences decreased nuclear localization": 0.00732, "lymphocytes induces nuclear factors": 0.00731, "tetrahexamer binding proteins": 0.00731, "ccgccc binding proteins": 0.00731, "induce cd23 mrna transcription": 0.00731, "inducing cd14 expression": 0.00731, "c-jun gene 1.4-fold": 0.00731, "micron/ml tumor necrosis factor alpha": 0.00731, "human peripheral leukocytes": 0.00731, "inhibited activation": 0.00731, "caat/enhancer binding proteins": 0.00731, "transient expression": 0.00731, "salicylates inhibit lipopolysaccharide-induced transcriptional activation": 0.00731, "sp1-like binding proteins": 0.00731, "ltr expression": 0.0073, "tumor necrosis factor alpha": 0.0073, "transcription factors important": 0.0073, "gal4 activation domain": 0.0073, "inducing mnp-1 expression": 0.0073, "constitutive elk-1 expression": 0.0073, "purified human neutrophils": 0.0073, "cosmids encoding human ciita": 0.0073, "proteins binding": 0.0073, "potential ets binding sites conserved": 0.0073, "-atpase b2 subunit gene": 0.0073, "zebra activation domain": 0.0073, "rapid expression": 0.0073, "isolated human housekeeping alas precursor": 0.0073, "binding proteins": 0.0073, "c-jun gene": 0.0073, "alter fibroblast collagenase expression": 0.00729, "light-chain gene structure": 0.00729, "phoq gene product": 0.00729, "zinc finger gene": 0.00729, "cd11b integrin expression": 0.00729, "vitro transcription analysis": 0.00729, "gata-1 expression": 0.00729, "functional activation antigen": 0.00729, "genes encoding eosinophil granule proteins": 0.00729, "high-level e1a oncoprotein expression": 0.00729, "air-1 gene product": 0.00729, "inhibited monocyte chemotactic activity": 0.00729, "ie2 gene product": 0.00728, "abolishes pma-induced ap-1 transcriptional activation": 0.00728, "human lymphoblastic jurkat": 0.00728, "single e2f-dna binding complex": 0.00728, "human group": 0.00728, "cellular glucocorticoid receptor levels": 0.00728, "p65-dependent transcriptional activation mediated": 0.00728, "gr expression": 0.00728, "rb expression vectors re-establishes": 0.00728, "tat-i gene product": 0.00728, "tax expression": 0.00728, "cd4 expression": 0.00728, "rat irf-1 gene": 0.00728, "human tissues examined": 0.00728, "hyaluronan augmented vcam-1 expression": 0.00728, "nm23 gene product": 0.00728, "human jurkat lymphoblastic": 0.00728, "retinoblastoma gene product": 0.00728, "regulate t-cell-specific expression": 0.00728, "viral binding induced": 0.00728, "failed expression": 0.00728, "specific binding complexes relative": 0.00727, "ifn-gamma expression": 0.00727, "constitutive hepor expression": 0.00727, "adult human tissues": 0.00727, "wild-type gene": 0.00727, "erg2 gene product": 0.00727, "hyperthyroidism nuclear t3 maximal binding capacity": 0.00727, "regulating bcl-xl expression": 0.00727, "single human tonsillar gc": 0.00727, "transcriptional activation mediated": 0.00727, "minimal adenovirus e1b promoter-luciferase gene": 0.00727, "augmented vcam-1 expression": 0.00727, "beta-casein gene regulated": 0.00727, "stat3 expression": 0.00727, "regulate interleukin-4 expression": 0.00727, "c-fos promoter sis-inducible element probe": 0.00727, "regulates expression": 0.00727, "fkhrl1 gene product": 0.00727, "low-level constitutive expression": 0.00727, "enhances interleukin-8 expression": 0.00727, "p50 gene coding": 0.00727, "provide transcriptional activation": 0.00727, "human carotid artery ecs express pparalpha": 0.00726, "activation domain": 0.00726, "mediating fasl expression": 0.00726, "gene product": 0.00726, "primary il-13 receptor complex": 0.00726, "mhc class ii gene-specific transcription activator": 0.00726, "inhibit transcriptional activation": 0.00726, "cloned gene coding": 0.00726, "human blood": 0.00726, "constitutive expression": 0.00726, "human bone marrow ec immortalized": 0.00726, "transcriptional activation domains": 0.00726, "coherent expression patterns": 0.00726, "increased myeloperoxidase activity": 0.00725, "lps toler ant human mono mac": 0.00725, "receptor promoter": 0.00725, "human chronic lymphocytic leukemias": 0.00725, "-30 promoter region upstream": 0.00725, "expression patterns": 0.00725, "e6 motif stimulated transcription": 0.00725, "phase expression": 0.00725, "immediate-early gene egr-1 encodes": 0.00724, "human erythroid 5-aminolevulinate synthase": 0.00724, "regulate b7.1 expression": 0.00724, "upregulate icam-1 expression": 0.00724, "unique expression profile": 0.00724, "vdr expression": 0.00724, "apparent tal1 gene alteration": 0.00724, "purified human t-cells": 0.00724, "human il-5 synthesis": 0.00724, "high malignancy human melanomas": 0.00724, "ifn-gamma-induced icam-1 expression": 0.00724, "gene structure": 0.00724, "decreases lps-mediated tf expression": 0.00724, "require mek1 kinase activity": 0.00724, "e. coli rpos gene": 0.00724, "hgata-3 expression plasmid": 0.00724, "proximal promoter region abolished": 0.00724, "gata-1 gene disruption": 0.00724, "dna response element": 0.00724, "gene mutations": 0.00723, "single gene": 0.00723, "aberrant pml gene products": 0.00723, "hematopoietic transcription factors gata-1": 0.00723, "il-6 downregulated expression": 0.00723, "enhance mrp14 expression": 0.00723, "e1a gene products": 0.00723, "lymphoid cell-specific nuclear factor": 0.00723, "report expression profiles": 0.00723, "expression <": 0.00723, "human peripheral mononuclear": 0.00723, "human dc mediate": 0.00723, "human p65 subunit": 0.00723, "il-4 gene": 0.00723, "inducing expression": 0.00723, "human primary b-cells": 0.00723, "il-12 expression": 0.00723, "increased pld activity": 0.00723, "pwm induced egr-1 transcription": 0.00722, "optimal transcriptional activity required": 0.00722, "nfat transcription factors play": 0.00722, "inducible expression": 0.00722, "characterize altered expression": 0.00722, "activation levels": 0.00722, "regulating expression": 0.00722, "il-4-producing th0-like human jurkat": 0.00722, "homeobox gene essential": 0.00722, "12-o-tetradecanoylphorbol 13-acetate/phytohemagglutinin-stimulated human jurkat": 0.00722, "sequence designated conserved lymphokine element": 0.00722, "harbor scl gene rearrangements": 0.00722, "early t-cell activation": 0.00722, "endogenous sp3 expression": 0.00722, "regulate expression": 0.00722, "early human": 0.00722, "endogenous gm-csf gene": 0.00722, "immunoglobulin gene superfamily": 0.00722, "c-rel-mediated transactivation and/or dna binding": 0.00722, "-induced hla-dr expression": 0.00722, "lipid kinase activity": 0.00721, "il-2r expression leading": 0.00721, "human gm-csf tata box": 0.00721, "upstream promoter region": 0.00721, "latent transcription factors called stat": 0.00721, "downregulated pu.1 expression": 0.00721, "human breast cancer": 0.00721, "nf-kappa b-dependent reporter genes selectively inhibits": 0.00721, "nitric oxide synthase expression": 0.00721, "human gamma delta": 0.00721, "potential sp1 binding sites": 0.00721, "report socs-3 expression": 0.00721, "il-10 downregulates expression": 0.00721, "human th2 clones": 0.0072, "human adult globin": 0.0072, "human primary cd34": 0.0072, "augment cytokine-induced vcam-1 expression": 0.0072, "gp120-mediated icam-1 expression": 0.0072, "pkc-dependent fas expression": 0.0072, "fetal-to-adult globin gene switching": 0.0072, "human lymphoid tumors": 0.0072, "nf-kappab and/or sp1 binding elements": 0.0072, "e2a gene products": 0.0072, "nuclear factor present": 0.0072, "nfat emsa binding complex": 0.0072, "transfected gene": 0.00719, "c-fos gene 7-fold": 0.00719, "lmp1 expression": 0.00719, "purified human colony": 0.00719, "tpa augmented dexamethasone-induced transcriptional activation": 0.00719, "human myelodysplastic syndrome": 0.00719, "full-length alg-4 induced transcription": 0.00719, "il-10 gene polymorphism": 0.00719, "cell-specific expression": 0.00719, "activate nuclear factor": 0.00719, "human erythroid precursors": 0.00719, "human ig heavy chain": 0.00719, "mzf-1 expression vectors": 0.00719, "stable expression maintains": 0.00719, "expression cloning strategy": 0.00719, "purified resting human": 0.00719, "additional expression": 0.00719, "increased chemotactic activity": 0.00719, "icam-1 expression": 0.00719, "related hemopoietic helix-loop-helix transcription factors": 0.00719, "globin gene switching": 0.00719, "enhance expression": 0.00719, "human ecs express pparalpha": 0.00719, "cellular factor nf-kappa b. transfections": 0.00719, "gamma-globin expression identifies eklf": 0.00718, "lack expression": 0.00718, "human erythrocyte ghost membrane": 0.00718, "nf-kappab activity inhibits": 0.00718, "cd40 expression": 0.00718, "mediated high-level nf-kappab activation": 0.00718, "inhibits nf-kappab activity": 0.00718, "xenobiotic response element-binding activity": 0.00718, "v-src expression correlates": 0.00718, "stable expression": 0.00718, "mnda expression occurs": 0.00718, "lps receptor complex": 0.00718, "exogenous e2f expression": 0.00718, "tcr gene": 0.00718, "platelet gpiib gene": 0.00718, "zap-70 kinase activity": 0.00718, "retinoic acid-induced expression": 0.00718, "bcl-6 gene products": 0.00718, "jak/stat inhibitory gene": 0.00718, "c-fos gene": 0.00717, "strong expression": 0.00717, "differential lymphokine expression": 0.00717, "human jurkat": 0.00717, "pituitary prl expression": 0.00717, "tal1 gene products": 0.00717, "serine kinase activity": 0.00717, "increased hydrolytic activity": 0.00717, "ebv transcription factors": 0.00717, "bcl-2 gene": 0.00717, "jun-d expression vectors": 0.00717, "t-cell antigen receptor signal transduction": 0.00717, "human b-cell lymphomas": 0.00717, "differential nf-kappab subunit activation": 0.00717, "p38 kinase activity": 0.00717, "primary human astrocytes": 0.00717, "determine critical transcription factors": 0.00717, "biphasic junb transcription induced": 0.00717, "interleukin-2 expression": 0.00717, "hiv long terminal repeat activation": 0.00717, "subsequent expression": 0.00717, "fos-b expression vectors": 0.00717, "fos kinase activity": 0.00716, "delta gene segments": 0.00716, "tcl1 oncogene expression": 0.00716, "gene confers responsiveness": 0.00716, "il-6 expression": 0.00716, "deltorphin enhanced transcriptional activity": 0.00716, "mobility complex termed complex ii": 0.00716, "increased activity": 0.00716, "dopamine stimulates expression": 0.00716, "expression vectors": 0.00716, "nos inhibitors enhance basal nf kappab activation": 0.00716, "cd28 expression": 0.00716, "transcriptional factor nf-kappa": 0.00716, "htlv-1 tax gene": 0.00716, "bacterial superantigen induces stat3 activation": 0.00716, "ap-1 transcriptional activation": 0.00716, "mediate transcriptional activation": 0.00716, "regulated transcriptional activation": 0.00716, "lytic expression program": 0.00716, "restored fasl expression": 0.00716, "exhibit heterogeneous expression": 0.00716, "pu.1 expression": 0.00715, "reactive oxygen intermediate-dependent nf-kappab activation": 0.00715, "fas expression": 0.00715, "t-cell antigen receptor expressed": 0.00715, "reduced enhancer activity": 0.00715, "dna binding assays": 0.00715, "-3 gene products": 0.00715, "distinct transcriptional activity": 0.00715, "e1a -and e7-expressing human fibroblastic": 0.00715, "transcriptional activation properties": 0.00715, "gata-1 gene": 0.00714, "b-cell-specific expression": 0.00714, "finding hlh-2 expression": 0.00714, "gene plays": 0.00714, "differential expression": 0.00714, "antisense myb expression": 0.00714, "induce dna binding": 0.00714, "transgenic expression": 0.00714, "immunoglobulin heavy-chain gene": 0.00714, "human b-lymphocyte cdna library": 0.00714, "forced exogenous expression": 0.00714, "down-regulated c-myc expression": 0.00714, "b-cell receptor complex": 0.00714, "human ciita cdna": 0.00714, "de novo cox-2 expression": 0.00714, "expression occurs": 0.00714, "oct-2 expression": 0.00714, "binding sequence": 0.00714, "human ebv": 0.00714, "mammalian sex-determining gene sry": 0.00714, "vpr suppresses expression": 0.00714, "suppress mn-sod expression": 0.00714, "stat5 expression": 0.00714, "endogenous prl gene": 0.00714, "human peripheral leucocytes": 0.00713, "alter mnda expression": 0.00713, "inhibit nf-kappab activation": 0.00713, "up-regulate vcam-1 expression": 0.00713, "il-2 receptor alpha chain": 0.00713, "nuclear factor nf-at": 0.00713, "efficient dra expression": 0.00713, "gc gene": 0.00713, "intact human mononuclear leukocytes": 0.00713, "tal-1 gene encodes": 0.00713, "assessed mnda expression": 0.00713, "htlv-i rex gene": 0.00713, "cloned tcl1 gene": 0.00713, "unstimulated human peripheral": 0.00713, "tr expression occur": 0.00713, "human primary b-lymphocytes": 0.00713, "ap-1-dependent luciferase expression": 0.00713, "integrin expression": 0.00713, "impaired expression": 0.00713, "human erythroid alas isozyme": 0.00713, "expression plasmids": 0.00713, "oncogene expression": 0.00712, "maintain nf-at transcription factors": 0.00712, "long-term expression": 0.00712, "anti-cd3-induced c-rel expression": 0.00712, "cloned mibp1 gene": 0.00712, "drosophila melanogaster homeobox gene proboscipedia": 0.00712, "t-cell-specific transcription factors nf-at": 0.00712, "augmented expression": 0.00712, "tax gene": 0.00712, "genes encoding proteins": 0.00712, "cd4 gene": 0.00712, "ifn-gamma gene": 0.00712, "human th1 clones": 0.00712, "human alveolar macrophages": 0.00712, "cat expression": 0.00712, "selective expression": 0.00712, "hla-dr expression": 0.00712, "up-regulate il-1beta expression": 0.00712, "histone promoter-driven beta-galactosidase gene": 0.00712, "tnf gene": 0.00712, "de novo expression": 0.00712, "factors activate transcription": 0.00712, "ciita expression serves": 0.00712, "decreases downstream nf-kappab activation": 0.00711, "human primary": 0.00711, "gene repression": 0.00711, "gm-csf expression": 0.00711, "rj2.2.5 restored expression": 0.00711, "brlf1 triggers expression": 0.00711, "expressing human cd14": 0.00711, "il-13/il-4 gene locus": 0.00711, "primary human": 0.00711, "-induced tf expression": 0.00711, "gene topography independent": 0.00711, "multiple consensus binding sites": 0.00711, "unusual persistent expression": 0.00711, "il-5 proximal promoter region": 0.00711, "diverged drosophila homeobox gene": 0.00711, "maximal expression": 0.00711, "e1a expression": 0.00711, "multiple transcription factors": 0.00711, "tnf-alpha gene": 0.00711, "isolated human erythrocytes": 0.00711, "induce transcriptional activity": 0.00711, "luciferase expression": 0.00711, "purified human megakaryocytes": 0.00711, "human macrophage inflammatory protein-1alpha": 0.00711, "immunoglobulin gene": 0.00711, "up-regulated rb expression": 0.0071, "targeted gene inactivation": 0.0071, "5-day human monocyte-derived macrophages": 0.0071, "human breast tumors": 0.0071, "tissue-specific expression": 0.0071, "ndp kinase activity": 0.0071, "gene leads": 0.0071, "b2 subunit promoter region": 0.0071, "egr-1 expression": 0.0071, "human nfil3/e4bp4 cdna promoted": 0.0071, "ra-inducible cd23 expression": 0.0071, "inducible transcriptional activity mediated": 0.0071, "v-abl kinase activity": 0.0071, "related dna binding specificity": 0.0071, "receptor activates lyn tyrosine kinase": 0.0071, "ap-1 enhancer activity resulting": 0.0071, "human cd14-transfected chinese hamster ovary fibroblasts": 0.0071, "erythroid transcription factors": 0.0071, "endogenous b29 gene": 0.0071, "bcl6 gene encodes": 0.00709, "transactivate btk expression": 0.00709, "alter expression": 0.00709, "activate human csf-1r": 0.00709, "high-level bcl-6 expression": 0.00709, "hmg box transcription factors": 0.00709, "diminished il-13-induced expression": 0.00709, "bind transcription factors": 0.00709, "pma-induced cd14 expression": 0.00709, "ectopic expression": 0.00709, "ciita expression": 0.00709, "cytoplasmic and/or nuclear receptor": 0.00709, "g0/g1 switch gene": 0.00709, "chimeric ebna2 gene": 0.00709, "erk1 kinase activity": 0.00709, "embryonic expression": 0.00709, "cultured human dermal fibroblasts": 0.00709, "dna binding studies": 0.00709, "organisms induced transcription": 0.00709, "transcription factors bind": 0.00709, "expression controlled": 0.00709, "human tcr delta": 0.00709, "gene truncation resulting": 0.00709, "11-base-pair dna sequence motif": 0.00709, "scl expression": 0.00709, "persistent expression": 0.00708, "201-bp core promoter region": 0.00708, "vcam-1 expression": 0.00708, "mcm gene products": 0.00708, "affect cd19 reporter construct activity": 0.00708, "il-1beta expression": 0.00708, "ikappabalpha expression": 0.00708, "hematopoietic transcription factors pu.1": 0.00708, "alpha-bound kinase activity": 0.00708, "rex gene encodes": 0.00708, "jak3 expression": 0.00708, "abnormal expression": 0.00708, "gcr-beta gene resulting": 0.00708, "active promoter region": 0.00708, "il-2-induced beta-casein expression": 0.00708, "restricted expression overcomes": 0.00708, "expression cloning": 0.00708, "nuclear transcription factor-kappa": 0.00708, "recombinant human il-10": 0.00708, "vdr gene": 0.00708, "human plasma": 0.00708, "tal-1 expression": 0.00708, "c-myc expression": 0.00708, "tal1 gene occur": 0.00707, "histone h5 gene": 0.00707, "diminished expression": 0.00707, "core promoter region": 0.00707, "il-5 expression": 0.00707, "healthy human leukocyte antigen-b8": 0.00707, "monoallelic paternal expression": 0.00707, "expression library": 0.00707, "kinase activity": 0.00707, "cd23 expression": 0.00707, "expression status": 0.00707, "rapid transcriptional activation": 0.00707, "transgene expression": 0.00707, "nf-atc expression switches": 0.00706, "er gene": 0.00706, "bcl-6 expression": 0.00706, "cultured human fibroblasts": 0.00706, "upstream promoter element": 0.00706, "a-myb gene encodes": 0.00706, "nf-at transcription factors": 0.00706, "ikappab expression": 0.00706, "thrombin receptor agonist peptide induce early events": 0.00706, "c-myb expression": 0.00706, "epo-induced beta-globin expression": 0.00706, "hiv-2 tat gene": 0.00706, "jak1 expression": 0.00706, "hiv1 gene products": 0.00706, "drosophila gene runt": 0.00706, "transcription factors nf-at": 0.00706, "circulating human mononuclear leukocytes": 0.00706, "tal1 expression": 0.00706, "regulates ap-1 dna binding": 0.00706, "kda called nuclear factor": 0.00706, "pml expression": 0.00706, "progressive expression": 0.00706, "nf-kappab binding sites": 0.00706, "restricted expression": 0.00706, "stimulating expression": 0.00705, "id3 impedes expression": 0.00705, "abundant tcl1 expression": 0.00705, "recent gene targeting": 0.00705, "tcf-1 gene encodes": 0.00705, "c5a-induced il-8 expression": 0.00705, "endogenous gene": 0.00705, "single promoter region": 0.00705, "cytoplasmic nls receptor complex": 0.00705, "developmental expression": 0.00705, "c-myc gene amplification": 0.00705, "gene products": 0.00705, "frequent maternal expression": 0.00705, "nf-il6beta expression": 0.00705, "mediated activation signals elicited": 0.00705, "lipid mediators increase activity": 0.00705, "biphasic time-dependent expression": 0.00705, "lipopolysaccharide-induced e-selectin expression": 0.00705, "gene segment": 0.00705, "-induced expression": 0.00704, "lmp1 gene": 0.00704, "visceral tsc2 expression": 0.00704, "b-cell-specific b29 gene": 0.00704, "spontaneous expression": 0.00704, "globin gene": 0.00704, "rb expression": 0.00704, "induced transcription": 0.00704, "bcl-6 gene rearrangement": 0.00704, "reduced transcriptional activity": 0.00704, "regulates transcriptional activation": 0.00704, "total human leukocytes": 0.00704, "gene responsible": 0.00704, "human tnf transgene accelerated pathology": 0.00704, "vimentin expression": 0.00704, "cd19 expression": 0.00704, "mediate nf-kappab activation": 0.00704, "lytic gene cascade": 0.00704, "signaling involves activation": 0.00704, "tgf-beta1 expression": 0.00704, "infected human t-lymphocytes": 0.00704, "il-2-induced expression": 0.00704, "human ifngr1 small deletion hotspot": 0.00704, "tal1 gene rearrangement": 0.00704, "kappa b-specific dna-binding activity": 0.00704, "transduced interferon gene": 0.00704, "affects expression": 0.00704, "require expression": 0.00704, "human genetic disorder": 0.00704, "il-8 expression": 0.00703, "cd95 expression": 0.00703, "ig expression": 0.00703, "phenotypic expression": 0.00703, "constitutive transcriptional activation": 0.00703, "human chromosome 5q23-31": 0.00703, "0.1-0.5 microm dmdtc inhibits tnf-alpha-induced activation": 0.00703, "cd16-induced fasl expression": 0.00703, "underlying ig gene extinction": 0.00703, "chloramphenicol acetyltransferase gene driven": 0.00703, "support nf-kappab-dependent transcriptional activation": 0.00703, "chimeric gene": 0.00703, "il-2r expression": 0.00703, "normal activation": 0.00703, "collagenase expression": 0.00703, "tata box promoter element": 0.00703, "cell-specific gene": 0.00703, "predominant expression": 0.00703, "monoallelic expression": 0.00703, "isg15-ltr-ifn hybrid gene": 0.00703, "e2f1 gene involves": 0.00703, "p45 nf-e2 expression": 0.00703, "icam-1 gene": 0.00703, "human peripheral granurocytes": 0.00702, "cd45 expression": 0.00702, "optimal cd95 ligand reporter activity": 0.00702, "aberrant tcl1 expression": 0.00702, "human chromosome": 0.00702, "chloramphenicol acetyl-transferase expression": 0.00702, "oxidative stresses inhibited activity": 0.00702, "fasl expression": 0.00702, "nef expression": 0.00702, "interleukin-2 gene": 0.00702, "lck expression": 0.00702, "cd5 structural gene": 0.00702, "family receptor levels": 0.00702, "human nf-at": 0.00702, "cd14 expression": 0.00702, "cd34 expression": 0.00702, "delayed expression": 0.00702, "rel-related human cdna": 0.00702, "antagonize expression": 0.00702, "gene fragments": 0.00702, "hybrid gene": 0.00702, "gamma-globin expression": 0.00702, "potential ets binding sites": 0.00702, "hiv1 tat gene": 0.00702, "exclusive paternal expression": 0.00702, "cd3-stimulated human peripheral": 0.00702, "cd95l proximal promoter sequence": 0.00702, "e-selectin expression": 0.00702, "fos expression": 0.00702, "human interleukin-13 activates": 0.00702, "optimal expression": 0.00702, "anti-cd3-activated peripheral human": 0.00702, "nfat transcriptional activation": 0.00702, "sustained expression": 0.00701, "relb expression": 0.00701, "erythroid-specific expression": 0.00701, "tf expression": 0.00701, "ino attenuates inos expression": 0.00701, "a-myb expression": 0.00701, "repress expression": 0.00701, "pu.1 represses gata-1-mediated transcriptional activation": 0.00701, "il-6 gene": 0.00701, "drip coactivator complex binding": 0.00701, "transcription factors c-jun": 0.00701, "nuclear factor regulated": 0.00701, "blr1 expression": 0.00701, "atra-induced expression": 0.00701, "nf-y expression": 0.00701, "human peripheral": 0.00701, "amplified expression": 0.00701, "slight expression": 0.00701, "targeted expression": 0.00701, "proper expression": 0.00701, "il-2ralpha expression": 0.00701, "pan gene encodes": 0.00701, "cd11b/cd18 expression": 0.00701, "human basal brain": 0.00701, "m-csf expression": 0.00701, "cellular activation events": 0.00701, "tat gene": 0.00701, "ip-10 expression": 0.00701, "human fkbp cdna": 0.00701, "ebna-2 expression": 0.00701, "putative human oncogene bcl-3": 0.00701, "abundant expression": 0.00701, "myelomonocytic lineage-specific expression": 0.00701, "widespread expression": 0.007, "receptor proteins": 0.007, "hsp70 expression": 0.007, "differentiation-associated expression": 0.007, "hla-dra expression": 0.007, "essential upstream il-2 response element": 0.007, "prl-inducible beta-casein expression": 0.007, "asm expression": 0.007, "mcp-1 expression": 0.007, "inhibit t-cell activation": 0.007, "il-10 gene": 0.007, "downregulates expression": 0.007, "t-cell-specific expression": 0.007, "chloramphenicol acetyltransferase gene": 0.007, "aly mediates context-dependent transcriptional activation": 0.007, "directs high-level expression": 0.007, "-alpha controls t-cell activation": 0.007, "heterogeneous expression": 0.007, "udg expression": 0.007, "tcf-1 expression": 0.007, "il-10 stimulates human b-cells": 0.007, "pml/raralpha expression": 0.007, "human hla-dq heterodimer": 0.007, "mek1 expression": 0.007, "bzlf1 expression": 0.007, "human ifngr1 small deletions": 0.007, "receptor cross-linking induced stress fiber assembly": 0.007, "dihydrofolate reductase gene homolog": 0.007, "hiv-infected human macrophages": 0.007, "ferritin expression": 0.007, "exclusive tax-induced expression": 0.007, "gene transfection": 0.007, "inhibited il-1-dependent nfkappab activity": 0.007, "alpha-globin expression": 0.00699, "minimal tissue-specific promoter region": 0.00699, "protooncogene expression": 0.00699, "lacked expression": 0.00699, "sex determining gene sry": 0.00699, "bsap expression": 0.00699, "ad5 e1a gene": 0.00699, "ig/tcr gene rearrangements": 0.00699, "cellular activation agents": 0.00699, "alpha2 integrin gene": 0.00699, "excessive expression": 0.00699, "discordant expression": 0.00699, "inducible transcriptional activation": 0.00699, "bcl-xl expression": 0.00699, "allele-specific expression profiles": 0.00699, "luciferase gene driven": 0.00699, "elf-1 expression": 0.00699, "frequent expression": 0.00699, "stat4 expression": 0.00699, "pma-enhanced lal expression": 0.00699, "hiv-2 expression": 0.00699, "experimental expression": 0.00699, "aberrant expression": 0.00699, "alpha2beta1 integrin gene": 0.00699, "p50 dna binding subunit": 0.00699, "induce nf-kappab activity": 0.00699, "limited expression": 0.00699, "human bone morphogenetic protein-2": 0.00699, "cd69 expression": 0.00699, "gene encodes": 0.00699, "stage-specific expression": 0.00699, "ig gene superfamily": 0.00698, "cd5 expression": 0.00698, "activation-dependent expression": 0.00698, "sp1 binding sites present": 0.00698, "cd18 expression": 0.00698, "fos gene families": 0.00698, "myeloid-cell-specific expression": 0.00698, "gata-3 expression": 0.00698, "cis-linked cat gene": 0.00698, "activating transcription factors responsible": 0.00698, "ebna expression": 0.00698, "coordinate expression": 0.00698, "nf-e1 expression": 0.00698, "box promoter element": 0.00698, "bob.1/obf.1 expression": 0.00698, "retrovirus-mediated gene transfer": 0.00698, "promoter proximal region": 0.00698, "elk-1 expression": 0.00698, "mnda expression": 0.00698, "prl-induced biphasic expression": 0.00698, "adenovirus-mediated gene transfer": 0.00698, "spi-b expression": 0.00698, "affect tnf-alpha-mediated nf-kappab activation": 0.00698, "structural gene": 0.00698, "tsc2 gene supports": 0.00698, "-2 expression": 0.00698, "proximal promoter region": 0.00698, "il4 expression": 0.00698, "gabp expression": 0.00698, "poor expression": 0.00698, "e2f-1 expression": 0.00698, "cd3-epsilon expression": 0.00698, "transcription control elements": 0.00698, "oct2 expression": 0.00697, "common human malignancies": 0.00697, "cytoplasmic transcription factors": 0.00697, "runt expression": 0.00697, "forced expression": 0.00697, "human gamma": 0.00697, "activation-induced expression": 0.00697, "human endothelial": 0.00697, "tcl1 expression": 0.00697, "limits expression": 0.00697, "limited gene rearrangement": 0.00697, "paternal expression": 0.00697, "nf-kappa b-binding activity": 0.00697, "activated activator protein-1-dependent transcription": 0.00697, "lal expression": 0.00697, "human anti-e. chaffeensis serum": 0.00697, "lymphoid-specific expression": 0.00697, "lineage-specific expression": 0.00697, "transcription factors active": 0.00697, "human platelet lysates": 0.00697, "cd48 gene demonstrates": 0.00697, "rantes expression": 0.00697, "inos expression": 0.00697, "high-level expression": 0.00697, "resistant icr27tk.3 human leukemic": 0.00697, "pparalpha expression": 0.00697, "il-16 expression": 0.00697, "biphasic expression": 0.00697, "limit expression": 0.00697, "unexpected expression": 0.00697, "glut4 expression": 0.00697, "msr expression": 0.00697, "hlh-2 expression": 0.00697, "differentiation-dependent expression": 0.00697, "cat gene": 0.00697, "gene rearrangements": 0.00697, "human mononuclear leukocytes": 0.00697, "gene selective": 0.00697, "ngal expression": 0.00696, "biallelic expression": 0.00696, "il2 expression": 0.00696, "metastatic suppressor gene": 0.00696, "gcrbeta expression": 0.00696, "peroxide sensitive human wurzburg t-cells": 0.00696, "interferon-regulated expression": 0.00696, "sp3 mediates transcriptional activation": 0.00696, "interleukin-6 expression": 0.00696, "human diseases": 0.00696, "b7.1 expression": 0.00696, "human skin cancer": 0.00696, "cd38 expression": 0.00696, "light-chain gene rearrangement": 0.00696, "luciferase gene": 0.00696, "parasite-induced nf-kappab activation plays": 0.00696, "p39c-jun expression": 0.00696, "lai expression": 0.00696, "gata1 expression": 0.00696, "domains bind megakaryocyte-specific nuclear proteins acting": 0.00696, "cox-2 expression": 0.00696, "gene transfer": 0.00696, "high transcriptional activity": 0.00696, "tcrzeta expression": 0.00696, "zta expression": 0.00696, "human macrophages": 0.00696, "aml1a expression": 0.00696, "nm23 expression": 0.00696, "stimulus-induced expression": 0.00696, "interleukin-3 expression": 0.00696, "gm-csf gene": 0.00696, "endogenous host transcription factors": 0.00696, "sla-dq expression": 0.00696, "divergent expression": 0.00696, "tr expression": 0.00696, "c/ebpbeta expression": 0.00696, "tpa-induced expression": 0.00696, "c-fms expression": 0.00696, "notch-1 expression": 0.00696, "lt-alpha1beta2 expression": 0.00696, "allele-specific expression": 0.00696, "differentiation-specific expression": 0.00696, "lipopolysaccharide-induced expression": 0.00696, "tgf expression": 0.00696, "hiv-2 transactivator gene": 0.00696, "pan expression": 0.00696, "enforced expression": 0.00695, "unregulated expression": 0.00695, "dysregulated expression": 0.00695, "fas-ligand expression": 0.00695, "document expression": 0.00695, "c-rel gene": 0.00695, "vascular-specific expression": 0.00695, "interleukin-12 expression": 0.00695, "steroid-regulated expression": 0.00695, "subset-restricted expression": 0.00695, "hb24 expression": 0.00695, "hsp expression": 0.00695, "p-lps-induced expression": 0.00695, "m-csf-induced expression": 0.00695, "laz3/bcl6 expression": 0.00695, "gst-pi expression": 0.00695, "unrestricted expression": 0.00695, "faithful expression": 0.00695, "coordinated expression": 0.00695, "p45 expression": 0.00695, "expression declines": 0.00695, "virus activation": 0.00695, "interleukin-2-gene expression": 0.00695, "concerted expression": 0.00695, "growth-regulated expression": 0.00695, "tax-induced expression": 0.00695, "mnp-2 expression": 0.00695, "tat-enhanced expression": 0.00695, "g0s2 expression": 0.00695, "sialoadhesin expression": 0.00695, "il-2 receptor alpha subunit": 0.00695, "hiv-gene expression": 0.00695, "deregulated expression": 0.00695, "15-lo expression": 0.00695, "constitutive nf-kappab dna-binding activity": 0.00695, "hck expression": 0.00695, "monocyte-specific expression": 0.00695, "sp3-dependent expression": 0.00695, "cd4+ human helper": 0.00695, "cd95l expression": 0.00695, "low-level expression": 0.00695, "jun-d expression": 0.00695, "cyclooxygenase-2 expression": 0.00695, "musculin expression": 0.00695, "il-2r-alpha expression": 0.00695, "targeted gene disruption": 0.00695, "units/ml human recombinant m-csf": 0.00695, "filament expression": 0.00695, "activation-specific expression": 0.00695, "ctcf expression": 0.00695, "hb-egf expression": 0.00695, "tr55 expression": 0.00695, "ikaros gene": 0.00695, "ets transcription factors regulate": 0.00695, "trans-gene expression": 0.00695, "lyn expression": 0.00695, "mediating transcriptional activation": 0.00695, "hsp60 expression": 0.00695, "icsat expression": 0.00695, "oct2-isoform expression": 0.00695, "-2-receptor expression": 0.00695, "galectin-3 expression": 0.00695, "ifn-gamma-inducible expression": 0.00695, "tr75 expression": 0.00695, "developmental-specific expression": 0.00695, "isg expression": 0.00695, "her-2/neu expression": 0.00695, "beta-gal expression": 0.00695, "differentiated human dc": 0.00695, "imbalanced expression": 0.00695, "myeloid-specific expression": 0.00695, "nfat-dependent expression": 0.00695, "ctl-specific expression": 0.00695, "th2-selective expression": 0.00695, "gamma-interferon expression": 0.00695, "gamma-chain expression": 0.00695, "transcription factors tested": 0.00694, "defective retinoblastoma gene": 0.00694, "rabbit 15-lipoxygenase gene": 0.00694, "mediates transcriptional activation": 0.00694, "spi-1 and/or fli-1 transcription factors": 0.00694, "tcf-1 alpha activity": 0.00694, "coding gene": 0.00694, "tal-1 gene specifies": 0.00694, "human genomic library": 0.00694, "cd11b gene": 0.00694, "lymphocyte nuclear t3 receptor": 0.00694, "ap-1 transcription factors": 0.00694, "egr-1 gene": 0.00694, "tnf promoter region": 0.00694, "gene coding": 0.00694, "transcription factors ap-1": 0.00694, "embryonic gene": 0.00694, "ciita gene": 0.00694, "expression": 0.00694, "intact human platelets": 0.00694, "ig gene silencing": 0.00694, "strong transcriptional activation": 0.00694, "e2a gene": 0.00693, "lymphokine receptor genes": 0.00693, "phorbol ester/ionomycin-induced nf-at activation": 0.00693, "human scl locus": 0.00693, "translocated pax-5 gene": 0.00693, "e3330 decreases transcriptional activation": 0.00693, "vcam-1 gene": 0.00693, "c-myc gene": 0.00693, "nf-kappa b-independent activity": 0.00693, "dna binding experiments": 0.00692, "tal-1 gene": 0.00692, "il-1beta gene": 0.00692, "ltr-chloramphenicol acetyltransferase-encoding gene chimeras": 0.00692, "human immunodeficiency viruses types": 0.00692, "ikappabalpha gene": 0.00692, "parasite-induced constitutive nf-kappab activation": 0.00692, "receptor 3'-untranslated region polymorphisms": 0.00692, "octamer transcription factors oct-1": 0.00692, "lymphocytes induces genes involved": 0.00692, "defective gene": 0.00692, "p53 tumor-suppressor gene": 0.00692, "irf-1 promoter region act": 0.00692, "positive transcription factors": 0.00692, "il-5 gene": 0.00692, "growth factor receptors play": 0.00692, "tnfalpha gene": 0.00692, "heterologous gene": 0.00692, "gene rearrangement": 0.00692, "recombinant human nucleolin": 0.00691, "human il-4": 0.00691, "cyclophilin gene": 0.00691, "dra gene depends": 0.00691, "recombinant human nm23-h1": 0.00691, "unknown gene": 0.00691, "gene consists": 0.00691, "transcription factors determines lineage specification": 0.00691, "transcription factors play": 0.00691, "induces nf kappab activation": 0.00691, "specific dna-binding activity": 0.00691, "lymphocyte activation results": 0.00691, "heterodimeric binding complex": 0.00691, "bcl-6 gene": 0.00691, "putative human homolog": 0.00691, "gene reveal": 0.00691, "decidual prl gene": 0.00691, "coproporphyrinogen oxidase gene": 0.00691, "inhibit phorbol ester/ionomycin-induced activation": 0.00691, "determine nf-kappab activation": 0.00691, "gene amplification": 0.0069, "b2 gene": 0.0069, "multiple dna binding": 0.0069, "b1 vitellogenin gene": 0.0069, "human mononuclear leukocyte": 0.0069, "blocks transcriptional activation": 0.0069, "gene pml": 0.0069, "c-myb gene": 0.0069, "ig gene extinction": 0.0069, "regulate stat3 dna binding": 0.0069, "pml gene": 0.0069, "fork head gene subfamily": 0.0069, "tal1 gene": 0.0069, "human inflammatory pathologies": 0.0069, "inhibited tpa-induced erk2 activity": 0.0069, "human toll transfected": 0.0069, "pooled human serum": 0.00689, "il-3 gene": 0.00689, "legionella pneumophila rpos gene": 0.00689, "cd19 gene": 0.00689, "rb gene": 0.00689, "nf-il6 gene": 0.00689, "l-selectin gene": 0.00689, "parasite induces constitutive activation": 0.00689, "distinct binding sites": 0.00689, "bsap gene shifts": 0.00689, "gene disruption": 0.00688, "human beta-globin locus": 0.00688, "ferritin heavy-chain gene": 0.00688, "human inflammatory": 0.00688, "human monocyte pdgf": 0.00688, "il-8 gene": 0.00688, "suppresses transcriptional activation": 0.00688, "human thymocytes": 0.00688, "beta-globin gene": 0.00688, "essential transcription factors": 0.00688, "dihydrofolate reductase gene": 0.00688, "bcl6 gene": 0.00688, "disulfide-linked dimer regulating human": 0.00688, "rj2.2.5 dqb gene": 0.00688, "immediate-early gene": 0.00688, "gm-csf promoter element responsible": 0.00688, "nucleoprotein extracts showing decreased dna-binding activity": 0.00688, "gene translated": 0.00688, "xpd gene impairs ner": 0.00688, "rex gene": 0.00688, "constitutive nuclear factor": 0.00688, "gene knock-out": 0.00687, "non-ig gene hypermutation": 0.00687, "germline cepsilon gene": 0.00687, "nonimmunoglobulin gene hypermutation": 0.00687, "gene pax-5": 0.00687, "gene generates": 0.00687, "p105 gene": 0.00687, "human monocyte": 0.00687, "pro-myelocytic leukaemia gene": 0.00687, "human hematopoietic neoplasms": 0.00687, "fasl gene": 0.00687, "human thyroid fragments": 0.00687, "pax-5 gene": 0.00687, "low molecular nuclear proteins": 0.00687, "nef gene": 0.00687, "aml1 gene": 0.00687, "differentiated human mononuclear phagocytes": 0.00687, "gamma-globin gene": 0.00687, "human tcr zeta-chain": 0.00687, "mu enhancer activation": 0.00687, "erythroid-specific gene": 0.00686, "human diploid fibroblasts": 0.00686, "htlv-1 infected human": 0.00686, "tf gene": 0.00686, "ip-10 gene": 0.00686, "synergistic activation observed": 0.00686, "human leukocyte membranes": 0.00686, "surface immunoglobulin-triggered b-cell activation": 0.00686, "xenogeneic human serum": 0.00686, "human neutrophil granulocytes": 0.00686, "ebna-2 gene": 0.00686, "human gata3 zinc fingers": 0.00686, "transfected human": 0.00686, "human burkitt lymphoma": 0.00686, "identified cellular kinases ikappab kinase alpha": 0.00686, "redundant receptor intracellular domain sequences": 0.00686, "ferritin h-chain gene": 0.00686, "il-2-inducible dna binding activities": 0.00686, "gene exists": 0.00686, "tuberous sclerosis gene": 0.00686, "e-selectin gene": 0.00686, "integrated alpha-globin gene": 0.00686, "diverged homeobox gene": 0.00686, "irf-1 gene": 0.00686, "human t-lymphocyte transformation": 0.00686, "transcription factors suggested": 0.00686, "il-13 gene": 0.00685, "transcription factors sp1": 0.00685, "archetypal t-cell-specific gene": 0.00685, "master gata1 gene": 0.00685, "human umbilical vein segments exposed": 0.00685, "nf-at dna binding": 0.00685, "sp1 transcription factors": 0.00685, "potential binding sites": 0.00685, "dra gene": 0.00685, "il-1alpha gene": 0.00685, "mip-1alpha gene": 0.00685, "endogenous nf-kappab activation": 0.00685, "tp1 gene": 0.00685, "bipartite dna binding domains": 0.00685, "hla-dra gene": 0.00685, "gammac gene": 0.00685, "gene targeting": 0.00685, "human serum": 0.00685, "m-csf gene": 0.00685, "promoter-reporter gene behavior": 0.00685, "mcp-1 gene": 0.00685, "regulate nuclear factor": 0.00685, "ar gene": 0.00684, "glucocorticoid receptor ]": 0.00684, "fos-related gene": 0.00684, "subtle gene movements": 0.00684, "human breast tumours": 0.00684, "efficient transcriptional activation": 0.00684, "homeobox gene": 0.00684, "human myelomonocytic lineage": 0.00684, "steroid-regulated gene networks": 0.00684, "bacterial peptidoglycan induces cd14-dependent activation": 0.00684, "104-bp minimal promoter region": 0.00684, "p40 gene": 0.00684, "entire ligand binding domain": 0.00684, "chemr1 gene scya3r2": 0.00684, "irf-2 gene": 0.00684, "dna binding activities": 0.00684, "cp activity required amino acids": 0.00684, "cmat binding complex": 0.00684, "human antigen-specific cd4": 0.00684, "immunogenic human malignant melanomas augments": 0.00684, "bzlf1 gene": 0.00684, "bsap gene": 0.00684, "humara gene": 0.00684, "decreased nf-kappab activity": 0.00684, "absolute 'master gene": 0.00683, "gangliosides suppress tumor necrosis factor production": 0.00683, "tata-less interferon-regulated gene": 0.00683, "cd69 gene": 0.00683, "sry-related gene sox9": 0.00683, "rpos gene": 0.00683, "cell-specific nuclear factor otf-2": 0.00683, "lymphocyte-specific mb-1 gene": 0.00683, "candidate gene": 0.00683, "hiv enhancer activity": 0.00683, "specific promoter sites": 0.00683, "sex-determining gene sry": 0.00683, "so-called octamer transcription factors": 0.00683, "b29 gene": 0.00683, "monocytic/myeloic gene mrp14": 0.00683, "gata-3 gene": 0.00683, ":735 ] initiation binding repressor": 0.00683, "anti-cd3-stimulated ap-1 enhancer activity": 0.00683, "e2f-1/dp1 complex binding": 0.00683, "cd36 gene": 0.00683, "lmp gene": 0.00683, "interleukin-4 gene": 0.00683, "element site": 0.00683, "human gingival fibroblasts": 0.00683, "oct2-mediated enhancer activation": 0.00683, "dna binding domains": 0.00683, "qr gene": 0.00683, "dem abolished phorbol 12-myristate 13-acetate-induced activation": 0.00683, "igh gene": 0.00683, "nuclear factor kb": 0.00683, "gene organization": 0.00683, "dna binding component": 0.00682, "nf-at transcriptional activity": 0.00682, "tsc2 gene": 0.00682, "mbp gene": 0.00682, "tcl1 gene": 0.00682, "cd5 gene": 0.00682, "enhancer activation": 0.00682, "gene technology": 0.00682, "hormone-induced tax activation induces": 0.00682, "icam-i gene": 0.00682, "beta-galactosidase gene": 0.00682, "caml gene": 0.00682, "human b-cell-specific ciita": 0.00682, "e2f-1 gene": 0.00682, "transcription factors regulates": 0.00682, "altered kappa b-binding activity": 0.00682, "endogenous tyrosine kinase receptor c-kit": 0.00682, "biopsy-derived human tissues": 0.00682, "rag-1 gene": 0.00682, "nf-kappab involves activation": 0.00682, "oncogenic human herpesvirus": 0.00682, "human fibroblasts": 0.00682, "beta-casein gene": 0.00682, "-2 gene": 0.00682, "human breast cancers": 0.00682, "cox-2 gene": 0.00681, "hpr gene": 0.00681, "eukaryotic gene": 0.00681, "cd40-mediated nf-kappab-dependent transcriptional activation": 0.00681, "t-cell antigen receptor function": 0.00681, "human nk": 0.00681, "putative human il-2re": 0.00681, "interleukin-5 gene": 0.00681, "allogen-specific human cd4+": 0.00681, "-alpha gene": 0.00681, "xpb gene": 0.00681, "healthy human volunteer": 0.00681, "ap-1 enhancer activity": 0.00681, "bcl2 gene": 0.00681, "jun-b gene": 0.00681, "gene truncation": 0.00681, "human gata-1": 0.00681, "pecam-1 gene": 0.00681, "cpo gene": 0.00681, "type ii bare lymphocyte syndrome-associated factor": 0.00681, "il-1 receptor complex": 0.00681, "evi1 gene": 0.00681, "mtcp1 gene": 0.00681, "viral dna polymerase inhibitor phosphonoformic acid": 0.00681, "human immunodeficiency virus-associated hodgkin": 0.00681, "transcription factors downstream": 0.00681, "air-1 gene": 0.00681, "sequester limiting activating transcription factors": 0.00681, "proliferating fresh human epstein-barr virus-negative": 0.0068, "darc gene": 0.0068, "delayed transcriptional activation": 0.0068, "ifn-stimulated gene": 0.0068, "pax5 gene": 0.0068, "tinur gene": 0.0068, "alpha1 gene": 0.0068, "pol gene": 0.0068, "nfat transcription factors": 0.0068, "pilot gene": 0.0068, "atopy gene": 0.0068, "human gr": 0.0068, "env gene": 0.0068, "xist gene": 0.0068, "il3 gene": 0.0068, "gm-csf promoter sequence": 0.0068, "increase activity": 0.0068, "p450ia1 gene": 0.0068, "laz3/bcl6 gene": 0.0068, "lox-1 gene": 0.0068, "hematopoietic-specific gene": 0.0068, "phop-activated gene": 0.0068, "optimal transcriptional activation": 0.0068, "eed gene": 0.0068, "taxi gene": 0.0068, "nm23 gene": 0.0068, "myf3 gene": 0.0068, "bcd gene": 0.0068, "il-3-responsive gene": 0.0068, "lbr gene": 0.0068, "human cd4+": 0.0068, "hb9 gene": 0.0068, "live-attenuated human immunodeficiency viruses": 0.0068, "co-stimulatory gene": 0.0068, "rhombotin gene": 0.0068, "gpiib gene": 0.0068, "ngal gene": 0.0068, "human cdnas fused": 0.0068, "brca2 gene": 0.0068, "p27kip1 gene": 0.0068, "interleukin-8 gene": 0.0068, "c-fms gene": 0.0068, "gene h-2kb": 0.00679, "mbcl6 gene": 0.00679, "rel/nf-kappab-responsive gene": 0.00679, "fos-b gene": 0.00679, "glucocorticoid binding sites": 0.00679, "blr2 gene": 0.00679, "cdc2 gene": 0.00679, "single-copy gene": 0.00679, "-reporter gene": 0.00679, "pivotal gene": 0.00679, "epsilon-globin-encoding gene": 0.00679, "androgen-regulated gene": 0.00679, "gh-n gene": 0.00679, "delta-globin gene": 0.00679, "erg2 gene": 0.00679, "il-4 stimulated nuclear factor-kappab nuclear translocation": 0.00679, "lymphoid-restricted gene": 0.00679, "cd40-inducible gene": 0.00679, "apoptosis-linked gene": 0.00679, "stat1alpha-responsive gene": 0.00679, "gh-v gene": 0.00679, "tal1/scl gene": 0.00679, "15-lox gene": 0.00679, "btk gene": 0.00679, "nuclear factor il-6": 0.00679, "alpha/mad-3 gene": 0.00679, "cd48 gene": 0.00679, "] dexamethasone binding": 0.00679, "osteoblast-specific gene": 0.00679, "raldh2 gene": 0.00679, "recombination-activating gene": 0.00679, "ifna gene": 0.00679, "ebna-1 gene": 0.00679, "rp1 gene": 0.00679, "gene hypermethylation": 0.00679, "human cbfa2 locus": 0.00679, "proil-1beta gene": 0.00679, "naive human helper": 0.00679, "il-9 gene": 0.00679, "site abolished lps induction": 0.00679, "rhom-2 gene": 0.00679, "epsilon-globin gene": 0.00679, "non-cytokine gene": 0.00679, "nfat-sensitive gene": 0.00679, "human cd4": 0.00679, "il-4-inducible gene": 0.00679, "metastasis-suppressor gene": 0.00679, "blk gene": 0.00679, "pit-1 gene": 0.00679, "gp91phox gene": 0.00679, "beta-interferon gene": 0.00679, "lacz gene": 0.00679, "nm23.h1 gene": 0.00679, "saa gene": 0.00679, "thrombin-activated human platelets": 0.00678, "tat- human immunodeficiency viruses": 0.00678, "human neutrophils utilized": 0.00678, "vitro transcription studies demonstrate": 0.00678, "gene": 0.00678, "vivo enhancer activity": 0.00678, "human member": 0.00678, "impaired nf-kappab activation": 0.00678, "intense self-perpetuated viral transcription observed": 0.00678, "mhc-diverse human population": 0.00678, "dexamethasone-resistant human leukemic": 0.00678, "inducible transcription factors": 0.00678, "increased il-8 transcription": 0.00678, "human tissues": 0.00678, "gm-csf promoter region": 0.00678, "germline transcriptional activation": 0.00677, "granulocyte-macrophage colony-stimulating factor induced": 0.00677, "human naive neonatal": 0.00677, "multiple response region demonstrated": 0.00677, "retinoic-acid receptor type alpha": 0.00677, "human leukemic": 0.00677, "human tumors": 0.00677, "human population": 0.00677, "stat3 activation occur early": 0.00677, "human platelets": 0.00677, "cloned human": 0.00677, "lmo-dependent transcriptional activation": 0.00677, "human neutrophil elastase": 0.00677, "full transcriptional activation": 0.00677, "human monocytic thp": 0.00677, "human c/ebp epsilon": 0.00677, "tnf-alpha promoter localized enhancer elements": 0.00676, "b-cell-specific transcription factors tcf-1": 0.00676, "human immunodeficiency viruses": 0.00676, "human tcf-1 displayed": 0.00676, "differentiation inhibitory activity": 0.00676, "ligand binding domain": 0.00676, "human mononulear leukocytes": 0.00676, "deleted human chr": 0.00676, "indicating permanent virus transcription": 0.00676, "resting human t-cells": 0.00676, "human thymocyte nuclei": 0.00676, "endogenous transcription factors": 0.00676, "s-allyl cysteine inhibits activation": 0.00676, "human atherosclerotic lesions": 0.00675, "pou transcription factors oct-1": 0.00675, "human aortic ec": 0.00675, "type ii major histocompatibility complex combined immune deficiency": 0.00675, "nf-kappa b/rel family proteins": 0.00675, "vitro binding analysis": 0.00675, "human leukocytes": 0.00675, "helix-loop-helix transcription factors encoded": 0.00675, "human erythrocyte ghost membranes": 0.00675, "tax-mediated transcriptional activation": 0.00674, "human erythrocyte membranes": 0.00674, "mutated nik inhibited stimulus-induced kappab-dependent transcription": 0.00674, "octamer-binding transcription factors oct-1": 0.00674, "ah receptor complex recognized": 0.00674, "functional binding sites": 0.00674, "nf-kappa b1 promoter identified": 0.00674, "cultured human ecs": 0.00674, "cyclosporin a-treated human": 0.00674, "conserved octanucleotide promoter element": 0.00674, "cell-specific transcription factors": 0.00674, "h2o2 potentiated nf-kappab activation": 0.00674, "transcription initiation sites": 0.00674, "and/or sp1 binding sites": 0.00674, "mature human": 0.00674, "nuclear hormone receptor retinoid": 0.00673, "-3 dna binding ability": 0.00673, "trigger activation signals leading": 0.00673, "bind myeloid nuclear proteins": 0.00673, "ap-1 dna binding": 0.00673, "il-15 induced stat5 binding": 0.00673, "c/ebp consensus binding sites": 0.00673, "mitogen-mediated transcriptional activation": 0.00673, "human immunodeficiency virus-1": 0.00673, "human neutrophil": 0.00673, "coordinated transcriptional activation": 0.00673, "octamer transcription factors": 0.00673, "epstein-barr virus-immortalized human": 0.00672, "transcription factors activating": 0.00672, "human fetal": 0.00672, "ap-1-mediated transcriptional activation": 0.00672, "human chromosomal bands 6q26-27": 0.00672, "cultured human keratinocytes": 0.00672, "specific dna sequence": 0.00672, "prototypic nuclear factor kappab": 0.00672, "human tcf-1 recognized": 0.00672, "gr-dependent transcriptional activation": 0.00672, "human taf subunits": 0.00672, "il-4-triggered transcriptional activation": 0.00672, "jnk-mediated transcriptional activation": 0.00672, "p65-mediated transcriptional activation": 0.00672, "enhanced stat1 activation": 0.00672, "nfat-dependent transcriptional activation": 0.00672, "nfat-mediated transcriptional activation": 0.00672, "dampened limbic-hippocampal glucocorticoid type ii receptor": 0.00672, "human matrix metalloproteinase": 0.00672, "lps induces ikk activity": 0.00671, "short promoter region": 0.00671, "hiv long terminal repeat activity": 0.00671, "nuclear hormone receptor": 0.00671, "transcriptional activation": 0.00671, "sp1 displayed normal binding activities": 0.00671, "human herpesvirus type-8": 0.00671, "nuclear factor nf-kb": 0.00671, "-dependent cell-free activation system": 0.00671, "stat6 dna-binding activity demonstrated": 0.00671, "metastatic human malignant melanomas": 0.00671, "human osteoclasts develop": 0.0067, "enhanced il-2 transcription correlates": 0.0067, "sustained nf-kappab dna-binding activity": 0.0067, "reduces nuclear factor": 0.0067, "human neutrophils": 0.0067, "encoded transcription factors": 0.0067, "increased transcription efficiency": 0.0067, "nuclear factor kappab": 0.0067, "ap-1 transcriptional activity": 0.0067, "human immunodeficiency virus-type": 0.0067, "transcription factors pu.1": 0.0067, "alternative receptor complex": 0.0067, "human mononuclear phagocytes": 0.0067, "il-6 induces activation": 0.00669, "human myeloproliferative disorders": 0.00669, "hepatic nuclear factor": 0.00669, "oct-2 transcription factors": 0.00669, "host transcription factors": 0.00669, "liver-enriched transcription factors result": 0.00669, "confers strong transcriptional activity": 0.00669, "human interleukin-2": 0.00669, "human coactivator bob1": 0.00669, "cultured human": 0.00669, "blocked tnf alpha production induced": 0.00669, "displayed constitutive nf-kappab activity": 0.00669, "human tonsillar t-lymphocytes": 0.00669, "increased lymphocyte binding": 0.00669, "total cellular pkc enzymatic activity": 0.00668, "activation mechanism": 0.00668, "increased transcription": 0.00668, "transcription factors ets-1": 0.00668, "stat transcription factors": 0.00668, "p65 dna binding": 0.00668, "individual nuclear factor": 0.00668, "human herpesvirus": 0.00668, "human embryonic kidney": 0.00668, "pg490 inhibits pma/iono-stimulated il-2 transcription": 0.00668, "il-10 induces activation": 0.00668, "gata transcription factors associate": 0.00668, "hla-dr alpha promoter constructs transfected": 0.00668, "human malignant melanomas": 0.00668, "transcription factors oct-1": 0.00668, "dna binding state": 0.00668, "human t-lymphocytes": 0.00668, "lps-induced nf-kappab activation": 0.00668, "human il-10": 0.00667, "human pterin carbinolamine dehydratase/dimerization cofactor": 0.00667, "adherent human igg": 0.00667, "sequence element present": 0.00667, "human interleukin": 0.00667, "encephalomyocarditis virus internal ribosomal entry site rna-protein interactions": 0.00667, "pnu156804 blocks human": 0.00667, "human disorders": 0.00667, "key transcription factors": 0.00667, "human u-937 monoblasts": 0.00667, "viral transcription observed": 0.00667, "promoter function analysis": 0.00667, "nuclear estrogen receptor content": 0.00667, "human vaginal fluid specimens": 0.00667, "c-fos sre dna sequence motifs": 0.00667, "human retinoic": 0.00667, "basal transcriptional activity": 0.00667, "nuclear factor nf-il6": 0.00667, "transcription factors ikaros": 0.00666, "human genome evolution": 0.00666, "human populations": 0.00666, "ets transcription factors": 0.00666, "dna binding subunit": 0.00666, "jeg-3 human choriocarcinoma-induced immunosuppression": 0.00666, "mitogen-stimulated human t-cells": 0.00666, "human u-937": 0.00666, "nuclear factor recruitment": 0.00666, "gcr-alpha dna binding capacity": 0.00666, "human coronary atherosclerotic plaques": 0.00666, "cytokine-induced nf-kappab activation": 0.00666, "irf-2 promoter region": 0.00666, "inefficient nf-kappab activation": 0.00666, "human host": 0.00666, "promoter region lacked": 0.00666, "octa abolished enhancer activity": 0.00665, "ubiquitous transcription factors": 0.00665, "dna binding forms": 0.00665, "human embryonic zeta": 0.00665, "human leukemias": 0.00665, "initial interleukin-1beta mrna transcription rate": 0.00665, "nf-kappab activation elicited": 0.00665, "tissue-specific transcription factors": 0.00665, "downregulated nf-kappab activation": 0.00665, "ang ii-induced nf-kappab activation": 0.00665, "dna binding capacity": 0.00665, "abrogate tlr2-mediated nf-kappab activation": 0.00665, "general transcription factors": 0.00665, "cytokine synthesis inhibitory activity": 0.00665, "htlv-1 transformed human": 0.00665, "human peripheral-blood granulocytes": 0.00665, "transcriptional activity relative": 0.00665, "egr-1 transcription factors": 0.00665, "gata-1 dna binding amplifies": 0.00665, "gata transcription factors": 0.00664, "human tfiid polypeptide": 0.00664, "heterogeneous transcription start sites": 0.00664, "saa promoter sequence": 0.00664, "blocking nuclear factor": 0.00664, "cd40-mediated nf-kappab activation": 0.00664, "naive human": 0.00664, "human progenitors": 0.00664, "-mediated nf-kappab activation": 0.00664, "early transient activation": 0.00664, "preferential gas-like dna binding patterns": 0.00664, "mhc class ii transcription": 0.00664, "human gm-csf": 0.00663, "binding sites similar": 0.00663, "apoptotic human vsmcs": 0.00663, "allergen-specific human helper": 0.00663, "nf-kappab dna-binding activity": 0.00663, "human gamma-globin chains": 0.00663, "lps initiate monocyte activation": 0.00663, "promoter sequence": 0.00663, "rantes promoter region": 0.00663, "unique activation signals": 0.00663, "mimics human apl": 0.00663, "human intestinal xenografts": 0.00663, "putative hormone binding domain": 0.00663, "nuclear proteins required": 0.00663, "human donors": 0.00663, "pma-activated human pbl": 0.00663, "human t-cells": 0.00663, "e2f transcriptional activity include": 0.00662, "human genome": 0.00662, "inhibit activation mediated": 0.00662, "human c-rel": 0.00662, "human cdnas": 0.00662, "multiple traf binding sites": 0.00662, "human umbilical cord": 0.00662, "human granulocyte-macrophage csf": 0.00662, "substantial kappa b-binding activity": 0.00662, "high-level nf-kappab activation": 0.00662, "human tuberculosis": 0.00662, "h2o2-induced nf-kappab activation": 0.00662, "ltr transcriptional activity": 0.00661, "human spleen": 0.00661, "human ciita": 0.00661, "nuclear proteins suggesting": 0.00661, "c-myb transcription factors": 0.00661, "human b-lymphocyte precursors": 0.00661, "regulate e2f transcriptional activity": 0.00661, "transcription analysis": 0.00661, "multiple traf3 binding sites": 0.00661, "human organ": 0.00661, "transcription factors c-myb": 0.00661, "transcription factors participate": 0.00661, "regulates dna binding": 0.00661, "pebp2 alpha/aml-1 transcription factors": 0.0066, "transformed human": 0.0066, "5-lox-dependent nf-kappab activation": 0.0066, "il-13 receptor complex": 0.0066, "cocl2-induced nf-kappab activation": 0.0066, "nuclear factor x2": 0.0066, "pertussis toxin blocked fmlp-induced activation": 0.0066, "lymphoid-specific nuclear factor": 0.0066, "selected human": 0.0066, "stress activation pathways": 0.0066, "multiple binding sites": 0.0066, "nuclear factor stat-1": 0.0066, "resting human tonsillar": 0.0066, "human proteasome": 0.0066, "human homologue": 0.0066, "human helper": 0.0066, "promoter region": 0.0066, "oxidant-induced nf-kappab activation": 0.0066, "-inducible nuclear factor": 0.0066, "apoptotic human": 0.0066, "tcr-regulated nuclear factor": 0.00659, "inhibits pma-stimulated activation": 0.00659, "human b-": 0.00659, "human resting": 0.00659, "human thymus lobules": 0.00659, "human raji": 0.00659, "human homolog baf155": 0.00659, "human adenosine deaminase": 0.00659, "human il-5": 0.00659, "drug inhibits isomerase activity": 0.00659, "human tsp": 0.00659, "sequence-specific transcription factors": 0.00659, "cni-1493 inhibits monocyte/macrophage tumor necrosis factor": 0.00659, "nfat dna binding": 0.00659, "nf-kappab activation": 0.00659, "human brain": 0.00659, "human lcr hss": 0.00659, "raji human": 0.00659, "resting human": 0.00659, "human monoamine oxidase": 0.00659, "quiescent human b-lymphocytes": 0.00658, "receptor signaling pathways involved": 0.00658, "human thymus": 0.00658, "nuclear receptor superfamily responsible": 0.00658, "transcription start sites": 0.00658, "transcription signaling pathways": 0.00658, "lps-induced transcription factors": 0.00658, "stimulate octamer-dependent enhancer activity": 0.00658, "clonal human": 0.00658, "human umbilical vein ecs": 0.00658, "upregulate nf-kappa b1 transcription": 0.00658, "nuclear factor nf-gm2": 0.00658, "stat3 transcriptional activity": 0.00658, "nuclear proteins involved": 0.00658, "viral activation process": 0.00658, "increase latent proviral transcription": 0.00658, "tobacco smoke induces coordinate activation": 0.00658, "human eosinophils": 0.00658, "transcription factors ap1": 0.00658, "human hepatitis": 0.00658, "human cmv": 0.00658, "ap1 transcription factors": 0.00658, "human th1": 0.00658, "astrocyte-derived kappa b-binding activity": 0.00658, "nuclear factor ms-2": 0.00657, "human homolog": 0.00657, "t-cell activation identification": 0.00657, "/fk506-sensitive nuclear factor": 0.00657, "thrombin induced binding": 0.00657, "nf-e2 transcription factors": 0.00657, "human skin cancers": 0.00657, "kappa b-binding activity": 0.00657, "cd2 + cd28 activation": 0.00657, "human b-cells": 0.00657, "protect human": 0.00657, "nuclear factor kappa-b": 0.00657, "activated transcription initiation": 0.00657, "tyloxapol inhibits activation": 0.00657, "human cd34+ hpc": 0.00656, "primary tcr activation": 0.00656, "human umbilical venous": 0.00656, "inhibits activation": 0.00656, "age ] binding": 0.00656, "ppargamma activation induces": 0.00656, "human glial astrocytes": 0.00656, "trimester human pregnancies": 0.00656, "nuclear factor": 0.00656, "human apl": 0.00656, "nfat transcriptional activity": 0.00656, "cd8+ t-cell activation": 0.00656, "human bcl6": 0.00656, "respective transcription factors": 0.00655, "human ptf": 0.00655, "t-cell-specific transcription factors": 0.00655, "human prl": 0.00655, "human arteritis-scid chimeras": 0.00655, "enriched human cd34+": 0.00655, "hiv-1 activation": 0.00655, "phoq [ membrane sensor kinase ]": 0.00655, "human aml1": 0.00655, "nf-at binding sites": 0.00655, "17-bp serum response factor": 0.00655, "natural calcineurin docking site increased": 0.00655, "t3 activated caii transcription": 0.00655, "octamer-binding transcription factors": 0.00655, "receptor complex relies": 0.00655, "putative pu.1 binding sites": 0.00654, "human cd14": 0.00654, "nuclear matrix-associated site iv": 0.00654, "kappa b-like activity": 0.00654, "receptor tyrosine kinase c-erbb": 0.00654, "megakaryocytic transcription factors": 0.00654, "human t-": 0.00654, "nm23 genes encode proteins": 0.00654, "neutralizing anti-tumor necrosis factor alpha": 0.00654, "cd40-positive immunogenic human mms": 0.00654, "xpd genes encode proteins": 0.00654, "maximal activity observed": 0.00654, "transcription factors ap-2": 0.00654, "human cd34": 0.00654, "optimized cell-free rna transcription assay": 0.00654, "serum response factor": 0.00654, "maximal enhancer activity": 0.00654, "cd3-t-cell receptor complex": 0.00654, "oct2 transcription factors": 0.00653, "induce stat6 activation": 0.00653, "lineage-specific transcription factors": 0.00653, "initiating t-cell activation": 0.00653, "inducible transcriptional activity": 0.00653, "human atherosclerosis": 0.00653, "human toll-like receptor-2": 0.00653, "human erythrocytes": 0.00653, "cellular activation": 0.00653, "lps-mediated nuclear binding": 0.00653, "human pathology": 0.00653, "lineage-restricted transcription factors": 0.00653, "rel-related transcription factors": 0.00653, "specific antigen recognition induced hiv ltr transactivation": 0.00653, "transcription factors belonging": 0.00653, "lymphocyte-specific transcription factors": 0.00652, "transcription factors ap2": 0.00652, "genes encode proteins": 0.00652, "vitro binding studies demonstrated": 0.00652, "transcription factors usf1": 0.00652, "cytokine-stimulated transcription factors": 0.00652, "ets-related transcription factors": 0.00652, "eukaryotic transcription factors": 0.00652, "human pbmcs": 0.00652, "bipartite human interleukin-4": 0.00652, "transcription factors c/ebpbeta": 0.00652, "il-2 promoter-driven transcription stimulated": 0.00652, "gp120-stimulated human astrocytes": 0.00652, "receptor complex": 0.00652, "transcriptional repressor activity": 0.00652, "csa-sensitive transcription factors": 0.00652, "human reticulocyte-type 15-lipoxygenase": 0.00652, "human tonsils": 0.00652, "transcription factors egr1": 0.00652, "human keratinocyte pcd/dcoh": 0.00652, "human tcf-1": 0.00652, "induced stat/dna binding": 0.00652, "human cytomegalovirus": 0.00652, "small nuclear rna genes": 0.00652, "human aging": 0.00652, "rna polymerase ii -and rna polymerase iii-transcribed mammalian small nuclear rna": 0.00652, "maturing human monocyte-derived": 0.00651, "human papillomavirus e6": 0.00651, "gst-tax m32 activation mutant": 0.00651, "tcr alpha enhancer complex reconstituted": 0.00651, "hematopoietic-specific transcription factors": 0.00651, "transcription factors rfx1": 0.00651, "mitogen-inducible transcription factors": 0.00651, "creb/atf transcription factors": 0.00651, "t-cell receptor alpha": 0.00651, "human burkitt": 0.00651, "il-2 activation": 0.00651, "human pmn": 0.00651, "human megakaryocytes": 0.00651, "optimized rna transcription assay": 0.00651, "specific proteolytic activity": 0.00651, "human antiviral": 0.00651, "bzip transcription factors": 0.00651, "human cd86": 0.00651, "human embryonic/fetal hematopoiesis": 0.00651, "growth factor deprivation apoptosis": 0.00651, "glucocorticoid receptor messenger ribonucleic acid": 0.00651, "tumor necrosis factor-induced nf-kappab binding": 0.00651, "transcription factors creb/atf": 0.00651, "rel/nf-kappab transcription factors": 0.00651, "transcription factors atf-1": 0.00651, "human ramos": 0.00651, "transcription factors stat1alpha": 0.00651, "mzf1 transcription factors": 0.0065, "differentiating human": 0.0065, "human bob.1/obf.1": 0.0065, "human blood-derived mo": 0.0065, "human antigen-specific": 0.0065, "induces dna-binding activity": 0.0065, "growth factor receptors": 0.0065, "uncharacterized transcription factors": 0.0065, "phorbol ester activation": 0.0065, "myogenic transcription factors": 0.0065, "hiv-infected human": 0.0065, "human endometrium": 0.0065, "human hematopoiesis": 0.0065, "/rel transcription factors": 0.0065, "specific transcriptional regulatory proteins": 0.0065, "human cd80": 0.0065, "cell-expressed transcription factors": 0.0065, "human counterpart": 0.0065, "human g-csfr": 0.0065, "human gata-3": 0.0065, "human ecs": 0.0065, "nfkb-like transcription factors": 0.0065, "synergizing transcription factors": 0.0065, "human glioblastoma": 0.0065, "cell-specific transcriptional activity": 0.0065, "human chromosomes": 0.0065, "transcription factors pat": 0.0065, "stat-related transcription factors": 0.0065, "human pcd/dcoh": 0.0065, "transcription factors ctf/nf-1": 0.0065, "invertebrate transcription factors": 0.0065, "human interleukin-4": 0.0065, "endogenous thyroid hormone receptor alpha": 0.0065, "human cancers": 0.0065, "pre-bound transcription factors": 0.0065, "host-cell transcription factors": 0.0065, "anti-onco-genic transcription factors": 0.0065, "nf-kappab-like transcription factors": 0.0065, "antigen-specific human": 0.0065, "human equivalent": 0.00649, "human cleo": 0.00649, "growth factor stimulation": 0.00649, "glucocorticoid receptor sites": 0.00649, "human csf-1": 0.00649, "hormone binding domain variants": 0.00649, "t-cell activation determines": 0.00649, "putative ets binding sites": 0.00649, "do- human": 0.00649, "rb inhibited elf-1-dependent transcription": 0.00649, "consensus binding sites": 0.00649, "dna binding specificity": 0.00649, "human il-10r": 0.00649, "human phagocytes": 0.00649, "human germ-line": 0.00649, "human mzf-1": 0.00649, "human hsf1": 0.00649, "ebv-transformed human": 0.00649, "il-2r alpha transcription": 0.00649, "human zeta": 0.00649, "tumour necrosis factor alpha": 0.00649, "scf induces activation": 0.00649, "human chr": 0.00649, "human osteosarcoma": 0.00649, "transcription factors": 0.00649, "binding consensus sites": 0.00649, "human toll": 0.00649, "human interleukin-6": 0.00648, "nuclear receptor occupancy correlates": 0.00648, "human allergen-specific": 0.00648, "human rbcs": 0.00648, "human vacuolar": 0.00648, "attenuated enhancer activity": 0.00648, "human fra-1": 0.00648, "human interleukin-3": 0.00648, "human interleukin-5": 0.00648, "increased [ ca2+ ]": 0.00648, "human placentae": 0.00648, "ligand activation": 0.00648, "phorbol myristate acetate-mediated activation": 0.00648, "dna binding subunits": 0.00648, "human monocytes/macrophages": 0.00648, "thyroid hormone receptors form distinct nuclear protein-dependent": 0.00648, "senescent human": 0.00648, "human partners": 0.00648, "human papillomaviruses": 0.00648, "subsequent transcriptional activity": 0.00648, "functional sp1 binding elements": 0.00648, "human retrovirus": 0.00648, "strong transcriptional activity": 0.00648, "-specific human": 0.00648, "human papillomavirus-": 0.00648, "human sle": 0.00648, "express nf-kappa b-inducible early genes": 0.00648, "human neoplasia": 0.00647, "human gammaherpesvirus": 0.00647, "human granzyme": 0.00647, "antigen-activated human": 0.00647, "human gata-4": 0.00647, "t-cell-receptor-mediated t-cell activation": 0.00647, "human atheroma": 0.00647, "human thrombospondin": 0.00647, "human b-lcl": 0.00647, "coinfected human": 0.00647, "human interleukin-12": 0.00647, "creb dna binding": 0.00647, "ciita mrna transcription": 0.00647, "human hss": 0.00647, "oct-1 dna binding": 0.00647, "human x-scid": 0.00647, "virus-infected human": 0.00647, "human neonates": 0.00647, "human adenoviruses": 0.00647, "human pbl-t": 0.00647, "fetal/neonatal t-cell activation": 0.00647, "virus-uninfected human": 0.00647, "human ccr-4": 0.00647, "-like promoter element": 0.00647, "tcr-directed t-cell activation": 0.00647, "human intestine": 0.00647, "anti-cd3-activated human": 0.00647, "human osteocalcin": 0.00647, "human cd40-activated": 0.00647, "human carboxylesterase": 0.00647, "antigen-driven t-cell activation": 0.00647, "human gamma-herpesvirus": 0.00647, "human autosome": 0.00647, "induces activation": 0.00647, "human rar-alpha": 0.00647, "human il-9ralpha": 0.00647, "tcr mediated activation": 0.00647, "non-antigen-selected human": 0.00647, "human prointerleukin": 0.00647, "human bruton": 0.00647, "human p75tnf-r": 0.00647, "human tonsillar": 0.00647, "minimal dna sequence required": 0.00647, "cd40-stimulated human": 0.00647, "htlv-1-infected human": 0.00647, "human epsilon-": 0.00647, "human mzf-2": 0.00647, "selective dna binding": 0.00647, "human cd37": 0.00647, "human mcm5": 0.00647, "nontransformed human": 0.00647, "human csf-1r": 0.00647, "th0-type human": 0.00647, "cd40-activated human": 0.00647, "human ehrlichiosis": 0.00647, "tax-transfected human": 0.00647, "cyclosporin-sensitive promoter element": 0.00646, "nf-at/ap-1-binding promoter element": 0.00646, "human lh-2": 0.00646, "pivotal promoter element": 0.00646, "hmrp8 promoter element": 0.00646, "cd3 cross-linking increased binding": 0.00646, "human baf170": 0.00646, "il-2 receptor beta chain": 0.00646, "human pro-interleukin": 0.00646, "bronchial asthma ] [ glucocorticoid receptors": 0.00646, "human herpesvirus-6": 0.00646, "human abf-1": 0.00646, "dna binding characteristics": 0.00646, "human tafii": 0.00646, "ebv-positive tumour tissues constitutively expressed ebv nuclear antigen": 0.00645, "t-cell activation": 0.00645, "normal ltr transcription": 0.00645, "hirak enhanced il-1-stimulated activation": 0.00645, "signaling molecules t-cell receptor": 0.00645, "human": 0.00645, "hiv-1 ltr activity": 0.00645, "promoter element": 0.00645, "il-4 receptor alpha-chain cytoplasmic domain": 0.00645, "major histocompatibility complex class ii transactivator constructs lacking": 0.00644, "transforming growth factor beta": 0.00644, "blocks transcriptional activity": 0.00644, "dexamethasone binding sites": 0.00644, "thp inhibited transcription": 0.00644, "mip-1 alpha transcription": 0.00643, "augmented transcriptional activity": 0.00643, "blocked activation": 0.00643, "constitutive complex termed complex": 0.00643, "specific isozyme activity": 0.00643, "il-4 binding sites": 0.00643, "ap-1 binding sites": 0.00643, "il-4 stat activation cycle": 0.00643, "ebv nuclear proteins": 0.00643, "activated dra transcription": 0.00642, "induce nf-kappab-dependent activation": 0.00642, "activation signals": 0.00642, "nitric oxide decreases cytokine-induced endothelial activation": 0.00642, "dna polymerase-associated processivity factor pcna": 0.00642, "defective dna binding": 0.00642, "proximal sequence element": 0.00641, "] pyrilamine binding": 0.00641, "platelet aggregation affected thrombin-induced activation": 0.00641, "weak dna binding": 0.00641, "inhibited il-2 production induced": 0.00641, "similar molecular mechanisms underlie transcription": 0.00641, "tfiid-dependent rna polymerase ii transcription systems": 0.00641, "activate ec activation": 0.00641, "specific binding interactions": 0.00641, "nuclear regulatory proteins": 0.00641, "distinct activation": 0.00641, "dna binding specificities": 0.00641, "class ii mhc x1 box dna-binding proteins": 0.0064, "genes encoding hepatocyte nuclear factor-3alpha": 0.0064, "enhanced activation": 0.0064, "reduced nf-at activity": 0.0064, "c-fos early response genes": 0.0064, "consensus kappab binding motif": 0.0064, "dna band-shift analysis reveals nf-kappa": 0.0064, "akv mlv transcriptional activity": 0.0064, "hiv-tf1-binding site induced": 0.00639, "high-level enhancer activity": 0.00639, "activation signal": 0.00639, "nuclear t3 receptor": 0.00639, "dna binding nfkb2": 0.00639, "purified viral ligand binding": 0.00639, "soluble tnf-alpha receptor type ii": 0.00639, "cn activity observed": 0.00639, "intracellular cyclic amp inhibits nf-kappab-mediated transcription": 0.00639, "tcr alpha control region": 0.00639, "heparin-binding epidermal growth factor-like growth factor": 0.00638, "sequence-specific dna binding": 0.00638, "rna polymerase ii transcription systems": 0.00638, "-3 dna binding": 0.00638, "bp lps response element": 0.00638, "activated rare-dependent transcription": 0.00637, "gata-3-dependent enhancer activity": 0.00637, "microb-dependent enhancer activity": 0.00637, "activation potential": 0.00637, "exogenous il-2 growth factor": 0.00637, "activated stat proteins form homo-": 0.00637, "r-dependent enhancer activity": 0.00637, "il-2 induced nuclear translocation": 0.00637, "suggesting activation": 0.00637, "transcription specific differences": 0.00637, "related retinoic acid receptor": 0.00637, "transcription inhibited": 0.00637, "nf-kappab transcriptional factor": 0.00637, "induce activation": 0.00637, "type-ii estrogen binding sites": 0.00636, "signaling pathway molecule analysis": 0.00636, "heterologous activation regions": 0.00636, "enhancer activity": 0.00636, "putative steroid binding domain": 0.00636, "sle disease activity index": 0.00636, "interleukin-2 receptor alpha chain": 0.00636, "receptor rna increased": 0.00636, "kappa b/rel family proteins": 0.00636, "long terminal repeat-driven secreted alkaline phosphatase activity": 0.00636, "t-cell growth factor interleukin": 0.00636, "] -dexamethasone binding": 0.00635, "unknown nuclear proteins bound": 0.00635, "sustained stat3 activation suggests": 0.00635, "nf-kappab complex induced": 0.00635, "activated transcription": 0.00635, "transcription activated": 0.00635, "nf-kappab-driven reporter activation": 0.00634, "sp1 binding sites": 0.00634, "optimal transcriptional activity": 0.00634, "signaling pathway molecules janus kinase": 0.00634, "vitd3 receptors [ retinoic acid receptors": 0.00634, "additional nf-il6 binding sites": 0.00634, "transcription regulatory function": 0.00634, "ifn-gamma treatment induced increased occupancy": 0.00634, "class ii transcription": 0.00634, "activation involved": 0.00634, "tcr alpha enhancer complex": 0.00634, "ebv [ epstein-barr early region": 0.00633, "complex upstream element": 0.00633, "reverse transcription pcr assay": 0.00633, "double nf-kappab site identified": 0.00633, "hiv ltr activation": 0.00633, "nuclear proteins isolated": 0.00633, "specific aldosterone binding indicating": 0.00633, "ets transcription factor/oncoprotein family": 0.00633, "lps-stimulated transcriptional activity": 0.00632, "efficient ebv activation": 0.00632, "inflammatory response increased levels": 0.00632, "e2f transcriptional activity": 0.00632, "reduced pma/ca2+ activation": 0.00632, "putative binding sites": 0.00632, "estrogen binding sites": 0.00632, "low level activity": 0.00632, "nuclear receptor superfamily": 0.00632, "activation and/or translocation": 0.00632, "ap-2 dna binding": 0.00632, "conserved sequence element": 0.00632, "monitor disease activity": 0.00632, "inhibited il-2 promoter": 0.00632, "gamma inhibitory activity suggests": 0.00632, "bed rest specific glucocorticoid binding": 0.00631, "cooperative dna binding": 0.00631, "mlv transcriptional activity": 0.00631, "age ] [ effect": 0.00631, "stat3 binding sites": 0.00631, "rapid activation suggests": 0.00631, "cytokines [ granulocyte/macrophage colony-stimulating factor": 0.00631, "nfat-1 decreased activation": 0.00631, "reduced il-9-induced activation": 0.00631, "mrna transcription": 0.00631, "individual binding sites reveals": 0.00631, "dna binding capability": 0.0063, "downstream activation events": 0.0063, "creb proteins bind dna": 0.0063, "normal b-cell-specific transcription": 0.0063, "reduced activation": 0.0063, "nuclear receptor ppargamma": 0.0063, "kappa immunoglobulin intron enhancer binds inducible factors": 0.0063, "shows increased binding": 0.0063, "po-b dna binding": 0.00629, "e2f-mediated transcriptional activity": 0.00629, "gre-specific dna binding": 0.00629, "increase hiv-1 steady-state mrna levels": 0.00629, "decreased transactivation activity": 0.00629, "nfat binding sites": 0.00629, "include binding sites": 0.00628, "transcription levels": 0.00628, "-kappab binding sites conserved": 0.00628, "conserved traf3 binding sites": 0.00628, "cbf beta required binding": 0.00628, "binding dna": 0.00628, "transcriptional stimulatory activity": 0.00628, "kappab-dependent transcriptional activity": 0.00628, "hormone binding domain": 0.00628, "nuclear export receptor crm1": 0.00628, "dna binding": 0.00628, "glucocorticoid receptor mrna": 0.00628, "functional activation": 0.00627, "stimulates kappa b-directed transcription": 0.00627, "early activation": 0.00627, "sle disease activity": 0.00627, "cord lymphocyte activation exhibits": 0.00627, "conserved binding sites": 0.00626, "stimulate kappa b-directed transcription": 0.00626, "critical il-2 dna enhancer elements": 0.00626, "regulate hiv activation": 0.00626, "diminished nf-kappab activity": 0.00626, "promiscuous transcriptional activity": 0.00626, "transcriptional transrepressive activity": 0.00626, "consensus binding motif": 0.00626, "ap-1-dependent transcriptional activity": 0.00626, "camp-regulated transcriptional activity": 0.00626, "comments ] activated platelets induce monocyte chemotactic protein-1 secretion": 0.00625, "characterized c. pneumoniae-mediated activation": 0.00625, "glucocorticoid receptor levels": 0.00625, "transcriptional activity": 0.00625, "activation inducer molecule": 0.00625, "retinoic acid receptor action": 0.00625, "tandem gata binding sites": 0.00625, "class ii major histocompatibility complex promoters plays": 0.00624, "disease activity": 0.00624, "core traf binding motif": 0.00624, "steroid hormone activation": 0.00624, "negative glucocorticoid response element": 0.00624, "thyroid hormone receptor alpha": 0.00624, "bcl-2 regulates nfat-mediated activation": 0.00624, "activate hiv-1 transcription": 0.00624, "single major transcriptional start site": 0.00624, "activation domains restored zebra": 0.00624, "primary tcr-mediated activation": 0.00623, "surfactants decreased activation": 0.00623, "activation responses": 0.00623, "synthetic peptides identified major phosphorylation sites": 0.00623, "subsequent proliferation activity": 0.00623, "single egr1 binding motif": 0.00623, "rna polymerase ii transcription": 0.00623, "demonstrate activation": 0.00623, "activation pathways": 0.00623, "c/ebp binding sites": 0.00622, "e2f dna site": 0.00622, "cis-acting dna site": 0.00622, "core binding motif": 0.00622, "octamer binding sites": 0.00622, "reverse lps-mediated endothelial activation": 0.00622, "decreased activation": 0.00622, "nuclear proteins bound": 0.00622, "roi-dependent nf-kappab mediated transcription": 0.00622, "gamma activated site": 0.00621, "il-4 receptor subunits alpha": 0.00621, "nuclear receptor": 0.00621, "il-2 receptor signal transduction": 0.0062, "monocyte tf activation occurs": 0.0062, "dna sequence motifs": 0.0062, "specific glucocorticoid binding": 0.0062, "high ligand binding affinity": 0.0062, "intact nf-kappab binding sequences": 0.0062, "octamer binding factors": 0.00619, "nf-kappa b. platelet-activating factor": 0.00619, "pu.1 binding sites": 0.00619, "tandem ap1 binding sites": 0.00619, "acidic activation domains": 0.00619, "t-lymphocyte activation mechanisms": 0.00619, "defined interferon stimulated response element": 0.00619, "tyrosine phosphatase activity": 0.00619, "heterologous activation domains": 0.00619, "il-2r alpha promoter constructs": 0.00619, "intact mzf-1 binding sites": 0.00618, "nk cell-mediated ec activation": 0.00618, "il-7 receptor alpha chain": 0.00618, "nf-at activity mediated": 0.00618, "vitro activation": 0.00618, "lps activation": 0.00617, "subunit binding domain": 0.00617, "primary activation": 0.00617, "-mediated b-cell activation": 0.00617, "interleukin-7 receptor alpha chain": 0.00617, "ifns inhibit il-4-induced activation": 0.00617, "ets-1 binding sites": 0.00617, "interleukin-4 receptor alpha chain": 0.00617, "tumor proliferative activity": 0.00616, "negative transcription regulation": 0.00616, "inverted gata binding sites": 0.00616, "putative nf-kappa b-binding site": 0.00616, "lps stimulated ap-1-mediated transcription": 0.00616, "increased binding efficiency": 0.00616, "direct pkc activation": 0.00616, "similar activation": 0.00616, "suppressed ifn-gamma-induced stat activation": 0.00615, "t-cell proliferative activity": 0.00615, "regulates nfat activation": 0.00615, "ets binding sites": 0.00615, "viral regulatory proteins expressed": 0.00615, "differential activation properties": 0.00615, "inhibit ras-induced ap1 activation": 0.00615, "genes encoding general initiation factors": 0.00615, "ikaros binding sites": 0.00615, "cytokine activation": 0.00615, "dominant-negative rxr-retinoic acid receptor alpha403 heterodimers": 0.00615, "x-ray irradiation up-regulates hiv-1 ltr transcription": 0.00615, "positive regulatory activity": 0.00614, "increased binding": 0.00614, "stat binding factors": 0.00614, "ltr activation remains obscure": 0.00614, "map kinase signal transduction pathway consisting": 0.00614, "dna-protein binding analysis": 0.00614, "sp1- mediated activation": 0.00614, "nf-kappa b-regulated inflammatory cytokine genes": 0.00613, "low shear-induced activation": 0.00613, "high-affinity ibr/f binding sites": 0.00613, "ig-mediated b-cell activation": 0.00613, "nf-kappab activity": 0.00613, "block stat3 activation": 0.00613, "enhanced cat activity": 0.00613, "jnk/sapk activation upstream": 0.00613, "gata binding sites": 0.00613, "inhibit wild-type rev activity": 0.00612, "mineralocorticoid binding sites grows": 0.00612, "increase [ ca2+ ]": 0.00612, "receptor alpha chain": 0.00612, "murine macrophage 12/15-lipoxygenase activity": 0.00612, "vitro transcription assays": 0.00612, "stat3 binding motif ylpq": 0.00612, "alveolar macrophage nuclear proteins": 0.00612, "signaling pathway induced": 0.00612, "intronic enhancer stimulates transcription": 0.00612, "b-cell activation": 0.00612, "increases viral transcription initiation": 0.00611, "block nfat activation": 0.00611, "ap-1 factor family": 0.00611, "sea urchin binding sites": 0.00611, "specific intracellular signaling pathways mediate specific events": 0.00611, "amino acid sequence information derived": 0.00611, "sp1 binding motif": 0.00611, "adjacent binding sites": 0.00611, "augment nf-at activation": 0.00611, "mineralocorticoid binding sites": 0.0061, "htlv-i tax activation": 0.0061, "elevated cyclic amp inhibits nf-kappab-mediated transcription": 0.0061, "vitro binding assay": 0.0061, "high-affinity binding sites": 0.0061, "interferons inhibit activation": 0.0061, "important transcriptional factor": 0.0061, "augment lymphocyte activation": 0.0061, "chimeric hlf proteins displayed transcriptional activator properties": 0.00609, "radio-ligand binding analysis": 0.00609, "rb binding sites": 0.00609, "heterologous thymidine kinase promoter failed": 0.00609, "fos early response genes": 0.00609, "receptor initiates phosphatidic acid dependent signalling": 0.00609, "activation involves calcium mobilization": 0.00608, "increased nf-kappab nuclear translocation": 0.00608, "chimeric receptor system demonstrated": 0.00608, "site selection analysis": 0.00608, "e47 binding sites": 0.00608, "dna consensus sequence recognized": 0.00607, "cooperative transcription complexes": 0.00607, "reverse transcription polymerase chain reaction amplification technique": 0.00607, "androgen binding sites": 0.00607, "low basal activity": 0.00607, "context-dependent activation domains": 0.00607, "primary amino acid sequence": 0.00607, "octamer independent activation": 0.00607, "244-bp deoxycytidine kinase core promoter": 0.00607, "activation mediated": 0.00607, "nf-at activation": 0.00607, "lymphocyte activation": 0.00606, "untransformed glucocorticoid receptor complexes": 0.00606, "activate nuclear cam kinase ii": 0.00606, "upregulate virus transcription": 0.00606, "sequence analysis reveals putative sp1": 0.00606, "control general octamer site-dependent transcription": 0.00606, "induce nf-kb activity": 0.00606, "dna sequence encoding fkbp": 0.00606, "nuclear transcriptional factors ap-1": 0.00605, "expressed endothelial tethering factor": 0.00605, "limit endothelial activation": 0.00605, "e2f binding sites": 0.00605, "inhibit nfkappab activity correlated": 0.00605, "induces c-jun transcription": 0.00605, "limits endothelial activation": 0.00605, "transcription complexes": 0.00605, "vitro transcription studies": 0.00605, "prevent monocyte activation": 0.00605, "activation domains": 0.00605, "antigen receptor signaling": 0.00605, "inhibit activation": 0.00605, "site specific mutation": 0.00604, "steroid hormone receptor family": 0.00604, "il-2 receptor stimulation": 0.00604, "transcriptional regulatory proteins distinct": 0.00604, "ligand-induced activation events": 0.00604, "induced nuclear nf-kappab": 0.00604, "stat-6 binding sites": 0.00604, "purine-rich binding sites": 0.00604, "normal binding affinity": 0.00604, "proteasome activity results": 0.00604, "process involves activation": 0.00604, "peroxisome-proliferator activated receptor gamma": 0.00604, "calcium dependent activation": 0.00603, "c-jun activation": 0.00603, "lupus express estrogen receptor transcripts similar": 0.00603, "affect glucocorticoid receptor function": 0.00603, "cultured rcc explants inhibit nfkappab activity": 0.00603, "sequence element": 0.00603, "stat6 activation plays": 0.00603, "hgata-3 binding sites": 0.00603, "elf-1 binding sites": 0.00603, "induce mapk activity": 0.00603, "normal vdr-rxr heterodimer binding": 0.00603, "] receptor": 0.00603, "mzf-1 binding sites": 0.00602, "uas1 binding sites": 0.00602, "hr induced c/ebpepsilon mrna levels": 0.00602, "endothelial activation": 0.00602, "peptide binding interactions": 0.00602, "ifn-alpha/b-stimulated early response genes": 0.00602, "hiv-1 nf-kappab site": 0.00602, "enhancer reduces transcription": 0.00602, "mouse mhc class ii genes": 0.00602, "dhea binding sites": 0.00602, "steroid binding domain": 0.00602, "gata- binding sites": 0.00602, "s-adenosylhomocysteine hydrolase inhibits bacterial lipopolysaccharide-induced transcription": 0.00602, "glucocorticoid receptor complexes": 0.00602, "nf-munr binding sites": 0.00601, "mutant erythropoietin receptor signaling": 0.00601, "enhanced asm activity": 0.00601, "gal4 binding sites": 0.00601, "virus transcription": 0.00601, "il-2 alpha genes": 0.00601, "murine kappa light chain enhancer motif": 0.00601, "/il-4ralpha cytokine receptor chimera potentiates allergic airway disease": 0.00601, "low sp1 activity": 0.00601, "binding complexes contained": 0.00601, "early response genes": 0.00601, "palindromic binding sites": 0.00601, "chronic activation": 0.00601, "activate specific genes involved": 0.006, "predicted amino acid sequence suggests": 0.006, "traf binding sites": 0.006, "transglutaminase type ii [ tgase ]": 0.006, "src-family tyrosine kinase genes": 0.006, "putative nuclear targeting sequence": 0.006, "mutant collagenase-1 promoter displayed ap-1 independent pma-mediated transactivation": 0.006, "region contained positive regulatory elements": 0.006, "stimulated ikk-beta activity": 0.006, "tnf-alpha-induced hiv activation": 0.006, "binding sites diminishes": 0.006, "activation phenotype": 0.006, "proliferation activity": 0.006, "il-2 response element": 0.006, "enhanced cytolytic activity": 0.006, "vivo transactivation activity": 0.00599, "monoclonal antibodies [ mabs ]": 0.00599, "induce catalase activity": 0.00599, "sp1/nf-at binding sites": 0.00599, "intact nf-kappa b-binding site": 0.00599, "blocked radiolabeled il-2 binding": 0.00599, "immune response genes": 0.00599, "specific glucocorticoid receptor blocker": 0.00599, "nonoptimal binding sites": 0.00599, "cellular factor required": 0.00599, "ap-1 dna-binding activity": 0.00599, "nonconsensus binding sites": 0.00599, "encompass binding sites": 0.00599, "induce e2f activity": 0.00598, "enhanced chemotactic activity": 0.00598, "c-fos sre binding complexes": 0.00598, "yang-deficiency ] [ glucocorticoid receptors": 0.00598, "phorbol ester response element": 0.00598, "activation events": 0.00598, "il-2r alpha enhancer binds nf-kappa": 0.00598, "binding sites": 0.00598, "lps-inducible factor nf-kappa": 0.00598, "lymphocyte-specific factors binding": 0.00598, "activation markers cd44": 0.00598, "tnf receptor family member": 0.00598, "t-cell receptor stimulation": 0.00598, "activation structure": 0.00597, "octamer-like factors binding": 0.00597, "induce nf-kappab binding": 0.00597, "ap1 activation suggested": 0.00597, "nef downmodulates ltr activation": 0.00597, "low pkc enzymatic activity": 0.00597, "hiv-1 ltr transcription": 0.00597, "ra receptor alpha": 0.00597, "hiv activation": 0.00597, "significant activation": 0.00597, "nf-kappa b-like factor": 0.00597, "determine activation status": 0.00597, "termed early b-cell factor": 0.00597, "sodium salicylate inhibit lps-induced nf-kappa b/c-rel nuclear translocation": 0.00597, "significant anti inflammatory activity": 0.00597, "isre binding factors": 0.00597, "interleukin-10 receptor intracellular domain": 0.00596, "proteasome activation correlated": 0.00596, "tumor necrosis factor alpha-induced degradation": 0.00596, "ap-1 activation": 0.00596, "viral transactivator activity": 0.00596, "enzyme activity mediated": 0.00596, "ccaat-box binding factors": 0.00596, "factor nf-kappa": 0.00596, "-csf receptor alpha subunit": 0.00596, "potential agonistic activity": 0.00596, "weak constitutive activation": 0.00596, "class ii antigen expressing t-cell lines": 0.00595, "major pb1 nuclear protein-binding complex": 0.00595, "nf kappab activation": 0.00595, "binding factors": 0.00595, "binding tpa responsive elements": 0.00595, "interferon affects nuclear proteins": 0.00595, "transcriptional regulatory factor": 0.00595, "factors binding": 0.00595, "p38 mapk activation remain": 0.00595, "major transcriptional initiation site": 0.00595, "exert immune activity": 0.00595, "transcriptional factor activator protein-1": 0.00594, "dna sequence isolated": 0.00594, "receptor alpha subunit": 0.00594, "regulates nf-at activity": 0.00594, "enhanced activity": 0.00594, "high cat activity": 0.00594, "il-2-induced stat3 activation": 0.00594, "high luciferase activity": 0.00594, "activation antigens": 0.00594, "studied activation": 0.00594, "kappa b-related sequence elements": 0.00594, "nuclear stat proteins": 0.00594, "fixed tissue macrophages express detectable hiv proteins": 0.00594, "stat nuclear proteins": 0.00594, "dna-binding factor specific": 0.00594, "dna target sequence": 0.00593, "enhanced hiv transcription": 0.00593, "induce akt/pkb activity": 0.00593, "nf-kappab family proteins": 0.00593, "stat proteins induced": 0.00593, "-independent pi 3-kinase activation": 0.00593, "nuclear proteins capable": 0.00593, "dna-binding complex contained stat1 alpha": 0.00593, "monocyte activation": 0.00592, "kappa b-like sites induced": 0.00592, "vivo activation": 0.00592, "pha-induced kappab-dependent reporter activity": 0.00592, "rapid posttranslational activation": 0.00592, "affected lps-mediated activation": 0.00592, "nf-kappa bp65 binding": 0.00592, "reduced tf activity": 0.00591, "suppressed activation": 0.00591, "alpha chain promoter": 0.00591, "mutants displayed differential activity": 0.00591, "jak/stat activation leads": 0.00591, "purine-rich il-2 promoter elements": 0.00591, "induce hiv enhancer-dependent transcription": 0.00591, "increased nuclear triiodothyronine receptors": 0.00591, "activation state": 0.00591, "tcr activation": 0.0059, "decrease enhancer-mediated activation": 0.0059, "major late promoter [": 0.0059, "il-2 regulates transcription": 0.0059, "jnk activation correlated": 0.0059, "classical thyroid hormone response element": 0.0059, "ras activation combine": 0.0059, "il-10 receptor sites": 0.0059, "estrogen receptor alpha": 0.00589, "agents induce transcription": 0.00589, "box reduced transcription": 0.00589, "ras activation": 0.00589, "increased ip-10 mrna induction": 0.00589, "multimerized short binding motif": 0.00589, "affect rho-induced ap-1 activity": 0.00589, "il-10 inhibits ifn-gamma-induced transcription": 0.00589, "il-1 -and lps-induced nf-kappab-luciferase activity": 0.00589, "activation remains unknown": 0.00589, "val augmented stat6 activation": 0.00589, "platelet activation": 0.00588, "direct activation": 0.00588, "rapid ca2+-mediated activation": 0.00588, "transient activation": 0.00588, "intracellular dioxin receptor mediates signal transduction": 0.00588, "nf-kappab enhancer element activities": 0.00588, "interleukin-2 control transcription": 0.00588, "zta reduced qp activity": 0.00588, "class ii major histocompatibility complex promoters": 0.00588, "consensus dna sequence": 0.00587, "il-2 promoter elements il-2a": 0.00587, "unoccupied receptor sites capable": 0.00587, "rapid activation": 0.00587, "reporter activity": 0.00587, "binds ig heavy chain switch region sequences": 0.00587, "hematopoietic growth factor release": 0.00587, "major mhc class ii genes": 0.00587, "ltr activation": 0.00587, "astrocytes regulates nf kappab activity": 0.00587, "constitutive dna-binding activity": 0.00587, "pma activation": 0.00587, "factor activated": 0.00587, "tar independent activation": 0.00586, "regulate il-2 transcription": 0.00586, "nfat dna-binding activity": 0.00586, "constitutive pag activation": 0.00586, "important activity": 0.00586, "alpha binding": 0.00586, "increased oestrogen receptor": 0.00586, "-induced fas ligand transcription": 0.00586, "specific dexamethasone binding": 0.00586, "inducible trans activation": 0.00586, "intracellular proteins regulating nf-kappa": 0.00586, "tax activation": 0.00585, "oligomerized nfat-1 binding motif": 0.00585, "bovine colostrum blocks activation": 0.00585, "rho enhances ap-1 activity": 0.00585, "70z/3-mediated nfat activation": 0.00585, "receptor tyrosine phosphorylation": 0.00585, "nuclear nf-at complex": 0.00584, "ifn-gamma activation": 0.00584, "prevents rar activation": 0.00584, "stat3 activation": 0.00584, "reduced activity": 0.00584, "amino-terminal cysteine-rich dna-binding domain lacking obvious sequence similarity": 0.00584, "pharmacology ] [ induction": 0.00584, "pkc activation acting": 0.00584, "tax stimulated transcription": 0.00583, "downstream activation": 0.00583, "constitutive activation": 0.00583, "p95vav-induced nfat activation": 0.00583, "tpl-2-mediated nfat activation": 0.00583, "t-cell antigen receptor engagement": 0.00583, "chloramphenicol acetyltransferase activity mediated": 0.00583, "locus activation": 0.00583, "calcineurin potentiates activation": 0.00583, "common cytokine receptor gamma chain": 0.00583, "cyclic amp-responsive element-dependent activation": 0.00583, "activation correlated": 0.00582, "gm-csf receptor beta common subunit": 0.00582, "steroid/thyroid hormone receptor family": 0.00582, "lymphoid enhancer factor": 0.00582, "stat1 activation": 0.00582, "chimeric receptor kit/il-4r alpha": 0.00582, "enhances activation": 0.00582, "stimulate nf-at activity": 0.00582, "ap-1 transrepression exhibit antiinflammatory activity": 0.00582, "nfat activation": 0.00582, "huvec nuclear proteins": 0.00582, "major growth factor": 0.00582, "il-2 promoter stimulation": 0.00582, "competitive reverse transcription polymerase chain reaction": 0.00582, "intracellular proteins increased": 0.00582, "mediate nfat activity": 0.00581, "block htoll-induced activation": 0.00581, "functional activity": 0.00581, "displayed impaired nfkappab activity prior": 0.00581, "low proliferative activity": 0.00581, "leukemia-specific retinoic acid receptor pml-rar": 0.0058, "cytokine modulating activity": 0.0058, "abrogated tax1-mediated activation": 0.0058, "block activation": 0.0058, "activation process": 0.0058, "constitutively activated receptor": 0.0058, "glucocorticoid response element": 0.0058, "differentiation inhibitory factor": 0.0058, "rap binding domain": 0.0058, "leucocytic estrogen receptor levels": 0.0058, "significant antimicrovascular ec activity": 0.0058, "nf kappa b2 site": 0.0058, "interleukin-2 receptor alpha": 0.0058, "specific promoter sequences": 0.0058, "activating protein-1 activation": 0.00579, "regulate activation": 0.00579, "major histocompatibility complex class ii combined immunodeficiency": 0.00579, "abnormal nfkappab activation": 0.00579, "fenofibrate inhibits vcam-1 transcription": 0.00579, "hiv long terminal repeat-driven transcription": 0.00579, "inducible activation": 0.00579, "major transcriptional start site": 0.00579, "pkc activation": 0.00579, "blocks erk activation": 0.00579, "tnf alpha genes suggests": 0.00579, "binding domain": 0.00579, "ec activation": 0.00578, "cellular transactivation factor nf-kb": 0.00578, "activation dependent": 0.00578, "c-fos serum response element": 0.00578, "glucocorticoid receptor regulates leukocyte adhesion": 0.00578, "nuclear localization sequence": 0.00578, "15-lo promoter dna": 0.00578, "egr1 binding motif": 0.00578, "nf kappa b1 site": 0.00577, "inhibit il-4/il-13-induced stat6 activity": 0.00577, "cytokines activate transcription": 0.00577, "interferon-gamma activated site": 0.00577, "beta-adrenergic receptor kinase": 0.00577, "high retinoidal activity": 0.00577, "promoter dna": 0.00577, "jak3-mediated type ii signaling pathway": 0.00577, "freshly isolated monocytes constitutively expressed high levels": 0.00577, "direct transcriptional target genes regulated": 0.00577, "control tal1 transcription": 0.00577, "fas ligand transcription": 0.00576, "comments ] mhc class ii signaling": 0.00576, "non-erythroid nuclear proteins": 0.00576, "activation responsible": 0.00576, "multiple response region": 0.00576, "specific nuclear factors": 0.00576, "cell-specific activation": 0.00576, "retinoic acid receptor": 0.00576, "pi 3-kinase activation": 0.00576, "estrogen binding assay": 0.00576, "high activity": 0.00576, "interferon gamma- induced genes": 0.00576, "binding motif": 0.00575, "inhibit stat6 activity": 0.00575, "cd40 activation": 0.00575, "dr alpha proximal promoter": 0.00575, "lymphocyte growth factor": 0.00575, "nuclear proteins": 0.00575, "mediates cd16-induced activation": 0.00575, "epsilon gas dna-protein binding complexes": 0.00575, "heterologous thymidine kinase promoter": 0.00575, "moderate ubiquitous activation": 0.00575, "hiv-1 long terminal repeat promoter": 0.00575, "immediate-early genes induced": 0.00575, "binds egr family proteins": 0.00575, "transcriptional factor c-fos/c-jun ap-1": 0.00575, "common dna sequence": 0.00574, "stimulated htlv-i transcription": 0.00574, "[ estrogen receptor content": 0.00574, "amino acid sequence comparison shows": 0.00574, "mononuclear phagocyte activation": 0.00574, "leukocyte activation": 0.00574, "activation-dependent fas promoter induction": 0.00574, "th2 ] [ molecular mechanism": 0.00574, "consequent differential activation": 0.00574, "strong activation": 0.00574, "subsequent activation": 0.00574, "tat activation": 0.00574, "distinct sequence motif": 0.00574, "transcription mechanism": 0.00574, "erythroid-specific hypersensitive site hs2 enhancer regulates": 0.00574, "efficient hiv-1 transcription": 0.00574, "reverse transcription nested polymerase chain reaction": 0.00574, "normal receptor affinity": 0.00574, "thapsigargin induces il-2 receptor alpha-chain": 0.00574, "activation involves": 0.00574, "minimal activation": 0.00574, "involves activation": 0.00574, "-dq beta transcription": 0.00573, "p38 mapk activation": 0.00573, "tcl1 oncogene activation": 0.00573, "anti-cd3 activation": 0.00573, "site alpha": 0.00573, "patients c/ebp beta regulation": 0.00573, "cd28 activation": 0.00573, "transcriptional factor ap-1": 0.00573, "zinc-finger dna-binding transcription activator": 0.00573, "selective dna-binding activity": 0.00573, "calcineurin activation": 0.00573, "stat dna-binding activity": 0.00573, "strong ap-1 activity": 0.00573, "ap-1 transcriptional factor": 0.00573, "promoter elements required": 0.00573, "reconstituted ligand-dependent activation": 0.00572, "specific promoter motifs": 0.00572, "major histocompatibility complex class ii molecules": 0.00572, "smad7 prevent ligand-induced activation": 0.00572, "enhance basal activity": 0.00572, "type ii tax proteins": 0.00572, "pha activation": 0.00572, "sp1 binding elements": 0.00572, "antigen receptor induces": 0.00572, "unique activation": 0.00572, "detectable activation": 0.00572, "-kappa b. activation": 0.00572, "epstein-barr virus binding": 0.00572, "hla dr alpha promoter": 0.00572, "plzf-rar alpha fusion proteins": 0.00572, "reverse transcription polymerase chain reaction": 0.00572, "differential activation": 0.00571, "t-cell antigen receptor": 0.00571, "late activation": 0.00571, "stat5 activation": 0.00571, "transcription initiation sequences": 0.00571, "specific constitutive binding": 0.00571, "macrophage activation": 0.00571, "activation occurs": 0.00571, "down-regulate wild-type ciita activity": 0.00571, "activation pyrrolidine dithiocarbamate": 0.00571, "phorbol ester reduces constitutive nuclear nf kappa": 0.00571, "zeta-globin mrna cap site": 0.00571, "critical serine phosphorylation site": 0.00571, "protease activation": 0.00571, "peroxisome proliferator-activated receptor alpha": 0.00571, "impaired activation": 0.0057, "stat activation": 0.0057, "binding site-specific transcriptional properties": 0.0057, "selective activation": 0.0057, "phop [ transcriptional activator ]": 0.0057, "similar activity": 0.0057, "receptor messenger ribonucleic acid": 0.0057, "precursor activation": 0.0057, "wild-type ciita activity": 0.00569, "glucocorticoid receptor regulation": 0.00569, "alpha b2 proteins bound": 0.00569, "rxr alpha receptor": 0.00569, "require simultaneous activation": 0.00569, "blocked antigen receptor agonism": 0.00569, "plasma sialyltransferase activity": 0.00569, "lps signaling receptor": 0.00569, "long-term activation": 0.00569, "lipoproteins stimulated tlr-dependent transcription": 0.00569, "glucocorticoid receptor beta": 0.00569, "dominant negative activity": 0.00569, "regulates nfat activity": 0.00569, "restored tat-mediated activation": 0.00569, "prior activation": 0.00569, "glucocorticoid receptor-ligand binding studies": 0.00569, "bhlh-pas partner factor arnt expressed": 0.00569, "activated t-cell nuclear extracts": 0.00569, "plasma renin activity": 0.00568, "potent immunosuppressive activity": 0.00568, "represses hiv-1 transcription": 0.00568, "alpha globin regulatory element": 0.00568, "nf- kappab activation": 0.00568, "receptor sites": 0.00568, "-independent activation": 0.00568, "trigger alphaiibbeta3 activation": 0.00568, "peroxisome proliferator activated receptor": 0.00567, "distinct growth factor-regulated signaling pathway": 0.00567, "stat6 activation": 0.00567, "heat activation": 0.00567, "repressed tpa-mediated activation": 0.00567, "plasma activity": 0.00567, "pma-induced jnk activation": 0.00567, "oxidative stress-dependent activation": 0.00567, "potent growth factor": 0.00567, "tumor necrosis factor-alpha [ tnf ]": 0.00567, "low renin activity": 0.00567, "cytokine receptor signaling": 0.00567, "chronic pulmonary heart disease ] [": 0.00567, "hypothalamic-pituitary-adrenal axis activation": 0.00567, "tissue-specific activation": 0.00567, "antigen receptor signals": 0.00567, "proto-oncogene activation": 0.00567, "gamma response region": 0.00567, "thyroid hormone response element": 0.00567, "low activity": 0.00566, "steroid binding assay": 0.00566, "complete activation programme": 0.00566, "il-6 luciferase activity occurs": 0.00566, "blocked il-4-induced germline cepsilon transcription": 0.00566, "interferon-stimulated genes induced": 0.00566, "mhc class ii dra promoter": 0.00566, "inhibit nf-kappab binding": 0.00566, "hiv-1 transcription depends": 0.00566, "immunoglobulin heavy-chain enhancer mu e1 site": 0.00566, "factor family": 0.00566, "marked enzymatic activation": 0.00566, "inhibit gsk-3beta activity": 0.00566, "nephrotic syndrome ] [ hormonal interactions": 0.00566, "pyruvate kinase erythroid-specific promoter": 0.00566, "tumor necrosis factor-alpha [ tnf-alpha ]": 0.00565, "calcineurin phosphatase activity": 0.00565, "potent transcription activator": 0.00565, "genes induced": 0.00565, "activation-induced p65/p50 nf-kappab heterodimer binding": 0.00565, "dna response elements": 0.00565, "proteasome activation": 0.00565, "reduced gr binding affinity": 0.00565, "nf-kappab transcription": 0.00565, "persistent activation": 0.00565, "nf-kb activation": 0.00565, "prevent inappropriate activation": 0.00565, "fibrinogen triggers activation": 0.00565, "abnormal activation": 0.00565, "jak3 activation": 0.00565, "lps response element": 0.00565, "core recognition binding motifs": 0.00565, "granulocyte-colony-stimulating factor [": 0.00565, "initial activation": 0.00565, "nfkappab activation": 0.00565, "control transcription": 0.00565, "trigger activation": 0.00564, "activation status": 0.00564, "fcr-mediated mapk activation": 0.00564, "age-related lymphocyte dysfunction ] [ molecular mechanisms": 0.00564, "stringent activation requirements": 0.00564, "glucocorticoid receptor function": 0.00564, "maximum transactivation activity": 0.00564, "nf-at-like response element present": 0.00564, "lps-induced dna-binding activity": 0.00564, "complete activation": 0.00564, "activation cascade": 0.00564, "prevent activation": 0.00564, "specific cd4 promoter mutants": 0.00564, "limit hiv-1 transcription": 0.00564, "exogenous tumor necrosis factor": 0.00564, "tal1 activation": 0.00563, "mapk activation": 0.00563, "immunologic activation": 0.00563, "mitogenic activation": 0.00563, "monoclonal antibody-mediated cross-linking induced tyrosine phosphorylation": 0.00563, "cell-to-cell contact activation": 0.00563, "intrinsic dna-binding activity": 0.00563, "nm epidermal growth factor": 0.00563, "multiple nuclear factors bind": 0.00562, "inhibits transcription": 0.00562, "marked activation": 0.00562, "tnf alpha mrna levels": 0.00562, "local thrombin activation": 0.00562, "class ii major histocompatibility genes": 0.00562, "zap-70 activation": 0.00562, "concomitant activation": 0.00562, "endogenous nfat activity": 0.00562, "undergoing activation": 0.00562, "conserved upstream promoter sequences regulate": 0.00562, "otf-1 activation": 0.00562, "5-day anti-cd3/il-2 activation": 0.00562, "abundant dna-binding activity": 0.00562, "n19rhoa inhibited receptor clustering": 0.00561, "hiv-1 transcription": 0.00561, "thymidine kinase promoter": 0.00561, "nf-at activity": 0.00561, "prolonged activation": 0.00561, "anti-cd3-induced erk activation": 0.00561, "jnk pathway-dependent activation": 0.00561, "fibronectin receptor mrna": 0.00561, "proteolytic activation": 0.00561, "bind ets family proteins": 0.00561, "virtual complete amino acid sequence identity": 0.00561, "gata-1 activity occurs": 0.00561, "-2 receptor alpha chain/cd25": 0.00561, "inducible pkc activity": 0.00561, "dna-binding activity lef1/bcf1": 0.0056, "enhances leukocyte anti-infective activity": 0.0056, "nfatx1 transactivation activity": 0.0056, "receptor-coupled pld activation": 0.0056, "octamer dna sequence": 0.0056, "lps-induced activation": 0.0056, "erk activation": 0.0056, "affect lps-induced tf activity": 0.0056, "il-2 induced tyrosine phosphorylation": 0.0056, "effective activation": 0.0056, "hiv transcription mediated": 0.0056, "signal transduction pathway activated": 0.0056, "activation program": 0.0056, "il-2 promoter-driven transcription": 0.0056, "jnk activation": 0.0056, "ppargamma activation": 0.0056, "phorbol 12-myristate 13-acetate-inducible transcription": 0.0056, "upstream nf-kappab site": 0.0056, "polyclonal activation": 0.0056, "monoallelic activation": 0.0056, "murine il-2 nfat recognition sequence": 0.00559, "represses p65-mediated activation": 0.00559, "interferon-gamma activation": 0.00559, "active protein-tyrosine kinase regulatory pathway": 0.00559, "gas-like dna-protein binding complexes": 0.00559, "activation ag": 0.00559, "t-cell-receptor-mediated trans activation": 0.00559, "suppressing activation": 0.00559, "simultaneous activation": 0.00559, "optimal activation": 0.00559, "tf activation": 0.00559, "mineralocorticoid receptor mrna": 0.00559, "assaying cat enzyme activity": 0.00559, "vitro protein-dna binding studies": 0.00559, "lymphocyte glucocorticoid receptor number": 0.00559, "activation requirements": 0.00559, "pld activation": 0.00559, "gata family proteins bind": 0.00559, "granulocyte-colony stimulating factor treatment": 0.00559, "catalytic activation": 0.00559, "expressed octamer-binding factor": 0.00558, "pma-induced activation": 0.00558, "e2f activation": 0.00558, "il-10 inhibitory activity": 0.00558, "intravascular coagulation activation": 0.00558, "ciita mrna induction levels": 0.00558, "vitro binding assays": 0.00558, "cytokine-induced activation": 0.00558, "increased hb24 mrna levels": 0.00558, "p21ras activation": 0.00558, "cat enzyme activity": 0.00558, "activates hiv transcription": 0.00558, "key macrophage growth factor": 0.00558, "jak/stat activation": 0.00558, "il-13 activation": 0.00558, "erythroid-specific activation": 0.00558, "-dependent activation": 0.00558, "mediate maximum transrepressive activity": 0.00558, "immediate-early t-cell specific genes": 0.00558, "down-regulates lck-mediated activation": 0.00558, "il-2 transcription": 0.00558, "cytosolic activation": 0.00558, "repress ap-1 activity": 0.00557, "enhance long terminal repeat-directed transcription": 0.00557, "dna sequence homology": 0.00557, "binds switch region sequences suggests": 0.00557, "thrombin activation": 0.00557, "t-cell-specific activation": 0.00557, "increased mmp9 mrna levels": 0.00557, "mtiia mrna levels increased": 0.00557, "granulocyte colony-stimulating factor receptors": 0.00557, "dna sequence specificity": 0.00557, "common growth factor": 0.00557, "anti-ig-mediated zp activation": 0.00557, "basic fibroblast growth factor": 0.00557, "long-lasting activation": 0.00557, "transactivation activity": 0.00557, "hrxr alpha receptor": 0.00557, "tcr-mediated activation": 0.00557, "hsf3 dna-binding activity": 0.00557, "ptk activation": 0.00557, "t-lymphocyte activation": 0.00557, "inhibited apoptosis induced": 0.00557, "pb-induced activation": 0.00557, "hematopoietic growth factor": 0.00557, "constitutive stat5 activity": 0.00557, "strong inducible activity": 0.00556, "receptor alpha": 0.00556, "lps-induced tumor necrosis factor": 0.00556, "stimulate nfat activity": 0.00556, "endonuclease activity contained": 0.00556, "alpha receptor": 0.00556, "mouse gata3 transcription units start": 0.00556, "activation dependence": 0.00556, "aml1b inhibits erythroid differentiation induced": 0.00556, "zp activation": 0.00556, "promoter analysis": 0.00556, "full activation": 0.00556, "reduced uptake and/or binding": 0.00556, "limited activation": 0.00556, "specific nuclear ra receptors": 0.00556, "substantial activation": 0.00556, "stat5-containing dna-binding activity": 0.00556, "motif-specific dna-binding activity": 0.00556, "predicted amino acid sequence": 0.00556, "negligible dna-binding activity": 0.00556, "parallel activation": 0.00556, "aberrant activation": 0.00556, "intracellular oxidant activity": 0.00556, "androgen receptor mrna": 0.00556, "ebna2 activation": 0.00556, "nf-kappab-dependent activation": 0.00556, "-mediated activation": 0.00556, "progesterone receptor levels": 0.00556, "zebra activation": 0.00555, "facilitate activation": 0.00555, "cd28-mediated activation": 0.00555, "pp70s6k activation": 0.00555, "dexamethasone inhibits binding": 0.00555, "anti-cd2 receptor antibodies activate": 0.00555, "rap1 activation": 0.00555, "tat-mediated activation": 0.00555, "posttranslational activation": 0.00555, "mitogen activation": 0.00555, "pak activation": 0.00555, "ap-2 activation": 0.00555, "dna-binding activity": 0.00555, "study htlv-i transcription": 0.00555, "normal binding": 0.00555, "coordinate activation": 0.00555, "caspase activity measured": 0.00554, "cytokine-stimulated activation": 0.00554, "whole-cell competitive binding assay": 0.00554, "dermal activation": 0.00554, "pparalpha activation": 0.00554, "preferential activation": 0.00554, "mef2c activation": 0.00554, "induces tcf-controlled transcription": 0.00554, "lineage-specific activation": 0.00554, "synergistic activation": 0.00554, "biphasic activation": 0.00554, "consequent activation": 0.00554, "caspase-3 activation": 0.00554, "simple activation": 0.00554, "phytohemagglutinin-mediated activation": 0.00554, "erk2 activation": 0.00554, "cleavage stimulation factor cstf-64": 0.00554, "stat-1 activation": 0.00554, "autocrine activation": 0.00554, "egf treatment induced stat3 phosphorylation": 0.00554, "enzymatic activation": 0.00554, "lymphotoxin-beta receptor stimulates hiv-1 replication": 0.00553, "suboptimal activation": 0.00553, "cooperative activation": 0.00553, "monocyte/macrophage activation": 0.00553, "combinatorial activation": 0.00553, "thrombin receptor mrna": 0.00553, "uv-induced activation": 0.00553, "induces transcription": 0.00553, "hormone-dependent activation": 0.00553, "lipopolysaccharide-mediated activation": 0.00553, "signal-induced activation": 0.00553, "tpa-induced activation": 0.00553, "tnf-induced activation": 0.00553, "regulate basal htlv-i transcription": 0.00553, "signalsome activation": 0.00553, "repetitive activation": 0.00553, "il-1-induced activation": 0.00553, "b-lymphocyte activation": 0.00553, "g-csf receptor mrna": 0.00553, "x-ray activation": 0.00553, "ca2+-stimulated activation": 0.00553, "agonist-induced activation": 0.00553, "akt/pkb activation": 0.00552, "activation scheme": 0.00552, "inappropriate activation": 0.00552, "expressed factor": 0.00552, "radiation-induced activation": 0.00552, "anomalous activation": 0.00552, "il-12-mediated activation": 0.00552, "modulating gata-1 activity": 0.00552, "p39c-jun ap-1 activity": 0.00552, "hiv-ltr activation": 0.00552, "relative low binding affinity": 0.00552, "ca2+-induced activation": 0.00552, "inducing cat activity": 0.00552, "tnf-mediated activation": 0.00552, "il-12-induced activation": 0.00552, "manlam-mediated activation": 0.00552, "cyclin/cdks activation": 0.00552, "low-level activation": 0.00552, "tcr-stimulated activation": 0.00552, "tax1-induced activation": 0.00552, "ionomycin-induced activation": 0.00552, "thermal activation": 0.00552, "-kappab activation": 0.00552, "-kinase activation": 0.00552, "pkc-induced activation": 0.00552, "regulatory promoter elements": 0.00552, "estradiol-dependent activation": 0.00552, "pma-dependent activation": 0.00552, "intrapulmonary activation": 0.00552, "undesirable activation": 0.00552, "genes encoding endothelial adhesion molecules": 0.00552, "c-erba-dependent activation": 0.00552, "il-2-independent activation": 0.00552, "tax-induced activation": 0.00552, "pgn-induced activation": 0.00552, "calcineurin-dependent activation": 0.00552, "gliotoxin-inhibitable activation": 0.00552, "platelet-induced activation": 0.00552, "tnf-alpha-mediated activation": 0.00552, "il-7-induced activation": 0.00552, "functional interplay potentiates t-cell-specific transcription": 0.00552, "e2f-dependent activation": 0.00552, "p/i activation": 0.00552, "cd3-mediated activation": 0.00552, "her-2/neu activation": 0.00552, "rela/nf-kappab1 binding complexes": 0.00552, "eventual activation": 0.00552, "anti-fas-induced activation": 0.00552, "aid activation": 0.00552, "taci-induced activation": 0.00552, "fcr-dependent activation": 0.00552, "anti-fos antibodies abolished binding": 0.00552, "ikkbeta activation": 0.00552, "transactivation response element": 0.00552, "signal-dependent activation": 0.00552, "il-4-triggered activation": 0.00552, "calcium-mediated activation": 0.00552, "il-18-induced activation": 0.00552, "tumor necrosis factor receptor-1": 0.00552, "estrogen-mediated activation": 0.00552, "cbl-b-mediated activation": 0.00552, "favor activation": 0.00552, "trans-cellular activation": 0.00552, "tpa-dependent activation": 0.00552, "il-4-dependent activation": 0.00552, "pma/ionomycin-induced activation": 0.00552, "ras-regulated activation": 0.00552, "jak3/stat activation": 0.00552, "jak2/stat5 activation": 0.00552, "activated receptor": 0.00552, "gp160-mediated activation": 0.00552, "half-maximal activation": 0.00552, "octamer-dependent activation": 0.00552, "cell-to-cell activation": 0.00552, "vdre binding complexes": 0.00552, "hsf activation": 0.00552, "anti-cd2-mediated activation": 0.00552, "gata-3 involves high affinity binding": 0.00551, "complexes binding": 0.00551, "binding complexes": 0.00551, "diminished stat3 activity": 0.00551, "dopamine stimulated transcription": 0.00551, "activation": 0.00551, "enhancer element identified": 0.00551, "cd40 ligation induced growth inhibition": 0.00551, "platelet peroxidase activity": 0.00551, "cd25 promoter induction": 0.00551, "galectin-3 promoter induction": 0.0055, "bcs stimulated transcription": 0.0055, "activator protein-1 family proteins": 0.0055, "metallothionein promoter induction": 0.0055, "specific nuclear translocation mechanism exists": 0.0055, "nf-at-driven transcription stimulated": 0.0055, "dna sequence selected": 0.0055, "responsive dna element": 0.0055, "ap-2 consensus binding sequences": 0.0055, "ap-1 activity": 0.0055, "il-4 activity": 0.0055, "osteoclast differentiation factor": 0.00549, "ag amino acid sequence": 0.00549, "intracellular activity": 0.00549, "ligand binding affinity": 0.00549, "bcl-2 promoter inhibits transactivation": 0.00549, "il-8 kappa b-like site": 0.00549, "promoter induction": 0.00549, "negative activity": 0.00549, "inhibit il-2 induced signal transduction": 0.00549, "elevated glucocorticoid receptor concentrations": 0.00549, "stimulated transcription": 0.00549, "peptide binding affinity": 0.00549, "endogenous ifn activity equivalent": 0.00549, "untransformed steroid receptor complexes": 0.00548, "inflammatory activity": 0.00548, "differentiation factor": 0.00548, "important functional site": 0.00548, "triiodothyronine receptor mrna": 0.00548, "tumor necrosis factor alpha-induced": 0.00548, "il-4 receptor stimulation": 0.00548, "deduced amino acid sequence similarity": 0.00548, "tumor necrosis factor-associated factor": 0.00548, "tumor necrosis factor alfa": 0.00548, "promoter deletion constructs demonstrated": 0.00548, "short dna sequence": 0.00547, "display agonist activity": 0.00547, "basal activity": 0.00547, "p45 nf-e2 proteins increased": 0.00547, "high affinity aldosterone binding": 0.00547, "activation-deficient glucocorticoid receptor mutant": 0.00547, "] genes": 0.00547, "tnf-alpha induced nuclear localization": 0.00547, "15-amino acid transactivation sequence": 0.00547, "wp activity leads": 0.00547, "promoter sites": 0.00547, "receptor mrna": 0.00547, "tf kappa b-like site": 0.00547, "efficient viral transcription": 0.00547, "tumor necrosis factor": 0.00547, "mhc class ii homologous proteins hla-dma": 0.00547, "early b-cell factor": 0.00546, "radioligand binding assay": 0.00546, "constitutively expressed receptor": 0.00546, "charcoal binding assay": 0.00546, "ad2 infection induced transient increase": 0.00546, "consensus binding sequences": 0.00546, "induce high-level transcription": 0.00546, "specific mapk/extracellular signal-regulated kinase kinase": 0.00546, "vivo activity": 0.00546, "enhanced transcription": 0.00546, "upstream promoter elements": 0.00546, "amino acid sequence identity": 0.00546, "phosphotyrosine phosphatase activity": 0.00546, "class ii promoter occupancy alterations": 0.00546, "peak inhibitory activity": 0.00545, "concurrent follow-up nk activity": 0.00545, "transcriptional enhancer element": 0.00545, "ifn receptor family": 0.00545, "sl3 enhancer factor": 0.00545, "identified nip repressor site": 0.00545, "suppressed activity": 0.00545, "limiting-component transcription assays": 0.00545, "il-4 response element": 0.00545, "il-6 luciferase activity": 0.00545, "glucocorticosteroid binding assay": 0.00545, "receptor beta chain": 0.00545, "reduced gcr binding affinity": 0.00544, "promoter factors": 0.00544, "whole-cell binding assay": 0.00544, "cytokines inducing transcription": 0.00544, "il-2r alpha promoter": 0.00544, "vitro transcription methods": 0.00544, "transcription assays": 0.00544, "constitutive p21ras activity": 0.00544, "deduced amino acid sequence": 0.00544, "affect nf-il-6 activity": 0.00544, "hiv-1 enhancer region": 0.00544, "decreased glucocorticoid receptor numbers": 0.00544, "receptor levels": 0.00544, "facilitates viral transcription": 0.00544, "ras activity": 0.00543, "induce transcription": 0.00543, "activity remains unknown": 0.00543, "patients develop progressive cytokine-mediated inflammatory lung disease": 0.00543, "virus core promoter": 0.00543, "decreased c-myc transcription": 0.00543, "optimal viral transcription": 0.00543, "receptor mediated interaction": 0.00543, "phosphatase activity": 0.00542, "nk activity variance": 0.00542, "transient activity": 0.00542, "chimeric receptor expressed": 0.00542, "adjacent cyclic amp response element": 0.00542, "lipopolysaccharide-induced monocyte interleukin-1 receptor antagonist synthesis": 0.00542, "expressed fc receptor": 0.00542, "dna sequence information": 0.00542, "vcam-1 promoter constructs demonstrated": 0.00542, "granulocyte-macrophage colony-stimulating factor production": 0.00542, "mab j393 induced tyrosine phosphorylation": 0.00541, "canonical dna sequence canntg": 0.00541, "ltr activity": 0.00541, "beta-catenin-lymphoid enhancer factor": 0.00541, "interferon receptor family": 0.00541, "amino acid sequence": 0.00541, "kappa b-like site": 0.0054, "steel factor stimulation": 0.0054, "normal tgf-beta receptor profile": 0.0054, "specific binding power": 0.0054, "il-1 receptor antagonist results": 0.0054, "retinoic acid inhibits cd40 + interleukin-4-mediated ige production": 0.0054, "nk activity": 0.0054, "regulates qp activity": 0.0054, "gata-1 activity": 0.0054, "il-6 controls junb transcription": 0.0054, "selectively blocking mkk activity": 0.0054, "tax selectively stimulates nf-kappab-directed transcription": 0.00539, "links b-cell antigen receptor": 0.00539, "9-cis ra induced c/ebp epsilon mrna accumulation": 0.00539, "il-10 receptor expressed": 0.00539, "constitutive nf-kappab-binding activity": 0.00539, "endogenous ikk enzymatic activity": 0.00539, "tax activity": 0.00539, "peripheral blood lymphocytes express progesterone receptors": 0.00539, "receptor mediated system": 0.00539, "normal receptor status": 0.00539, "kappa immunoglobulin germline promoter": 0.00539, "molecular mechanisms underlying monocytic differentiation induced": 0.00539, "specific binding": 0.00539, "serum response element": 0.00539, "promoter elements mediate proper hormone-dependent": 0.00539, "glucocorticoid receptor-dependent transcription": 0.00539, "possess anti-inflammatory activity": 0.00539, "promote basal htlv-i transcription": 0.00539, "enzyme activity": 0.00539, "constitutive pkr activity": 0.00538, "murine il-2 promoter": 0.00538, "ifn-gamma activity": 0.00538, "transformation activity": 0.00538, "lmp1 activates transcription": 0.00538, "genes expressed early": 0.00538, "repression activity": 0.00538, "mip-1 alpha promoter": 0.00538, "inducing c-jun transcription": 0.00538, "dr alpha promoter": 0.00538, "regulating cp activity": 0.00538, "spl binding elements": 0.00537, "p0-compatible nfat activity": 0.00537, "tnf-alpha activity": 0.00537, "ligand-binding activity correlated": 0.00537, "stage selector activity": 0.00537, "igh enhancer pi site": 0.00537, "observed ifn-alpha-induced binding": 0.00537, "rxr agonist activity": 0.00537, "induced nuclear translocation": 0.00537, "tissue-specific gata-binding site identified": 0.00537, ":910 ] increased proliferation": 0.00537, "gata-3 transcriptional initiation site": 0.00537, "major regulatory factor": 0.00537, "demonstrate membrane binding": 0.00536, "stat1 activity": 0.00536, "affect sv40 promoter specific protein-1": 0.00536, "pkc enzymatic activity": 0.00536, "inhibitory activity": 0.00536, "histone deacetylase activity": 0.00536, "lps-inducible nuclear factor-kappa b/rel complex": 0.00536, "lymphocyte lines expressed negligible levels": 0.00536, "nfat activity": 0.00536, "regulate nf-at-binding activity": 0.00536, "anti-inflammatory activity": 0.00536, "anti-human aortic ec activity": 0.00536, "dna sequence": 0.00536, "observed binding": 0.00535, "t-lymphocytes nfat-1 activity": 0.00535, "fc gamma ri transcription": 0.00535, "viral transcription": 0.00535, "membrane-associated pkc activity": 0.00535, "calcineurin activates transcription": 0.00534, "mhc class ii proteins": 0.00534, "cd16 ligand binding involves": 0.00534, "encoding tumour necrosis factor": 0.00534, "stimulates transcription mediated": 0.00534, "intrinsic biological activity": 0.00534, "70-bp ifn-gamma response element": 0.00534, "enhancer positive regulatory element": 0.00534, "hypersensitive site hs2 enhancer": 0.00534, "glucocorticoid receptor concentrations": 0.00534, "ligand binding data": 0.00534, "specific nuclear factor-dna complexes": 0.00534, "diminished proliferative activity": 0.00534, "epstein-barr virus latency bamhi-q promoter": 0.00534, "pkc activity": 0.00533, "inducible activity": 0.00533, "progesterone receptor complexes": 0.00533, "estrogen response element": 0.00533, "regulate activity": 0.00533, "ifn-gamma response element": 0.00533, "antioxidant activity": 0.00533, "transcriptional initiation site": 0.00533, "gata-1 negative jurkat t-cell line": 0.00533, "il-4-induced stat5 activity": 0.00532, "repressor activity": 0.00532, "putative peptide contact site": 0.00532, "inhibited dc responses induced": 0.00532, "transforming growth factor beta1": 0.00532, "long terminal repeat-directed transcription": 0.00532, "interleukin-2 receptor alpha-chain enhancer": 0.00532, "igg fc receptor type": 0.00532, "prototypic class ii promoter": 0.00531, "16-bp cyclic amp response element": 0.00531, "suggest cd2 receptor modulation": 0.00531, "polyoma enhancer a-binding protein-3 site": 0.00531, "distinct nuclear factors": 0.00531, "decrease ltr transcription": 0.00531, "receptor family": 0.00531, "dominant interference activity": 0.00531, "similar dna control elements": 0.00531, "il-2 promoter construct downregulated": 0.00531, "expressed chemokine receptor": 0.0053, "granulocyte-monocyte colony stimulating activity": 0.0053, "altered activity": 0.0053, "ap-1 family proteins": 0.0053, "synthetic thrombin receptor agonist peptide": 0.0053, "transcriptional factor stat-1alpha": 0.0053, "activate u2 snrna transcription": 0.0053, "regulating il-4 transcription": 0.0053, "enhancer termed cd28 responsive element": 0.0053, "cell-specific activity": 0.0053, "galdbd-raralpha hybrid activity": 0.0053, "inhibited beta-galactosidase mrna levels": 0.00529, "il-1 beta mrna increased": 0.00529, "transcriptional factor": 0.00529, "conserved ifn-stimulated response element": 0.00529, "full agonist activity": 0.00529, "strong deoxidizing activity": 0.00529, "nf kappab family proteins": 0.00529, "cyclic amp response element": 0.00529, "monocytic activity": 0.00529, "putative binding sequences": 0.00529, "transforming growth factor": 0.00529, "hla class ii genes": 0.00529, "decreased transcription": 0.00529, "antiandrogen-bound receptor complexes": 0.00529, "nuclear pore complex": 0.00528, "therapeutic activity": 0.00528, "diminished gr apparent binding affinity": 0.00528, "protein-dna binding studies suggested": 0.00528, "detectable dpd activity": 0.00528, "low reporter mrna levels relative": 0.00528, "tat activity": 0.00528, "epstein-barr virus cp latency-associated promoter": 0.00528, "nfat docking site peptide": 0.00527, "calcineurin activity": 0.00527, "cre site identified": 0.00527, "glucocorticoids ] [ regulation": 0.00527, "nuclear complex": 0.00527, "ptdins 3-kinase activity": 0.00527, "specific site": 0.00527, "promoter domain": 0.00527, "nuclear nf-kappab levels": 0.00527, "fetal/adult alpha globin genes": 0.00527, "induced significant internucleosomal dna fragmentation": 0.00527, "distinct inhibitory receptor leads": 0.00527, "conditional epstein-barr virus nuclear antigen": 0.00526, "biological activity": 0.00526, "chloramphenicol acetyltransferase activity": 0.00526, "cytokine genes expressed": 0.00526, "macrophage procoagulant activity": 0.00526, "steady-state mrna levels increase": 0.00525, "phosphorylation site": 0.00525, "epstein-barr virus zebra promoter": 0.00525, "normal receptor": 0.00525, "mhc class ii genes": 0.00525, "activity decreases": 0.00525, "nitric oxide synthetase activity": 0.00525, "differential activity": 0.00525, "class ii mhc genes": 0.00525, "expressed histone h2b promoter": 0.00525, "activate hiv-2 transcription": 0.00525, "dna-binding regulatory factor": 0.00525, "heat labile activity": 0.00525, "epidermal growth factor": 0.00525, "interleukin-2 sequence specific oligonucleotide probes": 0.00525, "okadaic acid-induced c-jun transcription": 0.00525, "nuclear factor-kappa b. inhibitory effect": 0.00524, "vitro transcription": 0.00524, "response genes": 0.00524, "activate e2f-mediated transcription": 0.00524, "bcl-2 family proteins": 0.00524, "comments ] nuclear association": 0.00524, "diminished cp activity": 0.00524, "nuclear factors involved": 0.00524, "agonist activity": 0.00524, "htlv-i basal transcription": 0.00524, "epstein-barr virus dr promoter": 0.00524, "stat activity": 0.00524, "lt-293 cat activity": 0.00524, "il-2 promoter regions": 0.00524, "stat proteins activated": 0.00524, "ad5e1a-specific ctl activity": 0.00524, "il-2 -and prl-induced dna-binding proteins": 0.00524, "transcription level": 0.00524, "cat activity": 0.00523, "fc gamma ric promoter sequences": 0.00523, "proximal promoter elements": 0.00523, "demonstrated differential binding": 0.00523, "decreased binding affinity": 0.00523, "native rfx activity": 0.00523, "sp1 binding motifs": 0.00523, "selective activity": 0.00523, "tf activity promoted": 0.00523, "prolactin receptor signal transduction": 0.00523, "activate ifn-beta transcription": 0.00523, "high affinity binding": 0.00523, "important molecular site": 0.00523, "oka stimulation induced intense phosphorylation": 0.00523, "hemopoietic growth factor": 0.00523, "cck-8-induced luciferase activity": 0.00523, "kruppel-related zinc finger proteins expressed": 0.00523, "hybrid promoter constructs demonstrate": 0.00523, "platelet-activating factor induces phospholipid turnover": 0.00523, "actual proliferative activity": 0.00522, "metabolic activity": 0.00522, "exhibit anti-tumour activity": 0.00522, "enhancer site": 0.00522, "cd28 response element": 0.00522, "-independent activity": 0.00522, "estrogen receptor beta": 0.00522, "examined glucocorticoid receptor characteristics": 0.00522, "zinc finger proteins expressed": 0.00522, "maximal activity": 0.00522, "hla binding motifs": 0.00522, "related factor spi-b bound": 0.00522, "blocking jnk activity": 0.00522, "bcl-2 inhibits apoptosis induced": 0.00522, "displays erythroid-specific activity": 0.00522, "additional factor required": 0.00522, "il-1 receptor type": 0.00521, "nfat regulates transcription": 0.00521, "transcriptional control element": 0.00521, "activate hiv-1-ltr-driven transcription": 0.00521, "lmp-1 ebna-2 response element": 0.00521, "activate tcf-dependent transcription": 0.00521, "lmp transcriptional start site": 0.00521, "deficient activity": 0.00521, "transcription called stat3": 0.00521, "rar alpha proteins": 0.00521, "activate nf-at-dependent transcription": 0.00521, "receptor complexes": 0.00521, "immunosuppressive activity": 0.00521, "growth factor deprivation": 0.00521, "activate tcf transcription": 0.00521, "hiv reverse transcription": 0.00521, "ifn stimulus response element": 0.00521, "stat6 activity": 0.00521, "negative control region upstream": 0.00521, "dominant negative helix loop helix factor id3": 0.0052, "nerve growth factor": 0.0052, "epstein-barr virus nuclear antigen": 0.0052, "truncated beta globin promoter": 0.0052, "insulin-like growth factor": 0.0052, "tissue-specific activity": 0.0052, "classical competition binding assays": 0.0052, "proliferative activity": 0.0052, "adjacent inverted ets binding motifs": 0.0052, "interferon beta prdii site": 0.0052, "tnfalpha-mediated nfkappab activity": 0.0052, "specific receptor consisting": 0.0052, "nfat-1 activity resembles": 0.0052, "analog activity": 0.0052, "platelet-derived growth factor": 0.0052, "activate transcription": 0.0052, "helper activity": 0.0052, "high affinity fc gammari receptor": 0.00519, "il-2 promoter level": 0.00519, "enhance il-1 receptor antagonist secretion": 0.00519, "receptor common gamma chain": 0.00519, "proteasome activity": 0.00519, "tax-response element dna": 0.00519, "major putative downstream site": 0.00519, "nadph oxidase activity": 0.00519, "nfkappab activity": 0.00519, "growth factor": 0.00519, "control discrete genes involved": 0.00519, "main activity": 0.00519, "suppressor activity": 0.00519, "epstein-barr virus latent proteins": 0.00518, "camp response element": 0.00518, "ifngamma response region": 0.00518, "multiple signaling proteins": 0.00518, "unidentified cellular factor": 0.00518, "glucocorticoid receptor present": 0.00518, "transcription activating subunit": 0.00518, "-1 family proteins interacted": 0.00518, "traf2 inhibits binding": 0.00518, "dominant-negative activity": 0.00518, "dna element": 0.00518, "nf-kappa b/rel proteins": 0.00517, "possesses immunomodulatory activity": 0.00517, "lcr activity": 0.00517, "weak activity": 0.00517, "select nf-kappa b-regulated genes": 0.00517, "lt biologic activity": 0.00517, "mapk activity": 0.00517, "comparative sequence analysis": 0.00517, "jak1 activity": 0.00517, "nf-kappa b-related proteins": 0.00517, "jnk enzymatic activity": 0.00517, "hiv-enhancer activity concomitant": 0.00517, "nonspecific esterase activity": 0.00516, "developmental activity": 0.00516, "transcriptional start site": 0.00516, "abundant pybf activity": 0.00516, "il-4 induced robust janus kinase": 0.00516, "microsomal p-nitrophenyl sulfatase activity": 0.00516, "nfat family proteins": 0.00516, "hla-dq3.2 molecule regulated binding": 0.00516, "deficiency-heat syndromes ] [ plasma cortisol concentration": 0.00516, "favorable activity profile": 0.00516, "replicative activity": 0.00516, "binding interaction": 0.00516, "repress alf1 activity": 0.00516, "rprl footprint ii repressor site": 0.00516, "modulating activity": 0.00516, "sustained high [ ca2+ ]": 0.00516, "p45 nf-e2 proteins inhibited": 0.00516, "stat6 response element": 0.00516, "similar ra binding affinities": 0.00516, "negligible cytotoxic activity": 0.00516, "physical activity": 0.00515, "wp activity": 0.00515, "major transactivation sequence required": 0.00515, "quantitative competitive reverse transcription pcr": 0.00515, "runt domain-encoding pebp2 alpha genes": 0.00515, "rho potentiates ap-1 transcription": 0.00515, "nf-kappa b/c-rel proteins": 0.00515, "sequence analysis": 0.00515, "silencer activity": 0.00515, "complex transcriptional regulation": 0.00515, "activates proenkephalin transcription": 0.00514, "heat shock induced hiv-1 production": 0.00514, "transforming activity": 0.00514, "jnk activity": 0.00514, "dna precursor pathway enzyme": 0.00514, "killing activity": 0.00514, "transcriptional regulatory proteins": 0.00514, "estrogen receptor diminishes dna-binding activities": 0.00514, "cytotoxic activity": 0.00514, "expressed p50 nf-kappa b. stimulation": 0.00514, "trans-activation activity": 0.00514, "i. estrogens ] [ mechanism": 0.00514, "lps-induced activity": 0.00514, "prominent e2f activity": 0.00514, "inhibit nf-kappab-mediated transcription": 0.00514, "stat binding sequences": 0.00514, "p93fes catalytic activity": 0.00514, "pld activity": 0.00513, "optimal activity": 0.00513, "ctla-4 ligation inhibited cd3/cd28-induced il-2 mrna accumulation": 0.00513, "steroid binding assays": 0.00513, "form binding": 0.00513, "cellular proteins involved": 0.00513, "inhibit gr-dependent transcription": 0.00513, "nfat-1 activity": 0.00513, "single mutation site": 0.00513, "upstream beta globin sequence": 0.00513, "devd-cleavable caspases activity": 0.00513, "transcription mediated": 0.00513, "enhancer element required": 0.00513, "catalytic activity": 0.00513, "factor-dependent pkb/akt activity": 0.00513, "low binding affinity": 0.00513, "neutral smase activity": 0.00513, "increases transcription": 0.00512, "nf-y activity": 0.00512, "sustained activity": 0.00512, "basal transcription unaffected": 0.00512, "hs-40 enhancer-mediated activity": 0.00512, "box-binding activity lef1/bcf1": 0.00512, "cellular factor cbf1/rbp-jkappa": 0.00512, "tf activity": 0.00512, "cortisol receptor function": 0.00512, "activates transcription": 0.00512, "dexamethasone down-regulates tpa-induced transcription": 0.00512, "hsv-1-activated cellular factor": 0.00512, "dual activity": 0.00512, "cd2 receptor stimulation": 0.00512, "repress activity": 0.00512, "inhibit c/ebpalpha-dependent transcription": 0.00512, "e2f activity": 0.00512, "high affinity ige receptor": 0.00512, "cellular factor": 0.00511, "12-lipoxygenase activity": 0.00511, "decreased binding capacity": 0.00511, "grbeta-mediated antiglucocorticoid activity": 0.00511, "cytolytic activity": 0.00511, "adenosine receptor stimulation": 0.00511, "beta-promoter activity": 0.00511, "transactivating activity": 0.00511, "lymphocyte gr binding parameters": 0.00511, "xpb helicase activity": 0.00511, "-beta activity": 0.00511, "il-12 induced strong tyrosine phosphorylation": 0.00511, "fc gammari promoter elements": 0.00511, "nf-kappab binding": 0.00511, "suppressive nfat1 activity": 0.00511, "tcf-1 activity": 0.00511, "maximum activity": 0.00511, "previous protein-dna binding studies": 0.00511, "glucocorticoid receptor antagonist ru": 0.00511, "isomerase activity": 0.00511, "nfat-1-mediated beta-galactosidase activity": 0.0051, "gtp-binding activity": 0.0051, "activated peripheral blood lymphocytes": 0.0051, "low relative binding affinities": 0.0051, "cp activity": 0.0051, "monitoring dpd activity": 0.0051, "antiviral activity": 0.0051, "ebna2 activity": 0.0051, "specific dna target sequences": 0.0051, "proximal cd19 promoter reveal important roles": 0.0051, "intermediate activity": 0.0051, "antiapoptotic activity": 0.0051, "motor activity": 0.0051, "cd16 ligand binding": 0.0051, "full activity": 0.0051, "specific receptor c-mpl": 0.0051, "leukemia inhibitory factor": 0.0051, "high affinity site": 0.0051, "] aldosterone-mbp-hbd complex": 0.0051, "rfx activity": 0.00509, "gata-3 activity": 0.00509, "tk activity": 0.00509, "ligand binding avidity": 0.00509, "serca activity": 0.00509, "e2f-1 activity": 0.00509, "g-csf receptor signaling": 0.00509, "cd28 response complex": 0.00509, "assaying ligand binding affinities": 0.00509, "c-jun transcription": 0.00509, "agonistic activity": 0.00509, "specific receptor": 0.00509, "lymphocyte glucocorticoid receptor": 0.00509, "ikk activity": 0.00509, "antagonistic activity": 0.00509, "beta-galactosidase activity": 0.00509, "qr activity": 0.00509, "glucocorticoid receptor antagonist ru38486": 0.00509, "spi-b activity": 0.00509, "egf treatment induced igm production": 0.00508, "antigen receptor leads": 0.00508, "enzymatic activity": 0.00508, "dq alpha genes": 0.00508, "adjacent promoter elements contributes": 0.00508, "transcription enhancement": 0.00508, "anti-zebra activity": 0.00508, "hybrids expressing nuclear nf-kappa": 0.00508, "nos activity": 0.00508, "pkb/akt activity": 0.00508, "low affinity fc receptor": 0.00508, "stimulatory activity": 0.00508, "rho activity": 0.00508, "site beta -but": 0.00508, "paired domain proteins": 0.00508, "decreased estrogen receptor concentration": 0.00508, "antiproliferative activity": 0.00508, "potentiating activity": 0.00508, "glucocorticoid receptor antagonist": 0.00508, "related hepatocyte nuclear factors hnf-1alpha": 0.00508, "augmented il-1 beta mrna levels": 0.00508, "p95vav activity": 0.00507, "mhc class ii antigen induction": 0.00507, "ap-1-binding activity": 0.00507, "cn activity": 0.00507, "qp activity": 0.00507, "pi3-kinase activity": 0.00507, "c-erba activity": 0.00507, "proto-enhancer activity": 0.00507, "regulatory enhancer region": 0.00507, "tad-a activity": 0.00507, "isgf3 activity": 0.00507, "suppressive activity": 0.00507, "natural dominant negative hlh factor id3": 0.00507, "nf-kappa b-dependent genes": 0.00507, "biologic activity": 0.00507, "affect lps-induced kappab-dependent transcription": 0.00507, "immunomodulatory activity": 0.00507, "cooperative activity": 0.00507, "b-cell-specific transcription coactivator oca-b": 0.00507, "activity variance": 0.00507, "cox-2 activity": 0.00507, "nf-at-binding activity": 0.00507, "c/ebpbeta activity": 0.00507, "pp90rsk activity": 0.00507, "mmp-9 activity": 0.00507, "il-1beta receptor type": 0.00507, "co-stimulatory activity": 0.00506, "cell-restricted activity": 0.00506, "dna-relaxing activity": 0.00506, "gpx activity": 0.00506, "syncytia-forming activity": 0.00506, "pkr activity": 0.00506, "pkb/pi3-kinase activity": 0.00506, "retinoidal activity": 0.00506, "hsf-1 activity": 0.00506, "trancriptional activity": 0.00506, "transformation-related activity": 0.00506, "b-cell-restricted activity": 0.00506, "beta-gal activity": 0.00506, "d3-24-hydroxylase activity": 0.00506, "adrenocortical activity": 0.00506, "mmp9 activity": 0.00506, "differentiation-inducing activity": 0.00506, "gp130-induced activity": 0.00506, "rela/nfkappab1-binding activity": 0.00506, "survival-promoting activity": 0.00506, "immunomodulating activity": 0.00506, "critical signal response domain": 0.00506, "hepatoprotective activity": 0.00506, "anti-proliferative activity": 0.00506, "antiestrogenic activity": 0.00506, "recombinase activity": 0.00506, "plap activity": 0.00506, "chymotryptic activity": 0.00506, "hsf2 activity": 0.00506, "ebv mrna transcripts encoding immediate-early transcriptional transactivators": 0.00506, "erk1 activity": 0.00506, "saf activity": 0.00506, "ctcf activity": 0.00506, "activity residing": 0.00506, "gene-suppressive activity": 0.00506, "death-promoting activity": 0.00506, "autokinase activity": 0.00506, "kappab-binding activity": 0.00506, "sport activity": 0.00506, "th2-specific activity": 0.00506, "hydrolytic activity": 0.00506, "basal-level activity": 0.00506, "hormone-binding activity": 0.00506, "transcription-enhancing activity": 0.00506, "ef1-like activity": 0.00506, "gamma-promoter activity": 0.00506, "insulin-gene activity": 0.00506, "cytokine-modulating activity": 0.00506, "diffusible activity": 0.00506, "bone-resorbing activity": 0.00506, "il1-induced activity": 0.00506, "camp-phosphodiesterase activity": 0.00506, "rotamase activity": 0.00506, "microbicidal activity": 0.00506, "cyclooxygenase activity": 0.00506, "dominant promoter elements consist": 0.00506, "lipoxygenase activity": 0.00506, "nip activity": 0.00506, "ros activity": 0.00506, "ap-1/cat activity": 0.00506, "activity": 0.00505, "sequence elements upstream": 0.00505, "variant receptor transcripts lacking exon": 0.00505, "low affinity bsap site": 0.00505, "erythroid factor gata-1": 0.00505, "monocytes inhibited ifn alpha-stimulated tyrosine phosphorylation": 0.00505, "active transcription": 0.00505, "upstream promoter sequences": 0.00505, "il-10 inhibits nuclear stimulation": 0.00505, "ebna2 response element": 0.00505, "activating specific stat proteins": 0.00505, "mediate high-level transcription": 0.00505, "t-cell-specific response element": 0.00505, "basal transcription machinery": 0.00504, "induce nf-at region transactivation": 0.00504, "specific complex formation": 0.00504, "interaction site": 0.00504, "il-2 binding": 0.00504, "class ii proteins": 0.00504, "mediate cell-type-specific transcription": 0.00504, "ets binding motifs": 0.00504, "receptor stimulation": 0.00503, "increased intracellular free calcium levels correlated": 0.00503, "signaling receptor": 0.00503, "t-cell factor": 0.00503, "jun family proteins": 0.00503, "carboxyl-terminal 15-amino acid sequence": 0.00503, "glucocorticoid receptor affinity": 0.00503, "mediating transcription initiation": 0.00503, "nf-at site provide": 0.00503, "il-7r alpha determines specific signaling events": 0.00503, "hiv transcription": 0.00503, "proliferation factor": 0.00503, "vd response element": 0.00503, "cellular genes involved": 0.00503, "glucocorticoid receptor number": 0.00503, "mouse inos promoter regions": 0.00503, "regulate multiple t-cell genes": 0.00503, "multiple nuclear factors": 0.00502, "il-2-r alpha genes": 0.00502, "early nf-kappa b-mediated transcriptional regulation": 0.00502, "complex effect": 0.00502, "affect a-myb transcription": 0.00502, "abrogated il-4-induced germline cepsilon transcription": 0.00502, "unidentified factor binds": 0.00502, "mediate transcription": 0.00502, "endogenous vitamin d3 receptor": 0.00501, "glucocorticosteroid response element": 0.00501, "fibronectin-vla-5 fibronectin receptor interaction": 0.00501, "ifn-stimulated response element": 0.00501, "multimerized response element": 0.00501, "adeno-associated virus p5 promoter": 0.00501, "b-lymphocytes ] [ regulation": 0.00501, "studied transcription": 0.00501, "metal response element": 0.00501, "transcriptional factors nf-kappa": 0.005, "intracellular signaling proteins": 0.005, "tumor necrosis factor-alpha promoter": 0.005, "repress ltr transcription": 0.005, "nf-kappa b-like sequence": 0.005, "cd14 sp1 site oligonucleotides bound": 0.005, "interferon-stimulated response element": 0.005, "peptide binding": 0.005, "cell-derived cdnas encoding oct-binding factor": 0.005, "il-6/interferon-gamma response element": 0.005, "ligand binding": 0.005, "interleukin-2 il-2 receptor beta-chain": 0.005, "low binding capacity": 0.005, "ap-2 binding sequences": 0.00499, "ifn beta promoter deletions": 0.00499, "interleukin-1 receptor type": 0.00499, "jurkat t-cell line treated": 0.00499, "run-on analysis demonstrated detectable levels": 0.00499, "basal transcription": 0.00499, "induced nuclear import": 0.00499, "characterized glucocorticoid receptor": 0.00499, "response element": 0.00499, "erba-binding site confers thyroid hormone responsiveness": 0.00499, "enhanced gata-3 promoter transactivation": 0.00499, "recombinant nf-ya subunit restores nf-y binding": 0.00498, "mouse granulocyte/macrophage-colony stimulating factor": 0.00498, "cap site confers erythroid specificity": 0.00498, "activate nuclear nf-kappa": 0.00498, "complex development pathways involved": 0.00498, "functional receptor number": 0.00498, "nf-kappab site": 0.00498, "sodium phenylacetate induced erythroid differentiation": 0.00498, "1,25-dihydroxyvitamin d3 receptor rna": 0.00498, "blocking tnf-alpha transcription": 0.00498, "intracellular glucocorticoid receptor": 0.00498, "hiv-1 ap-1 dna recognition sequences": 0.00497, "traf binding sequences": 0.00497, "glucocorticoid receptor isoforms": 0.00497, "ebv early promoter": 0.00497, "important prognostic factor": 0.00497, "inducible transcription units": 0.00497, "proteins mediating signal transduction": 0.00497, "enhancer element decreased": 0.00496, "kbf1/p50 factor binds": 0.00496, "activated genes": 0.00496, "c-fos transcription": 0.00496, "modulating dioxin receptor function": 0.00496, "il-6 transcription rate": 0.00496, "shared receptor subunit gamma c.": 0.00496, "identical rbtn-2 binding regions": 0.00496, "dna-protein binding assays": 0.00496, "functional nuclear localization signal present": 0.00495, "thr729-leu765 sequence deleted [ jalaguier": 0.00495, "-15 induce multiple stat proteins": 0.00495, "hsv-2 genes encoding hsv-2 type-specific cd4+ antigens": 0.00495, "cryptic splice site sequences": 0.00495, "stat1-like factor binds": 0.00495, "sp binding motifs": 0.00495, "active binding heterodimers": 0.00495, "binding sequences": 0.00495, "major constitutive dnase i-hypersensitive site": 0.00495, "phorbolmyristate-acetate-stimulated il-1 receptor antagonist secretion": 0.00495, "class ii genes": 0.00495, "high gcr binding affinities": 0.00495, "mitogen-mediated ltr transcription": 0.00495, "direct transcription": 0.00495, "nucleic acid sequence": 0.00494, "decreased creb binding": 0.00494, "lat-containing signaling complex involved": 0.00494, "determining receptor function": 0.00494, "interferon gamma induction pathway": 0.00494, "15-amino acid sequence": 0.00494, "harbor promoter elements": 0.00494, "situ reverse transcription": 0.00494, "intact beta interferon promoter": 0.00494, "transfected il-2 promoter": 0.00493, "antigen receptor costimulation": 0.00493, "stimulated t-cell nuclear extracts consisting": 0.00493, "granulocyte-macrophage colony-stimulating factor promoters": 0.00493, "ifn-gamma induced mhc class ii expressions": 0.00493, "reverse transcription pcr": 0.00493, "beta globin promoter": 0.00493, "constitutively represses transcription": 0.00493, "corticosteroid receptor function": 0.00493, "major risk factor": 0.00493, "gata-1 transcription": 0.00493, "tumor necrosis factor-alpha mrna levels": 0.00493, "cyp1a1 mrna level induced": 0.00493, "t-cell nuclear extract-dna complexes": 0.00493, "ap-1 site mediated": 0.00492, "potential nfat target genes": 0.00492, "anti-cd28 mab increased induction": 0.00492, "late il-6-induced junb transcription waves": 0.00492, "dna nuclear localization": 0.00492, "variable region beta chain": 0.00492, "enhanced binding": 0.00492, "membrane-proximal proline-rich sequence motif": 0.00492, "genomic transcription": 0.00492, "efficient transcription initiation": 0.00492, "required binding": 0.00491, "hepatic leukemia factor": 0.00491, "glucocorticoid receptor capacity": 0.00491, "stable tetrameric dcoh-hnf-1 alpha complex": 0.00491, "relative binding affinity": 0.00491, "synthesize tissue factor": 0.00491, "jurkat t-cell line zap-70 mutated": 0.00491, "receptor functions required": 0.00491, "transcriptional activator sequence": 0.00491, "cd4 transcription": 0.00491, "e3 sequence motif": 0.00491, "globin promoter interaction": 0.00491, "il-2 receptor components": 0.00491, "pma+pha-inducible ifn-gamma transcription": 0.00491, "cd14 receptor system": 0.00491, "increased basal plasma corticosterone levels": 0.0049, "regulates transcription": 0.0049, "msr promoter ap-1/ets elements": 0.0049, "casein kinase ii sites": 0.0049, "rel family proteins": 0.0049, "important factor": 0.0049, "nf-at-directed transcription responsive": 0.0049, "dna-binding nuclear factors": 0.0049, "binding assays": 0.0049, "kappa recognition sequence": 0.0049, "induced cellular differentiation": 0.0049, "dna-protein binding studies": 0.0049, "immune systems ] [ molecular-biologic aspects": 0.0049, "gata-binding family proteins": 0.00489, "murine il-16 genes share >": 0.00489, "ifn regulatory factor": 0.00489, "egr family proteins": 0.00489, "ets related pu.1 site": 0.00489, "tnf-alpha transcription": 0.00489, "basic transcription machinery": 0.00489, "ets-like binding motifs": 0.00489, "ca2+ [ ca2+ ]": 0.00489, "il-2 receptor promote": 0.00489, "mechanical ventilation induced low levels": 0.00489, "constitutive transcription": 0.00489, "tissue factor": 0.00489, "antigen receptor engagement": 0.00488, "viral proteins involved": 0.00488, "intact il-4 promoter constructs": 0.00488, "diverged octamer dna motif present": 0.00488, "cytoplasmic tyrosine kinase tec family": 0.00488, "binding results": 0.00488, "element sites": 0.00488, "promoter specific": 0.00488, "-pcr analysis demonstrated gh mrna": 0.00488, "transcription repressor evi1": 0.00487, "% [ vol/vol ]": 0.00487, "regulate monocyte-specific transcription": 0.00487, "cytokine promoter regions": 0.00487, "characterized murine b29 promoter": 0.00487, "perceived support factor values": 0.00487, "binding motifs": 0.00487, "hiv promoter required": 0.00487, "nf-kappab/rel family proteins": 0.00487, "erythropoietin receptor mutant defective": 0.00486, "gr binding affinity": 0.00486, "strong enhancer element essential": 0.00486, "active nf-kappab dna-binding complex": 0.00486, "genes encoding il-2": 0.00486, "inducing transcription": 0.00486, "il-2 promoter repression": 0.00486, "ii breast cancer patients": 0.00486, "consensus ap-1 site": 0.00486, "class ii restriction element": 0.00486, "regulating collagenase-1 transcription": 0.00486, "ap-1 consensus site": 0.00486, "complex response": 0.00486, "tumor site": 0.00486, "upstream enhancer element": 0.00486, "pb1 sequence motif": 0.00485, "promoter elements": 0.00485, "tnf-alpha-induced icam-1 transcription": 0.00485, "dioxin receptor function": 0.00485, "additional factor and/or post-translational modification": 0.00485, "inducible transcription": 0.00485, "regulating transcription": 0.00485, "interferon regulatory factor": 0.00485, "regulate transcription": 0.00485, "glucocorticoid receptor-gre binding": 0.00485, "prevent vcam-1 transcription": 0.00485, "family proteins": 0.00485, "upstream delta globin regulatory region": 0.00485, "jurkat leukemic t-cell line": 0.00485, "binding studies": 0.00484, "initiates tal-1 transcription": 0.00484, "erythropoietin stimulates transcription": 0.00484, "normal peripheral blood lymphocytes": 0.00484, "yeast two-hybrid screen identified tes2 interacting proteins": 0.00484, "tumor promoter pma": 0.00484, "sequence specific oligonucleotide typing": 0.00484, "-76 site binds": 0.00484, "glucocorticoid binding": 0.00484, "enhance hbb transcription": 0.00484, "dependent transcription": 0.00484, "dioxin receptor system": 0.00484, "transcriptional regulating proteins fos": 0.00484, "transforming growth factor-beta promoter polymorphisms": 0.00484, "cd19/vav/phosphatidylinositol-3 kinase complex": 0.00483, "tumor estrogen/progesterone receptor status": 0.00483, "low affinity receptor": 0.00483, "t-cell receptor loci": 0.00483, "important positive regulatory element": 0.00483, "receptor function": 0.00483, "surface proteins involved": 0.00483, "demonstrated increased levels": 0.00483, "binding activities displayed": 0.00483, "10-amino acid cd40 cytoplasmic signaling determinant required": 0.00483, "point mutations suppressing gabp binding": 0.00483, "functional ets site": 0.00483, "sequence motif": 0.00483, "icam-1 promoter-dependent transcription": 0.00483, "glucocorticoid receptor density": 0.00483, "il-2 promoter correlated": 0.00483, "glucocorticoid receptor concentration": 0.00483, "nf-kappa b-dependent element": 0.00483, "active nuclear nf-kappa": 0.00483, "low receptor affinity": 0.00483, "mutant tsap-binding site": 0.00483, "specific mrna levels": 0.00482, "compounds inhibited il-2 mrna": 0.00482, "altered transcription": 0.00482, "e2a-hepatic leukemia factor": 0.00482, "stimulate b29 transcription": 0.00482, "reduced binding": 0.00482, "single cytokine receptor": 0.00482, "enhance transcription": 0.00482, "nf-kappab target dna sequences": 0.00482, "cell-specific transcription": 0.00482, "ecotropic viral insertion site": 0.00481, "-and serum response factor-binding elements activates": 0.00481, "lipopolysaccharide [ lps ]": 0.00481, "768-bp upstream negative regulatory region": 0.00481, "steroid binding domains": 0.00481, "t-cell receptor alpha-": 0.00481, "inhibit granulocyte colony-stimulating factor": 0.00481, "nuclear dual-specific map kinase phosphatases": 0.00481, "vitro fibroblast binding": 0.00481, "receptor gamma chain": 0.00481, "mediating transcription": 0.00481, "il-2 mrna response": 0.00481, "il-4 promoter involved": 0.00481, "granulocyte colony-stimulating factor activates": 0.00481, "apoptosis effector proteins bak": 0.00481, "gpix promoter identified": 0.00481, "tyrosine kinase-linked receptor agonist collagen": 0.00481, "viral binding": 0.00481, "e2a-hlf induced t-cell apoptosis": 0.00481, "specific antibody induction": 0.00481, "transcriptional regulatory element": 0.0048, "antiapoptotic regulatory factor": 0.0048, "mediates transcription": 0.0048, "herpes simplex virus immediate-early genes": 0.0048, "murine il-10 receptor": 0.0048, "transcription correlates": 0.0048, "syndrome ] lymphocytic levels": 0.0048, "breast cancer ] [ correlation": 0.0048, "strong transcription": 0.0048, "competent transcription initiation": 0.0048, "stimulate transcription driven": 0.0048, "il-6 transcription": 0.0048, "apparent binding affinity": 0.0048, "major positive regulatory region": 0.0048, "activating transcription": 0.0048, "transcription initiation": 0.00479, "methyl ] phenyl ] methane": 0.00479, "site required": 0.00479, "danazol decreases transcription": 0.00479, "suppress nf-at binding impair": 0.00479, "transcription interact": 0.00479, "antigen receptor triggering": 0.00479, "duffy antigen receptor": 0.00479, "viral genes involved": 0.00479, "vivo gc receptor down-regulation": 0.00479, "specific granulomonocyte-associated lysosomal proteins myeloperoxidase": 0.00479, "lymphoid cell-specific factor otf2": 0.00479, "synergistic antigen receptor": 0.00479, "kit/il-4r alpha induces cellular proliferation": 0.00478, "fas ligand regulatory element": 0.00478, "scavenger receptor over-expressing monocytes": 0.00478, "c-jun promoter constructs": 0.00478, "dp alpha element": 0.00478, "general transcription machinery": 0.00478, "potential c/ebp-binding site": 0.00478, "stimulates transcription": 0.00478, "promoter identified": 0.00478, "b-cell-specific transcription": 0.00478, "target genes show": 0.00478, "receptor mutant subclones": 0.00477, "antigen receptor agonism": 0.00477, "cd3/t-cell antigen receptor": 0.00477, "gm-csf induced tyrosine phosphorylation": 0.00477, "prevented ap-1 binding": 0.00477, "distinct sequence-specific dna-binding proteins": 0.00477, "competent stat transcription": 0.00477, "late transcription": 0.00477, "augmented gr-dependent transcription": 0.00477, "related factor ets1": 0.00477, "transcription stat5": 0.00477, "stimulate transcription": 0.00477, "src family kinase function": 0.00477, "beta interferon promoter": 0.00477, "nuclear factors sp1": 0.00476, "bp crh promoter fragment": 0.00476, "ifn-gamma receptor beta-chain controls responsiveness": 0.00476, "il-2 receptor beta-chain": 0.00476, "murine c-fos promoter": 0.00476, "downstream sequence elements": 0.00476, "constitutive sp1 factor": 0.00476, "functional cre site": 0.00476, "reversed transcription": 0.00476, "antigen receptor": 0.00476, "ltr-driven proviral transcription unit": 0.00476, "vpr modulates t-cell receptor": 0.00476, "promoter sequences responsive": 0.00476, "inhibit il-4 receptor alpha-chain": 0.00476, "receptor interactions": 0.00475, "decreased binding": 0.00475, "dna bend induced": 0.00475, "vitamin d3 receptor": 0.00475, "il-2-gene transcription rate": 0.00475, "il-6 promoter demonstrated": 0.00475, "bp promoter fragment": 0.00475, "influence binding affinity": 0.00475, "gm-csf transcription": 0.00475, "augmented transcription": 0.00475, "cellular receptor": 0.00475, "il-2 regulatory region": 0.00475, "major initiation site": 0.00475, "de novo transcription": 0.00475, "microm 1-beta-d-arabinofuranosylcytosine induced nf-kappa": 0.00474, "gr binding capacity": 0.00474, "stat5 site present": 0.00474, "normal pbl express high levels": 0.00474, "typical binding pattern": 0.00474, "significant aldosterone binding": 0.00474, "mouse il-4 promoter": 0.00474, "general transcription apparatus": 0.00474, "decreased receptor concentration": 0.00474, "transcription rate": 0.00474, "death domain-containing receptor related": 0.00474, "stimulation induces rapid tyrosine phosphorylation": 0.00474, "hormone binding specificity": 0.00474, "il-2 receptor": 0.00474, "-150 proximal ap-1 site": 0.00474, "mouse mammary tumor virus long terminal repeat fused": 0.00474, "b-cell-specific activator protein-binding site": 0.00474, "reverse transcription": 0.00474, "antigen-specific t-cell receptor": 0.00473, "nmi augments stat-mediated transcription": 0.00473, "globin locus control region": 0.00473, "cellular inhibitor kappab alpha": 0.00473, "transcription unit spans": 0.00473, "sensitive chronic myelogenous leukemia patients": 0.00473, "egr-1 transcription": 0.00473, "nf-kappab signaling pathway": 0.00473, "proximal ap-1 site": 0.00473, "form functional nf-e2 complex": 0.00473, "scl transcription": 0.00473, "enzyme active site": 0.00473, "cellular transcriptional nuclear factor-kb": 0.00472, "wild-type promoter construct": 0.00472, "upstream stimulatory factor": 0.00472, "receptor intracellular domains": 0.00472, "tf site bound translated c-rel": 0.00472, "plasma factor vii/viia": 0.00472, "ah receptor ligand": 0.00472, "factor present": 0.00472, "glucocorticoid receptor characteristics": 0.00472, "] thymidine proliferation assay": 0.00472, "inhibit tcr signaling induced": 0.00472, "b-cell stimulatory factor": 0.00472, "akv mlv transcription": 0.00472, "steroid binding test": 0.00472, "binding peptides": 0.00472, "il-2 promoter bearing": 0.00472, "zymogen plasma factor": 0.00472, "ig heavy chain mu e1 site": 0.00472, "ap-2 site mutation": 0.00472, "murine tnf promoter": 0.00471, "persistent transcription": 0.00471, "development factor": 0.00471, "il-1beta transcription": 0.00471, "pml proteins observed": 0.00471, "tal-1 transcription": 0.00471, "t-cell-specific factor nf-at": 0.00471, "nf kappa b2 nucleoprotein complex": 0.00471, "epsilon germline transcription": 0.00471, "il-5 transcription": 0.00471, "c-sis/platelet-derived growth factor-b promoter": 0.00471, "expressing receptor mutants": 0.00471, "cd23 transcription": 0.00471, "il-2 mrna induction": 0.00471, "sendai virus induced hela extracts": 0.00471, "defective transcription": 0.00471, "functional gata-binding site": 0.00471, "ebv binding": 0.00471, "erythroid kruppel-like factor": 0.00471, "hiv protease cleavage site": 0.00471, "proteins expressed": 0.00471, "initiates transcription": 0.0047, "cytoplasmic factor ikappabalpha": 0.0047, "transcription initiates": 0.0047, "signal response domain": 0.0047, "janus family tyrosine kinase jak3": 0.0047, "hiv promoter construct": 0.0047, "il-2r beta mrna levels": 0.0047, "cyclosporin a-sensitive nuclear factors": 0.0047, "transcriptional activating proteins": 0.0047, "vitro binding": 0.0047, "efficient transcription": 0.0047, "-3 induced tyrosine phosphorylation": 0.00469, "platelet activating factor": 0.00469, "site reduced": 0.00469, "intact il-2 promoter": 0.00469, "ap-1 enhancer element": 0.00469, "increased plasma aldosterone levels": 0.00469, "c-jun mrna levels decreased": 0.00469, "tal1 transcription": 0.00469, "nf-kappa b-dna complex": 0.00469, "il-2r induced tyrosine phosphorylation": 0.00469, "lps binding": 0.00469, "transcription units": 0.00468, "t-cell receptor": 0.00468, "stimulating transcription": 0.00468, "ebv early genes bzlf1": 0.00468, "constitutive nuclear nf-kappa": 0.00468, "nf-kappa b/cd28-responsive complex": 0.00468, "il-4-driven germline cepsilon transcription": 0.00468, "cd28 surface receptor": 0.00468, "target site specificity": 0.00468, "tpa response elements demonstrated": 0.00468, "promyelocyte stage ] retinoic acid": 0.00468, "full promoter function": 0.00468, "low molecular weight transmembrane adaptor proteins": 0.00468, "kappa b-dependent genes": 0.00468, "augments transcription": 0.00468, "u2 snrna transcription": 0.00467, "binding experiments": 0.00467, "distinct dna-binding proteins": 0.00467, "ec epitope binding specificity": 0.00467, "cellular signaling pathway": 0.00467, "promoter regulation": 0.00467, "junb transcription": 0.00467, "partial cortisol receptor resistance": 0.00467, "irf-1 gas-binding complex activated": 0.00467, "transcription deficiency": 0.00467, "interferon-alpha activates multiple stat proteins": 0.00467, "antagonize dexamethasone-induced transcription": 0.00467, "affects transcription": 0.00467, "alf1 transactivated transcription": 0.00467, "interleukin-1 beta mrna levels": 0.00467, "retinoblastoma control element present": 0.00466, "pax-5 transcription": 0.00466, "glucocorticoid receptor content": 0.00466, "kappa b-driven genes": 0.00466, "signal transduction pathways induced": 0.00466, "nuclear translocated glucocorticoid receptors": 0.00466, "germline cepsilon transcription": 0.00466, "activate binding": 0.00466, "vitro increased nf-kappa": 0.00466, "] induces differentiation": 0.00466, "squirrel monkey glucocorticoid receptor": 0.00466, "collagenase transcription": 0.00466, "tumour necrosis factor": 0.00466, "kappa b-responsive genes": 0.00466, "upstream exonic cryptic splice site": 0.00466, "endogenous gm-csf mrna induced": 0.00466, "murine t-cell line": 0.00466, "core sp1 consensus element abolished footprinting": 0.00466, "kappa genes": 0.00465, "fasl transcription": 0.00465, "g-csf induced tyrosine phosphorylation": 0.00465, "potent costimulatory factor": 0.00465, "optimal transcription": 0.00465, "early serum responsive genes": 0.00465, "down-regulates cd95l transcription": 0.00465, "gcr binding affinity": 0.00465, "receptor mutant": 0.00465, "epsilon transcription": 0.00465, "ap-1 factor families": 0.00465, "ea/s-directed mlv transcription": 0.00465, "receptor sequences": 0.00465, "suppressing transcription": 0.00465, "adjacent activator site act-1": 0.00465, "transcription factor-1": 0.00465, "major positive regulatory element": 0.00465, "nf-kappab element present": 0.00464, "negative estrogen receptor status": 0.00464, "repress transcription": 0.00464, "er upstream regulatory region": 0.00464, "potentiate stat-dependent transcription": 0.00464, "activate tcf reporter genes": 0.00464, "murine g-csf receptor": 0.00464, "resting t-cell nuclear extracts contained kbf1/p50 homodimer": 0.00464, "represses transcription": 0.00464, "fusion reporter genes irrespective": 0.00464, "transcription rates": 0.00464, "tyrosine kinase inhibitor genistein": 0.00464, "abolish vp16-mediated transcription": 0.00464, "activate genes involved": 0.00464, "pu.1 consensus site": 0.00463, "bind response elements present": 0.00463, "single conserved site": 0.00463, "bzlf1 transcription": 0.00463, "transcription start": 0.00463, "typical ap-1 site": 0.00463, "stimulus-dependent cd44 transcription": 0.00463, "selectively increased antiproliferative effect": 0.00463, "ifn-gamma receptor chain": 0.00463, "germline transcription": 0.00463, "multiple genes involved": 0.00463, "genes expressed 'late": 0.00463, "expressed genes": 0.00462, "ifn-gamma-induced transcription": 0.00462, "nf-kappab-dependent transcription": 0.00462, "chimeric cytokine receptor": 0.00462, "enhance tnf-alpha induced neutrophil apoptosis": 0.00462, "hiv-2 transcription": 0.00462, "genes expressed": 0.00462, "influence histamine-induced [ ca2+ ]": 0.00462, "initiate transcription": 0.00462, "glucocorticoid receptor abnormality": 0.00462, "nuclear rela stimulates p100 mrna": 0.00462, "soluble factor independent": 0.00462, "-mediated transcription": 0.00462, "janus family tyrosine kinase jak2": 0.00462, "specific responsive element il-4re": 0.00462, "opposite glucocorticoid receptor": 0.00462, "alpha complex": 0.00462, "tpo induced tyrosine phosphorylation": 0.00462, "lymphocytic receptor concentrations": 0.00462, "shared receptor motifs": 0.00462, "normal mouse il-2 enhancer": 0.00462, "promoter function": 0.00462, "transcriptional suppressor proteins": 0.00461, "chronic kidney failure ] [": 0.00461, "sustained elevated [ ca2+ ]": 0.00461, "e2f-mediated transcription": 0.00461, "thrombopoietin induced tyrosine phosphorylation": 0.00461, "rickets-like diseases ] [ differential diagnostic": 0.00461, "activation-induced transcription": 0.00461, "up-regulate transcription": 0.00461, "ebna transcription": 0.00461, "elk-1 transcription": 0.00461, "monocytes aspirin inhibits nuclear factor-kappa": 0.00461, "proviral transcription": 0.00461, "platelet factor iv": 0.00461, "jak kinase specific antibodies": 0.00461, "dna-binding site specificity": 0.00461, "influences glucocorticoid receptor": 0.00461, "hlp-1 binding activities": 0.0046, "ifn-beta transcription": 0.0046, "interleukin-2-dependent transcription": 0.0046, "mouse t-cell line ctll-2": 0.0046, "il2 transcription": 0.0046, "show dna damage-induced apoptosis": 0.0046, "kappab-dependent transcription": 0.0046, "kappa b-like sequence": 0.0046, "directs transcription": 0.0046, "rare-mediated transcription": 0.0046, "eukaryotic transcription": 0.0046, "tissue-specific core promoter structure": 0.0046, "interleukin-1beta transcription": 0.0046, "differentiation-dependent transcription": 0.0046, "ongoing transcription": 0.0046, "tax-mediated transcription": 0.0046, "calcineurin active site": 0.0046, "upregulate il-1 receptor antagonist": 0.0046, "limits transcription": 0.0046, "induced tyrosine phosphorylation": 0.00459, "fas/apo-1 receptor results": 0.00459, "nf-kappab-mediated transcription": 0.00459, "core binding factor-alpha": 0.00459, "core region show": 0.00459, "binding activities": 0.00459, "csa-sensitive transcription": 0.00459, "glucocorticoid receptor determination": 0.00459, "inhibit lps-mcd14 binding": 0.00459, "stat nuclear factors": 0.00459, "g1 specific cellular response": 0.00459, "potent chemotactic factor": 0.00459, "forms specific dna-protein complex": 0.00459, "transcription efficiencies": 0.00459, "glucocorticoid receptor cooperates": 0.00459, "cd95 ligand promoter": 0.00459, "tumor necrosis factor-responsive genes": 0.00459, "sites mediate il-6 induction": 0.00459, "base pair long region encoding": 0.00459, "traf binding domains": 0.00459, "tyrosine kinase activated": 0.00458, "thymic locus control region": 0.00458, "octamer/oct-dependent transcription": 0.00458, "aldosterone membrane receptor": 0.00458, "janus kinase 3-stat5a pathway": 0.00458, "nfat-1-mediated transcription": 0.00458, "proenkephalin transcription": 0.00458, "rdna transcription": 0.00458, "nfat-directed transcription": 0.00458, "tyrosine kinase inhibitor herbimycin": 0.00458, "dna-binding factor": 0.00458, "gr-dependent transcription": 0.00458, "high-affinity surface receptor": 0.00458, "expressed sequence tags": 0.00458, "murine pu.1 promoter": 0.00458, "caii transcription": 0.00458, "hiv-1-ltr-driven transcription": 0.00458, "glucocorticoid induced apoptosis": 0.00458, "tcf-mediated transcription": 0.00458, "ltr-mediated transcription": 0.00458, "enhancer-dependent transcription": 0.00458, "beta-globin locus control region": 0.00458, "oct-2-directed transcription": 0.00458, "stat1alpha-induced transcription": 0.00458, "heat shock factor": 0.00458, "nf-at-dependent transcription": 0.00458, "cre-mediated transcription": 0.00458, "actual transcription": 0.00458, "monocyte-specific transcription": 0.00458, "tcf-1-mediated transcription": 0.00458, "elf-1-mediated transcription": 0.00458, "key nuclear factors": 0.00458, "oca-b/oct-1-dependent transcription": 0.00458, "xist transcription": 0.00458, "rela-mediated transcription": 0.00458, "receptor results": 0.00458, "ap-1-dependent transcription": 0.00458, "ap-1-mediated transcription": 0.00458, "ifngamma-dependent transcription": 0.00458, "-dp transcription": 0.00458, "collagenase-1 transcription": 0.00458, "ltr-directed transcription": 0.00458, "inducible cyclosporin a-sensitive dnase i-hypersensitive site": 0.00458, "site-dependent transcription": 0.00458, "tax-activated transcription": 0.00458, "express multiple gata-binding proteins": 0.00458, "c-fos mutant proteins": 0.00458, "mouse t-cell line": 0.00458, "enhancer element undergoes differential modification": 0.00457, "maximal binding capacity": 0.00457, "murine leukemia virus family": 0.00457, "transcription": 0.00457, "elevated [ ca2+ ] i. deltorphin": 0.00457, "gc receptor affinity": 0.00457, "antagonist binding": 0.00457, "map kinase pathway": 0.00457, "bronchial asthma ] [ endocrine status": 0.00457, "gata consensus site": 0.00457, "-dependent factor nf-atp plays": 0.00457, "hyperadhesion response induced": 0.00456, "active factor": 0.00456, "distal nf-at site": 0.00456, "positive transcriptional element": 0.00456, "box binding": 0.00456, "hiv-1 promoter": 0.00456, "tnf mrna induced": 0.00456, "nf-cle0 gamma binding": 0.00456, "t-cell apoptosis ] ngfi-b/nur77": 0.00456, "tp1 rna start site": 0.00456, "induced gr mrna": 0.00456, "monocyte colony-stimulating factor": 0.00456, "binding rfx species correlates": 0.00456, "nsaids induced hsp70 mrna species": 0.00456, "signal transduction mechanisms induced": 0.00456, "calculated binding affinity": 0.00456, "factor bound": 0.00456, "il-1 receptor antagonist": 0.00456, "primary site": 0.00456, "cellular genes plays": 0.00456, "upstream c/ebp-beta site": 0.00456, "significant factor": 0.00455, "murine gm-csf promoter": 0.00455, "gr binding parameters": 0.00455, "map kinase extracellular signal-regulated kinase": 0.00455, "individual sequence elements": 0.00455, "cortisol receptor resistance": 0.00455, "vitro translated tr2 orphan receptor": 0.00455, "ps -and ptdins-mcd14 binding": 0.00455, "adenovirus major late promoter": 0.00455, "hla binding characteristics": 0.00455, "syndrome ] [": 0.00455, "il-1beta promoter construct fused": 0.00455, "glucocorticoid receptor/progesterone receptor": 0.00455, "gr binding characteristics": 0.00455, "genes specific": 0.00454, "cbf beta genes": 0.00454, "steel factor suggests": 0.00454, "specific genes": 0.00454, "mononuclear leukocytes binding": 0.00454, "consensus response elements present": 0.00454, "receptor studies": 0.00454, "lymphoid enhancer-binding factor": 0.00454, "globin cis-elements demonstrates hmg-i binding": 0.00454, "deleted c-jun promoter fragments": 0.00454, "distinguishable gr binding abnormalities": 0.00454, "specific dna sequences": 0.00454, "nuclear run-on analysis": 0.00454, "glucocorticoid receptor": 0.00454, "co-transfected il-2 promoter": 0.00454, "ea-d promoter demonstrated": 0.00454, "cross-linking induced nf-kappa": 0.00454, "p56 src family non-receptor tyrosine kinase": 0.00454, "patients enter disease remission": 0.00454, "promoter deletion studies": 0.00453, "jurkat t-cell line": 0.00453, "tyrosine kinase inhibitor": 0.00453, "distal promoter sequences": 0.00453, "il-6 receptor subunit gp130 fused": 0.00453, "major site": 0.00453, "proteins identified": 0.00453, "hormone binding": 0.00453, "examined binding": 0.00453, "intracellular signaling complex": 0.00453, "guanine nucleotide exchange factor vav": 0.00453, "octamer factor variants": 0.00453, "receptor concentrations": 0.00453, "t-cell line jurkat": 0.00453, "hepatic leukemic factor": 0.00453, "sp1 site contribute": 0.00453, "eosinophil-specific genes encoding primary": 0.00453, "autocrine and/or paracrine factor": 0.00453, "identified proteins": 0.00453, "nuclear nf-at complexes": 0.00452, "double repeat-kb enhancer sequence": 0.00452, "affinity binding": 0.00452, "binding affinity": 0.00452, "complex effects": 0.00452, "promoter demonstrated": 0.00452, "negative factor": 0.00452, "strong constitutively active promoter": 0.00452, "dna elements present include": 0.00452, "-positive patients suggest": 0.00452, "src family tyrosine kinase lck": 0.00452, "initiation binding repressor": 0.00452, "epstein-barr virus lmp1 domain important": 0.00452, "il-2 promoter": 0.00452, "truncated delta promoter fragment": 0.00452, "significant gr mrna induction": 0.00452, "erythropoietin- induced erythroid differentiation": 0.00452, "thrombin-induced p65 homodimer binding": 0.00452, "trans-acting factor common": 0.00452, "sp ii promoter": 0.00451, "fusion proteins present": 0.00451, "nuclear factors nf-il6": 0.00451, "impaired cortisol binding": 0.00451, "upstream site": 0.00451, "nuclear factor-kappa b/rel induction": 0.00451, "multimerized octamer enhancer element": 0.00451, "site related": 0.00451, "negative regulatory region responsive": 0.00451, "downstream target genes regulated": 0.00451, "myeloid differentiation primary response": 0.00451, "tramtrack [ ttk ] -associated box": 0.00451, "separate sequence elements": 0.00451, "cytokine genes indicating": 0.00451, "patients carrying b27 antigen": 0.0045, "affected factor operates": 0.0045, "nuclear kinase": 0.0045, "lps-induced tnf-alpha factor": 0.0045, "comments ] glucocorticoid receptors": 0.0045, "t-cell-specific promoter sequences": 0.0045, "activated platelets induces il-1 beta": 0.0045, "fasl promoter enhanced": 0.0045, "signal transduction pathways mediate nf-kappa": 0.0045, "relative binding affinities": 0.0045, "fc gamma receptor": 0.0045, "stimulate granulocyte-macrophage colony-stimulating factor": 0.0045, "genes encoding proinflammatory cytokines": 0.00449, "dexamethasone binding": 0.00449, "heat-labile serum factor": 0.00449, "nf-m-estrogen receptor expressing progenitors": 0.00449, "specific cd8+ ctl line": 0.00449, "main factor responsible": 0.00449, "induced erythroid differentiation": 0.00449, "putative g0/g1 switch regulatory genes": 0.00449, "murine e3 promoter harbors": 0.00449, "ligand promoter": 0.00449, "hiv-1 ltr region": 0.00449, "ets proteins inhibits": 0.00449, "unknown inducible factor": 0.00449, "estrogen receptor positive": 0.00449, "zeta-globin promoter deletion constructs": 0.00449, "nuclear factor-kappab induction": 0.00449, "locus control region": 0.00448, "active cre site": 0.00448, "cd14 lps receptor": 0.00448, "acute promyelocytic leukemia patients": 0.00448, "mhc class ii deficient b-cell lines": 0.00448, "receptor dimerization process and/or": 0.00448, "adjacent ap-1 site": 0.00448, "affect constitutive signaling induced": 0.00448, "endogenous immunoglobulin surrogate light chain genes": 0.00448, "ap-1 binding": 0.00448, "tumor suppressor proteins p53": 0.00448, "studied glucocorticosteroid receptor density": 0.00448, "proteins gata-1 binds": 0.00448, "tf promoter required": 0.00448, "coexpressed genes identified": 0.00448, "cytokine receptor superfamily": 0.00448, "early proteins tested": 0.00448, "active transcriptional complex": 0.00448, "granulocyte macrophage colony-stimulating factor": 0.00447, "specific sequence": 0.00447, "chronic myelogenous leukemia patients": 0.00447, "essential factor": 0.00447, "pattern recognition receptor": 0.00447, "guanine nucleotide exchange factor": 0.00447, "target site": 0.00447, "nf-at site": 0.00447, "granulocyte-macrophage colony stimulating factor": 0.00447, "binding properties": 0.00447, "induced maximal monocyte differentiation": 0.00447, "key cellular proteins": 0.00447, "nuclear trans-acting factors": 0.00447, "sequence specific": 0.00447, "displayed differential binding": 0.00447, "nf-il6 sites mediate induction": 0.00447, "tumor promoter": 0.00447, "colony-forming unit monocyte [ cfu-m ]": 0.00447, "hmg i/y stimulates oct-2a binding": 0.00447, "m-csf increases c-fos mrna levels": 0.00447, "site alpha-binding activities": 0.00447, "minimal promoter regions": 0.00446, "mol/l 9-cis ra increased levels": 0.00446, "e2a proteins required intact": 0.00446, "potential phosphorylation sites include": 0.00446, "hormonal receptor presence": 0.00446, "nuclear factor-kappab-dependent induction": 0.00446, "platelet factor": 0.00446, "specific dna motifs": 0.00446, "mouse gm-csf promoter": 0.00446, "binding pattern": 0.00446, "steroid hormone receptor": 0.00446, "hs-40 enhancer region": 0.00446, "maximum binding capacity": 0.00446, "anti-rheumatic compound aurothioglucose inhibits tumor necrosis factor-alpha-induced hiv-1 replication": 0.00446, "surface receptor": 0.00446, "lef-1-binding site inhibit": 0.00446, "early lytic cycle proteins": 0.00445, "ikk2 inhibited lps induction": 0.00445, "b-cell-specific enhancer element": 0.00445, "alpha,25-dihydroxyvitamin d3 receptor": 0.00445, "patients express transcripts": 0.00445, "tlck inhibited lps induction": 0.00445, "transcriptional complex ap-1": 0.00445, "dominant negative atra receptor": 0.00445, "salicylates inhibited lps induction": 0.00445, "binding mutants": 0.00445, "nre gamma site": 0.00445, "nuclear induction": 0.00445, "viral promoter switching": 0.00445, "blocks cd28 binding": 0.00445, "lymphocytes activate nf-kappa": 0.00445, "proinflammatory lps receptor": 0.00445, "caat consensus site": 0.00445, "delayed stat3 binding": 0.00444, "tumor-infiltrating lymphocytes induced": 0.00444, "ubiquitous factor oct-1": 0.00444, "heterologous promoter reduced": 0.00444, "il-2 induced comparable formation": 0.00444, "measured binding": 0.00444, "sequence elements": 0.00444, "lps stimulation induced": 0.00444, "constitutively activated jak-stat pathway": 0.00444, "-like genes suggest": 0.00444, "enhanced lps-induced mrna levels": 0.00444, "hiv-1 tat genes": 0.00444, "factor plays": 0.00444, "critical factor": 0.00444, "t-cell line derived": 0.00444, "interleukin-1 receptor synthesis": 0.00444, "deletional vcam-1 promoter constructs": 0.00444, "[ regulatory effect": 0.00444, "monocyte binding": 0.00444, "ra binding": 0.00444, "rar-rxr response pathway": 0.00444, "yy1 nuclear factors": 0.00444, "lacked binding ability": 0.00444, "tnf receptor-associated factor": 0.00444, "steroid receptor agonist cortisol": 0.00444, "vitamin d-dependent rickets type ii show functional defects": 0.00444, "initial viral promoter": 0.00444, "identified dna sequences": 0.00444, "cognate nuclear factors": 0.00443, "consensus ckii site": 0.00443, "jak kinase pathway": 0.00443, "lmp promoter-binding proteins form": 0.00443, "dna-binding regulatory proteins": 0.00443, "transformation effector site": 0.00443, "genes encoding cytokines": 0.00443, "inhibited lps induction": 0.00443, "cytokine receptor dimerization": 0.00443, "sustained nuclear nf-kappa": 0.00443, ":3775 ] tyrosine phosphorylation": 0.00443, "sp1/egr-1 site termed": 0.00443, "labile inhibitory factor": 0.00443, "multiple cytokine genes": 0.00443, "putative il-3-regulated factor": 0.00443, "sequence analyses show": 0.00442, "colostrum inhibitory factor": 0.00442, "multisubunit adhesion receptor": 0.00442, "nuclear factors atf-2": 0.00442, "nf-at-regulated genes suggest": 0.00442, "internal functional promoter": 0.00442, "hepatocyte nuclear factor-1 alpha": 0.00442, "helix-loop-helix proteins function": 0.00442, "induced minimal levels": 0.00442, "site termed": 0.00442, "consensus ap-1/cre site": 0.00442, "cd40 signaling determinants regulating nuclear factor-kappa": 0.00442, "enhancer sequence": 0.00442, "mutated octamer site": 0.00442, "promoter chromatin structure resulting": 0.00442, "beta proteins": 0.00442, "mononuclear leukocyte receptor kinetics": 0.00441, "serine protease factor viia": 0.00441, "consensus site": 0.00441, "adjacent long terminal repeat region": 0.00441, "essential positive regulatory element": 0.00441, "thyroid hormone receptor": 0.00441, "direct binding": 0.00441, "intact pu.1 site adjacent": 0.00441, "c-myc promoter constructs": 0.00441, "nuclear factors evi-1": 0.00441, "conserved transcriptional element": 0.00441, "ebv receptor": 0.00441, "native promoter constructs": 0.00441, "parental granulocyte-macrophage colony-stimulating factor": 0.00441, "r-responsive enhancer region": 0.00441, "binds basic helix-loop-helix-zipper proteins": 0.00441, "vitro activated lymphocytes": 0.00441, "inducible t-cell genes": 0.00441, "pma/ionomycin-induced nuclear factors": 0.00441, "sendai virus induced extracts": 0.00441, "characteristic competitive binding profile": 0.00441, "stat1 factor": 0.0044, "ap-1 complexes induced": 0.0044, "69-bp proximal promoter fragment": 0.0044, "class ii non-inducible rb-defective tumor lines": 0.0044, "specific t-cell tolerance induction": 0.0044, "peripheral blood lymphocytes =": 0.0044, "aberrant retinoic-acid receptors type alpha": 0.0044, "stress-activated kinase pathway": 0.0044, "hiv-1 inhibited hiv-1 replication": 0.0044, "receptor level": 0.0044, "nuclear factors": 0.0044, "-65 region identified": 0.0044, "hematology tumor suppressor proteins": 0.0044, "receptor molecule": 0.0044, "nuclear signaling mechanisms": 0.0044, "coactivator creb binding protein/p300": 0.0044, "inhibitory factor": 0.0044, "binding capacity": 0.0044, "factor called ik": 0.0044, "enhancer region": 0.0044, "site contained": 0.0044, "nf-kappa b-dependent transcriptional stimulation": 0.0044, "normal glucocorticoid response": 0.0044, "peroxisome proliferator-activated receptor gamma": 0.0044, "e-box-dependent bhlh homo -or heterodimer complex formation": 0.0044, "dna-binding site": 0.0044, "interleukin-1 beta genes": 0.00439, "promoter assays": 0.00439, "single gata-binding site": 0.00439, "phorbol ester response elements": 0.00439, "e3330 decreased activated nf-kappa": 0.00439, "polymorphonuclear leukocytes binding": 0.00439, "gr binding power": 0.00439, "thrombin-induced [ ca2+ ]": 0.00439, "disease patients": 0.00439, "actual hla binding": 0.00439, "prognostic criteria ] [ hormonal metabolic status": 0.00439, "tnf alpha effect": 0.00439, "lps receptor": 0.00439, "histamine-induced [ ca2+ ]": 0.00438, "active site": 0.00438, "induced b-cell apoptosis": 0.00438, "cd4 promoter transactivation": 0.00438, "potent site": 0.00438, "hla binding": 0.00438, "regulating proteins involved": 0.00438, "promoter deletion analyses suggested": 0.00438, "inducible factor nf-gm2": 0.00438, "trans-activate cd19 promoter constructs": 0.00438, "additional taqi restriction site": 0.00438, "mutated nef genes expressing truncated nefs": 0.00438, "asthmatic subjects ] [": 0.00438, "receptor synthesis": 0.00438, "macrophage receptor isoforms": 0.00437, "gr binding": 0.00437, "[ ca2+ ]": 0.00437, "il-3 promoter constructs": 0.00437, "complex family": 0.00437, "murine tnf genes": 0.00437, "angiotensin at1 receptor antagonist losartan": 0.00437, "electrophoretic mobility shift assay analysis suggested": 0.00437, "prominent constitutive binding": 0.00437, "factor functions": 0.00437, "acute leukemia patients": 0.00437, "related kinase inhibitor": 0.00437, "inducible factor": 0.00437, "tcdd treatment decreased steady state levels": 0.00437, "granulocyte- macrophage colony-stimulating factor": 0.00437, "heterologous promoter construct": 0.00437, "virus contained high levels": 0.00437, "distinct stat5 proteins": 0.00437, "binding data": 0.00437, "cytokine receptor": 0.00437, "transmembrane receptor termed blr2": 0.00437, "important hematopoietic genes": 0.00437, "nf-at/dna binding defect": 0.00437, "short enhancer element": 0.00436, "show sequence homology": 0.00436, "extracellular factor": 0.00436, "block anti-cd3 induced peripheral blood": 0.00436, "phorbol ester induced jurkat t-cells": 0.00436, "macrophage colony-stimulating factor": 0.00436, "dominant control region": 0.00436, "tyrosine phosphorylation status increased": 0.00436, "recombinant vp16 fusion proteins": 0.00436, "estrogen receptor concentration": 0.00436, "mouse embryonic globin genes": 0.00436, "ubiquitous otf-1 factor": 0.00436, "pma treatment induced cd3": 0.00436, "igh enhancer prevents nuclear matrix attachment": 0.00436, "distinct stat proteins": 0.00436, "putative ap-1 recognition sequence predicted": 0.00436, "hormone receptor status": 0.00436, "kd factor": 0.00436, "e1a mutant proteins": 0.00436, "e1b-19 kda proteins suggesting": 0.00436, "upstream regulatory region": 0.00436, "tumor suppressor proteins": 0.00436, "increased sera il-4 levels": 0.00436, "chronic hepatitis c. functional b-cell response": 0.00435, "constitutive binding": 0.00435, "site mutations": 0.00435, "differentiation-dependent peroxisomal proliferator-activated receptor gamma": 0.00435, "granulocyte/macrophage colony stimulating factor": 0.00435, "region ii interacts": 0.00435, "secondary factor": 0.00435, "steroid-thyroid hormone receptor superfamily": 0.00435, "cloned binding": 0.00435, "transcribed genes demonstrated extensive": 0.00435, "nf-kappab proteins": 0.00435, "kd tnf receptor": 0.00435, "comments ] induction": 0.00435, "latent cycle regulatory genes": 0.00435, "induced nf-kappa": 0.00435, "monocyte-macrophage colony stimulating factor": 0.00435, "resting pbl-t suppresses binding": 0.00435, "ap-1 site": 0.00435, "nuclear nf-kappa": 0.00435, "dexamethasone induced eosinophil apoptosis": 0.00435, "proximal il-4 promoter": 0.00435, "promoter proximal repeat": 0.00435, "irreversible terminal differentiation induced": 0.00435, "beta zero-thalassemia patients": 0.00435, "steroid/thyroid hormone receptor superfamily": 0.00435, "fc gammar1 stat site": 0.00435, "single site": 0.00435, "kruppel-like zinc finger proteins termed tab": 0.00434, "receptor down-regulation due": 0.00434, "beta 2-integrin genes": 0.00434, "factor responsible": 0.00434, "block nf-kappab-dna binding": 0.00434, "displays binding consistent": 0.00434, "immunoglobulin heavy-chain mu e1 site": 0.00434, "endogenous ap-1 regulated genes": 0.00434, "ikb alpha induced": 0.00434, "mouse b29 promoter": 0.00434, "regulating genes required": 0.00434, "membrane receptor": 0.00434, "binding patterns": 0.00434, "receptor transcripts": 0.00434, "full length promoter construct": 0.00434, "nfat binding": 0.00434, "cell-specific factor": 0.00433, "distal enhancer element": 0.00433, "major histocompatibility complex class": 0.00433, "il-1alpha promoter constructs": 0.00433, "nuclear regulatory factor-kappa beta": 0.00433, "21-base pair sequence designated": 0.00433, "nucleotides [ nt ]": 0.00433, "il-8 promoter regions": 0.00433, "beta genes": 0.00433, "fc reduced pma-induced hiv-1 p24 antigen production": 0.00433, "early genes c-fos": 0.00433, "clinical stage i-ii patients": 0.00433, "putative nfat-1 site": 0.00433, "activating granulocyte-colony-stimulating factor": 0.00433, "c-myb mrna induced": 0.00433, "additional factor": 0.00433, "% sequence homology": 0.00433, "receptor activator": 0.00433, "neutralizing anti-tnf alpha monoclonal antibody": 0.00433, "murine leukemia virus enhancer cores": 0.00433, "t-cell receptor-cd3 complex activates": 0.00432, "peroxisomal proliferator-activated receptor gamma": 0.00432, "block binding": 0.00432, "longer prevents binding": 0.00432, "proil-1 beta cap site-proximal region": 0.00432, "affects oct-1 binding": 0.00432, "activated early signaling events": 0.00432, "well-established risk factor": 0.00432, "sv40 early promoter": 0.00432, "granulocyte macrophage-colony stimulating factor": 0.00432, "-230 gata-1 site": 0.00432, "comparable enhancer element": 0.00432, "multiple intracellular proteins": 0.00432, "cortisol binding": 0.00432, "increase virus production": 0.00432, "clonal immune response specific": 0.00431, "proximal jun1 tumor promoter-responsive element": 0.00431, "inducible binding": 0.00431, "ciita b-cell-specific promoter suppression": 0.00431, "erk pathway-specific inhibitor pd98059 inhibited il-6 secretion": 0.00431, "radioligand binding method": 0.00431, "promoter context-specific manner": 0.00431, "proteins show": 0.00431, "activating protein-1 binding": 0.00431, "proximal p0 site": 0.00431, "lipopolysaccharide increased viral production": 0.00431, "defined major depressive disorder patients": 0.00431, "delta promoter activates": 0.00431, "antioxidants inhibited tnf -or pma-induced nf-kappa": 0.00431, "lfa-3 induced moderate levels": 0.00431, "dra promoter construct": 0.0043, "lysopc increased monocytic camp levels": 0.0043, "risk factor": 0.0043, "box dna-binding proteins": 0.0043, "selectively upregulate delayed-early viral genes": 0.0043, "viral promoter": 0.0043, "differential binding affinities": 0.0043, "mutant ap-1 element": 0.0043, "growth factor-induced genes": 0.0043, "il-4 receptor engagement": 0.0043, "alpha induced": 0.0043, "cellular survival-promoting proteins": 0.0043, "neutrophil binding": 0.0043, "soluble factor": 0.0043, "b-cell-specific factor": 0.00429, "nuclear hormone receptors": 0.00429, "binding contribute": 0.00429, "essential site": 0.00429, "radio-ligand binding method": 0.00429, "cytokine signaling pathway": 0.00429, "proximal polya site": 0.00429, "cell-specific negative regulatory element": 0.00429, "abolished binding": 0.00429, "retinoic acid induces apoptosis": 0.00429, "cellular proteins": 0.00429, "granulocyte-macrophage colony-stimulating factor": 0.00429, "cytokines activated factors": 0.00429, "positive receptor status": 0.00429, "progesterone binding structures": 0.00429, "proximal pebp2/cbf site": 0.00429, "interleukin-12 receptor component": 0.00429, "hepatic leukaemia factor": 0.00429, "hiv-2 enhancer element": 0.00429, "sre motif induced": 0.00428, "lymphoid-specific enhancer element": 0.00428, "viral nuclear antigen": 0.00428, "selective eosinophil-activating factor": 0.00428, "receptor antagonist ru-38486": 0.00428, "hmg box proteins play": 0.00428, "increased il-4 levels": 0.00428, "lymphocyte-specific enhancer element": 0.00428, "proximal site": 0.00428, "common site": 0.00428, "negative regulatory dna sequences": 0.00428, "cell-specific binding": 0.00428, "early promoter": 0.00428, "cellular genes transcribed": 0.00428, "-responsive enhancer element": 0.00428, "gp91phox promoter constructs": 0.00428, "kda factor": 0.00428, "radiolabeled immunoglobulin heavy chain germline epsilon promotor sequence": 0.00428, "dprl promoter construct": 0.00428, "receptor antagonist pd-135,158": 0.00428, "murine b-cell specific transcriptional coactivator bob1": 0.00427, "nf-microb-binding site plays": 0.00427, "gata site abolishes hs": 0.00427, "tyrosine kinase inhibition": 0.00427, "related proteins bcl-2": 0.00427, "stable binding": 0.00427, "vitd3 induce distinct monocytic differentiation pathways": 0.00427, "tumor suppressor genes": 0.00427, "truncated pecam-1 promoter segments cloned": 0.00427, "nf-m-dependent promoter constructs": 0.00427, "proteolysis-resistant nuclear factor-kappab inhibitor": 0.00427, "platelet low-affinity igg receptor": 0.00427, "tyrosine phosphatase specific inhibitor pervanadate": 0.00427, "control patients": 0.00427, "activated nras induced": 0.00427, "branch site critical": 0.00427, "chain mrna induction": 0.00427, ":1091 ] induction": 0.00427, "il-4 induced phosphorylation": 0.00427, "receptor antagonist": 0.00427, "steroid binding": 0.00426, "induced myeloid differentiation": 0.00426, "core sp1 consensus element": 0.00426, "minimal lox promoter fragment": 0.00426, "gata-1 site": 0.00426, "site plays": 0.00426, "intact gpix ets site": 0.00426, "granulocyte colony-stimulating factor": 0.00426, "sp1 site": 0.00426, "single signal transduction pathway": 0.00426, "identified cis-acting element": 0.00426, "subsequent binding": 0.00426, "pre-i enhancer element": 0.00426, "induced nf kappa": 0.00426, "steroid receptor drugs": 0.00426, "stimulates gtp binding": 0.00426, "nuclear nf kappa": 0.00426, "fc gamma rii-negative b-cell line": 0.00426, "putative aml1-binding site": 0.00426, "9-cis ra inhibited virus replication": 0.00426, "promoter constructs": 0.00426, "lps-responsive enhancer element": 0.00426, "hla class ii molecules present antigen": 0.00426, "bp hepor promoter": 0.00426, "unique gata site": 0.00426, "receptor rna": 0.00426, "ig heavy chain promoter": 0.00425, "specific nuclear translocation": 0.00425, "gata-3 site abolished antigen-": 0.00425, "identified tat-responsive element corresponds": 0.00425, "prevents binding": 0.00425, "signaling events induced": 0.00425, "signaling pathway molecules jak1": 0.00425, "antibodies induces tyrosine phosphorylation": 0.00425, "ubiquitous factor": 0.00425, "il-2 induced tyrosine": 0.00425, "decreased promoter strength": 0.00425, "sites ]": 0.00425, "regulatory dna elements": 0.00425, "il-10 binding": 0.00425, "800-base pair proximal promoter": 0.00425, "characterized murine il-2-responsive element": 0.00424, "binding specificity": 0.00424, "glucocorticosteroid receptor number": 0.00424, "endothelial receptor": 0.00424, "immunosuppressive factor": 0.00424, "mnp site leads": 0.00424, "enhancer element": 0.00424, "inflammatory cytokine genes": 0.00424, "viral structural proteins": 0.00424, "hla-dq isotype-specific trans-acting factor": 0.00424, "detectable binding": 0.00424, "major transactivation region": 0.00424, "general factor": 0.00424, "chicken erythrocyte factor": 0.00424, "numerous cellular genes": 0.00424, "sh2 domain activated syk-family kinases": 0.00424, "increased c-fos mrna": 0.00424, "rat t-cell line": 0.00424, "increased il-2 production": 0.00424, "pu.1 binding": 0.00424, "vitro dna mobility shift assays": 0.00424, "sr patients demonstrated": 0.00424, "e74 site independent": 0.00423, "recovered proteins involved": 0.00423, "nf-kb factor": 0.00423, "increased tyrosine phosphorylation": 0.00423, "promoter regions": 0.00423, "tnf receptor systems": 0.00423, "conserved sequence motifs": 0.00423, "rel/nuclear factor kappab": 0.00423, "differential binding": 0.00423, "erythroid delta-aminolevulinate synthase mrna levels": 0.00423, "dominant-negative ets-binding factor": 0.00423, "impaired binding": 0.00423, "regulated zinc finger proteins": 0.00423, "receptor remains poorly defined": 0.00423, "comments ] alcoholic extracts prepared form arnicae flos": 0.00423, "binding reaction": 0.00423, "h. binding": 0.00423, "agonist binding": 0.00422, "specific dna-protein complex": 0.00422, "recognition site": 0.00422, "lymphocytes induces caspase-dependent apoptosis": 0.00422, "receptor number": 0.00422, "negative regulatory sequence": 0.00422, "heterodimeric binding partner": 0.00422, "ten in-vitro-stimulated normal adult peripheral blood lymphocyte samples": 0.00422, "stress responsive hsp70b promoter": 0.00422, "stat binding": 0.00422, "differential mrna display analysis": 0.00422, "isolated cdna clones encoding tcf-1 alpha": 0.00422, "receptor affinity": 0.00422, "multicomponent receptor model": 0.00422, "predicted peptide sequence": 0.00422, "distinct apoptosis signaling pathways": 0.00422, "27-amino acid regulatory motif": 0.00422, "wild-type receptor": 0.00422, "selective binding": 0.00422, "creb binding": 0.00422, "decreased activated levels": 0.00422, "class iii snrna genes": 0.00422, "il-4 inhibited lps-induced nf-kappa": 0.00422, "proximal tnf-alpha promoter": 0.00422, "induced mrna": 0.00422, "apl patients expressing hla dr11": 0.00422, "c-fos regulatory region participates": 0.00422, "factor consists": 0.00421, "intracellular receptor belonging": 0.00421, "intact tcr signaling pathway": 0.00421, "major 29-kda proteins phosphorylated": 0.00421, "hiv-1 transcriptional induction": 0.00421, "binding parameters": 0.00421, "cytoplasmic receptor": 0.00421, "gata-1 mrna increased": 0.00421, "glucocorticoid response elements": 0.00421, "prevented additional complex formation": 0.00421, "cd4 promoter plays": 0.00421, "hiv regulatory region": 0.00421, "binding characteristics": 0.00421, "granulocyte-colony stimulating factor": 0.00421, "murine nf-at complex": 0.00421, "promyelocyte stage ] [": 0.00421, "pma activated erk2 kinase": 0.00421, "nfat site": 0.00421, "calcineurin docking site": 0.00421, "chimeric il-6 receptor": 0.00421, "increased mrna accumulation": 0.0042, "upstream regulatory element": 0.0042, "b2 factor": 0.0042, "internal ribosome binding": 0.0042, "murine gm-csf genes": 0.0042, "adjacent 20-base pair upstream sequence": 0.0042, "stationary-phase sigma factor rpos": 0.0042, "internal ribosomal binding": 0.0042, "sequence shows high homology": 0.0042, "il-4 target genes": 0.0042, "regulatory element upstream": 0.0042, "cellular genes": 0.0042, "mcf13 murine leukemia virus long terminal repeat": 0.0042, "egr-1 binding": 0.00419, "nuclear levels": 0.00419, "identified element": 0.00419, "alter stat-1alpha binding": 0.00419, "determining factor": 0.00419, "ebv nuclear antigen": 0.00419, "key genes involved": 0.00419, "constitutively activated stat factors": 0.00419, "t-cell-specific elf-1 factor": 0.00419, "site conserved": 0.00419, "mutant proteins": 0.00419, "levels induced": 0.00419, "early g1 proteins p27": 0.00419, "ra nuclear receptors": 0.00419, "nf-kappab sequence": 0.00419, "chimeric e2a-hlf proteins isolated": 0.00419, "anti-cd28 moab costimulation increased nf kappa": 0.00419, "radiolabeled il-2r alpha kappa b-specific oligonucleotide probe": 0.00419, "involves nuclear inhibition": 0.00419, "negative regulatory region": 0.00419, "soluble interleukin-2 receptor": 0.00419, "viral latent genes": 0.00418, "granulocyte/macrophage colony-stimulating factor": 0.00418, "il-4 receptor": 0.00418, "genes encoding tissue-specific components": 0.00418, "signal transducing proteins": 0.00418, "sp1 phosphorylation induced": 0.00418, "bp ebna2 responsive region": 0.00418, "internal ribosomal entry site": 0.00418, "efficient mar-bp1 binding": 0.00418, "immediate-early factor": 0.00418, "genomic sterol regulatory sequence": 0.00418, "ra induced apoptosis": 0.00418, "lymphoid-specific octamer-binding factor": 0.00418, "affect receptor clustering": 0.00418, "lineage-specific factor acting": 0.00418, "group ii type ii mhc cid": 0.00418, "progesterone-induced blocking factor": 0.00418, "adult murine tissues demonstrate spi-b mrna": 0.00418, "il-2 genes": 0.00418, "soluble il-6 receptor": 0.00418, "abrogate ick-1 binding inactivates": 0.00417, "cell-specific enhancer elements identified": 0.00417, "abnormal binding": 0.00417, "erythroid-enriched nf-e2 factor": 0.00417, "ccaat-binding factor nf-y": 0.00417, "defective binding": 0.00417, "distinct proteins": 0.00417, "cdnas encoding octamer-binding proteins": 0.00417, "crucial factor": 0.00417, "igg immune complex model": 0.00417, "jak3 binding": 0.00417, "kappab binding": 0.00417, "extra taqi restriction site": 0.00417, "intracellular receptor": 0.00417, "acquired immunodeficiency syndrome patients": 0.00417, "base pair cis-acting regulatory element": 0.00416, "specific complex": 0.00416, "diminished receptor density": 0.00416, "unidentified factor": 0.00416, "il-10 induced signal transduction": 0.00416, "lymphoid cem line displayed resistance": 0.00416, "blocking factor": 0.00416, "diminished binding": 0.00416, "efficient binding": 0.00416, "intact chimeric egf-gp130 receptor": 0.00416, "receptor isoforms": 0.00416, "cyclin-dependent kinase inhibitor p27kip1 plays": 0.00416, "distinct genes encode": 0.00416, "estrogen receptor antagonists": 0.00416, "ca2+ signal-dependent regulatory element obligatory": 0.00416, "cytoplasmic tyrosine kinase required": 0.00416, "ifn-beta inhibited il-2 deprivation apoptosis": 0.00416, "immunoglobulin variable region promoters": 0.00416, "ap-1 complexes contained specific members": 0.00416, "627-bp full-length promoter fragment": 0.00416, "cd28 receptor ligation": 0.00416, "cytosolic factor": 0.00416, "prognostic factor": 0.00416, "induced neutrophil differentiation": 0.00415, "rpon sigma factor": 0.00415, "colony-stimulating factor": 0.00415, "exclusive binding selectivity": 0.00415, "hungarian male breast cancer patients": 0.00415, "vitro primary immune response": 0.00415, "gata site separated": 0.00415, "representative factor": 0.00415, "binding sites/cell": 0.00415, "ra target genes": 0.00415, "% sequence similarity": 0.00415, "receptor mutants": 0.00415, "progesterone binding": 0.00415, "vivo hla-dr promoter occupancy": 0.00415, "tryptophan photoproduct 6-formylindolo [ 3,2-b ] carbazole": 0.00415, "dnase i-hypersensitive chromatin site": 0.00415, "interleukin-1-beta [ il-1 ]": 0.00415, "il-4r alpha cytoplasmic domain": 0.00415, "factor associates": 0.00415, "% sequence identity": 0.00415, "trans-acting factor": 0.00415, "dna affinity precipitation assay": 0.00415, "nf-at core sequence tttcc": 0.00415, "whole-cell competitive binding radioassay": 0.00415, "high-affinity binding": 0.00415, "lymphoid-specific otf-2 factor": 0.00414, "respective factor": 0.00414, "order transcriptional complex": 0.00414, "full length c-jun promoter": 0.00414, "c/ebp site": 0.00414, "t-cell-specific factor": 0.00414, "tbp-associated factor tafii32": 0.00414, "high-affinity ifp53 gas site": 0.00414, "nf-kappab-dependent intracellular signaling pathway": 0.00414, "heterodimer complex formation": 0.00414, "tbp-associated factor tafii250": 0.00414, "major promoter": 0.00414, "von willebrand factor": 0.00414, "octamer site": 0.00414, "classical interferon-gamma-activated site": 0.00414, "activating arre-1 site": 0.00414, "resulting fusion genes encode": 0.00414, "type ii receptors decreased": 0.00414, "ra receptor": 0.00414, "pu.1 autoregulatory site": 0.00414, "repair/transcription factor tfiih": 0.00414, "androgen receptor locus": 0.00414, "pgg-glucan binding moiety": 0.00414, "male breast cancer patients": 0.00413, "androgen receptor agonist proteolytic attack": 0.00413, "accessory factor": 0.00413, "platelet fibrinogen receptor": 0.00413, "antiapoptotic factor": 0.00413, "p50/p50 kbf1 factor": 0.00413, "adjacent sp 1-binding site": 0.00413, "nf-kappa b/rel family members regulating": 0.00413, "zinc finger proteins sp1": 0.00413, "single conserved ubiquitous cyclic amp-responsive element": 0.00413, "chronic virus infection develop antibodies": 0.00413, "pre-existing nf-at-binding factor": 0.00413, "promoter chromatin structure": 0.00413, "developmental stage-specific nuclear factor-dna complexes": 0.00413, "sequence-specific binding": 0.00413, "constitutive interferon-gamma receptor": 0.00413, "upstream promoter": 0.00413, "binding require": 0.00413, "initiation site": 0.00412, "full-length chimeric receptor": 0.00412, "fusion promoter": 0.00412, "nf-kappab nuclear translocation correlate": 0.00412, "form heteromeric kappa b-binding complexes": 0.00412, "tnf induced apoptosis": 0.00412, "cbf site": 0.00412, "calcitriol binding": 0.00412, "export factor": 0.00412, "nf kappa b2 effect": 0.00412, "chronic renal failure patients": 0.00412, "t-cell genes": 0.00412, "platelet-activating factor": 0.00412, "optimal binding": 0.00412, "death receptor": 0.00412, "chronic pulmonary heart disease ]": 0.00412, "pu.1 site": 0.00412, "chemotactic factor": 0.00412, "intermediary factor": 0.00412, "proapoptotic factor": 0.00412, "monocytic differentiation induced": 0.00412, "binding avidity": 0.00412, "truncated tnf-alpha promoter": 0.00411, "kbf1 factor": 0.00411, "time-dependent binding": 0.00411, "-like factor": 0.00411, "h. oct-2 mrna induction": 0.00411, "positive activator region": 0.00411, "il-12 induced phosphorylation": 0.00411, "rantes factor": 0.00411, "immunoglobulin heavy chain constant region": 0.00411, "complex enhancer": 0.00411, "simultaneous binding": 0.00411, "nf-at-binding factor": 0.00411, "-70 gata site": 0.00411, "numerous genes required": 0.00411, "cytoplasmic tyrosine kinase involved": 0.00411, "receptor subunit": 0.00411, "cdnas encoding proteins": 0.00411, "dna electrophoresis mobility gel shift assays": 0.00411, "heme-responsive factor": 0.00411, "upstream prl response elements": 0.0041, "multiple proteins interact": 0.0041, "high molecular weight complex": 0.0041, "myeloid-specific factor": 0.0041, "c-fos mrna induction": 0.0041, "tyrosine kinase receptors": 0.0041, "stat1-stat2 signaling complex": 0.0041, "similar mrna levels": 0.0041, "p75 tnf receptor": 0.0041, "binding affinities": 0.0041, "deleted promoter lacking": 0.0041, "complex role": 0.0041, "proteins involved": 0.0041, "cis-acting negative regulatory element": 0.0041, "ifn-gamma receptor alpha-chain": 0.0041, "ptdins binding": 0.0041, "protein-dna binding": 0.0041, "binding competition": 0.0041, "increase mrna transcripts": 0.0041, "steel factor": 0.0041, "e2f binding": 0.0041, "interleukin-6 [ il-6 ]": 0.0041, "n-oct-3 factor": 0.0041, "il-12 signal transduction pathway": 0.0041, "latent membrane proteins": 0.0041, "vitro kinase assay": 0.0041, "dna mobility shift assay": 0.0041, "bcl-2 mrna induction": 0.0041, "nf-y binding": 0.0041, "prominent factor": 0.0041, "site recognized": 0.0041, "characterize estrogen receptor": 0.0041, "receptor overexpression": 0.0041, "inhibitory proteins termed": 0.0041, "nuclear run-on assays demonstrate": 0.00409, "stat4 binding": 0.00409, "polypryrimidine-binding factor": 0.00409, "'nuclear factor": 0.00409, "lymphoma receptor": 0.00409, "lyso-platelet-activating factor": 0.00409, "characterized signaling pathway": 0.00409, "-sensitive factor": 0.00409, "target promoter": 0.00409, "viral anti-apoptotic proteins": 0.00409, "interferon-responsive factor": 0.00409, "early proteins bzlf1": 0.00409, "cd14 distal sp1-binding site": 0.00409, "minimal cd4 promoter": 0.00409, "purine-box/nuclear factor": 0.00409, "effector site": 0.00409, "transcriptional regulatory elements required": 0.00409, "core-binding factor": 0.00409, "5'-most ets site": 0.00409, "e74-like factor": 0.00409, "leucocytic estrogen receptor": 0.00409, "gpix ets site": 0.00409, "tata-less blr1 core promoter": 0.00409, "site result": 0.00409, "hcmv binding": 0.00409, "molecular mechanism underlying il-2 transcriptional blockade": 0.00409, "primary ovarian carcinoma patients": 0.00409, "cytokine mrna levels": 0.00409, "nf-kappab-like factor": 0.00409, "myocyte-enhancer factor": 0.00409, "negative cis-acting dna elements": 0.00409, "mutated androgen receptor": 0.00409, "positive-acting factor": 0.00409, "sp1-related factor": 0.00409, "pma-inducible factor": 0.00409, "optimized peptide sequence": 0.00409, "estrogen receptor negativity": 0.00409, "ap1 transcriptional complex": 0.00409, "weak octamer-binding site": 0.00409, "tissue-specific primary transcriptional response": 0.00409, "nf-at-like factor": 0.00409, "granulocyte/macrophage-colony-stimulating factor": 0.00409, "dq2 binding": 0.00409, "cells-binding factor": 0.00409, "b3 factor": 0.00409, "paf activated map kinase kinase-3": 0.00409, "antiandrogen-bound mutated receptor": 0.00408, "binding protein-1": 0.00408, "trep binding": 0.00408, "activate stat proteins": 0.00408, "increased induction": 0.00408, "factor": 0.00408, "nfat-1 transcriptional complex": 0.00408, "ebv latent genes": 0.00408, "important proteins": 0.00408, "e2a-hlf prevents apoptosis induced": 0.00408, "signal-regulated kinase kinase": 0.00408, "complex regulatory mechanisms": 0.00408, "abolish binding": 0.00408, "binding media": 0.00408, "bglii restriction site": 0.00408, "gc receptor": 0.00408, "specific nuclear marker": 0.00408, "abrogate binding": 0.00408, "facilitate binding": 0.00408, "intact autophosphorylation site": 0.00408, "distinct genes": 0.00408, "induced differentiation occurs": 0.00408, "suppressed nfat-p0 complex formation": 0.00408, "spi-b binds dna sequences": 0.00408, "fluorescence [ channels ]": 0.00408, "il-2 induces tyrosine phosphorylation": 0.00408, "gata site implies": 0.00408, "major stat complexes activated": 0.00408, "endogenous cytokine genes": 0.00408, "multiple stat proteins": 0.00407, "binding trafs": 0.00407, "noncanonical gata site": 0.00407, "tnf receptor": 0.00407, "natural immunoglobulin promoter": 0.00407, "gm-csf proximal promoter": 0.00407, "srf binding": 0.00407, "genes encoding fas": 0.00407, "b2 site abolish": 0.00407, "mitogen binding": 0.00407, "main nf-kappab-binding site": 0.00407, "wild-type dra promoter": 0.00407, "p53-dependent cyclin kinase inhibitor p21/cip1": 0.00407, "steroid receptor superfamily": 0.00407, "genomic sequence upstream": 0.00407, "downstream regulatory region": 0.00407, "cd4 receptor": 0.00407, "kappab-sp1 composite site": 0.00407, "0.1-0.5 microm dmdtc inhibits intracellular il-2 production": 0.00407, "paf binding": 0.00407, "lps stimulation increased": 0.00407, "exclusive binding": 0.00407, "nf- kappab site": 0.00407, "ap-1 consensus sequence": 0.00407, "ap2 binding site/s": 0.00407, "lps stimulation selectively activated p38alpha": 0.00407, "egr-1 site": 0.00406, "gata site": 0.00406, "cloned delta-opioid receptor": 0.00406, "acute phase proteins": 0.00406, "fkbp binding": 0.00406, "okadaic acid increased": 0.00406, "increased viral rna synthesis": 0.00406, "amino acid domain": 0.00406, "downstream target genes": 0.00406, "viral survival-promoting proteins": 0.00406, "nf-munr binding": 0.00406, "p85 binding": 0.00406, "receptor saturating concentration": 0.00406, "donor splice site": 0.00406, "retinoic acid downmodulates erythroid differentiation": 0.00406, "prevented apoptosis induced": 0.00406, "9-cis retinoic acid induces monocyte chemoattractant protein-1 secretion": 0.00406, "simple binding": 0.00406, "anti-tnf-alpha inhibited hiv-1 long terminal repeat": 0.00406, "short sequence motifs": 0.00406, "genes required": 0.00406, "active nuclear form": 0.00406, "acute myeloid patients": 0.00406, "cd4 promoter occurs": 0.00406, "ifn-gamma receptor": 0.00406, "stimuli induced il-10 production": 0.00406, "estrogen receptor": 0.00406, "il-4 production induced": 0.00406, "de novo synthesized dioxin receptor": 0.00406, "il-6 promoter responsive": 0.00406, "cooperative binding": 0.00406, "epstein-barr virus early antigen diffuse component": 0.00406, "translation start site": 0.00406, "c-myc puf site": 0.00406, "gre binding": 0.00405, "igh pi site": 0.00405, "saturable binding": 0.00405, "numerous genes involved": 0.00405, "bind stat proteins": 0.00405, "immediate-early viral genes": 0.00405, "inappropriate binding": 0.00405, "gm-csf promoter plays": 0.00405, "cloned receptor": 0.00405, "monocytes express high levels": 0.00405, "chronic phase cml patients": 0.00405, "isre binding": 0.00405, "tf-specific kappab site": 0.00405, "cleavage site": 0.00405, "jun proteins bind": 0.00405, "coordinated binding": 0.00405, "receptor cloned": 0.00405, "promoter methylation suggests": 0.00405, "viral proteins": 0.00405, "diverse regulatory proteins": 0.00405, "site iv": 0.00405, "nf-kb site": 0.00405, "insulin receptor substrates": 0.00405, "promoter transactivation": 0.00405, "adherent monocytes regulate nuclear processing": 0.00405, "fli-1 binding": 0.00405, "traf binding": 0.00405, "cd3 receptor cross-linking": 0.00405, "inhibitory receptor": 0.00405, "mouse cd19 genes": 0.00405, "adenovirus early region": 0.00405, "camp-dependent reporter genes": 0.00405, "granulocytic differentiation induced": 0.00405, "cd28 costimulatory receptor": 0.00404, "site alpha-": 0.00404, "binding gm5": 0.00404, "erythroid cell-specific genes": 0.00404, "2d3-vdr binding": 0.00404, "early g1-regulating proteins": 0.00404, "genuine octamer-binding site abrogate": 0.00404, "tighter binding": 0.00404, "binding sites/nucleus": 0.00404, "half-maximal binding": 0.00404, "lef/tcf binding": 0.00404, "costimulatory receptor cd28": 0.00404, "calmodulin binding": 0.00404, "vdr/rxr binding": 0.00404, "il1b promoter fragment": 0.00404, "lps-mcd14 binding": 0.00404, "anti-tnf alpha antibody decreased": 0.00404, "dna- binding": 0.00404, "mhc class ii induction": 0.00404, "hiv-1 replication induced": 0.00404, "tax-independent binding": 0.00404, "actual binding": 0.00404, "multiple host defense genes": 0.00404, "negative regulatory element": 0.00404, "antiandrogen binding": 0.00404, "antioxidant sensitive activating pathway distinct": 0.00404, "c-jun promoter": 0.00404, "high-affinity bsap-binding site": 0.00404, "-e2 binding": 0.00404, "kappa b-induced nuclear exclusion": 0.00404, "optimum binding": 0.00404, "conserved region encoding": 0.00404, "liuwei dihuang pills ] [": 0.00404, "ehrlichial binding": 0.00404, "adenosine receptor agonist neca": 0.00404, "rbp binding": 0.00404, "weak rbp-jkappa-binding site": 0.00404, "yy-1 site": 0.00403, "il-12 target genes": 0.00403, "early proteins": 0.00403, "mimic receptor engagement": 0.00403, "ras signaling pathway": 0.00403, "early transcriptional response": 0.00403, "constitutively bound proteins": 0.00403, "expressing major histocompatibility complex": 0.00403, "ets proteins bind": 0.00403, "additional c/ebpalpha target genes": 0.00403, "viral genes transcribed": 0.00403, "nuclear protein-dna complexes": 0.00403, "cryptic splice site": 0.00403, "proximal il-5 promoter": 0.00403, "htlv-1-transformed t-cell lines expressed": 0.00403, "pma activated nf-kappa": 0.00403, "tnf-alpha mrna induction": 0.00403, "mutant sequence": 0.00403, "site adjacent": 0.00403, "signaling agonists induce myeloid differentiation": 0.00403, "receptor down-regulation": 0.00403, "binding": 0.00403, "studied regulatory element": 0.00403, "permanent nf-kappab translocation induced": 0.00402, "hiv infected patients": 0.00402, "chain mrna levels": 0.00402, "c-myb site": 0.00402, "b2 site": 0.00402, "positive regulatory element": 0.00402, "receptor functions": 0.00402, "normal adult erythroid differentiation": 0.00402, "cytokine-encoding genes involved": 0.00402, "receptor concentration": 0.00402, "high-affinity site": 0.00402, "identified h-7-sensitive kinase pathways": 0.00402, "vcam-1 [ cd106 ]": 0.00402, "genes results": 0.00402, "il-12 receptor": 0.00402, "il-1 receptor/toll-like receptor": 0.00402, "homologous genes encoding scm-1alpha": 0.00402, "5- [ p-methoxyphenyl ] -3h-1,2-dithiol-3-thione": 0.00402, "sequence ii": 0.00402, "ah receptor dependent": 0.00401, "insulin receptor substrate": 0.00401, "truncated erythropoeitin receptor": 0.00401, "genes involved": 0.00401, "increased camp levels": 0.00401, "mycoplasma fermentans lipid-associated membrane proteins": 0.00401, "aged long-distance runner ] [": 0.00401, "nf-kappab element": 0.00401, "increased ige levels": 0.00401, "osteoblast nuclear extract-dna complexes": 0.00401, "nf-kappa b. tnf-alpha signaling leads": 0.00401, "th2 cytokine genes": 0.00401, "receptor kd": 0.00401, "il-1 receptor": 0.00401, "tnf -or pma- induced hiv replication": 0.00401, "encode t-cell-specific membrane proteins": 0.00401, "activates stat proteins": 0.00401, "ad2 early genes": 0.00401, "increased skin tumor formation": 0.00401, "-1 receptor": 0.00401, "alpha-/- embryonic fibroblasts show minimal constitutive nf-kappa": 0.00401, "reporter gata-1/lacz genes": 0.00401, "ecto-5'-nt core promoter": 0.004, "pebp2 site": 0.004, "hypersensitive site": 0.004, "region ii": 0.004, "critical signaling pathway": 0.004, "macrophage scavenger receptor": 0.004, "camp signal transduction pathway": 0.004, "induces nf-kb nuclear translocation": 0.004, "acidic activator proteins": 0.004, "-130 ap-1-like site": 0.004, "cre site": 0.004, "nuclear export complexes": 0.004, "interleukin-2 receptor alpha-chain": 0.004, "ad early region": 0.004, "related c-c chemokine receptor-like genes reside": 0.004, "conserved sequence upstream": 0.004, "complex adaptor function": 0.004, "reporter genes": 0.004, "microb dna motif": 0.004, "lectin-type oxidized ldl receptor": 0.004, "specific monoclonal antibody recognition": 0.004, "pituitary-specific start site": 0.004, "composite site": 0.004, "corticosteroid receptor characteristics": 0.004, "polymorphic site": 0.004, "transcriptional complex": 0.004, "dnase i-hypersensitive site": 0.004, "sp 1-binding site": 0.004, "300-bp core promoter": 0.004, "distal sp1-binding site": 0.004, "protein-coupled receptor agonist thrombin": 0.004, "wild-type promoter": 0.004, "effective site": 0.004, "distinct region": 0.00399, "activated pbmc maintain elevated levels": 0.00399, "region distinct": 0.00399, "irf-1 gamma-activated site": 0.00399, "distal site": 0.00399, "[ ngfi-b/nur77 family involved": 0.00399, "signal-transducing receptor subunits": 0.00399, "core promoter": 0.00399, "important genes": 0.00399, "h. diffusible endothelial proteins": 0.00399, "hypertension ] [ age-related": 0.00399, "electrophoretic mobility shift assay analysis": 0.00399, "bmt inhibits nuclear translocation": 0.00399, "potential nf-kappab-binding sequence": 0.00399, "chimeric receptor ar/tr2/ar": 0.00399, "docking site": 0.00399, "optimal site": 0.00399, "increased pcdd/pcdf-body burden [ 25-140 ppt tcdd": 0.00399, "chimeric cd8alpha/il-4ralpha receptor": 0.00399, "methylation-sensitive hpaii site": 0.00399, "signal transduction pathway leading": 0.00399, "genes important": 0.00399, "identified functional aiolos-binding sites": 0.00399, "n-terminal regulatory region": 0.00399, "ikappab kinase alpha": 0.00398, "proximal lck promoter": 0.00398, "region enhanced": 0.00398, "hiv promoter": 0.00398, "e3 site": 0.00398, "cd40 receptor": 0.00398, "inhibited p24 antigen production": 0.00398, "burst-forming units-erythroid [ bfu-e ]": 0.00398, "promoter switching combined": 0.00398, "flutamide affects androgen receptor behavior": 0.00398, "ifn-alpha activated stat1 alpha": 0.00398, "increased nf-kappa": 0.00398, "tcr-contact site heterogeneity": 0.00398, "reticuloendotheliosis virus long terminal repeat elements": 0.00398, "ap3-l site": 0.00398, "proximal gamma-globin promoter": 0.00398, "tf site": 0.00398, "chimeric receptor": 0.00398, "histamine receptor subtypes": 0.00398, "cellular events induced": 0.00398, "nfat complex formation": 0.00398, "progesterone receptor status": 0.00398, "eosinophils ] [": 0.00398, "act-1 site analogous": 0.00398, "regulatory element called cle0": 0.00398, "specific anti-hrbc antibody production": 0.00398, "broad serine/threonine kinase inhibitor staurosporine": 0.00397, "signal transduction pathways activated": 0.00397, "proximal regulatory element": 0.00397, "receptor-positive murine monocytic line": 0.00397, "c-jun mrna levels": 0.00397, "caii-specific erba-binding site": 0.00397, "primary peripheral blood lymphocytes": 0.00397, "common regulatory element": 0.00397, "homologous genes encoding cd11a": 0.00397, "cd28 minimal promoter": 0.00397, "nf-kappab nuclear translocation": 0.00397, "nf-kappab regulatory effect": 0.00397, "promyelocytic leukemia zinc finger/rar alpha fusion transcript": 0.00397, "hybrid receptor": 0.00397, "immune response regulation": 0.00397, "young [ mody ]": 0.00397, "interleukin-2 receptor": 0.00397, "palindromic thyroid hormone responsive element aggtcatgacct": 0.00397, "il-4 promoter": 0.00397, "antigenic site": 0.00397, "form high intracellular levels": 0.00397, "sequence binds": 0.00397, "cd28 auxiliary receptor": 0.00397, "auxiliary receptor cd28": 0.00397, "tcf-1 site": 0.00397, "ligand-activated il-10 receptor": 0.00397, "transfected dprl promoter": 0.00397, "so-far-unrecognized sp-1 site": 0.00396, "early-stage breast cancer patients": 0.00396, "steroid receptor": 0.00396, "murine sequence": 0.00396, "complexes induced": 0.00396, "octamer-binding site": 0.00396, "related genes share": 0.00396, "examined mrna levels": 0.00396, "nf-y-binding site": 0.00396, "transfected lymphocyte-specific promoter": 0.00396, "-binding site": 0.00396, "start site": 0.00396, "nuclear complexes": 0.00396, "microsomal antibody levels decreased": 0.00396, "multiple minor susceptibility genes": 0.00396, "n'-tetrakis [ 2-pyridylmethyl ] ethylenediamine": 0.00396, "nonfunctional sequence motifs": 0.00396, "hypersensitivity site": 0.00396, "il-5 gene-nonexpressing t-cell line": 0.00396, "sites display disparate effects": 0.00396, "transfected ifn-beta promoter": 0.00396, "receptor kinetics": 0.00396, "induced complexes": 0.00396, "region designated": 0.00396, "oestrogen receptor variants": 0.00396, "[ editorial ] calcitriol": 0.00395, "ebv proteins": 0.00395, "cap site": 0.00395, "breast cancer patients": 0.00395, "mouse tis11 genes": 0.00395, "induced inhibition": 0.00395, "lymphoid development single strand conformation polymorphism analysis": 0.00395, "major histocompatibility complex molecules": 0.00395, "critical regulatory element": 0.00395, "downstream genes regulated": 0.00395, "gamma globin genes": 0.00395, "retinoic acid-alpha receptor": 0.00395, "encode related proteins": 0.00395, "inhibition induced": 0.00395, "transcripts encode proteins": 0.00395, "e1a induced cellular sensitivity": 0.00395, "ccaat site": 0.00395, "box recognition sequence": 0.00395, "early growth response gene-1": 0.00395, "butyric acid increased": 0.00395, "viral genes": 0.00395, "sequence motifs": 0.00395, "adherence-associated early genes": 0.00395, "young subjects type ii receptors": 0.00395, "cyclic amp signaling pathway": 0.00395, "sp-1 site": 0.00395, "androgen receptor status": 0.00395, "stat5 target genes": 0.00394, "complex regulation": 0.00394, "treatment increased ap-1": 0.00394, "ifn-gamma production induced": 0.00394, "zip site serves": 0.00394, "phase regulated genes": 0.00394, "early genes": 0.00394, "nf-kappa b. nf-kappa": 0.00394, "adhesion proteins": 0.00394, "-180 site": 0.00394, "notch1 transmembrane receptor engineered": 0.00394, "pip site": 0.00394, "il-12 signaling pathway": 0.00394, "lymphoblastoid t-cell line a2.01": 0.00394, "region binds": 0.00394, "genes encoding gamma-globin": 0.00394, "-45 site": 0.00394, "p1 site": 0.00394, "transferrin receptor mrnas": 0.00394, "vitro apoptosis induction": 0.00394, "adult beta-like globin genes": 0.00394, "consensus heat shock element": 0.00394, "early growth response": 0.00394, "chemokines [ darc ]": 0.00394, "regulatory immediate-early genes": 0.00394, "cytoplasmic effector proteins": 0.00394, "encoding proteins": 0.00394, "p98 precursor proteins play": 0.00394, "basal promoter": 0.00394, "contrasting il-12 -and ifn-alpha-inducible genes": 0.00394, "12-o-tetradecanoylphorbol-13-acetate induced hemopoietic differentiation": 0.00394, "allergy ] [ corticoids": 0.00393, "il-1 signaling pathway": 0.00393, "activated stat1 alpha": 0.00393, "rna polymerase iii-dependent genes": 0.00393, "divergent site": 0.00393, "nf-at-binding site": 0.00393, "promoter strength relative": 0.00393, "conserved signaling pathway": 0.00393, "stress commonly increase opioid levels": 0.00393, "receptor ligation": 0.00393, "immune genes": 0.00393, "jun proteins bound": 0.00393, "induced differentiation depends": 0.00393, "vitd3 receptor network operates": 0.00393, "ick-1 site": 0.00393, "bind usf proteins": 0.00393, "-160 site": 0.00393, "functional genes": 0.00393, "bcl-2 promoter implies": 0.00393, "increased mrna stability": 0.00393, "hla dra promoter": 0.00393, "regulatory proteins": 0.00393, "cognate site": 0.00393, "-like site": 0.00393, "complex interaction": 0.00393, "granulocytic differentiation pathway": 0.00393, "downstream tre-like camp response elements": 0.00393, "microb site": 0.00393, "promoter-proximal site": 0.00393, "palindromic site": 0.00393, "id3 levels increased": 0.00392, "similar proteins": 0.00392, "include proteins critical": 0.00392, "octa site": 0.00392, "synthetic nf-kappab-dependent promoter": 0.00392, "transcriptional regulator nuclear factor-kappab": 0.00392, "megakaryocytic differentiation induced": 0.00392, "c/ebp proteins play": 0.00392, "nonstructural trans-acting regulatory genes": 0.00392, "forty primary fms patients": 0.00392, "ckii site": 0.00392, "patients demonstrate": 0.00392, "pebp2/cbf site": 0.00392, "phorbol myristate acetate/ionomycin and/or anti-cd3 monoclonal antibody": 0.00392, "proximal hil-5 promoter": 0.00392, "adult globin genes": 0.00392, "caax site": 0.00392, "hiv-tf1-binding site": 0.00392, "specific nf-kappab complexes": 0.00392, "receptor cross-linking": 0.00392, "egr-1 promoter fragments": 0.00392, "important sequence": 0.00392, "dbf site": 0.00392, "nf-at/ap-1-binding site": 0.00392, "proximal cd25 promoter": 0.00392, "exact site": 0.00392, "nfat-binding site": 0.00392, "pre-i site": 0.00392, "mouse genomic dna clones": 0.00392, "zip site": 0.00392, "atf1 proteins present": 0.00392, "mnp site": 0.00392, "significance ] [": 0.00391, "site molarity": 0.00391, "potent oligonucleotide sequence": 0.00391, "balb/cbyj [ h-2d ]": 0.00391, "tissue-specific regulatory region": 0.00391, "promoter-distal site": 0.00391, "ap-1/oap-binding site": 0.00391, "gm-csf receptor": 0.00391, "atf/cre site": 0.00391, "kappa-binding site": 0.00391, "conditional gata-2/estrogen receptor chimera": 0.00391, "steroid/thyroid hormone response elements": 0.00391, "gm5 site": 0.00391, "downstream regulatory element": 0.00391, "c-fos promoter": 0.00391, "patients decreased": 0.00391, "augment il-2 mrna production": 0.00391, "tnf alpha mrna": 0.00391, "rbp-jkappa-binding site": 0.00391, "stat-6-binding site": 0.00391, "arre/nf-at site": 0.00391, "19-bp site": 0.00391, "polyadenylation site": 0.00391, "p40-kappab site": 0.00391, "nuclease-hypersensitive site": 0.00391, "nac inhibited il-1 beta-induced mrna": 0.00391, "c57bl/10snj [ h-2b ]": 0.00391, "immediate-early cytokine genes": 0.00391, "e74 site": 0.00391, "hiv-ltr-kappab site": 0.00391, "bcl-2 promoter": 0.00391, "increase hiv-1 production": 0.00391, "pets site": 0.00391, "nf-kappab-like site": 0.00391, "ebf-binding site": 0.00391, "induced morphological differentiation": 0.00391, "sp1/egr-1 site": 0.00391, "results link regulatory factors critical": 0.00391, "ap1-binding site": 0.00391, "c3heb/fej [ h-2k ]": 0.00391, "pu.1/elf-1 site": 0.00391, "ccacc site": 0.00391, "egr-1/sp1 site": 0.00391, "-dependent t-cell line ctll-2": 0.00391, "pu.1-binding site": 0.00391, "receptor numbers": 0.00391, "higher-affinity site": 0.00391, "eb1-binding site": 0.00391, "increases nf-kappa b/i kappa": 0.00391, "puf site": 0.00391, "pybf-binding site": 0.00391, "nip site": 0.00391, "polya site": 0.00391, "interferon signal transduction pathway": 0.00391, "lower-affinity site": 0.00391, "3'-most site": 0.00391, "receptor characteristics": 0.00391, "histamine receptor": 0.0039, "proximal promoter": 0.0039, "insulin receptor substrate-2": 0.0039, "important region": 0.0039, "local cellular immune response": 0.0039, "climacteric syndrome patients": 0.0039, "proteins present": 0.0039, "promoter proximal": 0.0039, "cd3 and/or cd2 proteins": 0.0039, "12-o-tetradecanoylphorbol-13-acetate induced differentiation": 0.0039, "site": 0.0039, "minimal ebna-2-responsive lmp-1 promoter": 0.0039, "jnk signal transduction pathway": 0.0039, "x-linked androgen receptor": 0.0039, "potent inhibitory sequence": 0.0039, "constitutive nuclear form": 0.0039, "erythroid specific enhancer upstream": 0.0039, "steady state mrna levels equivalent": 0.0039, "adenovirus e2 promoter": 0.0039, "msv ltr promoter": 0.00389, "cis element binds": 0.00389, "induces modest nuclear translocation": 0.00389, "potent il-1/tumor necrosis factor-responsive element": 0.00389, "syndrome patients": 0.00389, "complex system": 0.00389, "major proteins": 0.00389, "partial receptor occupancy": 0.00389, "wild-type il-2r alpha kappa": 0.00389, "nuclear run-on assay": 0.00389, "cd40 signaling pathway": 0.00389, "monoblastic differentiation induced": 0.00389, "[ csf-1 ]": 0.00389, "cytokine-activated janus kinase-stat signaling pathway": 0.00389, "ligand-induced receptor heterodimerization": 0.00389, "complex protein-dna interactions": 0.00389, "heterologous minimal promoter": 0.00388, "oestrogen receptor codon": 0.00388, "immunoglobulin heavy-chain promoter": 0.00388, "ms2-hbx fusion proteins": 0.00388, "gal4-ebna3c fusion proteins": 0.00388, "induced differentiation": 0.00388, "receptor allele": 0.00388, "gal4-elf-1 fusion proteins": 0.00388, "gynecomastia ] [": 0.00388, "related proteins": 0.00388, "signaling growth inhibition": 0.00388, "phosphoamino acid analysis": 0.00388, "adjacent regulatory region": 0.00388, "genes encoding hnf-3alpha": 0.00388, "expressed cbf alpha 2-encoded subunit": 0.00388, "androgen receptor blockade": 0.00388, "ltr promoter": 0.00388, "raralpha/pml fusion proteins": 0.00388, "multiple proteins": 0.00388, "genes encoding cytoskeletal": 0.00388, "identified potential nfat composite elements": 0.00388, "ut-7 expressed similar levels": 0.00388, "nf-kappab complex": 0.00388, "lif increased steady-state levels": 0.00388, "differentiation induced": 0.00388, "proinflammatory cytokine genes": 0.00388, "vla-5 fibronectin receptor": 0.00388, "surrogate tg receptor": 0.00388, "receptor abnormalities": 0.00388, "peroxisome proliferator-activated receptor": 0.00388, "tcdd receptor": 0.00387, "myeloid-specific genes encoding": 0.00387, "enhanced nuclear staining": 0.00387, "il-5 receptor": 0.00387, "vitd3 receptor": 0.00387, "purified proteins": 0.00387, "homing receptor blr1": 0.00387, "nuclear c/ebp beta": 0.00387, "hmg box proteins": 0.00387, "cytoplasmic nf-kappa b/rel complexes": 0.00387, "putative promoter area": 0.00387, "sequence-specific dna-binding proteins": 0.00387, "il-2 mrna production": 0.00387, "activate ap-1 complex": 0.00387, "inducible nuclear form": 0.00387, "membrane proteins": 0.00387, "increased intracellular ca2+ concentrations": 0.00387, "kb fasl promoter": 0.00387, "fibronectin receptor": 0.00387, "cd23 receptor": 0.00387, "chemokine receptor blr2/ebi1": 0.00387, "nf-kappa b-dependent induction": 0.00387, "chronic rheumatoid arthritis patients": 0.00387, "fusion proteins": 0.00387, "cognate cdna sequence reveals": 0.00387, "expressed high levels": 0.00387, "genomic dna identified": 0.00387, "squirrel monkey f774l receptor": 0.00387, "ebv genes": 0.00386, "immunoglobulin-like transcript-2/leukocyte ig-like receptor": 0.00386, "comments ] inhibition": 0.00386, "paf receptor antagonists": 0.00386, "steady state mrna levels": 0.00386, "receptor initiates": 0.00386, "[ editorial ]": 0.00386, "tnf promoter": 0.00386, "receptor turnover": 0.00386, "multiple sclerosis patients": 0.00386, "-negative t-cell line": 0.00386, "normal peripheral blood monocytes": 0.00386, "well-defined signal transduction pathway": 0.00386, "chemokine receptor": 0.00386, "bind proteins": 0.00386, "cd4 promoter": 0.00386, "[ hie ]": 0.00386, "kappa b-dependent pathway": 0.00386, "nf-kappa b/rel sites": 0.00386, "activated platelets induce monocyte chemotactic protein-1 secretion": 0.00386, "nuclear signaling steps": 0.00386, "cr2 complement receptor": 0.00386, "abelson murine leukemia virus results": 0.00386, "mhc class ii immunodeficiency [": 0.00386, "isolate short cdna sequence tags": 0.00386, "intrinsic kinase domain": 0.00386, "receptor status": 0.00386, "c-myb target genes": 0.00386, "ifn-gamma promoter": 0.00385, "progesterone receptor": 0.00385, "pebp2 alpha factors": 0.00385, "genes encoding": 0.00385, "increased mrna": 0.00385, "c-fos mrna levels": 0.00385, "squirrel monkey receptor": 0.00385, "htlv-i promoter central": 0.00385, "beta-globin minimal promoter": 0.00385, "receptor content": 0.00385, "type ii ebs levels": 0.00385, "epstein-barr virus-encoded nuclear antigen ebna-5 accumulates": 0.00385, "hematopoietin/cytokine receptor superfamily": 0.00385, "mineralocorticoid receptor": 0.00385, "induces nuclear translocation": 0.00385, "uninfected t-cell line": 0.00385, "disease progression induced": 0.00385, "androgen receptor behavior": 0.00385, "hematopoietin receptor superfamily": 0.00385, "early region": 0.00385, "] [": 0.00385, "high-affinity receptor": 0.00385, "kinase inhibitor h7": 0.00385, "minimal beta-globin promoter": 0.00385, "entire il2 regulatory region": 0.00385, "activator protein-1 cognate dna sequences": 0.00385, "integrin signaling pathway": 0.00385, "cellular immune response": 0.00384, "epo receptor": 0.00384, "tnf-alpha promoter": 0.00384, "mammary cancer patients": 0.00384, "constitutive promoter": 0.00384, "promoter lacking": 0.00384, "ep4 receptor subtype": 0.00384, "cd11b promoter shows": 0.00384, "pgn induced phosphorylation": 0.00384, "downstream beta-like globin genes 10-50 kilobases": 0.00384, "breast cancer reactive antibody-dependent cellular cytotoxicity facilitating antibody": 0.00384, "share extensive n-terminal sequence homology": 0.00384, "beta-globin promoter interact": 0.00384, "common stat proteins": 0.00384, "elevated ifn alpha levels": 0.00384, "h9 t-cell line": 0.00384, "cd28-associated signaling pathway leading": 0.00384, "potential tata element": 0.00384, "cd2 signaling involves jun kinase": 0.00383, "+ c-rich region": 0.00383, "recovered cyclosporin a-induced il-2r alpha inhibition": 0.00383, "crucial element important": 0.00383, "wnt signal transduction pathway": 0.00383, "th2-specific cytokine genes": 0.00383, "signaling pathway leading": 0.00383, "direct transcriptional repressive effect": 0.00383, "peptide-specific t-cell line": 0.00383, "nf-kappa b/rel factors": 0.00383, "erythrocyte receptor": 0.00383, "related sites identified": 0.00383, "tcr/cd3 signal transduction pathway": 0.00383, "positive element active": 0.00383, "assay cd34 mrna transcripts": 0.00383, "collagen receptor": 0.00383, "camp signaling pathway": 0.00383, "thalassaemia major patients": 0.00383, "related genes constitute": 0.00382, "tcr-dependent signal transduction pathway": 0.00382, "increased levels": 0.00382, "hil-5 receptor alpha-subunit": 0.00382, "induced phosphorylation": 0.00382, "cd95 receptor": 0.00382, "region promoters differ": 0.00382, "ifn-regulated signal transduction pathway": 0.00382, "cd14 receptor": 0.00382, "ii-expressing t-cell line": 0.00382, "normal ifn-gamma induction": 0.00382, "unidentified target genes": 0.00382, "c-terminal ankyrin motif domain": 0.00382, "mutation analysis demonstrated": 0.00382, "ig receptor": 0.00382, "androgen receptor": 0.00382, "ets-1 bends mu enhancer dna": 0.00382, "endothelial adhesion molecule induction": 0.00382, "wingless/wnt signal transduction pathway": 0.00382, "src kinase inhibitor": 0.00382, "traf3-mediated signal transduction pathway": 0.00382, "heterodimeric receptor": 0.00382, "levels increased": 0.00382, "t-cell-expressed cytokine genes": 0.00382, "th2 type response plays": 0.00382, "complex interactions": 0.00382, "receptor chains": 0.00382, "nuclear translocation signals": 0.00381, "cell-surface receptor": 0.00381, "90-kilodalton heat shock proteins": 0.00381, "mouse il-2 enhancer construct": 0.00381, "light chain genes": 0.00381, "binary tf.viia complex induces": 0.00381, "interferon-gamma receptor": 0.00381, "nf-kappa b-like factors": 0.00381, "duplicated dna regulatory motifs": 0.00381, "leukemia breakpoint region": 0.00381, "comments ] sequence-specific dna-binding small molecules": 0.00381, "gata-1 mrna levels": 0.00381, "bp region": 0.00381, "ag receptor": 0.00381, "mhc class ii mrna": 0.00381, "potential stat-binding sites reduced qp responsiveness": 0.00381, "tfiiia zinc-finger consensus amino acid sequences": 0.00381, "camp-dependent signaling pathway exerts": 0.00381, "t-cell line": 0.00381, "90-kda heat shock proteins": 0.00381, "inhibited erythroid differentiation": 0.00381, "consensus sequence characteristic": 0.00381, "cytokine genes": 0.00381, "inducible metallothionein promoter": 0.00381, "lmp promoter fragments": 0.00381, "rho-regulated receptor clustering": 0.00381, "signal transduction pathway": 0.00381, "erythropoietin receptor": 0.0038, "domain analysis": 0.0038, "pu.1 ggaa core sequence": 0.0038, "ra response elements": 0.0038, "m-csf receptor": 0.0038, "bound octamer-binding proteins": 0.0038, "homing receptor": 0.0038, "lymphocyte-specific dna-binding proteins": 0.0038, "promoter regulating": 0.0038, "b29 minimal promoter": 0.0038, "nuclear 3,5,3'-triiodothyronine receptors": 0.0038, "cyclin-dependent kinase inhibitor p27kip1": 0.0038, "gr mrna levels": 0.0038, "tar primary sequence": 0.0038, "c5a receptor": 0.0038, "inhibition effects versus time": 0.0038, "minimal b29 promoter": 0.0038, "elusive oct2 target genes": 0.0038, "inducible promoter": 0.0038, "chimeric promoter constructions": 0.0038, "il-7 receptor": 0.00379, "mutant line": 0.00379, "truncated promoter": 0.00379, "lipopolysaccharide-activated toll-like receptor": 0.00379, "transcriptional regulatory factors": 0.00379, "inflammatory effector genes": 0.00379, "b7 stimulation induced": 0.00379, "enhanced nuclear translocation": 0.00379, "inhibits cytokine mrna accumulation": 0.00379, "c-jun proteins": 0.00379, "strong myeloid-cell-specific promoter": 0.00379, "von willebrand receptor": 0.00379, "ets consensus sequence": 0.00379, "janus kinase family": 0.00379, "promoter segment": 0.00379, "extracellular matrix proteins": 0.00379, "dexamethasone inhibited lps-induced bioactive il-12 production": 0.00379, "related zinc-finger-encoding genes": 0.00379, "cif inhibited induction": 0.00379, "significant sequence homology": 0.00379, "hemopoietic-specific zinc finger proteins": 0.00379, "pre-b cell-specific genes remain silent": 0.00379, "dra promoter bearing": 0.00379, "il-3/il-5/gm-csf receptor beta-subunit": 0.00379, "nuclear receptors": 0.00379, "phorbol ester-inducible element": 0.00379, "erythroid genes": 0.00379, "increased transcriptional rate correlated": 0.00379, "receptor preparations": 0.00379, "interleukin-1 receptor": 0.00379, "multiple genes": 0.00379, "eukaryotic dna-binding proteins": 0.00379, "ifn-gamma mrna levels": 0.00379, "mrna species activated": 0.00379, "cml cytoplasmic proteins": 0.00379, "late lytic cycle genes": 0.00379, "retinoid differentiation pathway": 0.00378, "downstream effector proteins": 0.00378, "kb promoter": 0.00378, "related dna sequences": 0.00378, "oct2 target genes": 0.00378, "tnf-alpha mrna levels": 0.00378, "important trace element": 0.00378, "receptor coupling": 0.00378, "signal-transducing receptor": 0.00378, "endothelial proteins": 0.00378, "mpl receptor": 0.00378, "aml1 proteins play": 0.00378, "stat5 proteins correlated": 0.00378, "] mice transgenic": 0.00378, "nf kappa b-binding sites": 0.00378, "wild-type par proteins": 0.00378, "zinc finger proteins": 0.00378, "s-100 proteins contained": 0.00378, "genes related": 0.00378, "inhibited cellular proliferation": 0.00378, "related genes": 0.00378, "il2 regulatory region": 0.00378, "ifn-alpha receptor": 0.00378, "il-2 induced release": 0.00378, "[ effect": 0.00378, "kinase domain": 0.00378, "il-2-independent t-cell transformation induced": 0.00378, "cellular factors involved": 0.00378, "kinase inhibitor h-89": 0.00378, "enhanced lyn mrna production": 0.00378, "megakaryocytic glycoprotein ix promoter": 0.00377, "vd receptor": 0.00377, "receptor occupancy": 0.00377, "969-bp promoter fragments": 0.00377, "study cellular signaling pathways": 0.00377, "mature b-cell line bal-17": 0.00377, "dna-binding proteins": 0.00377, "regulatory sequence": 0.00377, "bind dna sequences": 0.00377, "globin promoter": 0.00377, "germline ige promoter": 0.00377, "inhibited induction": 0.00377, "heat shock proteins": 0.00377, "g-protein-coupled receptor": 0.00377, "c/ebp epsilon mrna levels": 0.00377, "tsh receptor": 0.00377, "full-length cdna sequence": 0.00377, "nm inhibited hiv production": 0.00377, "htlv-i promoter": 0.00377, "chimeric promoter": 0.00377, "cell-specific promoter": 0.00377, "apoptosis induced": 0.00377, "tr2 orphan receptor": 0.00377, "young adult patients": 0.00377, "primary sequence": 0.00377, "dhea receptor": 0.00377, "csf-1 receptor": 0.00377, "icam-1 promoter": 0.00377, "constitutive mrna levels": 0.00377, "breast cancer ] lymphocyte infiltration": 0.00377, "mcm6 genes mediated": 0.00377, "endogenous c/ebp proteins": 0.00377, "induced apoptosis": 0.00377, "h2 receptor desensitization": 0.00377, "ige germline promoter": 0.00377, "nfat sequence failed": 0.00376, "interleukin-2 promoter": 0.00376, "promoter carrying": 0.00376, "prolactin receptor": 0.00376, "scl mrna levels assessed": 0.00376, "low-affinity receptor": 0.00376, "activating gst-pi promoter": 0.00376, "phorbol ester induces monocyte differentiation": 0.00376, "alpha-chain receptor": 0.00376, "r-pk minimal promoter": 0.00376, "vitd3 response element-driven reporter construct": 0.00376, "induce nuclear translocation": 0.00376, "element involved": 0.00376, "h2 receptor": 0.00376, "elk-1 proteins mediate": 0.00376, "s-x-y regulatory region": 0.00376, "transcriptional factors present": 0.00376, "antibodies induced elevation": 0.00376, "kinase inhibitor": 0.00376, "mature b-cell line": 0.00376, "decreased blood histamine response": 0.00376, "nfat-driven minimal promoter": 0.00376, "receptor alpha-chain": 0.00376, "similar sequence": 0.00376, "epstein-barr nuclear antigen": 0.00376, "minimal thy-1 promoter": 0.00376, "isolated genes": 0.00376, "phosphotyrosine-containing proteins bound": 0.00376, "region encoding": 0.00376, "-cd3 complex induces": 0.00376, "receptor partners": 0.00376, "normal transendothelial migration response": 0.00376, "tpo receptor": 0.00376, "hela nuclear extracts contained": 0.00376, "prolactin-inducible target genes": 0.00375, "wild-type proteins": 0.00375, "hiv-1 tat induced": 0.00375, "differentiation required simultaneous treatment": 0.00375, "monocyte/macrophage receptor": 0.00375, "dioxin receptor": 0.00375, "regulatory region": 0.00375, "p105 promoter upregulation": 0.00375, "target predetermined dna sequences": 0.00375, "ta-rich sequence present": 0.00375, "orphan receptor": 0.00375, "receptor clusters": 0.00375, "receptor oligomerization": 0.00375, "ah receptor": 0.00375, "complex regulatory functions": 0.00375, "minimal promoter": 0.00375, "retinoid receptor": 0.00375, "t-cell receptor/cd3 complex": 0.00375, "signaling pathway contributes": 0.00375, "delta promoter": 0.00375, "thyrotropin receptor": 0.00375, "consensus zinc finger peptide domain": 0.00375, "initiator-like sequence present": 0.00375, "receptor c-erba": 0.00375, "base pair region demonstrates": 0.00375, "differentiation pathway": 0.00375, "src family kinase lck": 0.00375, "cognate receptor": 0.00375, "octamer-binding proteins play": 0.00375, "oestrogen receptor": 0.00375, "nuclear antigens involved": 0.00375, "il-10 promoter": 0.00374, "il-18 receptor": 0.00374, "cholecystokininb receptor": 0.00374, "interleukin-9 receptor": 0.00374, "notch1/tan-1 receptor": 0.00374, "apoptosis-mediating receptor": 0.00374, "signal-transmitting receptor": 0.00374, "protein-coupled receptor": 0.00374, "calcitonin receptor": 0.00374, "fcepsilonriib receptor": 0.00374, "-glucan receptor": 0.00374, "similar dna motifs": 0.00374, "resting pbl constitutively expressed prominent levels": 0.00374, "target genes": 0.00374, "lymphocytes activated": 0.00374, "beta-adrenergic receptor": 0.00374, "fcgamma receptor": 0.00374, "dna target sequences": 0.00374, "rel proteins play": 0.00374, "c-erba/t3 receptor": 0.00374, "dna-protein complex formation": 0.00374, "il-6 promoter": 0.00374, "occupied receptor": 0.00374, "receptor ebi1": 0.00374, "vla-5 receptor": 0.00374, "activated lymphocytes": 0.00374, "proteins bound": 0.00374, "nfat element contained": 0.00374, "activated coagulation factors": 0.00374, "receptor quantitation": 0.00374, "gata1 mrna induction": 0.00373, "promoter specificity": 0.00373, "rabbit beta-globin promoter": 0.00373, "carboxylesterase upstream sequence": 0.00373, "9-cis retinoic acid stimulate differentiation": 0.00373, "4-trifluoromethyl salicylate derivatives [ 2-acetoxy-4-trifluoromethyl-benzoic acid": 0.00373, "common deleted region": 0.00373, "jak/stat signaling pathway": 0.00373, "basic helix-loop-helix proteins e2a": 0.00373, "receptor": 0.00373, "e2a basic helix-loop-helix proteins": 0.00373, "activated rar alpha": 0.00373, "2.5-kilobase sequence upstream": 0.00373, "promoter deletion": 0.00373, "pu.1 promoter": 0.00373, "b-cell-specific promoter": 0.00373, "region promoters": 0.00372, "enhanced il-2 mrna stability": 0.00372, "prdii nf-kappa b-binding domain": 0.00372, "regulated proteins": 0.00372, "inhibited il-2r alpha": 0.00372, "apoptosis-associated proteins tested": 0.00372, "sequence upstream": 0.00372, "mnc nuclear extracts decreased": 0.00372, "severe atopic dermatitis patients": 0.00372, "tcr alpha beta lineage": 0.00372, "phosphorylated creb proteins": 0.00372, "eu -and hyperthyroid patients": 0.00372, "element reduced": 0.00372, "gm-csf promoter harboring": 0.00372, "ap-1 proteins": 0.00372, "early events induced": 0.00372, "sla-dra mrna induction": 0.00372, "ets proteins regulate": 0.00372, "upstream sequence": 0.00372, "normal cytoplasmic levels": 0.00372, "regulatory element consists": 0.00372, "htlv-ii tax proteins": 0.00371, "hybrid bcr/abl mrna levels": 0.00371, "characterized absorptive hypercalciuric patients": 0.00371, "mrna induction": 0.00371, "complex ii": 0.00371, "type ii il-1 receptors": 0.00371, "kox zinc finger genes": 0.00371, "cd30 ligation induces nuclear factor-kappa": 0.00371, "distinct complex": 0.0037, "synergistic complex formation": 0.0037, "upstream delta-globin region": 0.0037, "kruppel-related zinc finger genes": 0.0037, "okt3 + phorbol myristate acetate-activated lymphocytes": 0.0037, "gm-csf promoter": 0.0037, "intact e1a conserved region": 0.0037, "pyrimidine-rich region upstream": 0.0037, "tyrosine-phosphorylated stat1 proteins": 0.0037, "extracellular matrix genes": 0.0037, "r7-57 reporter line": 0.0037, "palindromic target sequence": 0.0037, "alternative promoter": 0.0037, "nf-kappab/nfat proteins play": 0.0037, "patients experience long-term disease-free survival": 0.0037, "fetal globin genes": 0.0037, "fos proteins failed": 0.0037, "krab-containing zinc finger genes": 0.0037, "bat box sequence": 0.0037, "show reduced immune function": 0.00369, "bacterial lipopolysaccharide activates nuclear factor-kappab": 0.00369, "gamma genes": 0.00369, "upstream region": 0.00369, "diminished nuclear nf-kappab": 0.00369, "treated cll patients": 0.00369, "viral nuclear antigens": 0.00369, "fusion region": 0.00369, "c-jun genes": 0.00369, "nfatp/ap-1 complex formation": 0.00369, "reduced dna synthesis": 0.00369, "specific monoclonal antibody": 0.00369, "e74 target sequence": 0.00369, "physiological coculture cellular assay system": 0.00369, "kb-enhancer target sequence": 0.00369, "functional element": 0.00369, "heteromeric complex formation": 0.00369, "virus dna": 0.00369, "exogenous promoter": 0.00369, "putative metastatic suppressor genes": 0.00369, "patients examined": 0.00369, "related region": 0.00369, "murine il-2 mrna inducibility": 0.00369, "activates nuclear factor-kappa b. cross-linking cd40": 0.00369, "concatenated linear ebv dna molecule": 0.00369, "monoclonal antibody specific": 0.00369, "region upstream": 0.00369, "92-bp cd11b promoter": 0.00369, "common sequence variants": 0.00369, "dna topoisomerase ii inhibitors": 0.00369, "nfat-1 regulatory element": 0.00368, "immunoglobulin switch region": 0.00368, "viral dna synthesis": 0.00368, "distinct signaling complexes": 0.00368, "stat-1 signaling pathway": 0.00368, "complete vdr coding region": 0.00368, "pervanadate activated nf-kappa": 0.00368, "recombinant proteins": 0.00368, "transcriptional activator nf-kappa": 0.00368, "ciita promoter": 0.00368, "egr-1 promoter": 0.00368, "sp-a activated nf-kappa": 0.00368, "il-6 mrna levels": 0.00368, "ifn alpha levels": 0.00368, "tissue-specific promoter": 0.00368, "lytic viral dna replication": 0.00368, "ovarian cancer patients": 0.00368, "cd11b promoter": 0.00368, "comments ] apoptosis": 0.00368, "target sequence": 0.00368, "core nfat complex consisting": 0.00368, "dna-receptor complex formation": 0.00368, "intact promoter": 0.00368, "dna consensus sequences": 0.00368, "vdr-rxr-vdre complex formation": 0.00368, "heat shock genes": 0.00368, "efficient viral dna replication": 0.00368, "cll patients tested": 0.00367, "genomic sequence reveals": 0.00367, "electrophoretic dna mobility shift assays": 0.00367, "c-myc promoter": 0.00367, "[ glucocorticoid receptors": 0.00367, "pu-sf complex binds": 0.00367, "nf-kappab sites present": 0.00367, "nf-at sequence": 0.00367, "rxr alpha levels": 0.00367, "promyelocytic leukemia line": 0.00367, "tcr-cd8 complex conditions long-term clonotype persistence": 0.00367, "patients sodium": 0.00367, "complex formation": 0.00367, "ikaros proteins correlates": 0.00367, "vcam-1 promoter": 0.00367, "jak-stat signaling pathway": 0.00366, "patients treated": 0.00366, "lymphocyte development induced": 0.00366, "tal-1 promoter": 0.00366, "rar-mediated signaling pathway": 0.00366, "native promoter": 0.00366, "notch1 ankyrin repeat region": 0.00366, "sp-1 consensus sequence": 0.00366, "notch signaling pathway": 0.00366, "lmp-1 promoter": 0.00366, "yy1 consensus sequence": 0.00366, "activated nf-kappa": 0.00366, "tuberculosis patients correlated": 0.00366, "class ii-peptide complex": 0.00366, "cd2-based signaling pathway": 0.00366, "r24 signaling pathway": 0.00366, "epsilon germline promoter": 0.00366, "il-2r alpha mrna": 0.00366, "kda stat5 proteins": 0.00366, "box1 consensus sequence": 0.00366, "il-1beta promoter": 0.00366, "wnt signaling pathway": 0.00366, "p65 proteins": 0.00366, "treated patients": 0.00366, "mek/erk signaling pathway": 0.00366, "oct-2 mrna levels": 0.00366, "thymidine kinase promoter-driven reporter construct": 0.00366, "small gtp-binding proteins": 0.00366, "c-fos proteins": 0.00366, "apoptosis pathway": 0.00365, "chronic kidney failure ] active metabolite": 0.00365, "fibronectin induced il-2 message": 0.00365, "jak kinase family": 0.00365, "short osteocalcin promoter": 0.00365, "moloney murine leukemia virus promoters": 0.00365, "promoter consists": 0.00365, "normal cellular function": 0.00365, "essential proteins": 0.00365, "weakly active region": 0.00365, "il-5 promoter": 0.00365, "signaling pathway": 0.00365, "increase camp levels": 0.00365, "cis-acting dna elements": 0.00365, "numerous inflammatory genes": 0.00365, "sterol regulatory element": 0.00365, "heterologous promoter": 0.00365, "mutated ap-1 element": 0.00365, "-positive patients lacking la": 0.00364, "hiv genes": 0.00364, "lipopolysaccharide-stimulated interleukin-1 beta messenger rna levels": 0.00364, "interacting basic helix-loop-helix proteins": 0.00364, "stat proteins capable": 0.00364, "core sequence cttgg": 0.00364, "serum responsive element": 0.00364, "leukocyte-specific pp52 promoter": 0.00364, "b2 promoter": 0.00364, "negative transcriptional regulatory elements": 0.00364, "mediate phorbol myristate acetate induction": 0.00364, "induce il-2 cytokine production": 0.00364, "myeloid-cell-specific c-fes promoter": 0.00364, "facilitate promoter occupation": 0.00364, "mediating biological responses induced": 0.00364, "prdii regulatory element": 0.00364, "consensus sequence ctcacntnc": 0.00363, "distal element upstream": 0.00363, "il-3 promoter": 0.00363, "six-base-pair consensus sequence": 0.00363, "patients studied": 0.00363, "l-selectin promoter": 0.00363, "-kappab consensus sequence": 0.00363, "consensus sequence 5'-gttacgtaat-3": 0.00363, "il-4 genes": 0.00363, "oxidative stress inhibits fasl induction": 0.00363, "leukocyte integrin genes cd11c": 0.00363, "nf kappa b2 motif": 0.00363, "tcf-1 alpha mrna": 0.00363, "cd19 promoter": 0.00363, "mrna stability studies demonstrated": 0.00363, "cdna sequence": 0.00363, "region termed cleo": 0.00363, "maximal mrna levels": 0.00363, "aspirin inhibits nuclear factor-kappa": 0.00363, "transcriptional regulatory domain": 0.00363, "transactivation sequence": 0.00363, "cam kinase family": 0.00362, "accessory proteins called": 0.00362, "dra promoter occupancy": 0.00362, "epor promoter": 0.00362, "patients positive": 0.00362, "sp1 proteins": 0.00362, "trans-activator protein-responsive promoter": 0.00362, "genes regulated": 0.00362, "nf-y-responsive dqbeta promoter": 0.00362, "il-8 promoter": 0.00362, "cyclosporin a. dna-binding phosphoproteins induced": 0.00362, "nfat proteins constitute": 0.00362, "spi-1 and/or fli-1 genes": 0.00362, "nf-kappab inhibitory effect": 0.00362, "cancer patients": 0.00362, "il-6 response elements": 0.00362, "lt promoter": 0.00362, "vdr interacting proteins": 0.00362, "consensus sequence": 0.00362, "beta-globin promoter": 0.00362, "complex group": 0.00362, "immature b-cell line": 0.00362, "influences antibody response": 0.00362, "differentiation effect": 0.00362, "phytohemagglutinin stimulated lymphocytes derived": 0.00361, "pxqxt/s core sequence": 0.00361, "pma responsive element": 0.00361, "chimeric hlf proteins": 0.00361, "structure function analysis": 0.00361, "significant sequence similarity": 0.00361, "cognate dna elements": 0.00361, ":8154 ] stimulation": 0.00361, "scl mrna levels": 0.00361, "sv40 core sequence": 0.00361, "ets proteins share": 0.00361, "distal promoter": 0.00361, "pml/rar alpha mrna": 0.00361, "bcl-x promoter": 0.00361, "collagenase promoter": 0.00361, "rearranged tcr genes": 0.00361, "ccaat element present": 0.00361, "box region": 0.00361, "stat4 inducible proteins": 0.00361, "genes studied": 0.00361, "cis-regulatory dna elements": 0.00361, "ctla-4 signaling inhibits events early": 0.00361, "individual latent proteins": 0.00361, "n-terminal conserved region": 0.00361, "inhibited terminal differentiation": 0.00361, "interferon-inducible regulatory element": 0.00361, "transcriptional control elements": 0.00361, "il-2ralpha promoter": 0.0036, "ra patients": 0.0036, "c-myc mrna levels": 0.0036, "transfected ifn-stimulated genes": 0.0036, "tcr beta analysis": 0.0036, "lmp1 usurps cellular signaling pathways resulting": 0.0036, "gamma-globin promoter": 0.0036, "vcam-1 mrna levels": 0.0036, "affected lymphokine genes": 0.0036, "tf promoter": 0.0036, "nuclear factor-kappab control": 0.0036, "hiv-1 ltrs lacking c/ebp sites": 0.0036, "deficiency-heat syndromes ] plasma cortisol concentration": 0.0036, "production induced": 0.0036, "dra promoter discriminates": 0.0036, "chicken il2 promoter": 0.0036, "promoter central": 0.0036, "zinc finger/homeodomain proteins": 0.0036, "hsv-1 icp4 promoter": 0.0036, "ferritin h-gene promoter": 0.0036, "fasl promoter": 0.0036, "inflammatory genes": 0.0036, "lck promoter": 0.0036, "cd14 promoter": 0.0036, "e-selectin promoter": 0.0036, "c-fes promoter": 0.0036, "specific calcitropic effect": 0.0036, "stat3 proteins": 0.0036, "interferon-gamma promoter": 0.0036, "cd34 promoter": 0.0036, "core sequence aggc": 0.00359, "activating nf-at complex": 0.00359, "ltb4 induced adhesive interactions": 0.00359, "constitutive complex bound": 0.00359, "atopic asthma patients": 0.00359, "regulatory element": 0.00359, "id3 mrna increase": 0.00359, "fp promoter": 0.00359, "monocyte genes": 0.00359, "ankyrin-rich inhibitory proteins": 0.00359, "dqb promoter": 0.00359, "fy*b promoter": 0.00359, "e3 promoter": 0.00359, "gal4-binding dna elements": 0.00359, "core sequence taat": 0.00359, "zinc finger region": 0.00359, "genes play": 0.00359, "early immune response": 0.00359, "secondary granule proteins": 0.00359, "promoter occupation": 0.00359, "promoter selectivity": 0.00359, "increased kappa": 0.00359, "cis-acting dominant negative regulatory effect": 0.00359, "pp52 promoter": 0.00359, "il-1alpha promoter": 0.00359, "nuclear localization sequences": 0.00359, "camp signaling inhibited stat1": 0.00359, "dra promoter": 0.00359, "ankyrin repeat region": 0.00359, "nuclear extracts derived": 0.00359, "embryonic globin genes": 0.00359, "recombination activating genes": 0.00359, "constitutive proteins": 0.00359, "relevant promoter": 0.00359, "tp1 promoter": 0.00359, "lytic cycle genes": 0.00359, "irf-1 promoter": 0.00359, "basic helix-loop-helix proteins": 0.00359, "box-dependent transcriptional pathway": 0.00358, "udg promoter": 0.00358, "germline promoter": 0.00358, "hla-dra promoter": 0.00358, "bcl-6 mrna levels": 0.00358, "type ii mhc combined immune deficiency": 0.00358, "patients affected": 0.00358, "generate vitamin d-responsive element": 0.00358, "29-kda proteins phosphorylated": 0.00358, "lymphocytes initiates signal transduction cascades": 0.00358, "nfat proteins": 0.00358, "transfected genes": 0.00358, "alpha-globin promoter": 0.00358, "respective promoter": 0.00358, "dna elements": 0.00358, "bzlf1 promoter": 0.00358, "stat1 proteins": 0.00358, "ifn-gamma responsive element": 0.00358, "t-cell mediated response": 0.00358, "proteins correlated": 0.00358, "p2 promoter": 0.00358, "inhibitory proteins": 0.00358, "affected patients": 0.00358, "lytic ebv dna replication": 0.00358, "regulating normal hematopoietic differentiation": 0.00358, "promoter context": 0.00358, "gos19 promoter": 0.00358, "pmlrar alpha impairs neutrophil differentiation": 0.00358, "cd28-responsive element present": 0.00358, "jurkat line": 0.00358, "transcriptional factors ap-1": 0.00357, "p40 promoter": 0.00357, "individual stat proteins": 0.00357, "tcr genes": 0.00357, "repressor proteins bp1": 0.00357, "ap-1 transcriptional factors": 0.00357, "core sequence": 0.00357, "vitro kinase assays": 0.00357, "oct-1 pou domain [": 0.00357, "tumor necrosis factor-alpha mrna accumulation": 0.00357, "chimeric ebna2 proteins": 0.00357, "bipartite nuclear localization signal": 0.00357, "igh promoter": 0.00357, "artificial promoter": 0.00357, "tgf-beta promoter": 0.00357, "ciita-induced promoter occupancy": 0.00357, "b-cell nuclear extracts": 0.00357, "dna mobility shift assays": 0.00357, "prevents high level induction": 0.00357, "alpha1 germ-line promoter": 0.00357, "minimal region responsible": 0.00357, "detect stat proteins": 0.00357, "tax1-inducible transcriptional pathway": 0.00357, "lmp promoter": 0.00357, "c-fos genes": 0.00357, "mrp14 promoter": 0.00356, "nf-il6 mrna levels": 0.00356, "-2 promoter": 0.00356, "erythroid differentiation [": 0.00356, "ap-1 sequence": 0.00356, "type ii ifn receptors": 0.00356, "cryptic promoter": 0.00356, "cd36 promoter": 0.00356, "basic hlh proteins": 0.00356, "cag repeat region": 0.00356, "hiv-1 transcriptional enhancer": 0.00356, "dna damage-induced apoptosis": 0.00356, "ebv-encoded nuclear antigen": 0.00356, "htlv-1 promoter": 0.00356, "stat3alpha proteins phosphorylated": 0.00356, "normal heterozygous lymphocytes": 0.00356, "essential genes": 0.00356, "tnf alpha treatment": 0.00356, "28-bp core region": 0.00356, "myeloid genes": 0.00356, "mbp promoter": 0.00356, "cytoplasmic region": 0.00356, "bare promoter": 0.00356, "high-titer antibody response": 0.00356, "death genes": 0.00356, "purified cam kinase ii": 0.00356, "zebra promoter": 0.00356, "beta-casein promoter": 0.00356, "cd18 promoter": 0.00356, "intracellular transcriptional factors": 0.00356, "element derived": 0.00356, "multiple cellular factors": 0.00356, "dprl promoter": 0.00356, "e2f-1 promoter": 0.00356, "strong positive regulatory effect": 0.00355, "p105 mrna levels": 0.00355, "sv40 promoter": 0.00355, "proteins resulting": 0.00355, "msr promoter": 0.00355, "nuclear localization signal": 0.00355, "mtetra-induced il-1 beta mrna accumulation": 0.00355, "plasminogen activator inhibitor type": 0.00355, "ifn-beta promoter": 0.00355, "400-base pair meta region": 0.00355, "increased tumor necrosis factor-alphaand interleukin-1betaproduction": 0.00355, "oxidative signals induced": 0.00355, "distinct enhancer elements": 0.00355, "kd transcriptional activator nf-kappab subunit": 0.00355, "patients infected": 0.00355, "infected patients": 0.00355, "kd proteins": 0.00355, "cd20 promoter": 0.00355, "il-16 promoter": 0.00355, "viral dna replication": 0.00355, "cd11c promoter": 0.00355, "icam-i promoter": 0.00355, "hematopoietic genes": 0.00355, "nuclear extracts bind": 0.00355, "lal promoter": 0.00355, "heavy-chain promoter": 0.00355, "immune complex": 0.00355, "genes association": 0.00355, "subsequent interferon alpha treatment": 0.00354, "alpha1 promoter": 0.00354, "hil-5 promoter": 0.00354, "h4 promoter": 0.00354, "gpiib promoter": 0.00354, "permissive b-cell line": 0.00354, "cle0 sequence interacts": 0.00354, "inhibited c-fos phosphorylation": 0.00354, "vcam promoter": 0.00354, "cd25 promoter": 0.00354, "ea-d promoter": 0.00354, "stress genes": 0.00354, "effect observed": 0.00354, "cd23b promoter": 0.00354, "vitd3 response elements": 0.00354, "rearranged immunoglobulin genes": 0.00354, "zeta-globin promoter": 0.00354, "element upstream": 0.00354, "electrophoresis mobility shift assays demonstrated gata-3 binds": 0.00354, "inducible interleukin-2 enhancer function bind": 0.00354, "pecam-1 promoter": 0.00354, "tata-less promoter": 0.00354, "intragenic promoter": 0.00354, "bmrf1 promoter": 0.00354, "lymphotoxin promoter": 0.00354, "disease-resistant background interleukin-2 induces tyrosine phosphorylation": 0.00354, "comments ] adhesion molecules": 0.00354, "mrna levels peak": 0.00354, "repressor proteins": 0.00354, "ra receptors alpha": 0.00354, "asthma patients": 0.00354, "tcr alpha enhancer": 0.00354, "gpix promoter": 0.00354, "il-1 beta convertase mrna accumulation": 0.00354, "stat proteins utilized": 0.00354, "il3 promoter": 0.00354, "parent promoter": 0.00354, "il1b promoter": 0.00354, "pthrp promoter": 0.00354, "increased transcriptional initiation": 0.00353, "bamhi-q promoter": 0.00353, "nf-kappab-regulated promoter": 0.00353, "gos19.1 promoter": 0.00353, "h5 promoter": 0.00353, "single tissue-specific element": 0.00353, "ifn-gamma-responsive promoter": 0.00353, "stress response system": 0.00353, "conalbumin promoter": 0.00353, "e3 mrna levels": 0.00353, "neomycin-resistance promoter": 0.00353, "c-sis/pdgf-b promoter": 0.00353, "iepsilon promoter": 0.00353, "hepor promoter": 0.00353, "motif-1/lymphotactin promoter": 0.00353, "metallothionein promoter": 0.00353, "cd21 promoter": 0.00353, "il2rbeta promoter": 0.00353, "cre-containing promoter": 0.00353, "normal erythroid differentiation": 0.00353, "cyc1 promoter": 0.00353, "megakaryocytic-specific promoter": 0.00353, "mb-1 promoter": 0.00353, "proteins remains": 0.00353, "tetracycline-regulated promoter": 0.00353, "proenkephalin promoter": 0.00353, "cp/wp promoter": 0.00353, "cd95l promoter": 0.00353, "mrna-type promoter": 0.00353, "r-pk promoter": 0.00353, "crh promoter": 0.00353, "putative g0s genes": 0.00353, "btk promoter": 0.00353, "fnf-e2 promoter": 0.00353, "enhancerless promoter": 0.00353, "rprl promoter": 0.00353, "interleukin-1alpha promoter": 0.00353, "galectin-3 promoter": 0.00353, "detect e2a proteins": 0.00353, "porcine b-cell line l23": 0.00353, "anf-e2 promoter": 0.00353, "h-2kb promoter": 0.00353, "fcgammari promoter": 0.00353, "blk promoter": 0.00353, "gata-1 genes": 0.00353, "nf-kappab pathway contributes": 0.00353, "15-lo promoter": 0.00353, "tcr constant region": 0.00353, "ecto-5'-nucleotidase promoter": 0.00353, "dpa promoter": 0.00353, "postmenopausal patients risk": 0.00353, "il-5 induced signals": 0.00353, "additional proteins crossreactive": 0.00353, "chimeric proteins": 0.00352, "endocrine beta-cells detect pan proteins": 0.00352, "type ii corticosteroid receptors": 0.00352, "multiple cis-acting regulatory sites interact": 0.00352, "altered proteins": 0.00352, "promoter": 0.00352, "additional proteins": 0.00352, "high level il-2 production": 0.00352, "vivo footprinted dna motifs": 0.00352, "gamma-ifn responsive genes": 0.00352, "[ induction": 0.00352, "differentiation induction systems": 0.00352, "transient nf-kappab response": 0.00352, "non-heat shock genes": 0.00352, "octamer-binding proteins oct-1": 0.00352, "specific receptors results": 0.00352, "b7 induce distinct effects": 0.00352, "key genes coding": 0.00352, "full differentiation response": 0.00352, "all-trans retinoic acid treatment": 0.00352, "estradiol induce extrathymic t-cell differentiation": 0.00351, "positive region": 0.00351, "increased tumor necrosis factor-alphaproduction": 0.00351, "fms patients remains": 0.00351, "patients lacking": 0.00351, "putative nfat-1 region": 0.00351, "nuclear antigen": 0.00351, "regulates erythroid-expressed genes": 0.00351, "cis-acting element termed": 0.00351, "high affinity il-2 receptors": 0.00351, "fc blocked pma induction": 0.0035, "major histocompatibility complex classes": 0.0035, "c/ebp proteins": 0.0035, "genes leads": 0.0035, "ets proteins synergize": 0.0035, "steady-state mrna levels": 0.0035, "mammalian pax genes": 0.0035, "proteins display": 0.0035, "activated levels": 0.0035, "determine dna sequences": 0.0035, "lymphocytes [": 0.0035, "cytokine receptors [": 0.0035, "regulate lineage-specific genes": 0.0035, "dyad symmetry element controls": 0.0035, "comments ] affinity-driven peptide selection": 0.0035, "regulates genes": 0.0035, "herpes simplex virus t-cell antigen": 0.0035, "increased il-2 secretion": 0.0035, "antigen induced": 0.0035, "immunoglobulin genes": 0.0035, "nf-at element": 0.00349, "agents reduced lps-stimulated tf mrna accumulation": 0.00349, "cd19-expressing b-cell line": 0.00349, "rel proteins c-rel": 0.00349, "develop u937 transfectants expressing antisense vdr mrna": 0.00349, "cloned genes": 0.00349, "full-length cd14 coding sequence": 0.00349, "transactivating rar-rxr response elements": 0.00349, "nf kappab-regulated genes": 0.00349, "genes responsive": 0.00349, "mnda mrna levels": 0.00349, "unique transcriptional mechanism distinct": 0.00349, "nf-kappa b/rel family": 0.00349, "b-cell line wehi-231": 0.00349, "expressed anti-tat single-chain intracellular antibody": 0.00349, "proteins interact": 0.00349, "proximal 0.2-kb region": 0.00349, "cytotoxic proteins secreted": 0.00349, "b-cell line bl41-p3hr1": 0.00349, "nf-kappa b/rel involves phosphorylation": 0.00349, "nuclear matrix attachment regions": 0.00349, "independent genes": 0.00349, "ets-domain proteins pu.1": 0.00349, "responsive genes": 0.00349, "cbp/p300 coactivator proteins": 0.00349, "fms patients displayed": 0.00349, "latent proteins": 0.00349, "major e2f complex": 0.00349, "normal induction": 0.00349, "essential cis-acting enhancer motif": 0.00349, "grb2 sh3-binding proteins sos1": 0.00348, "cml patients lack": 0.00348, "24-hydroxylase mrna levels": 0.00348, "b-cell line": 0.00348, "lung transplant patients": 0.00348, "sox9 coding sequence polymorphism": 0.00348, "fms patients display": 0.00348, "proteins encoded": 0.00348, "specific tyrosine phosphorylation": 0.00348, "mammalian genes": 0.00348, "enhancer elements involved": 0.00348, "il-2 induced": 0.00348, "individual homodimeric rel-related proteins": 0.00348, "element termed e1": 0.00348, "proximal 5'-flanking region": 0.00348, "regulating genes driven": 0.00348, "induced il-2": 0.00348, "targets unrearranged igh genes": 0.00348, "induction mechanism remain unknown": 0.00348, "major histocompatibility complex": 0.00347, "inducible ubiquitous nuclear component": 0.00347, "nf-kappa b-like family": 0.00347, "dimeric complex activator protein-1": 0.00347, "normal lymphocytes": 0.00347, "stat5 proteins": 0.00347, ":409 ] regulation": 0.00347, "resistant asthmatic patients": 0.00347, "tcrg mrna levels": 0.00347, "induce tumor necrosis factor-alpha production": 0.00347, "host proteins": 0.00347, "cellular camp levels inhibit": 0.00347, "il-1rii mrna levels": 0.00347, "ltr sequence": 0.00347, "mm patients": 0.00347, "specific nf-kappa b/rel subunits": 0.00347, "conserved cis-acting sequence": 0.00346, "blps stimulated nuclear factor-kappab": 0.00346, "inducible genes": 0.00346, "tumour suppressor genes": 0.00346, "endogenous il-6-responsive genes": 0.00346, "reduced nuclear localization": 0.00346, "signal growth inhibition": 0.00346, "g0s2 mrna levels": 0.00346, "endogenous mcm genes": 0.00346, "differentiation response": 0.00346, "basic domain-leucine zipper region": 0.00346, "genes constitutively": 0.00346, "murine genomic dna": 0.00346, "respective response elements": 0.00346, "kda proteins": 0.00346, "stat proteins": 0.00346, "genomic sequence": 0.00346, "common region": 0.00346, "20-base pair sequence": 0.00346, "alpha/mad-3 mrna levels": 0.00346, "oct-1 proteins": 0.00346, "creb proteins": 0.00346, "normal rar alpha": 0.00346, "proximal region": 0.00346, "identical proteins": 0.00345, "thrombopoietin induces rapid tyrosine phosphorylation": 0.00345, "increased phosphorylation": 0.00345, "proteins capable": 0.00345, "class ii-negative t-cell lines": 0.00345, "mrna levels": 0.00345, "lymphoid-specific oct-2a proteins": 0.00345, "monocytes induced": 0.00345, "tumor necrosis factor-alpha induction": 0.00345, "putative cis-acting control elements present": 0.00345, "ltr region": 0.00345, "identical nucleotide sequence": 0.00345, "induce growth inhibition": 0.00345, "jun proteins": 0.00345, "kappa b-like sites": 0.00345, "interleukin-4 genes correlates": 0.00345, "suppressive transcriptional effect": 0.00345, "downstream intronic sequence": 0.00345, "gamma- globin genes": 0.00345, "type ii estrogenic receptors": 0.00345, "semi-purified ap1 proteins mixed": 0.00345, "phorbol myristate acetate effect": 0.00345, "genes regulating": 0.00345, "eosinophil granule proteins": 0.00344, "region critical": 0.00344, "element termed": 0.00344, "region c. spi-c interacted": 0.00344, "cell-specific steroid-regulated genes": 0.00344, "observed glucocorticoid receptors": 0.00344, "consensus element": 0.00344, "e1a proteins": 0.00344, "minimal element inducible": 0.00344, "inactive cytoplasmic complex": 0.00344, "globin mrna expressed": 0.00344, "enhanced tcr-controlled nf-at induction": 0.00344, "ets proteins": 0.00344, "functional b-cell response": 0.00344, "induces rapid tyrosine phosphorylation": 0.00344, "northern blot analysis suggest": 0.00344, "b29 conserved sequence": 0.00344, "mrna species expressed": 0.00344, "ap-2 response elements": 0.00344, "genomic region": 0.00344, "critical region": 0.00344, "beta-like globin genes": 0.00344, "il-1 beta message induction": 0.00343, "ebna2 specific monoclonal antibodies": 0.00343, "il-2 activates nf-kappa": 0.00343, "-2 homology nfat-1 region": 0.00343, "cyclic amp-responsive element-like sequence": 0.00343, "nf-kappab pathway": 0.00343, "electrophoretic mobility shift assay complexes": 0.00343, "specific response": 0.00343, "c-rel proteins": 0.00343, "normal control group": 0.00343, "commonly deleted region": 0.00343, "small region": 0.00343, "high il-2 levels": 0.00343, "htlv-i genes": 0.00343, "induced proliferation": 0.00343, "strong repressor element": 0.00343, "u937 monocytic line": 0.00343, "polarized hla class ii antigen processing": 0.00343, "globin genes": 0.00343, "murine t-cell lines": 0.00343, "proliferation induced": 0.00343, "anti-ig response elements": 0.00342, "gata proteins": 0.00342, "retinoic acid treatment": 0.00342, "additional genes": 0.00342, "monocytic genes": 0.00342, "individual rel-related proteins": 0.00342, "type ii receptors": 0.00342, "ad proteins": 0.00342, "distinct il-4 signaling pathways exist": 0.00342, "il-2 transcriptional regulation differs": 0.00342, "activate c-jun n-terminal kinase": 0.00342, "recognition sequence": 0.00342, "differentiation dependent increase": 0.00342, "cell-specific genes": 0.00342, "distinct nuclear foci": 0.00342, "dm genes share": 0.00342, "ifn alpha production due": 0.00341, "e2a proteins": 0.00341, "chromosomal proteins": 0.00341, "fhit genes occurs": 0.00341, "tbp-containing complex related": 0.00341, "complex tissue-specific structure": 0.00341, "tyrosine kinase inhibitors genistein": 0.00341, "hematopoietic growth factors": 0.00341, "genes carrying": 0.00341, "full-length mzf-1 coding region": 0.00341, "mycobacterial response elements": 0.00341, "t-cell developmental pathway": 0.00341, "aids patients": 0.00341, "normal signal-dependent nf-kappa": 0.00341, "7-bp response elements": 0.00341, "sea urchin pax-258 proteins": 0.00341, "complex contained rela": 0.00341, "interleukin-2 genes": 0.00341, "increased gm-csf production": 0.00341, "interferon-stimulated response elements": 0.00341, "rbp-jkappa response elements": 0.00341, "il-4 p0 element": 0.00341, "selected proteins": 0.00341, "beta t-cell receptors": 0.00341, "oct-2a proteins": 0.00341, "increased apoptosis": 0.00341, "informative female patients": 0.00341, "genes displayed": 0.00341, "nf-kappa b. thiol modulation inhibits": 0.0034, "cell-type specific induction": 0.0034, "region downstream": 0.0034, "extracellular signals induce phosphorylation": 0.0034, "oncogenic proteins": 0.0034, "complete coding sequence": 0.0034, "element bound": 0.0034, "nuclear export signal": 0.0034, "latent genes": 0.0034, "pi 3-kinase inhibited tcr-mediated nf-at responses": 0.0034, "nf-kappa b-binding complexes": 0.0034, "responsive region": 0.0034, "nf kappa b/rel family": 0.0034, "burkitt lymphoma line raji": 0.0034, "il-6 genes": 0.0034, "il-2r alpha kappa": 0.0034, "targets non-ig genes": 0.0034, "42-nucleotide repeat element": 0.0034, "minimal beta-casein stat5 element": 0.0034, "hiv-1 mutant virus": 0.0034, "b-cell population induced": 0.0034, "specific docking sites": 0.0034, "cellular dna damage": 0.0034, "detect pan/e2a proteins": 0.0034, "conserved 20-bp sequence": 0.0034, "response elements": 0.0034, "normal nf-kappa": 0.0034, "unstable untreated asthmatic patients": 0.00339, "nur77 dominant negative transgenic mice suggest": 0.00339, "mice display elevated levels": 0.00339, "mutant escherichia coli endotoxin lacking myristoyl fatty acid": 0.00339, "ingested proteins setting": 0.00339, "downstream enhancer domain": 0.00339, "induced transient increases": 0.00339, "c-terminal serine/threonine/proline-rich region": 0.00339, "cd28re sequence reveals similarity": 0.00339, "patients free": 0.00339, "jnk phosphorylation sites": 0.00339, "conserved sequence": 0.00339, "host immune-response genes": 0.00339, "il-12 induce c-myc mrna accumulation": 0.00339, "nf-kappa b/rel complexes": 0.00339, "mgc formation induced": 0.00339, "core element": 0.00339, "recombinant ori lyt element": 0.00339, "transient nf-kappa b-dna interaction": 0.00339, "increased growth rate": 0.00339, "strong transcriptional activating effects": 0.00339, "integrated mouse mammary tumor virus": 0.00339, "partial nucleotide sequence": 0.00339, "il-10 genes": 0.00339, "lymphocytes expressed": 0.00339, "female patients": 0.00338, "conserved s-x-y region": 0.00338, "sequence analyses": 0.00338, "resistant patients": 0.00338, "single element": 0.00338, "ikappab-alpha proteins": 0.00338, "aml proteins": 0.00338, "pre-existing nf-at complex": 0.00338, "tcr alpha beta": 0.00338, "sequence localized": 0.00338, "herpes simplex tegument proteins": 0.00338, "combination cytokine therapy [ interleukin": 0.00338, "nac reduced nuclear factor-kappa": 0.00338, "genes reported": 0.00338, "rela proteins": 0.00338, "lymphoid nuclear extracts": 0.00338, "ap-1 complex consists": 0.00338, "indistinguishable sequence specificity": 0.00338, "selected a-t patients": 0.00338, "rb proteins": 0.00338, "similar regulatory response": 0.00338, "nf-kappa b/rel inhibition": 0.00338, "palindromic octamer sequence": 0.00338, "dna fragment derived": 0.00338, "ap-1 element": 0.00338, "monoclonal antibodies specific": 0.00338, "b-cell-specific genes": 0.00338, "normal adult peripheral blood": 0.00338, "large region": 0.00337, "common cis-acting element": 0.00337, "lambda light-chain genes": 0.00337, "stat5 genes": 0.00337, "agonists induced ca2+ release": 0.00337, "negative element": 0.00337, "actin genes": 0.00337, "c-rel/p65 heterodimers prevented lps induction": 0.00337, "mouse mammary tumor virus": 0.00337, "gata3 zinc-finger proteins": 0.00337, "oct-1-responsive octamer sequence atgcaaat": 0.00337, "kb 5'-flanking region": 0.00337, "c-terminal region": 0.00337, "nf-il6 proteins": 0.00337, "kb sequence": 0.00337, "putative gas element": 0.00337, "heparin-binding proteins crucial": 0.00337, "negative transcriptional effects": 0.00337, "nuclear run-on assays": 0.00337, "bcl-6 coding region": 0.00337, "nf-kappa b. stimulation": 0.00337, "proteins differ": 0.00337, "differentiation induction": 0.00337, "normal immune system": 0.00337, "yang deficient patients": 0.00337, "patients undergoing elective ptca": 0.00337, "mhc class ii signaling": 0.00337, "obvious sequence homology": 0.00337, "rheumatoid arthritis patients": 0.00336, "intracellular oxidant stress induced": 0.00336, "nuclear signal": 0.00336, "rac gtp-binding proteins": 0.00336, "jun genes": 0.00336, "conserved region": 0.00336, "inhibited hiv-1 replication": 0.00336, "jnk proteins": 0.00336, "adenoviruses encode proteins": 0.00336, "constitutively express high levels": 0.00336, "nf-kappa b.i kappa": 0.00336, "induced activities downstream": 0.00336, "nf-kappa b/i kappa": 0.00336, "atgcaaat octamer sequence": 0.00336, "distinct intracellular signaling pathways": 0.00336, "variant sequence": 0.00336, "il-12 induces tyrosine phosphorylation": 0.00336, "nf-kappa b-mediated signal transduction": 0.00336, "vzv proteins": 0.00336, "identified stat family member": 0.00336, "increased intracellular ca2+ concentration": 0.00336, "nf-at complex": 0.00336, "nuclear run-off assays": 0.00336, "octamer sequence atgcaaat": 0.00336, "genes characteristic": 0.00336, "extensive nucleotide sequence": 0.00336, "multiple kinase pathways": 0.00336, "region conserved": 0.00336, "e1a genes": 0.00335, "basic region": 0.00335, "] orthophosphate show": 0.00335, "ras-related gtp-binding proteins": 0.00335, "patients underwent fiberoptic bronchoscopy": 0.00335, "inhibited [": 0.00335, "linker proteins": 0.00335, "fos proteins": 0.00335, "tuberculosis patients": 0.00335, "systemic lupus erythematosus patients": 0.00335, "index absorptive hypercalciuric patients": 0.00335, "repressor region": 0.00335, "xq13 region carrying xic/xist": 0.00335, "cell-surface proteins": 0.00335, "nf-kappab/rel proteins translocated": 0.00335, "anti-inflammatory cytokines inhibited lps": 0.00335, "positive element": 0.00335, "octamer sequence": 0.00335, "nucleotide sequence requirements": 0.00335, "switch region": 0.00335, "exogenous genes": 0.00335, "partial amino acid sequences": 0.00335, "proteins recognizes": 0.00335, "important transcriptional elements": 0.00335, "e2a-hlf proteins": 0.00335, "specific trans-acting factors": 0.00335, "tepoxalin inhibited lymphocyte proliferation": 0.00335, "okadaic acid treatment": 0.00334, "enhance normal erythroid proliferation": 0.00334, "sequence mediates": 0.00334, "abundant proteins": 0.00334, "leukemia virus type": 0.00334, "n-terminal thr729-leu765 region": 0.00334, "altered cellular response": 0.00334, "jak/stat proteins": 0.00334, "timp-1-positive bl lines show resistance": 0.00334, "retinoic acid receptors": 0.00334, "relevant proteins": 0.00334, "syk kinases-interacting proteins": 0.00334, "cd15 cross-linking induced tnf-alpha release": 0.00334, "small cis-acting element": 0.00334, "variable region beta-chain families": 0.00334, "relb proteins": 0.00334, "ad patients": 0.00334, "enhanced stat3 tyrosine phosphorylation": 0.00334, "encode proteins": 0.00334, "eosinophil-associated granule proteins": 0.00334, "hiv-1 provirus dna": 0.00334, "fy*b coding sequence": 0.00334, "nf-y proteins": 0.00334, "important pathway leading": 0.00334, "induced ap-1 translocation": 0.00334, "signal-transducing smad proteins": 0.00334, "reported germ-line sequence": 0.00334, "delta sequence": 0.00334, "non-insulin-dependent diabetes mellitus patients": 0.00334, "fk506.fkbp12 drug-immunophilin complexes inhibited": 0.00334, "cd28 responsive complex": 0.00334, "homologue 38-kd murine map kinase homologous": 0.00334, "bhlh proteins": 0.00333, "increased interleukin-1 beta": 0.00333, "-beta proteins": 0.00333, "ankyrin motif-rich proteins": 0.00333, "additional region": 0.00333, "respective proteins": 0.00333, "nuclear factor-il6 motifs": 0.00333, "comments ] signal transducer": 0.00333, "hiv-1 proviral dna": 0.00333, "phytohemagglutinin-activated peripheral blood lymphocytes": 0.00333, "reported amino-terminal sequence": 0.00333, "negative regulatory effect": 0.00333, "pax-5b proteins": 0.00333, "cdc42 proteins": 0.00333, "anti-cd3-treated peripheral blood lymphocytes": 0.00333, "octamer-binding proteins": 0.00333, "increased transcriptional elongation": 0.00333, "protein-dna interactions mediating ifn-beta induction": 0.00333, "specific trans-activating factors": 0.00333, "fos-related proteins": 0.00333, "chronic immune response": 0.00333, "dr3-type vitamin d-responsive element": 0.00333, "determine mzf-1 transcriptional regulatory function": 0.00333, "untreated cml patients": 0.00333, "dna isolated contained": 0.00333, "pmlrar alpha transgenic mice": 0.00333, "minor proteins": 0.00333, "selected patients": 0.00333, "specific induction": 0.00333, "octamer dna motifs": 0.00333, "intact octamer element": 0.00333, "transdominant rev proteins": 0.00333, "hormone-inducible trans-activating proteins": 0.00333, "ap-1 sites bound c-fos/c-jun heterodimers": 0.00333, "tissue-specific genes": 0.00333, "egr-1 genes": 0.00333, "n-terminal region": 0.00333, "untreated euthymic patients": 0.00332, "allergic patients": 0.00332, "tissue specific regulation": 0.00332, "aes proteins": 0.00332, "monofactorial analysis identified": 0.00332, "patients allergic": 0.00332, "29-kda proteins": 0.00332, "rel proteins": 0.00332, "sequence homology": 0.00332, "immunogenic proteins": 0.00332, "ebna2 dependent cis-acting element": 0.00332, "rna complex": 0.00332, "ifn genes": 0.00332, "antiviral proteins": 0.00332, "c-myc genes": 0.00332, "lambda genes": 0.00332, "cardiac infarction patients": 0.00332, "interacting proteins": 0.00332, "untreated ibd patients": 0.00332, "janus kinase function": 0.00332, "selected genes": 0.00332, "proteins interacted": 0.00332, "increase apoptosis sensitivity": 0.00332, "alpha beta lineage": 0.00332, "tal-1 genes": 0.00332, "helix-loop-helix proteins": 0.00332, "major positive cis elements involved": 0.00332, "proteins interacting": 0.00332, "differentiation factors": 0.00332, "cd40 induces tyrosine phosphorylation": 0.00332, "sequence specificity": 0.00332, "defective genes": 0.00332, "sequence variants": 0.00332, "signalsome proteins ikk-alpha": 0.00332, "transactivate genes": 0.00332, "gtp-binding proteins": 0.00332, "specific p38 mapk inhibitor": 0.00332, "bcl-xl proteins": 0.00332, "globin mrna observed": 0.00332, "germinal center region": 0.00332, "specific complexes bound": 0.00332, "genes defective": 0.00332, "increased igm production": 0.00332, "short immunodominant antigenic region": 0.00331, ":910 ] previous studies": 0.00331, "normal activated": 0.00331, "apoptosis signaling pathways": 0.00331, "termed complex": 0.00331, "specific lymphocytes": 0.00331, "normal myeloid differentiation": 0.00331, "oncogenic genes": 0.00331, "phosphorylation induction": 0.00331, "oct proteins": 0.00331, "minimal region": 0.00331, "jun/fos proteins": 0.00331, "sequence variation": 0.00331, "inducible nuclear component": 0.00331, "ige synthesis induced": 0.00331, "clinical remissions induced": 0.00331, "beta-globin genes driven": 0.00331, "anti-cd2 antibodies stimulate viral production": 0.00331, "gata-3 proteins": 0.00331, "cyclic amp-responsive element modulator": 0.00331, "bmlf1 proteins": 0.00331, "il-1 beta mrna appearance": 0.00331, "core tfiid complex": 0.00331, "lysosomal proteins": 0.00331, "steroid-resistant asthmatic patients": 0.00331, "gata-binding proteins": 0.00331, "interleukin-2 induces tyrosine phosphorylation": 0.00331, "peripheral blood lymphocytes": 0.00331, "apl patients refractory": 0.00331, "activate specific ebv promoters": 0.00331, "proteins exist": 0.00331, "e7 proteins": 0.00331, "dual signal pathway": 0.00331, "patients respond": 0.00331, "activating region": 0.00331, "analysis identified": 0.00331, "selected dna sequences": 0.00331, "elk-1 proteins": 0.00331, "common element": 0.00331, "85-kda proteins": 0.00331, "jak/stat signal pathway": 0.00331, "activated normal": 0.00331, "increase hiv-1 replication": 0.00331, "il-5 genes": 0.00331, "relevant concentrations activates nf-kappa": 0.0033, "downstream tata element": 0.0033, "phosphorylation sites": 0.0033, "steroid-sensitive asthmatic patients": 0.0033, "induce critical rac-1 signaling pathways": 0.0033, "identical sequence ccgaaactgaaaagg": 0.0033, "postmenopausal patients": 0.0033, "53-kd proteins": 0.0033, "homology region": 0.0033, "select subordinate genes": 0.0033, "complex biological process": 0.0033, "proximal element": 0.0033, "unknown genes": 0.0033, "proteins p60": 0.0033, "ets-related proteins": 0.0033, "identified motif called": 0.0033, "unphosphorylated proteins": 0.0033, "enhancer-binding proteins": 0.0033, "stat1-containing dna-binding complex": 0.0033, "initiation region": 0.0033, "tegument proteins": 0.0033, "tpa induction inhibits": 0.0033, "key cytokine induced": 0.0033, "northern analysis demonstrated coordinate downregulation": 0.0033, "unrelated proteins": 0.0033, "ikappab alpha phosphorylation": 0.0033, "44-kda proteins": 0.0033, "bp il-2 promoter-luciferase reporter construct": 0.0033, "tyrosine kinase inhibitors": 0.0033, "blood fat ] exhibit": 0.0033, "ebna2 responsive element": 0.0033, "nf-kappab/rel proteins": 0.00329, "specific factors": 0.00329, "creb/atf proteins": 0.00329, "generate growth factors": 0.00329, "infection induced interleukin-8": 0.00329, "untreated patients": 0.00329, "nonsmoking asthmatic patients": 0.00329, "unique region": 0.00329, "consecutive ms patients": 0.00329, "dna-binding complex": 0.00329, "infectious mononucleosis patients": 0.00329, "vitro-translated proteins": 0.00329, "socs proteins": 0.00329, "erythroid specific enhancer": 0.00329, "individual genes": 0.00329, "resulting complex targets": 0.00329, "induce cellular differentiation": 0.00329, "nm23 proteins": 0.00329, "ss patients": 0.00329, "bone marrow contained increased numbers": 0.00329, "atf-2 proteins": 0.00329, "antibody studies demonstrated": 0.00329, "n-oct proteins": 0.00329, "immunoregulatory proteins": 0.00329, "transcriptional repression domain": 0.00329, "apl patients": 0.00329, "pan proteins": 0.00329, "beta-globin genes": 0.00328, "transcription-regulating proteins": 0.00328, "basic-helix-loop-helix proteins": 0.00328, "asthmatic patients": 0.00328, "/rel proteins": 0.00328, "aml-1 proteins": 0.00328, "psa proteins": 0.00328, "poxvirus proteins": 0.00328, "zinc-binding proteins": 0.00328, "e2a/heb proteins": 0.00328, "slp-76-associated proteins": 0.00328, "cytoplasmic complex": 0.00328, "gi proteins": 0.00328, "sp1 element": 0.00328, "eukaryotic genes transcribed": 0.00328, "mycobacterial proteins": 0.00328, "reconstituted sequence": 0.00328, "stat5-related proteins": 0.00328, "/stress proteins": 0.00328, "bzip proteins": 0.00328, "nf-kappab/nfat proteins": 0.00328, "antibody inhibited": 0.00328, "cationic proteins": 0.00328, "hlh proteins": 0.00328, "paramyxovirus infection induced": 0.00328, "blocking nfat nuclear translocation": 0.00328, "pax proteins": 0.00328, "epstein-barr viral dna": 0.00328, "critical element": 0.00328, "lim-only proteins": 0.00328, "dna-associated proteins": 0.00328, "interactive proteins": 0.00328, "t-cell clones activated": 0.00328, "stat-related proteins": 0.00328, "ezrin/moesin/radixin proteins": 0.00328, "-m2 proteins": 0.00328, "reverse sequence": 0.00328, "beta 2-m increased": 0.00328, "ifn-alpha-activated proteins": 0.00328, "fibrinogen-derived proteins": 0.00328, "pan/e2a proteins": 0.00328, "variant octamer motif binds oct-1": 0.00328, "caccc-binding proteins": 0.00328, "t-cell antigen receptors": 0.00328, "monocyte line": 0.00328, "cells-family proteins": 0.00328, "stimulated lymphocytes transfected": 0.00328, "architectural proteins": 0.00328, "bound tripartite complex": 0.00328, "activation-inducible proteins": 0.00328, "cytokines induced assembly": 0.00328, "coassociated proteins": 0.00328, "constituent proteins": 0.00328, "ca2+-binding proteins": 0.00328, "vitamin d3-responsive element": 0.00328, "c-rel-like proteins": 0.00328, "blocked c-fos induction": 0.00328, "grb2-binding proteins": 0.00328, "erythrocyte genes": 0.00328, "correspondent proteins": 0.00328, "growth factors act": 0.00328, "nfat-family proteins": 0.00328, "ets-domain proteins": 0.00328, "replicative genes": 0.00328, "c2 proteins": 0.00328, "so-called 'lysis genes": 0.00328, "kappab-binding proteins": 0.00328, "rel/nf-kappab proteins": 0.00328, "gas-binding proteins": 0.00328, "tcf/lef proteins": 0.00328, "fos/jun proteins": 0.00328, "ap-1-related proteins": 0.00328, "herpesviral proteins": 0.00328, "bound nfatp/ap-1-dna complex": 0.00328, "traf proteins": 0.00328, "anti-cd3 induced nf-at": 0.00327, "characterize genes up-regulated": 0.00327, "il-2r genes": 0.00327, "inducible dyad symmetry element": 0.00327, "inhibited il-2-mediated ifn-gamma production": 0.00327, "inhibited jak1 phosphorylation": 0.00327, "finger region": 0.00327, "negative regulatory elements involved": 0.00327, "coding sequence": 0.00327, "transcriptional response": 0.00327, "ten hiv-infected patients": 0.00327, "normal increase": 0.00327, "cd4 transduction pathway": 0.00327, "cbf sites form": 0.00327, "viral dna fragments": 0.00327, "hiv-1 tat potentiates tnf-induced nf-kappa": 0.00327, "decrease nuclear translocation": 0.00327, "expressing tax contained elevated levels": 0.00327, "sequence iii": 0.00327, "proteins": 0.00327, "ig genes": 0.00327, "optimal dna sequences preferred": 0.00327, "activated t-cell clone": 0.00327, "pdbu + iono induced": 0.00327, "relapsed patients": 0.00327, "nf kappa b-i kappa": 0.00327, "comments ] clinical outcome": 0.00327, "immediate-early genes": 0.00327, "bcl-x genes": 0.00326, "complete 491-amino-acid sequence": 0.00326, "apoptosis induction": 0.00326, "scm-1 genes": 0.00326, "pathway distinct": 0.00326, "sixteen anorexic patients": 0.00326, "il-4 naf complex": 0.00326, "predicted sequence": 0.00326, "a6h mab induced": 0.00326, "nucleotide sequence": 0.00326, "sex determining region": 0.00326, "mid-age hypertensive patients": 0.00326, "single mhc/peptide complex": 0.00326, "stat1-dependent immune-response genes": 0.00326, "normal tcrzeta levels": 0.00326, "hinge region distinguish androgen-bound": 0.00326, "protease inhibitors block lipopolysaccharide induction": 0.00326, "2.3-kb coding region": 0.00326, "hashimoto patients": 0.00326, "enhanced cytokine effects": 0.00326, "gata sequence": 0.00326, "e2f-dependent thymidine kinase regulation": 0.00326, "gas element eliminate responsiveness": 0.00326, "il-2 share common control mechanisms": 0.00326, "rars patients": 0.00326, "kappa b-alpha mrna": 0.00326, "e1a region": 0.00326, "central rel similarity region": 0.00326, "cytopathic viruses inhibits ifn induction": 0.00326, "cd34 genes": 0.00326, "bis [ 4- [": 0.00326, "vzv peptides induced": 0.00326, "early inflammatory response": 0.00326, "germ-line igh genes": 0.00326, "ca2+/calmodulin kinase type iv/gr": 0.00325, "ebv chronic response": 0.00325, "increased cd+8 t-cell numbers": 0.00325, "gp160-induced ap-1 complex": 0.00325, "undefined differentiation-promoting genes": 0.00325, "3696-bp coding region": 0.00325, "m-csf genes": 0.00325, "-dependent genes": 0.00325, "enhanced c-fos induction": 0.00325, "transcriptional analysis": 0.00325, "tcc expressed equal levels": 0.00325, "nf-kappa b-binding elements": 0.00325, "active dna replication": 0.00325, "brlf1/bzlf1 coding region": 0.00325, "genes encode": 0.00325, "dna fragment contained": 0.00325, "kappab sequence": 0.00325, "suggesting antigen specific": 0.00325, "cd14-mediated signal pathway": 0.00325, "true il-12 induced developmental stage": 0.00325, "separate genes": 0.00325, "relevant genes": 0.00325, "genes transcribed": 0.00325, "smoking menopausal patients": 0.00325, "immunoreceptor tyrosine-based inhibition motif": 0.00325, "eighteen hirsute patients": 0.00325, "agents blocked nf-kappa": 0.00325, "cd patients": 0.00325, "erythroid-specific genes": 0.00325, "arthritis patients": 0.00325, "dm genes": 0.00325, "relb genes": 0.00325, "stage selector element": 0.00325, "nf-kappa b1 encoding transcripts": 0.00325, "called cd28-responsive element": 0.00325, "fms patients": 0.00325, "ets-related genes constitute": 0.00325, "signal transduction activated": 0.00325, "ataxia telangiectasia patients": 0.00325, "single complex": 0.00324, "a-t patients": 0.00324, "cyclic amp-responsive element": 0.00324, "h/c link sequence": 0.00324, "lymphocytes undergo long-term proliferation": 0.00324, "corticosteroid-treated ibd patients": 0.00324, "proinflammatory genes": 0.00324, "[ molecular mechanism": 0.00324, "conserved lymphokine element": 0.00324, "induced functional": 0.00324, "amino-terminal acidic region": 0.00324, "bind enhancer elements": 0.00324, "complex fashion": 0.00324, "antigen stimulation signals": 0.00324, "coding region": 0.00324, "sr patients": 0.00324, "viral replicative pathway": 0.00324, "responsive element": 0.00324, "viral dna polymerase": 0.00324, "specific nf-kappa": 0.00324, "oca-b binds dna": 0.00324, "nfat element": 0.00324, "hypertensive patients": 0.00324, "ap-1 complex": 0.00324, "kappa b-alpha levels": 0.00324, "cortisol-dependent ba patients": 0.00324, "pebp2betamyh11 inhibited neutrophilic differentiation": 0.00324, "complete sequence": 0.00324, "depressed patients": 0.00324, "interleukin-1 genes": 0.00324, "atopic patients": 0.00324, "structural analysis demonstrated": 0.00324, "lupus patients": 0.00324, "multiple regulatory sites": 0.00324, "western blot analysis demonstrated": 0.00324, "hiv-1-infected patients": 0.00324, "resident genes": 0.00324, "intact gata element": 0.00324, "crf patients": 0.00324, "sequence alterations": 0.00324, "differentiation-associated genes": 0.00324, "region coding": 0.00324, "specific proteasome inhibitor": 0.00324, "genes up-regulated": 0.00323, "respective genes": 0.00323, "increased production": 0.00323, "control inappropriate apoptosis involved": 0.00323, "positive cases expressed granular er staining": 0.00323, "cml patients": 0.00323, "amino acid sequences": 0.00323, "phorbol 12-myristate 13-acetate increased": 0.00323, "patients responding": 0.00323, "euthyroid patients": 0.00323, "expressed comparable levels": 0.00323, "zinc-finger genes": 0.00323, "unrearranged ch genes": 0.00323, "muscle genes": 0.00323, "ms patients": 0.00323, "fms genes": 0.00323, "compound induced g1 arrest": 0.00323, "rex-viral mrna complexes": 0.00323, "h2o2-promoted stat3 nuclear translocation": 0.00323, "20-bp region surrounding": 0.00323, "hiv-infected patients": 0.00323, "normal levels": 0.00323, "inducible proto-enhancer element": 0.00323, "genes ul49": 0.00323, "camp-dependent genes": 0.00323, "node-positive patients": 0.00322, "conserved 19-bp element": 0.00322, "inhibits hiv-1 production": 0.00322, "pediatric patients": 0.00322, "hypothyroid patients": 0.00322, "cll patients": 0.00322, "numerous genes": 0.00322, "accessory genes": 0.00322, "jund genes": 0.00322, "ibd patients": 0.00322, "lbp patients": 0.00322, "hyperthyroid patients": 0.00322, "megakaryocytic genes": 0.00322, "cdk4 genes": 0.00322, "erythrocyte-specific genes": 0.00322, "study multiple nf-kappa": 0.00322, "septic patients": 0.00322, "rcc patients": 0.00322, "steroid-resistant patients": 0.00322, "glucocorticoid receptors form": 0.00322, "light-chain genes": 0.00322, "gc-rich region behaves": 0.00322, "premenopausal patients": 0.00322, "lymphoma line": 0.00322, "cytokines induced stat6": 0.00322, "manic patients": 0.00322, "mrna stability assay": 0.00322, "candidate genes": 0.00322, "reverse transcriptase polymerase chain reaction analysis": 0.00322, "transcribed 5'-untranslated leader region": 0.00322, "mdd patients": 0.00322, "myeloid-cell-specific genes": 0.00322, "atll patients": 0.00322, "bcl-6 5'-noncoding region": 0.00322, "b-cll patients": 0.00322, "mrd-positive patients": 0.00322, "-/st patients": 0.00322, "genetic element": 0.00322, "gata-3 genes": 0.00322, "il-4ralpha induces janus kinase": 0.00322, "composite element capable": 0.00321, "leukotriene b4 induced adhesion": 0.00321, "ags patients": 0.00321, "double-stranded gire sequence": 0.00321, "lymphotoxin-alpha genes": 0.00321, "st patients": 0.00321, "ebv [ anti-z epstein-barr replicative activator": 0.00321, "short 40-bp region": 0.00321, "il-6 kappa b-related kappa": 0.00321, "dna induces": 0.00321, "normal lymphoid tissue structure": 0.00321, "sle patients": 0.00321, "cortisol-resistant patients": 0.00321, "gas sequence": 0.00321, "transcriptional start sites": 0.00321, "xlh patients": 0.00321, "constitutive nuclear translocation": 0.00321, "intracellular adhesion molecule-1 induction": 0.00321, "additional putative regulatory sites": 0.00321, "increased form": 0.00321, "atl patients": 0.00321, "xp-d patients": 0.00321, "-inducible genes": 0.00321, "homeotic genes": 0.00321, "prolactin genes": 0.00321, "n-myc genes": 0.00321, "ap-1 type heterodimeric complexes": 0.00321, "seventeen patients": 0.00321, "hypercortisolemic patients": 0.00321, "lac operator sequence replaced": 0.00321, "immune systems ]": 0.00321, "prototype octamer element": 0.00321, "nuclear translocation independent": 0.00321, "weak inducible complex": 0.00321, "mcm6 genes": 0.0032, "t-cell dna": 0.0032, "hyperlipidemic patients": 0.0032, "drug-free patients": 0.0032, "high-risk patients": 0.0032, "ileostomized patients": 0.0032, "responder patients": 0.0032, "twenty-seven patients": 0.0032, "normocalcemic patients": 0.0032, "apoplexy patients": 0.0032, "cell-associated genes": 0.0032, "interleukin-5 genes": 0.0032, "fra-1 genes": 0.0032, "sarcoidosis patients": 0.0032, "transcriptional regulatory elements": 0.0032, "fifteen patients": 0.0032, "kox genes": 0.0032, "increased monocyte adhesion": 0.0032, "-induced ifn alpha production": 0.0032, "inhibited il 6-induced igm production": 0.0032, "nfat nuclear translocation": 0.0032, "il-2-treated patients": 0.0032, "nf-kappa b/sp1 enhancer": 0.0032, "twenty-two patients": 0.0032, "mgus patients": 0.0032, "bipolar patients": 0.0032, "shares sequence similarity": 0.0032, "arachidonic acid stimulation": 0.0032, "ltb4 induced adhesion": 0.0032, "patients f.r": 0.0032, "memory b-cell pathway": 0.0032, "steroid-treated patients": 0.0032, "jak1-binding proline-rich box1 region": 0.0032, "il-1rii genes": 0.0032, "aids-c patients": 0.0032, "genes kox": 0.0032, "lymphokine genes": 0.0032, "apoplexic patients": 0.0032, "] labelled dexamethasone measured": 0.0032, "ikb alpha phosphorylation": 0.0032, "quieiescent patients": 0.0032, "h2b-2 genes": 0.0032, "housekeeping genes": 0.0032, "inflammatory bowel disease [": 0.0032, "immunoregulatory genes": 0.0032, "nonimmunocompromised patients": 0.0032, "aids-gr patients": 0.0032, "gd patients": 0.0032, "ifngamma-inducible genes": 0.0032, "gcs-untreated patients": 0.0032, "phosphate-supplemented patients": 0.0032, "csa-treated patients": 0.0032, "precise sequence": 0.0032, "tuberculous patients": 0.0032, "eleven patients": 0.0032, "pcos patients": 0.0032, "lymphocyte-specific genes": 0.0032, "x-scid patients": 0.0032, "p47phox-deficient patients": 0.0032, "mrd+/lt patients": 0.0032, "mrd-/lt patients": 0.0032, "short region": 0.00319, "g0s genes": 0.00319, "end noncoding sequence": 0.00319, "sequence requirements": 0.00319, "substantial sequence similarity": 0.00319, "striking sequence divergence": 0.00319, "ifn-induced genes": 0.00319, "sap-1 genes": 0.00319, "il-4-inducible genes": 0.00319, "zymosan-mediated transcriptional induction": 0.00319, "myeloid-specific genes": 0.00319, "cortisol incubation induced": 0.00319, "considerable sequence identity": 0.00319, "pax genes": 0.00319, "interferon-inducible genes": 0.00319, "ang ii effect": 0.00319, "transmembrane region": 0.00319, "selectively inhibits nf-kappa": 0.00319, "carboxy-terminal dimerization region": 0.00319, "dna motifs homologous": 0.00319, "k562 nuclear extracts": 0.00319, "cysteamine treatment inhibited": 0.00319, "c-fos/c-jun genes": 0.00319, "inhibited il-2 secretion": 0.00319, "genes varied": 0.00319, "induce low levels": 0.00319, "tumor-suppressor genes": 0.00319, "b-lymphoid-specific genes": 0.00319, "fli-1 genes": 0.00319, "pbx1 genes": 0.00319, "hla-dm genes": 0.00319, "culture media blocked macrophage differentiation": 0.00319, "interferon-regulated genes": 0.00319, "vd-responsive genes": 0.00319, "nf-kappab-controlled genes": 0.00319, "pim-1 genes": 0.00319, "steroid-responsive genes": 0.00319, "fetal/adult genes": 0.00319, "cooh-terminal region": 0.00319, "snrna genes": 0.00319, "non-erythroid genes": 0.00319, "are-containing genes": 0.00319, "patients": 0.00319, "viral control elements": 0.00319, "eosinophil-specific genes": 0.00319, "ra-responsive genes": 0.00319, "hexon genes": 0.00319, "uncharted dna sequences": 0.00318, "hla class i-mediated induction": 0.00318, "muscle-specific genes": 0.00318, "ifn-gamma-responsive genes": 0.00318, "megakaryocytic-specific genes": 0.00318, "tcf-responsive genes": 0.00318, "antibody-encoding genes": 0.00318, "cell-encoded genes": 0.00318, "function-related genes": 0.00318, "primed monocytes transcribed tnf mrna": 0.00318, "ifn-alpha-stimulated genes": 0.00318, "freshly isolated monocytes expressed 94-kd stat5a": 0.00318, "important il-2 cis-regulatory elements": 0.00318, "extended region": 0.00318, "wildtype aes sequence": 0.00318, "il-1 beta message levels": 0.00318, "cd4 signaling mediates hiv-induced apoptosis": 0.00318, "ifn-gamma-inducible genes": 0.00318, "box enhancer elements": 0.00318, "stat5-regulated genes": 0.00318, "glucocorticoid-repressible genes": 0.00318, "myeloid-associated genes": 0.00318, "-96 sequence": 0.00318, "il-1 beta mrna": 0.00318, "ifn-regulated genes": 0.00318, "il-5-inducible genes": 0.00318, "cell-mediated immune response versus": 0.00318, "triflusal inhibited pge2 production": 0.00318, "growth-affecting genes": 0.00318, "cell-expressed genes": 0.00318, "specific peptide results": 0.00318, "octamer element 5'-atgcaaag-3": 0.00318, "ifn-responsive genes": 0.00318, "imprinted genes": 0.00318, "early-response genes": 0.00318, "flanking sequence": 0.00318, "non-cytokine genes": 0.00318, "c/ebp beta activated": 0.00318, "ebna2-dependent transcriptional induction": 0.00318, "integrin-ligand interactions trigger signaling pathways": 0.00318, "sequence-related genes": 0.00318, "sre sequence": 0.00318, "activation-related genes": 0.00318, "reiterated dna sequences": 0.00318, "hemoglobin-encoding genes": 0.00318, "cell-specific element": 0.00318, "genes relates": 0.00318, "trans-activation region": 0.00318, "e-protein genes": 0.00318, "camp-regulated genes": 0.00318, "hla-dq sequence": 0.00318, "cle0 sequence": 0.00318, "ap-1-regulated genes": 0.00318, "proline rich sequence": 0.00318, "specific hormone receptors": 0.00317, "22-bp sequence duplication": 0.00317, "dyad symmetrical sequence": 0.00317, "complex forms": 0.00317, "show 9-cis retinoic acid": 0.00317, "sequence variations": 0.00317, "ifn-gamma-activated sequence": 0.00317, "genes": 0.00317, "sequence diversity": 0.00317, "cis-acting sequence": 0.00317, "nef region": 0.00317, "lambda5 promoter/enhancer region": 0.00317, "br3 sequence": 0.00317, "carboxyl-terminal region": 0.00317, "cytokine pathway leading": 0.00317, "transcriptional induction": 0.00317, "dexamethasone inhibited leukocyte adhesion": 0.00317, "alpha phosphorylation": 0.00317, "proline-rich sequence": 0.00317, "kb-like sequence gggatttcacc": 0.00317, "dna sequences": 0.00317, "inhibit lps induction": 0.00317, "pas region": 0.00317, "effect purified cd4": 0.00317, "octamer element": 0.00317, "distal region": 0.00317, "growth response": 0.00317, "murine monoclonal antibody": 0.00317, "strong positive-acting element": 0.00317, "important role transducing distal signals": 0.00316, "dominant negative mapkk-1 prevents nfat induction": 0.00316, "tumor prevent local tumor control": 0.00316, "tnf-alpha controls dna repair": 0.00316, "hs2 sequence directs": 0.00316, "fas ligand induction": 0.00316, "synthesized nuclear component": 0.00316, "low basal il-2 production": 0.00316, "tata sequence": 0.00316, "nf-kappa b-controlled cytokine promoters": 0.00316, "primary structure analysis": 0.00316, "sequence abolishes": 0.00316, "pathway controls segment polarity": 0.00316, "pre-b-cell variant line": 0.00316, "-130 region": 0.00316, "pma induce il-2r alpha": 0.00316, "element correlates": 0.00316, "specific pan-pkc inhibitor bisindolylmaleimide": 0.00316, "retinoic acid-response element": 0.00315, "targeted mutational analysis demonstrated": 0.00315, "induced level": 0.00315, "nuclear extracts prepared": 0.00315, "pcd41 sequence": 0.00315, "tbp7 sequence": 0.00315, "prepared nuclear extracts": 0.00315, "increased c-fos synthesis": 0.00315, "alpha enhancer": 0.00315, "activated peripheral blood": 0.00315, "host cellular factors": 0.00315, "il-1 beta levels": 0.00315, "chromosome lacking xist dna": 0.00315, "left adnexal region": 0.00315, "-52 region": 0.00315, "nuclear level": 0.00315, "cis-acting region": 0.00315, "carboxy-terminal leucin-zipper region": 0.00315, "strong transactivation domain present": 0.00315, "function analysis": 0.00315, "disease sites": 0.00315, "eb1-responsive b-cell-specific element": 0.00315, "455-bp u3 region": 0.00315, "antimouse alpha a1 antibodies": 0.00315, "il3 5'-flanking sequence": 0.00315, "b-cell-specific eb1-responsive element": 0.00315, "flanking region": 0.00315, "sense sequence": 0.00314, "hs-40 region": 0.00314, "calm region": 0.00314, "fibroblast growth factors": 0.00314, "proline-rich region": 0.00314, "rat lung induced": 0.00314, "gamma-gene 5'-untranslated region": 0.00314, "distinct normalizing effect": 0.00314, "erythropoietin induces tyrosine phosphorylation": 0.00314, "increases plasma estradiol levels": 0.00314, "purine-rich region": 0.00314, "palindromic sequence": 0.00314, "respective region": 0.00314, "glutamine-rich region": 0.00314, "cellular glucocorticoid receptors": 0.00314, "specific elastase inhibitor": 0.00314, "dna band-shift assays": 0.00314, "increased cytokine secretion": 0.00314, "5'-untranslated leader region": 0.00314, "pxqxt/s sequence": 0.00314, "csa-resistant nfat complex": 0.00314, "identified nf-kappa": 0.00314, "dyad symmetry region": 0.00314, "gm2 sequence": 0.00314, "region translocated": 0.00314, "predictive protein-coding region": 0.00314, "blood fat ]": 0.00314, "sequence similarity": 0.00314, "mrna assay": 0.00314, "induction mechanism": 0.00314, "activating stimulus invokes signaling mechanisms distinct": 0.00314, "zinc-finger region": 0.00314, "nuclear presence": 0.00314, "dna ladder formation": 0.00314, "-59 region": 0.00313, "negative growth regulatory signals": 0.00313, "nuclear factor-mu negative regulator": 0.00313, "agonist induces terminal granulocytic differentiation": 0.00313, "affect intracellular il-2 signaling": 0.00313, "leader sequence": 0.00313, "gas-motif sequence": 0.00313, "5'-flanking sequence": 0.00313, "-65 region": 0.00313, "gm-kappa b/gc-box region": 0.00313, "cognate sequence": 0.00313, "cellular responses require intracellular signalling pathways": 0.00313, "nuclear run-on experiments": 0.00313, "il-4 activated signal transducers": 0.00313, "potential recognition sites": 0.00313, "amino-terminal sequence": 0.00313, "nuclear runoff experiments": 0.00313, "transcriptional factors": 0.00313, "c-jun nh2-terminal kinase activities": 0.00313, "tyrosine kinase-dependent pathway": 0.00313, "functional tcr delta mrna": 0.00313, "low plasma cysteine levels": 0.00313, "sequence thr729-lys984": 0.00313, "intronic sequence": 0.00313, "glucocorticoid receptor-mediated effect": 0.00313, "pocket region": 0.00312, "cofilin-homology sequence": 0.00312, "5'-untranslated region": 0.00312, "e2f-like sequence": 0.00312, "45-nucleotide sequence": 0.00312, "e3 enhancer motif": 0.00312, "gm2/gc-box sequence": 0.00312, "30-bp sequence": 0.00312, "v3 region": 0.00312, "serine-rich region": 0.00312, "5'-upstream sequence": 0.00312, "untranslated sequence": 0.00312, "sequence psptspt": 0.00312, "ttca sequence": 0.00312, "sequence comparisons": 0.00312, "transformed phenotype induced": 0.00312, "kappa immunoglobulin enhancer": 0.00312, "cd28re/ap-1 sequence": 0.00312, "scrambled sequence": 0.00312, "immunoglobulin kappa enhancer": 0.00312, "pxqxt/s-containing sequence": 0.00312, "region account": 0.00312, "base-pair sequence": 0.00312, "peak levels observed": 0.00312, "october sequence": 0.00312, "upstream nuclear factor-kappa": 0.00312, "e1 region": 0.00312, "chronological sequence": 0.00312, "lack functional glucocorticoid receptors": 0.00312, "17-bp sequence": 0.00312, "c-rel complexes play distinct roles": 0.00312, "47-bp sequence": 0.00312, "specific pkc inhibition": 0.00312, "-90/-79 sequence": 0.00312, "growth signaling pathways": 0.00312, "gamma-activating sequence": 0.00312, "octamerlike sequence": 0.00312, "sequence 5'-ggccaatggg-3": 0.00312, "il-2 increased": 0.00312, "dex induces gr mrna": 0.00312, "sequence ggggacgtcccc": 0.00312, "subsequent nuclear translocation": 0.00312, "oligo sequence": 0.00312, "minimum sequence": 0.00312, "sequence ggggactttcc": 0.00312, "sequence 5'-ggaacctccccc-3": 0.00312, "tetrahexamer sequence": 0.00312, "demonstrated increased elaboration": 0.00312, "antigen driven response": 0.00312, "hbx sequence": 0.00312, "u3 region": 0.00312, "sequence": 0.00311, "promoter/enhancer region": 0.00311, "poz/zinc finger transcriptional repressor expressed": 0.00311, "protein-binding region": 0.00311, "element identical": 0.00311, "specific intracellular receptors": 0.00311, "membrane-proximal region": 0.00311, "binds dna": 0.00311, "examined cytokine induction": 0.00311, "dna fragmentation studies": 0.00311, "nfat complex": 0.00311, "inhibitory complex": 0.00311, "single-stranded region": 0.00311, "herpesvirus saimiri cis-acting dna fragment": 0.00311, "biochemical events induced": 0.00311, "complex due": 0.00311, "scatchard plot analysis demonstrated": 0.00311, "promoter-proximal region": 0.00311, "5'-flanking region": 0.00311, "histone deacetylase complex": 0.00311, "key element": 0.00311, "transduction pathway leading": 0.00311, "tg induced increases": 0.0031, "amino-terminal region": 0.0031, "il-2 mrna accumulation": 0.0031, "mll region": 0.0031, "inhibitor specific": 0.0031, "sublining region": 0.0031, "region between-3134": 0.0031, "hydrophobic region": 0.0031, "inhibited stimulation": 0.0031, "glucocorticoid inhibits signals downstream": 0.0031, "flank region": 0.0031, "ikappab alpha regulation": 0.0031, "element demonstrates": 0.0031, "major nfat family member responsible": 0.0031, "hcleo region": 0.0031, "thrombin stimulated tyrosine phosphorylation": 0.0031, "divergent region": 0.0031, "specific inhibitor": 0.0031, "specific mrna": 0.0031, "-207 region": 0.0031, "gm-csf element": 0.0031, "distinct signaling pathways leading": 0.0031, "inhibited apoptosis": 0.0031, "nf-kappab signaling pathways": 0.0031, "carboxyterminal region": 0.0031, "enhancer/promoter region": 0.0031, "pseudoautosomal region": 0.0031, "kinase zap-70 induces": 0.0031, "noncoding region": 0.0031, "transcription-enhancer region": 0.00309, "act-1-activating region": 0.00309, "ap-1/octamer composite element": 0.00309, "dcs express high levels": 0.00309, "impaired nuclear translocation": 0.00309, "-120 region": 0.00309, "minimum region": 0.00309, "r/u5 region": 0.00309, "specific effects": 0.00309, "gp120 induces tyrosine phosphorylation": 0.00309, "dqb-w region": 0.00309, "main transcription-activation element": 0.00309, "q23-31 region": 0.00309, "testis-determining region": 0.00309, "untranslated region": 0.00309, "5869-bp region": 0.00309, "thrombopoietin induces tyrosine phosphorylation": 0.00309, "induced transcripts": 0.00309, "locus-activating region": 0.00309, "ck-1/cd28re region": 0.00309, "aminoterminal region": 0.00309, "il-4 promoter-reporter constructs carrying mutated p-like elements": 0.00309, "183-bp region": 0.00309, "verprolin-homology region": 0.00309, "nuclear membrane": 0.00309, "5'-regulatory region": 0.00309, "specific nfatp polyclonal antibody": 0.00309, "matrix-associated region": 0.00309, "intact element": 0.00309, "bamhi-a region": 0.00309, "nip region": 0.00309, "1-kb region": 0.00309, "pyrimidine-rich region": 0.00309, "complex process": 0.00309, "induces prominent tyrosine phosphorylation": 0.00309, "peripheral lymphocytes isolated": 0.00309, "nonfinger region": 0.00309, "nontranscribed region": 0.00309, "193-bp region": 0.00309, "nontranslated region": 0.00309, "2.0-kb region": 0.00309, "coiled-coil region": 0.00309, "151-bp region": 0.00309, "dna motifs": 0.00309, "steroid-binding region": 0.00309, "hinge region": 0.00309, "229-bp region": 0.00309, "-300 region": 0.00309, "cellular response": 0.00309, "u5 region": 0.00309, "nucleosome-free region": 0.00309, "yeast transcriptional regulator rpd3p [": 0.00309, "region -158/-90": 0.00309, "ifn alpha production": 0.00309, "gp41 induced camp accumulation": 0.00308, "-responsive nf-kappab/c-ebp composite element": 0.00308, "200-bp enhancer domain": 0.00308, "express high levels": 0.00308, "immobilized gas element": 0.00308, "early killing effect": 0.00308, "oxidative stress triggers stat3 tyrosine phosphorylation": 0.00308, "kd complex": 0.00308, "cd4+ t-cell clonal lines grown": 0.00308, "gata element": 0.00308, "study transcriptional regulation": 0.00308, "region": 0.00308, "1,25-dihydroxyvitamin d3 induces differentiation": 0.00308, "numerous growth factors": 0.00308, "inhibited il-2-mediated proliferative growth": 0.00308, "increased glucocorticoid responsiveness": 0.00308, "observed increase": 0.00307, "gel-shift analysis demonstrated": 0.00307, "lymphoblasts expressing high levels": 0.00307, "il-2r alpha regulation": 0.00307, "unique dna-protein complex": 0.00307, "affinity sites bind cvz": 0.00307, "mapk response required": 0.00307, "inducible ap-1 family members c-fos": 0.00307, "nuclear protein-binding activities": 0.00307, "kappab element": 0.00307, "hemopoietic growth factors": 0.00307, "induces tyrosine phosphorylation": 0.00307, "cellular analysis": 0.00307, "il-4 inhibit lps-induced il-6 mrna": 0.00306, "blood dna": 0.00306, "mrna observed": 0.00306, "nuclear oncogene c-fos": 0.00306, "structure-function analysis demonstrated": 0.00306, "high-affinity serum-inducible element": 0.00306, "inhibits erythroid differentiation": 0.00306, "phorbol ester response": 0.00306, "conserved c4 zinc finger dna-binding domain": 0.00306, "ifn-alpha enhanced tyrosine phosphorylation": 0.00306, "erythroid mrna steady-state level": 0.00306, "nmr analysis demonstrated": 0.00306, "activates nuclear factor-kappa": 0.00306, "viral transcriptional pattern similar": 0.00306, "nf-kappab dna-binding complexes": 0.00306, "kinetic analysis demonstrated": 0.00306, "increased neutrophil adhesion": 0.00306, "kappab-sp1 element documented": 0.00306, "increased proliferation": 0.00306, "nf-kappab induction": 0.00305, "alpha degradation exhibits similar": 0.00305, "normal wild type er": 0.00305, "observed effects": 0.00305, "cellular proliferation control": 0.00305, "cell-specific complex": 0.00305, "glucocorticoids induced down-regulation": 0.00305, "additional complex": 0.00305, "c-fos and/or c-jun mrna": 0.00305, "conditional tyrosine kinase oncogene": 0.00305, "regulating nuclear matrix attachment": 0.00305, "important protective cellular mechanism": 0.00305, "gp 160-induced nuclear extracts": 0.00305, "cell-specific tyrosine kinase": 0.00305, "fibronectin enhances ifn-gamma-induced early signaling events": 0.00305, "include specific cell-surface receptors": 0.00305, "c-jun n-terminal transactivation domain": 0.00305, "egr-1 mrna activating signals": 0.00305, "pdtc iron complex": 0.00305, "adenocarcinoma reactive human-mouse chimeric monoclonal antibody": 0.00305, "secondary response pathways": 0.00305, "control cellular proliferation": 0.00305, "mm concentration induced": 0.00305, "induced nf-at": 0.00304, "lysp100-associated nuclear domains": 0.00304, "studied genomic dna": 0.00304, "cellular signaling pathways": 0.00304, "stable complex": 0.00304, "nuclear factor-il6 activates": 0.00304, "mutant glucocorticoid receptors": 0.00304, "classical p50-p65 complex": 0.00304, "stimulated tyrosine phosphorylation": 0.00304, "camp-response element cre": 0.00304, "element repeated": 0.00304, "tcr beta chain sequences": 0.00304, "nfkappab nuclear translocation": 0.00304, "enhancer motif": 0.00304, "hypersensitive site-forming element": 0.00304, "examined early signaling events": 0.00304, "identified tata motif": 0.00304, "major positive regulatory role": 0.00303, "inhibits cellular proliferation": 0.00303, "t-cell lines tested": 0.00303, "negative regulatory factors": 0.00303, "levels observed": 0.00303, "viral dna": 0.00303, "oxidoreductive regulatory pathway": 0.00303, "complex mediates": 0.00303, "nuclear extracts assayed": 0.00303, "nf-kappab sites": 0.00303, "type alpha": 0.00303, "trigger cellular nf-kappa": 0.00303, "hypersensitive element": 0.00303, "2-hydroxyethyl ] decreased": 0.00303, "composite element": 0.00303, "induce hiv-1 production": 0.00303, "gas element": 0.00303, "active nuclear relb": 0.00303, "defective nuclear translocation": 0.00303, "cmv infection increased": 0.00303, "aids dementia complex": 0.00303, "important intracellular signaling molecules": 0.00303, "deletion mutation analysis": 0.00303, "enhanced il-2 production": 0.00303, "comments ] cytokine": 0.00303, "plasma growth hormone concentrations": 0.00303, "initiator element commonly": 0.00303, "glucocorticoid effect": 0.00303, "increased blood urea nitrogen": 0.00303, "growth factors": 0.00303, "normal control subjects": 0.00303, "heat shock induces hiv-1 replication": 0.00302, "sla-dq antigen induction": 0.00302, "interleukin-1 alpha production": 0.00302, "proliferation response": 0.00302, "cre element": 0.00302, "isgf3 gamma induced": 0.00302, "twelve amino acid peptides": 0.00302, "o-side chain-specific mabs inhibited mcd14-mediated lps uptake": 0.00302, "complementary dna encoding": 0.00302, "form dna-protein complexes common": 0.00302, "contained nuclear factor-kappab": 0.00302, "blocking element alpha/delta": 0.00302, "nf-kappab family members": 0.00302, "polymerase chain reaction analysis": 0.00302, "nuclear component": 0.00302, "nephrotic syndrome ]": 0.00302, "intracellular redox status controls nf-kappa": 0.00302, "blocked 12-o-tetradecanoylphorbol 13-acetate induction": 0.00302, "mrna production controlled": 0.00302, "prevent nuclear translocation": 0.00302, "regulatory pathway": 0.00302, "nf-kappa b-dna interaction": 0.00302, "fivefold increased formation": 0.00302, "anti-i kappa b-alpha antibody": 0.00302, "mutant kappab sites": 0.00301, "nfat-1 element": 0.00301, "examined nuclear factor-kappa": 0.00301, "age-related lymphocyte dysfunction ] aging": 0.00301, "cellular factors heb-1": 0.00301, "soluble nuclear matrix preparations": 0.00301, "induced ca2+ influx": 0.00301, "murine b-cell specific coactivator mbob1": 0.00301, "] glycosaminoglycan synthesis": 0.00301, "receptors and/or transduction pathways": 0.00301, "potent inhibitory effect": 0.00301, "t-cell response": 0.00301, "normal immunoregulatory signal transduction": 0.00301, "distal element": 0.00301, "nef inhibits nf-kappa": 0.00301, "express similar levels": 0.00301, "c3 receptor-mediated nuclear translocation": 0.00301, "surface marker analysis": 0.00301, "abelson murine leukemia virus": 0.00301, "decreased intracellular glutathione levels": 0.00301, "enhanced tyrosine phosphorylation": 0.00301, "results define essential cis-acting elements responsible": 0.00301, "heterodimers show distinct dna-binding specificities": 0.00301, "-selective antagonist inhibits differentiation": 0.00301, "show induction": 0.00301, "membrane-proximal traf6 interaction domain": 0.00301, "specific rna target termed tar": 0.00301, "il-10 inhibited b-cll proliferation": 0.003, "inhibitors exert multiple effects": 0.003, "heptamer element 5'-ctcagga-3": 0.003, "limiting element": 0.003, "synthesized nuclear subunit": 0.003, "b-cell-specific complex": 0.003, "high gssg levels inhibit": 0.003, "purine-rich cd3r element": 0.003, "il-2 promoter-enhancer induction": 0.003, "factors control": 0.003, "linear ebv dna": 0.003, "okadaic acid induces ap1": 0.003, "recognized peptides increased": 0.003, "cle0 element": 0.003, "osteoblast-specific cis-acting element": 0.003, "wild type domain": 0.003, "induce c-fos mrna": 0.003, "increased intracellular free calcium": 0.003, "normal platelet function": 0.003, "hiv-1 tat inhibitor": 0.003, "trace element preparation": 0.003, "recent functional analysis": 0.003, "show elevated circulating levels": 0.003, "ionomycin/cyclosporin a-responsive element": 0.003, "osteoblast nuclear extracts": 0.00299, "kb-like proto-enhancer element": 0.00299, "t-cell lines transfected": 0.00299, "il-4 enhances mrna degradation": 0.00299, "distinct immunophilin-drug complexes bind": 0.00299, "t-cell inhibitory effects": 0.00299, "cis-acting element": 0.00299, "lymphocytes show": 0.00299, "c26 element": 0.00299, "> asp amino acid": 0.00299, "enhanced hemin response": 0.00299, "complex translocations": 0.00299, "crude nuclear extracts": 0.00299, "tpa/calcium-activated ap-1/oap element": 0.00299, "constitutive nuclear localization": 0.00299, "cd40 induce nf-kappa": 0.00299, "expressing high levels": 0.00299, "immobilized grr element": 0.00299, "dna positions tax": 0.00299, "tax-responsive element": 0.00299, "induced gamma": 0.00299, "aspirin inhibits nf-kappa": 0.00299, "primary cd8+ ctl response": 0.00299, "dna-binding phosphoproteins induced": 0.00299, "dyad symmetry element": 0.00299, "myosin light chain kinase prevented": 0.00298, "purine-rich element": 0.00298, "unactivated nuclear extracts": 0.00298, "alpha beta": 0.00298, "mediate nf-at induction": 0.00298, "gata-1 nuclear bodies": 0.00298, "lps cellular signaling": 0.00298, "effective humoral immune response": 0.00298, "dna replication occurs": 0.00298, "vivo chronic response": 0.00298, "il-5 induced rapid": 0.00298, "drip coactivator complex": 0.00298, "persistent nuclear accumulation": 0.00298, "murine gata-3 factors shows": 0.00298, "parental line": 0.00298, "jak3-deficient severe combined immunodeficiency lymphocytes": 0.00298, "nuclear extracts distinguishes": 0.00298, "nuclear staining": 0.00298, "im-9 nuclear extracts": 0.00298, "d3 ]": 0.00298, "preformed interleukin-1 beta mrna": 0.00298, "inhibit active nf-kappab formation": 0.00298, "unrecognized element": 0.00298, "induce tyrosine phosphorylation": 0.00298, "tata element": 0.00298, "erythroid pathway contrasts": 0.00298, "kappa b-mediated inhibition": 0.00298, "amino acid level": 0.00298, "major pathway": 0.00298, "macrophages induced": 0.00298, "rapid nuclear depletion": 0.00298, "epo induced mature erythroblasts": 0.00298, "rac-1 mediated pathway": 0.00298, "janus tyrosine kinase": 0.00298, "cd8/hla class i-restricted response": 0.00297, "inhibited lps enhancement": 0.00297, "prevent sp-a induced inflammation": 0.00297, "5'-most carg element": 0.00297, "nuclear affinity": 0.00297, "ebna-2-negative nuclear extracts": 0.00297, "ovulation induced women": 0.00297, "complex capable": 0.00297, "reduced mitogenic response": 0.00297, "dna regions": 0.00297, "distinct dnase-i hypersensitive sites": 0.00297, "hiv-1 ltr reporter constructs": 0.00297, "express low levels": 0.00297, "nuclear relb translocation": 0.00297, "agents mediate il-8 induction": 0.00297, "c-jun inhibitory response mapped": 0.00297, "dna fragment interact": 0.00297, "kappa b-specific complexes": 0.00297, "wild type motif": 0.00297, "kappa b. stimulation": 0.00297, "il-2 octamer motif": 0.00297, "ebv-encoded nuclear antigens": 0.00297, "tnf alpha concentrations": 0.00297, "il-4-induced dna synthesis": 0.00297, "il-2 induction": 0.00297, "tyrosine phosphatase inhibitor phenylarsine oxide": 0.00297, "sustained nuclear translocation": 0.00297, "putative regulatory sites": 0.00296, "family play important roles": 0.00296, "tg induces il-2r alpha": 0.00296, "cleo element": 0.00296, "5-hydroxyeicosatetraenoic acid production": 0.00296, "important signaling molecule capable": 0.00296, "nuclear extracts": 0.00296, "enhanced response": 0.00296, "lymphoid-specific element": 0.00296, "erythroid pathway": 0.00296, "cis-regulatory element": 0.00296, "lymphocyte function-associated ag-3 pathway": 0.00296, "predominant e2f complex": 0.00296, "order nucleoprotein complex": 0.00296, "increase plasma cortisol concentration": 0.00296, "-64 element": 0.00296, "recurrent genital herpes simplex virus type": 0.00296, "anti-mhc class ii antibodies": 0.00296, "neonatal immune response": 0.00296, "increased cortisol feedback resistance": 0.00296, "enhanced tumor growth": 0.00296, "simple tandem repeat dna polymorphisms": 0.00296, "nuclear factor-il-6beta-ig/ebp-1 heterodimer": 0.00296, "native nf-gm2 complex": 0.00296, "e1 element": 0.00296, "multiple complexes suggesting": 0.00296, "cellular factors": 0.00295, "calcium-signal transduction pathway": 0.00295, "proteasome inhibitor n-ac-leu-leu-norleucinal inhibits": 0.00295, "t-cell lines infected": 0.00295, "arginine element": 0.00295, "intact nuclear matrix preparations": 0.00295, "nuclear proto-oncogenes c-fos": 0.00295, "microtubular assembly prevents nuclear access": 0.00295, "ck-1 element": 0.00295, "pka transduction pathway": 0.00295, "srf/nfkappab-like element": 0.00295, "order nf-atp/ap-1 complex": 0.00295, "typical nuclear localization": 0.00295, "display constitutively high levels": 0.00295, "fusion complementary dna": 0.00295, "events induced": 0.00295, "spi-1/pu.1 proto-oncogene induces opposite effects": 0.00295, "pancreatic beta-cell type-specific complex": 0.00295, "microb element": 0.00295, "response required": 0.00295, "complex phenomenon": 0.00295, "specific negative regulation": 0.00295, "element cross-competed": 0.00295, "dna cotransfection experiments": 0.00295, "casein kinase ii": 0.00295, "prevent nuclear uptake": 0.00295, "cam kinase ii": 0.00295, "oap40 element": 0.00294, "ebna-2-responsive element": 0.00294, "gasd/ebsd element": 0.00294, "iron-responsive element": 0.00294, "enhancer-like element": 0.00294, "inducible interleukin-2 enhancer function": 0.00294, "y-box element": 0.00294, "il-2 levels remain": 0.00294, "restriction fragment length polymorphism analysis": 0.00294, "serum-response element": 0.00294, "kappa3 element": 0.00294, "nfatd element": 0.00294, "positive regulatory domain i-binding factor-1": 0.00294, "70-bp element": 0.00294, "enhancer-blocking element": 0.00294, "cd28-responsive element": 0.00294, "order complex": 0.00294, "primary dna breakage": 0.00294, "study intracellular signaling events": 0.00294, "21-bp element": 0.00294, "pb1 element": 0.00294, "interleukin-4-responsive element": 0.00294, "e3330 inhibits nf-kappa": 0.00294, "anti-class ii monoclonal antibodies": 0.00294, "glucocorticoid-responsive element": 0.00294, "nuclear factor-kappab translocation": 0.00294, "eed-mediated transcriptional effects": 0.00294, "-1280 element": 0.00294, "nf-at-1 element": 0.00294, "camp-response element": 0.00294, "tyloxapol inhibits nf-kappa": 0.00294, "tat-responsive element": 0.00294, "proteasome complex": 0.00294, "sp-1-like element": 0.00294, "tax-response element": 0.00294, "sse-like element": 0.00294, "htlv-i-infected leukemic t-cell lines": 0.00294, "optimal kappa b/rel dna-binding motifs": 0.00294, "r-responsive element": 0.00294, "dexamethasone induced": 0.00294, "hcleo element": 0.00294, "sis-inducible element": 0.00294, "gasd element": 0.00294, "nf-kappab-like element": 0.00294, "type ii bare lymphocyte syndrome-associated transactivators ciita": 0.00294, "specific positive regulation": 0.00294, "activation-responsive element": 0.00294, "element tced": 0.00294, "gr-responsive element": 0.00294, "transcriptional effects": 0.00293, "migrating b2 complex": 0.00293, "constitutive nuclear appearance": 0.00293, "h2o2-induced nuclear translocation": 0.00293, "transfected nf-kappa b-regulated promoters": 0.00293, "cd4+ t-cell lines": 0.00293, "nuclear nfkappab correlated": 0.00293, "nf-kappab inhibitor ikappab-alpha": 0.00293, "sublytic tcc induced ras": 0.00293, "ebv dna": 0.00293, "complex consists": 0.00293, "inhibits nf-kappa": 0.00293, "amino acid residues c-terminal": 0.00293, "element": 0.00293, "suppressed lps-induced tnf mrna accumulation": 0.00293, "continued dna synthesis": 0.00293, "mutant elements added upstream": 0.00293, "il-4 induced": 0.00293, "reduced il-2 production": 0.00292, "core-specific mab inhibited mcd14-mediated uptake": 0.00292, "transcriptional levels": 0.00292, "c-jun n-terminal kinase cascade": 0.00292, "normal differentiation": 0.00292, "specific protein-dna complexes": 0.00292, "growth hormone receptors": 0.00292, "induce signaling events resulting": 0.00292, "r-pk dna fragment extending": 0.00292, "htlv-i-infected cord blood lymphocytes": 0.00292, "complex link": 0.00292, "contained positive regulatory elements": 0.00292, "activation-inducible enhancer elements responsible": 0.00292, "complex change": 0.00292, "distinct signaling pathways": 0.00292, "proliferation induction": 0.00292, "carboxy-terminal negative regulatory domain": 0.00292, "specific [": 0.00292, "nfatx1 nuclear translocation": 0.00292, "apoptotic process induced": 0.00292, "nuclear nf kappab": 0.00292, "hl-60/vinc line": 0.00292, "lipopolysaccharide-mediated nuclear translocation": 0.00292, "proviral dna present": 0.00292, "full length sp1/dna complex": 0.00292, "creb bound dna": 0.00292, "soluble peptide inhibitor": 0.00292, "lymphocytes induces": 0.00291, "zap-70 tyrosine kinase": 0.00291, "traf interaction domain": 0.00291, "effective immune response": 0.00291, "developing immune response": 0.00291, "inhibited growth": 0.00291, "c5b-9-induced dna synthesis": 0.00291, "markers induced": 0.00291, "similar transfection analysis": 0.00291, "specific dna-protein complexes": 0.00291, "nuclear antigens": 0.00291, "b2 complex": 0.00291, "kappa intron enhancer": 0.00291, "dna-protein complexes specific": 0.00291, "glioblastoma line": 0.00291, "tyrosine phosphatase inhibitor pervanadate": 0.00291, "genuine nf-e2 complex": 0.0029, "vitro effect": 0.0029, "additional enhancer elements": 0.0029, "form inhibitory complexes": 0.0029, "mediating il-4-induced tyrosine phosphorylation events": 0.0029, "anti-human immunodeficiency virus type": 0.0029, "dna synthesis": 0.0029, "germ line": 0.0029, "single strand conformation polymorphism analysis": 0.0029, "c-jun inhibitory response": 0.0029, "nh2cl inhibits pkc-mediated cellular responses": 0.0029, "glucocorticoid dexamethasone inhibits tpa-induced increases": 0.0029, "double-stranded dna target": 0.0029, "migrating b1 complex": 0.0029, "nuclear protooncogenes c-fos": 0.0029, "distinct regulatory elements": 0.0029, "distinct mitogen-inducible dna-binding complexes": 0.0029, "cellular nf-kappa": 0.0029, "efficient dna replication": 0.0029, "enhances growth inhibition": 0.0029, "phosphorylation modulates p70i kappa": 0.0029, "humoral hbx immune response": 0.0029, "kinase assays": 0.0029, "fl5.12 line": 0.0029, "increased ss rbc adhesion": 0.0029, "reduced vcam-1 induction": 0.0029, "ra signalling pathway": 0.00289, "activated form": 0.00289, "abolished lps induction": 0.00289, "normal peripheral blood": 0.00289, "gp ib-ix-v complex": 0.00289, "piec line": 0.00289, "agammaglobulinemia tyrosine kinase": 0.00289, "nuclear translocation": 0.00289, "adaptive immune response depends": 0.00289, "ig kappa enhancer": 0.00289, "regulatory effect": 0.00289, "receptor-negative line": 0.00289, "translocation induced": 0.00289, "beta inhibitor": 0.00289, "tre complex": 0.00289, "rac-1 signaling pathways important": 0.00289, "important immunoregulatory hormone [": 0.00289, "fc gamma ri transcript levels": 0.00289, "ra induced": 0.00288, "cord blood lymphocytes": 0.00288, "strong positive effect": 0.00288, "b1 complex": 0.00288, "functional glucocorticoid receptors": 0.00288, "potential signaling pathways": 0.00288, "morning fev1 increased >": 0.00288, "nuclear p65": 0.00288, "transgenic versus control mice": 0.00288, "primary effect": 0.00288, "nfat-1 complex": 0.00288, "tyrosine phosphatase inhibitor": 0.00288, "tyrosine kinase p56": 0.00288, "adp-activated platelets induced mcp-1": 0.00288, "> map kinase": 0.00288, "tt-selected line": 0.00288, "tlr2 complex": 0.00288, "pma induction increases": 0.00288, "comments ] genetic variation": 0.00288, "host immune factors": 0.00288, "clinical response": 0.00288, "anti-estrogen therapy show similar enhancement": 0.00288, "mbp-selected line": 0.00288, "gr n-terminal transactivation domain": 0.00288, "s-phase p107 complex": 0.00287, "cell-mediated immune response": 0.00287, "lymphocytes stimulated": 0.00287, "activated nf-kappab": 0.00287, "induce erythroid differentiation": 0.00287, "induced c-fos": 0.00287, "tcr beta enhancer": 0.00287, "proximal purine box sites": 0.00287, "similar effect": 0.00287, "high-affinity receptors expressed": 0.00287, "successful antituberculous immune response": 0.00287, "require dna replication": 0.00287, "differential nuclear localization": 0.00287, "ternary icsa-n-wasp-arp2/3 complex": 0.00287, "murine monoclonal antibodies": 0.00287, "il-4-induced complex": 0.00287, "redox control mechanism mediated": 0.00287, "tf complex": 0.00287, "protein-dna complex": 0.00287, "proliferation factors": 0.00287, "beta levels": 0.00287, "stimulated lymphocytes": 0.00287, "subunit p65 mrna accumulation": 0.00287, "t-cell lines constitutively": 0.00287, "phorbol ester 12,13-phorbol dibutyric acid": 0.00287, "line": 0.00287, "systemic lupus erythematosus ] er content": 0.00287, "tuberous sclerosis complex": 0.00287, "pml/rar alpha fusion transcript": 0.00287, "gabp factors enhanced": 0.00286, "dna-protein complex": 0.00286, "t-cell clones specific": 0.00286, "distinct sites": 0.00286, "amino acid domains": 0.00286, "induced alpha-naphthyl acetate esterase": 0.00286, "monocytes enhances lps-induced tnf production": 0.00286, "mediates lps induction": 0.00286, "acute phase response": 0.00286, "death induced": 0.00286, "jak2 tyrosine kinase": 0.00286, "dominant negative effect": 0.00286, "stimulate octamer-dependent enhancer elements": 0.00286, "tyrosine kinase syk": 0.00286, "transactivating complex": 0.00286, "mrna production": 0.00286, "potential regulatory elements": 0.00286, "syk tyrosine kinase": 0.00286, "detect il-2 mrna": 0.00286, "nuclear subunit": 0.00286, "blood estrogen levels": 0.00286, "inhibit tax induction": 0.00285, "] -aldosterone derivative": 0.00285, "murine pro-b lymphocytes": 0.00285, "nuclear forms": 0.00285, "decreased il-2 production": 0.00285, "p21ras effector pathway involves": 0.00285, "positive regulatory domain": 0.00285, "anti-tumor immune response": 0.00285, "c-type lectin receptors expressed": 0.00285, "induce terminal granulocytic differentiation": 0.00285, "induces hl-60 monocytic differentiation": 0.00285, "enhanced lps stimulation": 0.00285, "antibody specific": 0.00285, "nuclear association": 0.00285, "ifn-gamma-induced complex": 0.00285, "ongoing immune response": 0.00285, "inhibited cellular immunoreactions": 0.00285, "vitro footprinting analysis": 0.00285, "bind dna": 0.00285, "specific antibody": 0.00285, "g10-2/cd43 bore complex": 0.00285, "signaling pathways involved": 0.00285, "t-cell clone specific": 0.00285, "reduced gr levels": 0.00285, "combination induced": 0.00284, "so-called pml nuclear bodies": 0.00284, "potential nfat-binding sites": 0.00284, "overexpression induced": 0.00284, "trep complex": 0.00284, "impaired gamma interferon-mediated tyrosine phosphorylation": 0.00284, "normal retinoid signaling": 0.00284, "potential regulatory role": 0.00284, "ikk complex": 0.00284, "aspirin inhibited purified cox-2 enzyme": 0.00284, "activated calcineurin involved": 0.00284, "induced rapid": 0.00284, "pma induced": 0.00284, "rfx complex": 0.00284, "inefficient dna replication": 0.00284, "-dependent mouse pro-b lymphocytes": 0.00284, "increased leukocyte-platelet adhesion": 0.00284, "nuclear c-rel acts": 0.00284, "dna-binding heterodimer nf-kappa": 0.00284, "intermediate complex": 0.00284, "negative regulatory effects": 0.00284, "decreased il-9-mediated tyrosine phosphorylation": 0.00284, "specific complexes": 0.00284, "specific kappa": 0.00284, "co-ordinates important signaling pathways": 0.00284, "innate immune response": 0.00284, "viral response": 0.00284, "sites required": 0.00284, "ige/allergen immune complexes bind": 0.00284, "major cytoplasmic inhibitor": 0.00284, "drug-immunophilin complex": 0.00283, "lymphocytes signal": 0.00283, "self-distructed immune response": 0.00283, "tyrosine phosphorylation responses": 0.00283, "hcmv dna replication": 0.00283, "direct activating effect": 0.00283, "purified factors involves cooperation": 0.00283, "decreased tyrosine phosphorylation": 0.00283, "sodium salicylate suppressed nf-kappa": 0.00283, "accumulation induced": 0.00283, "enhanced biological effects": 0.00283, "complex interplay": 0.00283, "nuclear accumulation": 0.00283, "c-fos mrna indicating": 0.00283, "complex network": 0.00283, "signaling pathways important": 0.00283, "interleukin-4 induced vdr": 0.00283, "multispecific immune response": 0.00283, "exhibit distinct transcriptional activities": 0.00283, "hla-dq-specific immune response": 0.00283, "normal role": 0.00283, "potential aml1-binding sites": 0.00283, "il-1 receptor-like nf-kappab signaling cascade": 0.00283, "stat1 nuclear import": 0.00283, "ifn-gamma induced re-expression": 0.00283, "carriers chronic virus replication remains": 0.00283, "granulocyte differentiation observed": 0.00283, "il-7 induced substantial amounts": 0.00283, "tartrate resistant acid phosphatase positive": 0.00283, "il-7r complex": 0.00283, "retarded complex": 0.00282, "murine p105 nf-kappa": 0.00282, "gel-shift analyses demonstrated dose-dependent inhibition": 0.00282, "pd98059 inhibited gm-csf-dependent proliferation": 0.00282, "il-12 induced stat4": 0.00282, "nf-kappab inhibitor": 0.00282, "nuclear vitamin": 0.00282, "/cd3 complex": 0.00282, "migrating complex": 0.00282, "rickets-like diseases ]": 0.00282, "induced structural loci": 0.00282, "arp2/3 complex": 0.00282, "immune response": 0.00282, "mediating growth inhibition": 0.00282, "potential sites": 0.00282, "reduced constitutive levels": 0.00282, "form stable complexes": 0.00282, "constitutive c-fos transcript levels": 0.00282, "calcium ionophore induced": 0.00282, "complex array": 0.00282, "mediate g1/s phase control and/or enhancement": 0.00282, "il-12r complex": 0.00282, "pr complex": 0.00282, "ribosomal complex": 0.00282, "2-phase neutrophil-endothelial adhesion response": 0.00282, "asthmatic subjects ]": 0.00282, "intrinsic dna affinity": 0.00282, "nf-kappa b-dependent luciferase constructs": 0.00282, "nf-kappab/ikappab complex": 0.00282, "il-1ri complex": 0.00282, "hiv-1 nf kappa": 0.00282, "cd3/tcr complex": 0.00281, "hla-a3/peptide complex": 0.00281, "retinoid response pathways": 0.00281, "nuclear import process": 0.00281, "tight complex": 0.00281, "distal nuclear matrix": 0.00281, "anti-igm ab-induced b104 growth inhibition": 0.00281, "sedimenting complex": 0.00281, "-cd3 complex": 0.00281, "normal mice": 0.00281, "tyrosine kinase tyk2": 0.00281, "common jak/stat pathway": 0.00281, "nuclear p50": 0.00281, "pre-existing complex": 0.00281, "grpl-slp-76 complex": 0.00281, "oap40 complex": 0.00281, "receptor-associated tyrosine kinase": 0.00281, "cd28-responsive complex": 0.00281, "mrna encoding c-fos": 0.00281, "tcr/cd3 complex": 0.00281, "study putative teratogenic effects": 0.00281, "lr1-dna complex": 0.00281, "prothrombinase complex": 0.00281, "rb-e2f complex": 0.00281, "e2f-4/p130 complex": 0.00281, "inducible n-terminal transactivation domain": 0.00281, "cd3.tcr complex": 0.00281, "il4r complex": 0.00281, "tf.viia complex": 0.00281, "p62 complex": 0.00281, "cmat complex": 0.00281, "prevalent complex": 0.00281, "steroid-mr complex": 0.00281, "factors required": 0.00281, "ifn-gamma induced": 0.00281, "nucleoprotein complex": 0.00281, "ptf-oct-1-dna complex": 0.00281, "epstein-barr virus immediate-early antigen": 0.00281, "stat3 induced": 0.00281, "regulated cd43-mediated pathway": 0.00281, "pu-sf complex": 0.00281, "avidin-biotin complex": 0.00281, "ets-1-containing complex": 0.00281, "complex sedimenting": 0.00281, "cd28re/ap-1-specific complex": 0.00281, "dq3.2-peptide complex": 0.00281, "nf-gm2 complex": 0.00281, "inducible nuclear factor-kappab": 0.00281, "tyrosine kinase csk": 0.00281, "tri-molecular complex": 0.00281, "cytokine differential induction": 0.00281, "sterol-vdr complex": 0.00281, "tyrosine kinase p59fyn": 0.00281, "antibody-mr complex": 0.00281, "faster-migrating complex": 0.00281, "alpha b1 enhanced": 0.00281, "nfat/ap-1 complex": 0.00281, "notch complex": 0.00281, "cd3-tcr complex": 0.00281, "p50-p65 complex": 0.00281, "protein-tre-dna complex": 0.00281, "ap-1-like complex": 0.00281, "form latent complexes": 0.00281, "cytokine mediates biological effects": 0.00281, "v-src-induced complex": 0.00281, "blocked tnf-dependent nf-kappa": 0.00281, "hla/peptide complex": 0.00281, "putative stat3 serine kinase": 0.0028, "complex": 0.0028, "characterized pathway": 0.0028, "tyrosine kinase": 0.0028, "tcr signaling function": 0.0028, "21.4-kb dna clone": 0.0028, "transforming growth factor-beta family": 0.0028, "membrane proximal proline-rich domain": 0.0028, "murine lymphocytes": 0.0028, "corticosteroid treatment observed": 0.0028, "maximal lps induction": 0.0028, "bronchial asthma ] quantitation": 0.0028, "prevented nuclear factor-kappa": 0.0028, "defect induced": 0.0028, "important trans-acting factors": 0.0028, "functional analysis": 0.0028, "stimulated nf-kappa": 0.0028, "increased intracellular calcium": 0.0028, "mutated pp repeat elements demonstrate": 0.0028, "inducible nuclear import": 0.0028, "lymphocytes results": 0.0028, "mutant mice lacking mature": 0.0028, "ets dna-binding domain common": 0.0028, "cipro inhibited ifn-gamma synthesis": 0.0028, "cd3 cross-linking induced": 0.0028, "lymphocyte dna": 0.0028, "nf-kappab motif": 0.0028, "low cytoplasmic levels": 0.0028, "bronchial asthma ]": 0.00279, "dna clones": 0.00279, "blocked nf-kappa": 0.00279, "control levels": 0.00279, "t-cell stimulation increases": 0.00279, "important regulatory role": 0.00279, "effect mediated": 0.00279, "inhibited lif-induced hiv replication": 0.00279, "thyroid antibody production": 0.00279, "signal transduction elements": 0.00279, "negative transcriptional regulation": 0.00279, "involved sites": 0.00279, "c-jun n-terminal kinase": 0.00279, "intracellular pathway": 0.00279, "nuclear matrix preparations": 0.00279, "transcriptional regulatory sequences": 0.00279, "vivo dna footprinting": 0.00279, "express lineage specific markers": 0.00279, "nuclear nfat": 0.00279, "tpa induction increases": 0.00279, "n-terminal c-jun kinase": 0.00279, "increased adhesion": 0.00279, "multiple initiation sites": 0.00279, "nf-kappab levels": 0.00279, "specific progesterone receptors": 0.00279, "heterologous enhancer elements": 0.00278, "inhibited hiv replication": 0.00278, "vitro clonal growth assays": 0.00278, "increased level": 0.00278, "elevated cortisol plasma levels": 0.00278, "hybrid molecule pml/rar alpha": 0.00278, "chicken immature erythrocyte nuclear": 0.00278, "early b-cell differentiation": 0.00278, "lymphocytes involved": 0.00278, "activate ikappab kinase": 0.00278, "ra inhibits ige production": 0.00278, "polymorphic dna markers": 0.00278, "level increased": 0.00278, "glucocorticoid hormone inhibition": 0.00278, "major identifiable risk factors": 0.00278, "normal developmental regulation": 0.00278, "inhibit hiv-1 long terminal repeat": 0.00278, "tpo induced fetal": 0.00278, "gel shift assays demonstrated sp1": 0.00277, "duffy blood group system": 0.00277, "ap-1 consensus tre motif": 0.00277, "pkc subfamilies induced": 0.00277, "-beta mediate anti-apoptotic effect": 0.00277, "dna replication": 0.00277, "il-5 signal transduction mechanism": 0.00277, "digoxigenin-labeled complementary dna probe": 0.00277, "restored lps induction": 0.00277, "forms distinct heteromeric complexes": 0.00277, "inhibited superoxide formation": 0.00277, "mediate low levels": 0.00277, "nuclear run-on analyses": 0.00277, "lipopolysaccharide induced": 0.00277, "il-2 -and ifngamma-mediated signaling": 0.00277, "ets-related transcriptional regulators expressed": 0.00277, "specific radiometric assay": 0.00277, "c-terminal sequences control degradation": 0.00277, "enhanced nf-kappa": 0.00277, "intact gr dna-binding domain": 0.00277, "tax activates nf-kappa": 0.00277, "il-4 inhibit cytokine production": 0.00276, "culture supernatant increased": 0.00276, "delta-opioid receptors expressed": 0.00276, "increased synthesis": 0.00276, "tissue sites": 0.00276, "normal erythroid development": 0.00276, "early signaling events characterization": 0.00276, "blood lymphocytes": 0.00276, "anti-cd3 mab activated": 0.00276, "[ plasma cortisol concentration": 0.00276, "constitutively induced": 0.00276, "induce specific lineage maturation": 0.00276, "elevated serum hormone levels": 0.00276, "] dexamethasone": 0.00276, "gssg/gsh-induced adhesion response": 0.00276, "nf-kappa b-binding motifs": 0.00276, "cytokines control growth": 0.00276, "potent transactivation domain": 0.00276, "major mrna transcript": 0.00276, "signal nf-kappa": 0.00276, "factors involved": 0.00276, "monocytic nuclear factor-kappa": 0.00276, "trep-containing dna fragment": 0.00276, "similar adhesive response": 0.00276, "inhibited hsc proliferation": 0.00276, "activated monocytes": 0.00276, "reduced induction": 0.00276, "dna fragment": 0.00275, "lymphocyte cytosolic glucocorticoid receptors": 0.00275, "epo induced embryonic": 0.00275, "upstream kinase zap-70": 0.00275, "truncated surface domain": 0.00275, "proliferation and/or differentiation": 0.00275, "inhibited proliferation": 0.00275, "glucocorticoid receptors present": 0.00275, "il-2 mrna": 0.00275, "cd28 costimulation pathway": 0.00275, "dna staining": 0.00275, "hiv proviral dna": 0.00275, "alpha synthesis secondary": 0.00275, "% increase": 0.00275, "tumor specific antigens": 0.00275, "growth experiments demonstrated": 0.00275, "downstream positive regulatory elements": 0.00275, "cellular levels": 0.00274, "ca2+-modulating cyclophilin ligand modulates calcium influx signaling": 0.00274, "induce nf-kappa": 0.00274, "elevated total serum ige levels": 0.00274, "selectively induced": 0.00274, "amino acid differences": 0.00274, "adhesion response": 0.00274, "intracellular signaling components involved": 0.00274, "gel shift analysis shows": 0.00274, "kinase pathways": 0.00274, "potential nf-kappa": 0.00274, "stimuli activate nf-kappa": 0.00274, "previous mrna studies": 0.00274, "pml nuclear bodies": 0.00274, "increased plasma": 0.00274, "ras pathway": 0.00274, "inducing stat3 tyrosine phosphorylation": 0.00274, "gel shift assay studies": 0.00274, "vitro response": 0.00274, "phosphorylation processes require t-cell costimulation": 0.00274, "tumor necrosis factor-alpha-responsive elements": 0.00273, "activated t-cell": 0.00273, "dna repair enzyme uracil-dna glycosylase": 0.00273, "increase camp concentrations": 0.00273, "pulsed field gel electrophoresis analysis": 0.00273, "long-term clinical effects": 0.00273, "nf-kappa b. lps": 0.00273, "lps response": 0.00273, "common pathway": 0.00273, "discrete nuclear structures": 0.00273, "normal pancreatic beta-cell function": 0.00273, "herpes simplex virus type": 0.00273, "nuclear matrix": 0.00273, "stimulates nuclear export": 0.00273, "il-10 inhibit induction": 0.00273, "h2o2 induced lipid peroxidation": 0.00273, "increase hiv replication": 0.00273, "nfat regulatory domain": 0.00273, "regulated host defence response": 0.00273, "regulate stat3 tyrosine phosphorylation": 0.00273, "strong nuclear positivity": 0.00273, "t-cell lines transformed": 0.00273, "rapid signal-transduction pathway": 0.00273, "mediate transcriptional control": 0.00273, "early induction": 0.00273, "multiple ets family members": 0.00273, "immature t-cell lines": 0.00273, "beta interferon kappa": 0.00273, "precursor interleukin-1 alpha cytokine": 0.00273, "immune induction": 0.00272, "weak aggregation induced": 0.00272, "jurkat t-cells expressing hiv-1 tat": 0.00272, "t-cell signaling molecules": 0.00272, "il-2 levels": 0.00272, "il-1 -and lps-specific induction": 0.00272, "enhanced mrna stability": 0.00272, "nf-kappa b. transient-transfection experiments": 0.00272, "[ mechanism": 0.00272, "vitro analysis": 0.00272, "mouse lymphocytes": 0.00272, "il-6 induced macrophage-differentiation": 0.00272, "medium range [ 1-3 ppt tcdd": 0.00272, "cd40 induced": 0.00272, "interferon-alpha /beta-induced tyrosine phosphorylation increases": 0.00272, "functional ebf-binding sites": 0.00272, "hormone effect": 0.00272, "multiple functional elements": 0.00271, "genomic pathway": 0.00271, "protein-tyrosine kinase inhibitors genistein": 0.00271, "increase intracellular ca2+": 0.00271, "abnormal nuclear morphology indicative": 0.00271, "epstein-barr virus latent infection": 0.00271, "synthetic dna-binding ligands [": 0.00271, "switch dna recombination": 0.00271, "il-2 transcriptional inhibitors": 0.00271, "form sequence-specific dna-bound complexes": 0.00271, "nuclear basis": 0.00271, "stimuli induced": 0.00271, "control lines": 0.00271, "lymphoblastoid t-cell lines": 0.0027, "molecular factors responsible": 0.0027, "duffy blood group antigen": 0.0027, "soluble surface domain": 0.0027, "pi3-kinase inhibitor ly294002 blocked": 0.0027, "distinct histone deacetylase complexes": 0.0027, "host inflammatory response": 0.0027, "normal cellular equivalent c-myb": 0.0027, "three-dimensional nuclear magnetic resonance": 0.0027, "identified consensus sequences": 0.0027, "il-2 transcriptional regulators c-fos": 0.0027, "consensus c/ebp sites": 0.0027, "[ regulation": 0.0027, "induced processing": 0.0027, "serine kinase target": 0.0027, "direct dna sequencing": 0.0027, "allergy ] inflammation": 0.0027, "induced cem subclones": 0.0027, "target quantity increased": 0.00269, "il-4 down-regulatory effect": 0.00269, "express vdr mrna": 0.00269, "zap-70 signaling function leading": 0.00269, "mutant signaling molecules": 0.00269, "b-cell lines tested": 0.00269, "mhc-i mediated tyrosine phosphorylation": 0.00269, "decreased cellular proliferation": 0.00269, "inhibited edema formation": 0.00269, "terminal transactivation domain": 0.00269, "[ molecular mechanisms": 0.00269, "similar inhibitory effects": 0.00269, "demonstrate induction": 0.00269, "cyclin-like dna repair enzyme": 0.00269, "elements specific": 0.00269, "bcl-2 inhibited triptolide-induced degradation": 0.00269, "caprine arthritis-encephalitis virus long terminal repeat": 0.00269, "composite motif binds": 0.00269, "similar analysis": 0.00269, "myosin light chain kinase": 0.00269, "post-translationally modified amino acid side chains": 0.00269, "nuclear targets": 0.00269, "significant effect": 0.00269, "vitro erythroid differentiation": 0.00269, "major dnase-i hypersensitive sites": 0.00269, "dibutyryl camp induced": 0.00269, "il-10 induced": 0.00269, "specific biological function": 0.00268, "constitutive pi3-kinase/pkb/akt pathway": 0.00268, "hot acetic + p-toluenesulfonic acid": 0.00268, "prognostic criteria ] body weight": 0.00268, "downstream pkc/ras-mediated pathway": 0.00268, "heterologous viral transcription-activating domain": 0.00268, "immune factors": 0.00268, "cis-acting regulatory sites": 0.00268, "carboxy-terminal cytoplasmic domain essential": 0.00268, "lymphocytes demonstrate": 0.00268, "htlv-i tax production induces": 0.00268, "demonstrate potent inhibition": 0.00268, "inactive nuclear factor-kappab": 0.00268, "recognition sites play": 0.00268, "cd3/tcr pathway enhances": 0.00268, "mutant e6 motif": 0.00268, "transcriptional inhibition": 0.00268, "chimeric oncoprotein e2a-pbx1 induces apoptosis": 0.00268, "glucocorticoid mediated apoptosis": 0.00267, "tnf-alpha mrna transcripts": 0.00267, "cd28 costimulatory pathway": 0.00267, "nuclear localization": 0.00267, "lymphocyte glucocorticoid receptors": 0.00267, "fas ligation induces apoptosis": 0.00267, "specific role": 0.00267, "tnfrp55 function renders mice resistant": 0.00267, "adult mice activates cd4+": 0.00267, "stat1 pathway": 0.00267, "determine t-cell differentiation": 0.00267, "ebv transactivating factors": 0.00267, "cognate enhancer elements": 0.00267, "inhibitory pathway": 0.00267, "isoquinoline derivative h7 abolishes induction": 0.00267, "specific receptors": 0.00267, "normal regulation": 0.00267, "interleukin-1beta-converting enzyme family protease inhibitors ac-devd-cho": 0.00267, "latency type ii pattern": 0.00267, "inducible autoregulatory pathway": 0.00266, "leukocyte differentiation antigen": 0.00266, "cytokine signaling pathways": 0.00266, "induce early antigen": 0.00266, "low ifn-gamma levels": 0.00266, "induced naive": 0.00266, "negative effect": 0.00266, "dna probe": 0.00266, "th-dependent positive effect": 0.00266, "direct transcriptional control": 0.00266, "nf-kappab family": 0.00266, "triggering multiple signaling pathways": 0.00266, "ym268 increased glucose uptake": 0.00266, "activated mouse epor": 0.00266, "comments ] glucocorticoids": 0.00266, "atra-induced growth inhibition": 0.00266, "induce detectable cd28 tyrosyl phosphorylation": 0.00266, "electrophoretic mobility shift assays suggest": 0.00266, "infected cd4+ lymphocytes": 0.00266, "specific signaling": 0.00266, "mutant mrna": 0.00266, "conserved cell-death pathway": 0.00266, "distinct domain": 0.00266, "ap3-l motif binds": 0.00266, "induce functional interactions": 0.00265, "amino terminal domain": 0.00265, "g-csf-r/il-7r alpha contained stat1": 0.00265, "unidentified ets-like factors present": 0.00265, "multiple docking sites": 0.00265, "stat3 monoclonal antibody": 0.00265, "gm-csf induced": 0.00265, "leukocytes exhibit increased adherence": 0.00265, "nuclear factor-kappab-mediated phenomenon": 0.00265, "phosphorylated residues kinetic analysis": 0.00265, "secreted tnf alpha plays": 0.00265, "nuclear membranes": 0.00265, "c-rel protooncogene product represses nf-kappa": 0.00265, "enhancer elements": 0.00265, "] thymidine incorporation": 0.00265, "positive effect": 0.00265, "dna-binding domain relative": 0.00265, "nuclear c-rel": 0.00265, "nuclear autoantigen la/ss-b alters": 0.00265, "as2o3 induced pml": 0.00265, "il-10 effect occurs": 0.00265, "tgf-beta 1-mediated growth inhibition": 0.00265, "potential antiviral effects": 0.00265, "gamma interferon-induced tyrosine phosphorylation": 0.00265, "anti-il-1 beta antibody": 0.00265, "induced ad5e1a-specific immunity": 0.00265, "[ hormonal interactions": 0.00265, "initiate early tcr-mediated signaling events": 0.00265, "inorganic lead activates nf-kappa": 0.00265, "increased resistance": 0.00264, ":1709 ] repression": 0.00264, "kinase upstream": 0.00264, "induced c-rel": 0.00264, "nf-kappab-containing nuclear extract": 0.00264, "important primary mechanism": 0.00264, "comments ] cyclosporin": 0.00264, "minimal maturation effect": 0.00264, "stimulated levels": 0.00264, "active factors mediating": 0.00264, "interleukin-1beta-converting enzyme family protease inhibitors": 0.00264, "disease suggest adenovirus": 0.00264, "disease virus": 0.00264, "unfractionated nuclear extract": 0.00264, "upstream kinase": 0.00264, "multiple e2f sites": 0.00264, "il-10 inhibited tnf-alpha release": 0.00264, "vivo proliferative response": 0.00264, "distinct signaling properties": 0.00264, "signaling pathways activate": 0.00264, "increased oxidative stress": 0.00264, "similarly induced": 0.00264, "tcrzeta-associated signaling elements": 0.00264, "additional dna segments": 0.00264, "il-1beta-converting enzyme family protease inhibitors": 0.00264, "scf + epo-induced erythroid colony growth": 0.00264, "macrophages promotes induction": 0.00264, "mutant motif": 0.00264, "thymic atrophy induced": 0.00264, "induced egr-1": 0.00264, "low constitutive levels": 0.00264, "active mitogen-activated kinase": 0.00264, "transient dna transfections": 0.00264, "atl-16t nuclear extract": 0.00264, "transcriptional activator involved": 0.00264, "mrna stability studies": 0.00263, "specific peptide residue identifies": 0.00263, "nuclear fractions": 0.00263, "signal transduction mechanism": 0.00263, "nuclear body": 0.00263, "nuclear t3r alterations": 0.00263, "display normal proliferative responses": 0.00263, "plasma cortisol levels": 0.00263, "cytokine message induction": 0.00263, "nuclear fraction": 0.00263, "rp-camp- sensitive pathway": 0.00263, ":1830 ] constitutive": 0.00263, "transient transfection analysis": 0.00263, "tyrphostin ag-490 inhibits cytokine-mediated jak3/stat5a/b signal transduction": 0.00263, "amino acid residues": 0.00263, "induced extract": 0.00263, "increased rna": 0.00263, "induce 24-hydroxylase mrna": 0.00263, "induces neutrophil differentiation": 0.00263, "apoptotic pathway reveal": 0.00263, "signaling pathways upstream": 0.00263, "ra effect": 0.00263, "substantial growth inhibition": 0.00263, "distinct effects": 0.00263, "multiple start sites": 0.00263, "position effect": 0.00263, "increased c-jun": 0.00263, "normal function": 0.00263, "vivo effect": 0.00263, "allergic inflammatory response": 0.00263, "nuclear extract": 0.00263, "related kinase": 0.00263, "termed fos kinase": 0.00263, "14-amino acid serine-rich insertion present": 0.00263, "lps induction": 0.00263, "functional trans-activation domain": 0.00262, "nuclear structures": 0.00262, "nuclear distribution": 0.00262, "pathway dependent": 0.00262, "cyclosporin a-resistant pathway": 0.00262, "cyclosporin a-insensitive pathway": 0.00262, "hsv-1 strain f. immunoblot analysis": 0.00262, "lps-induced nuclear factor-kappab": 0.00262, "lymphocyte response": 0.00262, "putative transactivation domain": 0.00262, "htlv-i-infected t-cell lines": 0.00262, "require high circulating levels": 0.00262, "cytoplasmic domain common": 0.00262, "c-maf induces monocytic differentiation": 0.00262, "direct molecular effects": 0.00262, "induced nfkappab": 0.00262, "nuclear bodies": 0.00262, "long term glucocorticoid treatment": 0.00262, "examined tyrosine phosphorylation": 0.00262, "oxidant injury induced": 0.00262, "ltr-mediated synergy induced": 0.00261, "cytokine induction": 0.00261, "blocked il-10-induced stat3 phosphorylation": 0.00261, "] enhances": 0.00261, "primary lymphocytes": 0.00261, "cho-dr/b7/lfa-3 triple transfectant induced": 0.00261, "bind endogenous intracellular receptors": 0.00261, "nuclear appearance": 0.00261, "affect measured il-7r signaling events": 0.00261, "potential nfat composite elements": 0.00261, "differentiating agent retinoic acid": 0.00261, "pathway responsible": 0.00261, "enhanced levels": 0.00261, "oct-2 induction suggests": 0.00261, "multiple regulatory elements": 0.00261, "il-6 increases junb mrna": 0.00261, "vitro activated helper": 0.00261, ":524 ] down-regulation": 0.00261, "tax-expressing t-cell lines": 0.00261, "il-2 growth hormone": 0.00261, "pma-stimulated t-cell lines": 0.00261, "chromosome analysis": 0.00261, "mouse aml1/pebp2 alpha": 0.00261, "upstream regulatory elements": 0.00261, "il-13-induced regulatory factors": 0.00261, "ml-9 induced nitroblue tetrazolium": 0.00261, "major protein-binding sites": 0.00261, "common consensus motif": 0.00261, "il-5 induced": 0.00261, "rb-defective tumor lines": 0.00261, "signaling role": 0.0026, "genomic dna": 0.0026, "examined mrna accumulation": 0.0026, "il-10 suppressed seb induction": 0.0026, "increased number": 0.0026, "il-4 down-regulated mrna accumulation": 0.0026, "cd40 pathway": 0.0026, "cmv induced": 0.0026, "suppressing nuclear factor-kappa": 0.0026, "affected mutant mice": 0.0026, "vivo th1 response": 0.0026, "direct effect": 0.0026, "form tight complexes": 0.0026, "lymphocytes express": 0.0026, "potential inhibitor": 0.0026, "pml-rar alpha fusion oncoprotein": 0.0026, "immunosuppression induced": 0.0026, "immobilized anti-cd3 monoclonal antibody": 0.0026, "p50/p65 induced": 0.0026, "nuclear matrix-bound rb": 0.0026, "induced p53": 0.0026, "normal control": 0.0026, "mouse transgenic lines": 0.0026, "anti-inflammatory effect differs": 0.0026, "sites similar": 0.0026, "significant il-2 production": 0.0026, "plasma ifn alpha": 0.0026, "similarly stimulated normal": 0.0026, "induce mrna": 0.0026, "immune modulating effects": 0.0026, "kinase inhibitors staurosporine": 0.0026, "inhibited events downstream": 0.0026, "lipopolysaccharide induces phosphorylation": 0.0026, "ranbp1 restores nuclear export": 0.0026, "dna failed": 0.0026, "jak-stat pathway correlates": 0.0026, "adhesion molecules expressed": 0.0026, "nuclear signalling": 0.0026, "il-12 ]": 0.00259, "pathway involves": 0.00259, "nef-expressing t-cell lines": 0.00259, "detailed molecular analysis": 0.00259, "c-terminal ta1 transactivation domain": 0.00259, "functional differentiation markers": 0.00259, "clinical side effects": 0.00259, "nb4 reduced levels": 0.00259, "and/or specific compound tested": 0.00259, "regulatory factors": 0.00259, "32-kda nuclear phosphoprotein": 0.00259, "baseline lymphocyte gcii sites": 0.00259, ":8154 ] camp inducibility": 0.00259, "gel mobility shift assays show": 0.00259, "multicopy basal enhancer motifs": 0.00259, "serum influence steroid effects": 0.00259, "bound glucocorticoid receptors": 0.00259, "decreased nf-kappa": 0.00259, "increased degradation": 0.00259, "pharmacology ] glucocorticoids": 0.00259, "total serum ige levels": 0.00259, "selectively inhibit nf kappa": 0.00259, "synergy induced": 0.00259, "lymphocytes present": 0.00259, "atra-dependent growth inhibition": 0.00259, "surface ag receptor-initiated signaling events": 0.00259, "identified peptides derived": 0.00259, "form protein/drug complexes": 0.00259, "tpl-2 kinase activates": 0.00259, "potential effects": 0.00259, "electrophoretic mobility shift analysis": 0.00259, "catalase inhibited phase-1 adhesion": 0.00258, "cell-type specific regulation": 0.00258, "growth inhibition": 0.00258, "normal rbc show": 0.00258, "sites derived": 0.00258, "mediated signaling pathways": 0.00258, "delayed ros-dependent signalling pathway": 0.00258, "ras oncogene blocks terminal differentiation": 0.00258, "initiate rac-1 regulated signaling pathways": 0.00258, "late phase response": 0.00258, "lymphocytes derived": 0.00258, "affect constitutive nf-kappa": 0.00258, "h. similar effects": 0.00258, "signaling pathways mediated": 0.00258, "nuclear phosphoprotein": 0.00258, "cd28 pathway": 0.00258, "form complexes": 0.00258, "regulated host factors": 0.00258, "biological response include": 0.00258, "epstein-barr virus latent membrane protein-1": 0.00258, "cd8-positive lymphocytes purified": 0.00258, "promote high levels": 0.00258, "specific regions contained": 0.00258, "gel shift analysis": 0.00258, "purified cd8-positive lymphocytes": 0.00258, "t-cell lines": 0.00258, "single mrna transcript": 0.00258, "c-jun nh2-terminal kinase": 0.00258, "actinomycin d. increased stat1": 0.00257, "high initial levels": 0.00257, "polyamides inhibit virus replication": 0.00257, "express factors": 0.00257, "cd2 signalling pathway": 0.00257, "similar signaling mechanisms": 0.00257, "cytosolic tyrosine motif": 0.00257, "lmp-1 activates nf-kappa": 0.00257, "mutant alleles encode cell-surface ifngamma receptors": 0.00257, "il-13 phosphorylated insulin response substrate-1": 0.00257, "unspliced viral gag-pol mrna": 0.00257, "rna analysis": 0.00257, "multiple sites": 0.00257, "nuclear compartment": 0.00257, "induced dissociation": 0.00257, "c-jun amino-terminal kinase": 0.00257, "normal lymphoid development": 0.00257, "leukemic dna": 0.00257, "important immunoregulatory effects": 0.00257, "nfatc- specific antibodies": 0.00257, "nuclear autoantigen la/ss-b": 0.00257, "important autoregulatory inhibitor": 0.00257, "zymogen plasma factors vii": 0.00257, "suggesting pretranslational control mechanisms": 0.00257, "virus production": 0.00257, "hiv-2 transcriptional enhancer": 0.00257, "constitutive dna": 0.00257, "inhibits granulocyte differentiation": 0.00257, "vivo footprinting identified protected regions": 0.00257, "detect adenovirus dna": 0.00257, "values increased": 0.00257, "heat shock response": 0.00257, "replication-competent hiv-1 constructs carrying wild-type": 0.00257, "isotype-matched control antibody": 0.00257, "functional studies demonstrated": 0.00257, "janus kinase-stat pathway": 0.00257, "glucocorticoids ]": 0.00257, "comparable functional effects": 0.00257, "upregulate nuclear factor-kappab": 0.00257, "similar selective effects": 0.00257, "small effect": 0.00257, "sensitive mutation screening assay": 0.00256, ":3775 ] ionizing radiation triggers": 0.00256, "heterogeneous nuclear ribonucleoprotein": 0.00256, "c-myc mrna level": 0.00256, "multiple cytokine receptors": 0.00256, "nf-kappab complexes": 0.00256, "vdr dna-binding domain": 0.00256, "increased il-4": 0.00256, "plate-bound anti-cd3 monoclonal antibody": 0.00256, "gabp factors bind": 0.00256, "atf family members bind": 0.00256, "lysp100 nuclear dots": 0.00256, "il-13 induced dose-": 0.00256, "nuclear mobilization": 0.00256, "nuclear pool": 0.00256, "molecular analysis": 0.00256, "inhibit erythroid differentiation": 0.00256, "increased intracellular stores": 0.00256, "il-2r alpha promoters": 0.00256, "pathway occurs": 0.00256, "pronounced inhibitory effect": 0.00256, "nf-kappab inhibition": 0.00256, "outer nuclear volume": 0.00256, "nuclear rnas": 0.00256, ":633 ] v3 loop": 0.00256, "ifn-gamma cytoplasmic mrna": 0.00256, "specific type": 0.00256, "immune complexes leads": 0.00256, "inducible transcriptional enhancement mediated": 0.00256, "mrna differential display reverse transcriptase pcr": 0.00256, "important negative role": 0.00256, "dna recognition": 0.00256, "intracellular glucocorticoid receptors": 0.00256, "early hematopoietic differentiation": 0.00255, "defined oral glucocorticoid treatment": 0.00255, "specific anti-hla antibodies": 0.00255, "induced irf-1": 0.00255, "nuclear grade": 0.00255, "p/i mediated induction": 0.00255, "gh-induced inhibitory effect": 0.00255, "th2 pathway": 0.00255, "complementary dna encoded": 0.00255, "plasmids expressing nf kappa": 0.00255, "control immune responses": 0.00255, "comments ] background": 0.00255, "activated macrophages contribute": 0.00255, "vitamin d-dependent rickets type ii": 0.00255, "anti-cd3 monoclonal antibody": 0.00255, "restriction enzyme analysis": 0.00255, "antigen recognition stimulates limited proliferation": 0.00255, "unspliced viral mrna": 0.00255, "rare heterozygous dna variations": 0.00255, "hu induced": 0.00255, "interactions provide additional pathways": 0.00255, "nuclear exclusion": 0.00255, "potent enzyme inhibitor": 0.00255, "biological effects related": 0.00255, "related family members": 0.00255, "corticosteroid receptors regulation": 0.00255, "il-13 induced": 0.00255, "molecules enhanced lps-induced nf-kappab": 0.00255, "nuclear targeting": 0.00255, "pre-i forms multiple dna-protein complexes": 0.00255, "gel mobility shift assays demonstrated": 0.00255, "induction conditions": 0.00255, "affect ifn-gamma-induced tyrosine phosphorylation": 0.00255, "csa inhibited synthesis": 0.00255, "important immune-modulating effects": 0.00255, "csa treatment inhibits": 0.00255, "cortivazol mediated induction": 0.00255, "fos kinase phosphorylates c-fos": 0.00254, "large stimulatory effect": 0.00254, "default pathway leading": 0.00254, "multiple factors": 0.00254, "multiple prolactin-responsive elements mediate g1": 0.00254, "lysis pathway": 0.00254, "cd40 cytoplasmic domain interacted": 0.00254, "control virus spread": 0.00254, "] aldosterone": 0.00254, "tissue inhibitor": 0.00254, "elisa assay system": 0.00254, "ikappab alpha kinases": 0.00254, "early signaling events": 0.00254, "glucocorticoid effects": 0.00254, "nuclear envelope": 0.00254, "anti-v3 loop monoclonal antibody": 0.00254, "conserved dna-binding domain": 0.00254, "increase intracellular accumulation": 0.00254, "inhibitory effect": 0.00254, "antibodies specific": 0.00254, "control thymocyte differentiation": 0.00254, "maturation pathway": 0.00254, "c/ebp beta regulation": 0.00254, "restores ra response": 0.00254, "normal myeloid development": 0.00254, "poorly induced": 0.00254, "combined effect": 0.00254, "exert regulatory effects": 0.00254, "northern blot analysis failed": 0.00254, "cbl-b undergoes rapid tyrosine phosphorylation": 0.00254, "plasma membrane receptors": 0.00254, "active v-abl kinase": 0.00254, "specific antibodies": 0.00254, "pkc isoforms alpha": 0.00254, "selective pathway": 0.00254, "induce neutrophil differentiation": 0.00254, "> 10-fold increase": 0.00254, "kb 5'-flanking dna": 0.00254, "present results show": 0.00253, "18-bp dna segment": 0.00253, "nuclear contents": 0.00253, "il-2r alpha transcripts": 0.00253, "purified factors": 0.00253, "mediating tnf-alpha induction": 0.00253, "anti-inflammatory effect": 0.00253, "adjacent normal kidney tissue": 0.00253, "lymphocytes expressing socs-3": 0.00253, "cellular transduction mutant": 0.00253, "nuclear t3r mbc": 0.00253, "significant response": 0.00253, ":33705 ] characterization": 0.00253, "nf-kappa b-regulated promoters": 0.00253, "c-terminal cytoplasmic domain": 0.00253, "tpa maturation response": 0.00253, "express il-5 mrna": 0.00253, "nf-at induction": 0.00253, "specific mechanism": 0.00253, "nuclear nf-atp": 0.00253, "measured glucocorticoid receptors": 0.00253, "anti-cd3 stimulation demonstrated": 0.00253, "initiating intracellular signaling pathways": 0.00253, "oxidized low-density lipoproteins decrease early production": 0.00253, "transcriptional elements": 0.00253, "lymphoid src kinase pp56": 0.00253, "erythroid factors": 0.00253, "adenovirus antigen stimulation": 0.00253, "gut inflammatory response": 0.00253, "granulocytic pathway": 0.00253, "important role cbp/p300 plays": 0.00253, "mature b-cell lines": 0.00253, "monocytes [": 0.00253, "lymphoid lineage-determining factors ikaros": 0.00253, "alternative pathway": 0.00253, "pathway leading": 0.00253, "important b-cell growth": 0.00253, "induction mediated": 0.00253, "ubiquitous ap-1 factors": 0.00253, "membrane il-2r alpha": 0.00253, "bp repeat elements": 0.00252, "induced glycation": 0.00252, "trophic effect resulting": 0.00252, "ltb4 induced": 0.00252, "control virus": 0.00252, "cd2 signalling induces phosphorylation": 0.00252, "5-fold reduced levels": 0.00252, "elevated cortisol levels suppress cell-mediated immunity": 0.00252, "activated pkc isotypes tested": 0.00252, "cellular differentiation program": 0.00252, "nuclear factor-kappab": 0.00252, "suppressed vcam-1 induction": 0.00252, "nuclear import": 0.00252, "nuclear export": 0.00252, "ig levels decreased": 0.00252, "target sites": 0.00252, "inhibits signal transduction": 0.00252, "specific adhesion molecules": 0.00252, "nuclear retention": 0.00252, "molecular mechanism involved": 0.00252, "transcriptional enhancer": 0.00252, "amino acid homology": 0.00252, "functional domain": 0.00252, "viral mrna": 0.00252, "ifn-alpha induced": 0.00252, "adjacent regulatory motif": 0.00252, "early increase": 0.00252, "entire nh2 regulatory domain": 0.00252, "nuclear p52": 0.00252, "inhibit hsv-1-mediated induction": 0.00252, "igh enhancer regulation": 0.00252, "nuclear compartments": 0.00252, "receptor-mediated ap-1 induction": 0.00252, "ro 09-2210 exhibits potent anti-proliferative effects": 0.00252, "il-2r jak/stat pathway": 0.00252, "dna segment": 0.00252, "non-cultured peripheral lymphocytes": 0.00252, "il-2 reverted anti-tnf-alpha inhibition": 0.00252, "tnf-alpha-stimulated nuclear factor-kappa": 0.00252, "nuclear rel-a": 0.00251, "putative ikappabalpha kinase": 0.00251, "optimal enhancer function": 0.00251, "ap-1 response": 0.00251, "induced protooncogenes": 0.00251, "lymphocytes expressing": 0.00251, "zap-70 signaling function": 0.00251, "hormone inhibits proliferation": 0.00251, "relevant concentrations exert specific actions": 0.00251, "induce monocytic differentiation": 0.00251, "nf-kappa b-independent mechanisms": 0.00251, "nuclear protooncogenes": 0.00251, "pathways activated": 0.00251, "flow cytometric analysis": 0.00251, "nuclear ap-1/oap": 0.00251, "nuclear location": 0.00251, "nuclear factor-kappa": 0.00251, "vivo footprint analysis": 0.00251, "antioxidants inhibit nf-kappa": 0.00251, "clonal derivative alpha g2s": 0.00251, "high affinity receptors": 0.00251, "eosinophils express mrna": 0.00251, "nuclear abundance": 0.00251, "color flow cytometry analysis": 0.00251, "increased serum transaminase": 0.00251, "normal thyroid tissue": 0.00251, "induced hrf": 0.00251, "comments ] immunosuppression": 0.00251, "nuclear oncoproteins": 0.00251, "camp-dependent intracellular signaling pathways": 0.00251, "cd40 cytoplasmic domain truncation": 0.00251, "-dependent phosphorylation system": 0.00251, "lmp1 dna": 0.00251, "clonal derivative alpha b5a": 0.00251, "microtitre assay system": 0.00251, "inhibit induction": 0.00251, "specific regulation": 0.00251, "peripheral lymphocytes": 0.00251, "nuclear corepressor": 0.00251, "normal comparison group": 0.00251, "il-8 release increased": 0.00251, "immune system regulatory": 0.00251, "functional differences observed": 0.00251, "epstein-barr virus-immortalized b-cell lines": 0.0025, "response suggests": 0.0025, "increased steroid responsiveness": 0.0025, "nuclear t3r": 0.0025, "th2 ]": 0.0025, "consensus gata-binding sites": 0.0025, "ap-1 sites require": 0.0025, "bound kinase": 0.0025, "transcriptional stimulation": 0.0025, "expresses high levels": 0.0025, "twelve in-vitro-stimulated normal cord blood": 0.0025, "nuclear p62c-fos": 0.0025, "inflammatory response": 0.0025, "populations ]": 0.0025, "reduced levels": 0.0025, "spi-1 overexpression increased": 0.0025, "apoptotic pathway": 0.0025, "apparent effect": 0.0025, "activate nf-kappa": 0.0025, "secondary virus infection": 0.0025, "defective pathway": 0.0025, "anti-cd28 ab stimulation studies": 0.0025, "il-15 induced": 0.0025, "phorbol ester-induced monocytic differentiation": 0.0025, "alpha molecule": 0.0025, "9-29 ppt i-te ]": 0.0025, "normal monocytes": 0.0025, "reports describe significant systemic effects": 0.0025, "granulocyte-macrophage pathway": 0.0025, "paf activated c-jun nh2-terminal mapk": 0.0025, "influenza virus antigen": 0.0025, "blocks tax induction": 0.0025, "amino acid polymorphism": 0.0025, "myb consensus sites": 0.0025, "nuclear p50p50": 0.0025, "b-lymphocyte differentiation control": 0.0025, "pdbu induced": 0.0025, "decreased nf kappa": 0.0025, "neutralizing anti-il-6 monoclonal antibody": 0.0025, "active signaling pathways": 0.0025, "specific interaction": 0.0025, "ifn alpha-containing regimens ]": 0.00249, "n-acetylcysteine treatment attenuated neutrophil adhesion": 0.00249, "nuclear subvolumes": 0.00249, "vitro studies demonstrated": 0.00249, "p65 mrna accumulation": 0.00249, "enhance hiv-1 long terminal repeat": 0.00249, "upstream nf-kappa": 0.00249, "progesterone-induced lymphocyte factors": 0.00249, "positive functional role": 0.00249, "il-2-r alpha promoters": 0.00249, "l227 induced": 0.00249, "transient tyrosine phosphorylation": 0.00249, "ap-1 factors participate": 0.00249, "nuclear periphery": 0.00249, "messenger pathway": 0.00249, "il-7/il-7r system glucocorticoid-induced apoptosis": 0.00249, "nuclear run-on": 0.00249, "wk induced": 0.00249, "nuclear factor-kappab/rel": 0.00249, "low levels occur": 0.00249, "nuclear factor-activated": 0.00249, "nuclear factor.kappa": 0.00249, "common multi-point scatchard analysis": 0.00249, "plasma membrane redox system exerts": 0.00249, "43-50 ] supports": 0.00249, "dox induced": 0.00249, "nf-at factors": 0.00249, "nuclear run": 0.00249, "positive response": 0.00249, "putative guanine nucleotide exchange domain": 0.00249, "proil-1 beta enhancer": 0.00249, "nuclear factor-il6": 0.00249, "efficient c-fos induction": 0.00249, "hsfe induced": 0.00249, "nuclear factor-chi": 0.00249, "nuclear factor-90": 0.00249, "functional effects": 0.00249, "chloramphenicol acetyl-transferase assay demonstrated": 0.00249, "cd3 pathway": 0.00249, "tgf-beta1 mrna synthesis": 0.00249, "pgg-glucan induced": 0.00249, "dna fragments": 0.00249, "c-erbb induced": 0.00249, "mobility shift analysis": 0.00249, "assay system": 0.00249, "er inhibits regulation": 0.00249, "lif induced": 0.00249, "nuclear dots": 0.00249, "gam induced": 0.00249, "il2r alpha promoters": 0.00249, "nuclear factor-il-6beta": 0.00249, "c-jun induction": 0.00249, "erythroid differentiation events": 0.00249, "il-2r alpha chain": 0.00249, "nuclear translocalization": 0.00249, "increased capacity": 0.00248, "alters dna conformation": 0.00248, "hiv-1 virus": 0.00248, "nuclear": 0.00248, "mediate interleukin-1 induction": 0.00248, "early differentiation stage": 0.00248, "induced": 0.00248, "cloned jak3 kinase": 0.00248, "fn-induced il-1beta response remain unclear": 0.00248, "] t3": 0.00248, "blocked hiv-1 replication": 0.00248, "cross-linking increased camp": 0.00248, "pge2-dependent activating effect": 0.00248, "consensus ckii sites": 0.00248, "identified fusion transcripts": 0.00248, "hs-40 enhancer function": 0.00248, "cd40 cytoplasmic domain": 0.00248, "epstein-barr virus infection": 0.00248, "signalling pathway": 0.00248, "regulating tyrosine phosphorylation event": 0.00248, "pma increased": 0.00248, "il-2 inhibition": 0.00248, "purified nf-kappa": 0.00248, "analysis suggests": 0.00248, "related nf-kappa": 0.00248, "flow cytometry analysis": 0.00248, "b-cell lines carrying": 0.00248, "functional motif": 0.00248, "unknown pathway": 0.00248, "differentiation control": 0.00248, "decreased gsh levels": 0.00248, "immune receptors risk rearrangements": 0.00248, "rapid tyrosine phosphorylation": 0.00248, "express differentiation markers": 0.00248, "% inhibition": 0.00248, "surface domain": 0.00248, "dmso induces granulocytic/neutrophillic differentiation": 0.00248, "liuwei dihuang pills ]": 0.00248, "tnfalpha treatment induces": 0.00248, "il-4r alpha chain": 0.00248, "acute ethanol affects nf-kappa": 0.00248, "alpha synthesis": 0.00248, "express alpha": 0.00248, "multiple cytokine production deficiency": 0.00248, "il-1 signaling pathways leading": 0.00248, "tpck inhibits phosphorylation": 0.00248, "nf-kappa b. calcineurin acts": 0.00248, "clonality analysis utilizing x-chromosome inactivation": 0.00247, "diverse pathway": 0.00247, "dna probes": 0.00247, "dna homology": 0.00247, "additional effect": 0.00247, "anti-rabbit hsp90 monoclonal antibody": 0.00247, "examined induction": 0.00247, "native il-2 enhancer": 0.00247, "develop hypotetraploid dna": 0.00247, "progesterone receptor-specific monoclonal antibody mpri": 0.00247, "stat induction patterns": 0.00247, "sucrose density gradient analysis": 0.00247, "reported long-range cis-inactivating effect": 0.00247, "common downstream signaling events": 0.00247, "consensus octamer motif": 0.00247, "normal autoregulatory sequences": 0.00247, "powerful microbicidal pathway": 0.00247, "ra response": 0.00247, "anti-stat antibodies identified": 0.00247, "inositol 1,4,5-trisphosphate/calcium pathway": 0.00247, "mapk pathway": 0.00247, "specific function": 0.00247, "okadaic acid exposure": 0.00247, "distal il-2 enhancer differs": 0.00247, "isolated cd48 nf-kappa": 0.00247, "aged long-distance runner ]": 0.00246, "increased cortisol clearance": 0.00246, "proliferative response displayed": 0.00246, "increased accumulation": 0.00246, "ap-2 mediate induction": 0.00246, "amino acid substitutions": 0.00246, "icam-1 kappa b-reporter construct": 0.00246, "il-13r alpha chain": 0.00246, "ad5 e1a dna": 0.00246, "induce significant production": 0.00246, "surfactant downregulated inflammatory cytokine production similarly": 0.00246, "tcr response": 0.00246, "ikappab-alpha mrna transcripts": 0.00246, "therapeutic effect": 0.00246, "regulates cellular growth": 0.00246, "immunomodulatory stress response": 0.00246, "endogenous il-4 mrna": 0.00246, "specific tyrosine residues": 0.00246, "consensus sites": 0.00246, "macrophage differentiation results": 0.00246, "developmental pathway": 0.00246, "phorbol 12-myristate 13-acetate stimulation augment": 0.00246, "serum response": 0.00246, "monocyte tf induction": 0.00246, "electrophoretic mobility shift assays show": 0.00246, "tat effect": 0.00245, "ap-1 regulatory elements": 0.00245, "cre pathway": 0.00245, "bacterial peptides expressed": 0.00245, "generalized dna damage": 0.00245, "hla-dra mrna synthesis": 0.00245, "stat3 tyrosine phosphorylation": 0.00245, "p38 pathway": 0.00245, "adult tissues demonstrated hb9 transcripts": 0.00245, "adenovirus dna": 0.00245, "progesterone receptor-specific monoclonal antibody": 0.00245, "kappab alpha degradation": 0.00245, "vivo anti-inflammatory effects": 0.00245, "fasl inhibits paclitaxel-induced apoptosis": 0.00245, "dna variation": 0.00245, "termed rar alpha": 0.00245, "intracellular signaling pathways": 0.00245, "il-4 regulatory elements": 0.00245, "elevated serum ige levels": 0.00245, "enhanced hiv-1 replication": 0.00245, "heterodimer dna-binding complexes": 0.00245, "enhances il-2 production": 0.00245, "activating effect": 0.00245, "lipid-mediated dna transfer": 0.00245, "minimal effect": 0.00245, "alter dna organization": 0.00245, "staining lymphocytes": 0.00245, "percent inhibition +/- sem": 0.00245, "jun n-terminal kinase": 0.00245, "tax increased": 0.00245, "stat factors mammary gland factor-stat5": 0.00245, "observed interaction": 0.00245, "dna-binding sites": 0.00245, "fibrinogen activates nf-kappa": 0.00245, "mnda mrna level": 0.00245, "blocked all-trans ra-induced differentiation": 0.00245, "isolated cooh-terminal domain": 0.00245, "specific nf-kappab oligoprobe": 0.00245, "cdna encoding ptf beta": 0.00245, "nf-kappa b-like activities": 0.00245, "antioxidant inhibits agonist-induced monocyte adhesion": 0.00245, "constitutive tyrosine phosphorylation": 0.00244, "tissue-specific transcriptional control": 0.00244, "mice bearing tumor": 0.00244, "hs2 enhancer function": 0.00244, "ra-mediated type ii tgase up-regulation": 0.00244, "french-american-british acute myeloid leukemia-m3 [": 0.00244, "consistent effect": 0.00244, "differential hybridization analysis": 0.00244, "inhibited anti-cd3-induced interleukin-2 secretion": 0.00244, "nh2 regulatory domain": 0.00244, "characteristic dna-binding domain": 0.00244, "mediating murine thymocyte apoptosis": 0.00244, "presumed regulatory domain": 0.00244, "cis elements demonstrated": 0.00244, "intracellular calcium increase": 0.00244, "dna rearrangements": 0.00244, "-dependent signal-transduction pathway": 0.00244, "mrna indicating": 0.00244, "amino acid alterations": 0.00244, "adult lymphocytes": 0.00244, "cd2 pathway": 0.00244, "dna prepared": 0.00244, "tnf mrna accumulation": 0.00244, "il-10 effect": 0.00244, "jnk pathway": 0.00244, "detectable effect": 0.00244, "affinity sites": 0.00244, "dna recombination": 0.00244, "stress response": 0.00244, "c-fos mrna correlated": 0.00244, "vertebrate t-cell-specific transcriptional regulation": 0.00244, "ifn-gamma increased": 0.00244, "kappa light chain locus": 0.00244, "negative regulatory elements": 0.00244, "concentration specific manner": 0.00244, "maximal response identical": 0.00243, "comments ] hla-dr-": 0.00243, "-dependent pathway": 0.00243, "bind all-trans-retinoic acid": 0.00243, "tyrosine phosphorylation stat1": 0.00243, "distinct multi-protein complexes": 0.00243, "amino acid change": 0.00243, "irradiated pml/raralpha mice enhanced granulocyte recovery": 0.00243, "comments ] helenalin": 0.00243, "dna transfer": 0.00243, "comments ] bob.1/obf.1": 0.00243, "high levels": 0.00243, "viral rna production": 0.00243, "jak/stat pathway": 0.00243, "kappa b-related sequences": 0.00243, "pld pathway": 0.00243, "lfa-i alpha chain": 0.00243, "ii kappa b-2": 0.00243, "monoclonal antibody ki-67": 0.00243, "pathway participates": 0.00243, "nfat complexes present": 0.00243, "serum immunoglobulin levels": 0.00243, "ifn-gamma inhibited up-regulation": 0.00243, "constitutively expressed cepsilon germline transcripts": 0.00243, "tcralpha enhancer function": 0.00243, "nf-kappab essential modulator enhanced": 0.00243, "cd40 signaling activates downstream effectors": 0.00243, "electrophoretic mobility shift assays demonstrated": 0.00243, "activates nf-kappa": 0.00243, "il-10 inhibited translocation": 0.00243, "thyroid hormones inhibit [": 0.00243, "interferons induce normal": 0.00243, "tnf-alpha increased": 0.00243, "biological effect": 0.00243, "attenuated il-1 beta transcript degradation": 0.00243, "type ii mhc cid": 0.00243, "transient response": 0.00243, ":2430 ] oca-b": 0.00243, "increased organ infiltration": 0.00243, "decreased levels": 0.00243, "glucocorticoids induce apoptosis": 0.00243, "lymphocytes bound": 0.00243, "cd40/cd40 ligand interactions play": 0.00243, "smad7 exhibit differential inhibitory effects": 0.00243, "rapid mutational analysis": 0.00243, "mtetra induces il-1 beta": 0.00242, "genomic response": 0.00242, "ahr mrna level": 0.00242, "control phosphorylation": 0.00242, "mediate induction": 0.00242, "nf-kappab factor-binding elements": 0.00242, "direct analysis": 0.00242, "eosinophils ]": 0.00242, "anti-cd28 monoclonal antibody": 0.00242, "lymphocyte development suggest": 0.00242, "inducing il-2 production": 0.00242, "differential effect": 0.00242, "inhibit nf-kappa": 0.00242, "dominant effect": 0.00242, "heat shock factors": 0.00242, "repress functional il-12 signaling": 0.00242, "i. estrogens ]": 0.00242, "induce hiv-1 replication": 0.00242, "camp-dependent second-messenger pathway": 0.00242, "heme biosynthetic pathway": 0.00242, ":26721 ] identification": 0.00242, "ige immune complexes": 0.00242, "endogenous ikappab kinase": 0.00242, "induces eosinophilic differentiation": 0.00242, "ii kappa b-1": 0.00242, "constitutive viral enhancer": 0.00242, "src homology domain 2-mediated association": 0.00242, "tcf-1 alpha cdna": 0.00242, "granule exocytosis pathway": 0.00242, "peripheral lymphocyte receptors": 0.00242, "terminal b-cell differentiation": 0.00242, "tnf-alpha mrna accumulation": 0.00242, "regulatory domain": 0.00242, "examined alpha a1": 0.00242, "er levels play": 0.00242, "stat1 increased": 0.00242, "cbf alpha subunit": 0.00242, "mrna encoding": 0.00242, "mhc class ii-restricted antigen processing": 0.00242, "lymphocytes treated": 0.00242, "gata zinc finger domain": 0.00242, "proximal signaling events dependent": 0.00242, "vivo differentiation therapy": 0.00242, "cellular differentiation": 0.00242, "enhancer function": 0.00242, "activated stat1 correlated": 0.00241, "csa-resistant cd28-signaling pathway": 0.00241, "5-lox-independent pathway": 0.00241, "inflammation response": 0.00241, "-2-methylpiperazine ]": 0.00241, "activate nf kappa": 0.00241, "purified nf-gm2 activated": 0.00241, "tgf-beta inhibits ig chain synthesis": 0.00241, "signal-transducing pathway": 0.00241, "c/ebp epsilon mrna accumulation": 0.00241, "increased wet-to-dry ratio": 0.00241, "pi3k inhibits phosphorylation": 0.00241, "p105/p50 mrna synthesis": 0.00241, "growth stimulation": 0.00241, "domain similar": 0.00241, "tax response": 0.00241, "negative regulatory role": 0.00241, "dna similarly": 0.00241, "ligand-specific alpha chain": 0.00241, "mrna level": 0.00241, "share functional kappa": 0.00241, "normal bone marrow myeloid": 0.00241, "mlv transcriptional regulation": 0.00241, "pertussis toxin-insensitive pathway": 0.00241, "cellular treatment": 0.00241, "ligand-activated c-erba/tr induces differentiation": 0.00241, "nf-kappab/rel family members tested": 0.00241, "inducing tyrosine phosphorylation": 0.00241, "hexon primers amplified dna": 0.00241, "increase >": 0.00241, "inhibits tcr-mediated apoptosis": 0.00241, "transient-cotransfection assay demonstrated": 0.00241, "ccaat motif present": 0.00241, "putative functional role": 0.00241, "induces serine/threonine phosphorylation": 0.00241, "tcr signaling pathways": 0.00241, "major side effects": 0.0024, "distinct nucleoprotein complexes": 0.0024, "direct t-cell control": 0.0024, "express cdc2 mrna": 0.0024, "major signaling events": 0.0024, "constitutively activated stat3": 0.0024, "western blot analysis shows": 0.0024, "normal blood donor": 0.0024, "express hgata-3-specific mrna": 0.0024, "htlv-i transcriptional activator tax": 0.0024, "tyrosine phosphorylation resulting": 0.0024, "ras signaling pathways": 0.0024, "ap-1 sites": 0.0024, "express mafk mrna": 0.0024, "fk506-sensitive pathway": 0.0024, "similar increase": 0.0024, "nf-kappab-dependent pathway": 0.0024, "] overproduction": 0.0024, "intracellular glutathione disulfide levels": 0.0024, "tax-mediated dna damage": 0.0024, "virus induces": 0.0024, "antibody supershift assays": 0.0024, "single sites": 0.0024, "transduced hiv-1 long terminal repeat": 0.0024, "intracellular calcium levels": 0.0024, "ionomycin pathway": 0.0024, "cytoplasmic cat mrna": 0.0024, "factors bound": 0.0024, "oxidative stimuli trigger nf-kappa": 0.0024, "e-box motif upstream": 0.0024, "intrinsic cellular apoptosis": 0.0024, "gm-csf cytoplasmic mrna": 0.0024, "comments ] permissiveness": 0.0024, "megakaryocytic pathway": 0.0024, "response remains poorly understood": 0.0024, "interferon gamma activated": 0.0024, "maximal effect": 0.0024, "cellular transcriptional coactivator": 0.0024, "vitro effects": 0.0024, "specific protein-tre-dna interactions": 0.0024, "comments ] trapoxin": 0.0024, "alpha chain": 0.0024, "tcdd mediates atrophy induction": 0.0024, "active factors": 0.0024, "somatic dna": 0.0024, "map erk kinase kinase-1": 0.0024, "single-strand conformation polymorphism analysis": 0.0024, "chimeric surface receptors consisting": 0.00239, "proliferation reduction mechanism": 0.00239, "lps effects": 0.00239, "genistein inhibited nk cytotoxicity": 0.00239, "hypertension ]": 0.00239, "il-1ri-associated kinase similarly impaired": 0.00239, "mrna synthesis": 0.00239, "hormone delayed terminal differentiation": 0.00239, "positive induction": 0.00239, "recombinant thyroid hormone receptors": 0.00239, "tar-independent pathway": 0.00239, "aml1 runt dna-binding domain": 0.00239, "trans- dominant negative inhibitor": 0.00239, "similar cellular responses": 0.00239, "vitro culture system": 0.00239, "hyperimmunoglobulin e. analysis": 0.00239, "> dc differentiation": 0.00239, "basal factors interacting": 0.00239, "lymphocyte transcriptional activator sox-4": 0.00239, "similar cd30-mediated effects": 0.00239, "okadaic acid suggests": 0.00239, "anti-cd40 monoclonal antibody": 0.00239, "systematic dna footprinting": 0.00239, "ap-1 family members": 0.00239, "stimulate significant levels": 0.00239, "rank-mediated nf-kappab signaling": 0.00239, ":1830 ] interferon-gamma": 0.00239, "azt affected nf-kappa": 0.00239, "activation-dependent transcriptional regulation": 0.00239, "nf-kappa b-containing plasmids correlated": 0.00239, "regulatory effects": 0.00239, "genomic sequences show similarities": 0.00239, "rel-related complementary dna": 0.00239, "inhibits activation-induced apoptosis": 0.00239, "selective pkc inhibitor ro": 0.00239, "comments ]": 0.00239, "mzf-1 transcriptional regulation": 0.00239, "specific antigens bind": 0.00239, "heterologous dna-binding domain": 0.00239, "distinct complexes": 0.00239, "epstein-barr virus immediate-early transcripts": 0.00239, "dna strand competition": 0.00239, "determine t-cell function": 0.00238, "mediating interleukin-4-induced tyrosine phosphorylation": 0.00238, "dna damage": 0.00238, "enhanced ikappabalpha phosphorylation": 0.00238, "polymerase chain reaction assay": 0.00238, "proliferative effect": 0.00238, "upstream signaling molecules": 0.00238, "signaling events related": 0.00238, "] calcitriol": 0.00238, "consensus nf-kappa": 0.00238, "syndrome related antigen la": 0.00238, "phorbol ester treatment": 0.00238, "dominant negative inhibitor": 0.00238, "cytokine mrna": 0.00238, "moloney murine sarcoma virus": 0.00238, "dna recovered": 0.00238, "effects similar": 0.00238, "yeast two-hybrid interaction system": 0.00238, "increased sensitivity": 0.00238, "zii domain upstream": 0.00238, "il-13 induces phosphorylation": 0.00238, "immunosuppressive effect": 0.00238, "fmol t3/100 micrograms dna": 0.00238, "prog increased survival": 0.00238, "kinase isoform erk2": 0.00238, "measured ifn alpha": 0.00238, "major increase": 0.00238, "il-1 beta promoter/enhancer sequences": 0.00238, "inflammatory sites": 0.00238, "cd28-specific pathway": 0.00238, "similar effects": 0.00238, "signaling pathways operating downstream": 0.00238, "specific zinc-mediated immune modulation": 0.00238, "] testosterone": 0.00238, "messenger rna levels": 0.00238, "anti cd20 monoclonal antibody": 0.00238, ":399 ] rfx-b": 0.00238, "simplified 'representational difference analysis": 0.00238, "significant 2-4 fold increase": 0.00238, "conserved c-terminal domain shared": 0.00238, "partial dna-binding domain": 0.00238, "p65 restores intracellular inhibition": 0.00238, "essential regulatory elements": 0.00238, "nf-kappab signaling": 0.00238, "normal murine": 0.00237, "gal4-substituted hiv-1 enhancer": 0.00237, "interleukin-6 kappa b-related motifs": 0.00237, "] dex": 0.00237, "ros pathway": 0.00237, "dexamethasone inhibited il-2-induced": 0.00237, "pkc-independent pathway": 0.00237, "pi3-kinase pathway": 0.00237, "increased survival": 0.00237, "kappa b/mad-3 binds": 0.00237, "suggesting platelet production": 0.00237, "pmlrar alpha cdna": 0.00237, "transcriptional mechanism": 0.00237, "megakaryocytes blocked differentiation": 0.00237, "ras function required": 0.00237, "activated kinases": 0.00237, "characterized factors": 0.00237, "antibody ablation/supershift assays": 0.00237, "effect p70": 0.00237, "plasma tpo levels": 0.00237, "] cd45ra": 0.00237, "] thymidine": 0.00237, "heterologous cytoplasmic domain": 0.00237, "nf-kappab/rel pathway": 0.00237, "dna content": 0.00237, "vitro tcr stimulation": 0.00237, "dna change": 0.00237, "creb/atf pathway": 0.00237, "anti-cd2 pathway": 0.00237, "cd40 signaling pathways exerts": 0.00237, "apoptotic effect": 0.00237, "e2f sites failed": 0.00237, "estrogen receptors influence non-genomic events": 0.00237, "inhibited tat-mediated transactivation": 0.00237, "rat lymphocytes": 0.00237, "cytokine effects": 0.00237, "rxr-rxr pathway": 0.00237, "suggesting gamma-ifn inhibition": 0.00237, "mycobacterial infection [": 0.00236, "cd40/cd40l pathway": 0.00236, "erk-2 pathway": 0.00236, "c-jun rna observed": 0.00236, "jak-stat1 pathway": 0.00236, "] isolation": 0.00236, "cd-40 pathway": 0.00236, "raf1/mek1/erk1/2 pathway": 0.00236, "p56lck-independent pathway": 0.00236, "calcineurin/nfat pathway": 0.00236, "a6h monoclonal antibody": 0.00236, "similar levels": 0.00236, "serum induction": 0.00236, "cellular elements": 0.00236, "epithelial specific manner": 0.00236, "cd43/leukosialin-mediated pathway": 0.00236, "monocytic/macrophage pathway": 0.00236, "mek/erk pathway": 0.00236, "agonistic monoclonal antibody": 0.00236, "achievable concentrations [": 0.00236, "octamer factors oct-1": 0.00236, "genetic response": 0.00236, "vla-4/vcam-1 pathway": 0.00236, "protein-coupled pathway": 0.00236, "p53-independent pathway": 0.00236, "plasma sialyltransferase levels": 0.00236, "negative factors": 0.00236, "family members play": 0.00236, "mutant virus": 0.00236, "lps treatment enhances": 0.00236, "antigen-processing pathway": 0.00236, ":2351 ] elf-1": 0.00236, "oncogenic effect": 0.00236, "cdc2 mrna transcripts": 0.00236, "sek/jnk/c-jun/ap-1 pathway": 0.00236, "combined inhibitory effects": 0.00236, "nf-kappa b1/rela heterodimer": 0.00236, "inositol-1,4,5-trisphosphate/calcium pathway": 0.00236, "monocyte/macrophage leukemia lines": 0.00236, "control mice": 0.00236, "ca2+- signaling pathways downstream": 0.00236, "ubiquitin-proteasome pathway": 0.00236, "jak-stat pathway": 0.00236, "irf-1-dependent pathway": 0.00236, "c-fos induction": 0.00236, "levels similar": 0.00236, "ras/raf/erk pathway": 0.00236, "kappab sites deleted": 0.00236, "bcd mrna transcripts": 0.00236, "cell-dependent pathway": 0.00236, "granulocyte dna": 0.00236, "theoretical pathway": 0.00236, "granulopoietic pathway": 0.00236, "camp/pka pathway": 0.00236, "effect distinguishes th1": 0.00236, "h7-inhibitable pathway": 0.00236, "induces differentiation": 0.00236, "ca2+/calcineurin pathway": 0.00236, "vitro mutagenesis experiments demonstrated": 0.00236, "hiv-1 enhancer": 0.00236, "hlf ancillary dna-binding domain": 0.00236, "fas stimulation results": 0.00236, "dominant-negative effect": 0.00236, "endocytic pathway": 0.00236, "jak2/stat5 pathway": 0.00236, "il-7-signaling pathway": 0.00236, "diminished proliferative response": 0.00236, "significance ]": 0.00236, "-kappab pathway": 0.00236, "exerts direct physiological effects": 0.00235, "proliferation assay": 0.00235, "myeloid lineage-associated cytokine receptors": 0.00235, "transcriptional regulation": 0.00235, "mrna transcripts": 0.00235, "increased interleukin-2": 0.00235, "phosphorylation analyses demonstrate": 0.00235, "pathway": 0.00235, "class ii-clip complexes": 0.00235, "called cbf alpha": 0.00235, "t-cell differentiation": 0.00235, "gel retardation analysis": 0.00235, "cortisol response": 0.00235, "24-h prl induction time": 0.00235, "anti-tax1 monoclonal antibody lt-4": 0.00235, "mediating tyrosine phosphorylation": 0.00235, "low gssg levels": 0.00235, "irf-1 5'-flanking dna": 0.00235, "amino acid identity": 0.00235, "pou dna-binding motif defines": 0.00235, ":409 ] hydroxyurea": 0.00235, "individual enhancer sequences": 0.00235, "c-jun mrna inducibility": 0.00235, "weak effect": 0.00235, "c/ebp alpha regulate": 0.00235, "dna methylation": 0.00235, "increased amounts": 0.00235, "map kinase cascade": 0.00235, "affect induction": 0.00235, "active nf-kappa": 0.00235, "cytokine levels": 0.00235, "lytic effect": 0.00235, "cytoplasmic ikappab inhibitor": 0.00234, "interleukin-1 beta production": 0.00234, "phosphatase 2a-sensitive sites": 0.00234, "] methionine": 0.00234, "intracellular camp levels": 0.00234, "increased processing": 0.00234, "activated peripheral": 0.00234, "rapid pma-mediated induction": 0.00234, "transient induction": 0.00234, "multiple effects": 0.00234, "pdtc prevented nf-kappa": 0.00234, "regulate t-cell function": 0.00234, "remote il-2 enhancer": 0.00234, "specific polymerase chain reaction": 0.00234, "potential inhibition": 0.00234, "two-dimensional gel analysis": 0.00234, "downstream signaling pathways": 0.00234, "cytoplasmic domain homologous": 0.00234, "3-5-fold increased risk": 0.00234, "plasma levels": 0.00234, "t-cell stimulation defects": 0.00234, "related simian immunodeficiency virus": 0.00234, "nf-kappa b-inducing agents": 0.00234, "consensus gas motif": 0.00234, "bz1 monoclonal antibody": 0.00234, "common octamer motif": 0.00234, "bcl-2 family members": 0.00234, "] vd3": 0.00234, "stimulate il-2 production": 0.00234, "complementary dna": 0.00234, "anti-ptf beta antibodies": 0.00234, "variable proliferative response": 0.00234, "] dhea": 0.00234, "transgenic mice results": 0.00234, "antigen receptors": 0.00234, "increased il-6": 0.00234, "chronic hiv-1 infection": 0.00234, "normal tissue histiocytes": 0.00234, "nfat kinase": 0.00234, "concatameric linear dna": 0.00234, "mitogenic effect": 0.00234, "strong n-terminal trans-activation domain": 0.00233, "classical nfkappab sites": 0.00233, "cellular receptors": 0.00233, "entire dna-binding domain": 0.00233, "monoclonal anti-mbp antibody": 0.00233, "increased risk": 0.00233, "monoclonal antibody pmi-1": 0.00233, "sre dna": 0.00233, "extracellular signal-regulated kinase": 0.00233, "dna helix": 0.00233, "vitamin d3 receptors": 0.00233, "anti-cd30-specific monoclonal antibody": 0.00233, "rapid aldosterone effects": 0.00233, "normal pbl samples tested": 0.00233, "consensus motif a/t a/t": 0.00233, "il-1 receptor-associated kinase": 0.00233, "impaired uv-induced tyrosine phosphorylation": 0.00233, "monoclonal anti-hsp antibody": 0.00233, "aromatic amino acid hydroxylases": 0.00233, "constitutive factors a1": 0.00233, "kappa b-like motifs": 0.00233, "multiple levels": 0.00233, "gamma b*cam-k inhibited": 0.00233, "pma induction": 0.00233, "increased interleukin": 0.00233, "transcriptional activities mediated": 0.00233, "circular dichroism analysis reveals": 0.00233, "viral capsid antigen staining": 0.00233, "e1a oncogene induction": 0.00233, "86-amino acid fragment": 0.00233, "anti-e-selectin monoclonal antibody": 0.00233, "j393 induces apoptosis": 0.00233, "circulating immune complexes": 0.00233, "anti-hla-dr monoclonal antibody": 0.00233, "representational difference analysis": 0.00233, "dna strand breaks": 0.00233, "specific peptide": 0.00233, "cd11b abrogated fibrinogen-induced nf-kappa": 0.00233, "antigen stimulation": 0.00233, "il-10 increased": 0.00233, "press ]": 0.00233, "cytoplasmic ikappabalpha levels": 0.00233, "specific enzymes involved": 0.00233, "monoclonal antibody alphacd3": 0.00233, "double-stranded dna": 0.00233, "anti-vcam-1 monoclonal antibody": 0.00233, "inducible nf-at complexes": 0.00233, "peak csa drug levels": 0.00233, "resultant dna demethylation": 0.00233, "rapid induction": 0.00233, "dna fragmentation factor-45": 0.00232, "suggesting direct control": 0.00232, "gynecomastia ]": 0.00232, "cd40 signaling components upstream": 0.00232, "regulate cytokine-induced proliferation demonstrated": 0.00232, "adult alpha": 0.00232, "low levels": 0.00232, "cellular stimulation": 0.00232, "p38 map kinase": 0.00232, "map kinase p38": 0.00232, "monoclonal antibody": 0.00232, "il-2 deprivation apoptosis": 0.00232, "juxtaposed sp1 sites": 0.00232, "ap1 consensus motif": 0.00232, "urinary free cortisol levels": 0.00232, "chemokine family related": 0.00232, "carboxyl-terminal cytoplasmic domain": 0.00232, "subcellular localization analysis": 0.00232, "genomic aldosterone effects": 0.00232, "acute hiv-1 infection": 0.00232, "consensus ap1 motif": 0.00232, "dna repair": 0.00232, "alpha a-gene product": 0.00232, "cytotoxic effect": 0.00232, ":399 ]": 0.00232, "enhanced b-cll differentiation": 0.00232, "proximal upstream elements": 0.00232, "factors affected": 0.00232, "internucleosomal dna fragmentation": 0.00232, "increased fos content": 0.00232, "bind specific members": 0.00232, "stat serine kinase": 0.00232, "blocked differentiation": 0.00232, "normal erythroid progenitors": 0.00232, "endogenous ig heavy chain enhancer": 0.00232, "minimal repression domain": 0.00232, "il-2 enhancer": 0.00232, "dna viruses": 0.00232, "flanking dna": 0.00232, "mkp-1 inactivates map kinase": 0.00232, "amino acid carboxy-terminus": 0.00232, "nh2-terminal transactivation domain": 0.00232, ":633 ]": 0.00232, "] -dexamethasone": 0.00232, "electrophoretic mobility shift assay suggested": 0.00232, "critical signaling molecule": 0.00232, "il-10 activated stat1": 0.00232, "dna sequencing": 0.00232, "specific proliferation": 0.00232, "] -aldosterone": 0.00231, "ikappabalpha overexpression inhibited": 0.00231, "receptors induces conformational": 0.00231, "ciprofibrate-induced phorbol ester-dependent differentiation": 0.00231, "lymphocytes infected": 0.00231, "extracellular signal-related kinase": 0.00231, "altered cytokine profile observed": 0.00231, "cases expressed cd4": 0.00231, "il-2 stimulation": 0.00231, "mechanism mycobacterium tuberculosis induces": 0.00231, "generate transgenic mice expressing": 0.00231, "hypoxia enhances induction": 0.00231, "5306-5309 ]": 0.00231, "tax induction": 0.00231, "reporter transgenic mice": 0.00231, "] ablation": 0.00231, "] progesterone-mbp-hbd": 0.00231, ":1709 ]": 0.00231, "mitogenic signalling response": 0.00231, "ebv-specific memory response": 0.00231, "] -aldosterone-derivative": 0.00231, "] aldosterone-mbp-hbd": 0.00231, ":1091 ]": 0.00231, "stat tyrosine phosphorylation": 0.00231, "p13mtcp1 normal lymphoid tissues": 0.00231, "chromosome translocations [": 0.00231, "transcriptional regulatory properties": 0.00231, "b-lymphocytes ]": 0.00231, "chimera pmlrar alpha plays": 0.00231, ":33705 ]": 0.00231, "amino acid": 0.00231, "conserved rel homology domain": 0.00231, "block erythroid differentiation": 0.00231, "mutated analysis": 0.00231, "classical genomic effects": 0.00231, "paired dna-binding domain": 0.00231, "involves cluster analysis": 0.00231, "] calcitriol/vdr": 0.00231, "t-cell specific": 0.00231, "gcs induce apoptosis": 0.00231, "il-2 deprivation-induced apoptosis": 0.00231, "] ru-1881": 0.00231, "] dihydrotestosterone": 0.00231, "sp1 sites": 0.00231, "transcriptional function": 0.00231, "5269-5275 ]": 0.00231, "src family kinases lck": 0.00231, "rna-positive ]": 0.00231, "nf-kappa b-independent suppression": 0.00231, "jnk map kinase": 0.00231, "crma blocked fas-mediated apoptosis": 0.00231, "cortisol levels correlated": 0.00231, "yang-deficiency ]": 0.00231, ":16983 ]": 0.00231, "dna fragmentation": 0.00231, "putative nf-kappab-binding sites": 0.00231, "jun oncogene family members": 0.00231, "alpha degradation": 0.00231, "commetns ]": 0.00231, "long-lasting stimulatory effect": 0.00231, "critical sites": 0.00231, "nfat family play": 0.00231, ":3632 ]": 0.00231, ":26721 ]": 0.00231, "hsv dna": 0.00231, ":2351 ]": 0.00231, ":524 ]": 0.00231, "il-2 receptors": 0.00231, "express chimeric receptors consisting": 0.00231, "guanine nucleotide exchange factors": 0.00231, "microgram/ml ]": 0.00231, "proinflammatory cytokine signaling cascade leading": 0.00231, "heterozygous mutant mice": 0.0023, "distinct cis-acting elements": 0.0023, "regulate erythroid differentiation": 0.0023, "opposite effect": 0.0023, "circular dna": 0.0023, "ad2 virus infection": 0.0023, "priming effect": 0.0023, "v-abl kinase inactivation": 0.0023, "virus binds": 0.0023, "rar alpha plays": 0.0023, "primary normal b-cells": 0.0023, "normal healthy subjects": 0.0023, "induces phosphorylation": 0.0023, "slight effect": 0.0023, "increased camp": 0.0023, "specific cis-active sequences": 0.0023, "regulating signaling pathways": 0.0023, "general initiation factors": 0.0023, "cytoplasmic domain heterogeneity": 0.0023, "major stat complexes": 0.0023, "1,25-dihydroxyvitamin d3 [ 1,25-": 0.0023, "]": 0.0023, "memory response": 0.0023, "ifn-gamma induction": 0.0023, "augments tcr-mediated il-2 production": 0.0023, "yeast activated serum": 0.0023, "deficient il-2 production": 0.0023, "results show unequivocal evidence": 0.0023, "express cd4 receptors": 0.0023, "dual effect": 0.0023, "blocking effect": 0.0023, "exert strong ap-1 inhibition": 0.0023, "additional unknown factors": 0.0023, "il-2 signaling": 0.0023, "therapeutic response": 0.0023, "gr sites": 0.0023, "g0s2 mrna increases": 0.0023, "clonality analysis methods": 0.0023, "suppress il-1 alpha": 0.00229, "constitutive induction": 0.00229, "b4-2 dna": 0.00229, "bsap recognition sequences demonstrated": 0.00229, "ebv-negative b-cell lines": 0.00229, "il-2 -and pi 3-kinase-induced pathways": 0.00229, "dna templates": 0.00229, "consensus nf kappa": 0.00229, "identified interactions": 0.00229, "inactivation analysis": 0.00229, "cni-1493 inhibits macrophage tnf synthesis": 0.00229, "cd3 zeta tyrosine phosphorylation": 0.00229, "enhanced differentiation": 0.00229, "increased labeling": 0.00229, "activated macrophages": 0.00229, "cell-type-specific differential response": 0.00229, "determine induction": 0.00229, "classical metaphase analysis": 0.00229, "silencing effect": 0.00229, "tax-dependent transcriptional control": 0.00229, "episomal dna": 0.00229, "gal4 dna-binding domain": 0.00229, "results implicate c/ebp beta": 0.00229, "effects mediated": 0.00229, "intracellular glutathione levels": 0.00229, "-negative b-cell lines": 0.00229, "increased body burdens": 0.00229, "family members stat1 p91": 0.00229, "relevant creb kinase": 0.00229, "kappa b-dependent manner": 0.00229, "increased numbers": 0.00229, "survanta suppress tnf mrna": 0.00229, "tyrosine-containing stat docking sites": 0.00229, "e3330 inhibited degradation": 0.00229, "il-4-triggered transcriptional control": 0.00229, "macrophages activated": 0.00229, "delta transcripts expressed": 0.00229, "phorbol ester stimulation": 0.00229, "proviral dna": 0.00229, "suppresses tyrosine phosphorylation": 0.00229, "immunoglobulin heavy chain enhancer": 0.00229, "release nf kappa b. cu2+": 0.00229, "ligand-binding domain matched mutations": 0.00229, "cd4+ lymphocytes": 0.00229, "measured nf-kappa": 0.00229, "large granular lymphocytes": 0.00229, "induction phase": 0.00228, "janus protein-tyrosine kinase": 0.00228, "conserved regulatory elements": 0.00228, "full proliferative response": 0.00228, "analogous effect": 0.00228, "examined signaling molecules": 0.00228, "l. pneumophila rpos increased": 0.00228, "otfs expresses wild-type levels": 0.00228, "induce eosinophil apoptosis": 0.00228, "sp1 factors": 0.00228, "transcriptional control": 0.00228, "host defence response": 0.00228, "activated phenotype": 0.00228, "critical factors": 0.00228, "vpr induces apoptosis": 0.00228, "role monocytes": 0.00228, "n-terminal domain confers calcium-signaling dependence": 0.00228, "p50 nf-kappa b1": 0.00228, "gr precursor mrna": 0.00228, "stat6 tyrosine phosphorylation": 0.00228, "tnf-alpha mrna detectable": 0.00228, "heterologous herpes thymidine kinase": 0.00228, "transactivation domain": 0.00228, "induce il-12 production": 0.00228, "significant systemic effects": 0.00228, "il-7 effect": 0.00228, "nfat homology domain": 0.00228, "proximal membrane signaling": 0.00228, "inhibition studies": 0.00228, "1,25-dihydroxyvitamin d3 [": 0.00228, "increased rate": 0.00228, "increased transendothelial migration": 0.00228, "specific signals": 0.00228, "oxidative burst response": 0.00228, "reduced paf-stimulated kappa": 0.00228, "pharmacological effect": 0.00228, "multiple cellular promoters": 0.00228, "inhibited nk cytotoxicity": 0.00228, "gel-shift analysis reveals": 0.00228, "examined adult mice": 0.00228, "subtle down-regulatory effect": 0.00228, "principal cytoplasmic inhibitor": 0.00228, "potent transcriptional activator": 0.00228, "p65 nf-kappa": 0.00227, "xist dna": 0.00227, "zinc finger domain": 0.00227, "subsequent analysis": 0.00227, "pge2-dependent up-regulating effect": 0.00227, "cd30 cytoplasmic domain": 0.00227, "detailed structural analysis": 0.00227, "5'-flanking dna": 0.00227, "identified crucial signals": 0.00227, "gamma/delta tcr inhibited pibf": 0.00227, "chemical mismatch cleavage analysis": 0.00227, "anti-cd3 mab stimulation": 0.00227, "receptors induces": 0.00227, "differentiation assays": 0.00227, "peripheral levels": 0.00227, "lymphocytes responsive": 0.00227, "tced dna": 0.00227, "n-terminal kinase": 0.00227, "tnf alpha contributes": 0.00227, "independent sites": 0.00227, "nonactivating dna-binding domain": 0.00227, "ligand stimulation": 0.00227, "affect basal ltr function": 0.00227, "antiapoptotic effect": 0.00227, "undergo tyrosine phosphorylation": 0.00227, "protective effect": 0.00227, "copy dna": 0.00227, "macrophage response": 0.00227, "dna aneuploidy": 0.00227, "contrast mrna": 0.00227, "host response": 0.00227, "transient transfection experiments show": 0.00227, "alpha cd3 ab co-immobilized": 0.00227, "mrna stabilization events": 0.00227, "dna breaks": 0.00227, "attached dna": 0.00227, "induce phenotypical differentiation": 0.00227, "vitd3 -and ra-induced monocytic differentiation": 0.00227, "dna methyltransferase": 0.00227, "viral plaque assay": 0.00227, "inhibit il-2 responses": 0.00227, "initiating il-4-induced tyrosine phosphorylation": 0.00227, "dna transfections": 0.00227, "differentiation potential": 0.00227, "dse sites abrogated": 0.00227, "retinoic acid correlates": 0.00227, "soluble factors secreted": 0.00227, "icam-1 levels correlated": 0.00227, "dna sequence-": 0.00227, "b-cell-specific response": 0.00227, "jak2 janus kinase": 0.00227, "cis elements involved": 0.00227, "factors failed": 0.00227, "growth regulation": 0.00226, "transfection analysis": 0.00226, "ankyrin repeat domain": 0.00226, "nfat family members": 0.00226, "induce il-2 secretion": 0.00226, "dexamethasone inhibited": 0.00226, "epstein-barr virus negative bl": 0.00226, "potential cis-acting elements": 0.00226, "autocrine effect": 0.00226, "scid-hu- int mice blocked": 0.00226, "dose response": 0.00226, "lysosomal enzyme acid sphingomyelinase": 0.00226, "increases levels": 0.00226, "nuclease s1 protection analysis": 0.00226, "cruciform dna": 0.00226, "cyclosporin a-sensitive induction": 0.00226, "pml/rar alpha transcript": 0.00226, "lipopolysaccharide induction": 0.00226, "block induction": 0.00226, "antiproliferative effect": 0.00226, "putative factors": 0.00226, "intrinsic survival factors": 0.00226, "analysis reveals": 0.00226, "essential nf-kappa": 0.00226, "unique c-terminal domain": 0.00226, "dna reiterations": 0.00226, "induce differentiation": 0.00226, "recent sib-pair analysis": 0.00226, "nfat sites": 0.00226, "affect nf-kappa": 0.00226, "fragmented dna": 0.00226, "c-jun mrna": 0.00226, "g1-s-associated dna": 0.00226, "prevented induction": 0.00226, "dna ploidy": 0.00226, "profound effect": 0.00226, "intervening dna": 0.00226, "nucleosomal dna": 0.00226, "abnormal glucocorticoid receptors": 0.00226, "dna reiteration": 0.00226, "myogenic factors remain unaltered": 0.00226, "chromatin-assembled dna": 0.00226, "cytokine stimulation leads": 0.00226, "expressed surface igm": 0.00226, "regulate cellular proliferation": 0.00226, "antitumor effect": 0.00226, "dna accessibility": 0.00226, "cross-over dna": 0.00226, "dna-binding domain": 0.00226, "side effect": 0.00226, "gamma mrna": 0.00226, "deleterious effect": 0.00226, "block lps-induced nf-kappa": 0.00226, "intracellular domain close": 0.00226, "il-12 induction": 0.00226, "t-cell receptors": 0.00226, "ebv-immortalized b-cell lines": 0.00226, "surfactant affected transcriptional mechanisms": 0.00226, "interferon inhibits growth": 0.00226, "phorbol ester-induced differentiation": 0.00226, "induces apoptosis": 0.00226, "antagonistic effect": 0.00226, "nucleosome-assembled dna": 0.00226, "bent dna": 0.00226, "support cellular proliferation": 0.00225, "camp response": 0.00225, "25-dihydroxyvitamin d3 [": 0.00225, "tyrosine phosphorylation status": 0.00225, "nf-kappa b1 precursor p105": 0.00225, "dna": 0.00225, "vitro granulocytic differentiation": 0.00225, "soluble tn inhibits proliferation": 0.00225, "inositol phosphate response": 0.00225, "erythroid differentiation involves": 0.00225, "decreased dephosphorylated prb-e2f complexes": 0.00225, "inhibited mcp-1 secretion": 0.00225, "regulate induction": 0.00225, "viral inhibition": 0.00225, "cytoplasmic signaling molecules": 0.00225, "alpha b1/alpha b2 ratio": 0.00225, "effector response": 0.00225, "cooperative effect": 0.00225, "tissue damage observed": 0.00225, "potential treatment": 0.00225, "beneficial effect": 0.00225, "pronounced effect": 0.00225, "proximal nf-kappa": 0.00225, "recent studies suggest": 0.00225, "genistein suppress induction": 0.00225, "oct-2 c-terminal domain": 0.00225, "menopausal type ii diabetes": 0.00225, "dnase footprinting analysis": 0.00225, "key functional role": 0.00225, "t-cell stimulation": 0.00225, "synergistic effect": 0.00225, "adverse effect": 0.00225, "plasma cell-specific repressor function": 0.00225, "fourfold increased susceptibility": 0.00225, "spliced hiv mrna": 0.00225, "repressive effect": 0.00225, "stimulatory effect": 0.00225, "deletion analysis": 0.00225, "gm-csfralpha cytoplasmic domain": 0.00225, "diminished glucocorticoid receptors": 0.00225, "long enhancer transcripts": 0.00225, "western blot analysis": 0.00224, "gp120-anti-gp120 immune complexes": 0.00224, "alpha-tcp effect": 0.00224, "inducible complexes bound": 0.00224, "jun nh2-terminal kinase": 0.00224, "enhance anti-ig induction": 0.00224, "early inhibition": 0.00224, "alterations increased": 0.00224, "microtubules mediate cellular 25-hydroxyvitamin d3 trafficking": 0.00224, "cytopathic effect": 0.00224, "transient nf-kappa": 0.00224, "t-cell signaling": 0.00224, "quantitative immunohistochemical analysis": 0.00224, "long-distance effect": 0.00224, "map kinase phosphatase-1": 0.00224, "paracrine effect": 0.00224, "increased turnover": 0.00224, "functional inhibition": 0.00224, "hiv-1 disease": 0.00224, "signaling functions similar": 0.00224, "posttranscriptional effect": 0.00224, "functional complexes": 0.00224, "cck-8 effect": 0.00224, "adult beta-globin/alpha-globin mrna": 0.00224, "b-cell lines": 0.00224, "increased 10-fold": 0.00224, "suppressive effect": 0.00224, "nf kappa b. cyclosporin": 0.00224, "anti-cd3 monoclonal antibodies": 0.00224, "single hmg motif": 0.00224, "cytoplasmic domain": 0.00224, "model effective versus ineffective cd3-mediated stimulation": 0.00224, "mechanism underlying signal transducer": 0.00224, "th2 clones nfat-containing complexes": 0.00224, "hiv-1 long terminal repeats": 0.00224, "e2 response": 0.00224, "appreciable effect": 0.00224, "recent analysis": 0.00224, "gamma motif": 0.00224, "enhancer sequences": 0.00224, "reverse transcription-pcr analysis": 0.00224, "functional kappa": 0.00224, "elements distinct": 0.00224, "hiv-1 long terminal repeat": 0.00224, "differentiation-inducing effect": 0.00224, "transrepressive effect": 0.00224, "virus infection": 0.00224, "distinct elements": 0.00224, "tpa induction": 0.00224, "squirrel monkey glucocorticoid receptors": 0.00223, "immune complexes": 0.00223, "anti-atherogenic effect": 0.00223, "pro-apoptotic effect": 0.00223, "discernible effect": 0.00223, "hypercalcemic effect": 0.00223, "pcr analysis": 0.00223, "demonstrable effect": 0.00223, "map kinase-related kinase": 0.00223, "consensus motif": 0.00223, "transcriptional transactivation functions encoded": 0.00223, "deficient response": 0.00223, "hiv-1 tat induces": 0.00223, "internal repression domain": 0.00223, "anti-oxidative effect": 0.00223, "bone-sparing effect": 0.00223, "trophic effect": 0.00223, "tnf alpha-activated nf-kappa": 0.00223, "growth-modulating effect": 0.00223, "map kinase erk-2": 0.00223, "real effect": 0.00223, "prior studies suggest": 0.00223, "positive transcriptional activator": 0.00223, "enhance gc-mediated induction": 0.00223, "h. total mrna": 0.00223, "thyromimetic effect": 0.00223, "allosteric effect": 0.00223, "involves multiple interacting elements": 0.00223, "trans-acting elements involved": 0.00223, "conserved sites": 0.00223, "drastic effect": 0.00223, "cytoplasmic proteic inhibitor": 0.00223, "zinc-specific effect": 0.00223, "western blotting analysis": 0.00223, "half-maximal effect": 0.00223, "induce pge2 production": 0.00223, "net effect": 0.00223, "undetectable basal levels": 0.00223, "inhibited lps-stimulated accumulation": 0.00223, "tcr alpha": 0.00223, "tnf alpha-induced nf-kappa": 0.00223, "tartrate-resistant acid phosphatase": 0.00223, "phospholipase c/protein kinase": 0.00223, "dual colour fish analysis": 0.00223, "mek1-interfering mutants inhibited": 0.00223, "atherosclerosis-promoting effect": 0.00223, "phosphorylation and/or degradation": 0.00223, "examined effects": 0.00223, "growth-inhibitory effect": 0.00223, "il-4 signaling molecules": 0.00223, "nf-kappab regulation": 0.00223, "alpha tcr": 0.00223, "membrane glycoprotein expressed": 0.00223, "enhancer-dependent effect": 0.00223, "detrimental effect": 0.00223, "ig heavy chain enhancer components": 0.00222, "selective pkc inhibitor gf": 0.00222, "icam-1 induction": 0.00222, "sites contribute": 0.00222, "reporter assay": 0.00222, "putative nf-kappa": 0.00222, "termed il-6 kappa": 0.00222, "map kinase": 0.00222, "active treatment period": 0.00222, "tepoxalin selectively inhibits intercellular adhesion molecule-1": 0.00222, "viral latency observed": 0.00222, "fn-induced il-1beta response": 0.00222, "pma/ionomycin inducible factors": 0.00222, "blocking nf-kappab inhibits": 0.00222, "hs-40 enhancer motifs": 0.00222, "single 68-amino-acid domain": 0.00222, "lymphocytes support": 0.00222, "tandem gata sites": 0.00222, "cytoplasmic inhibitor": 0.00222, "effect": 0.00222, "cytoplasmic mrna": 0.00222, "mrna product": 0.00222, "elements required": 0.00222, "ciprofloxacin increased": 0.00222, "proliferative response": 0.00222, "two-dimensional electrophoretic analysis": 0.00222, "enhance induction": 0.00222, "inducible factors nk-kappa": 0.00222, "il-2-induced tyrosine phosphorylation": 0.00222, "myf3 show intensive hybridization signals": 0.00222, "significant increase": 0.00222, "murine igh enhancer": 0.00222, "low cd3+cd28-induced interleukin-2 production correlates": 0.00222, "biochemical response": 0.00222, "variant octamer motif": 0.00222, "kb sites": 0.00222, "ctl response": 0.00222, "methylation interference analysis": 0.00221, "jun kinase": 0.00221, "cdna probe identified": 0.00221, "potent inhibitor": 0.00221, "apoptotic response": 0.00221, "g-csf stimulation results": 0.00221, "pombe systems support effects": 0.00221, "gata-1 mrna concomitant": 0.00221, "alpha subunit": 0.00221, "morphological studies demonstrated characteristic features": 0.00221, "cd40 induction": 0.00221, "protein-tyrosine kinase zap-70": 0.00221, "type ii diabetes": 0.00221, "nf-kb comparative analysis": 0.00221, "tissue differentiation": 0.00221, "displayed undetectable nf-kappa": 0.00221, "mouse ig heavy-chain enhancer": 0.00221, "type ii interferon": 0.00221, "present data suggest": 0.00221, "increased 3-10 fold": 0.00221, "nf-kappa b/kbf1 p50": 0.00221, "gr mrna turnover": 0.00221, "severe combined immunodeficiency disease": 0.00221, "selective pkc inhibitor gf109203x": 0.00221, "adult levels": 0.00221, "impaired glucocorticoid-mediated induction": 0.00221, "ifn response": 0.00221, "intracellular signaling molecules": 0.00221, "conserved ets domain": 0.00221, "increased recruitment": 0.00221, "increased acth": 0.00221, "abnormal response": 0.00221, "expressed early": 0.00221, "inducible factors": 0.00221, "induces abnormal growth": 0.00221, "apparent th2 differentiation defect": 0.00221, "hormone levels": 0.00221, "adult hpc undergo unilineage erythropoietic differentiation": 0.00221, "janus kinase": 0.00221, "cdna fragments expressed": 0.00221, "kappa light chain enhancers": 0.00221, "important costimulatory role": 0.00221, "reduced mitogenic stimulation": 0.00221, "restriction analysis": 0.00221, "intense tyrosine phosphorylation": 0.00221, "chronic autoimmune inflammatory disease": 0.00221, "calcineurin inhibitor cyclosporin": 0.00221, "demonstrated redox regulation": 0.00221, "tandem ap1 sites abolishes": 0.00221, "nf-kappab inhibitory molecule ikappabalpha": 0.00221, "janus kinase/stat signaling pathways": 0.00221, "distinct receptors": 0.00221, "stat signaling pathways": 0.00221, "prostaglandin e2 induction": 0.00221, "important transcriptional regulator": 0.00221, "ms-2 mediates induction": 0.00221, "distinct role": 0.00221, "ras-transformed lymphocytes displayed": 0.0022, "immune function data": 0.0022, "optimal tyrosine phosphorylation": 0.0022, "p50 nf-kappa": 0.0022, "inhibited macrophage maturation": 0.0022, "intracellular domain": 0.0022, "inflammatory cytokine production": 0.0022, "significant effects": 0.0022, "tax mutants expressed": 0.0022, "pma-induced il-2 production": 0.0022, "identical signaling pathways": 0.0022, "direct cytotoxic effects": 0.0022, "normal oestrogen target organs": 0.0022, "synthesis [": 0.0022, "wild-type levels": 0.0022, "strong induction": 0.0022, "acid phosphatase": 0.0022, "hiv mrna": 0.0022, "serum ig levels": 0.0022, "igg response": 0.0022, "il-3-mediated stat5b tyrosine phosphorylation": 0.0022, "subsequent induction": 0.0022, "intracellular gsh levels": 0.0022, "messenger response": 0.0022, "phorbol myristake acetate-a23187 stimulation": 0.0022, "vitd3 selectively inhibited": 0.0022, "downstream nf-kappa": 0.0022, "showing glutamine synthetase induction": 0.0022, "biochemical analysis": 0.0022, "time-dependent tyrosine phosphorylation": 0.0022, "suppressing tyrosine phosphorylation": 0.0022, "separate cox analysis": 0.0022, "constitutive nf-kappa": 0.0022, "chronic gut inflammation observed": 0.0022, "northern blot analysis": 0.0022, "cell-specific transacting factors": 0.00219, "undefined serine kinase": 0.00219, "infectious hiv-1 molecular clone": 0.00219, "gata/er chimeric factors": 0.00219, "normal level": 0.00219, "morphologic risk factors": 0.00219, "adjacent cis-acting regulatory elements": 0.00219, "cytoplasmic levels": 0.00219, "glucocorticoid treatment": 0.00219, "inhibits tumor progression": 0.00219, "slight transient increase": 0.00219, "major cellular component": 0.00219, "increased pulmonary leukostasis": 0.00219, "octamer sites": 0.00219, "maintains significant levels": 0.00219, "weakly nf-kappa b1 homodimers": 0.00219, "individual gata factors": 0.00219, "48-hr filarial antigen stimulated t-cells": 0.00219, "related family": 0.00219, "attenuated phase-2 response": 0.00219, "hemin induction acts": 0.00219, "lymphocytes displayed": 0.00219, "cellular mechanism": 0.00219, "-independent signaling pathways": 0.00219, "growth control": 0.00219, "documented typical junb mrna": 0.00219, "study nfat regulation": 0.00219, "activated state": 0.00219, "inhibited g-csf-stimulated myeloid": 0.00219, "phosphatidic acid accumulation": 0.00219, "critical regulatory mechanism": 0.00219, "cultured lymphocytes": 0.00219, "hiv-1 regulation": 0.00219, "enhanced apoptosis": 0.00219, "sequences identified": 0.00219, "simian epstein-barr virus oncogene lmp1": 0.00219, "c/ebp sites": 0.00219, "neutralizing anti-csf-1r monoclonal antibodies": 0.00219, "increased stability": 0.00219, "ligand-induced tyrosine phosphorylation": 0.00218, "p24 antigen production": 0.00218, "southern blot analysis": 0.00218, "nf-kappab system": 0.00218, "serine/threonine kinase raf-1": 0.00218, "bp repeated elements": 0.00218, "induces interleukin-1 beta": 0.00218, "sucrose gradient analysis": 0.00218, "increased rates": 0.00218, "id2 mrna decrease": 0.00218, "increased mcp-1": 0.00218, "mouse tumorigenicity assay": 0.00218, "ubiquitous ap1 factors": 0.00218, "dm increased": 0.00218, "hmg box family": 0.00218, "nf-kappab control highlights": 0.00218, "transient transfection assay result": 0.00218, "virus host range": 0.00218, "significant levels": 0.00218, "subsequent cytosolic nf-kappa": 0.00218, "signal apoptosis": 0.00218, "c-terminal acidic domain": 0.00218, "factors responsible": 0.00218, "distinct silencer mechanism": 0.00218, "mrna differential display": 0.00218, "potential mechanism underlying ebv-mediated": 0.00218, "electrophoretic mobility gel shift assay": 0.00218, "gel electrophoretic mobility shift assay": 0.00218, "survival factors": 0.00218, "cellular system offers": 0.00218, "mrnas encoding receptors": 0.00217, "megakaryocytic differentiation pathways": 0.00217, "activated primed cd4": 0.00217, "n-terminal coactivator domain": 0.00217, "differential induction": 0.00217, "t1/2 increased 6-8-fold": 0.00217, "lipid kinase": 0.00217, "transcriptional trans-activator required": 0.00217, "tyrosine-based signaling motifs": 0.00217, "antibody supershift experiments": 0.00217, "src kinase p56": 0.00217, "nfatc mrna accumulation": 0.00217, "blocked superoxide anion production": 0.00217, "enhancer results": 0.00217, "consistent sites": 0.00217, "quantitative analysis": 0.00217, "pml-rar alpha enhances": 0.00217, "elements involved": 0.00217, "pma inhibited": 0.00217, "jak3 kinase": 0.00217, "cellular regulation": 0.00217, "potential role": 0.00217, "glucocorticoid effector mechanism": 0.00217, "negative effects": 0.00217, "ap-1 motif": 0.00217, "il-4r alpha-associated kinase jak-1": 0.00217, "tissue specific": 0.00217, "factors act": 0.00217, "well-characterized ets family members": 0.00217, "clonal analysis": 0.00217, "tnf alpha": 0.00217, "block nf-kappa": 0.00217, "epstein-barr virus mutants conditional": 0.00217, "linker scanning analysis": 0.00217, "t-cell immortalization mechanism": 0.00217, "activated ras": 0.00217, "early ra addition": 0.00217, "mrna isoforms": 0.00217, "ikappabalpha kinase": 0.00217, "footprinting analysis": 0.00217, "alpha failed": 0.00217, "inducing nf-kappa": 0.00217, "respective factors result": 0.00217, "modulating t-cell function": 0.00217, "cell-specific factors": 0.00217, "mnc homogenates increased": 0.00217, "serine phosphorylation responses": 0.00217, "freshly isolated normal": 0.00216, "concomitant inhibitory effects": 0.00216, "stat induction": 0.00216, "inflammatory effects": 0.00216, "okadaic acid occurs": 0.00216, "increased expressions": 0.00216, "genetic program underlying monocytic differentiation": 0.00216, "varicella-zoster virus peptides": 0.00216, "cycloheximide response": 0.00216, "receptor-mediated response": 0.00216, "tandem ap1 sites": 0.00216, "study il-5 signaling": 0.00216, "ikappabalpha levels correlated": 0.00216, "ltb4 increased": 0.00216, "dose-dependent tyrosine phosphorylation": 0.00216, "lymphocytes represent": 0.00216, "increased attention": 0.00216, "il-1-induced il-2 production": 0.00216, "western analysis": 0.00216, "activation-dependent tyrosine phosphorylation": 0.00216, "retinoic acid signalling": 0.00216, "type ii interferons": 0.00216, "regulate nf-kappa": 0.00216, "inducible nf-kappa": 0.00216, "vitro cortisol-induced inhibition": 0.00216, "mitogen-activated kinase": 0.00216, "cellular defense system": 0.00216, "hiv-1 production": 0.00216, "induce apoptosis": 0.00216, "syk/zap-70-family kinases [": 0.00216, "temporal analysis": 0.00216, "elderly individuals activated": 0.00216, "impaired induction": 0.00216, "dual enzyme inhibitor": 0.00216, "potential transcriptional regulators": 0.00216, "morning glucocorticoid receptors": 0.00216, "dominant interfering deltadna-binding domain rxr": 0.00216, "increase monokine secretion": 0.00216, "enhanced il-5 production": 0.00216, "electrolyte response": 0.00216, "elevated cortisol levels": 0.00216, "cbf sites": 0.00216, "regulating nf-kappa": 0.00216, "c-terminal sh2 domain": 0.00216, "functional testosterone receptors": 0.00216, "normal tonsil- derived": 0.00216, "repressed erythroid differentiation": 0.00216, "represent sites": 0.00216, "total nf-kappa": 0.00216, "pu.1 sites": 0.00216, "octamer motif acts": 0.00216, "cytotoxic response": 0.00216, "female steroid receptors play": 0.00215, "early treatment": 0.00215, "vitro inhibition": 0.00215, "alpha isoform": 0.00215, "serine/threonine kinase akt/pkb": 0.00215, "specific manner": 0.00215, "intracellular levels": 0.00215, "herpes thymidine kinase": 0.00215, "cox multivariate analysis": 0.00215, "de novo induction": 0.00215, "tyrosine-phosphorylated docking sites": 0.00215, "semiquantitative rt-pcr analysis": 0.00215, "rnase protection analysis": 0.00215, "mapk kinase": 0.00215, "gata regulatory elements": 0.00215, "single-cell rt-pcr analysis": 0.00215, "optimal response": 0.00215, "increased incidence": 0.00215, "activating factors": 0.00215, "severe acute disease": 0.00215, "ets-1 sites": 0.00215, "expressed significant amounts": 0.00215, "ikappab kinase": 0.00215, "normal development": 0.00215, "underlying signaling pathways": 0.00215, "hiv ltr observed": 0.00215, "kinase substrate": 0.00215, "type ii ifns": 0.00215, "t-cell type": 0.00215, "cellular production": 0.00215, "il-2 regulation": 0.00215, "critical threshold levels": 0.00215, "measurable il-2 production": 0.00215, "increased promotor strength": 0.00215, "spd increased": 0.00215, "nf-at family": 0.00215, "rbd increased": 0.00215, "gel supershift assays demonstrated": 0.00215, "tcr-induced il-2 production": 0.00215, "up-regulated endogenous fasl mrna": 0.00215, "th2 lymphocytes": 0.00215, "inhibitor prevented tetanus toxoid antigen-specific": 0.00215, "primary restriction elements": 0.00215, "critical regulatory interaction": 0.00215, "reduced pge2 production": 0.00215, "antisense oligomers targeting pml mrna": 0.00214, "extracellular domain consisting": 0.00214, "rheumatoid arthritis synovium express receptors": 0.00214, "maximal induction": 0.00214, "translation analysis": 0.00214, "okadaic acid augments pma-": 0.00214, "c/ebp family member": 0.00214, "interleukin-4-induced tyrosine phosphorylation": 0.00214, "tcr-induced tyrosine phosphorylation": 0.00214, "southwestern blot analysis": 0.00214, "kappab regulatory elements": 0.00214, "reduced p24 antigen release": 0.00214, "transgenic mice expressing e2a-hlf": 0.00214, "malignant lymphocytes": 0.00214, "predominant isoform constitutively expressed": 0.00214, "soluble factors": 0.00214, "physical stress-induced signaling pathways": 0.00214, "autoimmune response": 0.00214, "increased predisposition": 0.00214, "endogenous nf-kappa": 0.00214, "stat1 alpha": 0.00214, "il-4-mediated tyrosine phosphorylation": 0.00214, "activated germinal center follicular": 0.00214, "alternative polyadenylylation sites": 0.00214, "rantes increased": 0.00214, "increased sensitivities": 0.00214, "separate cis-acting regulatory elements": 0.00214, "ets family member reacts": 0.00214, "type ii il-1r": 0.00214, "p-selectin-specific monoclonal antibodies attenuated": 0.00214, "c-fos increase": 0.00214, "effector sites": 0.00214, "female family members": 0.00214, "primer extension analysis": 0.00214, "specific mhc molecules": 0.00214, "factors interact": 0.00214, "death domain": 0.00214, "positional effects relative": 0.00214, "p65 mrna": 0.00214, "5'-most ets sites": 0.00214, "mrna transcript": 0.00214, "inhibits monocyte adhesion": 0.00214, "upper range [": 0.00214, "steady-state immunoglobulin heavy-chain mrna": 0.00214, "specific functional programs": 0.00214, "src-family kinase lck": 0.00214, "risk factors": 0.00214, "constitutively activated p21ras": 0.00214, "measured effects": 0.00214, "transcriptional activator functions af-1": 0.00214, "lymphocytes resistant": 0.00214, "long-term virus exposure": 0.00214, "all-trans retinoic acid": 0.00214, "important immunomodulatory role": 0.00214, "growth inhibitory responses": 0.00214, "similar inhibition": 0.00213, "similar complexes": 0.00213, "unknown mechanisms treatment": 0.00213, "increased 2-fold": 0.00213, "phenotypic analysis": 0.00213, "serine/threonine kinase": 0.00213, "measured levels": 0.00213, "cupric ion blocks nf kappa": 0.00213, "cellular function": 0.00213, "thrombin-induced tyrosine phosphorylation": 0.00213, "major structural role": 0.00213, "stat family members": 0.00213, "tissue-specific induction": 0.00213, "anti-cd3-induced tyrosine phosphorylation": 0.00213, "peak responses observed": 0.00213, "cellular growth": 0.00213, "c-fos mrna": 0.00213, "il-12 activated stat4": 0.00213, "host factors": 0.00213, "integrin-mediated tyrosine phosphorylation": 0.00213, "modulating erythroid differentiation": 0.00213, "limiting dilution analysis": 0.00213, "thrombin response": 0.00213, "p80c-rel tyrosine phosphorylation": 0.00213, "inhibits pkc downstream events": 0.00213, "ifn-induced tyrosine phosphorylation": 0.00213, "9-cis retinoic acid": 0.00213, "2-fold increased": 0.00213, "alternative potential nf-kappab": 0.00213, "egr-1 induction": 0.00213, "bcl-2 mrna": 0.00213, "type ii tgase": 0.00213, "delayed-type hypersensitivity response": 0.00213, "antigenic response": 0.00213, "decreased il-12 production": 0.00213, "primary b-lymphocyte growth transformation": 0.00213, "tcrzeta increased": 0.00213, "activated cd4+": 0.00213, "steady state levels": 0.00213, "n-terminal acidic domain": 0.00213, "c-rel induction": 0.00213, "variant nf-kappa": 0.00213, "ifnalpha-stimulated tyrosine phosphorylation": 0.00213, "response predictors": 0.00213, "jun family members": 0.00213, "il-2 production": 0.00213, "oct-2 factors": 0.00213, "stat3 inhibited": 0.00213, "encoded factors": 0.00213, "basal levels": 0.00213, "transfection assays show": 0.00213, "activated gr": 0.00213, "vigorous tyrosine phosphorylation": 0.00213, "stimulates il-2r alpha": 0.00213, "degenerate oligonucleotide probe specific": 0.00213, "type ii ebs": 0.00213, "robust tyrosine phosphorylation": 0.00213, "rar alpha agonist": 0.00213, "selectively control il-5 synthesis": 0.00212, "transient increase": 0.00212, "tyrosine phosphorylation": 0.00212, "ectopic implantation sites": 0.00212, "inactive cytoplasmic complexes": 0.00212, "increased nuclearity": 0.00212, "northern analysis": 0.00212, "kappa light chain": 0.00212, "ets sites": 0.00212, "epstein-barr virus positive": 0.00212, "vcam-1 induction": 0.00212, "class ii-restricted antigen processing": 0.00212, "augmented biological effects": 0.00212, "cysteine protease inhibitor": 0.00212, "increased autophosphorylation": 0.00212, "urinary cortisol levels": 0.00212, "ikaros sites": 0.00212, "competition analysis": 0.00212, "tumor metastasis regulation": 0.00212, "influence il-1-mediated nf-kappa": 0.00212, "tsh-r transcript levels": 0.00212, "rar alpha rearranged band": 0.00212, "log10mbc increased": 0.00212, "alpha prevented": 0.00212, "increased tumorigenicity": 0.00212, "ikaros family members": 0.00212, "initial ebv transcriptional program": 0.00212, "type ii": 0.00212, "il-10 inhibit il-6 production": 0.00212, "form motifs capable": 0.00212, "represent membrane receptors": 0.00212, "phorbol-12-myristate-13-acetate increased": 0.00212, "fatty acid metabolites": 0.00212, "increased 3.4-fold": 0.00212, "putative gtp-binding motif": 0.00212, "activated cd4": 0.00212, "important role": 0.00212, "simultaneous analysis": 0.00212, "ets family member elf-1": 0.00212, "pkc isoenzymes alpha": 0.00212, "glucocorticoid receptors": 0.00212, "viral antigen recognition": 0.00212, "impaired transcriptional responses": 0.00212, "increased kcat": 0.00212, "specific chromosome translocations": 0.00212, "dex-mediated ikappabalpha induction": 0.00212, "differentiation pathways": 0.00212, "normal comparison subjects": 0.00212, "transgenic mice expressing pml/raralpha": 0.00212, "antioxidant thioctic acid": 0.00212, "log10kd increased": 0.00212, "ebv virus": 0.00212, "increased accessibility": 0.00212, "fas-fas ligand interaction": 0.00212, "increased pdgf": 0.00212, "-induced signaling pathways": 0.00212, "antigen peptide analogs": 0.00212, "% inhibitory concentrations": 0.00212, "increased 3.2-fold": 0.00212, "erk kinase": 0.00212, "activated platelets tether": 0.00212, "bfu-e response": 0.00212, "multimerized kappab sites": 0.00211, "normal conditions": 0.00211, "vitd3 induction": 0.00211, "fos kinase": 0.00211, "tsh response": 0.00211, "scatchard plot analysis": 0.00211, "cotransfection analysis": 0.00211, "signaling pathways contributes": 0.00211, "mrna suggested": 0.00211, "relative levels": 0.00211, "direct effects": 0.00211, "p-creb levels remain elevated": 0.00211, "clonal anergy induction": 0.00211, "er alpha": 0.00211, "common sh3-sh2-sh3 motif": 0.00211, "inhibition experiments": 0.00211, "il-1 alpha": 0.00211, "important signaling": 0.00211, "monocyte differentiation process": 0.00211, "alveolar lymphocytes": 0.00211, "cd2 signaling pathways": 0.00211, "cdna prevented apoptosis": 0.00211, "enhanced igm production": 0.00211, "calcium-ionophore activated platelets": 0.00211, "entire extracellular domain": 0.00211, "important mechanism underlying": 0.00211, "pkc alpha": 0.00211, "nfkappab induction": 0.00211, "ctla-4 engagement inhibited progression": 0.00211, "locus control regions": 0.00211, "digital image analysis": 0.00211, "hla-do blocked dm function": 0.00211, "humara analysis": 0.00211, "n-terminal sh2 domain": 0.00211, "steady-state tnf-alpha mrna": 0.00211, "transcript levels": 0.00211, "red cell-specific transcriptional activator": 0.00211, "ets family members": 0.00211, "protective response": 0.00211, "viral transcriptional transactivator": 0.00211, "pkc inhibitor h7": 0.00211, "serum levels": 0.00211, "immunoprecipitation analysis": 0.00211, "initial induction": 0.00211, "specific mab": 0.00211, "classical nf-kappa": 0.00211, "ebna2-deficient epstein-barr virus strain p3hr1": 0.00211, "nf-kappa b/rel subunits": 0.00211, "hiv-1 dse bind heterodimers": 0.00211, "increased": 0.00211, "stat factors": 0.00211, "synthetic e6 motif": 0.00211, "facilitate tumor growth": 0.00211, "rapid increase": 0.00211, "poor response": 0.0021, "purified hla-dm-do complexes": 0.0021, "transcriptional activator precursor p105": 0.0021, "tandem ap-1-binding sites": 0.0021, "nf-kb sites": 0.0021, "synthetic metalloproteinase inhibitor": 0.0021, "sertraline response": 0.0021, "southern analysis": 0.0021, "il-4 responsive elements": 0.0021, "secretion levels": 0.0021, "signaling pathways utilized": 0.0021, "clonality analysis": 0.0021, "mouse tissues demonstrated": 0.0021, "latent nf-kappa": 0.0021, "inhibited release": 0.0021, "ectopic sites": 0.0021, "rapid non-genomic effects": 0.0021, "antiproliferative response": 0.0021, "computer-assisted analysis": 0.0021, "potent cellular activator": 0.0021, "weak induction": 0.0021, "multiple complexes": 0.0021, "vitro reconstitution assay": 0.0021, "inducing monocyte differentiation": 0.0021, "severe malaria [": 0.0021, "viral enhancer": 0.0021, "apl encode factors": 0.0021, "thymidine kinase": 0.0021, "gata-1 mrna": 0.0021, "precise mechanism involved": 0.0021, "block terminal differentiation": 0.0021, "isg15 mrna accumulation": 0.0021, "infectious hiv-1 provirus carrying point mutations": 0.0021, "helper lymphocytes": 0.0021, "activated platelets": 0.0021, "apoptotic lymphocytes": 0.0021, "erythroid differentiation program": 0.0021, "transformed lymphocytes": 0.0021, "footprint analysis": 0.0021, "activated nfat": 0.0021, "gata sites": 0.0021, "inhibit hiv-1 replication": 0.0021, "la mrna due": 0.00209, "putative intracellular receptors": 0.00209, "enhanced type": 0.00209, "fibric acid derivatives": 0.00209, "antibodies blocked": 0.00209, "small increase": 0.00209, "normal hematopoietic progenitors": 0.00209, "major virus reservoir": 0.00209, "jak2 kinase": 0.00209, "constitutive basal phosphorylation": 0.00209, "prdii elements decreased": 0.00209, "kappab sites": 0.00209, "inhibit lps-induced tnf-alpha production": 0.00209, "internal sites": 0.00209, "b- lymphocytes": 0.00209, "pi-3 kinase": 0.00209, "antithyroid drug treatment alter reactivity": 0.00209, "inducible transcriptional activator": 0.00209, "putative ar-cre forms specific": 0.00209, "inhibited neutrophil influx": 0.00209, "dramatic response": 0.00209, "mrna accumulation": 0.00209, "efficient induction": 0.00209, "lps signaling cascade": 0.00209, "detect early invasive disease": 0.00209, "tolerance induction": 0.00209, "cbf alpha 2-451 twofold": 0.00209, "environmental factors": 0.00209, "pkc inhibitor staurosporine": 0.00209, "ebv disease pathogenesis": 0.00209, "s6 kinase": 0.00209, "pdbu + iono stimulation": 0.00209, "stat family member": 0.00209, "lmp1 -induced effects": 0.00209, "alpha remains": 0.00209, "previous results show": 0.00209, "compensatory response": 0.00209, "ubiquitous factors": 0.00209, "indirect response": 0.00209, "estrogenic response": 0.00209, "response acquisition": 0.00209, "downstream signaling events": 0.00209, "4.5-kilobase pair mrna": 0.00209, "scatchard analysis": 0.00209, "dna-protein kinase": 0.00209, "supershift analysis": 0.00209, "biologic response": 0.00209, "surfactant suppresses nf-kappa": 0.00209, "neonatal lymphocytes": 0.00209, "cytokine signaling abnormalities": 0.00209, "il-1-induced response": 0.00209, "repression domain": 0.00209, "rapid effects": 0.00209, "results suggest": 0.00209, "progesterone induction": 0.00209, "linkage analysis": 0.00209, "chimeric g-csf-r/il-7r alpha": 0.00209, "leucine-rich domain called ler": 0.00209, "immunoblot analysis": 0.00208, "proinflammatory cytokines il-1 beta": 0.00208, "gata-1 motif": 0.00208, "transcriptional signal": 0.00208, "fc gamma riia stimulation": 0.00208, "benzene induction": 0.00208, "adjacent sites": 0.00208, "general factors": 0.00208, "scf + epo-stimulated bfu-e colony growth": 0.00208, "gr mrna": 0.00208, "nfat-1 regulatory elements": 0.00208, "nongenomic response": 0.00208, "reiterated splicing sites": 0.00208, "inadequate response": 0.00208, "activate cellular immunity resulting": 0.00208, "hematopoietic control mechanisms": 0.00208, "underlying lymphocytes": 0.00208, "nucleoside diphosphate kinase": 0.00208, "protein-dna interaction assays": 0.00208, "immune system remain obscure": 0.00208, "anti-cd3-mediated response": 0.00208, "unaffected family members": 0.00208, "gel mobility shift assay": 0.00208, "sp family members interacted": 0.00208, "tnf mrna": 0.00208, "alpha globin": 0.00208, "maeca activated ec": 0.00208, "inhibits antigen": 0.00208, "bind kappa": 0.00208, "activated leukocytes": 0.00208, "phorbol-12-myristate-13-acetate response": 0.00208, "gr-mediated response": 0.00208, "sites participate": 0.00208, "gel shift mobility assay": 0.00208, "recent experiments suggest": 0.00208, "resting lymphocytes": 0.00208, "expressed pan transcripts": 0.00208, "tandem gata-like sites": 0.00208, "isgf3-independent response": 0.00208, "calcineurin-regulated inhibitory domain": 0.00208, "basic helix-loop-helix domain": 0.00208, "computer analysis": 0.00208, "inhibitory transcriptional activities": 0.00208, "monocyte-specific response": 0.00208, "ventilatory response": 0.00208, "alpha-hydroxyprogesterone response": 0.00208, "pou domain contribute": 0.00208, "erythroid-specific aminolaevulinic acid synthase": 0.00207, "il-7 signaling pathways": 0.00207, "constitutively activated": 0.00207, "specific protease inhibitors": 0.00207, "nf-kappa b.": 0.00207, "% -88 %": 0.00207, "agonistic anti-cd30 monoclonal antibodies": 0.00207, "n-terminal pou-specific domain": 0.00207, "functional role": 0.00207, "composite octamer motif": 0.00207, "vitro differentiation": 0.00207, "preformed nf-at complexes": 0.00207, "cord lymphocytes": 0.00207, "cellular immune functions": 0.00207, "complementation analysis": 0.00207, "statistical analysis": 0.00207, "c-myb sites": 0.00207, "stimulus-dependent nf-at complexes": 0.00207, "mutational analysis": 0.00207, "ifn-gamma mrna": 0.00207, "nfat transcriptional activities": 0.00207, "nk cell-mediated cytolysis [ ifn-mediated cytoprotection": 0.00207, "mechanism distinct": 0.00207, "serum contained antibodies": 0.00207, "single point assay": 0.00207, "alternate immune system targets": 0.00207, "morphological analysis": 0.00207, "individual sites": 0.00207, "stat3 mrna": 0.00207, "deletional analysis": 0.00207, "il-2 stimulated jak3": 0.00207, "tnf effects": 0.00207, "squirrel monkey lymphocytes": 0.00207, "vitro assay": 0.00207, "detailed analysis": 0.00207, "diminished biological effects": 0.00207, "kda nf-kappa": 0.00207, "gel-shift analysis": 0.00207, "response": 0.00207, "early stimulation": 0.00207, "u1 cellular proliferation": 0.00207, "dnasel hypersensitive sites": 0.00207, "virus derived": 0.00207, "ets family member": 0.00207, "transcriptional assays": 0.00207, "gata-1 levels": 0.00207, "a-myb n-terminal domain": 0.00207, "compounds inhibited": 0.00207, "sds-page analysis": 0.00207, "gata factors": 0.00207, "beta ii": 0.00207, "favor tumor growth": 0.00207, "cytogenetic analysis": 0.00207, "multiple alterations observed": 0.00207, "monocytic differentiation markers": 0.00207, "butyric acid-induced erythroid differentiation": 0.00206, "ostensible immune stimulation": 0.00206, "functional stimulation": 0.00206, "viral growth rate": 0.00206, "cbf alpha 2-451": 0.00206, "enzyme levels": 0.00206, "multimerized recognition motif": 0.00206, "calcineurin catalytic domain": 0.00206, "mobility-shift analysis": 0.00206, "bandshift analysis": 0.00206, "retinoic acid receptor-alpha": 0.00206, "cytofluorometry analysis": 0.00206, "super-shift analysis": 0.00206, "inhibited cox-2-mediated prostaglandin e2": 0.00206, "observed e1a reiterations provide": 0.00206, "enhance monocyte differentiation": 0.00206, "tumor growth": 0.00206, "comprehensive analysis": 0.00206, "specific peptides": 0.00206, "comparative analysis": 0.00206, "cis-acting regulatory elements": 0.00206, "tpa activated": 0.00206, "activated ec": 0.00206, "immunocytochemical analysis": 0.00206, "tnf-alpha mrna": 0.00206, "immune receptors": 0.00206, "individual cytokine receptors": 0.00206, "protect lymphocytes": 0.00206, "fos/jun-containing nf-at complexes": 0.00206, "activated phosphatidylinositol 3-kinase": 0.00206, "specific extracellular matrix processes": 0.00206, "normal range": 0.00206, "chronic hiv-1 replication": 0.00206, "consensus elements consistent": 0.00206, "immunoprecipitated kinase": 0.00206, "elevated camp levels": 0.00206, "immune system represent": 0.00206, "erk2 kinase": 0.00206, "organizational analysis": 0.00206, "activated pbmc": 0.00206, "collagenase induction": 0.00206, "t-cell growth": 0.00206, "haplotype analysis": 0.00206, "selectively inhibited": 0.00206, "pre-b lymphocytes": 0.00206, "mutated nf kappa": 0.00206, "pbmc activated": 0.00206, "cell-cycle analysis": 0.00206, "cd8+ lymphocytes": 0.00206, "facs analysis": 0.00206, "recognition nfat composite elements": 0.00206, "raf kinase": 0.00206, "structure-function analysis": 0.00206, "ndp kinase": 0.00206, "regression analysis": 0.00206, "normal adult hematopoiesis": 0.00206, "inhibitory effects vary": 0.00206, "c/ebp alpha": 0.00206, "vitro treatment": 0.00206, "examined [": 0.00206, "extracellular-regulated kinase": 0.00206, "hla-dr antigens expressed": 0.00206, "ultrastructural analysis": 0.00206, "histopathological analysis": 0.00206, "virus dutpase isolated": 0.00205, "induction requirements": 0.00205, "transcripts expressed": 0.00205, "epstein-barr virus interacts": 0.00205, "thymic lymphocytes": 0.00205, "nfat inhibitor": 0.00205, "regulate transcriptional activities": 0.00205, "defective hiv virus": 0.00205, "co-immunoprecipitation analysis": 0.00205, "transgenic mice expressing": 0.00205, "studies suggest": 0.00205, "30-fold induction": 0.00205, "factors participate": 0.00205, "zap-70-dependent signaling pathways": 0.00205, "trans-acting activator function regulating": 0.00205, "western-blot analysis": 0.00205, "tf induction": 0.00205, "cd14 induction": 0.00205, "multiple cis elements": 0.00205, "limiting-dilution analysis": 0.00205, "c-raf kinase": 0.00205, "distinct regulation": 0.00205, "selectively activated": 0.00205, "suppresses nf-kappa": 0.00205, "e-selectin induction": 0.00205, "early disease onset": 0.00205, "recent studies show": 0.00205, "nf-kappab-inducing kinase": 0.00205, "ig heavy chain enhancer": 0.00205, "pro-b lymphocytes depends": 0.00205, "src-family kinase": 0.00205, "scmv sne sites": 0.00205, "sp 1-binding sites": 0.00205, "tax transforms normal t-cells": 0.00205, "microsequence analysis": 0.00205, "pancreatic endocrine beta-cells share identical pan/e2a complexes": 0.00205, "immuno-histochemical analysis": 0.00205, "report comparable levels": 0.00205, "il-6 mrna stability": 0.00205, "growth transforming infection depends": 0.00205, "cyclin-dependent kinase": 0.00205, "fasl induction": 0.00205, "hypersensitive sites": 0.00205, "cytotoxic lymphocytes": 0.00205, "c/ebp epsilon mrna": 0.00205, "induce il-12r beta": 0.00205, "covariant analysis": 0.00205, "blocking induction": 0.00205, "c-terminal domain": 0.00205, "influences cellular proliferation": 0.00205, "anti-cd2 antibodies results": 0.00205, "simultaneous induction": 0.00205, "ras-dependent signaling pathways": 0.00205, "induce anti-dna antibodies": 0.00205, "lymphocytes differ": 0.00205, "life-table analysis": 0.00205, "mass-spectrometric analysis": 0.00205, "delayed induction": 0.00205, "optimal induction": 0.00205, "monoclonal antibodies pg-b6": 0.00205, "igh regulatory elements": 0.00205, "structure/function analysis": 0.00205, "essential genetic elements supporting": 0.00204, "cbf alpha": 0.00204, "icam-1 steady-state mrna": 0.00204, "operative kinase": 0.00204, "pre-i-thymidine kinase": 0.00204, "bcl-6 coding domain": 0.00204, "mice carrying targeted mutations": 0.00204, "strong transcriptional activator": 0.00204, "% diffuse large b-cell lymphomas": 0.00204, "analysis": 0.00204, "m-csf induction": 0.00204, "hypoxic induction": 0.00204, "accelerate erythroid differentiation": 0.00204, "anti-inflammatory effects": 0.00204, "alpha targets": 0.00204, "active hiv-1 replication": 0.00204, "intact nf-kappa": 0.00204, "staurosporine-sensitive kinase": 0.00204, "il-1alpha kappab-like sites": 0.00204, "il-1r-associated kinase": 0.00204, "steroid hormone receptors": 0.00204, "tre sites": 0.00204, "inactive nf-kappa": 0.00204, "e2f-1 blocks terminal differentiation": 0.00204, "inhibits proliferation driven": 0.00204, "il-6-induced b-cell differentiation": 0.00204, "docking sites": 0.00204, "vdr mrna": 0.00204, "cd40-mediated fra-1 induction": 0.00204, "circulating lymphocytes": 0.00204, "ras/protein kinase": 0.00204, "monoclonal anti-d antibodies": 0.00204, "dramatic coordinate induction": 0.00204, "inhibitory effects": 0.00204, "calmodulin-regulated kinase": 0.00204, "cam kinase": 0.00204, "cd27/cd70 interaction enhanced": 0.00204, "potential mechanism": 0.00204, "nfat motif": 0.00204, "tnfr-associated factors traf1": 0.00204, "lps treatment": 0.00204, "normal gamma": 0.00204, "-terminal kinase": 0.00204, "cell-specific control regions": 0.00204, "dna-bound oct-1 pou domain": 0.00204, "ras-raf-1-map kinase": 0.00204, "authentic e2f sites": 0.00204, "domain conserved": 0.00204, "called inhibitor": 0.00204, "surface receptors": 0.00204, "hiv-mediated mechanism results": 0.00203, "ifn-alpha-mediated signaling pathways": 0.00203, "active nf-kappab heterodimer": 0.00203, "immunoreactive ikappab alpha": 0.00203, "bound [": 0.00203, "integrin alpha": 0.00203, "il-2-induced factors": 0.00203, "constitutive levels": 0.00203, "normal controls": 0.00203, "chemical induction": 0.00203, "rel homology domain": 0.00203, "retinoic acid": 0.00203, "epo signaling mechanisms": 0.00203, "beta- bound complexes": 0.00203, "basic domain": 0.00203, "epstein-barr virus transformation": 0.00203, "receptors decreased": 0.00203, "nongenomic signaling pathways": 0.00203, "gamma/delta tcr-bearing lymphocytes": 0.00203, "mcp-1 induction": 0.00203, "mimic activated p21ras": 0.00203, "cloned genome [": 0.00203, "normal bone marrow": 0.00203, "enhancer regions": 0.00203, "calcineurin docking motif": 0.00203, "signaling events responsible": 0.00203, "pkc inhibitor staurosporin": 0.00203, "anti-cd4 monoclonal antibodies": 0.00203, "8.5-fold induction": 0.00203, "extracellular domain": 0.00203, "tcr-mediated induction": 0.00203, "1,25-dihydroxyvitamin d3 receptors": 0.00203, "total mrna": 0.00203, "functional rar beta": 0.00203, "kinase": 0.00203, "il-1 + il-2": 0.00203, "ap1 family members": 0.00203, "retinoid differentiation therapy": 0.00203, "growth stimulated": 0.00203, "activated neutrophils": 0.00203, "virus isolated": 0.00203, "ba-induced erythroid differentiation": 0.00203, "intact cooh-terminal domain": 0.00203, "hsp70 induction": 0.00203, "epo-induced erythroid differentiation": 0.00203, "enhanced virion production": 0.00203, "ap-1 family": 0.00203, "anti-thrombin iii inhibited": 0.00203, "tre-like camp-responsive dse sites": 0.00203, "ap3-l sites": 0.00203, "n-terminal poz domain": 0.00203, "recognized x-linked combined immunodeficiency disease": 0.00203, "cross-reactive signaling pathways": 0.00203, "enhanced p75tnf-r production": 0.00203, "synovial lymphocytes": 0.00203, "growth signals": 0.00203, "inhibited interleukin": 0.00202, "abolishes induction": 0.00202, "th2 type cytokines responding": 0.00202, "activated memory": 0.00202, "normal pregnant women": 0.00202, "zp induction": 0.00202, "grb2 family member": 0.00202, "abrogate induction": 0.00202, "-mediated induction": 0.00202, "er mrna": 0.00202, "x-y regulatory elements": 0.00202, "retroviral induction": 0.00202, "mutant form": 0.00202, "potential regulation": 0.00202, "nfatc family members": 0.00202, "motif functions": 0.00202, "il-10 inhibited": 0.00202, "endogenous ecto-5'-nt mrna": 0.00202, "secondary increase": 0.00202, "anti-cd3 activated hut-78": 0.00202, "erythropoietin-induced erythroid differentiation": 0.00202, "atrophy induction": 0.00202, "leucocytic er levels": 0.00202, "neoplastic t-lineage lymphocytes": 0.00202, "normal parent molecules": 0.00202, "progesterone-treated pregnancy lymphocytes": 0.00202, "il-13 share signaling events": 0.00202, "signaling pathways": 0.00202, "vdr levels": 0.00202, "vitro phosphorylation": 0.00202, "observed constitutive association": 0.00202, "p40 induction": 0.00202, "gel shift complexes": 0.00202, "clinical disease": 0.00202, "cis-acting sites": 0.00202, "additional signaling molecules": 0.00202, "e2f sites": 0.00202, "persistent nf-kappa": 0.00202, "p38 mapk inhibitor sb203580": 0.00202, "gabp-mediated promoter-enhancer induction": 0.00202, "sp family members": 0.00202, "precise factors": 0.00202, "unrecognized nfatp-binding sites": 0.00202, "hemin-mediated erythroid differentiation": 0.00202, "parallel induction": 0.00202, "anti-cd14 monoclonal antibodies": 0.00202, "lipopolysaccharide effects": 0.00202, "ibr sites": 0.00202, "nf-kappa b1 dimers": 0.00202, "cytokine treatment": 0.00202, "abnormal nf-kappa": 0.00202, "cytokines expressed": 0.00202, "enhanced production": 0.00202, "major treatment modality": 0.00202, "surface signaling": 0.00202, "arachidonic acid aggregation": 0.00202, "type-ii estrogen-binding sites": 0.00202, "histological prognostic factors": 0.00202, "provirus induction": 0.00202, "alpha result": 0.00202, "mhc-peptide ligand interactions": 0.00201, "peripheral-blood lymphocytes": 0.00201, "poor induction": 0.00201, "kappa b-alpha degradation": 0.00201, "cd44 induction": 0.00201, "ie-1 peptide-specific induction": 0.00201, "normal child-bearing-age women": 0.00201, "primary pathogenic role": 0.00201, "multiple signaling defects": 0.00201, "mitogen induction": 0.00201, "cell-type-specific trans-acting factors": 0.00201, "tissue type": 0.00201, "unique transcriptional activator": 0.00201, "activated p38 mapk": 0.00201, "erythroid differentiation": 0.00201, "activated t-lymphocytes": 0.00201, "immune system origin": 0.00201, "nf-y-binding sites": 0.00201, "pregnancy lymphocytes": 0.00201, "anti-cd3 activated": 0.00201, "monoclonal antibodies": 0.00201, "normal number": 0.00201, "nf-kappa b-": 0.00201, "phosphatidylinositol 3-kinase inhibitor": 0.00201, "anti-p selectin antibodies reduced": 0.00201, "quantitative assays demonstrated": 0.00201, "coordinate induction": 0.00201, "il-4-induced nuclear-activating factors": 0.00201, "pkc inhibitor": 0.00201, "pebp2 alpha a1": 0.00201, "simian immunodeficiency virus variant sivsmmpbj14": 0.00201, "bsap sites": 0.00201, "phosphorylation level": 0.00201, "lymphocyte immunoglobulin production": 0.00201, "thymus-derived lymphocytes": 0.00201, "activation-dependent induction": 0.00201, "activated calcineurin": 0.00201, "inhibits proliferation": 0.00201, "lbf4-binding sites": 0.00201, "hla-dr alpha": 0.00201, "conserved motif": 0.00201, "nfkb family members rel-a": 0.00201, "control group consisting": 0.00201, "gene-proximal regulatory elements": 0.00201, "clear induction": 0.00201, "nfatp/c-binding sites": 0.00201, "signaling events mediating": 0.00201, "cd28-mediated induction": 0.00201, "creb inhibited gal4-p65": 0.00201, "gc suppressed il-5 production": 0.00201, "heptamer sites": 0.00201, "oct-1 pou domain": 0.00201, "cytolytic lymphocytes": 0.00201, "vitro labeled receptors": 0.00201, "interferon-alpha induction": 0.00201, "b-cell differentiation": 0.00201, "n-terminal hydrophilic domain": 0.00201, "ap1 factors": 0.00201, "terminal complement complexes": 0.00201, "tg epsilon26 thymocytes expressed gata-3": 0.002, "mediates antiproliferative effects": 0.002, "mechanism involved": 0.002, "normal women": 0.002, "differentiation therapy": 0.002, "peptide antigen": 0.002, "cognate octamer motif atgcaaat": 0.002, "mrna species": 0.002, "unidentified factors": 0.002, "t-cell antigen receptor-cd3": 0.002, "hemin induction": 0.002, "gig18 induction": 0.002, "ap-2 sites": 0.002, "cd11/cd18 adhesion receptors": 0.002, "deacetylated metabolite 2-hydroxy-4-trifluoromethylbenzoic acid": 0.002, "regulatory elements": 0.002, "er levels": 0.002, "synergistic induction": 0.002, "oct sites": 0.002, "cytosolic factors": 0.002, "50-fold induction": 0.002, "pro-b lymphocytes": 0.002, "c-jun complexes": 0.002, "mub sites": 0.002, "influence cytokine production": 0.002, "elf-1 sites": 0.002, "cortisol levels": 0.002, "kb mrna": 0.002, "cd40 ligands expressed": 0.002, "lymphocyte growth transformation": 0.002, "rel oncogene family capable": 0.002, "congenital immunodeficiency disease characterized": 0.002, "blocking factors": 0.002, "preferential induction": 0.002, "specific promoters": 0.002, "n-terminal domain": 0.002, "integration sites": 0.002, "epo-induced cellular proliferation": 0.002, "proviral induction": 0.002, "hsv-2 intertypic recombinant virus": 0.002, "specific cytokine": 0.002, "important cross-talk mechanism": 0.002, "nf-kappab-mediated induction": 0.00199, "coordinated induction": 0.00199, "cellular cytotoxic assays": 0.00199, "ifn-gamma-activated factors": 0.00199, "ncl lymphocytes": 0.00199, "e2f-containing dna-binding complexes": 0.00199, "nf-kappa b2": 0.00199, "anergy induction": 0.00199, "activated stat5": 0.00199, "activated th2": 0.00199, "c-fos-positive lymphocytes": 0.00199, "17-amino acid epitope": 0.00199, "activated macrophage": 0.00199, "anti-ig induction": 0.00199, "70z/3-mediated induction": 0.00199, "nf-kappa b/rel homodimer": 0.00199, "pma-induced il-2r alpha": 0.00199, "calcineurin autoinhibitory domain": 0.00199, "trans-acting factors": 0.00199, "vivo involves phosphorylation": 0.00199, "induce production": 0.00199, "vdr/rxr dna-binding complexes": 0.00199, "effects remain unclear": 0.00199, "mtetra induction": 0.00199, "normal nonpregnant values": 0.00199, "accelerate virus replication": 0.00199, "gata-binding sites": 0.00199, "consensus kappa": 0.00199, "intracellular calcium signaling": 0.00199, "late activated": 0.00199, "sla-dq induction": 0.00199, "thyroid hormone receptors": 0.00199, "modulating nf-kappa": 0.00199, "nf- kappab/rel family members": 0.00199, "icam-1 mrna": 0.00199, "gata1 induction": 0.00199, "nf-matp35 induction": 0.00199, "factors synergize": 0.00199, "pma-induced ikb alpha phosphorylation/degradation irrespective": 0.00199, "monokine induction": 0.00199, "myb sites": 0.00199, "decreased growth rate": 0.00199, "phorbol ester-induced production": 0.00199, "p50/p65 nf-kappa": 0.00199, "assay conditions": 0.00199, "rxr facilitate monocyte differentiation": 0.00199, "activate interleukin-2 production": 0.00199, "transient chloramphenicol acetyltransferase assay": 0.00199, "mdhm-stimulated induction": 0.00199, "lps-mediated induction": 0.00199, "autoimmune disease primary biliary cirrhosis": 0.00199, "transient transfection assay": 0.00199, "th2 lymphocyte-mediated effects predominate": 0.00199, "intact paired domain": 0.00198, "mmtv induction": 0.00198, "important mechanism": 0.00198, "expected induction": 0.00198, "noncanonical octamer motif": 0.00198, "tnf-alpha-dependent induction": 0.00198, "gr-mediated induction": 0.00198, "stat-5 induction": 0.00198, "estrogen responsive elements": 0.00198, "lymphocytes ifn-beta": 0.00198, "120-amino-acid n-terminal motif": 0.00198, "nc2.10 induction": 0.00198, "nf-kappa b-related moieties differs": 0.00198, "bhlh factors": 0.00198, "pma/pha-mediated induction": 0.00198, "cd28-dependent induction": 0.00198, "-beta heterodimer expressed": 0.00198, "interaction results": 0.00198, "cellular proliferation": 0.00198, "control viral infections": 0.00198, "camp inhibited": 0.00198, "transcriptional activator capable": 0.00198, "phorbol myristate-induced production": 0.00198, "short-lived induction": 0.00198, "t-helper lymphocytes": 0.00198, "signal-mediated induction": 0.00198, "splenic lymphocytes": 0.00198, "subsequent increase": 0.00198, "inducible proximal enhancer": 0.00198, "th2 type cytokines": 0.00198, "il-4-dependent induction": 0.00198, "stat1-related factors": 0.00198, "half-maximal induction": 0.00198, "strong increase": 0.00198, "pma/ionomycin induction": 0.00198, "ovulation induction": 0.00198, "tnf-alpha-mediated induction": 0.00198, "endogenous levels": 0.00198, "-associated factors": 0.00198, "require nf-kappa": 0.00198, "constitutively expressed icam-1": 0.00198, "lowered induction": 0.00198, "rnaase protection assays demonstrated": 0.00198, "endotoxin-mediated induction": 0.00198, "caccc sites": 0.00198, "plasma membrane-proximal elements": 0.00198, "inhibited tnf-alpha-induced vcam-1": 0.00198, "12-fold induction": 0.00198, "protein-binding sites": 0.00198, "active tetrameric complexes": 0.00198, "cytoplasmic cellular extracts": 0.00198, "tnf-mediated induction": 0.00198, "influence msr levels": 0.00198, "dna-binding complexes": 0.00198, "heterodimeric p50-p65 nf-kappa": 0.00198, "adenovirus e1a inhibits ifn-induced resistance": 0.00198, "gal4 sites": 0.00198, "detectable basal phosphorylation": 0.00198, "ifna synthesis observed": 0.00198, "rel/nf-kappab-dependent induction": 0.00198, "erythropoietin-dependent induction": 0.00198, "ca2+-dependent induction": 0.00198, "taxi induction": 0.00198, "endothelium-derived vasoactive factors": 0.00198, "rank-dependent induction": 0.00198, "fn induction": 0.00198, "suppressed granulocytic differentiation": 0.00198, "il-2 induces": 0.00197, "nf-at/ap-1-binding sites": 0.00197, "primary role": 0.00197, "asymptomatic family members": 0.00197, "dbf sites": 0.00197, "inhibited lps-induced tf": 0.00197, "cdna expressed": 0.00197, "elevated junb levels": 0.00197, "bcl-2 family": 0.00197, "b-cell specific": 0.00197, "octa sites": 0.00197, "related effector mechanism": 0.00197, "secondary tcr stimulation": 0.00197, "potent transcriptional repressor icer": 0.00197, "oct factors": 0.00197, "modulating immune function": 0.00197, "lps-induced nf-kappa": 0.00197, "gabp factors": 0.00197, "relevant functional interaction": 0.00197, "spi-1 family members": 0.00197, "basal [": 0.00197, "constitutively active type": 0.00197, "ifn alpha": 0.00197, "predominant nf-kappa": 0.00197, "induction": 0.00197, "subsequent cellular responses": 0.00197, "rela-p100 cytoplasmic complexes": 0.00197, "sites suitable": 0.00197, "p105 nf-kappa": 0.00197, "kappab alpha": 0.00197, "study suggest": 0.00197, "lone c/ebp motif": 0.00197, "inhibitory domains function": 0.00197, "b-1 lymphocytes": 0.00197, "translocation [": 0.00197, "upregulated nf-kappa": 0.00197, "full th2 levels": 0.00197, "underlying regulatory mechanism": 0.00197, "dividing lymphocytes": 0.00197, "y319 sites": 0.00197, "cd2 antigen results": 0.00197, "pathogenic factors": 0.00197, "nf-kappab-binding sites": 0.00197, "lps receptors": 0.00197, "vitro stimulation": 0.00197, "additional major protein-dna interactions": 0.00197, "tar-deleted mutant hiv-1": 0.00197, "scl mrna documented": 0.00197, "gre sites": 0.00197, "signaling molecule": 0.00197, "octamer motif": 0.00197, "regions show homology": 0.00197, "messenger ribonucleic acid": 0.00197, "il-6 mrna": 0.00197, "vivo hiv-1 replication": 0.00197, "regulatory role": 0.00197, "bound th2-specific complexes": 0.00197, "estrogens exert effects": 0.00197, "lymphocytes synthesize": 0.00197, "nfatp-binding sites": 0.00197, "reduced growth rates": 0.00197, "trans-activating factors": 0.00197, "therapeutic effects": 0.00196, "ikappab alpha": 0.00196, "il-6-type cytokine receptors": 0.00196, "strategic sites": 0.00196, "50-kda nf-kappa": 0.00196, "alpha cd3": 0.00196, "nonconsensus sites": 0.00196, "suppressing nf-kappa": 0.00196, "il-7r alpha chains": 0.00196, "phytohemagglutinin-stimulated lymphocytes": 0.00196, "alternative la mrna": 0.00196, "zebra-binding sites": 0.00196, "lps signaling": 0.00196, "circulating adrenal androgen levels": 0.00196, "pos sites": 0.00196, "polyadenylation sites": 0.00196, "nf-kappa b1": 0.00196, "differentiation markers restricted": 0.00196, "nfil-2a sites": 0.00196, "helper-induced lymphocytes": 0.00196, "il-10-inhibited lymphocytes": 0.00196, "e1a activated": 0.00196, "lps stimulation": 0.00196, "antigen receptor-induced signals": 0.00196, "suppressed lps-stimulated tnf production 5-fold": 0.00196, "e2f-binding sites": 0.00196, "sp1-binding sites": 0.00196, "distal nf-kappa": 0.00196, "rxr alpha": 0.00196, "express receptors": 0.00196, "kappab3 sites": 0.00196, "chemotactic factors": 0.00196, "lower-affinity sites": 0.00196, "minimal effects": 0.00196, "multicomponent cytokine receptors": 0.00196, "promote monocyte differentiation": 0.00196, "tissue-specific transcriptional activator": 0.00196, "heterodimeric nf-kappa": 0.00196, "tumor-infiltrating lymphocytes": 0.00196, "atf/creb family members": 0.00196, "extrauterine sites": 0.00196, "bsap-binding sites": 0.00196, "predominant isoforms expressed": 0.00196, "nearby sites": 0.00196, "pu.1/elf-1 sites": 0.00196, "identified serine/threonine kinases": 0.00196, "nf-kappab/rel family members": 0.00196, "nonpregnancy lymphocytes": 0.00196, "similarly inhibited": 0.00196, "receptor-positive lymphocytes": 0.00196, "regulate transcriptional events": 0.00196, "c/ebp motif": 0.00196, "normal subjects": 0.00196, "pha-activated lymphocytes": 0.00196, "ets-binding sites": 0.00196, "rel-related factors": 0.00196, "traf-binding sites": 0.00196, "activated t-cells": 0.00196, "il-4 signaling occurs": 0.00196, "perforin-expressing lymphocytes": 0.00196, "suggesting autoregulatory control": 0.00196, "extrapituitary sites": 0.00196, "similar role": 0.00196, "epo-binding sites": 0.00196, "virus replication": 0.00196, "gata-associated sites": 0.00196, "calcineurin inhibitor": 0.00196, "aiolos-binding sites": 0.00196, "sites": 0.00195, "relevant nf-kappa": 0.00195, "factors cooperate": 0.00195, "fas mrna": 0.00195, "normal developmental patterns": 0.00195, "fosb mrnas increase": 0.00195, "lymphocytes": 0.00195, "mrna occurs": 0.00195, "complexes and/or interferes": 0.00195, "regulate lymphocyte growth": 0.00195, "virus exposure": 0.00195, "stat6 activated": 0.00195, "electrophoretic mobility shift assay": 0.00195, "peroxisomal enzyme 17beta-hydroxysteroid dehydrogenase type iv": 0.00195, "c-rel inhibition involves competition": 0.00195, "commonly observed transcript abnormalities": 0.00195, "induce nf-kappab": 0.00195, "cytosolic nf-kappa": 0.00195, "enhancer present": 0.00195, "e-protein family members": 0.00195, "cytosolic inhibitor ikappabalpha": 0.00195, "murine system": 0.00195, "b. domain": 0.00195, "creb/atf-1/crem family members": 0.00195, "potent inhibition": 0.00195, "healthy virus carriers maintain": 0.00195, "il-10 effects": 0.00195, "social factors": 0.00195, "lymphocyte differentiation": 0.00195, "pu.1 mrna": 0.00195, "stable levels": 0.00195, "amino acids function": 0.00195, "tcr delta enhancer": 0.00195, "/rel family members": 0.00195, "okadaic acid": 0.00195, "alpha b2": 0.00195, "cytokine receptors": 0.00195, "messenger rna production coding": 0.00195, "sustained nf-kappa": 0.00195, "il-4-induced cd23 mrna": 0.00195, "pma demonstrated considerable increases": 0.00195, "normal pattern": 0.00195, "transient cat assay": 0.00195, "pertussis toxin inhibited": 0.00195, "heterodimer complexes": 0.00195, "cocl2-induced cellular signals": 0.00195, "aldosterone levels": 0.00195, "patterns observed correlated": 0.00195, "actin mrna": 0.00194, "upstream elements": 0.00194, "family members": 0.00194, "atf/creb factors": 0.00194, "rar alpha": 0.00194, "reduced cellular content": 0.00194, "[ hormonal metabolic status": 0.00194, "selective increase": 0.00194, "pebp2/cbf factors": 0.00194, "ap-1-like factors": 0.00194, "csa-sensitive component limiting signaling": 0.00194, "cellular mutant": 0.00194, "maintain nf-kappa": 0.00194, "stat6 signaling molecules": 0.00194, "stimulation experiments": 0.00194, "vitd3 inhibited": 0.00194, "potent differentiation inducers": 0.00194, "n-oct factors": 0.00194, "hiv kappa": 0.00194, "alpha thf/thf ratios": 0.00194, "nf-kappab/rel factors": 0.00194, "important cellular mediator": 0.00194, "pkc mutants suggest": 0.00194, "domain capable": 0.00194, "activate camp production": 0.00194, "hiv inhibition": 0.00194, "effector domain": 0.00194, "ets-like factors": 0.00194, "cytokine signaling": 0.00194, "biological effects": 0.00194, "nac inhibited interleukin-1": 0.00194, "identified calcineurin mutations": 0.00194, "cytokine stimulation": 0.00194, "nm [": 0.00194, "il-6 levels": 0.00194, "alpha-/- mice exhibit severe runting": 0.00194, "significant inhibition": 0.00194, "major apoptotic mechanism": 0.00194, "lef/tcf factors": 0.00194, "anti-igm-induced b-cell apoptosis": 0.00194, "myristoyl fatty acid": 0.00194, "wild type peptides": 0.00194, "fk506 inhibited": 0.00194, "mediate cd4 accessory function": 0.00194, "affect hiv-1 replication": 0.00194, "cocl2 -or hypoxia-induced increase": 0.00194, "otf factors": 0.00194, "prevent terminal differentiation": 0.00194, "tnfr-associated factors": 0.00194, "specific cytokines": 0.00194, "transacting factors": 0.00194, "lymphocyte treatment": 0.00194, "oct-2 mrna": 0.00194, "alpha interferon": 0.00193, "interferon alpha": 0.00193, "x1-specific factors": 0.00193, "fatty acid": 0.00193, "endotoxin [ lipopolysaccharide": 0.00193, "permanent nf-kappa": 0.00193, "transactivation assay": 0.00193, "single kappa": 0.00193, "inhibited tnfalpha": 0.00193, "detectable levels": 0.00193, "etoposide -and dexamethasone-induced apoptosis": 0.00193, "de novo increase": 0.00193, "pebp2 alpha": 0.00193, "junb mrna peak": 0.00193, "nf-at-like factors": 0.00193, "major role": 0.00193, "transduction/transcription factors": 0.00193, "e1a domain": 0.00193, "activated immature": 0.00193, "yeast transcriptional activator": 0.00193, "lps identified": 0.00193, "aldosterone-specific membrane receptors": 0.00193, "gel shift assay": 0.00193, "ap-1 complexes": 0.00193, "display normal numbers": 0.00193, "systemic hgr levels": 0.00193, "wild-type virus": 0.00193, "factors oap": 0.00193, "carboxylic acid moiety": 0.00193, "differential effects": 0.00193, "lps-mediated viral production": 0.00193, "specific target": 0.00193, "permissivity factors": 0.00193, "tg epsilon26 mice provide": 0.00193, "epstein-barr virus involves": 0.00193, "selective cyto-differentiating effects": 0.00193, "ets domain": 0.00193, "t-cell-specific transcriptional activator tcf-1": 0.00193, "alpha displays": 0.00193, "slope factors": 0.00193, "calcineurin-nuclear factors": 0.00193, "pml-rar alpha blasts": 0.00193, "maximal increase": 0.00193, "antisense gata-3 rna inhibits il-5": 0.00193, "upstream enhancer": 0.00193, "nf-kb-related factors": 0.00193, "ig alpha": 0.00192, "selective inhibitor": 0.00192, "antigen receptor-initiated signal": 0.00192, "terminal granulocyte differentiation": 0.00192, "tnf family": 0.00192, "role upstream": 0.00192, "cytoplasmic tail underwent apoptosis": 0.00192, "membrane receptors": 0.00192, "basic-helix-loop-helix motif characteristic": 0.00192, "cd40-mediated nf-kappa": 0.00192, "bind hematopoietin receptors": 0.00192, "signaling mechanisms": 0.00192, "initial signaling events": 0.00192, "express cd40 antigen": 0.00192, "continuous nf-kappa": 0.00192, "gm-csf mrna": 0.00192, "positive antidsdna antibody": 0.00192, "leukocytes [ e.g.": 0.00192, "epithelial levels": 0.00192, "potential cellular homologues": 0.00192, "nf-kappab motifs": 0.00192, "il-2r alpha": 0.00192, "activate effector function": 0.00192, "gp ib alpha": 0.00192, "jun proto-oncogene family": 0.00192, "interferon gamma stimulation": 0.00192, "oxldl activated p50/p65": 0.00192, "mutated cd4 receptors": 0.00192, "selective effects": 0.00192, "exerts opposite effects": 0.00192, "factors": 0.00192, "arachidonic acid liberation": 0.00192, "dna-protein complexes common": 0.00192, "bzip domain defective": 0.00192, "steroid-treated control group": 0.00192, "transcriptional responses": 0.00192, "regulating stat serine phosphorylation": 0.00192, "arachidonic acid oxygenation": 0.00192, "related receptors": 0.00192, "predicted periplasmic domain": 0.00192, "virus-induced nf-kappa": 0.00192, "tartrate-resistant acid phosphatase-positive osteoclast-like": 0.00192, "il-5 activated": 0.00192, "mediate inhibition": 0.00192, "upregulate nf-kappa": 0.00192, "e3 alpha": 0.00191, "jak3 jh4 domain": 0.00191, "elevated aldh1 mrna": 0.00191, "ip-10 mrna inducibility": 0.00191, "activated eosinophils": 0.00191, "lambda phosphatase treatment": 0.00191, "precursor levels": 0.00191, "nf-kappa b/rel": 0.00191, "normal myeloid": 0.00191, "activated cord": 0.00191, "hiv-1 viral particle": 0.00191, "inhibits murine": 0.00191, "protein-dna interactions important": 0.00191, "previous levels": 0.00191, "il-4r alpha": 0.00191, "il-2 promoter-chloramphenicol acetyltransferase constructs": 0.00191, "acetyl salicylic acid": 0.00191, "csa inhibited": 0.00191, "b-cell stimulation": 0.00191, "common structural elements": 0.00191, "decreased p24 antigen synthesized": 0.00191, "lysosomal acid lipase": 0.00191, "hnf-1 alpha dimers": 0.00191, "b-cell apoptosis": 0.00191, "control group": 0.00191, "ets proto-oncogene family": 0.00191, "entire catalytic domain": 0.00191, "gr chimeric receptors": 0.00191, "bfu-e-derived colonies increase": 0.00191, "culture system reported": 0.00191, "latent epstein-barr virus": 0.00191, "heterologous replacement domain": 0.00191, "alpha b1": 0.00191, "jak3 jh2 domain": 0.00191, "specific increases": 0.00191, "constitutive hiv production": 0.00191, "long-term effects": 0.00191, "genistein inhibited": 0.00191, "tandem enhancer repeats": 0.0019, "arachidonic acid": 0.0019, "egr-1 mrna": 0.0019, "camp levels": 0.0019, "nf kappa b2": 0.0019, "alpha granules": 0.0019, "tnf-induced nf-kappa": 0.0019, "inhibited tcr-induced fasl": 0.0019, "oxidant hypochlorous acid": 0.0019, "immune regulation": 0.0019, "up-regulated tgf-beta1 mrna": 0.0019, "hla-dq alpha": 0.0019, "labeled nf-kappa": 0.0019, "reverse effects": 0.0019, "mutational analyses identified residues": 0.0019, "controls underwent apoptosis": 0.0019, "cd28 costimulation augments il-2 secretion": 0.0019, "maternal immune system": 0.0019, "cleavage domain": 0.0019, "high titre antibodies": 0.0019, "squirrel monkey gr expressed": 0.0019, "exert beneficial effects": 0.0019, "cellular signal": 0.0019, "alpha b-encoded isomers": 0.0019, "nf-kappa b-dependent": 0.0019, "il-1-induced nf-kappa": 0.0019, "cooperative nf-kappa": 0.0019, "inhibit il-6 production": 0.0019, "palindromic nf-kappa": 0.0019, "hgr glucocorticoid-binding domain": 0.0019, "dfx treatment reduces tnf-alpha bioavailability": 0.0019, "ciita mrna": 0.0019, "enhanced il-2": 0.0019, "chimera inhibited": 0.0019, "viral production": 0.0019, "studied minimal residual disease": 0.0019, "family member": 0.0019, "aml1/mds1/evi1 blocks differentiation resulting": 0.0019, "lipopolysaccharide-induced nf-kappa": 0.0019, "multimerized nf-kappa": 0.0019, "induce il-2 message": 0.0019, "activated erk mapks": 0.00189, "stimulation conditions": 0.00189, "interleukin-1 alpha": 0.00189, "gp160-induced nf-kappa": 0.00189, "exert immunmodulatory effects": 0.00189, "immunosuppressive effects": 0.00189, "nf-kappa bp65": 0.00189, "allele mrna": 0.00189, "acidic domain": 0.00189, "nfat family": 0.00189, "proteasome inhibitor psi": 0.00189, "viral growth": 0.00189, "beta interferon promoters": 0.00189, "cloned kv channels expressed": 0.00189, "insulin mrna": 0.00189, "regulates hiv-1 replication": 0.00189, "chimeric transcriptional properties": 0.00189, "tnf- alpha": 0.00189, "sequester nf-kappa": 0.00189, "cd40-induced nf-kappa": 0.00189, "il-10 treatment prevented": 0.00189, "healthy virus carriers": 0.00189, "6-keto-pgf1 alpha": 0.00189, "proteasome inhibitor n-acetyl-leu-leu-norleucinal": 0.00189, "cd30-mediated nf-kappa": 0.00189, "tcr- mediated apoptosis": 0.00189, "b-cell-derived nf-kappa": 0.00189, "dqbeta trans heterodimeric hla-dq molecules form": 0.00189, "oxidant-induced nf-kappa": 0.00189, "acute ethanol treatment": 0.00189, "potential interactions": 0.00189, "phenylarsine oxide inhibited": 0.00189, "general inhibitor": 0.00189, "vcam-1 mrna": 0.00189, "maximal levels": 0.00189, "c-myc mrna": 0.00189, "whilst nf-kappa": 0.00189, "c/ebp beta staining": 0.00189, "tcf-1 alpha": 0.00189, "hiv-mediated nf-kappa": 0.00189, "prototypical nf-kappa": 0.00189, "results show": 0.00189, "activated stat5a": 0.00189, "general effects": 0.00189, "vivo inhibition": 0.00189, "mediate virus": 0.00189, "fc gamma rii-mediated antigen presentation": 0.00189, "specific anti-fc gamma": 0.00189, "proteasome inhibitor n-acetyl-l-leucinyl-l-leucinyl-l-norleucinal": 0.00189, "proliferative effects": 0.00189, "traf6 inhibited": 0.00189, "nf-kappa b1/p105": 0.00189, "chronic treatment": 0.00189, "functional interaction": 0.00189, "steady state kappa": 0.00189, "form definitive erythroid colonies": 0.00188, "gata motif": 0.00188, "rise activated": 0.00188, "ara-c activated smase": 0.00188, "proteasome inhibitor": 0.00188, "progressive increase": 0.00188, "ifn mrna": 0.00188, "ikappabalpha mrna": 0.00188, "glutamic acid decarboxylase": 0.00188, "antigen results": 0.00188, "p65-containing nf-kappa": 0.00188, "10-fold increase": 0.00188, "polyclonal ctl lines": 0.00188, "recombinant adeno-associated virus": 0.00188, "effects predicted": 0.00188, "stress-induced vimentin increase": 0.00188, "nf-kappa b/ap-1": 0.00188, "weakly activated": 0.00188, "activated jnk": 0.00188, "activated endothelium": 0.00188, "cd23 mrna": 0.00188, "lps-induced nf kappa": 0.00188, "p65 complexes": 0.00188, "diverse biologic effects": 0.00188, "functional 5-lox system": 0.00188, "intracytoplasmic tnfalpha levels": 0.00188, "nac inhibited": 0.00188, "nf-kappa b-dependent-genes": 0.00188, "apoptotic effects": 0.00188, "nf-kappa b1/p50": 0.00188, "ebv type": 0.00188, "transcriptional synergy mediated": 0.00188, "somatic hypermutation mechanism active": 0.00188, "hormone treatment": 0.00188, "rela.p50 nf-kappa": 0.00188, "physiological inhibitor": 0.00188, "sodium phenylacetate treatment": 0.00188, "stimulating cytokine production": 0.00188, "monocytic differentiation marker": 0.00188, "retinoic acid-induced monocytic differentiation": 0.00188, "normal aging process": 0.00188, "cooh-terminal domain feeds": 0.00188, "nef inhibited": 0.00188, "thymocytes expressed four-": 0.00188, "symmetric nf-kappa": 0.00188, "background levels": 0.00188, "identified upstream": 0.00188, "oxldl-induced nf-kappa": 0.00188, "c-fos antibody": 0.00188, "hiv-1 viral burden": 0.00188, "bipartite motif consists": 0.00188, "il-5 mrna": 0.00188, "epstein-barr virus bzlf1 transactivator": 0.00188, "complexes undergo stimulus-responsive processing": 0.00187, "lmp-1 effects": 0.00187, "base levels": 0.00187, "mcp-1 inhibited": 0.00187, "family regulate": 0.00187, "low growth fraction": 0.00187, "antiinflammatory effects": 0.00187, "autocrine regulatory mechanism": 0.00187, "pml/rar alpha": 0.00187, "ikappab-alpha inhibitor hydrolysis": 0.00187, "alpha maps": 0.00187, "elevated levels": 0.00187, "vitro system consisting": 0.00187, "transcriptional level": 0.00187, "key molecular mechanism": 0.00187, "functional receptor-effector system": 0.00187, "specific inhibitors": 0.00187, "ara-c activated jnks": 0.00187, "observed increases": 0.00187, "nf kappa b1": 0.00187, "gabp alpha": 0.00187, "tcr beta locus": 0.00187, "soluble tnf receptors": 0.00187, "large family": 0.00187, "acid sphingomyelinase": 0.00187, "plzf-rar alpha apls": 0.00187, "innate immune system": 0.00187, "nf-kappa": 0.00187, "dex inhibited": 0.00187, "positive physiological role": 0.00187, "block granulocytic differentiation": 0.00187, "demonstrate regulation": 0.00187, "pretreatment levels": 0.00187, "inducible cytoplasmic form": 0.00187, "transmembrane domain": 0.00187, "decreased ino production": 0.00187, "transcriptional co-activators cbp/p300 bind": 0.00187, "il-7r alpha": 0.00187, "ams constitutively expressed p50/p65": 0.00187, "constitutively active form": 0.00187, "basic-leucine zipper domain": 0.00186, "pml mrna": 0.00186, "specific dna-binding": 0.00186, "4-6 fold increase": 0.00186, "normal vitamin": 0.00186, "cytokine stimulating growth": 0.00186, "epstein-barr virus ebna3c represses cp": 0.00186, "tal1 mrna": 0.00186, "weak effects": 0.00186, "hil-4r alpha": 0.00186, "clones identified correspond": 0.00186, "conserved family": 0.00186, "stat-1 alpha": 0.00186, "hlf bzip domain": 0.00186, "adaptive immune system": 0.00186, "individual nfat composite elements": 0.00186, "c-myb mrna": 0.00186, "productive hiv-1 infection": 0.00186, "lytic effects": 0.00186, "analogue effects": 0.00186, "nf-kb levels": 0.00186, "mip-1 alpha": 0.00186, "kappab motif": 0.00186, "marked increase": 0.00186, "c-jun phosphorylation": 0.00186, "erythroid progenitors show mosaicism": 0.00186, "activated p21ras": 0.00186, "sensitive western blot assay": 0.00186, "aspirin inhibited": 0.00186, "tf-h5r alpha": 0.00186, "apoptosis mediated": 0.00186, "intertypic recombinant virus": 0.00186, "primary type": 0.00186, "nur77 alpha": 0.00186, "efficient inhibitor": 0.00186, "mediated signaling": 0.00186, "alpha-rb oligomers inhibited": 0.00186, "inhibited tnf-": 0.00186, "exhibits pleiotropic effects": 0.00186, "healthy control subjects": 0.00186, "separate signalling complexes prior": 0.00186, "common complexes": 0.00186, "immunodepletion studies show": 0.00186, "ikb alpha": 0.00186, "dr alpha": 0.00186, "immune function": 0.00186, "mucosal hgr levels": 0.00186, "specific staining": 0.00186, "signaling activities": 0.00186, "box elements": 0.00186, "il2r alpha": 0.00186, "lacking bcl-6 function due": 0.00186, "bcl-6 mrna": 0.00186, "active treatment": 0.00186, "mrna splicing": 0.00186, "electro mobility shift assay": 0.00186, "cooh-terminal domain": 0.00186, "levels decline": 0.00186, "2-3 fold increase": 0.00186, "leukocytes undergoing apoptosis promote": 0.00186, "subdominant lytic cycle epitopes identified": 0.00186, "2-hydroxy-4-trifluoromethylbenzoic acid": 0.00186, "sh2 domain": 0.00186, "eosinophil life-prolonging effects": 0.00186, "inflammatory liver disease": 0.00186, "nordihydroguaiaretic acid": 0.00186, "g-csf activated": 0.00185, "powerful ptpase inhibitor": 0.00185, "hil-5r alpha": 0.00185, "normal breast ducts": 0.00185, "igg levels": 0.00185, "mitogenic effects": 0.00185, "high hbf production": 0.00185, "il-10 attenuated lps-stimulated tnf-alpha production": 0.00185, "plzf-rar alpha": 0.00185, "results demonstrated": 0.00185, "dp alpha": 0.00185, "hrar alpha": 0.00185, "phenotypic differences observed": 0.00185, "rel homology family": 0.00185, "nf-il6 mrna": 0.00185, "helper subsets [": 0.00185, "thrombin activated": 0.00185, "l-selectin mrna": 0.00185, "35s-tr alpha": 0.00185, "il-6 signaling leads": 0.00185, "isgf3 alpha": 0.00185, "immune system": 0.00185, "normal silent c-myc allele": 0.00185, "activated rac-1": 0.00185, "tr alpha": 0.00185, "sustained twofold increase": 0.00185, "alpha thf/thf": 0.00185, "normal tissues": 0.00185, "cellular stress agents": 0.00185, "testosterone = dihydrotestosterone >": 0.00185, "lymphocyte stimulation": 0.00185, "brca1 mrna": 0.00185, "potent t-cell-specific enhancer": 0.00185, "hnf-1 alpha": 0.00185, "infection inhibits": 0.00185, "beta peptides": 0.00185, "phosphatase inhibition": 0.00185, "erythroid colony growth": 0.00185, "normal breast parenchyma": 0.00185, "dexamethasone treatment": 0.00185, "normal individuals": 0.00185, "pas domain": 0.00185, "physiological levels": 0.00185, "mediate differentiation": 0.00185, "direct inhibition": 0.00185, "non-consensus gas motif": 0.00185, "il-2-r alpha": 0.00185, "studies show": 0.00185, "flexible regulatory mechanism": 0.00185, "bmt inhibited": 0.00185, "phop-phoq two-component regulatory system": 0.00185, "activated src": 0.00185, "mobility shift assay": 0.00185, "pml-rar alpha": 0.00185, "related targeting mechanism": 0.00185, "trans-activation domain": 0.00185, "activated p21": 0.00185, "2-5 fold increase": 0.00185, "delta-aminolaevulinic acid": 0.00185, "inducing hiv-1 replication": 0.00185, "glutathione levels": 0.00185, "inhibited raf-1": 0.00185, "cd19 mrna": 0.00185, "nonproductive hiv-1 infection": 0.00185, "silent normal c-myc allele": 0.00185, "lymphotoxin alpha": 0.00185, "normal phagocyte functions": 0.00184, "cell-specific negative regulation": 0.00184, "ace inhibitor captopril": 0.00184, "decreased production": 0.00184, "activated lamina propria": 0.00184, "pgf2 alpha": 0.00184, "alpha cp1": 0.00184, "ts activated hsf": 0.00184, "differentiation suggests": 0.00184, "functional nf-kappab": 0.00184, "ikappab levels": 0.00184, "signaling component": 0.00184, "sie gas motif": 0.00184, "all-trans-retinoic acid": 0.00184, "il-4 treatment": 0.00184, "alpha-lipoic acid": 0.00184, "inhibitor-kappab alpha": 0.00184, "ifngamma-induced ip-10 mrna": 0.00184, "vimentin mrna": 0.00184, "il4r alpha": 0.00184, "phosphatidic acid": 0.00184, "alpha cd3/il-2": 0.00184, "normal platelets": 0.00184, "activated protein-1": 0.00184, "catalytic domain": 0.00184, "retinoid-dependent differentiation markers": 0.00184, "6-k-pgf1 alpha": 0.00184, "inhibit apoptosis": 0.00184, "butyric acid": 0.00184, "lysopc inhibited": 0.00184, "alpha g2s": 0.00184, "family contribute": 0.00184, "unrearranged kappa locus": 0.00184, "id3 mrna": 0.00184, "activated rho-family gtpases": 0.00184, "short-term systemic effects": 0.00184, "allele-specific mrna stability": 0.00184, "pmn activated": 0.00184, "fold increase": 0.00184, "ebv lytic antigen": 0.00184, "il-8 mrna": 0.00184, "de novo hiv type": 0.00184, "bk virus vector": 0.00184, "caspase inhibitor zvad-fmk": 0.00184, "tfiie alpha": 0.00184, "junb mrna": 0.00184, "tcf-2 alpha": 0.00184, "kd tax1 antigen molecules": 0.00184, "dihydrolipoic acid": 0.00184, "kit/il-4r alpha": 0.00184, "alpha b5a": 0.00184, "hgr levels": 0.00184, "cd14 mrna": 0.00183, "breast cancer control": 0.00183, "normal population": 0.00183, "time-dependent increase": 0.00183, "tcr signaling cascade": 0.00183, "cd27/cd70 interaction augments ige secretion": 0.00183, "deoxyribonucleic acid": 0.00183, "ap-1/tpa responsive elements fused": 0.00183, "35-amino acid": 0.00183, "competitive inhibitor": 0.00183, "electrophoretic mobility shift analyses demonstrated": 0.00183, "lps antibodies": 0.00183, "nordihydroquairetic acid": 0.00183, "adenylate cyclase inhibitor": 0.00183, "activated receptor-1": 0.00183, "alpha": 0.00183, "9-cis-retinoic acid": 0.00183, "mediate glucocorticoid-induced apoptosis": 0.00183, "differentiation antigens": 0.00183, "receptor-mediated effects": 0.00183, "mn sod mrna": 0.00183, "p53 levels": 0.00183, "active nfat-like elements": 0.00183, "cadmium chloride increase": 0.00183, "up-regulate mnda mrna": 0.00183, "viral p24 antigen": 0.00183, "hypochlorous acid": 0.00183, "acetylsalicylic acid": 0.00183, "oleate inhibited": 0.00183, "simian immunodeficiency virus isolates": 0.00183, "viral capsid antigen": 0.00183, "3,5-dichloro-2-hydroxy-4-methoxy-6-n-propylbenzoic acid": 0.00183, "include creb phosphorylation": 0.00183, "caspase inhibitor z-vad-fmk": 0.00183, "hyaluronic acid": 0.00183, "erythrocyte polyamines levels": 0.00183, "hiv-1 infection": 0.00183, "proteasome-dependent inhibitory kappa": 0.00183, "apoptosis resistance": 0.00183, "differentiation markers": 0.00183, "expressed bcl-2": 0.00183, "sustained increase": 0.00183, "beta fragment fused": 0.00183, "thioctic acid": 0.00183, "comprise terminal differentiation": 0.00183, "unique inhibitory role": 0.00183, "nordihydroguiauretic acid": 0.00183, "scid phenotype observed": 0.00183, "tcr-mediated signaling events": 0.00183, "regulatory mechanism": 0.00183, "n'-tetraacetic acid": 0.00183, "cd44 activated": 0.00183, "phosphatidyl inositol levels": 0.00183, "short-term cellular responses elicited": 0.00183, "oleic acid": 0.00183, "ig mrna": 0.00183, "ascorbic acid": 0.00183, "30-fold increase": 0.00183, "p105 mrna": 0.00183, "moderate increase": 0.00183, "5-hydroxyeicosatetraenoic acid": 0.00183, "phosphonoacetic acid": 0.00183, "dtcs inhibited": 0.00183, "normal menstrual cycle": 0.00182, "cd34 mrna": 0.00182, "normal mammary glands": 0.00182, "c/ebp family": 0.00182, "inhibited pi3-k": 0.00182, "proline-rich domain": 0.00182, "40-kda transcriptional activator": 0.00182, "nf kappa b/rel": 0.00182, "activated pkb/akt": 0.00182, "phenotypic effects": 0.00182, "cytotoxic effects": 0.00182, "bhlh domain": 0.00182, "normal leukocytes": 0.00182, "ino inhibited": 0.00182, "pp52 mrna": 0.00182, "chronic pulmonary heart disease": 0.00182, "regulate monocyte production": 0.00182, "slight increase": 0.00182, "enhancer contained": 0.00182, "placebo treatment period": 0.00182, "inhibited agonist-induced": 0.00182, "direct vascular antiatherogenic mechanism": 0.00182, "molecular mechanism underlying": 0.00182, "autonomous transrepressor domain": 0.00182, "specific test": 0.00182, "suppressed il-12 production": 0.00182, "vimentin levels": 0.00182, "ca2+ signaling": 0.00182, "nitro blue tetrazolium reduction assay": 0.00182, "d3-induced monocyte differentiation": 0.00182, "pou-specific domain": 0.00182, "tata box suggest": 0.00182, "transactivating domain": 0.00182, "bzip transcriptional activator": 0.00182, "pou domain": 0.00182, "bob1 increase": 0.00182, "normal concentration": 0.00182, "acid": 0.00182, "hiv-1 tat affinity column": 0.00182, "gamma-globin mrna": 0.00182, "smad7 inhibited": 0.00182, "negative responding elements": 0.00182, "paradoxical priming effects": 0.00182, "threefold increase": 0.00182, "tf mrna": 0.00182, "underlying molecular mechanism": 0.00182, "normal alleles supports": 0.00182, "5-lipoxygenase inhibitor zileuton": 0.00182, "bronchoalveolar lavage levels": 0.00182, "fasl mrna": 0.00182, "cytokine production depends": 0.00182, "activated rho": 0.00182, "activated stat-3": 0.00182, "hmg domain": 0.00182, "transcriptional mechanisms": 0.00182, "ikappab-alpha levels": 0.00182, "hiv p24 antigen release": 0.00182, "e-selectin mrna": 0.00182, "amino-terminal rel-related domain": 0.00182, "mapk/erk-specific inhibitor pd": 0.00182, "competent transcriptional activator": 0.00182, "phosphorylation events": 0.00182, "lymphoid differentiation": 0.00182, "limited side effects": 0.00182, "motif presenting": 0.00182, "fos mrna": 0.00182, "systemic effects": 0.00182, "activated pr": 0.00182, "synergistic proinflammatory effects": 0.00182, "mrna stability": 0.00182, "nfatc mrna": 0.00181, "transcriptional activator": 0.00181, "noncoding control regions": 0.00181, "electrophoretic shift assay": 0.00181, "surface antigen cd8": 0.00181, "inhibited cytostasis": 0.00181, "anti-cd2 activated": 0.00181, "anti-fos mab demonstrated": 0.00181, "opposite effects": 0.00181, "relevant inhibitor": 0.00181, "virus genome encodes": 0.00181, "rel domain": 0.00181, "terminal differentiation": 0.00181, "b-cell type": 0.00181, "zinc-finger domain": 0.00181, "endogenous virus isolates": 0.00181, "aml1/eto mrna": 0.00181, "stat3 complexes": 0.00181, "undetectable levels": 0.00181, "m-csf mrna": 0.00181, "toxic side effects": 0.00181, "latent cytoplasmic form": 0.00181, "inhibitor staurosporine": 0.00181, "enhance hiv-1 replication": 0.00181, "il-15 activated": 0.00181, "monocyte differentiation": 0.00181, "immunoglobulin kappa": 0.00181, "striking increase": 0.00181, "carboxy-terminal domain": 0.00181, "divergent nf kappa": 0.00181, "mek1/mek2 inhibitor pd098059": 0.00181, "activated tumorigenic": 0.00181, "subnuclear domain": 0.00181, "pma-induced mrna": 0.00181, "vivo differentiation": 0.00181, "epstein-barr virus latency": 0.00181, "putative erythroid-specific cis-acting elements": 0.00181, "e3330 inhibited": 0.00181, "specific mutations": 0.00181, "dimerization domain": 0.00181, "hormone receptors": 0.00181, "gc-insensitive asthma expressed": 0.00181, "sustained effects": 0.00181, "clone identified": 0.00181, "ap1 motif": 0.00181, "active elements": 0.00181, "-specific inhibitor herbimycin": 0.00181, "activated monocytes/macrophages": 0.00181, "downregulates pre-talpha mrna": 0.00181, "dxm inhibited": 0.00181, "herpes simplex virus oct-1 coregulator vp16": 0.00181, "activated raw": 0.00181, "anionic domain": 0.00181, "documented cellular responses": 0.00181, "promotes monocytic differentiation": 0.00181, "% fetal bovine serum": 0.0018, "kruppel-like zinc-finger motif": 0.0018, "sre motif": 0.0018, "okadaic acid-induced monocytic differentiation": 0.0018, "gata-3 inhibits th1 cytokines": 0.0018, "v-src activated": 0.0018, "gggatttcacc motif abolishes": 0.0018, "ovarian carcinoma [": 0.0018, "activated shp1": 0.0018, "id2 mrna": 0.0018, "core elements": 0.0018, "activated mapkk-1": 0.0018, "activated htlv-i-ltr-cat": 0.0018, "sulindac activated": 0.0018, "activated gralpha": 0.0018, "independent complexes": 0.0018, "phytohemagglutinin/anti-cd28 activated": 0.0018, "dual effects": 0.0018, "hiv-1 tat cdna": 0.0018, "examined signaling": 0.0018, "vitro production": 0.0018, "undergo monocytic differentiation": 0.0018, "inhibitor p21": 0.0018, "activated tnfrii": 0.0018, "cd40 survival signaling": 0.0018, "biological active form": 0.0018, "normal pbmc": 0.0018, "histone deacetylase complexes": 0.0018, "major mechanism": 0.0018, "peak levels": 0.0018, "activated stat-5": 0.0018, "substantial increase": 0.0018, "precise differentiation stage": 0.0018, "activated lt-293": 0.0018, "inhibited": 0.0018, "ar mrna": 0.0018, "faster-migrating nf kappa": 0.0018, "properly activated": 0.0018, "pkc- dependent signaling systems": 0.0018, "il-4-induced effects": 0.0018, "heptamer motif aacaaag": 0.0018, "nf-kappab pathways": 0.0018, "moderate levels": 0.0018, "normal sensitivity": 0.0018, "cellular lysates derived": 0.0018, "tyrosine-protein kinase-specific inhibitor": 0.0018, "sp1 virus": 0.0018, "activated zap-70/syk": 0.0018, "prdii domain": 0.0018, "monocyte-macrophage lineage-associated surface antigen": 0.0018, "activated nf-kappabp65": 0.0018, "tcf-1 mrna": 0.0018, "spliced env mrna": 0.0018, "cytokines interleukin-1 beta": 0.0018, "additional protein-protein interactions and/or post-translational modifications": 0.0018, "amino enhancer": 0.0018, "prevented virus reactivation": 0.0018, "housekeeping alas mrna": 0.0018, "bzlf1 mrna": 0.0018, "plzf poz domain": 0.0018, "cytokine production profiles": 0.0018, "kappa locus": 0.0018, "equivalent increase": 0.00179, "specific pattern": 0.00179, "nucleoplasmic domain": 0.00179, "nfat complexes": 0.00179, "early antigen": 0.00179, "c/ebp-epsilon mrna": 0.00179, "dose-dependent increase": 0.00179, "interleukin-2 enhancer correlates": 0.00179, "active role": 0.00179, "gata-2 mrna": 0.00179, "ifn-gamma-induced mrna": 0.00179, "activated": 0.00179, "influence hiv-1 replication": 0.00179, "eightfold increase": 0.00179, "altered differentiation status": 0.00179, "lymphoid specific": 0.00179, "minor effects": 0.00179, "4-week-old adult mice": 0.00179, "[ differential diagnostic": 0.00179, "pharmacological effects": 0.00179, "unspliced gag-pol mrna": 0.00179, "mrna stabilization": 0.00179, "modest increase": 0.00179, "cytolytic effects": 0.00179, "mediate il-2 repression": 0.00179, "hmg motif": 0.00179, "comparable levels": 0.00179, "-2 increase": 0.00179, "cytokine regulation": 0.00179, "cytosolic levels": 0.00179, "runt domain": 0.00179, "pkc-mediated signaling events": 0.00179, "critical cis elements": 0.00179, "tgf-beta mrna": 0.00179, "rgd domain": 0.00179, "exact cellular mechanisms underlying": 0.00179, "ra treatment": 0.00179, "aberrant intracellular signaling": 0.00179, "calmodulin-binding domain": 0.00179, "tat-mediated increase": 0.00179, "expected dramatic increase": 0.00179, "studied il-6 production": 0.00179, "autoregulatory feedback inhibitor": 0.00179, "zebra domain": 0.00179, "levels comparable": 0.00179, "markers specific": 0.00179, "mds1/evi1 enhances tgf-beta1 signaling": 0.00179, "inhibitor pd98059": 0.00179, "observed marked accumulation": 0.00179, "unique model system": 0.00179, "t-tropic primary isolate hiv-1": 0.00179, "ebna2 mrna": 0.00179, "abundant cytosolic receptors called immunophilins": 0.00179, "spi-b mrna": 0.00179, "e-box motif": 0.00179, "me1a1 g3ag4ag3 motif": 0.00179, "irf-1 levels": 0.00179, "solution hybridization assay": 0.00179, "serum-free culture system": 0.00179, "continued increase": 0.00178, "interleukin-4-induced cd23b mrna": 0.00178, "icam-i mrna": 0.00178, "differentiating effects": 0.00178, "nf kappa": 0.00178, "stat3 serine phosphorylation": 0.00178, "emcv mrna": 0.00178, "recent data suggest": 0.00178, "maximum levels": 0.00178, "poz domain": 0.00178, "paired motif": 0.00178, "accelerate cytopathic effects": 0.00178, "dna-binding/dimerization domain": 0.00178, "nfkappab-mediated cytokine production": 0.00178, "mzf-1 mrna": 0.00178, "lim domain": 0.00178, "il-13 levels": 0.00178, "ap-1 elements": 0.00178, "enhancer core": 0.00178, "allele-specific regulatory system": 0.00178, "primary hiv-1 isolate": 0.00178, "ap-1-like domain": 0.00178, "disease conditions": 0.00178, "membrane-mediated signaling events": 0.00178, "fourfold increase": 0.00178, "dramatic increase": 0.00178, "myeloid differentiation": 0.00178, "la mrna": 0.00178, "twofold increase": 0.00178, "hiv enhancer": 0.00178, "normal variant": 0.00178, "fivefold increase": 0.00178, "cellular immune": 0.00178, "alas mrna": 0.00178, "hydrophobic domain": 0.00178, "antiapoptotic effects": 0.00178, "[ endocrine status": 0.00178, "mad3 mrna": 0.00178, "specific translocation": 0.00178, "ap-2 mrna": 0.00178, "synergistic increase": 0.00178, "s-adenosylhomocysteine hydrolase inhibitor": 0.00178, "adult mice": 0.00178, "inhibition correlated": 0.00178, "trans-activating effects": 0.00178, "mnda mrna": 0.00178, "nonspecific increase": 0.00178, "4-fold increase": 0.00178, "timp-1-negative bl lines": 0.00178, "cyp1a1 mrna": 0.00178, "normal brca1 allele": 0.00178, "core enhancer": 0.00178, "expressed tax": 0.00178, "functional interactions": 0.00178, "amino-terminal domain": 0.00178, "25-fold increase": 0.00178, "biphasic increase": 0.00178, "levels relevant": 0.00178, "obf-1 mrna": 0.00178, "il-2 promoter/reporter constructs": 0.00178, "cyclic amp inhibition": 0.00178, "ifn-beta mrna": 0.00177, "phd/ttc domain": 0.00177, "sh3 domain": 0.00177, "intracellular signaling cascades": 0.00177, "signaling molecules": 0.00177, "spi-1 mrna": 0.00177, "intra-cytoplasmic domain": 0.00177, "normal lung parenchyma": 0.00177, "stat family": 0.00177, "ap-1 enhancer": 0.00177, "proximal cis-acting elements": 0.00177, "140-kda surface antigen": 0.00177, "i-kappabbeta levels": 0.00177, "pleiotropic effects": 0.00177, "ccaat motif": 0.00177, "prdi domain": 0.00177, "labile inhibitor": 0.00177, "hormone-binding domain": 0.00177, "tcl1 mrna": 0.00177, "side effects": 0.00177, "significant apoptosis": 0.00177, "wild-type mice": 0.00177, "cytokine production": 0.00177, "gt motif": 0.00177, "fkbp mrna": 0.00177, "ligand-binding domain": 0.00177, "regulatory function": 0.00177, "deleterious effects": 0.00177, "cdk2 inhibitor": 0.00177, "normal diurnal decline": 0.00177, "transcription-activating domain": 0.00177, "anti-apoptotic effects": 0.00177, "antigen activates phospholipase": 0.00177, "phosphorylation pattern": 0.00177, "cd20 mrna": 0.00177, "resulting diminished phosphorylation": 0.00177, "srf constitutively expressed": 0.00177, "cell/monocyte surface antigen": 0.00177, "baseline levels": 0.00177, "differentiation capacity": 0.00177, "lymphocyte ig production": 0.00177, "constitutive serine phosphorylation": 0.00177, "significant role": 0.00177, "unspliced mrna": 0.00177, "-terminal domain": 0.00177, "ap2 mrna": 0.00177, "creb family": 0.00177, "standard gel retardation assay": 0.00177, "reported il-2 nf-at": 0.00177, "donors identified individuals": 0.00177, "elastase inhibitor": 0.00177, "trigger monocytic differentiation": 0.00177, "nf-kappab consensus oligonucleotides": 0.00177, "transient assay": 0.00177, "calyculin a-induced stat3 phosphorylation": 0.00177, "il-11 mrna": 0.00177, "dhea effects": 0.00177, "pathways inhibits": 0.00177, "il2 mrna": 0.00177, "proline/serine/threonine-rich domain": 0.00177, "7-fold increase": 0.00177, "2-fold increase": 0.00177, "protective effects": 0.00177, "nf-at1 mrna": 0.00177, "antagonistic effects": 0.00177, "caspase-3 inhibitor": 0.00177, "signaling events": 0.00177, "janus family": 0.00177, "zii domain": 0.00177, "tat-mediated effects": 0.00177, "inverse effects": 0.00177, "vitro system": 0.00177, "stimulates hiv-1 replication": 0.00177, "diminished transactivation function": 0.00177, "autoinhibitory domain": 0.00177, "toxic effects": 0.00177, "prominent increase": 0.00177, "5-fold increase": 0.00177, "bzip domain": 0.00177, "hiv-enhancer domain": 0.00177, "control peptides": 0.00177, "adherence-dependent increase": 0.00176, "leucine-zipper motif": 0.00176, "inhibition prevented": 0.00176, "inducible complexes": 0.00176, "gst pull-down experiments demonstrated": 0.00176, "steady-state levels": 0.00176, "8-fold increase": 0.00176, "dexamethasone stimulation": 0.00176, "ratio-dependent increase": 0.00176, "regulatory system": 0.00176, "stimulatory effects": 0.00176, "inductive effects": 0.00176, "mature platelet function": 0.00176, "cortisol inhibition": 0.00176, "c-raf-mediated increase": 0.00176, "mrna half-life": 0.00176, "ifn-dependent increase": 0.00176, "trident mrna": 0.00176, "6-h increase": 0.00176, "primary function": 0.00176, "il-1 signaling leading": 0.00176, "mdhm-induced increase": 0.00176, "cbp/p300-mediated increase": 0.00176, "dose-related increase": 0.00176, "clonal lines": 0.00176, "recognizable increase": 0.00176, "hdac-containing repressor complexes": 0.00176, "reverse csa inhibition": 0.00176, "twentyfold increase": 0.00176, "sp140 mrna": 0.00176, "posttranslational levels": 0.00176, "nf-kappab1 p105/p50 levels": 0.00176, "mitogen-induced increase": 0.00176, "cd28 stimulation involves": 0.00176, "dramatic effects": 0.00176, "pkc-mediated cellular responses": 0.00176, "box1 motif": 0.00176, "medium treatment": 0.00176, "sudden increase": 0.00176, "mzf-2 mrna": 0.00176, "ngal mrna": 0.00176, "vivo phosphorylation": 0.00176, "2.5-fold increase": 0.00176, "enhancer mutations": 0.00176, "exposed population show detectable deviations": 0.00176, "tenfold increase": 0.00176, "suppressed gp41-induced il-10 production": 0.00176, "rxr-alpha mrna": 0.00176, "2-4-fold increase": 0.00176, "jun family": 0.00176, "gsh levels": 0.00176, "domain": 0.00176, "nonspecific inhibitor": 0.00176, "transcriptional activities": 0.00176, "nf-ya mrna": 0.00176, "normal germinal center": 0.00176, "pma inducible function": 0.00176, "hb24 mrna": 0.00176, "normal amounts": 0.00176, "tight regulatory control": 0.00176, "p45 mrna": 0.00176, "recurrent genital herpes simplex virus": 0.00176, "inhibitory drug interactions": 0.00176, "bimodal increase": 0.00176, "autocrine and/or paracrine role": 0.00176, "tcdd-induced increase": 0.00176, "sixfold increase": 0.00176, "two-fold increase": 0.00176, "fosb mrna": 0.00176, "normal golgi processing": 0.00176, "r24-stimulated increase": 0.00176, "hiv-1 replication occurs": 0.00176, "antiproliferative effects": 0.00176, "phosphatase treatment": 0.00176, "additive increase": 0.00176, "proteolysis-resistant inhibitor": 0.00175, "biologic effects": 0.00175, "e2f-1 levels": 0.00175, "estrogenic effects": 0.00175, "c/ebpepsilon mrna": 0.00175, "aacaaag motif": 0.00175, "-dependent transcriptional events": 0.00175, "cytokine-specific mrna": 0.00175, "calpain inhibitor": 0.00175, "reactivated epstein-barr virus": 0.00175, "pma treatment": 0.00175, "equivalent levels": 0.00175, "intracellular receptors": 0.00175, "cdc2 mrna": 0.00175, "aldh1 mrna": 0.00175, "divergent effects": 0.00175, "adverse effects": 0.00175, "markers observed": 0.00175, "similar function": 0.00175, "mrna vary": 0.00175, "affected tyrosyl phosphorylation": 0.00175, "hb-egf mrna": 0.00175, "combinatorial effects": 0.00175, "myeloid specific": 0.00175, "ngal levels varied": 0.00175, "blr2 mrna": 0.00175, "nf-at4 mrna": 0.00175, "normal polyclonal granulocytes": 0.00175, "increase": 0.00175, "epo-r mrna": 0.00175, "mip-1alpha-r mrna": 0.00175, "tcf-1 knock-out mice readily yield antiserum titers": 0.00175, "glucocorticosteroid receptors play": 0.00175, "inducing ifn-gamma production": 0.00175, "lmp2b mrna": 0.00175, "positional effects": 0.00175, "microb motif": 0.00175, "qr-specific inhibitor": 0.00175, "ap-1-binding motif": 0.00175, "cytopathic effects": 0.00175, "proenkephalin mrna": 0.00175, "poz motif": 0.00175, "nf-atc.alpha mrna": 0.00175, "rxr-beta mrna": 0.00175, "ahr mrna": 0.00175, "normal circulating granulocytes": 0.00175, "levels equivalent": 0.00175, "individual transcriptional properties": 0.00175, "pi3-k inhibitor": 0.00175, "dr-nm23 mrna": 0.00175, "pkc-specific inhibitor": 0.00175, "il-4 stimulation": 0.00175, "ctcf mrna": 0.00175, "elam mrna": 0.00175, "rp1 mrna": 0.00175, "mek inhibitor": 0.00175, "delta-domain motif": 0.00175, "healthy control individuals": 0.00175, "rest levels": 0.00175, "g0s2 mrna": 0.00175, "corticosterone levels": 0.00175, "pretranslational level dimethyldithiocarbamate inhibits": 0.00175, "expressed nfat": 0.00175, "immunomodulatory effects": 0.00175, "additional structural role": 0.00175, "suppressive effects": 0.00175, "dominant-active inhibitor": 0.00175, "cellular surface": 0.00175, "blr2-specific mrna": 0.00175, "repressive effects": 0.00175, "egr2 mrna": 0.00175, "ets family": 0.00175, "tsh levels": 0.00175, "atra-induced neutrophil differentiation": 0.00175, "immunoregulatory effects": 0.00175, "12/15-lipoxygenase mrna": 0.00175, "transduction mechanism": 0.00175, "litaf mrna": 0.00175, "antigen responses": 0.00175, "negative role": 0.00175, "p27kip1 mrna": 0.00175, "cognate motif": 0.00175, "il-4 signaling": 0.00175, "control level": 0.00175, "beneficial effects": 0.00175, "cfms mrna": 0.00175, "lfa-i beta chain": 0.00175, "enhancer properties": 0.00175, "tax/rex mrna": 0.00175, "epstein-barr virus transactivators": 0.00175, "rhom-2 mrna": 0.00175, "hbv mrna": 0.00175, "affect ifn-alpha-induced growth arrest": 0.00175, "observed differences": 0.00175, "srg3 mrna": 0.00175, "saturating levels": 0.00175, "mice treated": 0.00175, "normal kinetics": 0.00175, "p35 mrna": 0.00175, "alpha/mad-3 mrna": 0.00175, "beta-actin mrna": 0.00175, "-induced monocytic differentiation": 0.00174, "calcemic effects": 0.00174, "antifungal effects": 0.00174, "differentiation-inducing effects": 0.00174, "lif effects": 0.00174, "endogenous gc production": 0.00174, "ebs motif": 0.00174, "cd28-dependent effects": 0.00174, "stimulation suggests": 0.00174, "fc receptors leading": 0.00174, "endotoxic effects": 0.00174, "ngal levels": 0.00174, "epstein-barr virus bamhi": 0.00174, "tcrzeta levels": 0.00174, "non-genomic effects": 0.00174, "raldh2 effects": 0.00174, "oap/octamer motif": 0.00174, "il-1 beta release": 0.00174, "cellular pathways": 0.00174, "[ correlation": 0.00174, "intracellular signaling": 0.00174, "posttranscriptional effects": 0.00174, "interleukin-6 levels": 0.00174, "modulatory effects": 0.00174, "putative transcriptional regulator": 0.00174, "mrna": 0.00174, "related interaction": 0.00174, "lineage differentiation": 0.00174, "mediate signaling": 0.00174, "phosphorylation state": 0.00174, "ire motif": 0.00174, "negligible effects": 0.00174, "dominant negative form": 0.00174, "expressed pkc isoenzymes": 0.00174, "growth-promoting effects": 0.00174, "inactive cytoplasmic form": 0.00174, "fibroblast lines": 0.00174, "varied effects": 0.00174, "nucleosome-assembly system derived": 0.00174, "h-7 [ 1-": 0.00174, "% +/-": 0.00174, "disease susceptibility markers": 0.00174, "retinoid-like receptors play": 0.00174, "microbicidal effects": 0.00174, "nongenomic effects": 0.00174, "pro-apoptotic effects": 0.00174, "roi-induced effects": 0.00174, "steroidal effects": 0.00174, "contrasting effects": 0.00174, "carg motif": 0.00174, "bcl-2 phosphorylation": 0.00174, "rxr-specific effects": 0.00174, "immuno-modulatory effects": 0.00174, "remote enhancer position": 0.00174, "opioid effects": 0.00174, "cellular responses": 0.00174, "antiatherogenic effects": 0.00174, "gc-induced monocyte apoptosis": 0.00173, "anti-cd45 antibodies inhibit": 0.00173, "suppresses hiv-1 replication": 0.00173, "non-octamer motif": 0.00173, "dc differentiation": 0.00173, "separate specific functions": 0.00173, "reactive oxygen intermediate production": 0.00173, "-516 motif": 0.00173, "aids-related epstein-barr virus": 0.00173, "positive role": 0.00173, "ap3-like motif": 0.00173, "post-transcriptional levels": 0.00173, "pdp motif": 0.00173, "gata family": 0.00173, "tcccctcccct motif": 0.00173, "transcriptional transactivation": 0.00173, "psa levels": 0.00173, "ttcaaag motif": 0.00173, "pth levels": 0.00173, "motif attta": 0.00173, "inhibitor": 0.00173, "specific members": 0.00173, "posttranscriptional levels": 0.00173, "n-terminal antibody": 0.00173, "expressed constitutively": 0.00173, "hiv-1 infected individuals": 0.00173, "autoimmune rheumatic disease characterized": 0.00173, "cdc10/ankyrin motif": 0.00173, "u1 lines": 0.00173, "dicysteine motif": 0.00173, "atf/cre motif": 0.00173, "pxp motif": 0.00173, "icam-1 kappa": 0.00173, "microa motif": 0.00173, "epstein-barr virus bclf1": 0.00173, "defined minimal enhancer": 0.00173, "translational levels": 0.00173, "simian immunodeficiency virus": 0.00173, "defined e2f complexes": 0.00173, "amino-acid motif": 0.00173, "ngfi-b/nur77 family consists": 0.00173, "gross levels": 0.00173, "p-creb levels": 0.00173, "undergo granulocytic differentiation": 0.00173, "lowered levels": 0.00173, "regulates differentiation": 0.00173, "motif contiguous": 0.00173, "lines differ": 0.00173, "3'nf-e2/ap1 motif": 0.00173, "platelet thromboxane receptors": 0.00173, "70-bp motif": 0.00173, "constitutively expressed": 0.00173, "sublethal levels": 0.00173, "synchronized differentiation selectively": 0.00173, "-605 motif": 0.00173, "tata-like motif": 0.00173, "gc treatment": 0.00173, "ea/s motif": 0.00173, "effects": 0.00173, "polyamine levels": 0.00173, "ros generation inhibition": 0.00172, "hiv-1 ltr responsive": 0.00172, "inflammatory airway disease": 0.00172, "beta chain": 0.00172, "ifn-gamma treatment": 0.00172, "18-hydroxycorticosterone levels": 0.00172, "u937 differentiation": 0.00172, "motif": 0.00172, "therapeutical levels": 0.00172, "ast/alt levels": 0.00172, "direct phosphorylation": 0.00172, "fas-mediated apoptosis plays": 0.00172, "p4 nfat elements": 0.00172, "quantitative reverse transcription-pcr assay": 0.00172, "near-basal levels": 0.00172, "26-kda membrane form": 0.00172, "b-cell growth": 0.00172, "suppresses stat5 phosphorylation": 0.00172, "pre-activation levels": 0.00172, "transgenic mice carrying": 0.00172, "high il-2": 0.00172, "normal thymus environment": 0.00172, "observed relative": 0.00172, "p24 antigen level": 0.00172, "restored il-4 production": 0.00172, "normal ductal epithelium": 0.00172, "s727 stat1 phosphorylation": 0.00172, "cell-independent culture system": 0.00172, "electromobility shift assay": 0.00172, "ra receptors": 0.00172, "semiquantitative competitive hybridization assay": 0.00172, "cellular thiol level": 0.00172, "xenogeneic serum promotes leukocyte-endothelium interaction": 0.00172, "vivo role": 0.00172, "marginal levels": 0.00172, "maintain v-abl-mediated differentiation arrest": 0.00172, "lymphocyte function associated-antigen-1": 0.00172, "essential elements": 0.00172, "restored apoptosis sensitivity": 0.00171, "zinc finger type": 0.00171, "enhancer positions": 0.00171, "adhesion molecule-mediated interactions": 0.00171, "inhibition correlates": 0.00171, "monocyte apoptosis": 0.00171, "transient transcriptional upregulation": 0.00171, "culture system": 0.00171, "phosphorylation status correlates": 0.00171, "activate nf-kappab": 0.00171, "strong inhibition": 0.00171, "-induced mononuclear differentiation": 0.00171, "serine proteases expressed": 0.00171, "levels": 0.00171, "membrane form": 0.00171, "endogenous virus": 0.00171, "% fetal calf serum": 0.00171, "pou family primers": 0.00171, "specific uptake": 0.00171, "natural gata elements": 0.00171, "inducible retarded bands observed": 0.00171, "transcriptional enhancement": 0.00171, "anti-cd3 antibody": 0.00171, "block antigen-induced il-2 secretion": 0.00171, "altered ikappab-alpha phosphorylation": 0.00171, "il-6 kappa": 0.00171, "common elements": 0.00171, "responsive cis-acting elements": 0.00171, "adaptive immunity [": 0.00171, "minimal inhibition": 0.00171, "interleukin-5/receptor interaction activates lyn": 0.00171, "ba-induced differentiation process": 0.00171, "antigen molecules recognized": 0.00171, "rapid phosphorylation": 0.00171, "differentiation stage": 0.00171, "tnf-alpha treatment": 0.00171, "late differentiation stages": 0.00171, "autoimmune disease subjects": 0.00171, "specific chromosomal translocations": 0.0017, "expressed selectively": 0.0017, "inhibit il-1-induced production": 0.0017, "< .001 versus control": 0.0017, "relative role": 0.0017, "experimental evidence suggest": 0.0017, "specific cd4": 0.0017, "subsequent inhibition": 0.0017, "full length wild-type form": 0.0017, "normal lymph nodes": 0.0017, "combined treatment": 0.0017, "cellular adhesion": 0.0017, "endogenous il-1 beta": 0.0017, "specific 32p-labelled oligonucleotide": 0.0017, "primary cellular initiator": 0.0017, "sp1 phosphorylation": 0.0017, "cd8+ t-pll expressed il-2ralpha": 0.0017, "selectively expressed": 0.0017, "observed decrease": 0.0017, "herpes virus transactivator vp16": 0.0017, "two-dimensional gel electrophoresis system": 0.0017, "affect total cellular": 0.0017, "neuroendocrine-immune regulatory interactions": 0.0017, "growth conditions": 0.0017, "normal numbers": 0.0017, "macrophage-like hl-60 differentiation": 0.0017, "liquid culture show": 0.0017, "differentiation block": 0.0017, "gata-1 autoregulatory enhancer": 0.0017, "gel retardation assay": 0.0017, "tcr stimulation": 0.0017, "specific tissues": 0.00169, "sp1 elements": 0.00169, "ifns inhibit growth": 0.00169, "anti-tr55 antibody cross-linking": 0.00169, "cd40 expressed": 0.00169, "gel-retardation experiments show": 0.00169, "igg fc receptors": 0.00169, "combinatorial differentiation switch": 0.00169, "antibody super-shift reaction": 0.00169, "immunoglobulin light-chain enhancer": 0.00169, "all-trans-retinoic acid-induced monocytic differentiation": 0.00169, "il-10 inhibition": 0.00169, "hl-60 myelomonocytic differentiation": 0.00169, "cellular level": 0.00169, "endotoxin lethality [ bianchi": 0.00169, "inducing differentiation": 0.00169, "essential role": 0.00169, "normal components": 0.00169, "differentiation process": 0.00169, "anti-cd95 ab treatment": 0.00169, "creb complexes implies": 0.00169, "mutagenesis experiments demonstrated": 0.00169, "disease phenotype": 0.00169, "pebp2 alpha/aml-1 family": 0.00169, "serum stimulation": 0.00169, "molecular mechanism": 0.00169, "show partial resistance": 0.00169, "il-10 inhibits th1 functions": 0.00169, "tcr signaling": 0.00169, "[ molecular-biologic aspects": 0.00169, "adult type": 0.00169, "restricted hiv-1 replication": 0.00169, "estradiol inhibits polymorphonuclear leukocyte chemotaxis": 0.00169, "normal rats": 0.00169, "electrophoretic mobility supershift assay": 0.00169, "elements abolished inducibility": 0.00169, "full transactivation function": 0.00169, "upstream nf-kappab": 0.00169, "9-cis ra-mediated granulocytic differentiation": 0.00169, "70z/3-derived pre-b-cell lines": 0.00169, "epstein-barr virus": 0.00169, "heterodimeric p50/p65 complexes": 0.00169, "ras signaling": 0.00168, "specific phase": 0.00168, "direct role": 0.00168, "n-acetyl-cysteine treatment prevented": 0.00168, "vitro demonstrated": 0.00168, "extended family": 0.00168, "transcriptional events": 0.00168, "mixed combination suggest": 0.00168, "immunoglobulin heavy-chain enhancer": 0.00168, "inhibits development": 0.00168, "differential inhibition": 0.00168, "abolish inducible phosphorylation": 0.00168, "virus particles": 0.00168, "reactive oxygen production": 0.00168, "mitotic arrest assay": 0.00168, "experiments show": 0.00168, "cellular macromolecular synthesis": 0.00168, "bha treatment prevents": 0.00168, "inhibit ifnalpha production": 0.00168, "affect apoptosis": 0.00168, "antibody recognized": 0.00168, "interferon family": 0.00168, "adult stage-specific interaction": 0.00168, "sub-optimal neutrophil differentiation": 0.00168, "stat5 complexes": 0.00168, "regulating differentiation": 0.00168, "cellular events leading": 0.00168, "il-8 family": 0.00168, "transient transfection system": 0.00168, "properties suggest": 0.00168, "elevated antibody titres": 0.00168, "cyclic adenosine monophosphate signaling": 0.00168, "direct stimulation": 0.00168, "nf-kappab p50/p65 heterodimer": 0.00167, "ebf-deficient mice suggested": 0.00167, "lef-1 complexes": 0.00167, "beta zero-thalassemia patient": 0.00167, "trigger stat phosphorylation": 0.00167, "fos family": 0.00167, "similar interactions": 0.00167, "phosphorylation defect": 0.00167, "pma stimulation": 0.00167, "specific ligands": 0.00167, "transient stimulation": 0.00167, "granulocytic differentiation program": 0.00167, "activate hiv-1": 0.00167, "x2 box protein-dna interactions": 0.00167, "zap-70 [": 0.00167, "basal transcriptional machinery": 0.00167, "tpa-induced hl-60 differentiation": 0.00167, "stat complexes": 0.00167, "il-2-dependent lines": 0.00167, "cd40 signaling cascade": 0.00167, "constitutive phosphorylation": 0.00167, "ra-induced monocytic differentiation": 0.00167, "kappa b.": 0.00167, "neutrophil differentiation": 0.00167, "enhancer interacts": 0.00167, "antioxidant treatment": 0.00167, "stat3 phosphorylation": 0.00167, "prompt rapid apoptosis": 0.00167, "reversed inhibition": 0.00167, "transcriptional properties diverged": 0.00167, "selective kappa": 0.00167, "molecular regulation": 0.00167, "antibody cross-linking": 0.00167, "specific stage": 0.00167, "gene- specific functions": 0.00167, "tpa-induced monocytic differentiation": 0.00167, "normal allele": 0.00167, "support differentiation": 0.00167, "cortisol metabolism observed": 0.00167, "normal maturing granulocytes": 0.00167, "inhibit g-csf-induced growth": 0.00167, "-3- [ 5-": 0.00167, "normal exon": 0.00166, "translation-dependent degradation mechanism": 0.00166, "lps addition": 0.00166, "lymphocyte function": 0.00166, "block fas-mediated apoptosis": 0.00166, "stat1 phosphorylation": 0.00166, "stimulate ifn-gamma production": 0.00166, "neutralizing anti-il-1beta antibody": 0.00166, "cellular promoters": 0.00166, "complexes capable": 0.00166, "hiv disease": 0.00166, "selective transcriptional repressor": 0.00166, "-induced hiv-1 replication": 0.00166, "camp inhibition": 0.00166, "mthc lines": 0.00166, "evidence suggest disturbances": 0.00166, "cd56+ [": 0.00166, "specific down-regulation": 0.00166, "mice lacking rel": 0.00166, "critical mechanism underlying": 0.00166, "neutralizing anti-m-csf antibody": 0.00166, "specific block": 0.00166, "recombinant ptf beta": 0.00166, "critical role": 0.00166, "u1 cellular clone": 0.00166, "present antigen": 0.00166, "signaling capacity": 0.00166, "selective inhibition": 0.00166, "gm-csf receptors share": 0.00166, "hiv type": 0.00166, "differentiation remains": 0.00166, "tpa treatment": 0.00166, "critical control point": 0.00166, "control developmental events": 0.00166, "cd28 signaling cascade": 0.00165, "endogenous tg receptors": 0.00165, "varicella-zoster virus glycoprotein": 0.00165, "case expressed cd2": 0.00165, "e2f family": 0.00165, "additional cis-acting elements": 0.00165, "normal resting": 0.00165, "mice lacking nnos responds": 0.00165, "responsive elements": 0.00165, "growth phase-dependent resistance": 0.00165, "hl-60 differentiation": 0.00165, "atra-induced granulocytic differentiation": 0.00165, "oct-2 expressed": 0.00165, "maximal inhibition": 0.00165, "c-rel complexes": 0.00165, "immunohistochemical staining demonstrated relb": 0.00165, "cytokine il-2": 0.00165, "transient-transfection experiments demonstrated": 0.00165, "transgenic mice shows": 0.00165, "rb-defective lines": 0.00165, "filarial inflammatory disease": 0.00165, "normal intergenic splicing": 0.00165, "camkiv/ gr signaling": 0.00165, "b-lymphoid lines": 0.00165, "p65- selected kappa": 0.00165, "myeloma lines": 0.00165, "cyclin a-cdk2-dependent phosphorylation": 0.00165, "mice infected": 0.00165, "min post-alphacd3 stimulation": 0.00165, "multifactor cis-dominant negative regulation": 0.00165, "il-2 synthesis": 0.00165, "tnf receptors": 0.00165, "nf-kappab abolished cd40-induced up-regulation": 0.00165, "mody and/or late-onset type": 0.00165, "inflammatory bowel disease": 0.00165, "immunoglobulin enhancer microe5/kappa": 0.00165, "single type": 0.00165, "min post-pha stimulation": 0.00165, "antisense inhibition": 0.00165, "normal granulocytes": 0.00165, "action mechanism": 0.00165, "nfatc family": 0.00165, "% similar": 0.00165, "v-erba-mediated differentiation arrest": 0.00165, "expressed late": 0.00165, "co-immunoprecipitation experiments demonstrated": 0.00165, "central nervous system-enriched kappa": 0.00164, "transcriptional differences": 0.00164, "nfat elements": 0.00164, "estrogen receptors": 0.00164, "loss-of-function signaling defect": 0.00164, "multiple cellular": 0.00164, "tnf signaling": 0.00164, "ligand-inducible transactivation function": 0.00164, "beta degradation": 0.00164, "recent findings suggest": 0.00164, "family history": 0.00164, "non-b-cell lines": 0.00164, "ba-induced differentiation remain": 0.00164, "suppress tnf production": 0.00164, "stat serine phosphorylation": 0.00164, "assay involves": 0.00164, "order nucleoprotein complexes": 0.00164, "monocytic differentiation": 0.00164, "endothelial production": 0.00164, "cyclosporin treatment": 0.00164, "normal individual": 0.00164, "bhlh family": 0.00164, "lymphocytic aldosterone receptors": 0.00164, "rel family": 0.00164, "differentiation arrest": 0.00164, "differentiation marker": 0.00164, "glucose oxidase selectively inhibits p75": 0.00164, "-positive virus carriers": 0.00164, "adolescent callithrix jacchus inhibition": 0.00164, "normal pml": 0.00164, "disease suggests": 0.00164, "transgenic mice spleen": 0.00164, "normal thymus": 0.00164, "hiv-1 ltr-based vectors suggested": 0.00164, "cellular mechanisms": 0.00164, "tnf stimulation": 0.00164, "lines": 0.00163, "interleukin 6-induced differentiation": 0.00163, "activates nf-kappab": 0.00163, "normal artery specimens": 0.00163, "pre-formed hsp90 complexes": 0.00163, "independent role": 0.00163, "mineralocorticoid receptors decreases": 0.00163, "u2 dna-protein complexes": 0.00163, "normal cd56+": 0.00163, "gamma inhibits p50-": 0.00163, "vcam-1 antibody": 0.00163, "helix-loop-helix family": 0.00163, "dc stimulation": 0.00163, "anti-ehrlichia chaffeensis antibody complexed": 0.00163, "transactivation function": 0.00163, "prenatal steroid treatment": 0.00163, "anti-e. chaffeensis antibody complexed": 0.00163, "laboratory data suggest": 0.00163, "ifn-gamma stimulation": 0.00163, "tnf-alpha receptors": 0.00163, "repressor specific": 0.00163, "cellular membrane": 0.00163, "antenatal steroid treatment": 0.00163, "transcriptional trans-activator tax": 0.00163, "no-induced downstream signaling": 0.00163, "normal hematopoiesis mimics": 0.00163, "donors expressed p62c-fos": 0.00163, "signaling systems leading": 0.00163, "placebo [": 0.00163, "local adjacent augmentative cis elements": 0.00163, "influences hiv-1 replication": 0.00163, "stat3 signaling": 0.00163, "jak family": 0.00163, "normal volunteers": 0.00163, "tal-1 transgenic mice": 0.00163, "inducible phosphorylation": 0.00163, "ifn-gamma signaling": 0.00163, "inflammatory disease": 0.00163, "normal program": 0.00162, "cd28 stimulation contributes": 0.00162, "species specific": 0.00162, "aspirin [": 0.00162, "granulocyte maturation observed": 0.00162, "split [": 0.00162, "lymphocyte-specific negative regulation": 0.00162, "partial cn inhibition": 0.00162, "identified sp1": 0.00162, "rescue rapamycin inhibition": 0.00162, "mice bearing mc38 colon adenocarcinoma": 0.00162, "chloramphenicol acetyltransferase assay": 0.00162, "normal profile": 0.00162, "tnf-alpha stimulation": 0.00162, "efficient adenovirus-mediated inhibition": 0.00162, "genetic elements": 0.00162, "downstream signaling": 0.00162, "age-matched control subjects": 0.00162, "p3hr1 virus genome": 0.00162, "rfx family": 0.00162, "signaling defect": 0.00162, "pou [": 0.00162, "3-day pha treatment": 0.00162, "receptors involves g-protein coupling": 0.00162, "jun/fos family": 0.00162, "enhancer include": 0.00162, "constitutive apoptosis": 0.00162, "signaling isoform": 0.00162, "normal vaginal flora": 0.00162, "signaling downstream": 0.00162, "gata elements surrounding": 0.00162, "low il-2": 0.00162, "molecular function": 0.00162, "myb family": 0.00162, "ikkbeta cellular kinases": 0.00162, "informative probes specific": 0.00161, "il-2 therapy": 0.00161, "selectin family": 0.00161, "il-6 treatment": 0.00161, "nested pcr assay": 0.00161, "inversions [ inv14": 0.00161, "thp-1 differentiation": 0.00161, "specific modulation": 0.00161, "reversible dose-dependent inhibition": 0.00161, "expressed cdnas": 0.00161, "combined signaling": 0.00161, "anti-cd3 treatment": 0.00161, "paf-receptor antagonist inhibits": 0.00161, "direct ctl control": 0.00161, "growth hormone": 0.00161, "block calcineurin-dependent signaling": 0.00161, "macrophage differentiation": 0.00161, "il-4ralpha abolished signaling": 0.00161, "high-level il-4 production": 0.00161, "complete inhibition": 0.00161, "alternative treatment approaches": 0.00161, "commonly observed histological features": 0.00161, "mononuclear differentiation": 0.00161, "stat1 signaling": 0.00161, "steroid treatment": 0.00161, "conserved elements": 0.00161, "specific genotoxic stimuli": 0.00161, "r- inducible enhancer": 0.00161, "normal humans": 0.00161, "nf-munr enhancer repressor": 0.00161, "mice leads": 0.00161, "hiv regulation": 0.00161, "tnfr family": 0.00161, "combined stimulation": 0.00161, "rho family": 0.00161, "exogenous virus": 0.00161, "ick-1 family": 0.00161, "show pu box-dependent transactivation": 0.00161, "adjacent kappa": 0.00161, "nf-kappab subunits p50": 0.00161, "pregnancy [": 0.00161, "subsequent treatment": 0.00161, "translocated hormone/receptor complexes compete": 0.0016, "th2 differentiation": 0.0016, "regulating cellular functions": 0.0016, "nf-kappab inhibitory subunits": 0.0016, "[ age-related": 0.0016, "proto-oncogene expressed": 0.0016, "inducible enhancer": 0.0016, "anti-human cd14 antibody": 0.0016, "nf-kappab/rel family": 0.0016, "dl312 virus defective": 0.0016, "1,25-dihydroxycholecalciferol [ 1,25-": 0.0016, "bzip family": 0.0016, "myristate 13-acetate treatment": 0.0016, "il-10 treatment": 0.0016, "mimic mitogenic stimulation": 0.0016, "anti-igm antibody": 0.0016, "mice lacking": 0.0016, "pan anti gamma/delta antibody": 0.0016, "weak inhibition": 0.0016, "creb/atf-1 family": 0.0016, "kappa b-alpha pool": 0.0016, "reverse transcriptase assay": 0.0016, "hiv-1 nf-kb probe": 0.0016, "observed difference": 0.0016, "ap-1 regulation": 0.0016, "virus genome": 0.0016, "defective sexual differentiation": 0.0016, "normal occupation": 0.0016, "transcriptional state": 0.0016, "normal upper limit": 0.0016, "retinoblastoma family": 0.0016, "dna-binding form": 0.0016, "centromere specific probes": 0.0016, "rel/nf-kappab family": 0.0016, "tissue-damaging granulocytes undergo apoptosis": 0.0016, "mcm family": 0.0016, "specific marker": 0.0016, "normal skin": 0.0016, "normal menstrual history": 0.0016, "poly [": 0.0016, "normal expansion": 0.0016, "underlying mechanism remains unclear": 0.0016, "anti-e. chaffeensis antibody": 0.0016, "septic shock suggest": 0.0016, "partial inhibition": 0.0016, "enhance il-6 production": 0.0016, "c-fos/c-jun family": 0.0016, "creb/atf family": 0.0016, "ngfi-b/nur77 family": 0.0016, "icp36 family": 0.00159, "rel/nf-kb family": 0.00159, "late treatment": 0.00159, "hiv-1 increases": 0.00159, "normal females": 0.00159, "integrity determines normal": 0.00159, "multigene family": 0.00159, "aml/pebp2/cbf family": 0.00159, "normal wound healing": 0.00159, "ccacc/sp1 family": 0.00159, "elucidate normal immunoregulation": 0.00159, "il-12 signaling": 0.00159, "dsl family": 0.00159, "hiv production": 0.00159, "variable weak phosphorylation": 0.00159, "beta-chemokine family": 0.00159, "pax-gene family": 0.00159, "il-1 receptors": 0.00159, "ongoing hiv-1 replication": 0.00159, "mnp family": 0.00159, "normal donor": 0.00159, "kappa b-alpha proteolysis": 0.00159, "conserved role": 0.00159, "negative regulation": 0.00159, "prevented apoptosis": 0.00159, "lipopolysaccharide stimulation": 0.00159, "socs/cis/ssi family": 0.00159, "pebp2/cbf family": 0.00159, "signaling process": 0.00159, "southern blot hybridization identified": 0.00159, "truncated gp130 receptors": 0.00159, "msin3 family": 0.00159, "stimulation process": 0.00159, "lipopolysaccharide signaling": 0.00159, "rhombotin family": 0.00159, "avian sarcoma/leukemia virus ltrs": 0.00159, "differentiation blocks": 0.00159, "marked inhibition": 0.00159, "acetyl salicylic acid-mediated inhibition": 0.00159, "id family": 0.00159, "prodigiosin family": 0.00159, "minimal mu enhancer": 0.00159, "il-12 stimulation": 0.00159, "polyclonal anti-tf antibody": 0.00159, "-c-c family": 0.00159, "zfh family": 0.00159, "il 6-induced differentiation": 0.00159, "specific hla-dq alleles": 0.00159, "mild detergent treatment": 0.00159, "block signaling": 0.00159, "enzyme-linked immunosorbent assay procedure": 0.00159, "identified member": 0.00159, "cellular target": 0.00159, "enhancer repressor": 0.00159, "show genomic rearrangements": 0.00159, "[ g.nabel": 0.00159, "inducing apoptosis": 0.00159, "sequestered cytoplasmic form": 0.00159, "bovine papilloma virus": 0.00158, "luciferase assay": 0.00158, "nf-kappab components p50": 0.00158, "normal persons": 0.00158, "promotes eosinophil apoptosis": 0.00158, "prolonged corticosteroid treatment": 0.00158, "normal erythropoiesis": 0.00158, "identified ligands": 0.00158, "recent data show": 0.00158, "normal tonsils": 0.00158, "identified stat1": 0.00158, "protease treatment": 0.00158, "glucocorticoid-mediated apoptosis correlates": 0.00158, "nf-kappab inhibitors": 0.00158, "cytokines il-2": 0.00158, "helper differentiation proceeds": 0.00158, "beta isoforms": 0.00158, "common type": 0.00158, "polyclonal antibody": 0.00158, "rnase treatment prior": 0.00158, "differential treatment": 0.00158, "p130 complexes e2f-4": 0.00158, "current findings suggest": 0.00158, "untransformed steroid receptors": 0.00158, "regulating signaling": 0.00158, "pbmc receptors": 0.00158, "il-1 signaling": 0.00158, "family": 0.00158, "mutated receptors": 0.00158, "il-4-induced stat6 phosphorylation": 0.00158, "rxrs form heterodimers": 0.00158, "data suggest": 0.00158, "active form": 0.00158, "activating phosphorylation": 0.00158, "pcd41 clone demonstrated": 0.00158, "key transcriptional regulator": 0.00158, "granulocytic differentiation": 0.00158, "mitogen assay procedure": 0.00158, "cytopathic virus infections": 0.00158, "il-2 target": 0.00158, "cd2-mediated interleukin-2 production occurs": 0.00158, "augmented il-2 secretion": 0.00158, "[ 1,25-": 0.00158, "il-1 stimulation": 0.00158, "extracellular stimulation": 0.00158, "composite kappa": 0.00158, "pkc stimulation": 0.00158, "regulated interaction": 0.00158, "sequence-specific complexes": 0.00158, "cellular activities": 0.00158, "oncogenic virus": 0.00158, "inducible transcriptional regulators": 0.00158, "alternative splicing generates type": 0.00158, "extracellular receptors": 0.00158, "model system": 0.00158, "mononitrosyl iron complexes": 0.00157, "hiv-1 gp41-induced il-10 up-regulation": 0.00157, "nf-kappab action": 0.00157, "pdgf [": 0.00157, "hiv-1 rna": 0.00157, "sequence-specific transcriptional repressor": 0.00157, "neutrophil apoptosis": 0.00157, "[ dre": 0.00157, "cell-specific enhancer": 0.00157, "differentiation processes": 0.00157, "blocking antibody": 0.00157, "htlv-i enhancer": 0.00157, "lsf [": 0.00157, "hiv-1 iiib replication": 0.00157, "long-term treatment": 0.00157, "il-2 -and il-3": 0.00157, "heterodimeric complexes": 0.00157, "hiv-1 transactivation": 0.00157, "fast-migrating protein-dna complexes": 0.00157, "neutrophil stimulation": 0.00157, "specific targets": 0.00157, "[ corticoids": 0.00157, "additional enhancer": 0.00157, "normal myelopoiesis": 0.00157, "tcr beta clonotypes": 0.00157, "effective inhibition": 0.00157, "ig kappa": 0.00157, "kappa enhancers": 0.00157, "cell-specific bifunctional role": 0.00157, "specific dor1 agonist": 0.00157, "celiac disease due": 0.00157, "il-6 neutralizing antibodies": 0.00157, "transcriptional capacity": 0.00157, "positive regulation": 0.00157, "cbf beta subunits": 0.00157, "normal counterpart": 0.00157, "observed retrovirus-like particles": 0.00157, "recombinant nfatp demonstrated": 0.00156, "vivo il-2 administration": 0.00156, "normal ln": 0.00156, "fc receptors": 0.00156, "complicated assay procedure": 0.00156, "normal pbm": 0.00156, "vivo regulation": 0.00156, "cytoplasmic nf-kappab": 0.00156, "normal splenic": 0.00156, "active nf-kappab": 0.00156, "normal adults": 0.00156, "skeletal muscle expressed": 0.00156, "il-2-induced ifn-gamma production": 0.00156, "initial peak observed": 0.00156, "% bovine serum albumin": 0.00156, "nf-kappab bound": 0.00156, "octamer enhancer": 0.00156, "c/ebp transcriptional activators": 0.00156, "interleukin-2 enhancer": 0.00156, "ifn-gamma-activated sequence-binding complexes": 0.00156, "virus latency": 0.00156, "infectious virus stocks": 0.00156, "normal hematopoiesis": 0.00156, "t-cells treatment": 0.00156, "kappa e3": 0.00156, "hpc differentiation program": 0.00156, "activating elements": 0.00156, "additional role": 0.00156, "p100 inhibition": 0.00156, "hiv-1 replication": 0.00156, "healthy donors show": 0.00156, "intrinsic kappa": 0.00156, "nfat-containing complexes devoid": 0.00156, "specific lysis": 0.00155, "protein-dna complexes": 0.00155, "calcium signaling": 0.00155, "e2f complexes": 0.00155, "vivo footprinting demonstrated": 0.00155, "lmp1 signaling": 0.00155, "additional stimulation": 0.00155, "aldosterone receptors": 0.00155, "common mechanism": 0.00155, "pml/raralpha transgenic mice": 0.00155, "normal limits": 0.00155, "p-like element-binding complexes": 0.00155, "specific mrnas": 0.00155, "dex inhibition": 0.00155, "single form": 0.00155, "anti-ig stimulation involves": 0.00155, "dna-bound multi-protein complexes": 0.00155, "nuclease protection assay": 0.00155, "original al1 virus stock": 0.00155, "differential phosphorylation": 0.00155, "[": 0.00155, "cd40 stimulation": 0.00155, "interleukin-2 receptors": 0.00155, "tcr beta": 0.00155, "ten control subjects": 0.00155, "calcium stimulation": 0.00155, "wild- type cd4": 0.00155, "complementation groups identified": 0.00155, "vivo interaction": 0.00155, "chicken anemia virus": 0.00155, "inhibits ligand-inducible degradation": 0.00155, "promote differentiation": 0.00155, "c-myc transcriptional regulator": 0.00155, "negative function": 0.00155, "differentiation step": 0.00154, "antagonistic anti-tr55 antibody": 0.00154, "anti-hbx antibody titers": 0.00154, "steroid receptors": 0.00154, "maximum inhibition": 0.00154, "pertussis toxin treatment": 0.00154, "ptk inhibition": 0.00154, "specific features": 0.00154, "subsequent interaction leading": 0.00154, "normal race-": 0.00154, "growth suppression": 0.00154, "cd40 signaling": 0.00154, "radiolabeled hormone/receptor complexes": 0.00154, "affect spi-b function": 0.00154, "chimeric mice": 0.00154, "phosphorylation reaction": 0.00154, "normal cem-c7": 0.00154, "tumour differentiation": 0.00154, "normal myeloblasts": 0.00154, "subtypes expressed ebnai": 0.00154, "normal livers": 0.00154, "normal menses": 0.00154, "vivo antigen challenge": 0.00154, "molecular interactions": 0.00154, "virus progeny": 0.00154, "anti-ebv antibody titres": 0.00154, "beta subunit": 0.00154, "antiandrogens show agonistic properties": 0.00154, "non-depressed control subjects": 0.00154, "form heterodimers": 0.00154, "identified pi 3-kinase effectors": 0.00154, "regulates zap-70 function": 0.00154, "% homologous porcine serum": 0.00154, "promoter-bound multi-protein complexes": 0.00154, "maturing normal": 0.00154, "dna-protein complexes": 0.00154, "vzv ge expressed": 0.00154, "monitor minimal residual disease": 0.00154, "virus carriers": 0.00154, "stat5 phosphorylation": 0.00154, "normal epidermis": 0.00154, "competitive enzyme-linked immunosorbent assay": 0.00154, "normal counterparts": 0.00154, "indistinguishable kappa": 0.00154, "nf-kappab essential modulator": 0.00154, "pocket protein-e2f complexes": 0.00154, "avian erythroblastosis virus": 0.00153, "mice carrying transgenes": 0.00153, "positive function": 0.00153, "tcr-mediated signaling processes": 0.00153, "system suggests": 0.00153, "weakly expressed": 0.00153, "estrogen type": 0.00153, "specific proteases": 0.00153, "infectious virus": 0.00153, "nonatopic control subjects": 0.00153, "anti-cd3 stimulation": 0.00153, "normal ter": 0.00153, "normal brother": 0.00153, "normal mande": 0.00153, "normal constituent": 0.00153, "elements recognized": 0.00153, "normal hemopoiesis": 0.00153, "transcriptional defect": 0.00153, "quantitative assay": 0.00153, "normal rh": 0.00153, "transcriptional repression": 0.00153, "proximal beta": 0.00153, "observed 3-6 months": 0.00153, "-mediated inhibition": 0.00153, "downregulates tnf production": 0.00153, "p50-p65 nf-kappab heterodimers": 0.00153, "alpha2 integrin enhancer": 0.00153, "virus particle": 0.00153, "p50/c-rel complexes": 0.00153, "kappa b/mad-3 masks": 0.00153, "il-10 receptors": 0.00153, "clonal assay": 0.00153, "selective phosphorylation": 0.00153, "cellular defect leading": 0.00153, "cd28 receptors": 0.00153, "cd3 epsilon enhancer": 0.00153, "specific substrates": 0.00153, "jun phosphorylation": 0.00153, "specific polyclonal antisera": 0.00153, "continued adjuvant tamoxifen treatment": 0.00153, "yeast transcriptional regulator rpd3p": 0.00153, "subsequent apoptosis": 0.00153, "specific components": 0.00153, "mediate nf-kappab": 0.00153, "herpes simplex virus": 0.00153, "il-6 stimulation": 0.00153, "mediating apoptosis": 0.00153, "signaling involves": 0.00153, "thyroid hormone-response elements": 0.00152, "epitope specific": 0.00152, "specific strategies": 0.00152, "cd28 stimulation": 0.00152, "eosinophil differentiation": 0.00152, "differentiation program foreign": 0.00152, "partial differentiation": 0.00152, "gcr treatment": 0.00152, "dor1 augments il-2 secretion": 0.00152, "unique biological function": 0.00152, "fkbp12/fk506 complexes": 0.00152, "coordinate inhibition": 0.00152, "tax1-related antigen molecules": 0.00152, "myc promotes activation-induced apoptosis": 0.00152, "exogenous growth stimuli": 0.00152, "direct ebna-2-pu.1 interaction": 0.00152, "macrophage receptors": 0.00152, "tgf-beta regulates iga production": 0.00152, "phosphotyrosine antibody": 0.00152, "normal": 0.00152, "il-1beta treatment": 0.00152, "cellular phenotype": 0.00152, "slow migrating complexes": 0.00152, "export complexes": 0.00152, "electrophoretic mobility-shift assay": 0.00152, "glucocorticoid-mediated inhibition": 0.00152, "lymphocytic mineralocorticoid receptors": 0.00152, "constitutive gh production": 0.00152, "vivo function": 0.00152, "okt3 antibody": 0.00152, "longer expressed": 0.00152, "tnfalpha treatment": 0.00152, "treatment periods symptoms": 0.00152, "il-2 controls": 0.00152, "apoptosis effector bax": 0.00152, "c-fos production": 0.00152, "prevents apoptosis": 0.00152, "treatment sufficient": 0.00152, "critical mechanism": 0.00152, "turn inhibits translocation": 0.00152, "negative control": 0.00152, "biological role": 0.00152, "kappa b-alpha": 0.00152, "antibody titres": 0.00152, "lymphoid system": 0.00152, "expressed beta-": 0.00152, "undergo signal-induced phosphorylation": 0.00152, "specific abs": 0.00152, "kappa b-binding": 0.00152, "cd28 signaling": 0.00152, "resultant tnf-alpha production": 0.00152, "n-acetylcysteine inhibition": 0.00152, "subsequent recurrences identified": 0.00151, "pha stimulation": 0.00151, "expressed a-myb": 0.00151, "interleukin-10 inhibition": 0.00151, "dose-dependent inhibition": 0.00151, "complement receptors cr1": 0.00151, "differentiation stages": 0.00151, "and/or growth": 0.00151, "concomitant 40-50 % decrease": 0.00151, "biological stimulation": 0.00151, "kappa b/mad-3": 0.00151, "pr antibody": 0.00151, "granulocyte differentiation": 0.00151, "identical signaling cascades": 0.00151, "concentration-dependent inhibition": 0.00151, "modulating differentiation": 0.00151, "varicella zoster virus": 0.00151, "control subjects": 0.00151, "affect production": 0.00151, "direct interaction": 0.00151, "profound inhibition": 0.00151, "reported role": 0.00151, "rnase protection assay": 0.00151, "facilitate virus spread": 0.00151, "site-specific antibody": 0.00151, "anti-tnf-alpha antibody": 0.00151, "alternative tat function": 0.00151, "vivo protein-dna interactions": 0.00151, "nf- kappa": 0.00151, "skeletal muscles expressed": 0.00151, "virus reactivation": 0.00151, "pr complexes": 0.00151, "nf-kappab suppression": 0.00151, "hiv-1 kappab oligonucleotide": 0.00151, "suppressed growth": 0.00151, "observed failure": 0.00151, "differential role": 0.00151, "tnf translational regulation": 0.00151, "il-2 contained": 0.00151, "cro-ap/5 expressed indeterminate": 0.00151, "pebp2betamyh11 transgenic mice": 0.00151, "fas signaling": 0.00151, "context-dependent apoptosis regulator": 0.00151, "pg490 inhibition": 0.00151, "stat6 phosphorylation": 0.00151, "kappa b-2": 0.00151, "irf-1 gas elements": 0.00151, "p50/nf-kappa b-mediated inhibition": 0.00151, "transgenic mice engineered": 0.00151, "receptor-mediated anti-cd3/anti-cd3+ anti-cd28 stimulation": 0.00151, "hiv-1 harboring mutations": 0.00151, "ribonuclease protection assay": 0.00151, "retinoid-induced differentiation program": 0.00151, "abnormal effector mechanism": 0.0015, "blocks paclitaxel-induced apoptosis": 0.0015, "anti-fas antibody": 0.0015, "tcf-1 expressed": 0.0015, "pnu156804 inhibition": 0.0015, "proteolytic assay": 0.0015, "stat3 antibodies": 0.0015, "maf complexes": 0.0015, "dominant role": 0.0015, "il13 receptors share": 0.0015, "thy-tax transgenic mice": 0.0015, "anti-ig antibody": 0.0015, "p55/c-rel complexes": 0.0015, "transcriptional up-regulation": 0.0015, "platelet/endothelium interaction plays": 0.0015, "thymocytes control": 0.0015, "pkc-dependent signaling systems": 0.0015, "p24 ag assay": 0.0015, "anti-tnf antibody": 0.0015, "specific band": 0.0015, "hiv-ltr/tat transgenic mice": 0.0015, "-induced differentiation": 0.0015, "promoted differentiation": 0.0015, "kappa b-1": 0.0015, "simian virus": 0.0015, "retarded complexes": 0.0015, "reactivated virus": 0.0015, "key leukemogenetic role": 0.0015, "specific antigenic stimulus": 0.0015, "transcriptional down-regulation": 0.0015, "antibody mib-1": 0.0015, "aid kappa": 0.0015, "cooperative inhibition": 0.0015, "activin a-induced smad2 phosphorylation": 0.0015, "short treatment": 0.0015, "dramatic inhibition": 0.0015, "cellular events": 0.0015, "caprine arthritis-encephalitis virus": 0.0015, "subsequent coactivator function": 0.0015, "inhibits tnf translation": 0.0015, "positive control": 0.0015, "differential stimulation": 0.0015, "expressed ebna2": 0.0015, "differential signaling": 0.0015, "bone growth": 0.0015, "cn inhibition": 0.0015, "regulate zap-70 function": 0.0015, "tshr antibody": 0.0015, "antibody d07": 0.0015, "suppress transcriptional activators": 0.0015, "% staining": 0.0015, "virus envelope": 0.0015, "epo treatment": 0.0015, "cellular extracts": 0.0015, "specific depletion": 0.0015, "apoptosis occurs": 0.0015, "sl3 virus": 0.0015, "reversible differentiation": 0.0015, "transcriptional repressor icer": 0.0015, "granulocytic-neutrophilic differentiation program": 0.0015, "cellular stimuli involves": 0.0015, "platelet production": 0.0015, "yy1-mediated inhibition": 0.0015, "gcrbeta-specific antibody": 0.00149, "blocks apoptosis": 0.00149, "p70i kappa": 0.00149, "authentic kappa": 0.00149, "beta-bound complexes": 0.00149, "kappa b-site": 0.00149, "stat3-containing complexes": 0.00149, "mad3/i kappa": 0.00149, "ligand-activated c-erba/tr accelerated differentiation": 0.00149, "anti-cd18 antibody": 0.00149, "dexamethasone-mediated inhibition": 0.00149, "cf lung disease": 0.00149, "unilineage erythropoietic differentiation": 0.00149, "affect function": 0.00149, "durable inhibition": 0.00149, "abortive stimulation leading": 0.00149, "nfat-dna complexes": 0.00149, "lef-1-beta-catenin complexes": 0.00149, "pentoxifylline-mediated inhibition": 0.00149, "hsf/hsp70-mediated inhibition": 0.00149, "kappa bs": 0.00149, "kappa 1-kappa": 0.00149, "mechanism independent": 0.00149, "kappa b-alpha/mad-3": 0.00149, "specific cytotoxicity": 0.00149, "sp1 interaction": 0.00149, "activin a-induced growth arrest": 0.00149, "il-2 action": 0.00149, "inhibitory mechanism": 0.00149, "anti-tag antibody": 0.00149, "low-mobility complexes": 0.00149, "regulates cellular immunity": 0.00149, "anti-p65 antibody": 0.00149, "pulse treatment": 0.00149, "anti-capsular antibody": 0.00149, "kappa b/mad3": 0.00149, "eosinophil specific beta-chemokine": 0.00149, "program commonly observed": 0.00149, "expressed cd44": 0.00149, "rel/stat complexes": 0.00149, "stat4-containing complexes": 0.00149, "steroid-receptor complexes": 0.00149, "mhc-peptide complexes": 0.00149, "ap1 transcriptional regulator": 0.00149, "agonist stimulation": 0.00149, "ad5-induced inhibition": 0.00149, "support proper regulation": 0.00149, "faster-migrating complexes": 0.00149, "phenotypic differentiation": 0.00149, "selective role": 0.00149, "pha-mediated ifn-gamma production": 0.00149, "kappa b-fos-cat": 0.00149, "fk506-mediated inhibition": 0.00149, "yae antibody": 0.00149, "metalloproteinase inhibition": 0.00149, "selenium-mediated inhibition": 0.00149, "anti-ifn-alpha/beta antibody": 0.00149, "gc-induced inhibition": 0.00149, "dimeric complexes": 0.00149, "nf-kappab translocation": 0.00149, "csa treatment": 0.00149, "ec1 antibody": 0.00149, "2-week captopril treatment": 0.00149, "antiserum specific": 0.00149, "dmso treatment": 0.00149, "timp-1 suppresses apoptosis": 0.00149, "kappa b-beta": 0.00149, "transgenic mice": 0.00149, "disease process": 0.00149, "specific antiserum": 0.00149, "p65-i kappa": 0.00149, "persistent phosphorylation": 0.00149, "gm-csf enhancer": 0.00149, "mut-i kappa": 0.00149, "antioxidant-mediated inhibition": 0.00149, "identified calcineurin": 0.00149, "fractional inhibition": 0.00149, "recent reports suggest": 0.00149, "mediate protein-protein interactions": 0.00149, "stat1alpha-dna complexes": 0.00149, "nk- kappa": 0.00149, "mice transgenic": 0.00149, "costimulatory receptors cd2": 0.00149, "cd18 expressed": 0.00149, "kappa b-4": 0.00149, "anti-ikappabalpha antibody": 0.00149, "ctla-4-mediated inhibition": 0.00149, "rapamycin-mediated inhibition": 0.00149, "isotype-matched antibody": 0.00149, "c-jun-containing complexes": 0.00149, "pharmacologic inhibition": 0.00149, "multiprotein complexes": 0.00149, "anti-il-10 antibody": 0.00149, "specific actions": 0.00149, "rapid production": 0.00149, "rela-i kappa": 0.00149, "kappa b-3": 0.00149, "cd8-mediated inhibition": 0.00149, "antibodies due": 0.00149, "key role": 0.00149, "underwent differentiation": 0.00149, "prolonged treatment": 0.00149, "camp signaling": 0.00148, "transcriptional analyses": 0.00148, "maximal stimulation": 0.00148, "ikappabalpha phosphorylation": 0.00148, "blast differentiation": 0.00148, "time-dependent differentiation": 0.00148, "parallels morphological differentiation": 0.00148, "nf-kappab p65": 0.00148, "ige production shows": 0.00148, "phosphorylation status": 0.00148, "atra-induced differentiation": 0.00148, "basic helix-loop-helix protein-mediated regulation": 0.00148, "effective treatment": 0.00148, "cell-specific transcriptional coactivators": 0.00148, "corticosteroid treatment": 0.00148, "expressed mnda": 0.00148, "cd30-cd30l interactions mediate": 0.00148, "specific interferon isotypes": 0.00148, "h2o2 treatment": 0.00148, "complexes": 0.00148, "observed phenomenon": 0.00148, "lipopolysaccharide-induced tnf-alpha production": 0.00148, "cellular redox state": 0.00148, "isoform-specific c-terminal antibodies": 0.00148, "gm-csf stimulation": 0.00148, "platelet function": 0.00148, "rt-pcr assay": 0.00148, "immunoblot assay eightfold": 0.00148, "general transcriptional activators": 0.00148, "gata elements": 0.00148, "intestinal permeability observed": 0.00148, "kappa": 0.00148, "antibody": 0.00148, "specific families": 0.00148, "efficient phosphorylation": 0.00147, "alpha-tocopherol treatment": 0.00147, "sex differentiation": 0.00147, "significant il-2": 0.00147, "interleukin-1 signaling mediators": 0.00147, "hematopoietic system": 0.00147, "-10 inhibits lipopolysaccharide": 0.00147, "captopril treatment": 0.00147, "cotransfection assay": 0.00147, "expressed bcl2": 0.00147, "general role": 0.00147, "stat1 beta": 0.00147, "adeno-associated virus": 0.00147, "pcr analyses demonstrated": 0.00147, "band-shift assay indistinguishable": 0.00147, "inhibition": 0.00147, "rapid growth": 0.00147, "t-lymphocyte differentiation": 0.00147, "alternative splicing mechanism": 0.00147, "twenty-four hour treatment": 0.00147, "transient heterokaryon system": 0.00147, "tnf production": 0.00147, "influenza virus": 0.00147, "c-fos control": 0.00147, "nonepithelial mineralocorticoid receptors": 0.00147, "pma-induced differentiation": 0.00147, "b-lymphocyte growth transformation": 0.00147, "friend virus": 0.00147, "mice exposed": 0.00147, "transcriptional repressor": 0.00147, "beta isoform": 0.00147, "signaling processes": 0.00147, "mineralocorticoid effector mechanism": 0.00147, "regulating interleukin-1 production": 0.00147, "show differences": 0.00147, "observed nfkappab": 0.00147, "erythropoietic differentiation": 0.00147, "-mediated differentiation": 0.00146, "nac treatment": 0.00146, "tunel assay": 0.00146, "specific progeny": 0.00146, "alterations observed": 0.00146, "differentiation inducers": 0.00146, "ar assay": 0.00146, "cyclosporin a-sensitive mechanism": 0.00146, "humara assay": 0.00146, "principal cis-acting elements": 0.00146, "g-protein-coupled chemoattractant receptors": 0.00146, "stress system": 0.00146, "nf-kappab subunit": 0.00146, "gene-targeted mice deficient": 0.00146, "nfat regulation": 0.00146, "cellular oxidant stress": 0.00146, "ebv-induced growth transformation": 0.00146, "simultaneous treatment": 0.00146, "simplified assay performance": 0.00146, "surrogate tg receptors": 0.00146, "vascular disease": 0.00146, "chimeric type ii/type": 0.00146, "leukocyte clearance mechanism": 0.00146, "eosinophilic differentiation": 0.00146, "expressed gata-2/er": 0.00146, "specific antagonists": 0.00146, "ifn-gamma production": 0.00146, "dex treatment": 0.00146, "specific program": 0.00146, "minimal residual disease": 0.00146, "specific methylation": 0.00146, "lymphotropic virus": 0.00146, "gct expressed": 0.00146, "ubiquitous transcriptional regulators": 0.00146, "t-cell-specific transcriptional regulator": 0.00146, "atra treatment": 0.00146, "specific property": 0.00146, "dextran-coated charcoal assay": 0.00146, "stimulate ikappab production": 0.00146, "regulating e2f function": 0.00146, "virus stocks": 0.00146, "expressed e2a-pbx1": 0.00146, "virus reservoir": 0.00146, "undergone pre-terminal differentiation": 0.00146, "mtetra-induced il-1 beta": 0.00146, "obstructive renal disease": 0.00146, "m-csf treatment": 0.00146, "monocytoid differentiation": 0.00146, "polarized differentiation": 0.00146, "neuronal differentiation": 0.00146, "apparent dual function": 0.00146, "varicella-zoster virus": 0.00146, "assay volume": 0.00146, "interferon-gamma treatment": 0.00146, "gata-1 function": 0.00146, "immunoglobulin production": 0.00145, "encephalomyocarditis virus": 0.00145, "met treatment": 0.00145, "supershift assay": 0.00145, "tax function": 0.00145, "nonleukemogenic virus": 0.00145, "monitor disease progression": 0.00145, "il-3 ck-1/ck-2 elements": 0.00145, "conserved mechanism": 0.00145, "il-2-induced phosphorylation": 0.00145, "salicylate treatment": 0.00145, "hiv-1 transfected": 0.00145, "specific modification": 0.00145, "growth transformation": 0.00145, "require phosphorylation": 0.00145, "autoimmune thyroid disease": 0.00145, "physiological role": 0.00145, "non-cytotoxic lmp-1 signaling": 0.00145, "nf-kappab subunits c-rel": 0.00145, "form metastatic tumors": 0.00145, "cd40-mediated differentiation": 0.00145, "reticuloendotheliosis virus": 0.00145, "inhibits h2o2 release": 0.00145, "independent interaction": 0.00145, "isogenic control ltr": 0.00145, "ctg-dimer virus": 0.00145, "megakaryocytic differentiation": 0.00145, "undergo apoptosis": 0.00145, "virus infectivity": 0.00145, "notch receptors signalling": 0.00145, "putative function": 0.00145, "identified leading": 0.00145, "enzyme-linked immunosorbent assay": 0.00145, "methylation interference analyses demonstrated": 0.00145, "stabilization assay": 0.00145, "ctg-monomer virus": 0.00145, "nfatp/ap-1 composite elements": 0.00145, "serine phosphorylation": 0.00145, "proliferative signaling": 0.00145, "generate anti-tcf-1 antibodies": 0.00145, "hiv-1 nef leads": 0.00145, "tnf-alpha production": 0.00145, "peroxisome proliferator-activated receptors": 0.00145, "dfx treatment limits": 0.00145, "morphologic differentiation": 0.00145, "strong transcriptional repressors": 0.00145, "nf-at-deficient mice supports": 0.00145, "hiv-1 strain iiib": 0.00145, "radiation-induced signaling cascade": 0.00145, "promote apoptosis": 0.00145, "air-1 locus function": 0.00145, "standard treatment": 0.00145, "gr function": 0.00145, "type iv collagen": 0.00145, "virus multiplication": 0.00145, "c-rel nf-kappab subunits": 0.00145, "enhancer consists": 0.00145, "fp treatment": 0.00145, "il-13 treatment": 0.00145, "squamous differentiation": 0.00145, "characterize nfat function": 0.00145, "abelson virus": 0.00145, "rnf-il6 expressed": 0.00145, "mice deficient": 0.00145, "cmv elements": 0.00145, "blocking cellular uptake": 0.00145, "sex steroid regulation": 0.00145, "cis-acting elements gm-kappa b/gc-box": 0.00144, "studied il-2": 0.00144, "findings suggest": 0.00144, "virus": 0.00144, "tcf-1 knock-out mice": 0.00144, "nf-kappab regulates fas/apo-1/cd95-": 0.00144, "expressed": 0.00144, "defective apoptosis": 0.00144, "specific inducer": 0.00144, "logarithmic growth phase": 0.00144, "differentiation dose-response": 0.00144, "antisera specific": 0.00144, "il-1beta stimulation": 0.00144, "myelomonocytic differentiation": 0.00144, "ifn stimulation": 0.00144, "gas elements": 0.00144, "chemokine receptors": 0.00144, "so-called au-rich elements": 0.00144, "il-1 beta": 0.00144, "flanking negative-acting elements": 0.00144, "nf-kappab/ikappab system regulates": 0.00144, "specific antisera": 0.00144, "full er function": 0.00144, "lung disease": 0.00144, "diminished j393/cd43-mediated apoptosis": 0.00144, "specific granules": 0.00144, "immunosuppression observed": 0.00144, "initial signaling": 0.00144, "ets1 specific": 0.00144, "neuroblastoma differentiation": 0.00144, "ifn signaling": 0.00144, "show evidence": 0.00144, "as2o3 treatment": 0.00144, "synergism observed": 0.00144, "cis -regulatory elements": 0.00144, "junb phosphorylation": 0.00144, "wnt signaling cascade": 0.00144, "enzymatic assay": 0.00144, "specific event": 0.00144, "specific bands": 0.00144, "central pathogenic role": 0.00144, "nf-kappab plays": 0.00144, "apoptotic signaling": 0.00144, "classic androgen receptors": 0.00144, "methylprednisolone treatment": 0.00144, "il-5 stimulation": 0.00144, "clonogenic assay": 0.00144, "abnormal apoptosis": 0.00144, "chicken c/ebp beta": 0.00144, "u2 enhancer constructions": 0.00144, "hiv-1 genome carrying": 0.00144, "uncoupling activation-dependent hs1 phosphorylation": 0.00144, "disease marker": 0.00144, "mechanism dependent": 0.00144, "hiv-1 ltr responds": 0.00143, "b-lymphocyte differentiation": 0.00143, "progesterone receptors": 0.00143, "il-3 enhancer": 0.00143, "specific mitogens": 0.00143, "vd3 treatment": 0.00143, "diverse receptors": 0.00143, "cell-type specific": 0.00143, "plasmacytoid differentiation": 0.00143, "gel-shift assay": 0.00143, "tcr-beta/tcr-delta double knockout mice": 0.00143, "morphological differentiation": 0.00143, "complement receptors": 0.00143, "transcriptional repressors encoded": 0.00143, "p50 form": 0.00143, "isoforms demonstrated": 0.00143, "tetanus toxoid specific": 0.00143, "monocyte interactions": 0.00143, "preclinical models suggest": 0.00143, "cis elements": 0.00143, "neutrophilic differentiation": 0.00143, "ionomycin treatment": 0.00143, "complementation assay": 0.00143, "primers specific": 0.00143, "il-2-independent growth correlated": 0.00143, "cyclic amp production": 0.00143, "il-5 signaling": 0.00143, "signaling cascade": 0.00143, "ic50 = <": 0.00143, "transcriptional basis": 0.00143, "elements homologous": 0.00143, "tnfalpha stimulation": 0.00143, "megakaryocyte differentiation": 0.00143, "il-2/ifn alpha-based treatment": 0.00143, "-1 beta": 0.00143, "intron enhancer": 0.00143, "nef phosphorylation": 0.00143, "cotton-top tamarin receptors": 0.00143, "transformation system": 0.00143, "solid tumours influence growth": 0.00143, "continuous treatment": 0.00143, "endogenous il-1ra production": 0.00143, "alpha-globin hs-40 enhancer": 0.00143, "haematopoietic differentiation": 0.00143, "ifn-alpha treatment": 0.00143, "10-fold stimulation": 0.00143, "% suppression": 0.00143, "immunosorbent assay": 0.00143, "composite elements": 0.00143, "tal-1 mice": 0.00143, "inhibitory function": 0.00142, "function independent": 0.00142, "specific context": 0.00142, "pma inhibits": 0.00142, "cell-specific translational regulation": 0.00142, "acth stimulation tests": 0.00142, "unique deleterious mechanism": 0.00142, "specific cooperation": 0.00142, "concomitant stimulation": 0.00142, "cadmium treatment": 0.00142, "nf-kappab components c-rel": 0.00142, "hemin treatment": 0.00142, "cd3-induced hsi phosphorylation": 0.00142, "crucial elements": 0.00142, "nf-il6 enhancer": 0.00142, "form granulocytic colonies": 0.00142, "interleukin-1 beta precursor": 0.00142, "cysteine-rich antigen segments resistant": 0.00142, "th1/th2 differentiation": 0.00142, "form platelets": 0.00142, "epo-induced differentiation": 0.00142, "nonradioactive assay": 0.00142, "vd treatment": 0.00142, "eosinophil stimulation": 0.00142, "ifngamma treatment": 0.00142, "neutrophil interleukin-8 production": 0.00142, "affinity-binding assay": 0.00142, "inducibility/cell type specificity": 0.00142, "observed extended": 0.00142, "adipocyte differentiation": 0.00142, "analogous cell-cycle-regulated phosphorylation": 0.00142, "treatment regimens": 0.00142, "ra-induced differentiation": 0.00142, "cobalt chloride-induced signaling": 0.00142, "mitogenic stimulation": 0.00142, "dfx treatment": 0.00142, "monocyte-macrophage differentiation": 0.00142, "mineralocorticoid receptors": 0.00142, "determining role": 0.00142, "anti-igm stimulation": 0.00142, "separate prl-responsive elements": 0.00142, "unilineage differentiation": 0.00142, "healthy control": 0.00142, "cell-specific mechanism": 0.00142, "additional mechanism": 0.00142, "specific bright foci": 0.00142, "xenoreactive natural antibodies": 0.00142, "il-12 production": 0.00142, "mitogenic signaling": 0.00142, "tpa-induced differentiation": 0.00142, "faster assay": 0.00142, "powerful enhancer": 0.00142, "stat1 function": 0.00142, "epo-dependent differentiation": 0.00142, "neutralizing antibodies renders": 0.00142, "whole-cell assay": 0.00142, "ifn-beta treatment": 0.00142, "assay conditions-concentration": 0.00141, "specific sets": 0.00141, "ig enhancer": 0.00141, "pma/ca2+ ionophore stimulation": 0.00141, "coimmunoprecipitation assay": 0.00141, "eosinophil apoptosis": 0.00141, "pin*point assay": 0.00141, "cortisol production": 0.00141, "activin a-mediated signaling": 0.00141, "disease pathogenesis": 0.00141, "mature monocyte/macrophage function": 0.00141, "nf-kappab p50": 0.00141, "immunoradiometric assay": 0.00141, "rhythmic differentiation": 0.00141, "radioligand-binding assay": 0.00141, "osteoclast differentiation": 0.00141, "ra addition": 0.00141, "dna-binding/immunoprecipitation assay": 0.00141, "flow-cytometric assay": 0.00141, "anthracycline-induced differentiation": 0.00141, "marked stimulation": 0.00141, "pf treatment": 0.00141, "hematopoletic differentiation": 0.00141, "mobility-shift assay": 0.00141, "run-on assay": 0.00141, "transmembrane signaling": 0.00141, "monocyte-binding receptors e-selectin": 0.00141, "ba-induced differentiation": 0.00141, "assay reproducibility": 0.00141, "interferon receptors": 0.00141, "undergoing apoptosis": 0.00141, "gel-retardation assay": 0.00141, "dmso-induced differentiation": 0.00141, "scmv mie enhancer": 0.00141, "monocyte-to-macrophage differentiation": 0.00141, "adjuvant treatment": 0.00141, "hm-induced differentiation": 0.00141, "disease specificity": 0.00141, "nfat-luc assay": 0.00141, "conserved physical interactions": 0.00141, "chromogenic assay": 0.00141, "osteoblast-specific cis-acting elements": 0.00141, "receptors contributes": 0.00141, "control individuals": 0.00141, "transient-transfection assay": 0.00141, "distal enhancer": 0.00141, "virus-induced cellular transformation": 0.00141, "resulting production": 0.00141, "haemopoietic differentiation": 0.00141, "polyomavirus enhancer binding-protein": 0.00141, "monoblast differentiation": 0.00141, "life-threatening disease progression": 0.00141, "proximal il-2 promoter-enhancer": 0.00141, "acetate-induced differentiation": 0.00141, "block hla-dm function": 0.00141, "chromium-release assay": 0.00141, "ba treatment": 0.00141, "p130 phosphorylated form": 0.00141, "radioreceptor assay": 0.00141, "modulating apoptosis": 0.00141, "il-2r enhancer": 0.00141, "ml-9-induced differentiation": 0.00141, "high-throughput assay": 0.00141, "restricts differentiation": 0.00141, "flutamide treatment": 0.00141, "epo stimulation": 0.00141, "pma-induced phosphorylation": 0.00141, "ra-independent differentiation": 0.00141, "slide assay": 0.00141, "ra-dependent differentiation": 0.00141, "myeloid/monocytic differentiation": 0.00141, "r24 treatment": 0.0014, "gp160 treatment": 0.0014, "physiologic role": 0.0014, "differentiation": 0.0014, "immunized knock-out mice": 0.0014, "scl suggest": 0.0014, "complementary role": 0.0014, "sp-a treatment": 0.0014, "function remains unclear": 0.0014, "cysteamine treatment": 0.0014, "assay": 0.0014, "observed repertoire heterogeneity": 0.0014, "surrogate thyroglobulin receptors": 0.0014, "adenovirus type": 0.0014, "transcriptional regulator": 0.0014, "hiv-1 provirus correlated": 0.0014, "extensive apoptosis": 0.0014, "cell-specific regulation": 0.0014, "ligand-induced phosphorylation": 0.0014, "deoxycholate treatment": 0.0014, "spontaneous stimulation": 0.0014, "interleukin-2-receptor alpha-subunit enhancer": 0.0014, "prolonged stimulation": 0.0014, "hiv-1 ltr": 0.0014, "tgf-beta1 signaling": 0.0014, "surgical treatment": 0.0014, "specific consequence": 0.0014, "conservative treatment": 0.0014, "homozygous stat6-deficient mice": 0.0014, "precise role": 0.0014, "cd19 signaling": 0.0014, "cd16 stimulation": 0.0014, "sp1 show": 0.0014, "hbmp-2-induced smad1/smad5 phosphorylation": 0.0014, "pma/ionomycin treatment": 0.0014, "corticosteroid receptors": 0.0014, "ra/vd treatment": 0.0014, "rnase treatment": 0.0014, "il-2r beta supports": 0.0014, "footprinting identified": 0.0014, "specific autoantibodies": 0.0014, "relb knockout mice": 0.0014, "calcitriol receptors": 0.0014, "altered regulation": 0.0014, "anti-ig treatment": 0.0014, "cd2 receptors": 0.0014, "dopamine treatment": 0.0014, "nur77 knock-out mice": 0.0014, "anti-cd3 antibodies": 0.0014, "cyto-differentiating treatment": 0.0014, "-induced apoptosis": 0.0014, "hiv-1 transactivator tat": 0.0014, "thapsigargin treatment": 0.0014, "ketoconazole treatment": 0.0014, "cis-acting elements": 0.0014, "c3a stimulation": 0.0014, "anticancer treatment": 0.00139, "genetic system": 0.00139, "allergic eosinophilic disease": 0.00139, "nf-kappab correlated": 0.00139, "impairs tnf-alpha-induced apoptosis": 0.00139, "zinc-finger primers identified": 0.00139, "specific instance": 0.00139, "hbmp-2-induced growth arrest": 0.00139, "il-2r signaling": 0.00139, "observations suggest": 0.00139, "c/ebp beta": 0.00139, "nfat-like elements exist": 0.00139, "p1 nfat-binding elements": 0.00139, "identified prb": 0.00139, "inducible form": 0.00139, "jak phosphorylation": 0.00139, "oxidant stress-induced signaling": 0.00139, "cell-surface receptors": 0.00139, "cytotoxic effector function": 0.00139, "signaling defects": 0.00139, "er form": 0.00139, "octamer-binding elements": 0.00139, "assembly mechanism": 0.00139, "identified substrate": 0.00139, "prepartal treatment": 0.00139, "il-2r stimulation": 0.00139, "mammalian nf-kappab": 0.00139, "nfat-binding elements p0": 0.00139, "ag receptors": 0.00139, "tnf 5'-region show": 0.00139, "central role": 0.00139, "longer observed": 0.00139, "great stimulation": 0.00139, "far-upstream alpha-globin enhancer": 0.00139, "crucial role": 0.00139, "il-2 secretion": 0.00139, "-4 stimulation": 0.00139, "hiv-1 provirus involves cooperation": 0.00139, "androgen receptors": 0.00139, "native ptf beta": 0.00139, "prl stimulation": 0.00139, "relevant role": 0.00138, "transcriptional synergy elicited": 0.00138, "glucocorticoid-induced apoptosis": 0.00138, "mimics tcr-cd3/cd28-mediated signaling": 0.00138, "cell-specific interaction": 0.00138, "dual stimulation": 0.00138, "simultaneous stimulation": 0.00138, "alpha-globin enhancer": 0.00138, "phosphorylation profiles": 0.00138, "sea stimulation": 0.00138, "dual role": 0.00138, "unique mechanism": 0.00138, "data show": 0.00138, "specific bindings": 0.00138, "fk506 suggest": 0.00138, "t-cell-specific enhancer": 0.00138, "signaling requirements": 0.00138, "blocking apoptosis": 0.00138, "fragmentation observed": 0.00138, "confers il-2 responsiveness": 0.00138, "equivalent phosphorylation": 0.00138, "newborn mice": 0.00138, "specific nucleosome": 0.00138, "% decrease": 0.00138, "se stimulation": 0.00138, "alternative type": 0.00138, "surrogate receptors": 0.00138, "treatment": 0.00138, "il-6 regulation": 0.00138, "anti-rantes neutralizing antibodies": 0.00138, "inhibits anti-cd3-induced shift": 0.00138, "il-13 inhibits anti-cd3 mab/il-2-": 0.00138, "specific subdomains": 0.00138, "inducible system": 0.00138, "specific ags": 0.00138, "tg epsilon26 mice": 0.00138, "ap-2 elements": 0.00138, "disease progression": 0.00138, "augments pma-dependent il-5 production": 0.00138, "sp-1 elements": 0.00138, "activation-induced phosphorylation": 0.00138, "p130 phosphorylation": 0.00138, "stat-1 phosphorylation": 0.00138, "mub elements": 0.00138, "pld stimulation": 0.00138, "activin-mediated growth arrest": 0.00138, "neutrophil function": 0.00138, "p60 phosphorylation": 0.00137, "respective receptors": 0.00137, "individuals show": 0.00137, "specific limitations": 0.00137, "cd4 antigen": 0.00137, "neutralizing anti-tnf-alpha antibodies": 0.00137, "hs1 phosphorylation": 0.00137, "inducible dna-protein interactions": 0.00137, "thyroid disease": 0.00137, "undefined role": 0.00137, "caat elements": 0.00137, "tcr-mediated signaling thresholds": 0.00137, "mutated form": 0.00137, "cellular hemoglobin concentration": 0.00137, "il-1beta-induced il-6 production": 0.00137, "jak/stat signaling": 0.00137, "prevented nf-kappab": 0.00137, "negative-acting elements": 0.00137, "genetic control": 0.00137, "canonical elements": 0.00137, "hiv-2 enhancer": 0.00137, "il-13 signaling": 0.00137, "epo-induced phosphorylation": 0.00137, "disease parameters": 0.00137, "nf-kappab functions": 0.00137, "truncated form": 0.00137, "pecam-1 phosphorylation": 0.00137, "il-10 regulation": 0.00137, "pml/raralpha role": 0.00137, "maximum stimulation": 0.00137, "relevant stimulation": 0.00137, "ebna 2-dependent enhancer": 0.00137, "cbf beta": 0.00137, "well-recognized adhesive role": 0.00137, "transcriptional coactivator": 0.00137, "igh enhancer": 0.00137, "monocytic production": 0.00137, "specific 'pre-activation": 0.00137, "phosphorylated form": 0.00137, "kd tax1 antigen": 0.00137, "proposed role": 0.00137, "signal-induced phosphorylation": 0.00137, "wild type p53": 0.00137, "knock-out mice": 0.00137, "cellular uptake": 0.00137, "sl3 enhancer": 0.00137, "tcr-induced phosphorylation": 0.00137, "indirect interaction occurs": 0.00137, "pma-induced stimulation": 0.00137, "doxepin-sensitive h1-histamine receptors": 0.00137, "heat-activated unliganded receptors": 0.00137, "exact cellular defect": 0.00137, "g-csf receptors": 0.00137, "g-protein-coupled serpentine receptors": 0.00137, "show structural alterations": 0.00137, "inducing nf-kappab": 0.00137, "kd =": 0.00137, "agonist-induced phosphorylation": 0.00136, "b-cell-specific regulation": 0.00136, "cd3-epsilon enhancer": 0.00136, "cellular transformation": 0.00136, "shared receptors": 0.00136, "oct-dna interaction reveals": 0.00136, "genetic location show": 0.00136, "jnk-mediated phosphorylation": 0.00136, "variant form": 0.00136, "retinoblastoma phosphorylation": 0.00136, "il-4-mediated phosphorylation": 0.00136, "apoptosis resembles": 0.00136, "il-12-induced phosphorylation": 0.00136, "p38-catalysed phosphorylation": 0.00136, "cross-linking antibodies": 0.00136, "pleckstrin phosphorylation": 0.00136, "resistant mechanism": 0.00136, "coronary heart disease": 0.00136, "main transcriptional co-activator": 0.00136, "thrombin stimulation": 0.00136, "g-csf receptor-/- mice": 0.00136, "abrogate gc-induced apoptosis": 0.00136, "il4 enhancer": 0.00136, "tcr-mediated apoptosis": 0.00136, "control kd": 0.00136, "cd3-epsilon knockout mice": 0.00136, "beta subunits": 0.00136, "ligand-inducible phosphorylation": 0.00136, "signal-dependent phosphorylation": 0.00136, "x-y elements": 0.00136, "cdk-2-dependent phosphorylation": 0.00136, "cd3-dependent phosphorylation": 0.00136, "tcr-mediated signaling": 0.00136, "-inducible enhancer": 0.00136, "influence production": 0.00136, "cis-regulatory elements": 0.00136, "interleukin-2 production": 0.00136, "antigenic stimulation": 0.00136, "lysis mechanism": 0.00136, "lmp1 function": 0.00136, "apoptosis inducers": 0.00136, "yeast suggest": 0.00136, "tcr-mediated stimulation": 0.00136, "hox11 null mice": 0.00136, "c-raf-induced phosphorylation": 0.00136, "antiapoptotic role": 0.00136, "sequential phosphorylation": 0.00136, "anti-cd3+ anti-cd28-mediated stimulation": 0.00136, "receptors depends": 0.00136, "g-csf stimulation": 0.00136, "agonist-dependent phosphorylation": 0.00136, "observed hematopoiesis": 0.00136, "specific": 0.00136, "promoter-proximal elements": 0.00136, "substantial role": 0.00136, "mu enhancer": 0.00136, "fas-mediated apoptosis": 0.00136, "well-characterized role": 0.00136, "facilitates antigen processing": 0.00135, "lymphocyte-specific enhancer": 0.00135, "p-like elements": 0.00135, "ionomycin stimulation": 0.00135, "tcc-inducible mitotic signaling": 0.00135, "wild type phenotypes": 0.00135, "ires elements": 0.00135, "wild type cem": 0.00135, "cdk2-dependent phosphorylation": 0.00135, "mechanism leading": 0.00135, "pathogenic role": 0.00135, "camp-responsive elements": 0.00135, "renal function": 0.00135, "initiate signaling": 0.00135, "integrin beta": 0.00135, "accessory receptors": 0.00135, "growth arrest": 0.00135, "cell-free processing system": 0.00135, "dr enhancer": 0.00135, "control pbmc": 0.00135, "helper type": 0.00135, "hpa axis regulation": 0.00135, "tnf-alpha-activity neutralizing antibodies": 0.00135, "alternative mechanism": 0.00135, "il2 enhancer": 0.00135, "additional function": 0.00135, "il-7 signaling": 0.00135, "initiate apoptosis": 0.00135, "cell-specific function": 0.00135, "-mediated signaling": 0.00135, "il-6-responsive elements": 0.00135, "signaling intermediate": 0.00135, "exclusive role": 0.00135, "versatile cellular homeostatic switch": 0.00135, "limited stimulation": 0.00135, "b10 mice": 0.00135, "differential regulation": 0.00135, "ltb4 stimulation": 0.00135, "inhibits lipopolysaccharide": 0.00135, "tnfalpha-induced phosphorylation": 0.00135, "il-6 production": 0.00135, "cd36-ox ldl interaction": 0.00135, "protective role": 0.00135, "control groups": 0.00134, "proil-1 beta promoter-proximal requirement": 0.00134, "prevent disease relapses": 0.00134, "mitogen stimulation": 0.00134, "host interaction": 0.00134, "ifn-alpha signaling": 0.00134, "intronic enhancer": 0.00134, "micrococcal nuclease identified": 0.00134, "ubiquitous bioinactivation mechanism": 0.00134, "glucocorticoid-mediated apoptosis": 0.00134, "cadmium stimulation": 0.00134, "triggering role": 0.00134, "nfat-like elements": 0.00134, "replaced enhancer": 0.00134, "transcriptional status": 0.00134, "unliganded c-erba/tr supports growth": 0.00134, "persistent type": 0.00134, "kappa-opioid receptors": 0.00134, "message-destabilizing elements": 0.00134, "il-2-inducible enhancer": 0.00134, "isoelectric point =": 0.00134, "autoregulatory enhancer": 0.00134, "il-10 production": 0.00134, "antigen recognition": 0.00134, "differential interaction": 0.00134, "autocrine role": 0.00134, "activating function": 0.00134, "postulated role": 0.00134, "enhancer replacement": 0.00134, "allogeneic stimulation": 0.00134, "phosphorylation": 0.00134, "stat6-responsive elements": 0.00134, "kappab-responsive elements": 0.00134, "interleukin-7 signaling": 0.00134, "x-chromosome-specific elements": 0.00134, "dose-dependent stimulation": 0.00134, "gata-responsive elements": 0.00134, "inhibits histone deacetylation": 0.00134, "liver function": 0.00134, "pyrimidine-rich elements": 0.00134, "21-bp elements": 0.00134, "inactive form unable": 0.00134, "toll-like receptors": 0.00134, "neighboring elements": 0.00134, "neutralizing antibodies": 0.00134, "interleukin-4 signaling": 0.00134, "selective regulation": 0.00134, "mitotic signaling": 0.00133, "long-term regulation": 0.00133, "transcriptional transactivator": 0.00133, "h2 receptors": 0.00133, "tcf-1 identified": 0.00133, "hbxag stimulation": 0.00133, "fundamental role": 0.00133, "il-6-induced apoptosis": 0.00133, "enhancer tc-ii": 0.00133, "authentic enhancer": 0.00133, "lmp-1-triggered signaling": 0.00133, "observed phenomena": 0.00133, "favor ige production": 0.00133, "biologic role": 0.00133, "hiv-1 transmembrane glycoprotein": 0.00133, "cellular oncogene c-myb": 0.00133, "leukocyte function": 0.00133, "aldosterone =": 0.00133, "il-2 independent": 0.00133, "fgf receptors": 0.00133, "hs2 enhancer": 0.00133, "monocyte/macrophage receptors": 0.00133, "elements": 0.00133, "activation-induced apoptosis": 0.00133, "p53-mediated apoptosis": 0.00133, "diminished type": 0.00133, "enhancer shuffling": 0.00133, "distant enhancer": 0.00133, "ebna2-dependent enhancer": 0.00133, "megakaryocyte/platelet-specific enhancer": 0.00133, "cd25 receptors": 0.00133, "oestrogen receptors": 0.00133, "delay growth late": 0.00133, "/cd3 stimulation": 0.00133, "glucocorticosteroid receptors": 0.00133, "gamma-ifn signaling": 0.00133, "zinc addition": 0.00133, "cho-cd86 stimulation": 0.00133, "il-7r signaling": 0.00133, "anti-igm-induced apoptosis": 0.00133, "latent form": 0.00133, "fgf-1 stimulation": 0.00133, "enhancer works": 0.00133, "nonspecific stimulation": 0.00133, "broad role": 0.00133, "tcrg enhancer": 0.00133, "fgf-1 signaling": 0.00133, "enhancer inactivity": 0.00133, "disease status": 0.00133, "control plasmid": 0.00133, "general mechanism": 0.00133, "biochemical mechanism": 0.00133, "tnf-alpha-induced apoptosis": 0.00133, "dramatic stimulation": 0.00133, "beta e2": 0.00133, "thiol modulation inhibits": 0.00133, "stimulate production": 0.00133, "surrounding cellular background": 0.00133, "ori1yt enhancer": 0.00133, "biphasic stimulation": 0.00133, "as2o3-induced apoptosis": 0.00133, "prominent role": 0.00133, "observed cooperativities": 0.00133, "il-2 leads": 0.00133, "metallothionein enhancer": 0.00133, "developing central nervous system": 0.00133, "avidin-biotin peroxidase detection system": 0.00132, "calcium-dependent apoptosis": 0.00132, "monocyte-binding receptors": 0.00132, "cho-cd80 stimulation": 0.00132, "inducing vdr/drip interactions": 0.00132, "bifunctional role": 0.00132, "hbsag stimulation": 0.00132, "il-4-mediated signaling": 0.00132, "death-inducing receptors": 0.00132, "interleukin-5 signaling": 0.00132, "suppressing central nervous system": 0.00132, "calcium-mobilizing receptors": 0.00132, "observed": 0.00132, "notch receptors": 0.00132, "lung nf-kappab": 0.00132, "5-fold stimulation": 0.00132, "triptolide-induced apoptosis": 0.00132, "physiopathologic role": 0.00132, "tnf-induced signaling": 0.00132, "pma/a23187 stimulation": 0.00132, "phagocyte stimulation": 0.00132, "tax-mediated apoptosis": 0.00132, "ebf identified": 0.00132, "ra-induced apoptosis": 0.00132, "german control populations": 0.00132, "cellular functions": 0.00132, "beta-adrenergic receptors": 0.00132, "transcriptional activators": 0.00132, "tcr-induced apoptosis": 0.00132, "stress-induced apoptosis": 0.00132, "anti-c/ebp beta abs": 0.00132, "zebra/ebv biological system": 0.00132, "phasing analyses demonstrated": 0.00132, "mitogenic anti-cd2 antibodies": 0.00132, "hematopoietin receptors": 0.00132, "integral role": 0.00132, "compounds show": 0.00132, "ige production": 0.00132, "causal role": 0.00132, "biological function": 0.00132, "analyses show": 0.00132, "tnfr1 signaling": 0.00132, "il-2 responsive": 0.00132, "selective interaction": 0.00132, "exact role": 0.00132, "agonistic anti-cd28 antibodies": 0.00132, "selected antibodies": 0.00132, "decisive role": 0.00132, "enhancer": 0.00132, "pivotal role": 0.00132, "% versus": 0.00132, "salt-transformed receptors": 0.00132, "inducible protein/dna interactions": 0.00132, "tissue-specific regulation": 0.00131, "balb/c mice": 0.00131, "sn50-induced apoptosis": 0.00131, "thapsigargin stimulation": 0.00131, "pwm stimulation": 0.00131, "interleukin-6-induced apoptosis": 0.00131, "identified bhrf1": 0.00131, "scid-hu-int mice": 0.00131, "v-abl-mediated signaling": 0.00131, "cellular incorporation": 0.00131, "newborn hemolytic disease": 0.00131, "sustained progenitor growth": 0.00131, "wild type ikk1": 0.00131, "traf signaling": 0.00131, "low-serum apoptosis": 0.00131, "mice harboring": 0.00131, "gld/gld mice": 0.00131, "cryptococcal stimulation": 0.00131, "5-10 % difference": 0.00131, "hiv-induced apoptosis": 0.00131, "radiation-induced apoptosis": 0.00131, "delay apoptosis": 0.00131, "signaling capabilities": 0.00131, "anti-fas-mediated apoptosis": 0.00131, "resist apoptosis": 0.00131, "macrophage form": 0.00131, "transcriptional silencer": 0.00131, "fasl-mediated apoptosis": 0.00131, "camp production": 0.00131, "r24 stimulation": 0.00131, "e2a-pbx1-induced apoptosis": 0.00131, "macrophage function": 0.00131, "differential function": 0.00131, "p/i stimulation": 0.00131, "nude mice": 0.00131, "ra-mediated apoptosis": 0.00131, "pulmonary heart disease": 0.00131, "hbxag-specific stimulation": 0.00131, "ru486 suggest": 0.00131, "pha/pma stimulation": 0.00131, "role": 0.00131, "cd14-mediated signaling": 0.00131, "signaling branch": 0.00131, "benzene-induced apoptosis": 0.00131, "hydrocortisone-induced apoptosis": 0.00131, "steroid-regulated apoptosis": 0.00131, "morphological analyses demonstrated": 0.00131, "oligo stimulation": 0.00131, "inducer-mediated stimulation": 0.00131, "/alpha-cd28 stimulation": 0.00131, "hpa axis function": 0.00131, "il-12-induced signaling": 0.00131, "dex-induced apoptosis": 0.00131, "trp stimulation": 0.00131, "tnf-mediated apoptosis": 0.00131, "wnt signaling": 0.00131, "disease susceptibility": 0.00131, "injury-induced apoptosis": 0.00131, "trigger hiv-1 upregulation": 0.00131, "unique function": 0.00131, "intentional stimulation": 0.00131, "glucocorticoid-dependent stimulation": 0.00131, "drug-induced apoptosis": 0.00131, "tcr-initiated signaling": 0.00131, "40-fold stimulation": 0.00131, "jak-stat signaling": 0.00131, "developmental stage-specific regulation": 0.00131, "pg490 inhibits interleukin": 0.00131, "tcr-stimulated apoptosis": 0.00131, "cytoplasmic/nuclear signaling": 0.00131, "nf-kappab generation": 0.00131, "cold-shock-induced apoptosis": 0.00131, "receptors": 0.00131, "sn50-mediated apoptosis": 0.00131, "identified erk2": 0.0013, "corticosteroid type": 0.0013, "cell-deficient mice": 0.0013, "dominant form": 0.0013, "report show": 0.0013, "pu.1-/- mice": 0.0013, "nf-atp-/- mice": 0.0013, "identified p130": 0.0013, "signaling": 0.0013, "nf-atp-deficient mice": 0.0013, "impaired function": 0.0013, "underlying mechanism": 0.0013, "tumor-bearing mice": 0.0013, "c-myc regulation": 0.0013, "transcriptional inducibility": 0.0013, "apoptosis": 0.0013, "kda form": 0.0013, "scid mice": 0.0013, "rodent central nervous system": 0.0013, "homozygous type": 0.0013, "stimulation": 0.0013, "% concentration": 0.0013, "il-2 concentration": 0.0013, "gene-targeted mice": 0.0013, "c57 mice": 0.0013, "tnfrp55-deficient mice": 0.0013, "c/ebpalpha-deficient mice": 0.0013, "cns disease states": 0.0013, "il production": 0.0013, "control cultures": 0.0013, "enhance il-2 promoter-reporter": 0.0013, "thr beta": 0.0013, "transcriptional regulators": 0.0013, "cell-free system reconstituted": 0.0013, "c3h mice": 0.0013, "fibroblast growth factor-1": 0.0013, "longer disease duration": 0.0013, "motheaten mice": 0.0013, "irf-1-/- mice": 0.0013, "-deficient mice": 0.0013, "nontransgenic mice": 0.0013, "efficient mechanism": 0.0013, "hiv-1 variant": 0.0013, "syngeneic mice": 0.0013, "irradiated mice": 0.0013, "c/ebpalpha-/- mice": 0.0013, "alpha-deficient mice": 0.0013, "p53-/- mice": 0.0013, "double-transgenic mice": 0.0013, "mechanism underlying": 0.0013, "cellular repressor": 0.00129, "kappab beta": 0.00129, "regulate il-2": 0.00129, "cholesterol feedback mechanism": 0.00129, "type 2-": 0.00129, "hypothalamic-pituitary-adrenal function intact": 0.00129, "physiological regulation": 0.00129, "% effective dose": 0.00129, "unknown mechanism": 0.00129, "rabbit anti-c/ebp-epsilon antibodies": 0.00129, "transcriptional trans-activator": 0.00129, "transcriptional cofactor": 0.00129, "immunocytochemistry identified": 0.00129, "nf-kappab occurs": 0.00129, "cell-extracellular matrix interactions": 0.00129, "identified homologues": 0.00129, "interactions remain unchanged": 0.00129, "identified lymphotoxin": 0.00129, "abnormal regulation": 0.00129, "responding beta chains": 0.00129, "nf-kappab targets": 0.00129, "cellular redox status influences": 0.00129, "effector function": 0.00129, "show overt homology": 0.00129, "show good correlation": 0.00129, "cre-loxp recombination system": 0.00129, "anti-igm antibodies": 0.00129, "granulocyte antibodies": 0.00129, "nf-kappab confers": 0.00129, "transcriptional enhancers": 0.00129, "cellular products": 0.00129, "host control": 0.00128, "antibodies ki-67": 0.00128, "efficient hormonal control": 0.00128, "identified dil": 0.00128, "gcr regulation": 0.00128, "transmembrane mechanism": 0.00128, "suppress growth": 0.00128, "cellular calcium": 0.00128, "reticulocyte lysate system": 0.00128, "mice": 0.00128, "impaired dna-protein interactions": 0.00128, "low-level ifn production": 0.00128, "analyses demonstrated": 0.00128, "mixed endothelial-raw264.7 coculture system": 0.00128, "quantitative southern blotting demonstrated hemizygosity": 0.00128, "identified alg-4f": 0.00128, "growth rate": 0.00128, "transcriptional means": 0.00128, "% reduction": 0.00128, "nf-kappab subunits": 0.00128, "tpa addition": 0.00128, "initial interaction": 0.00128, "thyroid function": 0.00128, "il-2 dependent": 0.00128, "neutrophils show": 0.00128, "dominant control": 0.00128, "optimal slp-76 function": 0.00128, "polyclonal antibodies": 0.00127, "altered interactions": 0.00127, "ebna-2 type": 0.00127, "defective production": 0.00127, "mediates protein-protein interactions": 0.00127, "wild type 430-444": 0.00127, "disease states": 0.00127, "identified": 0.00127, "cd40 antigen": 0.00127, "transcriptional interference": 0.00127, "thyroid system": 0.00127, "motor neuron disease": 0.00127, "cd20/b1 antigen correlates": 0.00127, "activating hiv-1": 0.00127, "reconstituted system": 0.00127, "hiv-1 tat": 0.00127, "ikappabalpha turnover demonstrated": 0.00127, "rar beta": 0.00127, "receptor-mediated mechanism": 0.00127, "monitoring residual disease": 0.00127, "inhibits interleukin": 0.00127, "transcriptional targeting": 0.00127, "blocking cd8 interaction": 0.00127, "cd2 antibodies": 0.00127, "p70 production": 0.00127, "transcriptional silencing": 0.00127, "suppressing cellular infiltration": 0.00127, "homologous mechanism": 0.00127, "autoimmune disease": 0.00127, "efficient interaction": 0.00126, "hypothalamo-pituitary-adrenal axis function": 0.00126, "% loss": 0.00126, "latent hiv-1": 0.00126, "wild type ikk2": 0.00126, "il-5 production": 0.00126, "weak interaction": 0.00126, "recent reports demonstrated": 0.00126, "ciita function": 0.00126, "precise mechanism": 0.00126, "lymphocytic origin demonstrated": 0.00126, "show homology": 0.00126, "inactive form": 0.00126, "spontaneous il-1ra production": 0.00126, "diminished production": 0.00126, "type iia hyperlipidemia": 0.00126, "il-1beta production": 0.00126, "tnfalpha production": 0.00126, "suggest utilization": 0.00126, "cellular stimuli": 0.00126, "developmental regulation": 0.00126, "form heinz bodies": 0.00126, "celiac disease": 0.00126, "fosb suggest": 0.00126, "physiologic mechanism": 0.00126, "proteolytic regulation": 0.00125, "interferon beta": 0.00125, "hiv-ltr suggest": 0.00125, "suppressor function": 0.00125, "chemokine production": 0.00125, "beta chains": 0.00125, "cellular basis": 0.00125, "il-2r beta": 0.00125, "soluble antigen": 0.00125, "nf-kappab components": 0.00125, "control donors": 0.00125, "p300/cbp-type transcriptional coactivators": 0.00125, "yeast two-hybrid system": 0.00125, "exogenous nf-kappab": 0.00125, "hetero-oligomeric mr form": 0.00125, "hiv-1 pathogenesis": 0.00125, "ptf beta": 0.00125, "strong interactions": 0.00125, "antigen processing": 0.00125, "semiquantitative detection system": 0.00125, "control oligonucleotides": 0.00125, "ig beta": 0.00125, "beta isozymes": 0.00125, "antihuman tnf-alpha-neutralizing antibodies": 0.00124, "adrenal cortex function": 0.00124, "proliferative control": 0.00124, "monocyte-derived il-1beta inhibits": 0.00124, "productive replicative form": 0.00124, "wild type": 0.00124, "hiv-1 latency reactivation": 0.00124, "hiv-1 protease": 0.00124, "multipotent /erythroid/monocytic hpc growth": 0.00124, "precise regulation": 0.00124, "prolonged poor glycemic control": 0.00124, "transcriptional hierarchy": 0.00124, "quinone reductase-dependent mechanism": 0.00124, "p-lps-mediated signal-transducing mechanism": 0.00124, "findings show": 0.00124, "-dependent mechanism": 0.00124, "rare form": 0.00124, "cysteine inhibits": 0.00124, "heart disease": 0.00124, "dominant-negative form": 0.00124, "beta stability": 0.00124, "relevant mechanism": 0.00124, "physical interaction": 0.00124, "c5a-induced il-8 production": 0.00124, "hiv-1 plasmids": 0.00124, "central nervous system": 0.00124, "suggest": 0.00124, "demonstrated crucial roles": 0.00124, "hpv type": 0.00124, "metastatic disease": 0.00123, "clonal growth": 0.00123, "anti-fos antibodies": 0.00123, "fasl regulation": 0.00123, "control day": 0.00123, "heterologous system": 0.00123, "ebv-associated disease": 0.00123, "subsequent addition": 0.00123, "cellular targets": 0.00123, "show failure": 0.00123, "adenovirus antigen": 0.00123, "immobilized antibodies": 0.00123, "nf-kappab correlate": 0.00123, "messenger system": 0.00123, "steroid addition": 0.00123, "dissociation constant =": 0.00123, "production require": 0.00123, "lyme disease": 0.00123, "control subclone": 0.00123, "redox mechanism": 0.00123, "mr =": 0.00123, "interleukin-6-induced igm production": 0.00123, "secreted form": 0.00123, "immunologic function": 0.00123, "alter nf-kappab": 0.00123, "bcr1 type": 0.00123, "oca-b function": 0.00123, "unknown function": 0.00123, "interactions represent": 0.00123, "transcriptional competence": 0.00122, "c2h2 type": 0.00122, "il-13 regulation": 0.00122, "transcriptional repressors": 0.00122, "nf-kappab-dependent mechanism": 0.00122, "unrecognized mechanism": 0.00122, "htlv-i-associated disease": 0.00122, "cellular redox status": 0.00122, "transcriptional efficiency": 0.00122, "cellular localization": 0.00122, "protective mechanism": 0.00122, "il-8 production": 0.00122, "fundamental cellular processes": 0.00122, "attenuated function": 0.00122, "spontaneous production": 0.00122, "growth retarding property": 0.00122, "interleukin-1 beta": 0.00122, "apc function": 0.00122, "transcriptional cooperativity": 0.00122, "fabry disease": 0.00122, "transforming growth factor-beta": 0.00122, "cellular cysteine supply": 0.00122, "control animals": 0.00122, "e2f regulation": 0.00122, "cellular blocks": 0.00122, "e3 regulation": 0.00122, "grb2 form": 0.00122, "rex production": 0.00122, "rela function": 0.00122, "screening system": 0.00122, "hormonal regulation": 0.00122, "p21ras regulation": 0.00122, "detectable il-2": 0.00122, "ap-2 antibodies": 0.00122, "integrin-dependent adhesive function": 0.00122, "hiv-1 mrnas": 0.00122, "tubulointerstitial disease": 0.00121, "biochemical approaches demonstrated": 0.00121, "disease associations": 0.00121, "il-2 ligation": 0.00121, "pel growth": 0.00121, "sepsis-associated disease": 0.00121, "protein-dna interaction": 0.00121, "cellular mcp-1 content": 0.00121, "tar-independent mechanism": 0.00121, "short form": 0.00121, "codon-10-variant type": 0.00121, "main cellular source": 0.00121, "replicative form": 0.00121, "haemolytic disease": 0.00121, "anti-vca antibodies": 0.00121, "permissive enhancer/promoter interaction": 0.00121, "z-lll-h-insensitive transcriptional": 0.00121, "redox regulation": 0.00121, "quantitative control": 0.00121, "multifactorial disease": 0.00121, "transcriptional template": 0.00121, "absolute htr beta": 0.00121, "immune-mediated disease": 0.00121, "joint disease": 0.00121, "immunoelectron microscopy demonstrated": 0.00121, "global mechanism": 0.00121, "circulating des-arg form": 0.00121, "granulomatous disease": 0.00121, "early-onset type": 0.00121, "gabp alpha/gabp beta": 0.00121, "brca1 function": 0.00121, "graft-versus-host disease": 0.00121, "antipaternal antibodies": 0.00121, "il-2-induced growth": 0.00121, "ms-like disease": 0.00121, "rb function": 0.00121, "cellular mrnas": 0.00121, "adaptor function": 0.00121, "disease variables": 0.00121, "type cys2-xaa12-his2": 0.00121, "transcriptional 'silencer": 0.00121, "igm production": 0.00121, "type iv/gr": 0.00121, "camp-dependent regulation": 0.0012, "rex function": 0.0012, "barrier function": 0.0012, "oxidant production": 0.0012, "igd antibodies": 0.0012, "cellular electrolyte transport": 0.0012, "type": 0.0012, "abundant production": 0.0012, "nf-kappab p50-p65 recruitment": 0.0012, "cytotoxic function": 0.0012, "hiv-1 proviral latency": 0.0012, "faster growth rates": 0.0012, "h. addition": 0.0012, "methods demonstrated": 0.0012, "feedback mechanism": 0.0012, "temporal control": 0.0012, "cellular processes": 0.0012, "disease": 0.0012, "cellular parameters": 0.0012, "transcriptional": 0.0012, "interferon-gamma production": 0.0012, "% nucleotide identity": 0.0012, "autocrine mechanism": 0.0012, "hiv-1 genome": 0.0012, "dmso solvent/media control": 0.0012, "antipeptide antibodies": 0.00119, "anti-stat3 antibodies": 0.00119, "autoregulatory mechanism": 0.00119, "cd11b antigen": 0.00119, "anti-dnp antibodies": 0.00119, "intercellular interaction": 0.00119, "anti-icam-1 antibodies": 0.00119, "anti-peptide antibodies": 0.00119, "% identical": 0.00119, "restores production": 0.00119, "stringent regulation": 0.00119, "pi-3,4,5-p3 production": 0.00119, "obvious regulation": 0.00119, "gamma-specific antibodies": 0.00119, "weeks show": 0.00119, "taci-specific antibodies": 0.00119, "exact mechanism": 0.00119, "autosomal recessive form": 0.00119, "slp-76 function": 0.00119, "cellular substrates": 0.00119, "developmental control": 0.00119, "mcp-1 production": 0.00119, "predominant form": 0.00119, "anti-lambda antibodies": 0.00119, "moderate form": 0.00119, "cellular background": 0.00119, "c-sis/platelet-derived growth factor-b": 0.00119, "antigen responsiveness": 0.00119, "hiv-1 laboratory isolates": 0.00119, "hsp70 production": 0.00119, "heterodimeric form": 0.00119, "anti-p-selectin antibodies": 0.00119, "anti-timp-1 antibodies": 0.00119, "central function": 0.00119, "anti-cd45 antibodies": 0.00119, "anti-ar antibodies": 0.00119, "anti-vcam antibodies": 0.00119, "inverse regulation": 0.00119, "cellular components": 0.00119, "reciprocal mechanism": 0.00119, "posttranscriptional mechanism": 0.00119, "pkc-independent mechanism": 0.00119, "optimal function": 0.00119, "monospecific antibodies": 0.00119, "proil-1 beta": 0.00118, "feedback regulation": 0.00118, "htr beta": 0.00118, "provocative mechanism": 0.00118, "disturb microtubule function": 0.00118, "readily form": 0.00118, "ciita-independent mechanism": 0.00118, "cellular fractions": 0.00118, "cellular systems": 0.00118, "nongenomic mechanism": 0.00118, "dual function": 0.00118, "mabs inhibits": 0.00118, "dr beta": 0.00118, "specificity-conferring mechanism": 0.00118, "redox-regulatory mechanism": 0.00118, "usual mechanism": 0.00118, "exhibit interactions": 0.00118, "il-4-independent mechanism": 0.00118, "nur77 beta": 0.00118, "fibrosis biphasic control": 0.00118, "cell-intrinsic mechanism": 0.00118, "receptor-dependent mechanism": 0.00118, "heterogeneous hiv-1 pool": 0.00118, "growth retardation": 0.00118, "adrenal function": 0.00118, "alternate mechanism": 0.00118, "bzlf-1-dependent mechanism": 0.00118, "il-12r beta": 0.00118, "p40 production": 0.00118, "suppress il-2": 0.00118, "luciferase demonstrated": 0.00118, "longer form": 0.00118, "defective hiv-1": 0.00118, "tgf beta": 0.00118, "tax-independent mechanism": 0.00118, "end growth": 0.00118, "nonmutational mechanism": 0.00118, "exogenous il-2": 0.00118, "ifn-gamma-dependent mechanism": 0.00118, "compensation mechanism": 0.00118, "il-2 share": 0.00118, "growth modulator": 0.00118, "e2f function": 0.00118, "demonstrated graft infiltration": 0.00118, "ifn-mediated regulation": 0.00118, "-dependent growth": 0.00118, "tr beta": 0.00118, "gst control": 0.00118, "p53-independent mechanism": 0.00118, "exclusive interaction": 0.00118, "csa-sensitive regulation": 0.00117, "cell-type-specific regulation": 0.00117, "conditional form": 0.00117, "vcam regulation": 0.00117, "beta 2-m": 0.00117, "hormonal form": 0.00117, "nf-kappab protects": 0.00117, "beta pools": 0.00117, "transactivating function": 0.00117, "il-2 responsiveness": 0.00117, "relevant form": 0.00117, "rac-1 function": 0.00117, "hiv-1 transactivator": 0.00117, "allele-specific regulation": 0.00117, ",1 beta": 0.00117, "post-translational regulation": 0.00117, "hnf3 beta": 0.00117, "mechanism": 0.00117, "antibodies": 0.00117, "dp1 form": 0.00117, "exogenous addition": 0.00117, "egr1 regulation": 0.00117, "function analogous": 0.00117, "ra-induced regulation": 0.00117, "tcralpha beta": 0.00117, "autocrine production": 0.00116, "hormone.2+o regulation": 0.00116, "cooperative interaction": 0.00116, "oxidoreductive regulation": 0.00116, "/gabp beta": 0.00116, "tfiie beta": 0.00116, "27-kda unphosphorylated form": 0.00116, "retinoid-dependent regulation": 0.00116, "il-2-gene regulation": 0.00116, "blocking nf-kappab": 0.00116, "cognate interaction": 0.00116, "secreted il-2 serves": 0.00116, "successful production": 0.00116, "continued production": 0.00116, "vav function": 0.00116, "permanent growth": 0.00116, "beta h1-globin": 0.00116, "cell-cycle regulation": 0.00116, "beta 2-microglobulin": 0.00116, "e2f-dependent regulation": 0.00116, "demonstrated abnormalities": 0.00116, "species-specific regulation": 0.00116, "cellular cholesterol homeostasis": 0.00116, "positive-negative regulation": 0.00116, "il-4-dependent regulation": 0.00116, "possess repressive function": 0.00116, "cell-tropic hiv-1 entry": 0.00116, "hpa system": 0.00116, "alcohol-induced regulation": 0.00116, "post-transcriptional regulation": 0.00116, "cellular distribution": 0.00116, "mutual regulation": 0.00116, "full function": 0.00116, "cellular immunity": 0.00116, "unrecognized form": 0.00116, "aml1/cbf beta": 0.00116, "hiv-1 infections": 0.00116, "positive/negative regulation": 0.00116, "crh regulation": 0.00116, "posttranscriptional regulation": 0.00116, "insulin-gene regulation": 0.00116, "unrecognized function": 0.00116, "aberrant form": 0.00116, "interleukin-10 production": 0.00116, "post hiv-1 entry": 0.00116, "growth depends": 0.00116, "post-transcription regulation": 0.00116, "hiv-1 entry": 0.00115, "spi-b function": 0.00115, "cd27/cd70 interaction": 0.00115, "ino production": 0.00115, "nervous system": 0.00115, "mar-bp1/enhancer interaction": 0.00115, "beta": 0.00115, "sedentary control persons": 0.00115, "p24 production": 0.00115, "tgf-alpha production": 0.00115, "dephosphorylated form": 0.00115, "interleukin-6 production": 0.00115, "roi production": 0.00115, "traf/rank interaction": 0.00115, "demonstrated importance": 0.00115, "interleukin-8 production": 0.00115, "experimental system": 0.00115, "-8 production": 0.00115, "% predicted": 0.00115, "oct-2-dependent cis-regulatory function": 0.00115, "lymphokine production": 0.00115, "protein-protein interaction": 0.00115, "cellular iron availability": 0.00115, "bhlh-hsp90 interaction": 0.00115, "df =": 0.00115, "acquired form": 0.00115, "regulation": 0.00115, "cellular content": 0.00115, "vwf production": 0.00115, "bmax =": 0.00115, "p24rex production": 0.00115, "cd40-traf2 interaction": 0.00114, "footprinting demonstrated": 0.00114, "5-20 % sucrose gradients": 0.00114, "ras-aiolos interaction": 0.00114, "lcr hs4 demonstrated": 0.00114, "link cellular": 0.00114, "antitumor function": 0.00114, "two-site interaction": 0.00114, "control megakaryocytopoiesis": 0.00114, "p130 form": 0.00114, "megakaryocyte growth": 0.00114, "phenylarsine oxide inhibits": 0.00114, "tax1-nf-y interaction": 0.00114, "cellular susceptibility": 0.00114, "ets-nf-kappab/nfat interaction": 0.00114, "form heterocomplexes": 0.00114, "nef inhibits": 0.00114, "synergistic function": 0.00114, "pharmacological control": 0.00114, "cellular cytoplasm": 0.00114, "il-7r function": 0.00114, "calcineurin-nfat interaction": 0.00114, "hiv-1 isolates": 0.00114, "interactions require atp/mg2+": 0.00114, "receptor/stat interaction": 0.00114, "haemoglobin production": 0.00114, "consequent function": 0.00114, "-gamma production": 0.00114, "ic50 =": 0.00114, "2d3-vdr interaction": 0.00114, "il-18-mediated function": 0.00114, "isozymes show": 0.00114, "tip function": 0.00114, "coordinated production": 0.00114, "form homo-": 0.00113, "physical interactions": 0.00113, "repressive function": 0.00113, "nf-kappab contents": 0.00113, "il-8 antigen": 0.00113, "biologic function": 0.00113, "qp function": 0.00113, "accumulated form": 0.00113, "haematopoietic system": 0.00113, "ki-67 antigen": 0.00113, "hla-cw*0702 system": 0.00113, "antagonists show": 0.00113, "cooperative function": 0.00113, "two-hybrid system": 0.00113, "maintain cellular homeostasis": 0.00113, "interaction": 0.00113, "hyperphosphorylated form": 0.00113, "hla-dmb function": 0.00113, "il-2 respond": 0.00113, "permanent control": 0.00113, "c-erba function": 0.00113, "cell-free system": 0.00113, "function tests": 0.00113, "monocyte/macrophage function": 0.00113, "production": 0.00113, "rpos control": 0.00113, "local control": 0.00113, "phagocyte system": 0.00112, "bipartite system": 0.00112, "immune-endocrine function": 0.00112, "monomeric form": 0.00112, "allelic form": 0.00112, "underphosphorylated form": 0.00112, "concatenated form": 0.00112, "monocyte-specific function": 0.00112, "= .0002": 0.00112, "coordinated function": 0.00112, "p14tcl1 form": 0.00112, "activity-stimulating growth": 0.00112, "paracrine growth": 0.00112, "= sivmac239": 0.00112, "gtp-bound form": 0.00112, "shed form": 0.00112, "hypothalamic-pituitary-adrenal system": 0.00112, "interleukin-2-independent growth": 0.00112, "mthc system": 0.00112, "hiv-1 isolate": 0.00112, "stringent control": 0.00112, "monocyte/macrophage system": 0.00112, "prototypical form": 0.00112, "% amplification": 0.00112, "nm23 function": 0.00112, "growth retarding": 0.00112, "il-2-independent growth": 0.00112, "gm-csf-mediated growth": 0.00112, "dimeric form": 0.00112, "uncertain function": 0.00111, "hiv-1 reactivation": 0.00111, "52-kda form": 0.00111, "hemo-lymphoid system": 0.00111, "homeostatic control": 0.00111, "= 4-6": 0.00111, "cd14 antigen": 0.00111, "phosphorylation-defective form": 0.00111, "ebna-2 trans-activates cellular": 0.00111, "tf antigen": 0.00111, "adrenocortical function": 0.00111, "adult-onset form": 0.00111, "cellular environment": 0.00111, "tnt system": 0.00111, "hypophosphorylated form": 0.00111, "tcf/lef function": 0.00111, "huvecs demonstrated": 0.00111, "biphasic control": 0.00111, "gamma-ifn inhibits 1,25-": 0.00111, "= slvmac239": 0.00111, "input function": 0.00111, "cellular extraction": 0.00111, "entire il-2 promoter-enhancer": 0.00111, "dopamine system": 0.00111, "prolonged il-2": 0.00111, "nf-kappab translocates": 0.00111, "females show": 0.00111, "= .3": 0.00111, "b27 antigen incidence": 0.00111, "growth": 0.00111, "two-color immunohistochemistry demonstrated": 0.00111, "trans-dominant form": 0.00111, "p65/p50 nf-kappab": 0.00111, "= .003": 0.00111, "cellular event": 0.0011, "cellular stimulus": 0.0011, "ec50 =": 0.0011, "renin-angiotensin system": 0.0011, "= -0.784": 0.0011, "hypothalamic-hypophyseal-adrenocortical system": 0.0011, "nfkappab/ikappab system": 0.0011, "control flcs": 0.0011, "= .0014": 0.0011, "show pharmacological": 0.0011, "tetracycline-regulatable system": 0.0011, "id50 =": 0.0011, "= .011": 0.0011, "= .005": 0.0011, "= -0.821": 0.0011, "= .01": 0.0011, "% effective": 0.0011, "replicating hiv-1": 0.0011, "antigen presentation": 0.0011, "protein-dna interactions": 0.0011, "nf-kappab deprivation": 0.0011, "cre-cat plasmide show": 0.0011, "= .03": 0.0011, "electron-transport system": 0.0011, "form": 0.0011, "r2 =": 0.0011, "= .0048": 0.0011, "ubiquitin-proteasome system": 0.0011, "= 4-9": 0.0011, "transwell system": 0.0011, "vp16 interactions": 0.0011, "= -0.791": 0.0011, "= -0.63": 0.0011, "= .0009": 0.0011, "= .2": 0.0011, "endosomal/lysosomal system": 0.0011, "il-1/il-1ra system": 0.0011, "= .0007": 0.0011, "interleukin-4 inhibits": 0.0011, "il-2 inducibility": 0.0011, "= -0.568": 0.0011, "= .05": 0.0011, "= .0035": 0.0011, "autoregulatory control": 0.0011, "ag-490 inhibits": 0.0011, "function": 0.0011, "cd23-induced nf-kappab": 0.00109, "pharmacologic control": 0.00109, "120,000-140,000 mw antigen": 0.00109, "sophisticated control": 0.00109, "system": 0.00109, "pg490 inhibits": 0.00109, "dza inhibits": 0.00109, "deliver nf-kappab": 0.00109, "=": 0.00109, "nf-kappab resides": 0.00109, "inhibits il-2-dependent": 0.00109, "hiv-1 provirus": 0.00109, "% e-selectin": 0.00109, "il-2 protects": 0.00109, "cell-cycle control": 0.00109, "cellular metabolism": 0.00109, "cellular context": 0.00109, "nf-kappab activation/translocation": 0.00109, "tight control": 0.00109, "control": 0.00108, "hiv-1 dse": 0.00108, "nf-kappab": 0.00108, "cd69 antigen": 0.00108, "simultaneous addition": 0.00108, "immunodominant antigen": 0.00108, "% hcs downregulates": 0.00108, "show similarity": 0.00108, "site-directed mutagenesis demonstrated": 0.00108, "% probability": 0.00108, "cd8 antigen": 0.00108, "anti-viral capsid antigen": 0.00108, "cellular redox": 0.00108, "intimate interactions": 0.00108, "p24 antigen measurement": 0.00108, "rt-pcr demonstrated": 0.00108, "cellular composition": 0.00108, "long-lasting il-2 receptivity": 0.00108, "epitope-labeled bko demonstrated": 0.00107, "inhibits granzyme": 0.00107, "p55 interactions": 0.00107, "cd18 antigen": 0.00107, "pka inhibits": 0.00107, "glia inhibits": 0.00107, "hiv-1 promoter-enhancer": 0.00107, "hiv-1 nre": 0.00107, "dimethyldithiocarbamate inhibits": 0.00107, "antigen b27": 0.00107, "m-csf addition": 0.00107, "cu2+ inhibits": 0.00107, "cellular srf": 0.00107, "numerous cellular": 0.00107, "antigen complexed": 0.00106, "% correspond": 0.00106, "antigen proceeds": 0.00106, "isoelectric focusing demonstrated": 0.00106, "tat- hiv-1": 0.00106, "x2 interactions": 0.00106, "a6h antigen": 0.00106, "charybdotoxin inhibits": 0.00106, "authors demonstrated": 0.00106, "live hiv-1": 0.00106, "% cd30+": 0.00106, "% displacement": 0.00106, "cellular disposition": 0.00106, "otf2 interactions": 0.00106, "receptor-ligand interactions": 0.00106, "cellular sensitization": 0.00105, "% identity": 0.00105, "cooperative interactions": 0.00105, "cellular morphological": 0.00105, "cognate antigen": 0.00105, "addition spi-b": 0.00105, "crossreactions show": 0.00105, "il-2 reporters": 0.00105, "cd38 antigen": 0.00105, "hiv-1 gp120": 0.00105, "inhibits": 0.00105, "hiv-1 parasitism": 0.00105, "productive interactions": 0.00105, "cognate interactions": 0.00105, "foreign antigen": 0.00105, "heat-inactivated hiv-1": 0.00105, "synergistic interactions": 0.00105, "prostate-specific antigen": 0.00104, "cell-matrix interactions": 0.00104, "cellular permissivity": 0.00104, "cellular senescence": 0.00104, "cellular haptenation": 0.00104, "antigen receptor-stimulated": 0.00104, "cellular programme": 0.00104, "protein-protein interactions": 0.00104, "anti-early antigen": 0.00104, "il-2 immunotherapy": 0.00104, "155+/-31 %": 0.00104, "hiv-1": 0.00104, "il-2 cd28re": 0.00104, "185+/-38 %": 0.00104, "nonproductive interactions": 0.00104, "glycosylphosphatidylinositol-linked antigen": 0.00104, "heteromeric interactions": 0.00104, "cellular collaboration": 0.00104, "show": 0.00104, "antigen carriage": 0.00104, "secrete il-2": 0.00104, "antigen": 0.00103, "cd40/cd40l interactions": 0.00103, "il-2 -but": 0.00103, "factor/dna interactions": 0.00103, "% 1,25-": 0.00103, "cellular organelle": 0.00103, "monocyte-endothelial interactions": 0.00103, "neuroendocrine-immune interactions": 0.00103, "% fcs": 0.00103, "macrophage-lymphocyte interactions": 0.00103, "hormone-receptor interactions": 0.00103, "ebv-receptor interactions": 0.00103, "protein/dna interactions": 0.00103, "neuro-immuno interactions": 0.00103, "synthesize il-2": 0.00103, "cd40-cd40l interactions": 0.00103, "% mcm": 0.00103, "protein/protein interactions": 0.00103, "il-2 deprivation": 0.00103, "ligand-receptor interactions": 0.00103, "il-2 message": 0.00103, "co-operative interactions": 0.00103, "secreting il-2": 0.00103, "cellular organelles": 0.00103, "electrostatic interactions": 0.00103, "otf interactions": 0.00103, "il-2 superinduction": 0.00102, "% hcss": 0.00102, "concurrent addition": 0.00102, "il-2 teceptor": 0.00102, "il-2 nf-chi": 0.00102, "interactions": 0.00102, "moieties demonstrated": 0.00102, "20-50 %": 0.00102, "3-5 %": 0.00102, "exogeneous il-2": 0.00102, "cellular": 0.00102, "% o2": 0.00101, "il-2": 0.00101, "% wt/vol": 0.00101, "% und": 0.00101, "% v/v": 0.00101, "80-90 %": 0.00101, "35-55 %": 0.00101, "% increment": 0.00101, "addition": 0.001, "%": 0.001, "demonstrated": 0.001}